Citrus Sinensis ID: 036081
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 614 | 2.2.26 [Sep-21-2011] | |||||||
| O04086 | 625 | Probable receptor-like pr | yes | no | 0.913 | 0.897 | 0.515 | 1e-167 | |
| P93050 | 617 | Probable LRR receptor-lik | no | no | 0.895 | 0.891 | 0.391 | 1e-106 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.485 | 0.292 | 0.420 | 1e-69 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.550 | 0.327 | 0.413 | 5e-66 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.524 | 0.627 | 0.406 | 5e-65 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.530 | 0.478 | 0.406 | 8e-65 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.460 | 0.296 | 0.434 | 9e-65 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.478 | 0.450 | 0.446 | 2e-64 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.464 | 0.397 | 0.435 | 2e-64 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.511 | 0.496 | 0.413 | 5e-64 |
| >sp|O04086|Y1105_ARATH Probable receptor-like protein kinase At1g11050 OS=Arabidopsis thaliana GN=At1g11050 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 590 bits (1521), Expect = e-167, Method: Compositional matrix adjust.
Identities = 303/588 (51%), Positives = 413/588 (70%), Gaps = 27/588 (4%)
Query: 21 IDSATNSSCPLDLSYVQTYPWDRSQCLDPDGKL-----CCQTLTSLVGIGLALYLRETSM 75
+ + + +CPLD S+V T PW+ + C D CCQ+L +L+GI LA L++TS
Sbjct: 19 VAQSPSQTCPLDFSHVLTIPWNTTDCQKSDKSADSKNSCCQSLLTLIGIPLAHRLKQTSN 78
Query: 76 FQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRPSSCAGIVTTKDWRKLV 135
F+LPN S SCL++ Q L++LS++ +L + CF D QFV +CAGI TT+DW +
Sbjct: 79 FRLPNLATSISCLNNLQTKLSSLSLSSNLTSLCF-DPNQFVINNETCAGIQTTQDWVSRL 137
Query: 136 GPTSALDSDCKN-MTGFTQCSSCVEAGYKVNSQLVSIQQNSTK---CFYFAILYAAGILN 191
GP++ALDS C + +T T+C +CV AG++V QL+++ NS+ C++F + YAAGI+N
Sbjct: 138 GPSTALDSACSSGLTDLTRCDACVAAGFRVQKQLITLDGNSSHGVYCYHFVVTYAAGIVN 197
Query: 192 D--PKDEATAACILGLPLSTSGSKNSSSNDRVIKIVVALLGALLGVLLAGGLIIMYRKWY 249
P+ + +C+ L L + NS + + + + GA+ G L+ GLI +Y ++
Sbjct: 198 KKGPESDDALSCLFSLSLRSP--LNSKKKRHTVALALGITGAIFGALVIAGLICLYFRFG 255
Query: 250 KKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTL 309
K K + E S + PN+G+ WF+ EL++AT FSQKN IG+G G VYKG L
Sbjct: 256 KAVKGGEVGWEDQGS-RPKWRPNTGSIWFKIEELEKATNNFSQKNFIGRGGFGFVYKGVL 314
Query: 310 EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369
DG+++AVK++ + + +GD EF NEVEIIS ++HRNL+ LRGC + DD + +R+LVYD
Sbjct: 315 PDGSVIAVKKVIESEFQGDAEFRNEVEIISNLKHRNLVPLRGCSMVDDDSE-SQRYLVYD 373
Query: 370 FMPSGSLGDHI--SNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNIL 427
+M +G+L DH+ T+ L+WPQRK IILDVAKGLAYLHYG+KPAIYHRDIK TNIL
Sbjct: 374 YMSNGNLDDHLFPRGETTKMPLSWPQRKSIILDVAKGLAYLHYGVKPAIYHRDIKGTNIL 433
Query: 428 LDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVIL 487
LD +M+A+VADFGLAKQS EG+SHLTTRVAGT+GYLAPEYALYGQLTEKSDVYSFG+VIL
Sbjct: 434 LDVDMRARVADFGLAKQSREGESHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVIL 493
Query: 488 ELMSGRKVLETSNS---SFLLITDWAWMLANSGKVDEIFDE-FIREEGS-----RAVMER 538
E+M GRK L+ S S + LITDWAW L +GK +E ++ +REEGS + +MER
Sbjct: 494 EIMCGRKALDLSTSGSPNTFLITDWAWSLVKAGKTEEALEQSLLREEGSGLSNPKGIMER 553
Query: 539 FVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPERPLPLTHESFK 586
F++VGILCAHV+VALRPTI DALKMLEGDI++P +P+RP+PL H S++
Sbjct: 554 FLQVGILCAHVLVALRPTILDALKMLEGDIEVPPIPDRPVPLAHPSYR 601
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P93050|RKF3_ARATH Probable LRR receptor-like serine/threonine-protein kinase RKF3 OS=Arabidopsis thaliana GN=RKF3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (990), Expect = e-106, Method: Compositional matrix adjust.
Identities = 229/585 (39%), Positives = 340/585 (58%), Gaps = 35/585 (5%)
Query: 12 LLFFSTVSFIDSATNSSCPLDLSYVQTYPWDRSQCLDPDGKLCCQTLTSLVGIGLALYLR 71
++FF SF +A NS+CPLD S ++ P+ R + PDG CQ L + + + +LR
Sbjct: 9 VVFFVFTSF-SAAQNSTCPLDFSVLE--PFRRPK---PDGATTCQYLLQGLRLLYSHHLR 62
Query: 72 ETSMFQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRPSSCAGIVTTKDW 131
+T F P E+A+S C + Q ++A + + C +Q C I T +
Sbjct: 63 QTGSFLPPPESAAS-CWAALQSSVAGFLPRFDVRSTC---GFQTPWISQGCMDITTRSQF 118
Query: 132 RKLVGPTSALDSDC----KNMTGFTQCSSCVEAGYKVNSQLVSIQ-QNSTKCFYFAILYA 186
L+ P S+L + ++ T C+SC ++ L N + C F +YA
Sbjct: 119 ESLI-PNSSLATTAMRCNTSLESNTPCASCTQSLSAFQPYLSGPSLGNVSDCASFPSIYA 177
Query: 187 AGILND--PKDEATAACILGLPLSTSGSKNSSSNDRVIKIVVALLGALLGVLLAGGLIIM 244
A N P D+ TA C+ L L++ +SS +K++V+ LL +A L+I
Sbjct: 178 AAFANSLGPTDKGTAKCLFQLDLASP----TSSGANKVKVLVSSFSVLL---VASVLVIT 230
Query: 245 YRKWYKKRKRNALH-------EEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIG 297
WY +RK++ L E +S DS+ ++ F E+ +AT FS+ N+IG
Sbjct: 231 AWFWYCRRKKSKLLKPRDTSLEAGTQSRLDSMSESTTLVKFSFDEIKKATNNFSRHNIIG 290
Query: 298 QGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357
+G G V+KG L DGT VA K+ + GD F +EVE+I+ IRH NLL+LRG C ++
Sbjct: 291 RGGYGNVFKGALPDGTQVAFKRFKNCSAGGDANFAHEVEVIASIRHVNLLALRGYCTATT 350
Query: 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIY 417
+G +R +V D + +GSL DH+ L QLAWP R++I L +A+GLAYLHYG +P+I
Sbjct: 351 PYEGHQRIIVCDLVSNGSLHDHLFGDL-EAQLAWPLRQRIALGMARGLAYLHYGAQPSII 409
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKS 477
HRDIK++NILLD +AKVADFGLAK + EG +H++TRVAGT GY+APEYALYGQLTEKS
Sbjct: 410 HRDIKASNILLDERFEAKVADFGLAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQLTEKS 469
Query: 478 DVYSFGIVILELMSGRKVLETSNSSFLL-ITDWAWMLANSGKVDEIFDEFIREEGSRAVM 536
DVYSFG+V+LEL+S RK + T + + DWAW L G+ ++ ++ + E+G V+
Sbjct: 470 DVYSFGVVLLELLSRRKAIVTDEEGQPVSVADWAWSLVREGQTLDVVEDGMPEKGPPEVL 529
Query: 537 ERFVRVGILCAHVMVALRPTIADALKMLE-GDIDIPTLPERPLPL 580
E++V + +LC+H + RPT+ +KMLE + + +P+RP+PL
Sbjct: 530 EKYVLIAVLCSHPQLHARPTMDQVVKMLESNEFTVIAIPQRPIPL 574
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 130/309 (42%), Positives = 203/309 (65%), Gaps = 11/309 (3%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
F +L AT F Q N +G+G G V+KG L DGT++AVKQ++ ++G+ EF+NE+ +
Sbjct: 661 FSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGM 720
Query: 338 ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI--SNALTRKQLAWPQRK 395
IS + H NL+ L GCCV D + LVY++M + SL + N+L +L W R+
Sbjct: 721 ISGLNHPNLVKLYGCCVERD-----QLLLVYEYMENNSLALALFGQNSL---KLDWAARQ 772
Query: 396 KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR 455
KI + +A+GL +LH G + HRDIK+TN+LLD+++ AK++DFGLA+ +H++T+
Sbjct: 773 KICVGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTK 832
Query: 456 VAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR-KVLETSNSSFLLITDWAWMLA 514
VAGT GY+APEYAL+GQLTEK+DVYSFG+V +E++SG+ + N+ + + +WA L
Sbjct: 833 VAGTIGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQ 892
Query: 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLP 574
+G + EI D + E +R+ R ++V ++C + +LRPT+++A+KMLEG+I+I +
Sbjct: 893 QTGDILEIVDRMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQVM 952
Query: 575 ERPLPLTHE 583
P H+
Sbjct: 953 SDPGIYGHD 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 153/370 (41%), Positives = 216/370 (58%), Gaps = 32/370 (8%)
Query: 224 IVVALLGALLGVLLAGGLIIMYRKWYKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESEL 283
IV ++G L +++G +I + RK +RKR EE + V P + F SEL
Sbjct: 637 IVGVIVGVGLLSIISGVVIFIIRK---RRKRYTDDEEILSM---DVKPYT----FTYSEL 686
Query: 284 DQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRH 343
AT F N +G+G G VYKG L DG VAVK ++ +G +F+ E+ IS ++H
Sbjct: 687 KSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQH 746
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403
RNL+ L GCC +G+ R LVY+++P+GSL + T L W R +I L VA+
Sbjct: 747 RNLVKLYGCCY-----EGEHRLLVYEYLPNGSLDQALFGEKTL-HLDWSTRYEICLGVAR 800
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
GL YLH + I HRD+K++NILLDS++ KV+DFGLAK + ++H++TRVAGT GYL
Sbjct: 801 GLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYL 860
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR----KVLETSNSSFLLITDWAWMLANSGKV 519
APEYA+ G LTEK+DVY+FG+V LEL+SGR + LE L +WAW L G+
Sbjct: 861 APEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLL---EWAWNLHEKGRE 917
Query: 520 DEIFD----EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPE 575
E+ D EF EEG +R + + +LC ALRP ++ + ML GD+++ +
Sbjct: 918 VELIDHQLTEFNMEEG-----KRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTS 972
Query: 576 RPLPLTHESF 585
+P LT F
Sbjct: 973 KPGYLTDWRF 982
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 5e-65, Method: Compositional matrix adjust.
Identities = 144/354 (40%), Positives = 207/354 (58%), Gaps = 32/354 (9%)
Query: 230 GALLGVLLAGGLIIMYRKWY---KKRKRNALHEEFVRSFKDSVLPNS-------GAKWFR 279
GA++G+ + GG+ ++ ++ KKR R+ D LP F
Sbjct: 124 GAVVGISIGGGVFVLTLIFFLCKKKRPRD-----------DKALPAPIGLVLGIHQSTFT 172
Query: 280 ESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIIS 339
EL +AT FS+ NL+G+G G VYKG L +G VAVKQ+ +G++EF EV IIS
Sbjct: 173 YGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIIS 232
Query: 340 KIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL 399
+I HRNL+SL G C++ G +R LVY+F+P+ +L H+ + R + W R KI +
Sbjct: 233 QIHHRNLVSLVGYCIA-----GAQRLLVYEFVPNNTLEFHL-HGKGRPTMEWSLRLKIAV 286
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT 459
+KGL+YLH P I HRDIK+ NIL+D + +AKVADFGLAK +L+ +H++TRV GT
Sbjct: 287 SSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGT 346
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS-SFLLITDWAWML----A 514
+GYLAPEYA G+LTEKSDVYSFG+V+LEL++GR+ ++ +N + + DWA L
Sbjct: 347 FGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQAL 406
Query: 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568
+ + D + E R M R V C RP + +++LEG+I
Sbjct: 407 EESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNI 460
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 8e-65, Method: Compositional matrix adjust.
Identities = 140/344 (40%), Positives = 205/344 (59%), Gaps = 18/344 (5%)
Query: 239 GGLIIMY--RKWYKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLI 296
G ++++ R + R+ +++ + DS + ++ WF EL Q T GFS+KNL+
Sbjct: 286 GSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSYDELSQVTSGFSEKNLL 345
Query: 297 GQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSS 356
G+G G VYKG L DG VAVKQ+ ++G+ EF EVEIIS++ HR+L++L G C+S
Sbjct: 346 GEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISE 405
Query: 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAI 416
+ R LVYD++P+ +L H+ +A R + W R ++ A+G+AYLH P I
Sbjct: 406 -----QHRLLVYDYVPNNTLHYHL-HAPGRPVMTWETRVRVAAGAARGIAYLHEDCHPRI 459
Query: 417 YHRDIKSTNILLDSEMKAKVADFGLAK--QSLEGQSHLTTRVAGTYGYLAPEYALYGQLT 474
HRDIKS+NILLD+ +A VADFGLAK Q L+ +H++TRV GT+GY+APEYA G+L+
Sbjct: 460 IHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLS 519
Query: 475 EKSDVYSFGIVILELMSGRKVLETSNS-SFLLITDWAWMLANSGKVDEIFDEFIREEGSR 533
EK+DVYS+G+++LEL++GRK ++TS + +WA L +E FDE + +
Sbjct: 520 EKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGK 579
Query: 534 ----AVMERFVRVGILCAHVMVALRPTIAD---ALKMLEGDIDI 570
M R V C A RP ++ AL LE DI
Sbjct: 580 NFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDI 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 127/292 (43%), Positives = 188/292 (64%), Gaps = 9/292 (3%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
F ++ AT F N IG+G G VYKG L DGT++AVKQ++ +G+ EF+NE+ +
Sbjct: 612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGM 671
Query: 338 ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKK 396
IS + H NL+ L GCCV +G + LVY+F+ + SL + T+ +L WP R+K
Sbjct: 672 ISALHHPNLVKLYGCCV-----EGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRK 726
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRV 456
I + VA+GLAYLH + I HRDIK+TN+LLD ++ K++DFGLAK E +H++TR+
Sbjct: 727 ICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRI 786
Query: 457 AGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR--KVLETSNSSFLLITDWAWMLA 514
AGT+GY+APEYA+ G LT+K+DVYSFGIV LE++ GR K+ + N++F LI DW +L
Sbjct: 787 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLI-DWVEVLR 845
Query: 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566
+ E+ D + E +R +++ I+C RP++++ +KMLEG
Sbjct: 846 EKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEG 897
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 137/307 (44%), Positives = 191/307 (62%), Gaps = 13/307 (4%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
F EL +AT GFS+ NL+GQG G V+KG L G VAVKQ+ +G+ EF EVEI
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 338 ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKI 397
IS++ HR+L+SL G C++ G +R LVY+F+P+ +L H+ + R + W R KI
Sbjct: 328 ISRVHHRHLVSLIGYCMA-----GVQRLLVYEFVPNNNLEFHL-HGKGRPTMEWSTRLKI 381
Query: 398 ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457
L AKGL+YLH P I HRDIK++NIL+D + +AKVADFGLAK + + +H++TRV
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVM 441
Query: 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF-LLITDWAWMLAN- 515
GT+GYLAPEYA G+LTEKSDV+SFG+V+LEL++GR+ ++ +N + DWA L N
Sbjct: 442 GTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNR 501
Query: 516 ---SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPT 572
G + + D + E R M R V C RP ++ ++ LEG++ +
Sbjct: 502 ASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSD 561
Query: 573 LPE--RP 577
L E RP
Sbjct: 562 LNEGMRP 568
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 247 bits (630), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 129/296 (43%), Positives = 188/296 (63%), Gaps = 11/296 (3%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
F EL +AT GFS+ NL+GQG G V+KG L +G VAVKQ+ + ++G+ EF EV I
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 338 ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKI 397
IS++ HR+L++L G C++ +R LVY+F+P+ +L H+ + R + W R KI
Sbjct: 402 ISRVHHRHLVALVGYCIAD-----AQRLLVYEFVPNNTLEFHL-HGKGRPTMEWSSRLKI 455
Query: 398 ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457
+ AKGL+YLH P I HRDIK++NIL+D + +AKVADFGLAK + + +H++TRV
Sbjct: 456 AVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVM 515
Query: 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSN-SSFLLITDWAWMLANS 516
GT+GYLAPEYA G+LTEKSDV+SFG+V+LEL++GR+ ++ +N + + DWA L N
Sbjct: 516 GTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQ 575
Query: 517 ----GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568
G + + D+ + E + M R V C RP + ++LEG+I
Sbjct: 576 VSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNI 631
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (627), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 134/324 (41%), Positives = 194/324 (59%), Gaps = 10/324 (3%)
Query: 248 WYKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKG 307
W++ R+ + + + D + K + EL AT F+ KN++G+G G+VYKG
Sbjct: 260 WWRYRRNKQIFFDVNEQY-DPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKG 318
Query: 308 TLEDGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366
L DGTLVAVK++ D + G E +F EVE IS HRNLL LRG C S+ + R L
Sbjct: 319 HLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSN-----QERIL 373
Query: 367 VYDFMPSGSLGDHIS-NALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTN 425
VY +MP+GS+ + N L W +RKKI + A+GL YLH P I HRD+K+ N
Sbjct: 374 VYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAAN 433
Query: 426 ILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIV 485
ILLD + +A V DFGLAK SH+TT V GT G++APEY GQ +EK+DV+ FGI+
Sbjct: 434 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 493
Query: 486 ILELMSGRKVLETSNSSFL--LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVG 543
+LEL++G+K L+ S+ ++ DW L GK+ ++ D+ + ++ R +E V+V
Sbjct: 494 LLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVA 553
Query: 544 ILCAHVMVALRPTIADALKMLEGD 567
+LC + RP +++ +KMLEGD
Sbjct: 554 LLCTQFNPSHRPKMSEVMKMLEGD 577
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 614 | ||||||
| 224082334 | 622 | predicted protein [Populus trichocarpa] | 0.954 | 0.942 | 0.707 | 0.0 | |
| 225459647 | 612 | PREDICTED: probable receptor-like protei | 0.972 | 0.975 | 0.669 | 0.0 | |
| 356547489 | 613 | PREDICTED: probable receptor-like protei | 0.946 | 0.947 | 0.658 | 0.0 | |
| 356551236 | 603 | PREDICTED: probable receptor-like protei | 0.936 | 0.953 | 0.593 | 0.0 | |
| 255558588 | 562 | kinase, putative [Ricinus communis] gi|2 | 0.814 | 0.889 | 0.599 | 0.0 | |
| 224065114 | 652 | predicted protein [Populus trichocarpa] | 0.942 | 0.888 | 0.517 | 1e-176 | |
| 224065122 | 652 | predicted protein [Populus trichocarpa] | 0.942 | 0.888 | 0.514 | 1e-176 | |
| 225447949 | 658 | PREDICTED: probable receptor-like protei | 0.936 | 0.873 | 0.505 | 1e-173 | |
| 224079543 | 620 | predicted protein [Populus trichocarpa] | 0.908 | 0.9 | 0.523 | 1e-171 | |
| 356558471 | 642 | PREDICTED: probable receptor-like protei | 0.928 | 0.887 | 0.510 | 1e-170 |
| >gi|224082334|ref|XP_002306651.1| predicted protein [Populus trichocarpa] gi|222856100|gb|EEE93647.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2166), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/599 (70%), Positives = 492/599 (82%), Gaps = 13/599 (2%)
Query: 1 MAKSLLFSFHL-----LLFFSTVSFIDSATNSSCPLDLSYVQTYPWDRSQCLDPDG-KLC 54
M +LLFS L FF+ +SF + SSCP+DLSYVQT PWD S C PDG + C
Sbjct: 1 MGNNLLFSSSLCPCFFFFFFTILSFHPVSAASSCPVDLSYVQTVPWDTSLCRQPDGLEHC 60
Query: 55 CQTLTSLVGIGLALYLRETSMFQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQ 114
CQTL SL G+GLA LRETSMFQ PN ASS+CLSDFQ LA LSI+PSLV +CF + Q
Sbjct: 61 CQTLLSLFGMGLAQQLRETSMFQFPNLNASSACLSDFQAKLATLSIDPSLVPSCFKNSSQ 120
Query: 115 FVTRPSSCAGIVTTKDWRKLVGPTSALDSDCK-NMTGFTQCSSCVEAGYKVNSQLVSIQQ 173
FV+ SSC GIVTT+DW + VGP + L++ C+ + + T+CSSC++AG KVNSQL S+
Sbjct: 121 FVSSTSSCIGIVTTQDWIEKVGPMTPLNTACRGDFSELTRCSSCLDAGQKVNSQLTSLDP 180
Query: 174 NST---KCFYFAILYAAGILND--PKDEATAACILGLPLSTSGSKN-SSSNDRVIKIVVA 227
N+T KCFY+ LYAAGI+++ P D TAAC L LPL+ SG+K + S D+++K+V
Sbjct: 181 NATATSKCFYYTCLYAAGIVSELGPLDAKTAACTLALPLANSGTKKPAKSKDKLLKLVFG 240
Query: 228 LLGALLGVLLAGGLIIMYRKWYKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQAT 287
LLG+L+GVLLA GLI MYRKW +KRK +A HE FV SFK S+LPNSGAKWF SEL++AT
Sbjct: 241 LLGSLIGVLLAFGLITMYRKWDRKRKVSASHERFVSSFKASMLPNSGAKWFHLSELERAT 300
Query: 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL 347
GFSQ+N IGQGA G VYKGTL DGTLVAVKQ+ DLD++GDE+F NEVEIISKIRHRNLL
Sbjct: 301 QGFSQRNFIGQGAYGFVYKGTLADGTLVAVKQMHDLDSQGDEDFSNEVEIISKIRHRNLL 360
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
SLRGCCV+SD+ KGKRR++VYDFM +GSLGDH+SN +RKQL WPQRK IILDVAKGLAY
Sbjct: 361 SLRGCCVTSDNSKGKRRYIVYDFMSNGSLGDHLSNDHSRKQLTWPQRKNIILDVAKGLAY 420
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
LHYG+KPAIYHRDIK+TNILLD EMKAKVADFGLAKQSL+GQSHLTTRVAGT+GYLAPEY
Sbjct: 421 LHYGIKPAIYHRDIKATNILLDLEMKAKVADFGLAKQSLDGQSHLTTRVAGTHGYLAPEY 480
Query: 468 ALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527
ALYGQLTEKSDVYSFGIVILE+MSGRKV++TSNSSFLLITDWAW LA SGK+ EI DE I
Sbjct: 481 ALYGQLTEKSDVYSFGIVILEIMSGRKVIDTSNSSFLLITDWAWTLAKSGKLQEILDESI 540
Query: 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPERPLPLTHESFK 586
R++G +AVMERFV VGILCAHVMVA RPTIADAL+MLEGDIDIP LPERPLPL HESF+
Sbjct: 541 RDQGPKAVMERFVLVGILCAHVMVAFRPTIADALRMLEGDIDIPRLPERPLPLGHESFR 599
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225459647|ref|XP_002284588.1| PREDICTED: probable receptor-like protein kinase At1g11050 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2138), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/612 (66%), Positives = 489/612 (79%), Gaps = 15/612 (2%)
Query: 4 SLLFSFHLLLFFSTVSFIDSATNSSCPLDLSYVQTYPWDRSQCLDPDGKLCCQTLTSLVG 63
S + S L +F +DSA+ SSCP+DL YV+TYPWD S C D D CC L SL G
Sbjct: 9 SFIVSLSLFVFS-----VDSAS-SSCPIDLGYVETYPWDTSSCRDGDQDHCCMALLSLFG 62
Query: 64 IGLALYLRETSMFQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRPSSCA 123
+GLA +L+ETSMFQLP SSSCLS+ Q L+A++ PSLV+ CF + QFV SSCA
Sbjct: 63 MGLAQHLKETSMFQLPTAAVSSSCLSELQTRLSAMAFQPSLVSLCFKNSTQFVANSSSCA 122
Query: 124 GIVTTKDWRKLVGPTSALDSDCKNMTGFTQCSSCVEAGYKVNSQLVSIQQNSTKCFYFAI 183
GI+T +DW K VG +ALDS CK++TG QC SC++AG KVNSQL ++ NSTKCFYF I
Sbjct: 123 GIITKEDWIKRVGEKTALDSSCKDLTGLVQCGSCLDAGMKVNSQLRALAPNSTKCFYFTI 182
Query: 184 LYAAGILND--PKDEATAACILGLPLSTSGSKNSS---SNDRVIKIVVALLGALLGVLLA 238
LYAAGI+N+ P+D TAACILGLPLS S + +S S + + K++ LGA L VL A
Sbjct: 183 LYAAGIVNELGPQDGTTAACILGLPLSNSKTGETSNHLSQETLFKLIFGFLGAFLVVLFA 242
Query: 239 GGLIIMYRKWYKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQ 298
G +++YR W +K+K+NA HEEFV S + VLPN+GAKW+ +E+++AT GFSQKN IGQ
Sbjct: 243 LGSVVLYRIW-QKKKKNAFHEEFVSSMQARVLPNTGAKWYHIAEIERATDGFSQKNFIGQ 301
Query: 299 GASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358
GA GVV+KGTL DGTLVAVKQI DLD++GDEEF NEVEIISKIRHRNLLSLRGCCV+SDD
Sbjct: 302 GAYGVVHKGTLSDGTLVAVKQILDLDSQGDEEFSNEVEIISKIRHRNLLSLRGCCVTSDD 361
Query: 359 EKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIY 417
KGKRR+LV D+M +G+L DH+ N+ +RK+L WPQRK IILDV KGLAYLH G+KPAIY
Sbjct: 362 CKGKRRYLVCDYMLNGNLSDHLFNSSNSRKELTWPQRKNIILDVGKGLAYLHDGIKPAIY 421
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKS 477
HRDIK+TNILLD EMKAKVADFGLAKQS EGQSHLTTRVAGT+GYLAPEYALYGQLTEKS
Sbjct: 422 HRDIKTTNILLDLEMKAKVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKS 481
Query: 478 DVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVME 537
DVYSFGIVILE MSGRKVL+TS+SS +LITDWAWML SGKV+E+FD FIR+EG + VME
Sbjct: 482 DVYSFGIVILETMSGRKVLDTSSSSMVLITDWAWMLVKSGKVEEVFDNFIRKEGPKGVME 541
Query: 538 RFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPERPLPLTHESFKASPSRYSFLMT 597
RFV VGILCAHVMVA RPTIA+ALKMLEGDIDIP LP+RP PL+HE+F++S + SFL T
Sbjct: 542 RFVLVGILCAHVMVAFRPTIAEALKMLEGDIDIPRLPDRPWPLSHEAFRSSL-QCSFL-T 599
Query: 598 NERSIATSGMTS 609
NERS ++ M++
Sbjct: 600 NERSRPSTSMST 611
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547489|ref|XP_003542144.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2049), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/592 (65%), Positives = 468/592 (79%), Gaps = 11/592 (1%)
Query: 1 MAKSLLFSFHLLLFFSTVSFIDSATNSSCPLDLSYVQTYPWDRSQCLDP-DGKLCCQTLT 59
M K +LF LL+ I + ++SSCP+DL+YV+T+PWD S C DP D CCQ L
Sbjct: 1 MDKQILFLLPLLIMSLFTVSIAAESSSSCPMDLNYVETFPWDSSSCRDPVDKNHCCQVLL 60
Query: 60 SLVGIGLALYLRETSMFQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRP 119
S++GIGL+ +L++TS+FQLPNET SS+CLS+FQ L ALSI+PSLV +CFP+ QFVT
Sbjct: 61 SVIGIGLSQHLKQTSLFQLPNETISSNCLSNFQAKLTALSIDPSLVNSCFPNSSQFVTNS 120
Query: 120 SSCAGIVTTKDWRKLVGPTSALDSDCK-NMTGFTQCSSCVEAGYKVNSQLVSIQQNSTKC 178
S+CAGI+T DW++ VG S LD+ C +++ T+CS C +AG KV S L S NST+C
Sbjct: 121 STCAGIITIDDWKQKVGLISPLDTSCNGDLSDQTRCSICSDAGLKVTSGLNS---NSTRC 177
Query: 179 FYFAILYAAGILND--PKDEATAACILGLPLSTSGSKNSSSNDRVIKIVVALLGALLGVL 236
FYF ILYAA I+N P + TA+CILG+PLS GS N V+K+V+ LLGA +GVL
Sbjct: 178 FYFTILYAAAIVNQFGPTNLGTASCILGMPLSVKGSSNRG---LVLKLVIGLLGAFVGVL 234
Query: 237 LAGGLIIMYRKWYKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLI 296
LA LI++YRKW K+RK + H E ++SVLPN+GAKWF SEL++AT FSQ+N++
Sbjct: 235 LAFVLIVVYRKWDKRRKEDMHHREIESGVRNSVLPNTGAKWFHISELERATSKFSQRNML 294
Query: 297 GQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSS 356
GQG GVVYKGTL DGT+VAVK+I L+TKGDE+F EVEIISKI+HRNLL+LRGCC+SS
Sbjct: 295 GQGGDGVVYKGTLSDGTVVAVKEIFGLETKGDEDFTYEVEIISKIKHRNLLALRGCCISS 354
Query: 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAI 416
D+ KGKRRFLVYDFMP+GSL +S A + L WPQRK IILDVAKGLAYLHY +KP I
Sbjct: 355 DNVKGKRRFLVYDFMPNGSLSHQLSIAGANR-LTWPQRKNIILDVAKGLAYLHYEIKPPI 413
Query: 417 YHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEK 476
YHRDIK+TNILLDS+MKAKV+DFGLAKQ EGQSHLTTRVAGTYGYLAPEYALYGQLTEK
Sbjct: 414 YHRDIKATNILLDSKMKAKVSDFGLAKQGNEGQSHLTTRVAGTYGYLAPEYALYGQLTEK 473
Query: 477 SDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVM 536
SDVYSFGIVILE+MSGRKVL+T NSS +LITDWAW LA SG +++IFD+ IREEG VM
Sbjct: 474 SDVYSFGIVILEIMSGRKVLDTMNSSVVLITDWAWTLAKSGNMEDIFDQSIREEGPEKVM 533
Query: 537 ERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPERPLPLTHESFKAS 588
ERFV VGILCAH MVALRPTIA+ALKMLEGDIDIP LP+RP+PL HESF +S
Sbjct: 534 ERFVLVGILCAHAMVALRPTIAEALKMLEGDIDIPQLPDRPVPLGHESFPSS 585
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551236|ref|XP_003543983.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/595 (59%), Positives = 427/595 (71%), Gaps = 20/595 (3%)
Query: 5 LLFSFHLLLFFS---TVSFIDSATNSSCPLDLSYVQTYPWDRSQCLDP-DGKLCCQTLTS 60
LLF L F+ T SF SCP+DLSYV T PW+ S C DP D + CC L S
Sbjct: 9 LLFLMSLFTIFAPWITASF-------SCPIDLSYVDTIPWNTSTCKDPIDKEPCCDILLS 61
Query: 61 LVGIGLALYLRETSMFQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRPS 120
+ IGLA L++T F LPNE+ SSSCL DF L ALSI P +V CFP+ +FV S
Sbjct: 62 VFAIGLAELLKDTKTFYLPNESTSSSCLHDFNLRLQALSIPPKMVPLCFPNSTRFVFNAS 121
Query: 121 SCAGIVTTKDWRKLVGPTSALDSDCK-NMTGFTQCSSCVEAGYKVNSQLVSI--QQNSTK 177
+CAGI TT DW + VG S +D+ C ++ T+C +C EA Y+V SQL +I N+TK
Sbjct: 122 ACAGIRTTLDWTQRVGMVSPVDTFCNGDLKDKTRCKTCTEAAYQVTSQLTTIDPNANTTK 181
Query: 178 CFYFAILYAAGILND--PKDEATAACILGLPLSTSG--SKNSSSNDRVIKIVVALLGALL 233
CFY+ +LYAA ++N D +T +CILGL +SG + SS+ + V+K+ +LLG ++
Sbjct: 182 CFYYIVLYAAAVVNQFGTTDVSTTSCILGLRQPSSGVIEEGSSNTEEVLKLGFSLLGVII 241
Query: 234 GVLLAGGLIIMYRKWYKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQK 293
GV+LA I+MY+KW K+RK + H E + VLPN+GAKWF SEL AT FS +
Sbjct: 242 GVVLALLTIVMYKKWDKRRKEHVYHREIENKVRAGVLPNAGAKWFDVSELKCATNKFSPR 301
Query: 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
N++GQG GVVYKG L DG +VAVK+I DL+ KGDE+F EVEIISKI+HRNLL+LRGCC
Sbjct: 302 NVVGQGGDGVVYKGILSDGAVVAVKEIFDLEAKGDEDFCYEVEIISKIKHRNLLALRGCC 361
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
V+SD+ GKRRFLVYDFMP+GSL D + +L WPQRK IIL VA+GLAYLHY +K
Sbjct: 362 VASDNLNGKRRFLVYDFMPNGSLSDQLCFD-GANRLTWPQRKNIILGVARGLAYLHYEIK 420
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL 473
P IYHRDIK+TNILLDSEM AK+ADFGLAKQ E QSHLTT+VAGTYGY+APEYALYG+L
Sbjct: 421 PPIYHRDIKATNILLDSEMNAKLADFGLAKQGSEDQSHLTTKVAGTYGYVAPEYALYGKL 480
Query: 474 TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSR 533
TEKSDVYSFGIVILE+MSGRKVL+ NSS ITDW W L SGK EIF E IR EG
Sbjct: 481 TEKSDVYSFGIVILEIMSGRKVLDALNSSADSITDWVWTLVESGKKGEIFCESIR-EGPV 539
Query: 534 AVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPERPLPLTHESFKAS 588
VMERFV VG+LCAH +V LRPTI +ALKMLEGDI+IP LPERP+PL H SF++S
Sbjct: 540 KVMERFVLVGMLCAHGVVTLRPTIVEALKMLEGDIEIPELPERPVPLGHVSFQSS 594
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558588|ref|XP_002520319.1| kinase, putative [Ricinus communis] gi|223540538|gb|EEF42105.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/567 (59%), Positives = 397/567 (70%), Gaps = 67/567 (11%)
Query: 29 CPLDLSYVQTYPWDRSQCLDPDGKLCCQTLTSLVGIGLALYLRETSMFQLPNETASSSCL 88
CP+D SYVQT PWD S C PD CC TL SL G+GLA +LRETSMFQL N TA +SCL
Sbjct: 34 CPIDFSYVQTTPWDTSGCRKPDQGHCCVTLLSLFGMGLAQHLRETSMFQLANATAQASCL 93
Query: 89 SDFQHNLAALSINPSLVAACFPDKYQFVTRPSSCAGIVTTKDWRKLVGPTSALDSDCK-N 147
SDFQ L A+SI SLV CF + QFV SSC GI TT+DW + VGP + L + CK +
Sbjct: 94 SDFQAKLGAMSIESSLVPTCFDNPNQFVANASSCVGINTTQDWTEKVGPMTTLQTSCKGD 153
Query: 148 MTGFTQCSSCVEAGYKVNSQLVSIQQNST-KCFYFAILYAAGILND--PKDEATAACILG 204
++G TQCSSC+EAG KV SQL SI N+T KCFYF LYAA I+N+ P + +TA CILG
Sbjct: 154 VSGLTQCSSCLEAGQKVTSQLTSIDPNTTSKCFYFTCLYAAAIVNEFGPMNASTAGCILG 213
Query: 205 LPLSTSGSKNSSSNDRVIKI---VVALLGALLGVLLAGGLIIMYRKWYKKRKRNALHEEF 261
LPL+ S NSS + + K+ V +GA+LG L+A G+II YR++ KKRK NA HEE+
Sbjct: 214 LPLTGSAINNSSKSSKKDKLLKLVFGFIGAVLGALIAFGVIIWYRRYDKKRKLNASHEEY 273
Query: 262 VRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQIT 321
V SF+ SVLPNSGAKWF SEL++AT GFSQKN IGQG GVVYKGTL DGT+VAVKQ+
Sbjct: 274 VSSFRASVLPNSGAKWFHFSELERATNGFSQKNFIGQGTYGVVYKGTLADGTIVAVKQMQ 333
Query: 322 DLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS 381
D D++GDEEF NEVEIISKIRHRNLLSLRGCCV+SD +GKRR+LVYDFM +GSL DH+S
Sbjct: 334 DSDSQGDEEFSNEVEIISKIRHRNLLSLRGCCVTSDHLRGKRRYLVYDFMSNGSLSDHLS 393
Query: 382 NALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441
+ +RKQL WP RK I+LDVAKGLAYLHYG+KPAIYHRDIKSTNILLD EM
Sbjct: 394 SEHSRKQLTWPHRKNIVLDVAKGLAYLHYGIKPAIYHRDIKSTNILLDMEM--------- 444
Query: 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501
K+ V FG+ ++ LE
Sbjct: 445 ----------------------------------KAKVADFGL-------AKQSLE---- 459
Query: 502 SFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADAL 561
DWAWMLA SGK ++IFDE IRE+G + VMERFV VG+LCAHVMVA RPTIADAL
Sbjct: 460 ------DWAWMLAKSGKTEQIFDESIREQGPKGVMERFVLVGMLCAHVMVAFRPTIADAL 513
Query: 562 KMLEGDIDIPTLPERPLPLTHESFKAS 588
KMLEGDIDIP LP+RP PL+HESFK S
Sbjct: 514 KMLEGDIDIPKLPDRPTPLSHESFKPS 540
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065114|ref|XP_002301677.1| predicted protein [Populus trichocarpa] gi|222843403|gb|EEE80950.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1612), Expect = e-176, Method: Compositional matrix adjust.
Identities = 327/632 (51%), Positives = 440/632 (69%), Gaps = 53/632 (8%)
Query: 5 LLFSFHLLLFFSTVSFIDSATNSSCPLDLSYVQTYPWDRSQC--LDPDGK---------- 52
+L SF L L T + +++T++ CP+DL+YV PW+++ C +P +
Sbjct: 14 VLISFCLPL---TSAAAETSTSNICPMDLNYVLRIPWNQTLCRNFNPLAQNDNTNSTSKP 70
Query: 53 LCCQTLTSLVGIGLALYLRETSMFQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDK 112
CCQT+ SL G+ L+ +L+ETS FQLPN SSSCL D+Q L++ S++ LV+ CF +
Sbjct: 71 PCCQTILSLFGVALSQHLKETSFFQLPNLATSSSCLQDYQSKLSSFSLSDDLVSHCF-NP 129
Query: 113 YQFVTRPSSCAGIVTTKDWRKLVGPTSALDSDCK-NMTGFTQCSSCVEAGYKVNSQLVSI 171
QFVT P+ CA I T++DW +G +++LDSDC+ ++T T C SC+ AG KV S L+S
Sbjct: 130 LQFVTAPNICARIETSQDWVDQLGKSTSLDSDCRSDLTDLTACDSCLRAGNKVQSLLLSA 189
Query: 172 QQNSTK---CFYFAILYAAGILND--PKDEATAACILGLPLSTSGSKNSSSNDRVIKIVV 226
N T CFYFA+LYAAG++N+ P+ + +CI GL L+ S+ S+++ +V
Sbjct: 190 DGNQTHAQDCFYFAVLYAAGVVNEFGPESDGVVSCIFGLELN---SRVGSASNSHSALVF 246
Query: 227 ALLGALLGVLLAGGLIIMYRKWYKK---RKRNA-----LHEEFVRSFKDSVLPNSGAKWF 278
L GA + +L+ L+ +Y WY K RK+N L E+ + + + PN+G+ WF
Sbjct: 247 GLTGAGVAILVMSSLLGLYL-WYDKKWRRKKNLGFGFDLDEQ--QGSRPKLRPNTGSIWF 303
Query: 279 RESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEII 338
+ +L++AT FSQKN IG+G G VYKG L DGT+VA+K++ + D +GD EF NEVEII
Sbjct: 304 KIRDLEKATDNFSQKNFIGRGGFGFVYKGVLSDGTVVAIKRVIESDFQGDAEFCNEVEII 363
Query: 339 SKIRHRNLLSLRGCCVSSDD----EKGKRRFLVYDFMPSGSLGDHI----SNALTRKQLA 390
S ++HRNL+ LRGCCV DD E+G +R+LVYD+M +G+L DH+ N + ++ L+
Sbjct: 364 SNLKHRNLVPLRGCCVIDDDVNSDERGNQRYLVYDYMSNGNLDDHLFPSSDNQIQKQLLS 423
Query: 391 WPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450
WPQRK IILDVAKGLAYLH+G+KP IYHRDIK TNILLD+EM+A+VADFGLAKQS EGQS
Sbjct: 424 WPQRKSIILDVAKGLAYLHHGVKPGIYHRDIKGTNILLDAEMRARVADFGLAKQSREGQS 483
Query: 451 HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSS---FLLIT 507
HLTTRVAGT+GYLAPEYALYGQLTEKSDVYSFG+V+LE+MSGRK L+ S+S LLIT
Sbjct: 484 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVVLEIMSGRKALDLSSSGSPRALLIT 543
Query: 508 DWAWMLANSGKVDEIFDEFIREEGS------RAVMERFVRVGILCAHVMVALRPTIADAL 561
DWAW L +GKV++ D + G + +MERFV VGILCAH+MVALRPTI DAL
Sbjct: 544 DWAWSLVKAGKVEQALDASLLRGGDSSNSNPKGIMERFVLVGILCAHIMVALRPTILDAL 603
Query: 562 KMLEGDIDIPTLPERPLPLTHESFKASPSRYS 593
KMLEGDI++P +P+RP+PL H SF A + +S
Sbjct: 604 KMLEGDIEVPQIPDRPVPLGHPSFHADGNSFS 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065122|ref|XP_002301680.1| predicted protein [Populus trichocarpa] gi|222843406|gb|EEE80953.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1609), Expect = e-176, Method: Compositional matrix adjust.
Identities = 325/632 (51%), Positives = 440/632 (69%), Gaps = 53/632 (8%)
Query: 5 LLFSFHLLLFFSTVSFIDSATNSSCPLDLSYVQTYPWDRSQC--LDPDGK---------- 52
+L SF L L ++ +++T++ CP+DL+YV PW+++ C +P +
Sbjct: 14 VLISFCLPLTYAAA---ETSTSNICPMDLNYVLRIPWNQTLCRNFNPLAQNDNTNSTSKP 70
Query: 53 LCCQTLTSLVGIGLALYLRETSMFQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDK 112
CCQT+ SL G+ L+ +L+ETS FQLPN SSSCL D+Q L + S++ +LV+ CF +
Sbjct: 71 PCCQTILSLFGVALSQHLKETSFFQLPNLATSSSCLQDYQSKLISFSLSDNLVSHCF-NP 129
Query: 113 YQFVTRPSSCAGIVTTKDWRKLVGPTSALDSDCK-NMTGFTQCSSCVEAGYKVNSQLVSI 171
QFVT P+ CA I T++DW +G +++LDSDC+ ++T T C SC+ AG KV S L+S
Sbjct: 130 LQFVTAPNICARIETSQDWVDQLGKSTSLDSDCRSDLTDLTACDSCLRAGNKVQSLLLSA 189
Query: 172 QQNSTK---CFYFAILYAAGILND--PKDEATAACILGLPLSTSGSKNSSSNDRVIKIVV 226
N T CFYFA+LYAAG++N+ P+ + +CI GL L+ S+ S+++ +V
Sbjct: 190 DGNQTHAQDCFYFAVLYAAGVVNEFGPESDGVVSCIFGLELN---SRVGSASNSHSALVF 246
Query: 227 ALLGALLGVLLAGGLIIMYRKWYKK---RKRNA-----LHEEFVRSFKDSVLPNSGAKWF 278
L GA + +L+ L+ +Y WY K RK+N L E+ + + + PN+G+ WF
Sbjct: 247 GLTGAGVAILVISSLLGLYL-WYDKKWRRKKNLGFGFDLDEQ--QGSRPKLRPNTGSIWF 303
Query: 279 RESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEII 338
+ +L++AT FSQKN IG+G G VYKG L DGT+VA+K++ + D +GD EF NEVEII
Sbjct: 304 KIRDLEKATDNFSQKNFIGRGGFGFVYKGVLSDGTVVAIKRVIESDFQGDAEFCNEVEII 363
Query: 339 SKIRHRNLLSLRGCCVSSDD----EKGKRRFLVYDFMPSGSLGDHI----SNALTRKQLA 390
S ++HRNL+ LRGCCV DD E+G +R+LVYD+M +G+L DH+ N + ++ L+
Sbjct: 364 SNLKHRNLVPLRGCCVIDDDVNSDERGNQRYLVYDYMSNGNLDDHLFPSSDNQIQKQLLS 423
Query: 391 WPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450
WPQRK IILDVAKGLAYLH+G+KP IYHRDIK TNILLD+EM+A+VADFGLAKQS EGQS
Sbjct: 424 WPQRKSIILDVAKGLAYLHHGVKPGIYHRDIKGTNILLDAEMRARVADFGLAKQSREGQS 483
Query: 451 HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSS---FLLIT 507
HLTTRVAGT+GYLAPEYALYGQLTEKSDVYSFG+V+LE+MSGRK L+ S+S LLIT
Sbjct: 484 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVVLEIMSGRKALDLSSSGSPRALLIT 543
Query: 508 DWAWMLANSGKVDEIFDEFIREEGS------RAVMERFVRVGILCAHVMVALRPTIADAL 561
DWAW L + KV++ D + G + +MERFV VGILCAH+MVALRPTI DAL
Sbjct: 544 DWAWSLVKAAKVEQALDASLLRGGDSSNSNPKGIMERFVLVGILCAHIMVALRPTILDAL 603
Query: 562 KMLEGDIDIPTLPERPLPLTHESFKASPSRYS 593
KMLEGDI++P +P+RP+PL H SF+A + +S
Sbjct: 604 KMLEGDIEVPQIPDRPVPLGHPSFQADGNNFS 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225447949|ref|XP_002269016.1| PREDICTED: probable receptor-like protein kinase At1g11050 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1586), Expect = e-173, Method: Compositional matrix adjust.
Identities = 315/623 (50%), Positives = 421/623 (67%), Gaps = 48/623 (7%)
Query: 16 STVSFIDSATNSSCPLDLSYVQTYPWDRSQCLD---------PDGKLCCQTLTSLVGIGL 66
+T + S+ S+CP+D +YV W+ S C + CC TL SL + L
Sbjct: 24 ATTALSQSSNASACPMDFNYVLRISWNSSNCHNFVSQGNTSVNSKSSCCTTLLSLFAVSL 83
Query: 67 ALYLRETSMFQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRPSSCAGIV 126
A +L+ETS+F LP+ + S SCL DFQ L +L + +L ++CF D QFV P CAG+
Sbjct: 84 AQHLKETSLFNLPDVSTSQSCLHDFQSKLTSLPLANNLASSCF-DPQQFVIGPDICAGVQ 142
Query: 127 TTKDWRKLVGPTSALDSDCK-NMTGFTQCSSCVEAGYKVNSQLVSIQQN---STKCFYFA 182
DW +GP++ALDS C+ ++T T C +CV AG++V S+L+ I N ST CFYF
Sbjct: 143 NISDWVAKLGPSTALDSSCRADLTDLTACDACVNAGFEVQSKLIEIDGNKSHSTDCFYFT 202
Query: 183 ILYAAGILNDPKDEATAA--CILGLPLSTSGSKNSSSNDRVIKIVVALLGALLGVLLAGG 240
+LYAAGI+N+ E+T A C+L +PL++ +S S+ +I GA + VL+
Sbjct: 203 VLYAAGIVNEAGPESTGAMSCVLAVPLNSDEGSSSKSHSALI---FGFTGAGVAVLVMSC 259
Query: 241 LIIMY----RKWYKKRKRNA-----LHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFS 291
L+ +Y RKW KK KR+ + E + + V PN+G+ WF+ +L++AT FS
Sbjct: 260 LLGLYFWWERKWGKKSKRSGSGFFGVDLEDLGGSRPRVRPNTGSIWFKIPDLERATDNFS 319
Query: 292 QKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
QKN IG+G G+VYKGTL DG+ VAVK+I + D + D +F NE+EIIS ++HRNL+ LRG
Sbjct: 320 QKNFIGRGGFGLVYKGTLADGSTVAVKKIIESDIQVDADFCNEIEIISNLKHRNLVPLRG 379
Query: 352 CCVSSD----DEKGKRRFLVYDFMPSGSLGDHI--------SNALTRKQLAWPQRKKIIL 399
CCV D++ R+LVYD+MP+G+L DH+ N + +K L WPQRK IIL
Sbjct: 380 CCVVDGGEGYDDRASPRYLVYDYMPNGNLDDHLFSKWENGNGNGMGKKPLTWPQRKSIIL 439
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT 459
DVAKGLAYLHYG+KPAIYHRDIK+TNILLD++M+A+VADFGLAKQS EGQSHLTTRVAGT
Sbjct: 440 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 499
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSS--FLLITDWAWMLANSG 517
+GYLAPEYALYGQLTEKSDVYSFG+V+LE+M GRK L+ S+ S LITDWAW + +G
Sbjct: 500 HGYLAPEYALYGQLTEKSDVYSFGVVVLEIMCGRKALDLSSRSPRAFLITDWAWSMVKAG 559
Query: 518 KVDEIFDEFIREEGS------RAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIP 571
K +E D + ++G +A+MERF+ VGILCAHVMVALRPTI+DALKMLEGD+++P
Sbjct: 560 KAEEALDASLVKDGDSSNSNPKAIMERFLLVGILCAHVMVALRPTISDALKMLEGDVEVP 619
Query: 572 TLPERPLPLTHESFKASPSRYSF 594
+P+RP+PL H SF + +S
Sbjct: 620 AIPDRPVPLGHPSFLTDGNTFSI 642
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224079543|ref|XP_002305887.1| predicted protein [Populus trichocarpa] gi|222848851|gb|EEE86398.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 317/605 (52%), Positives = 417/605 (68%), Gaps = 47/605 (7%)
Query: 31 LDLSYVQTYPWDRSQCLD---PDGK---------LCCQTLTSLVGIGLALYLRETSMFQL 78
+D SYV PW+RS C + PD CCQ+L SL G+ +A +L+ETS+F+L
Sbjct: 1 MDFSYVLRIPWNRSLCQNFQPPDENDNTNTTSKPQCCQSLLSLFGVAVAQHLKETSLFRL 60
Query: 79 PNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRPSSCAGIVTTKDWRKLVGPT 138
PN S+SCL D+Q L + S+ +LV+ C D QFVT+P+ CA I + +DW +G +
Sbjct: 61 PNLATSNSCLRDYQSKLNSFSLANNLVSYCL-DPLQFVTKPNICARIQSLQDWVARLGKS 119
Query: 139 SALDSDCK-NMTGFTQCSSCVEAGYKVNSQLVSI---QQNSTKCFYFAILYAAGILND-- 192
++LD+ CK ++T T C CV AGYKV S L+SI Q ++T CFYFAILYAAGI+N+
Sbjct: 120 TSLDTACKSDLTDNTACDGCVRAGYKVQSTLLSIDSNQTHATSCFYFAILYAAGIVNEFG 179
Query: 193 PKDEATAACILGLPLSTSGSKNSSSNDRVIKIVVALLGALLGVLLAGGLIIMYRKWYKKR 252
P+ + +CILGL L+ S+ S++ +V L GA + +L+ L+ +Y WY K+
Sbjct: 180 PESDGAVSCILGLELN---SRVGSASKAHSALVFGLTGAGVALLVMFSLLGLYF-WYDKK 235
Query: 253 KRNALHEEF------VRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYK 306
R + F + + + PN+G+ WF+ +L++AT FSQ N IG+G G VYK
Sbjct: 236 WRRKKNSGFGFDLDEQQGSRPKLRPNTGSIWFKIQDLEKATHNFSQNNFIGRGGFGFVYK 295
Query: 307 GTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-----EKG 361
GTL DGT+VA+K++ + D +G EF NEVEIIS ++HRNL+ LRGCCV DD E+G
Sbjct: 296 GTLSDGTVVAIKRVIESDFQGAAEFCNEVEIISNLKHRNLVPLRGCCVIDDDDGNNDERG 355
Query: 362 KRRFLVYDFMPSGSLGDHI----SNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIY 417
+R+LVYD+M +G+L DH+ N + ++ L+WPQRK IILDVAKGLAYLHYG+KPAIY
Sbjct: 356 NQRYLVYDYMSNGNLDDHLFPSSGNQIGKQPLSWPQRKSIILDVAKGLAYLHYGVKPAIY 415
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKS 477
HRDIK TNILLD++M+A+VADFGL KQS EGQSHLTTRVAGT+GYLAPEYALYGQLTEKS
Sbjct: 416 HRDIKGTNILLDADMRARVADFGLVKQSKEGQSHLTTRVAGTHGYLAPEYALYGQLTEKS 475
Query: 478 DVYSFGIVILELMSGRKVLETSNSS---FLLITDWAWMLANSGKVDEIFDEFIREEGS-- 532
DVYSFG+V+LE+M GRK L+ S+ LLITDWAW L +GKV+E D + G
Sbjct: 476 DVYSFGVVVLEIMCGRKALDLSSGGSPRALLITDWAWSLVKAGKVEEALDASLLRCGDSS 535
Query: 533 ----RAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPERPLPLTHESFKAS 588
+ +MERFV VGILCAHVMVALRPTI ALKMLEGDI++P +P+RP+PL H SF A
Sbjct: 536 NSNPKGIMERFVLVGILCAHVMVALRPTILVALKMLEGDIEVPPIPDRPMPLGHPSFHAD 595
Query: 589 PSRYS 593
+ +S
Sbjct: 596 GNNFS 600
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558471|ref|XP_003547530.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1563), Expect = e-170, Method: Compositional matrix adjust.
Identities = 314/615 (51%), Positives = 415/615 (67%), Gaps = 45/615 (7%)
Query: 11 LLLFFSTVSFIDSATNSSCPLDLSYVQTYPWDRSQCLD----------PDGKLCCQTLTS 60
L L F+ S SA ++CP+DL+YV PW+ S C + D CC +L S
Sbjct: 4 LPLMFALFSCTSSANTTTCPMDLNYVLRIPWNTSACHNFQQTLAAKNGTDANTCCISLLS 63
Query: 61 LVGIGLALYLRETSMFQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRPS 120
L GIGLA +L+ETS FQLPN S SC+ DFQ L++LS+ +L CF D QFV P+
Sbjct: 64 LFGIGLAQHLKETSQFQLPNLATSLSCIQDFQLKLSSLSLPSNLADTCF-DPLQFVISPN 122
Query: 121 SCAGIVTTKDWRKLVGPTSALDSDCK-NMTGFTQCSSCVEAGYKVNSQLVSIQQN---ST 176
CAGI T DW K +G ++ L++ CK ++T + C C++AG + L+SI N S
Sbjct: 123 ICAGIQTIPDWTKKLGQSTPLNTACKSDLTDISLCDVCLQAGLQAKQVLISIDGNASHSI 182
Query: 177 KCFYFAILYAAGILND--PKDEATAACILGLPLSTSGSKNSSSNDRVIKIVVALLGALLG 234
CFYFAILYAAG++N+ P+ +CI + + + G + +V L GA +
Sbjct: 183 DCFYFAILYAAGVVNEFGPESNGAVSCIFSISVYSQGGSGGKGHQ---ALVFGLTGAGIA 239
Query: 235 VLLAGGLIIMYRKWYKKRKRNALHEEFVRSF-------KDSVLPNSGAKWFRESELDQAT 287
+L+ + +Y WY ++ R E F F + + PN+G+ WF+ EL++AT
Sbjct: 240 LLVMSSFLGIY-AWYDRKHRRKKLETFQFDFDPEEQGSRPRLRPNTGSIWFKIEELEKAT 298
Query: 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL 347
FS KN IG+G G+V+KGTL DGT+V VK+I + D +GD EF NEVEIIS ++HRNL+
Sbjct: 299 DNFSSKNFIGRGGFGMVFKGTLSDGTVVGVKRILESDFQGDAEFCNEVEIISNLKHRNLV 358
Query: 348 SLRGCCVSSD----DEKGKRRFLVYDFMPSGSLGDHI----SNALTRKQLAWPQRKKIIL 399
LRGCCV+ + DE+G +R+LVYD+MP+G+L DH+ + + L WPQRK IIL
Sbjct: 359 PLRGCCVAEENENYDERGSQRYLVYDYMPNGNLEDHLFLSTDSQKAKGSLTWPQRKSIIL 418
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT 459
DVAKGLAYLHYG+KPAI+HRDIK+TNILLD++M+A+VADFGLAKQS EGQSHLTTRVAGT
Sbjct: 419 DVAKGLAYLHYGVKPAIFHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 478
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSS---FLLITDWAWMLANS 516
+GYLAPEYALYGQLTEKSDVYSFG+V LE+M GRK L+ S+S LITDWAW L +
Sbjct: 479 HGYLAPEYALYGQLTEKSDVYSFGVVALEIMCGRKALDLSSSGSPRAFLITDWAWSLVKA 538
Query: 517 GKVDEIFDEFIREE------GSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDI 570
GK++E D F+ ++ +++MERF+ VGILC+HVMVALRPTIADALKMLEGDI++
Sbjct: 539 GKIEEALDAFLVKDENFPSSNPKSIMERFLLVGILCSHVMVALRPTIADALKMLEGDIEV 598
Query: 571 PTLPERPLPLTHESF 585
P +P+RP+PL H SF
Sbjct: 599 PQIPDRPMPLGHPSF 613
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 614 | ||||||
| TAIR|locus:2197414 | 625 | AT1G11050 [Arabidopsis thalian | 0.913 | 0.897 | 0.5 | 8.8e-150 | |
| TAIR|locus:2066390 | 617 | RKF3 "receptor-like kinase in | 0.889 | 0.884 | 0.383 | 1e-93 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.477 | 0.302 | 0.440 | 1.1e-63 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.475 | 0.270 | 0.450 | 7.3e-63 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.511 | 0.496 | 0.419 | 1.3e-61 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.555 | 0.325 | 0.408 | 2.7e-61 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.501 | 0.452 | 0.417 | 4.3e-61 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.475 | 0.306 | 0.425 | 1.1e-60 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.485 | 0.353 | 0.414 | 1.5e-60 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.477 | 0.449 | 0.444 | 2.4e-60 |
| TAIR|locus:2197414 AT1G11050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1462 (519.7 bits), Expect = 8.8e-150, P = 8.8e-150
Identities = 294/588 (50%), Positives = 399/588 (67%)
Query: 21 IDSATNSSCPLDLSYVQTYPWDRSQCLDPDGKL-----CCQTLTSLVGIGLALYLRETSM 75
+ + + +CPLD S+V T PW+ + C D CCQ+L +L+GI LA L++TS
Sbjct: 19 VAQSPSQTCPLDFSHVLTIPWNTTDCQKSDKSADSKNSCCQSLLTLIGIPLAHRLKQTSN 78
Query: 76 FQLPNETASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRPSSCAGIVTTKDWRKLV 135
F+LPN S SCL++ Q L++LS++ +L + CF D QFV +CAGI TT+DW +
Sbjct: 79 FRLPNLATSISCLNNLQTKLSSLSLSSNLTSLCF-DPNQFVINNETCAGIQTTQDWVSRL 137
Query: 136 GPTSALDSDCKN-MTGFTQCSSCVEAGYKVNSQLVSIQQNSTK---CFYFAILYAAGILN 191
GP++ALDS C + +T T+C +CV AG++V QL+++ NS+ C++F + YAAGI+N
Sbjct: 138 GPSTALDSACSSGLTDLTRCDACVAAGFRVQKQLITLDGNSSHGVYCYHFVVTYAAGIVN 197
Query: 192 D--PKDEATAACILGLPLXXXXXXXXXXNDRVIKXXXXXXXXXXXXXXXXXXXXMYRKWY 249
P+ + +C+ L L + + +Y ++
Sbjct: 198 KKGPESDDALSCLFSLSLRSPLNSKKKRH--TVALALGITGAIFGALVIAGLICLYFRFG 255
Query: 250 KKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTL 309
K K + E S + PN+G+ WF+ EL++AT FSQKN IG+G G VYKG L
Sbjct: 256 KAVKGGEVGWEDQGS-RPKWRPNTGSIWFKIEELEKATNNFSQKNFIGRGGFGFVYKGVL 314
Query: 310 EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369
DG+++AVK++ + + +GD EF NEVEIIS ++HRNL+ LRGC + DD + +R +LVYD
Sbjct: 315 PDGSVIAVKKVIESEFQGDAEFRNEVEIISNLKHRNLVPLRGCSMVDDDSESQR-YLVYD 373
Query: 370 FMPSGSLGDHI--SNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNIL 427
+M +G+L DH+ T+ L+WPQRK IILDVAKGLAYLHYG+KPAIYHRDIK TNIL
Sbjct: 374 YMSNGNLDDHLFPRGETTKMPLSWPQRKSIILDVAKGLAYLHYGVKPAIYHRDIKGTNIL 433
Query: 428 LDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVIL 487
LD +M+A+VADFGLAKQS EG+SHLTTRVAGT+GYLAPEYALYGQLTEKSDVYSFG+VIL
Sbjct: 434 LDVDMRARVADFGLAKQSREGESHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVIL 493
Query: 488 ELMSGRKVLETSNS---SFLLITDWAWMLANSGKVDEIFDE-FIREEGS-----RAVMER 538
E+M GRK L+ S S + LITDWAW L +GK +E ++ +REEGS + +MER
Sbjct: 494 EIMCGRKALDLSTSGSPNTFLITDWAWSLVKAGKTEEALEQSLLREEGSGLSNPKGIMER 553
Query: 539 FVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPERPLPLTHESFK 586
F++VGILCAHV+VALRPTI DALKMLEGDI++P +P+RP+PL H S++
Sbjct: 554 FLQVGILCAHVLVALRPTILDALKMLEGDIEVPPIPDRPVPLAHPSYR 601
|
|
| TAIR|locus:2066390 RKF3 "receptor-like kinase in in flowers 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 1.0e-93, P = 1.0e-93
Identities = 218/568 (38%), Positives = 318/568 (55%)
Query: 23 SATNSSCPLDLSYVQTYPWDRSQCLDPDGKLCCQTLTSLVGIGLALYLRETSMFQLPNET 82
+A NS+CPLD S ++ P+ R + PDG CQ L + + + +LR+T F P E+
Sbjct: 19 AAQNSTCPLDFSVLE--PFRRPK---PDGATTCQYLLQGLRLLYSHHLRQTGSFLPPPES 73
Query: 83 ASSSCLSDFQHNLAALSINPSLVAACFPDKYQFVTRPSSCAGIVTTKDWRKLVGPTSALD 142
A+S C + Q ++A + + C +Q C I T + L+ P S+L
Sbjct: 74 AAS-CWAALQSSVAGFLPRFDVRSTC---GFQTPWISQGCMDITTRSQFESLI-PNSSLA 128
Query: 143 SD---CK-NMTGFTQCSSCVEAGYKVNSQLVSIQQ-NSTKCFYFAILYAAGILND--PKD 195
+ C ++ T C+SC ++ L N + C F +YAA N P D
Sbjct: 129 TTAMRCNTSLESNTPCASCTQSLSAFQPYLSGPSLGNVSDCASFPSIYAAAFANSLGPTD 188
Query: 196 EATAACILGLPLXXXXXXXXXXNDRVIKXXXXXXXXXXXXXXXXXXXXMYRKWYKKRK-R 254
+ TA C+ L L +V+ RK K K R
Sbjct: 189 KGTAKCLFQLDLASPTSSGAN-KVKVLVSSFSVLLVASVLVITAWFWYCRRKKSKLLKPR 247
Query: 255 NALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTL 314
+ E +S DS+ ++ F E+ +AT FS+ N+IG+G G V+KG L DGT
Sbjct: 248 DTSLEAGTQSRLDSMSESTTLVKFSFDEIKKATNNFSRHNIIGRGGYGNVFKGALPDGTQ 307
Query: 315 VAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSG 374
VA K+ + GD F +EVE+I+ IRH NLL+LRG C ++ +G +R +V D + +G
Sbjct: 308 VAFKRFKNCSAGGDANFAHEVEVIASIRHVNLLALRGYCTATTPYEGHQRIIVCDLVSNG 367
Query: 375 SLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA 434
SL DH+ L QLAWP R++I L +A+GLAYLHYG +P+I HRDIK++NILLD +A
Sbjct: 368 SLHDHLFGDL-EAQLAWPLRQRIALGMARGLAYLHYGAQPSIIHRDIKASNILLDERFEA 426
Query: 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK 494
KVADFGLAK + EG +H++TRVAGT GY+APEYALYGQLTEKSDVYSFG+V+LEL+S RK
Sbjct: 427 KVADFGLAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQLTEKSDVYSFGVVLLELLSRRK 486
Query: 495 VLETSNSSF-LLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL 553
+ T + + DWAW L G+ ++ ++ + E+G V+E++V + +LC+H +
Sbjct: 487 AIVTDEEGQPVSVADWAWSLVREGQTLDVVEDGMPEKGPPEVLEKYVLIAVLCSHPQLHA 546
Query: 554 RPTIADALKMLEG-DIDIPTLPERPLPL 580
RPT+ +KMLE + + +P+RP+PL
Sbjct: 547 RPTMDQVVKMLESNEFTVIAIPQRPIPL 574
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 638 (229.6 bits), Expect = 1.1e-63, Sum P(2) = 1.1e-63
Identities = 134/304 (44%), Positives = 195/304 (64%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
F +L AT F N IG+G G VYKG L DGTL+AVK+++ +G++EF+NE+ +
Sbjct: 628 FSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNEIGM 687
Query: 338 ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKI 397
I+ ++H NL+ L GCCV EK + LVY+++ + L D + + +L W R KI
Sbjct: 688 IACLQHPNLVKLYGCCV----EKNQL-LLVYEYLENNCLSDALFAGRSCLKLEWGTRHKI 742
Query: 398 ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457
L +A+GLA+LH I HRDIK TN+LLD ++ +K++DFGLA+ + QSH+TTRVA
Sbjct: 743 CLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVA 802
Query: 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLE-TSNSSFLL-ITDWAWMLAN 515
GT GY+APEYA+ G LTEK+DVYSFG+V +E++SG+ + T + + + DWA++L
Sbjct: 803 GTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDDECCVGLLDWAFVLQK 862
Query: 516 SGKVDEIFDEFIREEGSRAVME--RFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTL 573
G + EI D R EG VME R ++V +LCA+ LRP ++ +KMLEG+ +I +
Sbjct: 863 KGDIAEILDP--RLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGETEIEQI 920
Query: 574 PERP 577
P
Sbjct: 921 ISDP 924
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 636 (228.9 bits), Expect = 7.3e-63, Sum P(2) = 7.3e-63
Identities = 137/304 (45%), Positives = 195/304 (64%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
F +L AT F+ N IG+G G VYKG L +GTL+AVK+++ +G++EFINE+ I
Sbjct: 665 FSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGI 724
Query: 338 ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKI 397
I+ ++H NL+ L GCCV EK + LVY+++ + L D + K L W R KI
Sbjct: 725 IACLQHPNLVKLYGCCV----EK-TQLLLVYEYLENNCLADALFGRSGLK-LDWRTRHKI 778
Query: 398 ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457
L +A+GLA+LH I HRDIK TNILLD ++ +K++DFGLA+ + QSH+TTRVA
Sbjct: 779 CLGIARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVA 838
Query: 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETS--NSSFLLITDWAWMLAN 515
GT GY+APEYA+ G LTEK+DVYSFG+V +E++SG+ + N + + DWA++L
Sbjct: 839 GTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQK 898
Query: 516 SGKVDEIFDEFIREEGSRAVME--RFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTL 573
G DEI D + EG VME R ++V +LC+ LRPT+++ +KMLEG+ +I +
Sbjct: 899 KGAFDEILDPKL--EGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEIEEI 956
Query: 574 PERP 577
P
Sbjct: 957 ISDP 960
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 136/324 (41%), Positives = 195/324 (60%)
Query: 248 WYKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKG 307
W++ R+ + + + D + K + EL AT F+ KN++G+G G+VYKG
Sbjct: 260 WWRYRRNKQIFFDVNEQY-DPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKG 318
Query: 308 TLEDGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366
L DGTLVAVK++ D + G E +F EVE IS HRNLL LRG C SS+ E R L
Sbjct: 319 HLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFC-SSNQE----RIL 373
Query: 367 VYDFMPSGSLGDHIS-NALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTN 425
VY +MP+GS+ + N L W +RKKI + A+GL YLH P I HRD+K+ N
Sbjct: 374 VYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAAN 433
Query: 426 ILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIV 485
ILLD + +A V DFGLAK SH+TT V GT G++APEY GQ +EK+DV+ FGI+
Sbjct: 434 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 493
Query: 486 ILELMSGRKVLETSNSSFL--LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVG 543
+LEL++G+K L+ S+ ++ DW L GK+ ++ D+ + ++ R +E V+V
Sbjct: 494 LLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVA 553
Query: 544 ILCAHVMVALRPTIADALKMLEGD 567
+LC + RP +++ +KMLEGD
Sbjct: 554 LLCTQFNPSHRPKMSEVMKMLEGD 577
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 2.7e-61, P = 2.7e-61
Identities = 147/360 (40%), Positives = 209/360 (58%)
Query: 250 KKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTL 309
+KR++ +E + S V P + F SEL AT F N +G+G G VYKG L
Sbjct: 676 RKRRKPYTDDEEILSM--DVKPYT----FTYSELKNATQDFDLSNKLGEGGFGAVYKGNL 729
Query: 310 EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369
DG VAVKQ++ +G +F+ E+ IS + HRNL+ L GCC D R LVY+
Sbjct: 730 NDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGD-----HRLLVYE 784
Query: 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429
++P+GSL + + L W R +I L VA+GL YLH I HRD+K++NILLD
Sbjct: 785 YLPNGSLDQALFGDKSL-HLDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLD 843
Query: 430 SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILEL 489
SE+ KV+DFGLAK + ++H++TRVAGT GYLAPEYA+ G LTEK+DVY+FG+V LEL
Sbjct: 844 SELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALEL 903
Query: 490 MSGRKVLETS---NSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILC 546
+SGRK + + +LL +WAW L + E+ D+ + E V +R + + +LC
Sbjct: 904 VSGRKNSDENLEEGKKYLL--EWAWNLHEKNRDVELIDDELSEYNMEEV-KRMIGIALLC 960
Query: 547 AHVMVALRPTIADALKMLEGDIDIPTLPERPLPLTHESFK-ASPSRYSFLMTNERSIATS 605
ALRP ++ + ML GD ++ +P LT +F + S +S T + S +TS
Sbjct: 961 TQSSYALRPPMSRVVAMLSGDAEVNDATSKPGYLTDCTFDDTTSSSFSNFQTKDTSFSTS 1020
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 4.3e-61, P = 4.3e-61
Identities = 134/321 (41%), Positives = 198/321 (61%)
Query: 252 RKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTLED 311
+ R+ +++ + DS + ++ WF EL Q T GFS+KNL+G+G G VYKG L D
Sbjct: 301 KMRSHSGSDYMYASSDSGMVSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSD 360
Query: 312 GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371
G VAVKQ+ ++G+ EF EVEIIS++ HR+L++L G C+S + R LVYD++
Sbjct: 361 GREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISE-----QHRLLVYDYV 415
Query: 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE 431
P+ +L H+ +A R + W R ++ A+G+AYLH P I HRDIKS+NILLD+
Sbjct: 416 PNNTLHYHL-HAPGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNS 474
Query: 432 MKAKVADFGLAK--QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILEL 489
+A VADFGLAK Q L+ +H++TRV GT+GY+APEYA G+L+EK+DVYS+G+++LEL
Sbjct: 475 FEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLEL 534
Query: 490 MSGRKVLETSNS-SFLLITDWAWMLANSGKVDEIFDEFIREE-GSRAV---MERFVRVGI 544
++GRK ++TS + +WA L +E FDE + G + M R V
Sbjct: 535 ITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAA 594
Query: 545 LCAHVMVALRPTIADALKMLE 565
C A RP ++ ++ L+
Sbjct: 595 ACVRHSAAKRPKMSQVVRALD 615
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 626 (225.4 bits), Expect = 1.1e-60, P = 1.1e-60
Identities = 129/303 (42%), Positives = 193/303 (63%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
F ++ AT F N IG+G G VYKG L DGT++AVKQ++ +G+ EF+NE+ +
Sbjct: 612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGM 671
Query: 338 ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKK 396
IS + H NL+ L GCCV +G + LVY+F+ + SL + T+ +L WP R+K
Sbjct: 672 ISALHHPNLVKLYGCCV-----EGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRK 726
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRV 456
I + VA+GLAYLH + I HRDIK+TN+LLD ++ K++DFGLAK E +H++TR+
Sbjct: 727 ICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRI 786
Query: 457 AGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR--KVLETSNSSFLLITDWAWMLA 514
AGT+GY+APEYA+ G LT+K+DVYSFGIV LE++ GR K+ + N++F LI DW +L
Sbjct: 787 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLI-DWVEVLR 845
Query: 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD--IDIPT 572
+ E+ D + E +R +++ I+C RP++++ +KMLEG +++
Sbjct: 846 EKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEK 905
Query: 573 LPE 575
L E
Sbjct: 906 LEE 908
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 596 (214.9 bits), Expect = 1.5e-60, Sum P(2) = 1.5e-60
Identities = 129/311 (41%), Positives = 190/311 (61%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
F + ATG F+++N +GQG G VYKG +G +AVK+++ +G EEF NE+ +
Sbjct: 513 FSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILL 572
Query: 338 ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKI 397
I+K++HRNL+ L GCC+ D+EK L+Y++MP+ SL + + + L W +R ++
Sbjct: 573 IAKLQHRNLVRLLGCCIE-DNEK----MLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEV 627
Query: 398 ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT-RV 456
I +A+GL YLH + I HRD+K++NILLD+EM K++DFG+A+ Q H T RV
Sbjct: 628 IGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRV 687
Query: 457 AGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516
GTYGY+APEYA+ G +EKSDVYSFG++ILE++SGRK + + + +AW L +
Sbjct: 688 VGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQ 747
Query: 517 GKVDEIFDEFIREEGSRAVME--RFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLP 574
GK E+ D +++ +R V E R + VG+LC V RP + L MLE P
Sbjct: 748 GKTKEMIDPIVKD--TRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPP 805
Query: 575 ERPLPLTHESF 585
+P T SF
Sbjct: 806 RQP---TFHSF 813
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 618 (222.6 bits), Expect = 2.4e-60, P = 2.4e-60
Identities = 137/308 (44%), Positives = 194/308 (62%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
F EL +AT GFS+ NL+GQG G V+KG L G VAVKQ+ +G+ EF EVEI
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 338 ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKI 397
IS++ HR+L+SL G C++ G +R LVY+F+P+ +L H+ + R + W R KI
Sbjct: 328 ISRVHHRHLVSLIGYCMA-----GVQRLLVYEFVPNNNLEFHL-HGKGRPTMEWSTRLKI 381
Query: 398 ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457
L AKGL+YLH P I HRDIK++NIL+D + +AKVADFGLAK + + +H++TRV
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVM 441
Query: 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LITDWAWMLAN 515
GT+GYLAPEYA G+LTEKSDV+SFG+V+LEL++GR+ ++ +N+ ++ + DWA L N
Sbjct: 442 GTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVD-ANNVYVDDSLVDWARPLLN 500
Query: 516 ----SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIP 571
G + + D + E R M R V C RP ++ ++ LEG++ +
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLS 560
Query: 572 TLPE--RP 577
L E RP
Sbjct: 561 DLNEGMRP 568
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O04086 | Y1105_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5153 | 0.9136 | 0.8976 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 614 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 5e-51
Identities = 74/206 (35%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G+G G VY + G VA+K I + + EE + E+EI+ K+ H N++ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
E +LV ++ GSL D + +L+ + +I+L + +GL YLH
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLH---S 110
Query: 414 PAIYHRDIKSTNILLDS-EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL-YG 471
I HRD+K NILLDS K K+ADFGL+K +S L T V GT Y+APE L G
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKG 169
Query: 472 QLTEKSDVYSFGIVILELMSGRKVLE 497
+EKSD++S G+++ EL + ++
Sbjct: 170 YYSEKSDIWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 75/202 (37%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
+G G+ G VYK G +VAVK + +K D+ E+ I+ ++ H N++ L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
D +LV ++ G L D++S L+ + KKI L + +GL YLH
Sbjct: 67 FEDKD-----HLYLVMEYCEGGDLFDYLSR---GGPLSEDEAKKIALQILRGLEYLH--- 115
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ 472
I HRD+K NILLD K+ADFGLAK+ L+ S LTT V GT Y+APE L G
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGN 174
Query: 473 L-TEKSDVYSFGIVILELMSGR 493
K DV+S G+++ EL++G+
Sbjct: 175 GYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLL 347
+ +G+G+ G VY + G LVA+K I K E + E++I+ K++H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
L D +LV ++ G L D + R +L+ + + + + L Y
Sbjct: 61 RLYDVFEDEDK-----LYLVMEYCEGGDLFDLLKK---RGRLSEDEARFYLRQILSALEY 112
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
LH I HRD+K NILLD + K+ADFGLA+Q L+ LTT V GT Y+APE
Sbjct: 113 LH-SKG--IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEV 167
Query: 468 ALYGQLTEKSDVYSFGIVILELMSGR 493
L + D++S G+++ EL++G+
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-45
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 296 IGQGASGVVYKGTLED-----GTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G+GA G VYKG L+ VAVK + D + EEF+ E I+ K+ H N++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G C + + ++V ++M G L ++ R +L+ L +A+G+ YL
Sbjct: 67 LGVCT-----EEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE 119
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
K I HRD+ + N L+ + K++DFGL++ + + ++APE
Sbjct: 120 --SKNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 470 YGQLTEKSDVYSFGIVILELMS 491
G+ T KSDV+SFG+++ E+ +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-43
Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 21/206 (10%)
Query: 296 IGQGASGVVYKGTL-----EDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLSL 349
+G+GA G VYKGTL T VAVK + + ++ + EEF+ E I+ K+ H N++ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G C +G+ ++V ++MP G L D + ++L ++ L +AKG+ YL
Sbjct: 67 LGVCT-----QGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG---YLAPE 466
K + HRD+ + N L+ + K++DFGL++ E + G ++APE
Sbjct: 120 --SKNFV-HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPE 174
Query: 467 YALYGQLTEKSDVYSFGIVILELMSG 492
G+ T KSDV+SFG+++ E+ +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 28/214 (13%)
Query: 294 NLIGQGASGVVYKGTLEDG----TLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLS 348
+G+GA G VYKG L+ T VAVK + + ++ + ++F+ E ++ K+ H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNA------LTRKQLAWPQRKKIILDVA 402
L G C + +LV ++M G L D++ + + L+ + +A
Sbjct: 61 LLGVCTEEE-----PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR-----VA 457
KG+ YL HRD+ + N L+ ++ K++DFGL++ + + +
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
++APE G T KSDV+SFG+++ E+ +
Sbjct: 173 ----WMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 296 IGQGASGVVYKGTLEDG-----TLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G+GA G VYKGTL+ VAVK + D + EEF+ E I+ K+ H N++ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G C + +V ++MP G L D++ K+L+ L +A+G+ YL
Sbjct: 67 LGVCTEEE-----PLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE 120
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
K I HRD+ + N L+ + K++DFGL++ + + ++APE
Sbjct: 121 --SKNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 470 YGQLTEKSDVYSFGIVILELMS 491
G+ T KSDV+SFG+++ E+ +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 26/273 (9%)
Query: 294 NLIGQGASGVVYKGTLED-GTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
L+G+G+ G VY +D G L+AVK + + + E E+ I+S ++H N++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
G DE+ + +++ GSL + +L P +K + +GLAYLH
Sbjct: 66 GSER---DEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLH- 118
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR-VAGTYGYLAPEYAL 469
I HRDIK NIL+DS+ K+ADFG AK+ + ++ T V GT ++APE
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
+ +D++S G ++E+ +G+ + + + + +SG+ EI E + E
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL----YKIGSSGEPPEI-PEHLSE 231
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
E + F+R C RPT + L+
Sbjct: 232 EA-----KDFLR---KCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-38
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 21/209 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLL 347
F IG+G G VYK G VA+K I L++K +E I NE++I+ K +H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNA---LTRKQLAWPQRKKIILDVAKG 404
G + D ++V +F GSL D + + LT Q+A + ++ KG
Sbjct: 61 KYYGSYLKKD-----ELWIVMEFCSGGSLKDLLKSTNQTLTESQIA-----YVCKELLKG 110
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
L YLH I HRDIK+ NILL S+ + K+ DFGL+ Q + ++ + GT ++A
Sbjct: 111 LEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMA 165
Query: 465 PEYALYGQLTEKSDVYSFGIVILELMSGR 493
PE K+D++S GI +EL G+
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 290 FSQKNLIGQGASGVVYKG-TLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNL 346
+ +LIG+GA GVVYKG LE G VA+KQI + + + + E++++ ++H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 347 LSLRGCCVSSDDEKGKRRFL--VYDFMPSGSLGDHISN--ALTRKQLAWPQRKKIILDVA 402
+ G +SD L + ++ +GSL I +A + V
Sbjct: 62 VKYIGSIETSD-------SLYIILEYAENGSLRQIIKKFGPFPESLVA-----VYVYQVL 109
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
+GLAYLH + + HRDIK+ NIL + K+ADFG+A + L S V GT +
Sbjct: 110 QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATK-LNDVSKDDASVVGTPYW 165
Query: 463 LAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
+APE + SD++S G ++EL++G
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 70/198 (35%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
IG+GASG VYK T G VA+K++ L + E INE+ I+ +H N++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY- 84
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP 414
G ++V ++M GSL D I+ ++ PQ + +V +GL YLH +
Sbjct: 85 ----LVGDELWVVMEYMDGGSLTDIITQ--NFVRMNEPQIAYVCREVLQGLEYLH--SQN 136
Query: 415 AIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLT 474
I HRDIKS NILL + K+ADFG A Q + +S + V GT ++APE
Sbjct: 137 VI-HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYG 194
Query: 475 EKSDVYSFGIVILELMSG 492
K D++S GI+ +E+ G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 71/224 (31%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNL 346
+ IG+G+ G VY DG L +K+I +++ K E+ +NEV+I+ K+ H N+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD----VA 402
+ EKGK +V ++ G L I + P ++ ILD +
Sbjct: 62 IKYYESFE----EKGKL-CIVMEYADGGDLSQKIKKQKKEGK---PFPEEQILDWFVQLC 113
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
L YLH I HRDIK NI L S K+ DFG++K L L V GT Y
Sbjct: 114 LALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVVGTPYY 169
Query: 463 LAPE------YALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
L+PE Y KSD++S G V+ EL + + E N
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGEN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 69/202 (34%), Positives = 109/202 (53%), Gaps = 16/202 (7%)
Query: 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
IG+G G V G G VAVK + D D+ + F+ E +++ +RH NL+ L G
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
+ +G ++V ++M GSL D++ + R + Q+ LDV +G+ YL
Sbjct: 69 VL-----QGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLE--- 119
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ 472
+ HRD+ + N+L+ ++ AKV+DFGLAK++ +GQ V T APE +
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKK 175
Query: 473 LTEKSDVYSFGIVILELMS-GR 493
+ KSDV+SFGI++ E+ S GR
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 31/218 (14%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHRNLLSLR 350
IG+G G VYK + G LVA+K+I ++ E F I E++++ K+RH N++ L+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-RMEN-EKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRK---QLAWPQRKKIILDVAKGLAY 407
S + ++V+++M DH L + Q K + + +GL Y
Sbjct: 65 EIVTS---KGKGSIYMVFEYM------DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA-KQSLEGQSHLTTRVAGTYGYLAPE 466
LH I HRDIK +NIL++++ K+ADFGLA + + T RV T Y PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171
Query: 467 YAL----YGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
L YG + D++S G ++ EL G+ + + S
Sbjct: 172 LLLGATRYG---PEVDMWSVGCILAELFLGKPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLL 347
F +G+G+ G VYK E G +VA+K + + D +E I E+ I+ + ++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
G + D ++V ++ +GS+ D + +T K L + I+ KGL Y
Sbjct: 62 KYYGSYFKNTD-----LWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEY 114
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
LH HRDIK+ NILL+ E +AK+ADFG++ Q L V GT ++APE
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ-LTDTMAKRNTVIGTPFWMAPEV 170
Query: 468 ALYGQLTEKSDVYSFGIVILELMSGR 493
K+D++S GI +E+ G+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 296 IGQGASGVVYKGTL-EDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+GQG+SGVVYK G + A+K+I D D + ++ + E++ + ++ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG-- 66
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLAYLHYG 411
+ ++G +V ++M GSL D L +K P+ I + KGL YLH
Sbjct: 67 --AFYKEG-EISIVLEYMDGGSLAD-----LLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY---A 468
I HRDIK +N+L++S+ + K+ADFG++K T V GT Y++PE
Sbjct: 119 RH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGE 175
Query: 469 LYGQLTEKSDVYSFGIVILELMSGR 493
Y +D++S G+ +LE G+
Sbjct: 176 SYSY---AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 19/222 (8%)
Query: 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNL 346
F N IG+G+ GVV+K + D + A+KQI + ++ + EE I+E +++K+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTR---KQLAWPQRKKIILDVAK 403
+ + +KGK +V ++ +G L + R + W + + +
Sbjct: 62 IRYYESFL----DKGKL-NIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILL 112
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
GLA+LH I HRDIKS N+ LD+ K+ D G+AK L ++ + GT YL
Sbjct: 113 GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYL 168
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL 505
+PE EKSDV++ G+V+ E +G+ + +N L+
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 77/217 (35%), Positives = 114/217 (52%), Gaps = 30/217 (13%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G G V+ GT T VAVK + T E F+ E +I+ K+RH L+ L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-- 70
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---HYGL 412
S++E ++V ++M GSL D + + K+L PQ + +A+G+AYL +Y
Sbjct: 71 SEEEP---IYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNY-- 124
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPEYALY 470
HRD+ + NIL+ + K+ADFGLA+ L T R + + APE A Y
Sbjct: 125 ----IHRDLAARNILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 471 GQLTEKSDVYSFGIVILEL----------MSGRKVLE 497
G+ T KSDV+SFGI++ E+ M+ R+VLE
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE 215
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G G V++G + T VAVK + T ++F+ E +I+ K+RH L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT- 71
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---HYGL 412
+ ++V + M GSL +++ + L PQ + VA G+AYL +Y
Sbjct: 72 ----LEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQNY-- 124
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ 472
HRD+ + N+L+ KVADFGLA+ E + APE ALY +
Sbjct: 125 ----IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR 180
Query: 473 LTEKSDVYSFGIVILEL----------MSGRKVLE 497
+ KSDV+SFGI++ E+ M+ +VL+
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ 215
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 292 QKNLIGQGASGVVYKG-TLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLS 348
+ N IG G G VY L+ G L+AVK+I D D K +E +E++++ ++H NL+
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMP---SGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
G V + VY FM G+L + + + + +L +GL
Sbjct: 64 YYGVEVHREK--------VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL---EGL 112
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG---Y 462
AYLH I HRDIK NI LD K+ DFG A + + + V G Y
Sbjct: 113 AYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169
Query: 463 LAPEYALYGQLTEK---SDVYSFGIVILELMSGRK 494
+APE G+ +D++S G V+LE+ +G++
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 72/202 (35%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+GQG G V+ GT T VA+K + T E F+ E +++ K+RH L+ L V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYA--VV 70
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
S++ ++V ++M GSL D + K L PQ + +A G+AY+ +
Sbjct: 71 SEEPI----YIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE---RMN 122
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPEYALYGQL 473
HRD+++ NIL+ + KVADFGLA+ L + T R + + APE ALYG+
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 474 TEKSDVYSFGIVILELMSGRKV 495
T KSDV+SFGI++ EL + +V
Sbjct: 181 TIKSDVWSFGILLTELTTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 78/322 (24%), Positives = 127/322 (39%), Gaps = 37/322 (11%)
Query: 295 LIGQGASGVVYKGTLEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIRH-RNLLSLR 350
+G+G+ G VY D LVA+K + + +K E F+ E++I++ + H N++ L
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
+LV +++ GSL D + + L+ + I+ + L YLH
Sbjct: 65 DFFQDEGSL-----YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 411 GLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQSLEGQSHLTTR-----VAGTYGYLA 464
I HRDIK NILLD + K+ DFGLAK + S + GT GY+A
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 465 PEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN------ 515
PE L + SD++S GI + EL++G E +S +L
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 516 -------SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568
+ + + +++ ++ R L H ++A L L
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS-HDLLAHLKLKESDLSDLLKPD 295
Query: 569 DIPTLPERPLPLTHESFKASPS 590
D L P + S
Sbjct: 296 DSAPLRLSLPPSLEALISSLNS 317
|
Length = 384 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 77/214 (35%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G G V+ GT T VAVK + T E F+ E +I+ K+RH L+ L V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYA--VV 70
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
S++ ++V ++M GSL D + + R L P + VA G+AY+ +
Sbjct: 71 SEEPI----YIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RMN 122
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPEYALYGQL 473
HRD++S NIL+ + K+ADFGLA+ L + T R + + APE ALYG+
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 474 TEKSDVYSFGIVILEL----------MSGRKVLE 497
T KSDV+SFGI++ EL M+ R+VLE
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE 214
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQIT--DLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
IG+G+ G V K DG ++ K+I ++ K ++ ++EV I+ +++H N++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYG 411
+ D + ++V ++ G L I RK + +I+ + L H
Sbjct: 68 II---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 412 L--KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ HRD+K NI LD+ K+ DFGLAK L S GT Y++PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGHDSSFAKTYVGTPYYMSPEQLN 183
Query: 470 YGQLTEKSDVYSFGIVILELMSGR 493
+ EKSD++S G +I EL +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 38/213 (17%)
Query: 296 IGQGASGVVY----KGTLEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIRHRNLLS 348
+G+G+ G V K T G L A+K + + K E + E I+S+I H ++
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK----- 403
L +EK +LV ++ P G L H+S + + + A+
Sbjct: 58 LH--YAFQTEEK---LYLVLEYAPGGELFSHLS-----------KEGRFSEERARFYAAE 101
Query: 404 ---GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
L YLH I +RD+K NILLD++ K+ DFGLAK+ S T GT
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTP 157
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
YLAPE L + D +S G+++ E+++G+
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 15/202 (7%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+GQG G V+ GT T VA+K + T E F+ E +I+ K+RH L+ L V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYA--VV 70
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
S++ ++V +FM GSL D + K L PQ + +A G+AY+ +
Sbjct: 71 SEEPI----YIVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMN 122
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPEYALYGQL 473
HRD+++ NIL+ + K+ADFGLA+ L + T R + + APE ALYG+
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 474 TEKSDVYSFGIVILELMSGRKV 495
T KSDV+SFGI++ EL++ +V
Sbjct: 181 TIKSDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 60/202 (29%), Positives = 109/202 (53%), Gaps = 10/202 (4%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
F+ + +G G G V++G ++ VA+K + D ++F EV+ + ++RH++L+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
C + +++ + M GSL + + + L + VA+G+AYL
Sbjct: 68 FAVCSVGEP-----VYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE 121
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ HRD+ + NIL+ ++ KVADFGLA+ ++ +L++ Y + APE A
Sbjct: 122 ---EQNSIHRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 470 YGQLTEKSDVYSFGIVILELMS 491
+G + KSDV+SFGI++ E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 70/207 (33%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDE-EFIN-EVEIISKIRHRNL 346
F+ IG+G+ G VYK +VA+K I DL+ DE E I E++ +S+ R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIILDVAKGL 405
G + KG + +++ ++ GS D + L +A+ I+ +V GL
Sbjct: 62 TKYYGSFL-----KGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-----ILREVLLGL 111
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
YLH K HRDIK+ NILL E K+ADFG++ Q S T V GT ++AP
Sbjct: 112 EYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAP 167
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSG 492
E EK+D++S GI +EL G
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 295 LIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLSLRGCC 353
IG+G G VYKG L+ T VAVK +F+ E EI+ + H N++ L G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHI---SNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
V ++V + +P GSL + N LT K+L ++ LD A G+ YL
Sbjct: 62 VQKQP-----IYIVMELVPGGSLLTFLRKKKNRLTVKKLL-----QMSLDAAAGMEYLES 111
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT-YGYLAPEYAL 469
K I HRD+ + N L+ K++DFG++++ G ++ + + APE
Sbjct: 112 --KNCI-HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 470 YGQLTEKSDVYSFGIVILELMSG 492
YG+ T +SDV+S+GI++ E S
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 17/222 (7%)
Query: 294 NLIGQGASGVVYKGTLE---DGT--LVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLL 347
+G+G G V + D T VAVK + + + +F E+EI+ + H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
+G C + G+ L+ +++PSGSL D++ R Q+ + + KG+ Y
Sbjct: 70 KYKGVC---EKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDY 124
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG--YLAP 465
L HRD+ + NIL++SE K++DFGLAK E + + + G + AP
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 466 EYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLI 506
E + + SDV+SFG+ + EL + G +I
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 21/220 (9%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
IG G G+V+ G + VA+K I + +E+FI E +++ K+ H L+ L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
LV++FM G L D++ R + + + LDV +G+AYL
Sbjct: 71 RSP-----ICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLE---SSN 120
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTE 475
+ HRD+ + N L+ KV+DFG+ + L+ Q +T + +PE + + +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 476 KSDVYSFGIVILELMS-GR---------KVLETSNSSFLL 505
KSDV+SFG+++ E+ S G+ +V+ET N+ F L
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G G SGVV K G ++AVK I +++ ++ + E++I+ K ++ G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
++ D + ++M GSL + + ++ KI + V KGL YLH K
Sbjct: 69 YNNGD-----ISICMEYMDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA----GTYGYLAPEYAL 469
I HRD+K +NIL++S + K+ DFG++ Q L +A GT Y+APE
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSGQ-------LVNSLAKTFVGTSSYMAPERIQ 172
Query: 470 YGQLTEKSDVYSFGIVILELMSGR 493
+ KSD++S G+ ++EL +GR
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 34/275 (12%)
Query: 296 IGQGASG--VVYKGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
+G+GA G +Y+ T ED +LV K++ T L K + +NE+ I+S ++H N+++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKI--ILDVAKGLAYLH 409
+ ++ G+L D I +K + + + + + ++Y+H
Sbjct: 67 -----HFMDDNTLLIEMEYANGGTLYDKIVR---QKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
K I HRDIK+ NI L K+ DFG++K S T V GT Y++PE
Sbjct: 119 ---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQ 174
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
+ KSD+++ G V+ EL++ ++ + +N L+ + N V ++
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV---VKIVQGNYTPVVSVY-----S 226
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564
+++ RPT + L
Sbjct: 227 SELISLVHS-------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 45/224 (20%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLS 348
+G+GA G V+ G D LVAVK + + ++F E E+++ +H N++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDH-----------ISNALTRKQLAWPQRKKI 397
G C D +V+++M G L S +L Q +I
Sbjct: 73 FYGVCTEGDPP-----IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 398 ILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-------SLE 447
+ +A G+ YL H+ HRD+ + N L+ ++ K+ DFG+++ +
Sbjct: 128 AVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181
Query: 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
G + L R ++ PE +Y + T +SDV+SFG+V+ E+ +
Sbjct: 182 GHTMLPIR------WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 38/231 (16%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGT----LEDGTL-VAVKQI-TDLDTKGDEEF 331
+E+EL++ ++G GA G VYKG E + VA+K + + K ++E
Sbjct: 4 LKETELEKI-------KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEI 56
Query: 332 INEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTR----K 387
++E +++ + H +++ L G C+SS + L+ MP G L D++ N
Sbjct: 57 LDEAYVMASVDHPHVVRLLGICLSS------QVQLITQLMPLGCLLDYVRNHKDNIGSQY 110
Query: 388 QLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447
L W + +AKG++YL + + HRD+ + N+L+ + K+ DFGLAK
Sbjct: 111 LLNWC------VQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161
Query: 448 GQSHLTTRVAG---TYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
+ G ++A E L+ T KSDV+S+G+ + ELM+ G K
Sbjct: 162 DEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 52/284 (18%)
Query: 295 LIGQGASGVVYKG-TLEDGTLVAVKQ--ITDLDTKGDE---EFINEVEIISKIRHRNLLS 348
L+G G+ G VY+G L+DG AVK+ + D G E + E+ ++SK++H N++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQ-LAWPQRKKIILDVAKGLAY 407
G D ++ + +P GS ++ L + P + + GL Y
Sbjct: 67 YLGTEREED-----NLYIFLELVPGGS----LAKLLKKYGSFPEPVIRLYTRQILLGLEY 117
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
LH HRDIK NIL+D+ K+ADFG+AKQ +E S + G+ ++APE
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKS-FKGSPYWMAPEV 172
Query: 468 AL-YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA--------WMLANSGK 518
G +D++S G +LE+ +G+ W+ + + S +
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK-------------PPWSQLEGVAAVFKIGRSKE 219
Query: 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
+ I D E + F+ C +LRPT A+ L+
Sbjct: 220 LPPIPDHLSDE------AKDFIL---KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 2e-23
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHR 344
+ + +G+G GVVYK + G +VA+K+I LD +E + E+ ++ +++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LD-NEEEGIPSTALREISLLKELKHP 58
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
N++ L + ++ +LV+++ L ++ L+ K I+ + +G
Sbjct: 59 NIVKLLDVIHTE-----RKLYLVFEYCDM-DLKKYLDK--RPGPLSPNLIKSIMYQLLRG 110
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
LAY H I HRD+K NIL++ + K+ADFGLA+ T V T Y A
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRA 166
Query: 465 PEYALYGQLTEKS--DVYSFGIVILELMSGR 493
PE L G + D++S G + E+++G+
Sbjct: 167 PE-ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 80/275 (29%), Positives = 127/275 (46%), Gaps = 23/275 (8%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
IGQGASG VY + G VA+KQ+ E INE+ ++ + +H N+++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP 414
D+ ++V +++ GSL D +T + Q + + + L +LH
Sbjct: 87 VGDE-----LWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLH---SN 134
Query: 415 AIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLT 474
+ HRDIKS NILL + K+ DFG Q QS +T V GT ++APE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 475 EKSDVYSFGIVILELMSGRKVLETSN---SSFLLITDWAWMLANSGKVDEIFDEFIREEG 531
K D++S GI+ +E++ G N + +L+ T+ L N K+ IF +F+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253
Query: 532 SRAVMERFVRVGIL------CAHVMVALRPTIADA 560
V +R +L A + +L P IA A
Sbjct: 254 EMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAAA 288
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 23/211 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDE--EFINEVEIISKIRH--- 343
+ + LIG+GA G VY+G + G +VA+K I +LDT D+ + EV ++S++R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQ-LAWPQRKKIILDVA 402
N+ G + KG R +++ ++ GS+ L + +A II +V
Sbjct: 62 PNITKYYGSYL-----KGPRLWIIMEYAEGGSV-----RTLMKAGPIAEKYISVIIREVL 111
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
L Y+H K + HRDIK+ NIL+ + K+ DFG+A + S +T V GT +
Sbjct: 112 VALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYW 167
Query: 463 LAPEYALYGQLTE-KSDVYSFGIVILELMSG 492
+APE G+ + K+D++S GI I E+ +G
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFIN-----EVEIISKIRH 343
+ + +G+G VVYK E G +VA+K+I + K ++ IN E++++ +++H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 344 RNLLSLRGCCVSSDDEKGKRRF--LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDV 401
N++ L D G + LV++FM + L I + A K +L
Sbjct: 62 PNIIGLL-------DVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPA--DIKSYMLMT 111
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG 461
+GL YLH I HRD+K N+L+ S+ K+ADFGLA+ +T +V T
Sbjct: 112 LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 462 YLAPEYALYG--QLTEKSDVYSFGIVILELMSGR 493
Y APE L+G D++S G + EL+
Sbjct: 168 YRAPEL-LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGD--EEFINEVEIISKIRHRNLLSLRGC 352
IG GA+ VVY L + VA+K+I DL+ +E EV+ +S+ H N++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
V G +LV ++ GSL D + ++ R L ++ +V KGL YLH
Sbjct: 68 FV-----VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--- 119
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG---QSHLTTRVAGTYGYLAPEYAL 469
HRDIK+ NILL + K+ADFG++ +G + GT ++APE
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 470 YGQ-LTEKSDVYSFGIVILELMSGR 493
K+D++SFGI +EL +G
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G GVV+ G VA+K I + +++FI E +++ K+ H NL+ L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT- 69
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
K + F+V ++M +G L +++ + +L + DV + + YL
Sbjct: 70 ----KQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLE---SNG 120
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTE 475
HRD+ + N L+ + KV+DFGLA+ L+ Q + + PE Y + +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 476 KSDVYSFGIVILELMSGRKV 495
KSDV+SFG+++ E+ S K+
Sbjct: 181 KSDVWSFGVLMWEVFSEGKM 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
IG+GA G+V+K E G VA+K++ L+ + + E++ + +H ++ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGD---HISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
V G LV ++MPS L + L Q K + + KG+AY+H
Sbjct: 67 -VFPH---GSGFVLVMEYMPS-DLSEVLRDEERPLPE-----AQVKSYMRMLLKGVAYMH 116
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
I HRD+K N+L+ ++ K+ADFGLA+ E + L + T Y APE L
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL-L 172
Query: 470 YGQ--LTEKSDVYSFGIVILELMSGR 493
YG D+++ G + EL++G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 294 NLIGQGASGVVYKGTL----EDGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLS 348
+IG G G V +G L + VA+K + + +F+ E I+ + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
L G K + ++ ++M +GSL + + Q ++ +A G+ YL
Sbjct: 70 LEGVVT-----KSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL 122
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR-----VAGTYGYL 463
+ HRD+ + NIL++S + KV+DFGL+++ + ++ TT+ + T
Sbjct: 123 S---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT---- 175
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMS 491
APE Y + T SDV+SFGIV+ E+MS
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHRNLLSLR 350
+G+G G VYK ++ G +VA+K+I + K + F + E++I+ K++H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLI 73
Query: 351 GCCVSSDDEKGKRRFLVYDFMP------SGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
V D+ ++R VY P SG L + +L Q K +L + +G
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN------PSVKLTESQIKCYMLQLLEG 127
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA------KQSLEGQSHLTTR--- 455
+ YLH + I HRDIK+ NIL+D++ K+ADFGLA + +G TR
Sbjct: 128 INYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 456 -VAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLE 497
+ T Y PE L + T D++ G V E+ + R +L+
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 68/199 (34%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 295 LIGQGASGVVYKGTLEDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
L+G+G G V+KGTL+D T VAVK DL + +F++E I+ + H N++ L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRK-QLAWPQRKKIILDVAKGLAYLHYGL 412
+R +Y M GD +S +K +L Q K LD A G+AYL
Sbjct: 62 T--------QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE--S 111
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ 472
K I HRD+ + N L+ K++DFG+++Q +G + + APE YG+
Sbjct: 112 KNCI-HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 473 LTEKSDVYSFGIVILELMS 491
+ +SDV+S+GI++ E S
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 68/209 (32%), Positives = 114/209 (54%), Gaps = 25/209 (11%)
Query: 295 LIGQGASGVVYK---GTLEDGT--LVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G+G G V L+D T +VAVK++ + +F E+EI+ ++H N++
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 350 RGCCVSSDDEKGKRRF-LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL---DVAKGL 405
+G C S+ G+R LV +++P GSL D++ R++L +K++L + KG+
Sbjct: 71 KGVCYSA----GRRNLRLVMEYLPYGSLRDYLQK--HRERL---DHRKLLLYASQICKGM 121
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG---TYGY 462
YL G K + HRD+ + NIL++SE + K+ DFGL K + + + R G + Y
Sbjct: 122 EYL--GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 463 LAPEYALYGQLTEKSDVYSFGIVILELMS 491
APE + + SDV+SFG+V+ EL +
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 37/217 (17%)
Query: 292 QKNLIGQGASGVVYKG-TLEDGTLVAVKQI-TDLDTKGDEEFIN----EVEIISKIRHRN 345
+ L+GQGA G VY ++ G +AVKQ+ D D+ ++ +N E++++ ++H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI------SNALTRKQLAWPQRKKIIL 399
++ GC DDE + ++MP GS+ D + + +TRK + IL
Sbjct: 66 IVQYYGC--LRDDET---LSIFMEYMPGGSVKDQLKAYGALTETVTRKY------TRQIL 114
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK--QSLEGQSHLTTRVA 457
+ G+ YLH + I HRDIK NIL DS K+ DFG +K Q++ V
Sbjct: 115 E---GVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 458 GTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMS 491
GT +++PE YG+ K+DV+S G ++E+++
Sbjct: 169 GTPYWMSPEVISGEGYGR---KADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 70/242 (28%), Positives = 118/242 (48%), Gaps = 17/242 (7%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS 348
+++ IGQGASG V+ + G VA+KQI E INE+ ++ ++++ N+++
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
+ D+ F+V +++ GSL D +T + Q + + + L +L
Sbjct: 81 FLDSFLVGDE-----LFVVMEYLAGGSLTD----VVTETCMDEAQIAAVCRECLQALEFL 131
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
H + HRDIKS N+LL + K+ DFG Q QS +T V GT ++APE
Sbjct: 132 HAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 187
Query: 469 LYGQLTEKSDVYSFGIVILELMSGRKVLETSN---SSFLLITDWAWMLANSGKVDEIFDE 525
K D++S GI+ +E++ G N + +L+ T+ L N K+ IF +
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247
Query: 526 FI 527
F+
Sbjct: 248 FL 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 72/227 (31%), Positives = 104/227 (45%), Gaps = 30/227 (13%)
Query: 283 LDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKI 341
L TG F +IG+G G VYK + G LVA+K I D+ +EE E I+ K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59
Query: 342 -RHRNLLSLRGCCVSSDDE-KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKK--- 396
H N+ + G + + + +LV + GS+ D L + +R K
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-----LVKGLRKKGKRLKEEW 114
Query: 397 ---IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLT 453
I+ + +GLAYLH + + HRDIK NILL + K+ DFG++ Q L+
Sbjct: 115 IAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ-LDSTLGRR 170
Query: 454 TRVAGTYGYLAPEY--------ALYGQLTEKSDVYSFGIVILELMSG 492
GT ++APE A Y +SDV+S GI +EL G
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDA---RSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 74/211 (35%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 294 NLIGQGASGVVYKGTLEDG----TLVAVK---QITDLDTKGDEEFINEVEIISKIRHRNL 346
+IG+G G VY GTL D AVK +ITDL+ E+F+ E I+ H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV--EQFLKEGIIMKDFSHPNV 58
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKII---LDVAK 403
LSL G C+ S+ +V +M G L + I R + P K +I L VAK
Sbjct: 59 LSLLGICLPSEGSP----LVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAK 109
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ---SHLTTRVAGTY 460
G+ YL HRD+ + N +LD KVADFGLA+ + + H T
Sbjct: 110 GMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
++A E + T KSDV+SFG+++ ELM+
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQIT-DLDTKGDEEF-INEVEIISKIRHRNLLSLRGC 352
IG+G GVVYK G +VA+K+I +++G + + E++++ ++ H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
V +LV++FM + L I + ++ L K + + +GLA+ H
Sbjct: 66 -VFRH---KGDLYLVFEFMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCH--- 115
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG- 471
I HRD+K N+L+++E K+ADFGLA+ S T T Y APE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVVTRWYRAPE-LLLGD 173
Query: 472 -QLTEKSDVYSFGIVILELMSGR 493
+ D++S G + EL+S R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 296 IGQGASGVV----YKGTLED-GTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G+G G V Y + G +VAVK + + + + E+ I+ + H N++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+GCC ++ GK L+ +++P GSL D+ L + +L Q + +G+AYLH
Sbjct: 72 KGCC---SEQGGKGLQLIMEYVPLGSLRDY----LPKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG--YLAPEY 467
HRD+ + N+LLD++ K+ DFGLAK EG + R G + A E
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 468 ALYGQLTEKSDVYSFGIVILELMS 491
+ + SDV+SFG+ + EL++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 71/227 (31%), Positives = 114/227 (50%), Gaps = 48/227 (21%)
Query: 294 NLIGQGASGVVYKGTLED----GT---LVAVKQITDLDTKGDE-EFINEVEIISKIRHRN 345
N +G GA G VY+GT D G+ VAVK + T ++ EF+ E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNA---------LTRKQLAWPQRKK 396
++ L G C+ ++ + +++ + M G L ++ +A LT K+L
Sbjct: 61 IVKLLGVCLLNEPQ-----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELL-----D 110
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILL-----DSEMKAKVADFGLAKQ------- 444
I LDVAKG YL + HRD+ + N L+ D++ K+ DFGLA+
Sbjct: 111 ICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY 167
Query: 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
EG+ L R ++APE L G+ T +SDV+SFG+++ E+++
Sbjct: 168 RKEGEGLLPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
IG+G G V G G VAVK I + T + F+ E +++++RH NL+ L G V
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV- 69
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
+EKG ++V ++M GSL D++ + R L K LDV + + YL
Sbjct: 70 --EEKGGL-YIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---N 122
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTE 475
HRD+ + N+L+ + AKV+DFGL K++ Q V T APE + +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 476 KSDVYSFGIVILELMS-GR 493
KSDV+SFGI++ E+ S GR
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G GVV G VA+K I + + ++EFI E +++ K+ H L+ L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT- 69
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
K + ++V ++M +G L +++ R Q + Q ++ DV +G+AYL
Sbjct: 70 ----KQRPIYIVTEYMSNGCLLNYLREHGKRFQPS--QLLEMCKDVCEGMAYLE---SKQ 120
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPEYALYGQL 473
HRD+ + N L+D + KV+DFGL++ L+ + T+ V + + PE LY +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 474 TEKSDVYSFGIVILELMS-GRKVLETSNSS 502
+ KSDV++FG+++ E+ S G+ E N+S
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 289 GFSQKNLIGQGASGVVYKGTLED-GTLVAVKQIT--DLDTKGD-EEFINEVEIISKIRHR 344
F +IG+GA G V D + A+K + KG +NE I+ ++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 345 NLLSLRGCCVSS--DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
L++L S D+E +LV D + G L H+S + + Q K I ++
Sbjct: 61 FLVNLW----YSFQDEEN---MYLVVDLLLGGDLRYHLSQKVKFSE---EQVKFWICEIV 110
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
L YLH I HRDIK NILLD + + DF +A + + + LTT +GT GY
Sbjct: 111 LALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDT-LTTSTSGTPGY 165
Query: 463 LAPE---YALYGQLTEKSDVYSFGIVILELMSGRK 494
+APE Y D +S G+ E + G++
Sbjct: 166 MAPEVLCRQGYSVA---VDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 9e-21
Identities = 69/217 (31%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT-------KGDEEFINEVEIISKIR 342
+++ ++G+GA G VY G G L+AVKQ+ +LDT K E+ EV+++ ++
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTR-KQLAWPQRKKIILDV 401
H N++ G C+ D+ F+ +F+P GS IS+ L R L P K +
Sbjct: 61 HVNIVQYLGTCL---DDNTISIFM--EFVPGGS----ISSILNRFGPLPEPVFCKYTKQI 111
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ----SLEG-QSHLTTRV 456
G+AYLH + HRDIK N++L K+ DFG A++ L G S++ +
Sbjct: 112 LDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 457 AGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
GT ++APE KSD++S G + E+ +G+
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 32/217 (14%)
Query: 295 LIGQGASGVVYKG-TLEDGTLVAVKQ--ITDLDTKGD-------EEFINEVEIISKIRHR 344
LIG G+ G VY G G L+AVKQ + + + E+ ++ +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVA 402
N++ G + +D FL Y +P GS+ AL A+ + + + +
Sbjct: 67 NIVQYLGSSLDADH---LNIFLEY--VPGGSVA-----ALLNNYGAFEETLVRNFVRQIL 116
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR------V 456
KGL YLH I HRDIK NIL+D++ K++DFG++K+ LE S T +
Sbjct: 117 KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSL 172
Query: 457 AGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
G+ ++APE T K+D++S G +++E+++G+
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 24/202 (11%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGD---EEFINEVEIISKIRHRNLLSLRGC 352
IG+G G V +G G VAVK I K D + F+ E +++K+ H+NL+ L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNI-----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
+ + ++V + M G+L + + R ++ Q + LDVA+G+ YL
Sbjct: 68 ILHNG------LYIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLE--- 117
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ 472
+ HRD+ + NIL+ + AKV+DFGLA+ G + V T APE + +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKK 173
Query: 473 LTEKSDVYSFGIVILELMS-GR 493
+ KSDV+S+G+++ E+ S GR
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 71/208 (34%), Positives = 104/208 (50%), Gaps = 35/208 (16%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLLSLRGCC 353
IG G G VYK + G LVA+K I L+ D E I E+ ++ + RH N+++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGD--HISN-ALTRKQLAWPQRKKIILDVAKGLAYLHY 410
+ D + ++V ++ GSL D ++ L+ Q+A+ R + KGLAYLH
Sbjct: 70 LRRD-----KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHE 119
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA------GTYGYLA 464
K HRDIK NILL + K+ADFG++ Q LT +A GT ++A
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVSAQ-------LTATIAKRKSFIGTPYWMA 169
Query: 465 PEYA---LYGQLTEKSDVYSFGIVILEL 489
PE A G K D+++ GI +EL
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 45/225 (20%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITD-LDTKGDEEFINEVEIISKIRHRNLLS 348
+G+GA G VYKG L T VA+K + + + K +EF E E++S ++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDH-ISNA------------LTRKQLAWPQRK 395
L G C K + ++++++ G L + + N+ + L
Sbjct: 73 LLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 396 KIILDVAKGLAYL--HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-------SL 446
I + +A G+ YL H+ HRD+ + N L+ + K++DFGL++ +
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ +S L R ++ PE LYG+ T +SD++SFG+V+ E+ S
Sbjct: 183 QSKSLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 25/221 (11%)
Query: 295 LIGQGASGVVYKGTLEDG--TLVAVKQIT---DLDTKGDEE-------FINEVEIISK-I 341
+G GA G VYK ++ L+A+K+I K E ++EV II + +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 342 RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK--KIIL 399
RH N++ + +D R ++V D + LG+H N+L K+ + + + I +
Sbjct: 67 RHPNIVRYYKTFLEND-----RLYIVMDLIEGAPLGEHF-NSLKEKKQRFTEERIWNIFV 120
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT 459
+ L YLH + I HRD+ NI+L + K + DFGLAKQ +S LT+ V GT
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTS-VVGT 176
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
Y PE EK+DV++FG ++ ++ + + ++N
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 296 IGQGASGVVYKGT--LEDGTL--VAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLSLR 350
+G G G V KG ++ G VAVK + + EF+ E +++++ H ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G C KG+ LV + P G L ++ R+++ K++ VA G+AYL
Sbjct: 63 GVC------KGEPLMLVMELAPLGPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES 113
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAP 465
H+ HRD+ + N+LL + +AK++DFG+++ G + AG + + AP
Sbjct: 114 KHF------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167
Query: 466 EYALYGQLTEKSDVYSFGIVILELMS 491
E YG+ + KSDV+S+G+ + E S
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 295 LIGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFIN----EVEIISKIRHRNLLSL 349
++G+GA GVV K G +VA+K+ +++ DE+ EV+++ ++RH N+++L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLAY 407
+ R +LV++++ L L P + I + + +AY
Sbjct: 66 KEAFRRKG-----RLYLVFEYVERTLLEL-----LEASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-SLEGQSHLTTRVAGTYGYLAPE 466
H I HRDIK NIL+ K+ DFG A+ S LT VA T Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 467 YAL----YGQLTEKSDVYSFGIVILELMSGR 493
+ YG+ DV++ G ++ EL+ G
Sbjct: 172 LLVGDTNYGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 6e-20
Identities = 53/231 (22%), Positives = 94/231 (40%), Gaps = 51/231 (22%)
Query: 295 LIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFI----------NEVEIISKI-R 342
+IG+G+ V E A+K + D+ + E E+++++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
H ++ L D+E + V ++ P+G L +I L + ++
Sbjct: 61 HPGIIKLYYT--FQDEEN---LYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEIL 112
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK------------------- 443
L YLH I HRD+K NILLD +M K+ DFG AK
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 444 -QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
Q + + + V GT Y++PE + SD+++ G +I ++++G+
Sbjct: 170 SQIEKNRRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 90/357 (25%), Positives = 161/357 (45%), Gaps = 39/357 (10%)
Query: 220 RVIK------IVVALLGALLGVLLAGGLIIMYRKWYKKRKRNALHEE--FVRSFKDSVLP 271
RV K + LGA L + L + R + +E+ + F DS
Sbjct: 621 RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDS--- 677
Query: 272 NSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEE 330
K + ++ ++N+I +G G YKG ++++G VK+I D+++
Sbjct: 678 ----KVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-PSS 732
Query: 331 FINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLA 390
I + + K++H N++ L G C S EKG +L+++++ +L + + N L+
Sbjct: 733 EIAD---MGKLQHPNIVKLIGLCRS---EKGA--YLIHEYIEGKNLSEVLRN------LS 778
Query: 391 WPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450
W +R+KI + +AK L +LH PA+ ++ I++D D + SL G
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLL 832
Query: 451 HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA 510
T+ + Y+APE +TEKSD+Y FG++++EL++G+ + I +WA
Sbjct: 833 CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892
Query: 511 WMLANSGKVDEIFDEFIREEGS--RAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
+ +D D IR + S + + + + + C RP D LK LE
Sbjct: 893 RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLS 348
+GQG+ G+VY+G E T VA+K + + + + EF+NE ++ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGD----HISNALTRKQLAWPQRKKII---LDV 401
L G G+ +V + M G L A L P +K I ++
Sbjct: 74 LLGVV-----STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE-------GQSHLTT 454
A G+AYL K HRD+ + N ++ ++ K+ DFG+ + E G+ L
Sbjct: 129 ADGMAYLA-AKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 455 RVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILEL 489
R ++APE G T KSDV+SFG+V+ E+
Sbjct: 186 R------WMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 288 GGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRN 345
+ + +G+GA G V K L G + A+K I TD + ++ + E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVA- 402
++ G + DE + ++ GSL +++ +K R +K++ +A
Sbjct: 61 IVKYYGAFL---DESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAE 112
Query: 403 ---KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT 459
KGL+YLH I HRDIK +NILL + + K+ DFG++ + + + T GT
Sbjct: 113 SVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GT 166
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
Y+APE + SDV+S G+ +LE+ R
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 294 NLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEE-----FINEVEIISKIR---HR 344
IG+GA G VYK L G VA+K++ EE + E+ ++ ++ H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
N++ L C ++ + LV++ + L ++S + L K ++ + +G
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRG 119
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
+ +LH I HRD+K NIL+ S+ + K+ADFGLA+ + LT+ V T Y A
Sbjct: 120 VDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV-TLWYRA 174
Query: 465 PEYALYGQLTEKS--DVYSFGIVILEL 489
PE L Q + + D++S G + EL
Sbjct: 175 PEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 295 LIGQGASGVVYKG-TLEDGTLVAVKQI---------TDLDTKGDEEFIN-EVEIISKIRH 343
LIG+G G VY + G ++AVKQ+ D K + + E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVY-DFMPSGSLGDHISN-ALTRKQLAWPQRKKIILDV 401
N++ G E + ++ +++P GS+G + +QL + V
Sbjct: 68 LNIVQYLGF------ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV----RFFTEQV 117
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL-TTRVAGTY 460
+GLAYLH I HRD+K+ N+L+D++ K++DFG++K+S + + + G+
Sbjct: 118 LEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 461 GYLAPEY-ALYGQ-LTEKSDVYSFGIVILELMSGRK 494
++APE Y Q + K D++S G V+LE+ +GR+
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 295 LIGQGASGVVYKGTL--EDGTL--VAVKQI-TDLDTKGD-EEFINEVEIISKIRHRNLLS 348
++G+G G V +G L +DG+ VAVK + D+ T + EEF++E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 349 LRGCCV-SSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRK--KIILDVAKG 404
L G C +S +K + ++ FM G L + + L P + K ++D+A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT-YGYL 463
+ YL HRD+ + N +L +M VADFGL+K+ G + R+A ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMS 491
A E T KSDV++FG+ + E+ +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 289 GFSQKNLIGQGASGVVYK-GTLEDGTLVAVKQ--ITDLDTKGDEEFINEVEIISKIRHRN 345
F +G+G+ G VYK L D A+K+ + + K E+ +NE+ I++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN-ALTRKQLAWPQRKKIILDVAKG 404
++S + + D G + +V ++ P G L IS RK + + +I + + +G
Sbjct: 61 IISYKE---AFLD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
L LH + I HRD+KS NILL + K+ D G++K + ++ GT Y+A
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMA 169
Query: 465 PEYALYGQLTEKSDVYSFGIVILELMSGR 493
PE + KSD++S G ++ E+ +
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 294 NLIGQGASGVVYKGTL--EDGTL----VAVKQITDLDTKGDEE-FINEVEIISKIRHRNL 346
+G GA G VY+G DG VAVK + + ++ DE F+ E I+SK H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRK----QLAWPQRKKIILDVA 402
+ L G RF++ + M G L + R L DVA
Sbjct: 72 VRLIGVSFERLP-----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 403 KGLAYL---HYGLKPAIYHRDIKSTNILLDSEMK---AKVADFGLAKQ-------SLEGQ 449
KG YL H+ HRDI + N LL + AK+ADFG+A+ G+
Sbjct: 127 KGCKYLEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 450 SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ L + ++ PE L G T K+DV+SFG+++ E+ S
Sbjct: 181 AMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 36/222 (16%)
Query: 290 FSQKNLIGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEE-------FINEVEIISKI 341
F + N IG+G G+VY+ G +VA+K++ + D E + E+ ++ +
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLREITLLLNL 63
Query: 342 RHRNLLSLRGCCVSSDDEKGKRR---FLVYDFMPS--GSLGDHISNALTRKQLAWPQRKK 396
RH N++ L+ V GK FLV ++ SL D++ + Q K
Sbjct: 64 RHPNIVELKEVVV------GKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-----SQVKC 112
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRV 456
++L + +GL YLH I HRD+K +N+LL + K+ADFGLA+ +T +V
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 457 AGTYGYLAPEYALYGQL--TEKSDVYSFGIVILELMSGRKVL 496
T Y APE L G T D+++ G ++ EL++ + +L
Sbjct: 170 V-TLWYRAPEL-LLGCTTYTTAIDMWAVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 6e-19
Identities = 68/237 (28%), Positives = 116/237 (48%), Gaps = 19/237 (8%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
IGQGASG VY + G VA+KQ+ E INE+ ++ + ++ N+++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNA-LTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
D+ ++V +++ GSL D ++ + Q+A + + + L +LH
Sbjct: 87 VGDE-----LWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHSN-- 134
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL 473
+ HRDIKS NILL + K+ DFG Q QS +T V GT ++APE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 474 TEKSDVYSFGIVILELMSGRKVLETSN---SSFLLITDWAWMLANSGKVDEIFDEFI 527
K D++S GI+ +E++ G N + +L+ T+ L N ++ +F +F+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 6e-19
Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
IGQGASG VY + G VA++Q+ E INE+ ++ + ++ N+++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNA-LTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
D+ ++V +++ GSL D ++ + Q+A + + + L +LH
Sbjct: 88 VGDE-----LWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSN-- 135
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL 473
+ HRDIKS NILL + K+ DFG Q QS +T V GT ++APE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 474 TEKSDVYSFGIVILELMSGRKVLETSN---SSFLLITDWAWMLANSGKVDEIFDEFI--- 527
K D++S GI+ +E++ G N + +L+ T+ L N K+ IF +F+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 528 -------REEGSRAVMERFVRVGILCAHVMVALRPTIADA 560
R + +F+++ A + +L P IA A
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKI----AKPLSSLTPLIAAA 289
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 25/269 (9%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G GVV+ G VA+K I + +E+FI E +++ K+ H L+ L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
K ++V +FM +G L +++ + +L+ + DV +G+ YL + +
Sbjct: 71 Q-----KPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLE---RNS 120
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTE 475
HRD+ + N L+ S KV+DFG+ + L+ + ++ + PE + + +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 476 KSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAV 535
KSDV+SFG+++ E+ + K+ S++ ++ + F + + S V
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE----------MISRGFRLYRPKLASMTV 230
Query: 536 MERFVRVGILCAHVMVALRPTIADALKML 564
E V C H RPT A+ L+ +
Sbjct: 231 YE----VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 57/234 (24%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITD---LDTKGDEEFINEVEIISKIRHRNL 346
IGQGA G V++ E T+VAVK + + D + D F E ++++ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREAALMAEFDHPNI 70
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-------------------SNALTRK 387
+ L G C GK L++++M G L + + L
Sbjct: 71 VKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 388 QLAWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444
L+ ++ I VA G+AYL + HRD+ + N L+ M K+ADFGL++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 445 -------SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ R ++ PE Y + T +SDV+++G+V+ E+ S
Sbjct: 180 IYSADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 58/211 (27%), Positives = 110/211 (52%), Gaps = 28/211 (13%)
Query: 294 NLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEE---F----INEVEIISKIRHRN 345
N I +G GVVY+ + G +VA+K++ K ++E F + E+ I+ K++H N
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREINILLKLQHPN 65
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSG--SLGDHISNALTRKQLAWPQRKKIILDVAK 403
+++++ V S+ +K ++V +++ SL + + + + K ++L +
Sbjct: 66 IVTVKEVVVGSNLDK---IYMVMEYVEHDLKSLMETMKQPFLQ-----SEVKCLMLQLLS 117
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
G+A+LH I HRD+K++N+LL++ K+ DFGLA++ T V T Y
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYR 173
Query: 464 APEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
APE L + + D++S G + EL++ +
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHRNLL 347
IG GA GVV G VA+K+I+++ D + E++++ +RH N++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENII 62
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGD-----HISNALTRKQLAWPQRKKIILDVA 402
L E ++V + M + D LT + + + +
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELMET----DLHKVIKSPQPLTDDHIQY-----FLYQIL 113
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ---SLEGQSHLTTRVAGT 459
+GL YLH + HRD+K +NIL++S K+ DFGLA+ + + LT V T
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169
Query: 460 YGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVL 496
Y APE L + T+ D++S G + EL+ RK L
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 71/226 (31%), Positives = 112/226 (49%), Gaps = 35/226 (15%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTL--EDGTL---VAVKQITDLD-TKGDEEF 331
+E+EL + ++G GA G VYKG E T+ VA+K + + K + EF
Sbjct: 4 LKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF 56
Query: 332 INEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL----GDHISNALTRK 387
++E I++ + H +L+ L G C+S + LV MP G L +H N ++
Sbjct: 57 MDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQL 110
Query: 388 QLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447
L W + +AKG+ YL + + HRD+ + N+L+ S K+ DFGLA+ LE
Sbjct: 111 LLNW------CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LE 160
Query: 448 GQSHLTTRVAGTY--GYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
G G ++A E Y + T +SDV+S+G+ I ELM+
Sbjct: 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 295 LIGQGASGVVYKGTLED--GTL--VAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G G+ GVV +G G + VAVK + +D + ++F+ E I+ + H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD----VAKGL 405
G ++ +V + P GSL D + RK + D +A G+
Sbjct: 62 YGVVLT------HPLMMVTELAPLGSLLDRL-----RKDALGHFLISTLCDYAVQIANGM 110
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT----RVAGTYG 461
YL K I HRD+ + NILL S+ K K+ DFGL + + + H +V +
Sbjct: 111 RYLE--SKRFI-HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FA 165
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILEL----------MSGRKVLET 498
+ APE + SDV+ FG+ + E+ +SG ++L+
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 60/203 (29%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 291 SQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+ K+ +G G G VY+G + VAVK + + DT EEF+ E ++ +I+H NL+ L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G C + +++ +FM G+L D++ R+++ + ++ + YL
Sbjct: 68 LGVCT-----REPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLE 121
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT---YGYLAPE 466
K HRD+ + N L+ KVADFGL++ + G ++ T AG + APE
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTY--TAHAGAKFPIKWTAPE 175
Query: 467 YALYGQLTEKSDVYSFGIVILEL 489
Y + + KSDV++FG+++ E+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIRHRNLLSLR 350
+ ++G G G VYK L ++AVK I D+ + ++ ++E+EI+ K ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
G + R + +FM GSL + +++ +I + V KGL YL +
Sbjct: 66 GAFFVEN-----RISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYL-W 112
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
LK I HRD+K +N+L+++ + K+ DFG++ Q + S T V GT Y+APE
Sbjct: 113 SLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYV-GTNAYMAPERISG 167
Query: 471 GQLTEKSDVYSFGIVILELMSGR 493
Q SDV+S GI +EL GR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 72/239 (30%), Positives = 118/239 (49%), Gaps = 32/239 (13%)
Query: 258 HEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVA 316
HE+F + + V P S LD F + IG+G++G+V T G VA
Sbjct: 1 HEQFRAALQLVVDPGD-----PRSYLDN----FVK---IGEGSTGIVCIATDKSTGRQVA 48
Query: 317 VKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL 376
VK++ + E NEV I+ +H N++ + + D+ ++V +F+ G+L
Sbjct: 49 VKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE-----LWVVMEFLEGGAL 103
Query: 377 GDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV 436
D + T ++ Q + L V K L++LH + HRDIKS +ILL S+ + K+
Sbjct: 104 TDIV----THTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKL 156
Query: 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY---ALYGQLTEKSDVYSFGIVILELMSG 492
+DFG Q + + V GT ++APE YG TE D++S GI+++E++ G
Sbjct: 157 SDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYG--TE-VDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
+G GA G VYK E G A K I + E+F+ E++I+S+ +H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP 414
+ +++ +F G+L + + L PQ + + + + L +LH
Sbjct: 73 YENK-----LWILIEFCDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK-- 123
Query: 415 AIYHRDIKSTNILLDSEMKAKVADFGL-AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL 473
+ HRD+K+ NILL + K+ADFG+ AK Q T GT ++APE
Sbjct: 124 -VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETF 180
Query: 474 TE-----KSDVYSFGIVILELMSGR 493
+ K+D++S GI ++EL
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDL-DTKGD-----EEFINEVEIISKIRHRNLL 347
+G GA Y+ ++ GTL+AVKQ+T + +T + E E+ +++++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 348 SLRGCCVSSDDEKGKRRFLVY-DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
+ G F ++ ++M GS+ +S K+ + +GL+
Sbjct: 67 RMLGATCE------DSHFNLFVEWMAGGSVSHLLSKYGAFKEAV---IINYTEQLLRGLS 117
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQ---SLEGQSHLTTRVAGTYGY 462
YLH + I HRD+K N+L+DS + ++ADFG A + G ++ GT +
Sbjct: 118 YLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 463 LAPEYALYGQLTEKS-DVYSFGIVILELMSGR 493
+APE L G+ +S DV+S G VI+E+ + +
Sbjct: 175 MAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 18/202 (8%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G G V+ T T VAVK + + E F+ E ++ ++H L+ L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP 414
+ +++ +FM GSL D + S+ +++ L P+ +A+G+A++ +
Sbjct: 73 ------EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QR 121
Query: 415 AIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPEYALYGQ 472
HRD+++ NIL+ + + K+ADFGLA+ + + T R + + APE +G
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 473 LTEKSDVYSFGIVILELMS-GR 493
T KSDV+SFGI+++E+++ GR
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 295 LIGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
++G+G G+VY L +A+K+I + D++ + E+ + S ++HRN++ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 354 VSSDDEKGKRRFLVY-DFMPSGSLGDHISNA---LTRKQLAWPQRKKIILDVAKGLAYLH 409
+ F ++ + +P GSL + + L + K IL+ GL YLH
Sbjct: 75 SENG------FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE---GLKYLH 125
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKA-KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
I HRDIK N+L+++ K++DFG +K+ L G + T GT Y+APE
Sbjct: 126 ---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR-LAGINPCTETFTGTLQYMAPEVI 181
Query: 469 LYGQ--LTEKSDVYSFGIVILELMSGR 493
G +D++S G I+E+ +G+
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G G V+ G T VA+K + + E F+ E ++ +++H L+ L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
+ +++ ++M +GSL D + +L + + +A+G+A++ K
Sbjct: 73 ------EPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE--RKNY 123
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPEYALYGQL 473
I HRD+++ NIL+ + K+ADFGLA+ L + T R + + APE YG
Sbjct: 124 I-HRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 474 TEKSDVYSFGIVILELMS-GR 493
T KSDV+SFGI++ E+++ GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 65/223 (29%), Positives = 113/223 (50%), Gaps = 21/223 (9%)
Query: 288 GGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLDT-KGDEEFINEVEIISKIR 342
+++ +IG G G V++G L+ VA+K + T K ++F++E I+ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
H N++ L G K K ++ ++M +G+L ++ + + + Q ++ +A
Sbjct: 65 HHNIIRLEGVV-----TKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIA 117
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG---T 459
G+ YL HRD+ + NIL++S ++ KV+DFGL++ LE T +G
Sbjct: 118 AGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIP 173
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMS--GRKVLETSN 500
+ APE Y + T SDV+SFGIV+ E+MS R + SN
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 72/218 (33%), Positives = 101/218 (46%), Gaps = 13/218 (5%)
Query: 283 LDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKI 341
L T + IG+G G VYK T +DG+L AVK I D + DEE E I+ +
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSL 75
Query: 342 -RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQ-LAWPQRKKIIL 399
H N++ G +D G + +LV + GS+ + + L Q L I+
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT 459
GL +LH I HRD+K NILL +E K+ DFG++ Q + T V GT
Sbjct: 136 GALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GT 191
Query: 460 YGYLAPEYALYGQLTEKS-----DVYSFGIVILELMSG 492
++APE Q + S DV+S GI +EL G
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G G V+ G + T VAVK + T + F+ E ++ ++H L+ L V
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYA--VV 70
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP 414
+ +E +++ ++M GSL D + S+ + L P+ +A+G+AY+ +
Sbjct: 71 TKEEP---IYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RK 122
Query: 415 AIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPEYALYGQ 472
HRD+++ N+L+ + K+ADFGLA+ + + T R + + APE +G
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGS 180
Query: 473 LTEKSDVYSFGIVILELMSGRKV 495
T KSDV+SFGI++ E+++ K+
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKI 203
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 296 IGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
IG+G++G+V T++ G LVAVK++ + E NEV I+ +H N++ + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP 414
D+ ++V +F+ G+L D +T ++ Q + L V K L+ LH
Sbjct: 88 VGDE-----LWVVMEFLEGGALTD----IVTHTRMNEEQIAAVCLAVLKALSVLH---AQ 135
Query: 415 AIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLT 474
+ HRDIKS +ILL + + K++DFG Q + + + GT ++APE
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ-VSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 475 EKSDVYSFGIVILELMSG 492
+ D++S GI+++E++ G
Sbjct: 195 PEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 55/186 (29%), Positives = 96/186 (51%), Gaps = 17/186 (9%)
Query: 312 GTLVAVKQITDLDTKGDEEFIN----EVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367
G VAVK L + I E+EI+ + H N++ +G C ++ G L+
Sbjct: 33 GEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC---TEDGGNGIKLI 86
Query: 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNIL 427
+F+PSGSL +++ + L Q+ K + + KG+ YL G + + HRD+ + N+L
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVL 141
Query: 428 LDSEMKAKVADFGLAKQSLEGQSHLTTR--VAGTYGYLAPEYALYGQLTEKSDVYSFGIV 485
++SE + K+ DFGL K + + T + + + APE + + SDV+SFG+
Sbjct: 142 VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVT 201
Query: 486 ILELMS 491
+ EL++
Sbjct: 202 LYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 76/236 (32%), Positives = 115/236 (48%), Gaps = 47/236 (19%)
Query: 290 FSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEF----INEVEIISKIRHR 344
F IG+G G VYK +D G LVA+K++ LD + E F I E++I+ ++ HR
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR-LDNE-KEGFPITAIREIKILRQLNHR 66
Query: 345 NLLSLRGCCVSSDD----EKGKRRF-LVYDFMPSGSLG-----------DHISNALTRKQ 388
N+++L+ D +K K F LV+++M +G DHI + + KQ
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM--KQ 124
Query: 389 LAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448
L L+ GL Y H K HRDIK +NILL+++ + K+ADFGLA+
Sbjct: 125 L---------LE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 449 QSHLTTRVAGTYGYLAPEYAL----YGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
+S T T Y PE L YG DV+S G ++ EL + + + + +
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAI---DVWSCGCILGELFTKKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 283 LDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKI 341
L G F L+G G G VYKG ++ G L A+K + D+ +EE E+ ++ K
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKY 59
Query: 342 -RHRNLLSLRGCCVSSDDE-KGKRRFLVYDFMPSGSLGDHISNA----LTRKQLAWPQRK 395
HRN+ + G + + + +LV +F +GS+ D I N L + +A+
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY---- 115
Query: 396 KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR 455
I ++ +GL++LH + + HRDIK N+LL + K+ DFG++ Q L+
Sbjct: 116 -ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNT 170
Query: 456 VAGTYGYLAPEYALYGQLTE-----KSDVYSFGIVILELMSG 492
GT ++APE + + KSD++S GI +E+ G
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 45/224 (20%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G+GA G V+ +D LVAVK + + ++F E E+++ ++H++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI------------SNALTRKQLAWPQRKKI 397
G C +G+ +V+++M G L + + QL Q I
Sbjct: 73 YGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 398 ILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-------SLE 447
+A G+ YL H+ HRD+ + N L+ + K+ DFG+++ +
Sbjct: 128 ASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
G++ L R ++ PE LY + T +SD++SFG+V+ E+ +
Sbjct: 182 GRTMLPIR------WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 292 QKNLIGQGASGVVYKGTLED-GTLVAVKQIT-DLDTKGDEEFIN----EVEIISKIRHRN 345
L+G+GA G VY D G +AVKQ+ D D++ + +N E++++ +RH
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS--NALTRKQLAWPQRKKIILDVAK 403
++ GC D E+ K V ++MP GS+ D + ALT ++ + +
Sbjct: 66 IVQYYGCL--RDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENV-----TRRYTRQILQ 117
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK--QSLEGQSHLTTRVAGTYG 461
G++YLH + I HRDIK NIL DS K+ DFG +K Q++ V GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+++PE K+DV+S ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 16/199 (8%)
Query: 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
IG+G++G+V T + G VAVK++ + E NEV I+ H N++ + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNA-LTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
D+ ++V +F+ G+L D +++ + +Q+A + L V + L+YLH
Sbjct: 90 VGDE-----LWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH---N 136
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL 473
+ HRDIKS +ILL S+ + K++DFG Q + + + GT ++APE
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ-VSKEVPKRKSLVGTPYWMAPEVISRLPY 195
Query: 474 TEKSDVYSFGIVILELMSG 492
+ D++S GI+++E++ G
Sbjct: 196 GTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 296 IGQGASGVVY--KGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
IG+G+ G +Y K + V +K+I T + K E EV +++K++H N+++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF-- 64
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNA----LTRKQ-LAWPQRKKIILDVAKGLA 406
+S E G R F+V ++ G L I+ + Q L+W + ++ GL
Sbjct: 65 --FASFQENG-RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLK 115
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
++H I HRDIKS NI L M AK+ DFG+A+Q L L GT YL+P
Sbjct: 116 HIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVGTPYYLSP 171
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
E K+D++S G V+ EL + + E +N
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 27/225 (12%)
Query: 275 AKWFRESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTL----VAVKQITDLDTKGD- 328
A+ +E+EL + L+G G G V+KG + +G VA+K I D +
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 329 EEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQ 388
+E + + + + H ++ L G C G LV P GSL DH+ +
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC------PGASLQLVTQLSPLGSLLDHVRQ---HRD 104
Query: 389 LAWPQRK-KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL- 446
PQR + +AKG+ YL + + HR++ + NILL S+ ++ADFG+A
Sbjct: 105 SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161
Query: 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ + + + ++A E L+G+ T +SDV+S+G+ + E+MS
Sbjct: 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 296 IGQGASGVVY---KGTLEDGTLVAVKQITDLDTKGD---EEFINEVEIISKIRHRNLLSL 349
I +GA G V+ K + D + A+K I D ++ + E +I+S+ + ++ L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN--ALTRKQLAWPQRKKIILDVAKGLAY 407
K +LV +++P G L + N +L + +A + I ++ L Y
Sbjct: 59 Y-YSFQGK----KNLYLVMEYLPGGDLASLLENVGSLD-EDVA----RIYIAEIVLALEY 108
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ-------SHLTTRVAGTY 460
LH I HRD+K NIL+DS K+ DFGL+K L + R+ GT
Sbjct: 109 LH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMSG 492
Y+APE L ++ D +S G ++ E + G
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 32/229 (13%)
Query: 314 LVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMP 372
LVAVK + D+ +F+ E++I+S++++ N++ L G CVS D ++ ++M
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYME 100
Query: 373 SGSLGDHISNALTRKQLAWPQRKKII---------LDVAKGLAYLHYGLKPAIYHRDIKS 423
+G L +S + + +A G+ YL HRD+ +
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157
Query: 424 TNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSF 482
N L+ + K+ADFG+++ G + + R ++A E L G+ T SDV++F
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217
Query: 483 GIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531
G+ + E+ F L + + L + +V E EF R +G
Sbjct: 218 GVTLWEM-------------FTLCKEQPYSLLSDEQVIENTGEFFRNQG 253
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 40/281 (14%)
Query: 296 IGQGASGVVYK-GTLEDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G G G V K + GT++A K + + ++ + E++I+ + R ++S G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK----KIILDVAKGLAYLH 409
++ ++ + +FM GSL + + +K P KI + V +GL YL+
Sbjct: 73 LNENN-----ICMCMEFMDCGSL-----DRIYKK--GGPIPVEILGKIAVAVVEGLTYLY 120
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ I HRDIK +NIL++S + K+ DFG+ S E + + GT Y++PE
Sbjct: 121 NVHR--IMHRDIKPSNILVNSRGQIKLCDFGV---SGELINSIADTFVGTSTYMSPERIQ 175
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
G+ T KSDV+S GI I+EL G+ SN D +L ++ + ++E
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-------DLLQQIVQE 228
Query: 530 EGSR-------AVMERFVRVGILCAHVMVALRPTIADALKM 563
R + FV C RPT M
Sbjct: 229 PPPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF---INEVEIISKIRHRNLLSLRG 351
IG G+ G VY + +VA+K+++ + +E++ I EV + ++RH N + +G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
C + + +LV ++ GS D + + +K L + I +GLAYLH
Sbjct: 83 CYL-----REHTAWLVMEYC-LGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY- 470
+ HRDIK+ NILL K+ADFG A S + GT ++APE L
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAM 186
Query: 471 --GQLTEKSDVYSFGIVILEL 489
GQ K DV+S GI +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 8e-17
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDE--EFINEVEIISKIRHRNLL 347
F++ IG+G+ G VYKG V +I DL+ DE + E+ ++S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS-NALTRKQLAWPQRKKIILDVAKGLA 406
G + KG + +++ +++ GS D + L +A I+ ++ KGL
Sbjct: 66 RYYGSYL-----KGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLD 115
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
YLH K HRDIK+ N+LL + K+ADFG+A Q + Q T V GT ++APE
Sbjct: 116 YLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 171
Query: 467 YALYGQLTEKSDVYSFGIVILELMSG 492
K+D++S GI +EL G
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 296 IGQGASGVV----YKGTLEDGTLVAVKQITDLDTKGDEEFINEVE----------IISKI 341
+G+G G V YK T G L A+K + KGD +EVE +
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALK----KGDIIARDEVESLMCEKRIFETANSE 59
Query: 342 RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDV 401
RH L++L C + D V ++ G L HI + P+ V
Sbjct: 60 RHPFLVNLFACFQTED-----HVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACV 110
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG 461
GL YLH + I +RD+K N+LLD+E K+ADFGL K+ + G T+ GT
Sbjct: 111 VLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPE 166
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILELMSG 492
+LAPE T D + G++I E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 293 KNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL 346
K +G+GA G V+ +D LVAVK + D ++F E E+++ ++H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGD----HISNALTR------KQLAWPQRKK 396
+ G CV D +V+++M G L H +A+ +L Q
Sbjct: 70 VKFYGVCVEGDP-----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-------SLEGQ 449
I +A G+ YL HRD+ + N L+ + K+ DFG+++ + G
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 450 SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ L R ++ PE +Y + T +SDV+S G+V+ E+ +
Sbjct: 182 TMLPIR------WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 295 LIGQGASGVVY--KGTLEDGTLVAVKQI-TDLDTKGDEEFI-NEVEIISKIRHRNLLSLR 350
++G+GA G+V+ + D LV +KQI + TK + NE +++ + H N++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD-VAKGLAYLH 409
+ K +V ++ P G+L ++I R + IL + L LH
Sbjct: 66 ENFLED-----KALMIVMEYAPGGTLAEYIQK---RCNSLLDE--DTILHFFVQILLALH 115
Query: 410 YGLKPAIYHRDIKSTNILLDS-EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
+ I HRD+K+ NILLD +M K+ DFG++K L +S T V GT Y++PE
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI-LSSKSKAYT-VVGTPCYISPELC 173
Query: 469 LYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
+KSD+++ G V+ EL S ++ E +N
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 295 LIGQGASGVV----YKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
++G+G+ G V KGT E + +K+ L E + E +++ L+
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
C + D R F V +++ G L HI + P+ + ++ GL +LH
Sbjct: 62 HSCFQTKD----RLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLH- 113
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS-LEGQSHLTTRVAGTYGYLAPEYAL 469
+ I +RD+K N+LLDSE K+ADFG+ K+ L G + T+ GT Y+APE
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILS 169
Query: 470 YGQLTEKSDVYSFGIVILELMSGR 493
Y D ++ G+++ E+++G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 46/228 (20%)
Query: 293 KNLIGQGASGVVYKGT------LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL 346
K +G+GA G V+ +D LVAVK + D ++F E E+++ ++H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGD----HISNAL---------TRKQLAWPQ 393
+ G C D +V+++M G L H +A+ + +L Q
Sbjct: 70 VKFYGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 394 RKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ------ 444
I +A G+ YL H+ HRD+ + N L+ + + K+ DFG+++
Sbjct: 125 MLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 445 -SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ G + L R ++ PE +Y + T +SDV+SFG+++ E+ +
Sbjct: 179 YRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 30/215 (13%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDG----TLVAVKQITDLDT-KGDEEFINEVEIISKIRH 343
F + ++G GA G VYKG + +G VA+K++ + + K ++E ++E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI----SNALTRKQLAWPQRKKIIL 399
++ L G C++S + L+ MP G L D++ N ++ L W +
Sbjct: 69 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 116
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG- 458
+AKG+ YL + + HRD+ + N+L+ + K+ DFGLAK L G G
Sbjct: 117 QIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAK--LLGADEKEYHAEGG 171
Query: 459 --TYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
++A E L+ T +SDV+S+G+ + ELM+
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 67/224 (29%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 281 SELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIIS 339
S L G F ++G G G VYKG ++ G L A+K + D+ +EE E+ ++
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLK 67
Query: 340 KI-RHRNLLSLRGCCVS-SDDEKGKRRFLVYDFMPSGSLGDHIS----NALTRKQLAWPQ 393
K HRN+ + G + S + +LV +F +GS+ D + NAL +A+
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 394 RKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLT 453
R ++ +GLA+LH + HRDIK N+LL + K+ DFG++ Q L+
Sbjct: 128 R-----EILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRR 178
Query: 454 TRVAGTYGYLAPEYALYGQLTE-----KSDVYSFGIVILELMSG 492
GT ++APE + + +SD++S GI +E+ G
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDE--EFINEVEIISKIRHRNLL 347
F++ IG+G+ G V+KG V +I DL+ DE + E+ ++S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIILDVAKGLA 406
G + KG + +++ +++ GS D + + Q+A ++ ++ KGL
Sbjct: 66 KYYGSYL-----KGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLD 115
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
YLH K HRDIK+ N+LL + K+ADFG+A Q + Q T V GT ++APE
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 171
Query: 467 YALYGQLTEKSDVYSFGIVILELMSG 492
K+D++S GI +EL G
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 295 LIGQGASGVVYKG-TLEDGTLVAVKQIT-DLDTKGDEEFIN----EVEIISKIRHRNLLS 348
L+GQGA G VY ++ G +A KQ+ D ++ + ++ E++++ ++H ++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 349 LRGCCVSSDDEKGKRRFLVY-DFMPSGSLGDHIS--NALTRKQLAWPQRKKIILDVAKGL 405
GC ++ ++ ++ ++MP GS+ D + ALT +K + +G+
Sbjct: 69 YYGCL----RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV-----TRKYTRQILEGM 119
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK--QSLEGQSHLTTRVAGTYGYL 463
+YLH + I HRDIK NIL DS K+ DFG +K Q++ V GT ++
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
+PE K+DV+S G ++E+++ +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 30/209 (14%)
Query: 295 LIGQGASGVVYK-GTLEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHRNLLSL 349
L+G+G+ G+V K E G +VA+K+ L+++ D+ + E+ ++ ++RH NL++L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGD--HISNALTRKQLAWPQRKKIILDVAKGLAY 407
+ KR +LV++F+ L D N L ++ +K + + +G+ +
Sbjct: 66 IEVF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRV-----RKYLFQILRGIEF 115
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
H I HRDIK NIL+ K+ DFG A+ T VA T Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPEL 171
Query: 468 AL----YGQLTEKSDVYSFGIVILELMSG 492
+ YG+ D+++ G ++ E+++G
Sbjct: 172 LVGDTKYGRAV---DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 75/233 (32%), Positives = 111/233 (47%), Gaps = 56/233 (24%)
Query: 281 SELDQATGGFSQKNLIGQGASGVVYK----GTLEDGTLVAVKQI-TDLDTKGDEEFINEV 335
SEL++ N IG GA G VYK T G L A+K I + + + E+
Sbjct: 74 SELERV-------NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREI 123
Query: 336 EIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL-GDHISNALTRKQLAWPQR 394
EI+ + H N++ C D G+ + L+ +FM GSL G HI++ + LA
Sbjct: 124 EILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEGTHIAD---EQFLA---- 171
Query: 395 KKIILDVAK----GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450
DVA+ G+AYLH + I HRDIK +N+L++S K+ADFG+++ +
Sbjct: 172 -----DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223
Query: 451 HLTTRVAGTYGYLAPE----------YALYGQLTEKSDVYSFGIVILELMSGR 493
+ V GT Y++PE Y Y D++S G+ ILE GR
Sbjct: 224 PCNSSV-GTIAYMSPERINTDLNHGAYDGYA-----GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 45/225 (20%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLD-------TKGDEEFINEVEIISKI 341
+ + IG+GA G+V T G VA+K+I+ + T + E++I+ +
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT------LREIKILRRF 60
Query: 342 RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMP--------SGSLG-DHISNALTRKQLAWP 392
+H N++ + E ++V + M + L DHI
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHI------------ 108
Query: 393 QRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH- 451
+ + + +GL Y+H + HRD+K +N+LL++ K+ DFGLA+ + H
Sbjct: 109 --QYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 452 --LTTRVAGTYGYLAPEYALYGQLTEKS-DVYSFGIVILELMSGR 493
LT VA T Y APE L + K+ D++S G ++ E++S R
Sbjct: 164 GFLTEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 45/233 (19%)
Query: 295 LIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHR--NLLSLR 350
IG G G VYK + G ++AVKQ+ K + + I +++++ K H ++
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIVKCY 80
Query: 351 GCCVSSDD------------EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKII 398
G ++ D +K +R + +P LG K+
Sbjct: 81 GYFITDSDVFICMELMSTCLDKLLKR--IQGPIPEDILG------------------KMT 120
Query: 399 LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
+ + K L YL K + HRD+K +NILLD+ K+ DFG++ + ++ ++ TR AG
Sbjct: 121 VAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAG 176
Query: 459 TYGYLAPEY----ALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLIT 507
Y+APE + ++DV+S GI ++EL +G+ + + F ++T
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT 229
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 23/203 (11%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEE---FINEVEIISKIRHRNLLSLRG 351
+G GA G VYK E G L A K I +TK +EE ++ E+EI++ H ++ L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
GK ++ +F P G++ D I L R L PQ + I + + L YLH
Sbjct: 77 AFY----WDGKLWIMI-EFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLH-- 127
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
I HRD+K+ N+LL + K+ADFG++ ++++ + + GT ++APE +
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCE 185
Query: 472 QLTE-----KSDVYSFGIVILEL 489
+ + K+D++S GI ++E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 295 LIGQGASGVVYKGTLE----DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSL 349
+IG G G V +G L+ VA+K + T K +F++E I+ + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G S + ++ +FM +G+L + Q Q ++ +A G+ YL
Sbjct: 71 EGVVTKS-----RPVMIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH--LTTRVAGTYG--YLAP 465
+ HRD+ + NIL++S + KV+DFGL++ + S T+ + G + AP
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 466 EYALYGQLTEKSDVYSFGIVILELMS 491
E Y + T SDV+S+GIV+ E+MS
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 296 IGQGASG--VVYKGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
IG+G+ G ++ K EDG +K+I + + K EE EV ++S ++H N++ +
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ- 65
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD----VAKGLAY 407
S +E G ++V D+ G L I+ ++ + +P+ + ILD + L +
Sbjct: 66 ---ESFEENGNL-YIVMDYCEGGDLYKKINA---QRGVLFPEDQ--ILDWFVQICLALKH 116
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
+H I HRDIKS NI L + K+ DFG+A+ L L GT YL+PE
Sbjct: 117 VH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEI 172
Query: 468 ALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLI 506
KSD+++ G V+ E+ + + E N L++
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 290 FSQKNLIGQGASGVVYKG-TLEDGTLVAVKQIT-DLDTKG-DEEFINEVEIISKIRHRNL 346
F + IG+G GVVYK G +VA+K+I D +T+G I E+ ++ ++ H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
+ L + + +LV++F+ L + +A + P K + + +GLA
Sbjct: 62 VKLLDVIHTE-----NKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+ H + HRD+K N+L+++E K+ADFGLA+ T V T Y APE
Sbjct: 115 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 170
Query: 467 YALYGQL-TEKSDVYSFGIVILELMSGRKVL 496
L + + D++S G + E+++ R+ L
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 32/219 (14%)
Query: 293 KNLIGQGASGVVYKGTLEDGTL---VAVKQITDLDTKGDE-EFINEVEIISKI-RHRNLL 347
+++IG+G G V K ++ L A+K++ + +K D +F E+E++ K+ H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQR 394
+L G C E +L ++ P G+L D + + T L+ Q
Sbjct: 72 NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 395 KKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT 454
DVA+G+ YL + HRD+ + NIL+ AK+ADFGL++ GQ
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 179
Query: 455 RVAGTYG--YLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ G ++A E Y T SDV+S+G+++ E++S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 23/213 (10%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF---INEVEIISKIRHRNLLSLRG 351
IG G+ G VY T +VAVK+++ + +E++ I EV+ + +++H N + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
C + K +LV ++ GS D + + +K L + I +GLAYLH
Sbjct: 89 CYL-----KEHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLH-- 138
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY- 470
+ HRDIK+ NILL + K+ADFG A +S S + GT ++APE L
Sbjct: 139 -SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 471 --GQLTEKSDVYSFGIVILELMSGRKVLETSNS 501
GQ K DV+S GI +EL + L N+
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITD-----LDTKGDEEFINEVEIISKIRHRNLLSL 349
IG+GA G+V E VA+K+I + +D K + E++++ + H N++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAK---RTLREIKLLRHLDHENVIAI 69
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI--SNALTRKQLAWPQRKKIILDVAKGLAY 407
+ E ++VY+ M + L I S L+ + + + +GL Y
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQY-----FLYQLLRGLKY 123
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
+H + HRD+K +N+LL++ K+ DFGLA+ + E +T V T Y APE
Sbjct: 124 IH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL 179
Query: 468 AL-YGQLTEKSDVYSFGIVILELMSGRKVL 496
L + T DV+S G + EL+ GRK L
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD----EEFIN--EVEIISKI-RHRNLL 347
+G G G VY E G LVA+K++ K EE +N EV+ + K+ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-----KKKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
L+ +D+ + V+++M G+L + + K + + II + +GLA+
Sbjct: 62 KLKEVFRENDE-----LYFVFEYM-EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAH 114
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
+H K +HRD+K N+L+ K+ADFGLA+ + + T V T Y APE
Sbjct: 115 IH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTDYV-STRWYRAPEI 169
Query: 468 AL----YGQLTEKSDVYSFGIVILELMSGR 493
L Y D+++ G ++ EL + R
Sbjct: 170 LLRSTSYSS---PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHRNLLSLR 350
IGQG G V+K + +VA+K++ + K E F + E++I+ ++H N+++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 77
Query: 351 GCCVSSDDEKGKRR---FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
C + + + +LV++F L +SN + L + KK++ + GL Y
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKNVKFTL--SEIKKVMKMLLNGLYY 134
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK---QSLEGQSHL-TTRVAGTYGYL 463
+H I HRD+K+ NIL+ + K+ADFGLA+ S + + T RV T Y
Sbjct: 135 IHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYR 190
Query: 464 APEYAL----YGQLTEKSDVYSFGIVILEL 489
PE L YG D++ G ++ E+
Sbjct: 191 PPELLLGERDYGP---PIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDE--EFINEVEIISKIRHRNLL 347
F++ IG+G+ G V+KG V +I DL+ DE + E+ ++S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS-NALTRKQLAWPQRKKIILDVAKGLA 406
G + K + +++ +++ GS D + L Q+A I+ ++ KGL
Sbjct: 66 KYYGSYL-----KDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLD 115
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
YLH K HRDIK+ N+LL + K+ADFG+A Q + Q T V GT ++APE
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 171
Query: 467 YALYGQLTEKSDVYSFGIVILELMSG 492
K+D++S GI +EL G
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 28/234 (11%)
Query: 276 KWFRESELDQATGGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGD- 328
+W E D+ T G +G+GA G V K + + VAVK + D T+ D
Sbjct: 6 EW--ELPRDRLTLG----KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL 59
Query: 329 EEFINEVEIISKI-RHRNLLSLRGCC--------VSSDDEKGKRRFLVYDFMPSGSLGDH 379
+ ++E+E++ I +H+N+++L G C V G R + P G
Sbjct: 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119
Query: 380 ISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439
+ L VA+G+ +L K I HRD+ + N+L+ + K+ADF
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADF 176
Query: 440 GLAKQSLEGQSHL-TTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMS 491
GLA+ + TT ++APE AL+ ++ T +SDV+SFG+++ E+ +
Sbjct: 177 GLARDIHHIDYYRKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 296 IGQGASGVVYKGTLED-GTLVAVKQITDLDTK------GDEEFINEVEIISKIRHRNLLS 348
+G+G G V ++ G + A K+ LD K G++ +NE +I+ K+ R ++S
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK---LDKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL--DVAKGLA 406
L + DD LV M G L HI N +P+ + I + GL
Sbjct: 58 LAYAFETKDD-----LCLVMTLMNGGDLKYHIYNVGEP---GFPEARAIFYAAQIICGLE 109
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+LH + I +RD+K N+LLD +++D GLA + G+ AGT GY+APE
Sbjct: 110 HLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPE 164
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGR 493
D ++ G + E+++GR
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 295 LIGQGASGVVYKGTLED-GTLVAVKQIT-DLDTKGDEEFIN----EVEIISKIRHRNLLS 348
L+GQGA G VY D G +AVKQ+ D ++ + +N E++++ + H ++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN--ALTRKQLAWPQRKKIILDVAKGLA 406
GC D + + + MP GS+ D + + ALT +K + +G++
Sbjct: 69 YYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV-----TRKYTRQILEGVS 120
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ----SLEGQSHLTTRVAGTYGY 462
YLH + I HRDIK NIL DS K+ DFG +K+ L G + V GT +
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYW 175
Query: 463 LAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
++PE K+D++S G ++E+++ +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 67/241 (27%), Positives = 107/241 (44%), Gaps = 51/241 (21%)
Query: 294 NLIGQGASGVVYKG-TLEDGTLVAVKQIT----DLDTKGDEEFIN----------EVEII 338
+G+G G V K G +VA+K++ D D + + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 339 SKIRHRNLLSLRGCCVSSDDEKGKRRF--LVYDFMPSGSLGDHISNALTRK-QLAWPQRK 395
++I+H N++ L V D F LV D M S + + RK +L Q K
Sbjct: 75 NEIKHENIMGLVDVYVEGD-------FINLVMDIMAS-----DLKKVVDRKIRLTESQVK 122
Query: 396 KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ--------SLE 447
I+L + GL LH K HRD+ NI ++S+ K+ADFGLA++ +L
Sbjct: 123 CILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 448 GQSH------LTTRVAGTYGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVLETS 499
+T++V T Y APE L G + D++S G + EL++G+ +
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPEL-LMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 500 N 500
N
Sbjct: 238 N 238
|
Length = 335 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 32/219 (14%)
Query: 293 KNLIGQGASGVVYKGTLE-DGTLV--AVKQITDLDTKGDE-EFINEVEIISKI-RHRNLL 347
+++IG+G G V + ++ DG + A+K + + ++ D +F E+E++ K+ H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQR 394
+L G C E ++ ++ P G+L D + + T L Q
Sbjct: 67 NLLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 395 KKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT 454
+ DVA G+ YL + HRD+ + N+L+ + +K+ADFGL++ G+
Sbjct: 122 LQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK 174
Query: 455 RVAGTYG--YLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ G ++A E Y T KSDV+SFG+++ E++S
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 62/228 (27%)
Query: 296 IGQGASGVVYKGTLED---GTLVAVKQI-------TD----------LDTKGDEEFINEV 335
+G+GA G+V+K D +VA+K+I TD L GD I V
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNI--V 70
Query: 336 EIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK 395
++++ I+ N + +LV+++M + L +A+ R + K
Sbjct: 71 KLLNVIKAENDKDI---------------YLVFEYMET-DL-----HAVIRANILEDVHK 109
Query: 396 K-IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK-----QSLEGQ 449
+ I+ + K L Y+H G + HRD+K +NILL+S+ + K+ADFGLA+ +
Sbjct: 110 RYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
Query: 450 SHLTTRVAGTYGYLAPEYAL----YGQLTEKSDVYSFGIVILELMSGR 493
LT VA T Y APE L Y T+ D++S G ++ E++ G+
Sbjct: 167 PVLTDYVA-TRWYRAPEILLGSTRY---TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 25/212 (11%)
Query: 293 KNLIGQGASGVVYKGT---LEDGTL-VAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLL 347
IG+G G VY+G E+ + VAVK E+F+ E I+ + H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI---SNALTRKQLAWPQRKKIILDVAKG 404
L G + ++V + P G L ++ +L L ++
Sbjct: 71 KLIGVITENP------VWIVMELAPLGELRSYLQVNKYSLDLASLI-----LYSYQLSTA 119
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLT-TRVAGTYGYL 463
LAYL HRDI + N+L+ S K+ DFGL++ LE +S+ ++ ++
Sbjct: 120 LAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWM 175
Query: 464 APEYALYGQLTEKSDVYSFGIVILE-LMSGRK 494
APE + + T SDV+ FG+ + E LM G K
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 296 IGQGASGVV-YKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
IG+G++G+V G VAVK + + E NEV I+ +H+N++ + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNA-LTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
G+ +++ +F+ G+L D +S L +Q+A + V + L YLH
Sbjct: 89 V-----GEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TVCESVLQALCYLH---S 135
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL 473
+ HRDIKS +ILL + + K++DFG Q + + GT ++APE
Sbjct: 136 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ-ISKDVPKRKSLVGTPYWMAPEVISRTPY 194
Query: 474 TEKSDVYSFGIVILELMSG 492
+ D++S GI+++E++ G
Sbjct: 195 GTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 34/207 (16%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFIN-EVEIISKIRHRNLLSLRGCC 353
+G G G VYK L G L AVK I L+ D I E+ ++ + +H N+++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVK-IIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGD--HISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
+S + + ++ ++ GSL D H++ L+ Q+A+ R+ + +GLAYLH
Sbjct: 76 LSRE-----KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK 125
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA------GTYGYLAP 465
K HRDIK NILL K+ADFG+A + +T +A GT ++AP
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVAAK-------ITATIAKRKSFIGTPYWMAP 175
Query: 466 EYALY---GQLTEKSDVYSFGIVILEL 489
E A G + D+++ GI +EL
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 36/211 (17%)
Query: 296 IGQGASGVVYK-GTLEDGTLVAVKQITDLDTKGDEEFIN-----EVEIISKIRHRNLLSL 349
IG+G+ GVV+K E G +VA+K+ + + D+ I E+ ++ +++H NL++L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESE---DDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 350 RGCCVSSDDE--KGKRRF-LVYDFMPSGSLGDH-ISNALTRKQLAWP--QRKKIILDVAK 403
E + KR+ LV+++ DH + N L + P KKII +
Sbjct: 66 I--------EVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQ 111
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
+ + H K HRD+K NIL+ + + K+ DFG A+ T VA T Y
Sbjct: 112 AVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYR 167
Query: 464 APEYALYG--QLTEKSDVYSFGIVILELMSG 492
APE L G Q DV++ G V EL++G
Sbjct: 168 APEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 296 IGQGASGVVYK-GTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCC 353
IG+G G V+K ++G+ AVK I D DEE E I+ + H N++ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTR-KQLAWPQRKKIILDVAKGLAYLHYGL 412
D + G + +LV + GS+ D + L R +++ P I+ + GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY-ALYG 471
HRD+K NILL +E K+ DFG++ Q L GT ++APE A
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ-LTSTRLRRNTSVGTPFWMAPEVIACEQ 200
Query: 472 QL----TEKSDVYSFGIVILELMSG 492
QL + DV+S GI +EL G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 295 LIGQGASGVVYKGT-LEDG----TLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLS 348
++G GA G VYKG + DG VA+K + + K ++E ++E +++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL----TRKQLAWPQRKKIILDVAKG 404
L G C++S + LV MP G L D++ ++ L W + +AKG
Sbjct: 74 LLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKG 121
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK-QSLEGQSHLTTRVAGTYGYL 463
++YL + + HRD+ + N+L+ S K+ DFGLA+ ++ + ++
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMS 491
A E L+ + T +SDV+S+G+ + ELM+
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 295 LIGQGASGVVYKGTL-EDGTLVAVKQIT-DLDTKGD--EEFINEVEIISKIRHRNLLSLR 350
++G+G+ G V L E G L AVK + D+ + D E + E I+S R+ L+
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
CC + D R F V +F+ G L HI + ++ + + ++ L +LH
Sbjct: 62 YCCFQTPD----RLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLH- 113
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY--- 467
I +RD+K N+LLD E K+ADFG+ K+ + T+ GT Y+APE
Sbjct: 114 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTPDYIAPEILQE 170
Query: 468 ALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
LYG D ++ G+++ E++ G E N
Sbjct: 171 MLYGPSV---DWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 28/210 (13%)
Query: 297 GQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFI---NEVEIISKIRHRNLLSLRGCC 353
+ K TLVAVK +LD+ E+ E+ +++H N+L
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVK-KINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTR--KQLAWPQRKKIILDVAKGLAYLHYG 411
+ + ++V M GS D + +LA I+ DV L Y+H
Sbjct: 69 IVDSE-----LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNALDYIH-- 118
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE-GQSH-----LTTRVAGTYGYLAP 465
HR +K+++ILL + K ++ + ++ G+ +L+P
Sbjct: 119 -SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 466 EYALYGQL---TEKSDVYSFGIVILELMSG 492
E L L EKSD+YS GI EL +G
Sbjct: 178 E-VLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 295 LIGQGASGVVYKGTLE----DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSL 349
+IG G G V G L+ VA+K + T K +F++E I+ + H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRK---QLAWPQRKKIILDVAKGLA 406
G K K +V ++M +GSL +A RK Q Q ++ +A G+
Sbjct: 71 EGVVT-----KSKPVMIVTEYMENGSL-----DAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG--QSHLTTRVAGT-YGYL 463
YL HRD+ + NIL++S + KV+DFGL++ LE ++ TTR +
Sbjct: 121 YLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWT 176
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMS--GRKVLETSNSSFLLITDWAWML 513
APE Y + T SDV+S+GIV+ E+MS R E SN + + + L
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 290 FSQKNLIGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEF---INEVEIISKIRHRN 345
FS IG G+ G VY + + +VA+K+++ + +E++ I EV + K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
+ RGC + + +LV ++ GS D + + +K L + + +GL
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAVTHGALQGL 128
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
AYLH + HRD+K+ NILL K+ DFG A + GT ++AP
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAP 180
Query: 466 EYALY---GQLTEKSDVYSFGIVILELMSGRKVLETSNS 501
E L GQ K DV+S GI +EL + L N+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 35/217 (16%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLS 348
+GQG+ G+VY+G E T VA+K + + + + EF+NE ++ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQ----LAWPQRKKIIL---DV 401
L G +G+ ++ + M G L ++ + + A P KK+I ++
Sbjct: 74 LLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE-------GQSHLTT 454
A G+AYL+ HRD+ + N ++ + K+ DFG+ + E G+ L
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 455 RVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
R +++PE G T SDV+SFG+V+ E+ +
Sbjct: 186 R------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 294 NLIGQGASGVVYKGTLEDGTL---VAVKQITDLDTKGD-EEFINEVEIISKI-RHRNLLS 348
++IG+G G V K ++ L A+K++ + +K D +F E+E++ K+ H N+++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRK 395
L G C E +L ++ P G+L D + + T L+ Q
Sbjct: 61 LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 396 KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR 455
DVA+G+ YL + HRD+ + NIL+ AK+ADFGL++ GQ +
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 168
Query: 456 VAGTYG--YLAPEYALYGQLTEKSDVYSFGIVILELMS 491
G ++A E Y T SDV+S+G+++ E++S
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 296 IGQGASGVVYKGTLE-DGTLVAVKQITD-LDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
IG+G G V+ G L D T VAVK + L +F+ E I+ + H N++ L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
+ + ++V + + G + R L + +++ + A G+ YL K
Sbjct: 63 T-----QKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLES--K 113
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT-YGYLAPEYALYGQ 472
I HRD+ + N L+ + K++DFG++++ +G T + + APE YG+
Sbjct: 114 HCI-HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 473 LTEKSDVYSFGIVILELMS 491
+ +SDV+SFGI++ E S
Sbjct: 173 YSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 290 FSQKNLIGQGASGVVY-KGTLEDGTLVAVKQITDLDTKGDEEF---INEVEIISKIRHRN 345
F+ IG G+ G VY + +VA+K+++ + +E++ I EV+ + +I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
+ +GC + + +LV ++ GS D + + +K L + I +GL
Sbjct: 87 SIEYKGCYL-----REHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGL 138
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
AYLH + HRDIK+ NILL + K+ADFG A + S + GT ++AP
Sbjct: 139 AYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAP 190
Query: 466 EYALY---GQLTEKSDVYSFGIVILELMSGRKVLETSNS 501
E L GQ K DV+S GI +EL + L N+
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 296 IGQGASGVVYKGTLE-DGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLR-GC 352
+G+GA GVV K GT++AVK+I ++++ + + +++I S+R
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDI----------SMRSVD 58
Query: 353 CVSSDDEKGK--RRFLVYDFMP--SGSLGDHISNALTRKQ-LAWPQRKKIILDVAKGLAY 407
C + G R V+ M SL + + KI + + K L Y
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
LH L + HRD+K +N+L++ + K+ DFG++ ++ S T AG Y+APE
Sbjct: 119 LHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPE- 173
Query: 468 ALYGQLTE-----KSDVYSFGIVILELMSGR 493
+ +L + KSDV+S GI ++EL +GR
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 296 IGQGASGVVYKGTL--EDGTL-VAVKQIT-DLDTKGD-EEFINEVEIISKIRHRNLLSLR 350
+G+G G V +G L +D L VAVK + + T+ + E+F++E + + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 351 GCCVSSDDEKG-KRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRK--KIILDVAKGLA 406
G C+ + + +G ++ FM G L + + L P + K + D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT-YGYLAP 465
YL + HRD+ + N +L+ M VADFGL+K+ G + R+A ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 466 EYALYGQLTEKSDVYSFGIVILELMS 491
E T KSDV+SFG+ + E+ +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKG--DEEFINEVEIISKIRHRNLLSLRGCC 353
+G G GVV K + L+ +++ L+ K + I E++++ + ++ G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA- 71
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
SD E + + M GSL + A K++ K+ + V +GLAYL K
Sbjct: 72 FYSDGEIS----ICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLRE--K 122
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL 473
I HRD+K +NIL++S + K+ DFG++ Q ++ + GT Y++PE
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHY 179
Query: 474 TEKSDVYSFGIVILELMSGR 493
+ +SD++S G+ ++EL GR
Sbjct: 180 SVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 287 TGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVK--QITDL-DTKGDEEFINEVEIISKIR 342
G F + IG+G VVYK L DG +VA+K QI ++ D K ++ + E++++ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK--KIILD 400
H N++ + +++ +V + +G L I + +K+L P+R K +
Sbjct: 61 HPNVIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLI-PERTIWKYFVQ 114
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
+ L ++H I HRDIK N+ + + K+ D GL + ++ + GT
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTP 170
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILEL 489
Y++PE KSD++S G ++ E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 63/227 (27%), Positives = 113/227 (49%), Gaps = 24/227 (10%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDL-DTKGDEEFI-NEVEIISKIRHRNLLSLRG 351
+IG+G+ GVV G VA+K+I D+ + D I E++++ +RH +++ ++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHI--SNALTRKQLAWPQRKKIIL-DVAKGLAYL 408
+ + K ++V++ M S L I ++ LT P+ + L + + L Y+
Sbjct: 67 IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT------PEHHQFFLYQLLRALKYI 119
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE---GQSHLTTRVAGTYGYLAP 465
H ++HRD+K NIL +++ K K+ DFGLA+ + T VA T Y AP
Sbjct: 120 H---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-TRWYRAP 175
Query: 466 EY--ALYGQLTEKSDVYSFGIVILELMSGRKVLETSN--SSFLLITD 508
E + + + T D++S G + E+++G+ + N LITD
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 296 IGQGASGVVYKGT--LEDGTL-VAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLSLRG 351
+G G G V KG + + VA+K + + + K +E + E EI+ ++ + ++ + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
C + + LV + G L +S + ++ +++ V+ G+ YL
Sbjct: 63 VC------EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLE-- 112
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPEYAL 469
HRD+ + N+LL ++ AK++DFGL+K S+ R AG + + APE
Sbjct: 113 -GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 470 YGQLTEKSDVYSFGIVILELMS-GRK 494
+ + + +SDV+S+GI + E S G+K
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 70/217 (32%), Positives = 101/217 (46%), Gaps = 51/217 (23%)
Query: 296 IGQGASGVV----YKGTLEDGTLVAVK-----QITDLDTKGDEEFINEVEIISKIRHRNL 346
+G G+ G V +KG+ G A+K +I L K E +NE I+ IRH L
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKL--KQVEHVLNEKRILQSIRHPFL 63
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK--- 403
++L G DD +LV +++P G L H+ RK + VA+
Sbjct: 64 VNLYGS--FQDD---SNLYLVMEYVPGGELFSHL-----RK------SGRFPEPVARFYA 107
Query: 404 -----GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
L YLH +Y RD+K N+LLDS+ K+ DFG AK+ T + G
Sbjct: 108 AQVVLALEYLHS--LDIVY-RDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCG 160
Query: 459 TYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSG 492
T YLAPE L YG+ D ++ GI+I E+++G
Sbjct: 161 TPEYLAPEIILSKGYGKA---VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEE-----FINEVEIISKIRHRNLLSL 349
IG+G GVVYK G +VA+K+I L+T ++E I E+ ++ ++ H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR-LET--EDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 350 RGCCVSSDDEKGKRRFLVYDF--MPSGSLGDHISN-ALTRKQLAWPQRKKIILDVAKGLA 406
S + +LV++F + D L + K + + +G+A
Sbjct: 64 LDVVHS-----ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI-----KSYLYQLLQGIA 113
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ---SLEGQSHLTTRVAGTYGYL 463
Y H + HRD+K N+L+D E K+ADFGLA+ + +H T Y
Sbjct: 114 YCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYR 166
Query: 464 APEYALYG-QLTEKSDVYSFGIVILELMSGRKVL 496
APE L Q + D++S G + E M R+ L
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAE-MVNRRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 45/143 (31%), Positives = 75/143 (52%), Gaps = 13/143 (9%)
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
C + D R + V +++ G L HI K+ P ++A GL +LH
Sbjct: 68 SCFQTMD----RLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIGLFFLH-- 118
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRV-AGTYGYLAPEYALY 470
I +RD+K N++LD+E K+ADFG+ K+++ G TTR GT Y+APE Y
Sbjct: 119 -SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAY 175
Query: 471 GQLTEKSDVYSFGIVILELMSGR 493
+ D ++FG+++ E+++G+
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 295 LIGQGASGVVY----KGTLEDG--TLVAVKQITDLDTKGDE----EFINEVEIISKIRHR 344
+G+G G V+ KG E+G TLV VK L DE EF E+++ K+ H+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKA---LQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI------SNALTRKQLAWPQRKKII 398
N++ L G C ++ +++ ++ G L + L L+ Q+ +
Sbjct: 69 NVVRLLGLCREAEPH-----YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 399 LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
+A G+ +L HRD+ + N L+ S+ + KV+ L+K + +
Sbjct: 124 TQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 459 TYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+LAPE + KSDV+SFG+++ E+ +
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 47/150 (31%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
L L C + D R + V +++ G L HI K+ PQ +++ GL
Sbjct: 63 LTQLHSCFQTVD-----RLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGL 114
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL-EGQSHLTTRV-AGTYGYL 463
+LH + I +RD+K N++LDSE K+ADFG+ K+ + +G +TTR GT Y+
Sbjct: 115 FFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYI 168
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
APE Y + D +++G+++ E+++G+
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGC 352
IG GA GVV+ T DG VA+K++ ++ + + E++++ +H N+LS
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL-DVAKGLAYLHYG 411
+ + ++V + M S + + Q K+ L + +GL YLH
Sbjct: 68 LQPPHIDPFEEIYVVTELMQS-----DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH-- 120
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLA-KQSLEGQSHLTTRVAGTYGYLAPEYALY 470
I HRDIK N+L++S K+ DFGLA + + H+T V Y Y APE L
Sbjct: 121 -SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI-LM 177
Query: 471 G--QLTEKSDVYSFGIVILELMSGRKVLETSN--SSFLLITD 508
G T D++S G + EL+ R + + + LITD
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 60/231 (25%), Positives = 106/231 (45%), Gaps = 28/231 (12%)
Query: 287 TGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI-----TDLDTKGDEEFINEVEIISK 340
T + +G GA G+V G VA+K+I T + K E++++
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK---RTYRELKLLKH 65
Query: 341 IRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD 400
+RH N++SL +S ++ + V + + G + LT + L + +
Sbjct: 66 LRHENIISLSDIFISPLEDI----YFVTELL-----GTDLHRLLTSRPLEKQFIQYFLYQ 116
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
+ +GL Y+H + HRD+K +NIL++ K+ DFGLA+ +T V+ Y
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYVSTRY 170
Query: 461 GYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLETSN--SSFLLITD 508
Y APE L Q + D++S G + E++ G+ + + + F +ITD
Sbjct: 171 -YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 26/203 (12%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFIN-EVEIISKIRHRNLLSLRGCC 353
IG G G VYK + G L A+K I L+ D + E+ ++ +H N+++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGD--HISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
+ D + ++ +F GSL D H++ L+ Q+A+ R+ + +GL YLH
Sbjct: 76 LRRD-----KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK 125
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA--GTYGYLAPEYAL 469
K HRDIK NILL K+ADFG++ Q + + R + GT ++APE A
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAA 179
Query: 470 Y---GQLTEKSDVYSFGIVILEL 489
G + D+++ GI +EL
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 56/208 (26%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG--DEEFINEVEIISKIRHRNLL 347
F + + +G G GVV+K + + L+ +++ L+ K + I E++++ + ++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGL 405
G SD E + + M GSL + + +K P++ K+ + V KGL
Sbjct: 67 GFYGA-FYSDGEIS----ICMEHMDGGSL-----DQVLKKAGRIPEQILGKVSIAVIKGL 116
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
YL K I HRD+K +NIL++S + K+ DFG++ Q ++ + GT Y++P
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSP 171
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGR 493
E + +SD++S G+ ++E+ GR
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 310 EDGTLVAVKQITDLDTKGDEE---FINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366
G VA+K + + + + F E + +++ H N+++L + F
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG----LLFA 56
Query: 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNI 426
V++++P +L + ++ L + +++L V LA H I HRD+K NI
Sbjct: 57 VFEYVPGRTLREVLAA---DGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNI 110
Query: 427 LL---DSEMKAKVADFGL------AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ-LTEK 476
++ AKV DFG+ + + TT V GT Y APE L G+ +T
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPN 169
Query: 477 SDVYSFGIVILELMSGRKVLE 497
SD+Y++G++ LE ++G++V++
Sbjct: 170 SDLYAWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 50/225 (22%)
Query: 296 IGQGASGVVYKG---TLEDGTLVAVKQITDLDTKGDEEF--------INEVEIISKIRHR 344
IG+G G VYK +DG A+K+ KGD+E E+ ++ +++H
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLG---DHISNALTRKQLAWPQRKKIILDV 401
N++SL + D K +L++D+ H R + K ++ +
Sbjct: 63 NVVSLVEVFLEHAD---KSVYLLFDYAEHDLWQIIKFHRQAK--RVSIPPSMVKSLLWQI 117
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA----KVADFGLA-------KQSLEGQS 450
G+ YLH + HRD+K NIL+ E K+ D GLA K +
Sbjct: 118 LNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD- 173
Query: 451 HLTTRVAGTYGYLAPEYAL----YGQLTEKSDVYSFGIVILELMS 491
V T Y APE L Y T+ D+++ G + EL++
Sbjct: 174 ----PVVVTIWYRAPELLLGARHY---TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/196 (26%), Positives = 95/196 (48%), Gaps = 26/196 (13%)
Query: 314 LVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMP 372
LVAVK + D + +F+ EV+I+S+++ N++ L G CV D ++ ++M
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDP-----LCMITEYME 102
Query: 373 SGSLGDHIS-NALTRKQ---------------LAWPQRKKIILDVAKGLAYLHYGLKPAI 416
+G L +S + L K+ +++ + L +A G+ YL
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNF 159
Query: 417 YHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTE 475
HRD+ + N L+ + K+ADFG+++ G + + R ++A E L G+ T
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219
Query: 476 KSDVYSFGIVILELMS 491
SDV++FG+ + E++
Sbjct: 220 ASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 54/235 (22%)
Query: 295 LIGQGASGVVYKGTLED-GTLVAVKQI-TDLDTKGDEEFINEVEIISK-------IRHRN 345
IG+GA G V K + GT++AVK+I + +D K + + +++++ + ++
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 346 LLSLRGCC--------VSSDD------EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAW 391
L G C +S D E K P LG
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVI------PEEILG-------------- 110
Query: 392 PQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451
KI + K L YL LK I HRD+K +NILLD K+ DFG++ Q ++ S
Sbjct: 111 ----KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SI 162
Query: 452 LTTRVAGTYGYLAPEYALYGQLTE---KSDVYSFGIVILELMSGRKVLETSNSSF 503
TR AG Y+APE +SDV+S GI + E+ +G+ NS F
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 296 IGQGASGVVYKGTLEDGT--LVAVKQIT---DLDTKGDEEFINEVEIISKIRHRNLLSLR 350
IG GA GVV ++ + VA+K+I D+ T E++I+ +H N++++R
Sbjct: 13 IGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDNIIAIR 70
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGD-----HISNALTRKQLAWPQRKKIILDVAKGL 405
+ K ++V D M S D H LT + + + + + +GL
Sbjct: 71 DILRPPGAD-FKDVYVVMDLMES----DLHHIIHSDQPLTEEHIRY-----FLYQLLRGL 120
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK----QSLEGQSHLTTRVAGTYG 461
Y+H + HRD+K +N+L++ + + ++ DFG+A+ E + +T VA T
Sbjct: 121 KYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRW 176
Query: 462 YLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVL 496
Y APE L + T D++S G + E M GR+ L
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAE-MLGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 295 LIGQGASG-VVYKGTLEDGTLVAVKQITD---LDTKGDEEFINEVEIISK-IRHRNLLSL 349
+IG+G+ G V+ DG AVK + L+ K + + E ++ K ++H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+++ + + V DF+ G L H+ + + P+ + ++A L YLH
Sbjct: 62 HYSFQTTE-----KLYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLH 113
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ I +RD+K NILLDS+ + DFGL K+ + QS TT GT YLAPE
Sbjct: 114 -SIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIR 169
Query: 470 YGQLTEKSDVYSFGIVILELMSG 492
D + G V+ E++ G
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 46/223 (20%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHR 344
F ++G+GA GVV K E +VA+K+ D ++ +EE + E++++ ++
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLKQE 60
Query: 345 NLLSLRGCCVSSDDEKGKRR---FLVYDF-----------MPSGSLGDHISNALTRKQLA 390
N++ L+ E +RR +LV+++ MP+G + +
Sbjct: 61 NIVELK--------EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV---------- 102
Query: 391 WPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450
+ I + K + + H K I HRDIK N+L+ K+ DFG A+ EG +
Sbjct: 103 ----RSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155
Query: 451 HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
T T Y +PE L + D++S G ++ EL G+
Sbjct: 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRN 345
F Q ++G+G G V + G + A K++ KG+ +NE +I+ K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL--DVAK 403
++SL + D LV M G L HI + + + + + + ++
Sbjct: 62 VVSLAYAYETKD-----ALCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICC 113
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
GL LH + I +RD+K NILLD +++D GLA EGQ+ + RV GT GY+
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 168
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
APE + T D ++ G ++ E+++G+
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 296 IGQGASGVVYKGTLEDGTLVA---VKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRG 351
IG G G V G G A VK++ T F+ EV+ ++ H N+L G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQ-RKKIILDVAKGLAYLH 409
C+ S LV +F P G L +++ SN Q+A +++ +VA GL +LH
Sbjct: 63 QCIESIP-----YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT-RVAGTYGYLAPEYA 468
+ H D+ N L +++ K+ D+GLA + ++T A +LAPE
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 469 -------LYGQLTEKSDVYSFGIVILEL 489
L T+KS+++S G+ + EL
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 30/195 (15%)
Query: 313 TLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371
LVAVK + D E+F+ EV+I+S++ N+ L G C ++ ++M
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL-----CMIMEYM 101
Query: 372 PSGSLGD----HI----SNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKS 423
+G L H+ A K L++ + +A G+ YL L HRD+ +
Sbjct: 102 ENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLN--FVHRDLAT 158
Query: 424 TNILLDSEMKAKVADFGLAKQ-------SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEK 476
N L+ K+ADFG+++ ++G++ L R ++A E L G+ T K
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR------WMAWESVLLGKFTTK 212
Query: 477 SDVYSFGIVILELMS 491
SDV++FG+ + E+++
Sbjct: 213 SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 52/225 (23%), Positives = 106/225 (47%), Gaps = 45/225 (20%)
Query: 296 IGQGASGVVYKGTL-----EDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLSL 349
+G+ A G +YKG L + LVA+K + D++ EF E +++++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI--------------SNALTRKQLAWPQRK 395
G + ++++++ G L + + + + L
Sbjct: 73 LGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 396 KIILDVAKGLAYL--HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-------SL 446
I + +A G+ YL H+ H+D+ + NIL+ ++ K++D GL+++ +
Sbjct: 128 HIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ +S L R ++ PE +YG+ + SD++SFG+V+ E+ S
Sbjct: 183 QPKSLLPIR------WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 290 FSQKNLIGQGASGVVYKGTL--EDGTL--VAVKQI-TDLDTKGD-EEFINEVEIISKIRH 343
F+ ++G+G G V + L EDG+ VAVK + D+ + D EEF+ E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 344 RNLLSLRGCCVSSDDEKGKRRF----LVYDFMPSGSLGDHI-SNALTRKQLAWPQRK--K 396
N++ L G + S + K R ++ FM G L + + + + P + +
Sbjct: 61 PNVIKLIGVSLRS---RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRV 456
++D+A G+ YL HRD+ + N +L+ M VADFGL+K+ G +
Sbjct: 118 FMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 457 AG-TYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ +LA E T SDV++FG+ + E+M+
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVK--QITDL-DTKGDEEFINEVEIISKIRHRN 345
F + IG+G VY+ T L DG VA+K QI DL D K + I E++++ ++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK--KIILDVAK 403
++ + ++ +V + +G L I + +K+L P++ K + +
Sbjct: 64 VIKYYASFIEDNELN-----IVLELADAGDLSRMIKHFKKQKRLI-PEKTVWKYFVQLCS 117
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
L ++H + HRDIK N+ + + K+ D GL + ++ + GT Y+
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYM 173
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMS 491
+PE KSD++S G ++ E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 77/308 (25%), Positives = 132/308 (42%), Gaps = 64/308 (20%)
Query: 296 IGQGASGVVYKGTLED------GTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLS 348
+GQG+ G+VY+G D T VAVK + + + + EF+NE ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI----SNALTRKQLAWPQRKKII---LDV 401
L G VS KG+ +V + M G L ++ A P +++I ++
Sbjct: 74 LLGV-VS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE-------GQSHLTT 454
A G+AYL+ HRD+ + N ++ + K+ DFG+ + E G+ L
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 455 RVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA 514
R ++APE G T SD++SFG+V+ E+ S LA
Sbjct: 186 R------WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------------LA 218
Query: 515 N---SGKVDEIFDEFIREEGS----RAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567
G +E +F+ + G ER + +C +RPT + + +L+ D
Sbjct: 219 EQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
Query: 568 IDIPTLPE 575
+ P+ PE
Sbjct: 279 LH-PSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 41/129 (31%), Positives = 69/129 (53%), Gaps = 7/129 (5%)
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424
F V +++ G L HI + + P+ ++ GL +LH I +RD+K
Sbjct: 72 FFVMEYLNGGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLD 125
Query: 425 NILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGI 484
NILLD++ K+ADFG+ K+++ G + T GT Y+APE L + D +SFG+
Sbjct: 126 NILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGV 184
Query: 485 VILELMSGR 493
++ E++ G+
Sbjct: 185 LLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 290 FSQKNLIGQGASGVVYKG-TLEDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIRHRNLL 347
F Q +G+G VYKG G +VA+K+I D + I E+ ++ +++H N++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
L + + + LV+++M L ++ R L K + KG+A+
Sbjct: 62 RLHDVIHTEN-----KLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
H + + HRD+K N+L++ + K+ADFGLA+ + + V T Y AP+
Sbjct: 116 CH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 468 ALYGQLTEKS-DVYSFGIVILELMSGRKVLETSN 500
L + S D++S G ++ E+++GR + +N
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 296 IGQGASGVV-YKGTLEDGTLVAVKQI-----TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G GA G V G VA+K++ ++L K E+ ++ ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMKHENVIGL 79
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
V + D R Y MP +G + + ++L+ + + ++ + KGL Y+H
Sbjct: 80 LD--VFTPDLSLDRFHDFYLVMPF--MGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH 135
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
I HRD+K N+ ++ + + K+ DFGLA+Q+ S +T V T Y APE L
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVV-TRWYRAPEVIL 188
Query: 470 -YGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
+ T+ D++S G ++ E+++G+ + + +
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 296 IGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRG 351
+G G G V ++ A+K + +T E +E EI+ + H ++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
+ D+K +++ ++ G L + + R + I V YLH
Sbjct: 61 ---TFKDKK--YIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVVLAFEYLH-- 110
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL-- 469
I +RD+K N+LLDS K+ DFG AK+ GQ T GT Y+APE L
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEIILNK 167
Query: 470 -YGQLTEKSDVYSFGIVILELMSGR 493
Y D +S GI++ EL++GR
Sbjct: 168 GYDFS---VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 296 IGQGASGVVYKG-TLEDG-TLVAVKQITDLDTKGDEE-----FINEVEIISKIR---HRN 345
IG+GA G V+K L++G VA+K++ + EE I EV ++ + H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR-------KKII 398
++ L C S ++ + LV++ H+ LT P+ K ++
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFE---------HVDQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 399 LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
+ +GL +LH + HRD+K NIL+ S + K+ADFGLA+ + T V
Sbjct: 117 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVV 171
Query: 459 TYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501
T Y APE L D++S G + E M RK L +S
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAE-MFRRKPLFRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 22/206 (10%)
Query: 295 LIGQGASGVVY---KGTLED-GTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLS 348
++GQG+ G V+ K T D G L A+K + L + E +I++++ H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLA 406
L + +GK +L+ DF+ G L +S K++ + + K + ++A L
Sbjct: 63 LH----YAFQTEGKL-YLILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLAELALALD 112
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+LH L I +RD+K NILLD E K+ DFGL+K+S++ + GT Y+APE
Sbjct: 113 HLH-SL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPE 168
Query: 467 YALYGQLTEKSDVYSFGIVILELMSG 492
T+ +D +SFG+++ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEE-----FINEVEIISKIRHRNLLSL 349
IG+G GVVYKG + G +VA+K+I + +EE I E+ ++ +++H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+ + R +L+++F+ S L ++ + + + K + + +G+ + H
Sbjct: 65 QDVLMQES-----RLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ HRD+K N+L+D++ K+ADFGLA+ + + T T Y APE L
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 470 YGQL-TEKSDVYSFGIVILELMSGR 493
+ D++S G + E+ + +
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 295 LIGQGASGVVY----KGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
++G+G+ G V KGT E + +K+ L + + E I++ L+
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
CC + D R F V +++ G L I + ++ P+ + +V L +LH
Sbjct: 62 HCCFQTKD----RLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLH- 113
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ + +RD+K NILLD+E K+ADFG+ K+ + TT GT Y+APE
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEILQE 170
Query: 471 GQLTEKSDVYSFGIVILELMSGRKVLETSN 500
+ D ++ G+++ E+M+G+ E N
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 62/239 (25%), Positives = 111/239 (46%), Gaps = 47/239 (19%)
Query: 282 ELDQATGGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITD-LDTKGDEEFINE 334
E++ +T F ++ +G+ G VYKG L E VA+K + D + EEF +E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 335 VEIISKIRHRNLLSLRGC-------------CVSSDDEKGKRRFLVYDFMPSGSLGDHIS 381
+ S+++H N++ L G C SD FLV P +G
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD----LHEFLVMR-SPHSDVGSTDD 113
Query: 382 NALTRKQLAWPQRKKIILDVAKGLAYL--HYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439
+ + L I+ +A G+ +L H+ + H+D+ + N+L+ ++ K++D
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDL 168
Query: 440 GLAKQ-------SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
GL ++ L G S L R +++PE +YG+ + SD++S+G+V+ E+ S
Sbjct: 169 GLFREVYAADYYKLMGNSLLPIR------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 14/153 (9%)
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
L L C + D R + V +++ G L I K+ P ++A GL
Sbjct: 63 LTQLHSCFQTMD-----RLYFVMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIAIGL 114
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL-EGQSHLTTRVAGTYGYLA 464
+LH I +RD+K N++LDSE K+ADFG+ K+++ +G + T GT Y+A
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIA 169
Query: 465 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLE 497
PE Y + D ++FG+++ E+++G+ E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITD---LDTKGDEEFINEVEIISK-IRHRNLLSLR 350
IG+G+ G V DG AVK + L K + + E ++ K ++H L+ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
++D + + V D++ G L H+ + P+ + ++A L YLH
Sbjct: 63 YSFQTAD-----KLYFVLDYVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLH- 113
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
L I +RD+K NILLDS+ + DFGL K+ +E S T+ GT YLAPE L
Sbjct: 114 SLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCGTPEYLAPE-VLR 169
Query: 471 GQLTEKS-DVYSFGIVILELMSG 492
Q +++ D + G V+ E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 34/198 (17%)
Query: 315 VAVKQITDLDTKGD-EEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMP 372
VAVK + D T D + I+E+E++ I +H+N+++L G C ++G +++ ++
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT----QEGPL-YVIVEYAA 101
Query: 373 SGSLGDHIS-------------NALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHR 419
G+L + + + +QL++ VA+G+ YL + I HR
Sbjct: 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCI-HR 158
Query: 420 DIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG-----YLAPEYALYGQL- 473
D+ + N+L+ + K+ADFGLA+ G + + G ++APE AL+ ++
Sbjct: 159 DLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKKTSNGRLPVKWMAPE-ALFDRVY 213
Query: 474 TEKSDVYSFGIVILELMS 491
T +SDV+SFGI++ E+ +
Sbjct: 214 THQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 43/130 (33%), Positives = 64/130 (49%), Gaps = 15/130 (11%)
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLAYLHYGLKPAIYHRDIK 422
+LV +++ G +L + P+ K+ I +V G+ LH + I HRDIK
Sbjct: 73 YLVMEYLNGGDCA-----SLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIK 124
Query: 423 STNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSF 482
N+L+D K+ DFGL++ LE + + GT YLAPE L + SD +S
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 483 GIVILELMSG 492
G VI E + G
Sbjct: 180 GCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 35/98 (35%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 396 KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR 455
KI + V +GL YL K I HRD+K +NIL++S + K+ DFG++ Q ++ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157
Query: 456 VAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
GT Y++PE T +SD++S G+ ++E+ GR
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEE---FINEVEIISKIRHRNLLSLRG 351
+G GA G VYK E G L A K I DTK +EE ++ E++I++ H N++ L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
++ +++ +F G++ D + L R L PQ + + + L YLH
Sbjct: 70 AFYYENN-----LWILIEFCAGGAV-DAVMLELERP-LTEPQIRVVCKQTLEALNYLH-- 120
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
+ I HRD+K+ NIL + K+ADFG++ ++ + + GT ++APE +
Sbjct: 121 -ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCE 178
Query: 472 QLTE-----KSDVYSFGIVILEL 489
+ K+DV+S GI ++E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR---HRNLLSLRG 351
IG+G V K + + G A+K + K E+ N EI + R H N+L L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKK-HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR-KKIILDVAKGLAYLHY 410
D K R LV++ M +L + I RK+ +R K + + K L ++H
Sbjct: 66 VLF---DRKTGRLALVFELM-DMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ I+HRDIK NIL+ ++ K+ADFG + + + T ++ T Y APE L
Sbjct: 118 --RNGIFHRDIKPENILIKDDI-LKLADFGSCR-GIYSKPPYTEYIS-TRWYRAPECLLT 172
Query: 471 -GQLTEKSDVYSFGIVILELMS 491
G K D+++ G V E++S
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 37/223 (16%)
Query: 290 FSQKNL-----IGQGASGVVYKGTL-----EDGTL-VAVKQI---TDLDTKGDEEFINEV 335
F + NL +G GA G V + T D + VAVK + + E ++E+
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSEL 89
Query: 336 EIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR 394
+I+S + H N+++L G C G ++ ++ G L N L RK+ ++
Sbjct: 90 KIMSHLGNHENIVNLLGACT-----IGGPILVITEYCCYGDL----LNFLRRKRESFLTL 140
Query: 395 KKII---LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451
+ ++ VAKG+A+L K I HRD+ + N+LL K+ DFGLA+ + ++
Sbjct: 141 EDLLSFSYQVAKGMAFLAS--KNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 452 L---TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ R+ ++APE T +SDV+S+GI++ E+ S
Sbjct: 198 VVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRN 345
F Q ++G+G G V + G + A K++ KG+ +NE +I+ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWP--QRKKIILDVAK 403
+++L + D LV M G L HI N + P + ++ + A+
Sbjct: 62 VVNLAYAYETKD-----ALCLVLTIMNGGDLKFHIYN------MGNPGFEEERALFYAAE 110
Query: 404 ---GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
GL LH + +RD+K NILLD +++D GLA + EG+S + RV GT
Sbjct: 111 ILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTV 165
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
GY+APE + T D + G +I E++ G+
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 295 LIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-----RHRNLLSL 349
+IG+G+ V L+ + ++ + D+E I+ V+ + H L+ L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
C + R F V +++ G L H+ +++L + +++ L YLH
Sbjct: 62 HSCF-----QTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH 113
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ I +RD+K N+LLDSE K+ D+G+ K+ L T+ GT Y+APE
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCGTPNYIAPEILR 169
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSS 502
D ++ G+++ E+M+GR + SS
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 294 NLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFIN---------EVEIISKIRH 343
+ +G GA G V + G VA+K K F + E+ ++ + H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIK-------KLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 344 RNLLSLRGC-CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
N++ L +S E + +LV M G ++N + ++L+ + ++ +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
+GL Y+H I HRD+K +NI ++ + + K+ DFGLA+ + +T VA T Y
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVA-TRWY 181
Query: 463 LAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
APE L + + D++S G ++ EL++G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 288 GGFSQKNLIGQGASGVVYK-GTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL 346
G F + L+ + ASG Y L+ ++A ++ + E ++ RH L
Sbjct: 6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVA--------HTLTESRVLKNTRHPFL 57
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKII-LDVAKGL 405
SL+ + D R V +++ G L H+S R+++ R + ++ L
Sbjct: 58 TSLKYSFQTKD-----RLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSAL 108
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
YLH G I +RD+K N++LD + K+ DFGL K+ + + + T GT YLAP
Sbjct: 109 DYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAP 164
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGR 493
E D + G+V+ E+M GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 295 LIGQGASG-VVYKGTLEDGTLVAVKQITD---LDTKGDEEFINEVEIISK-IRHRNLLSL 349
+IG+G+ G V+ + AVK + L K ++ ++E ++ K ++H L+ L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
++D + + V D++ G L H+ + P+ + ++A L YLH
Sbjct: 62 HFSFQTAD-----KLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH 113
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
I +RD+K NILLDS+ + DFGL K+++E T+ GT YLAPE L
Sbjct: 114 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTFCGTPEYLAPE-VL 168
Query: 470 YGQLTEKS-DVYSFGIVILELMSGRKVLETSNSS 502
+ Q +++ D + G V+ E++ G + N++
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 9/130 (6%)
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424
F V +++ G L HI ++ + + + ++ GL +LH K I +RD+K
Sbjct: 72 FFVMEYLNGGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLD 125
Query: 425 NILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFG 483
N+LLD + K+ADFG+ K+++ G+ +T GT Y+APE L GQ E D +SFG
Sbjct: 126 NVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPE-ILKGQKYNESVDWWSFG 183
Query: 484 IVILELMSGR 493
+++ E++ G+
Sbjct: 184 VLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEE-----FINEVEIISKIR---HRNL 346
IG GA G VYK G VA+K + + +E+ + EV ++ ++ H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
+ L C +S ++ + LV++ + L ++ L K ++ +GL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLD 122
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+LH I HRD+K NIL+ S + K+ADFGLA+ + T V T Y APE
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR--IYSCQMALTPVVVTLWYRAPE 177
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501
L D++S G + E M RK L NS
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAE-MFRRKPLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 39/129 (30%), Positives = 69/129 (53%), Gaps = 7/129 (5%)
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424
F V +F+ G L HI + + + + ++ GL +LH I +RD+K
Sbjct: 72 FFVMEFLNGGDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLD 125
Query: 425 NILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGI 484
N++LD + K+ADFG+ K+++ G + +T GT Y+APE + T D +SFG+
Sbjct: 126 NVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 485 VILELMSGR 493
++ E++ G+
Sbjct: 185 LLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 296 IGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRG 351
+G+G G V + G L A K++ KG E + E I++K+ R ++SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL--DVAKGLAYLH 409
+ D LV M G L HI N + + +P+ + + GL +LH
Sbjct: 61 AFQTKTD-----LCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ I +RD+K N+LLD++ +++D GLA + +GQS T AGT G++APE
Sbjct: 115 ---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQ 170
Query: 470 YGQLTEKSDVYSFGIVILELMSGR 493
+ D ++ G+ + E+++ R
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 45/188 (23%), Positives = 91/188 (48%), Gaps = 18/188 (9%)
Query: 314 LVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMP 372
LVAVK + D + +F+ E++I+S+++ N++ L C++SD ++ ++M
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP-----LCMITEYME 102
Query: 373 SGSLGDHISNALTRKQLA--------WPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424
+G L +S ++ + + +A G+ YL HRD+ +
Sbjct: 103 NGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR 159
Query: 425 NILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFG 483
N L+ K+ADFG+++ G + + R +++ E L G+ T SDV++FG
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 219
Query: 484 IVILELMS 491
+ + E+++
Sbjct: 220 VTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 50/199 (25%), Positives = 100/199 (50%), Gaps = 26/199 (13%)
Query: 310 EDGTLVAVKQITDLDTKGD-EEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLV 367
++ VAVK + D T+ D + ++E+E++ I +H+N+++L G C + +++
Sbjct: 45 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-----QDGPLYVI 99
Query: 368 YDFMPSGSLGDHIS-------------NALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP 414
++ G+L +++ + +Q+ + VA+G+ YL
Sbjct: 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQ 156
Query: 415 AIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQL 473
HRD+ + N+L+ K+ADFGLA+ + TT ++APE AL+ ++
Sbjct: 157 KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE-ALFDRV 215
Query: 474 -TEKSDVYSFGIVILELMS 491
T +SDV+SFG+++ E+ +
Sbjct: 216 YTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 295 LIGQGASGVVYKGTLE-DGTLVAVKQ--ITD-LDTKGDEEFINEVEIISKIRHRNLLSLR 350
+G G G V+ A+K I + + K ++ NE ++ ++ H ++ L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 351 GCCVSSDDEKGKRRFL--VYDFMPSGSLGDHISNALT-RKQLAWPQRKKIILDVAKGLAY 407
D RFL + +++P G L ++ N+ +I+ L Y
Sbjct: 68 --WTEHDQ-----RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC----ALEY 116
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
LH I +RD+K NILLD E K+ DFG AK+ + T + GT YLAPE
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEV 169
Query: 468 ALYGQLTEKSDVYSFGIVILELMSG 492
+ D ++ GI+I E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 290 FSQKNLIGQGASGVV----YKGTLEDGTLVAVKQITDLDT--KGDEEFI-NEVEIISKIR 342
F +IG+GA G V +K + + A+K ++ + + D F E +I++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
++ L DD K ++V ++MP G L + +SN ++ A + +V
Sbjct: 102 SEWIVQL--HYAFQDD---KYLYMVMEYMPGGDLVNLMSNYDIPEKWA----RFYTAEVV 152
Query: 403 KGLAYLH-YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA-KQSLEGQSHLTTRVAGTY 460
L +H G HRD+K N+LLD K+ADFG K G T V GT
Sbjct: 153 LALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTP 207
Query: 461 GYLAPEYAL----YGQLTEKSDVYSFGIVILELMSG 492
Y++PE G + D +S G+ + E++ G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 12/131 (9%)
Query: 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL---DVAKGLAYLHYGLKPAIYHRDIK 422
LV M G L HI N R + +++I + G+ +LH I +RD+K
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGL----EMERVIHYSAQITCGILHLH---SMDIVYRDMK 122
Query: 423 STNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSF 482
N+LLD + +++D GLA + +G++ T+ AGT GY+APE + D ++
Sbjct: 123 PENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180
Query: 483 GIVILELMSGR 493
G I E+++GR
Sbjct: 181 GCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFI-----NEVEIISKIRHRNLLSL 349
IG+G G VYK G LVA+K+ T L+ DEE I E+ ++ + +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK-TRLEM--DEEGIPPTALREISLLQMLSESIYIVR 65
Query: 350 RGCCVSSDDEKGKRR-FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKII----LDVAKG 404
+++ GK +LV++++ S L + + P K I + KG
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMD--SNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQ-SLEGQSHLTTRVAGTYGY 462
+A+ H K + HRD+K N+L+D + K+AD GL + S+ +S+ T T Y
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWY 177
Query: 463 LAPEYALYG-QLTEKSDVYSFGIVILELMSG 492
APE L + D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 296 IGQGASGVV----YKGTLEDGTLVAVKQITDLDTKG--DEEFINEVEIISKIR-HRNLLS 348
+GQGA G+V T + VA+K+IT++ +K + + E++++ R H+N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 349 LRGC-CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTR--KQLAWPQRKKIILDVAKGL 405
L V + +Y + L + + + R + L + I + GL
Sbjct: 67 LYDMDIVFPGNFNE-----LYLYE---ELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK----QSLEGQSHLTTRVAGTYG 461
Y+H + HRD+K N+L++++ + K+ DFGLA+ E +T VA T
Sbjct: 119 KYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRW 174
Query: 462 YLAPEYALYGQLTEKS-DVYSFGIVILELMSGRKVLETSNS 501
Y APE L Q K+ DV+S G ++ EL+ + V + +
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 295 LIGQGASG-VVYKGTLEDGTLVAVKQI---TDLDTKGDEEFINEVEIISK-IRHRNLLSL 349
+IG+G+ G V+ DG+ AVK + T L K + E ++ K ++H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+++ + + V D++ G L H+ + P+ + +VA + YLH
Sbjct: 62 HYSFQTAE-----KLYFVLDYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLH 113
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
I +RD+K NILLDS+ + DFGL K+ +E + T+ GT YLAPE
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTSTFCGTPEYLAPEVLR 169
Query: 470 YGQLTEKSDVYSFGIVILELMSG 492
D + G V+ E++ G
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 296 IGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
IG+G G VY+ +D + A+K ++ +E + + E+ I RN+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILV----RT 50
Query: 355 SSDD-----------EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWP-QRKKI-ILDV 401
D+ + +LV D+M G L H+ +K+ + R K I ++
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHL-----QKEGRFSEDRAKFYIAEL 105
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG 461
L +LH K I +RD+K NILLD+ + DFGL+K +L + T GT
Sbjct: 106 VLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT-DNKTTNTFCGTTE 161
Query: 462 YLAPEYALYGQ-LTEKSDVYSFGIVILELMSG 492
YLAPE L + T+ D +S G+++ E+ G
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRN 345
F ++G+G G V + G + A K++ KG+ +NE I+ K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL--DVAK 403
++SL + E LV M G L HI N + +++ I ++
Sbjct: 62 VVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCC 113
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
GL L + I +RD+K NILLD +++D GLA Q EG++ + RV GT GY+
Sbjct: 114 GLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYM 168
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
APE + T D + G +I E++ G+
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 24/195 (12%)
Query: 313 TLVAVKQI-TDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDD--------EKGK 362
T VAVK + +D K + I+E+E++ I +H+N+++L G C KG
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422
R + P G + + +QL++ VA+G+ YL K I HRD+
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCI-HRDLA 167
Query: 423 STNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG-----YLAPEYALYGQL-TEK 476
+ N+L+ + K+ADFGLA+ H+ T G ++APE AL+ ++ T +
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDI----HHIDYYKKTTNGRLPVKWMAPE-ALFDRIYTHQ 222
Query: 477 SDVYSFGIVILELMS 491
SDV+SFG+++ E+ +
Sbjct: 223 SDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 296 IGQGASGVVYKGTLE-DGTLVAVKQIT-DLDTKGDEEFINEVEIISKIRHRNLLSLRGC- 352
+G+G G VYK G +A+K+I +LD + I E++I+ K ++ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 353 ----CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
V ++ ++M +GSL + + + + ++I V KGL +L
Sbjct: 69 FIEGAV----------YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
I HRD+K TN+L++ + K+ DFG++ + + L G Y+APE
Sbjct: 119 KEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPERI 173
Query: 469 LYGQLTE------KSDVYSFGIVILELMSGR 493
G + +SDV+S G+ ILE+ GR
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 296 IGQGASGVVYKG---TLEDGTLVAVKQIT--DLDTKGDEEFINEVEIISKIRHRNLLSLR 350
+G G G V KG + VAVK + + D +E + E ++ ++ + ++ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHI--SNALTRKQLAWPQRKKIILDVAKGLAYL 408
G C + + LV + G L + + +T K + +++ V+ G+ YL
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYL 111
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY--GYLAPE 466
+ HRD+ + N+LL ++ AK++DFGL+K +++ + G + + APE
Sbjct: 112 E---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 467 YALYGQLTEKSDVYSFGIVILELMS-GRK 494
Y + + KSDV+SFG+++ E S G+K
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 290 FSQKNLIGQGASGVVY---KGTLED-GTLVAVKQITDL----DTKGDEEFINEVEIISKI 341
F ++G GA G V+ K + D G L A+K + K E E +++ I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 342 RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDV 401
R L +D + L+ D++ G L H+S R++ + + ++
Sbjct: 62 RQSPFLVTLHYAFQTD----TKLHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEI 114
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG 461
L +LH K I +RDIK NILLDS + DFGL+K+ E + GT
Sbjct: 115 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 462 YLAPEYALYGQLTEKS--DVYSFGIVILELMSG 492
Y+AP+ G D +S G+++ EL++G
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 55/191 (28%), Positives = 93/191 (48%), Gaps = 16/191 (8%)
Query: 313 TLVAVKQITDLDTKGD-EEFINEVEIISKI-RHRNLLSLRGCCVSSDD--------EKGK 362
VAVK + D T D + ++E+E++ I +H+N+++L G C KG
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422
R + P G + L +QL + VA+G+ YL HRD+
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161
Query: 423 STNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQL-TEKSDVY 480
+ N+L+ + K+ADFGLA+ + TT ++APE AL+ ++ T +SDV+
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVW 220
Query: 481 SFGIVILELMS 491
SFG+++ E+ +
Sbjct: 221 SFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 30/210 (14%)
Query: 296 IGQGASGVVYKG----TLEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHRNLL 347
IG+G GVVYK T E +A+K+I L+ + DE I E+ ++ +++H N++
Sbjct: 10 IGEGTYGVVYKARDRVTNE---TIALKKIR-LEQE-DEGVPSTAIREISLLKEMQHGNIV 64
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGL 405
L+ V S+ KR +LV++++ L H+ ++ A R K + + +G+
Sbjct: 65 RLQDV-VHSE----KRLYLVFEYL-DLDLKKHMDSS---PDFAKNPRLIKTYLYQILRGI 115
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKA-KVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
AY H + HRD+K N+L+D A K+ADFGLA+ T V T Y A
Sbjct: 116 AYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRA 171
Query: 465 PEYALYG-QLTEKSDVYSFGIVILELMSGR 493
PE L + D++S G + E+++ +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 35/223 (15%)
Query: 289 GFSQKNLIGQGASGVVYKGTLEDGTL-----VAVKQITDLDTKGDEE----FINEVEIIS 339
+ +L+ +G G ++ G L D V VK + D E + E ++
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLLY 63
Query: 340 KIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL----------GDHISNALTRKQL 389
+ H+N+L + C+ E G+ F++Y +M G+L + AL+ +QL
Sbjct: 64 GLSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 390 AWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449
+ + +A G++YLH K + H+DI + N ++D E++ K+ D L++
Sbjct: 120 V-----HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 450 SH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
H L ++A E + + + SDV+SFG+++ ELM+
Sbjct: 172 YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK---GDEEFINEVEIISKIRHRN 345
F ++G+G G V + G + A K++ K G+ +NE +I+ K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL--DVAK 403
++SL + D LV M G L HI N + + + + ++
Sbjct: 62 VVSLAYAYETKD-----ALCLVLTLMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITC 113
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
GL LH + I +RD+K NILLD +++D GLA + EG++ + RV GT GY+
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYM 168
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
APE + T D + G +I E++ G+
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 295 LIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN-----LLSL 349
+IG+G+ V L+ + ++ + D+E I+ V+ + + L+ L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
C ++ R FLV +++ G L H+ +++L + ++ L +LH
Sbjct: 62 HSCFQTT-----SRLFLVIEYVNGGDLMFHMQR---QRKLPEEHARFYAAEICIALNFLH 113
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ I +RD+K N+LLD++ K+ D+G+ K+ L G T+ GT Y+APE
Sbjct: 114 ---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPEILR 169
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITD 508
+ D ++ G+++ E+M+GR S F +ITD
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR-------SPFDIITD 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 43/129 (33%), Positives = 66/129 (51%), Gaps = 9/129 (6%)
Query: 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTN 425
L+ D++ G + H+ R + + + ++ L +LH K I +RDIK N
Sbjct: 82 LILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLEN 135
Query: 426 ILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKS--DVYSFG 483
ILLDSE + DFGL+K+ L + T GT Y+APE + G+ D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-IIRGKGGHGKAVDWWSLG 194
Query: 484 IVILELMSG 492
I+I EL++G
Sbjct: 195 ILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 288 GGFSQKNLIGQGASGVVYK-GTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL 346
G F + L+ + A+G Y L ++A ++ + E ++ RH L
Sbjct: 6 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA--------HTVTESRVLQNTRHPFL 57
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKII-LDVAKGL 405
+L+ + D R V ++ G L H+S R+++ +R + ++ L
Sbjct: 58 TALKYAFQTHD-----RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSAL 108
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
YLH + +RDIK N++LD + K+ DFGL K+ + + + T GT YLAP
Sbjct: 109 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 164
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGR 493
E D + G+V+ E+M GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 282 ELDQATGGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITD-LDTKGDEEFINEVE 336
ELD + + ++G G G + +G L+ VA+ + K F+ E
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 337 IISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRK---QLAWPQ 393
+ + H N++ L G +G +V ++M +G+L ++ RK QL Q
Sbjct: 59 TLGQFDHSNIVRLEGVIT-----RGNTMMIVTEYMSNGAL-----DSFLRKHEGQLVAGQ 108
Query: 394 RKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLT 453
++ +A G+ YL + H+ + + +L++S++ K++ F ++ + T
Sbjct: 109 LMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT 165
Query: 454 TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ APE Y + SDV+SFGIV+ E+MS
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 21/138 (15%)
Query: 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK------KIILDVAKGLAYLHYGLKPAI 416
R F V +F+ G L H+ ++Q P+ +I L L +LH I
Sbjct: 70 RLFFVIEFVSGGDLMFHM-----QRQRKLPEEHARFYSAEISL----ALNFLHER---GI 117
Query: 417 YHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEK 476
+RD+K N+LLD+E K+ D+G+ K+ + T+ GT Y+APE L G+
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTSTFCGTPNYIAPE-ILRGEDYGF 175
Query: 477 S-DVYSFGIVILELMSGR 493
S D ++ G+++ E+M+GR
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 296 IGQGASGVVYKGTLEDGT---LVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
+G+G G VYK +DG A+KQI T E+ ++ +++H N+++L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEG--TGISMSACREIALLRELKHPNVIALQKV 66
Query: 353 CVSSDDEKGKRRFLVYDFMPSG---SLGDHISNALTRKQLAWPQR--KKIILDVAKGLAY 407
+S D K +L++D+ + H ++ +K + P+ K ++ + G+ Y
Sbjct: 67 FLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 408 LHYGLKPAIYHRDIKSTNILLDSE----MKAKVADFGLAK---QSLEGQSHLTTRVAGTY 460
LH + HRD+K NIL+ E + K+AD G A+ L+ + L V T+
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179
Query: 461 GYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVL 496
Y APE L + T+ D+++ G + EL++ +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 46/206 (22%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 295 LIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGD----EEFINEVEIISKIRHRNLLSLR 350
LI + +YKG + V ++ KG + NE++ + +I N+L +
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKK-FHKGHKVLIDITENEIKNLRRIDSNNILKIY 84
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH- 409
G + D+ R L+ ++ G L + + K L++ + + +D KGL L+
Sbjct: 85 GFIIDIVDDL-PRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK 140
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
Y KP ++++ S + L+ K K+ GL K + Y + +
Sbjct: 141 YTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLN 193
Query: 470 --YGQLTEKSDVYSFGIVILELMSGR 493
+ + T K D+YS G+V+ E+ +G+
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 296 IGQGASGVVYKGTLEDGTL---VAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
+G+G G VYK +DG A+KQI T E+ ++ +++H N++SL+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKV 66
Query: 353 CVSSDDEKGKRRFLVYDFMPSG---SLGDHISNALTRKQLAWPQR--KKIILDVAKGLAY 407
+S D K +L++D+ + H ++ +K + P+ K ++ + G+ Y
Sbjct: 67 FLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 408 LHYGLKPAIYHRDIKSTNILLDSE----MKAKVADFGLAK---QSLEGQSHLTTRVAGTY 460
LH + HRD+K NIL+ E + K+AD G A+ L+ + L V T+
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179
Query: 461 GYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVL 496
Y APE L + T+ D+++ G + EL++ +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 64/235 (27%), Positives = 116/235 (49%), Gaps = 28/235 (11%)
Query: 280 ESELDQATG-GFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFIN-EVE 336
+++++++ + N+IG G+ GVVY+ ++ VA+K++ D ++ N E+
Sbjct: 57 DNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-----DPQYKNRELL 111
Query: 337 IISKIRHRNLLSLRGCCVSSDDEKGKRR-FL--VYDFMPSGSLGDHISNALTRKQLAWPQ 393
I+ + H N++ L+ + +K ++ FL V +F+P ++ ++ + R A P
Sbjct: 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKH-YARNNHALPL 169
Query: 394 R--KKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA-KVADFGLAKQSLEGQ- 449
K + + LAY+H I HRD+K N+L+D K+ DFG AK L GQ
Sbjct: 170 FLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226
Query: 450 --SHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNS 501
S++ +R Y APE L T D++S G +I E++ G + +S
Sbjct: 227 SVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 296 IGQGASGVV---YKGTLEDGTLVAVKQITD--LDTKGDEEFINEVEIISKIRHRNLLSLR 350
IG GA G+V Y L+ VA+K+++ + + E+ ++ + H+N++SL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 351 GCCVSSDD-EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
E+ + +LV + M +L I L +++++ ++ + G+ +LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 136
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
I HRD+K +NI++ S+ K+ DFGLA+ + G S + T T Y APE L
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVIL 191
Query: 470 YGQLTEKSDVYSFGIVILELM 490
E D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 13/160 (8%)
Query: 334 EVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQ 393
E +++S+++H N+++ R S + E G L+Y M GD +K P+
Sbjct: 49 EAQLLSQLKHPNIVAYRE---SWEGEDG----LLYIVMGFCEGGDLYHKLKEQKGKLLPE 101
Query: 394 RKKI--ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451
+ + + +A L YLH + I HRD+K+ N+ L KV D G+A+ LE Q
Sbjct: 102 NQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCD 157
Query: 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ + + GT Y++PE KSDV++ G + E+ +
Sbjct: 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 296 IGQGASGVVYKGT------LEDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLS 348
+G+G G V K T T VAVK + + + + + ++E ++ ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 349 LRGCCVSSDD-----EKGK----RRFL--VYDFMPSGSLGDHISN----------ALTRK 387
L G C E K R FL PS D N ALT
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 388 QL---AWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444
L AW +++G+ YL + + HRD+ + N+L+ K K++DFGL++
Sbjct: 128 DLISFAW--------QISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 445 SLEGQSHLT-TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
E S++ ++ ++A E T +SDV+SFG+++ E+++
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 296 IGQGASGVVYKG--TLEDGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLSLRGC 352
+G+G V+KG L + LVA+K+I +G I EV ++ ++H N+++L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 353 CVSSDDEKGKRRFLVYDFMPSG--SLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
V +D K LV++++ D N ++ + K + + +GLAY H
Sbjct: 73 -VHTD----KSLTLVFEYLDKDLKQYMDDCGNIMSMHNV-----KIFLYQILRGLAYCH- 121
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK-QSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ + HRD+K N+L++ + K+ADFGLA+ +S+ +++ V T Y P+ L
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLL 177
Query: 470 -YGQLTEKSDVYSFGIVILELMSGRKVLETS 499
+ + + D++ G + E+ SGR + S
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFIN------EVEIISKIRHRNLLS 348
+G GA G V + G VAVK+++ + + I+ E+ ++ ++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS----RPFQSIIHAKRTYRELRLLKHMKHENVIG 80
Query: 349 LRGCCVSSDD-EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
L + E+ +LV M G ++N + ++L + +I + +GL Y
Sbjct: 81 LLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
+H I HRD+K +N+ ++ + + K+ DFGLA+ + + +T VA T Y APE
Sbjct: 136 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVA-TRWYRAPEI 188
Query: 468 AL-YGQLTEKSDVYSFGIVILELMSGRKVL 496
L + + D++S G ++ EL++GR +
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 41/129 (31%), Positives = 63/129 (48%), Gaps = 8/129 (6%)
Query: 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTN 425
L+ D++ G L H+ R+ + + I ++ L +LH + I +RDIK N
Sbjct: 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLEN 135
Query: 426 ILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKS--DVYSFG 483
ILLDSE + DFGL+K+ L + GT Y+APE G D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 484 IVILELMSG 492
++ EL++G
Sbjct: 196 VLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 290 FSQKNLIGQGASGVV----YKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN 345
F +G G+ G V +KGT E + +K+ L K + E I+ ++ H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK-- 403
++++ C D+ R + + +F+ G L H+ RK +P DVAK
Sbjct: 80 IVNM--MCSFQDE---NRVYFLLEFVVGGELFTHL-----RKAGRFPN------DVAKFY 123
Query: 404 ------GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457
YLH I +RD+K N+LLD++ KV DFG AK+ + T +
Sbjct: 124 HAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----RTFTLC 176
Query: 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 492
GT YLAPE + D ++ G+++ E ++G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 48/206 (23%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQIT---DLDTKGDEEFINEVEIISKIRHRN 345
F + IG+G VY+ T L D VA+K++ +D K ++ + E++++ ++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK--KIILDVAK 403
++ + ++ +V + +G L I +K+L P+R K + +
Sbjct: 64 VIKYLDSFIEDNELN-----IVLELADAGDLSQMIKYFKKQKRLI-PERTVWKYFVQLCS 117
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
+ ++H + HRDIK N+ + + K+ D GL + ++ + GT Y+
Sbjct: 118 AVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYM 173
Query: 464 APEYALYGQLTEKSDVYSFGIVILEL 489
+PE KSD++S G ++ E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 295 LIGQGASGVVYKGTLED-GTLVAVKQITDLDTK---GDEEFINEVEIISKIRHRNLLSLR 350
+IG+G G VY D G + A+K + K G+ +NE ++S L+S
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTG 54
Query: 351 GC----CVSSDDEKGKRRFLVYDFMPSGSLGDHISN--ALTRKQLAWPQRKKIILDVAKG 404
C C++ + + D M G L H+S + K++ + +IIL G
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIIL----G 109
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
L ++H + +RD+K NILLD +++D GLA + + H + GT+GY+A
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163
Query: 465 PEYALYGQLTEKS-DVYSFGIVILELMSG 492
PE G + S D +S G ++ +L+ G
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 63/275 (22%), Positives = 122/275 (44%), Gaps = 34/275 (12%)
Query: 296 IGQGASGVVY----KGTLEDGTLVAVKQITDLDTKGDE--EFINEVEIISKIRHRNLLSL 349
+G+G+ G VY K + + L +K+I + +E + E +++SK+ H ++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 350 RGCCVSSDDEKGKRRF-LVYDFMPSGSLGDHISN-ALTRKQLAWPQRKKIILDVAKGLAY 407
+ D F ++ ++ L + T K L+ Q + + + G+ Y
Sbjct: 68 HASFLERDA------FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
+H + I HRD+K+ NI L + + K+ DFG+++ L G L T GT Y++PE
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLATTFTGTPYYMSPEA 176
Query: 468 ALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527
+ KSD++S G ++ E+ E N FL + + G + + +
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--FLSVV----LRIVEGPTPSLPETYS 230
Query: 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
R+ ++M+ + +LRP+ A+ L+
Sbjct: 231 RQ--LNSIMQSMLNKD-------PSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 43/162 (26%), Positives = 86/162 (53%), Gaps = 14/162 (8%)
Query: 334 EVEIISKIRHRNLLSLRGCCV-SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWP 392
E+ ++ ++H N++ L ++ E +LV + M G ++N + ++L+
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-----GADLNNIVKCQKLSDE 118
Query: 393 QRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL 452
+ +I + +GL Y+H I HRD+K +N+ ++ + + ++ DFGLA+Q+ + +
Sbjct: 119 HVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EM 172
Query: 453 TTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
T VA T Y APE L + + D++S G ++ EL+ G+
Sbjct: 173 TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 290 FSQKNLIGQGASGVV---YKGTLEDGTLVAVKQIT---DLDTKGDEEFINEVEIISKIRH 343
+ Q IG GA G+V + L G VAVK+++ T + E+ ++ + H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNH 79
Query: 344 RNLLSLRGCCVSSDD-EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
+N++SL E+ + +LV + M +L I L +++++ ++ +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQML 133
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
G+ +LH I HRD+K +NI++ S+ K+ DFGLA+ + + + T T Y
Sbjct: 134 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYY 188
Query: 463 LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
APE L E D++S G ++ EL+ G + + ++
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 296 IGQGASGVV---YKGTLEDGTLVAVKQIT---DLDTKGDEEFINEVEIISKIRHRNLLSL 349
IG GA G+V Y LE VA+K+++ T + E+ ++ + H+N++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 350 RGCCVSSDD-EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
E+ + ++V + M +L I L +++++ ++ + G+ +L
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
H I HRD+K +NI++ S+ K+ DFGLA+ + G S + T T Y APE
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVI 197
Query: 469 LYGQLTEKSDVYSFGIVILELMSGR 493
L E D++S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 58/212 (27%), Positives = 109/212 (51%), Gaps = 25/212 (11%)
Query: 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLSLRGCC 353
+G+G V+KG + LVA+K+I +G I EV ++ ++H N+++L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI- 71
Query: 354 VSSDDEKGKRRFLVYDFMPSG--SLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
+ ++ + LV++++ S D+ N ++ + K + + +GL+Y H
Sbjct: 72 IHTE----RCLTLVFEYLDSDLKQYLDNCGNLMSMHNV-----KIFMFQLLRGLSYCH-- 120
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAK-QSLEGQSHLTTRVAGTYGYLAPEYALY 470
K I HRD+K N+L++ + + K+ADFGLA+ +S+ +++ V T Y P+ L
Sbjct: 121 -KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPD-VLL 176
Query: 471 GQLTEKS---DVYSFGIVILELMSGRKVLETS 499
G TE S D++ G ++ E+ +GR + S
Sbjct: 177 GS-TEYSTPIDMWGVGCILYEMATGRPMFPGS 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 295 LIGQGASGVVYKGTLED-GTLVAVKQITDLDTK------GDEEFINEVEIISKIRHRNLL 347
+IG+G G VY D G + A+K LD K G+ +NE ++S L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKC---LDKKRIKMKQGETLALNERIMLS------LV 51
Query: 348 SLRGC----CVSSDDEKGKRRFLVYDFMPSGSLGDHISN--ALTRKQLAWPQRKKIILDV 401
S C C+S + + D M G L H+S + ++ + +IIL
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIIL-- 108
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG 461
GL ++H + +RD+K NILLD +++D GLA + + H + GT+G
Sbjct: 109 --GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHG 160
Query: 462 YLAPEYALYGQLTEKS-DVYSFGIVILELMSG 492
Y+APE G + S D +S G ++ +L+ G
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRV 456
I + +GL YLH + I HRD+K+ NI ++ + + D G A+ + + L +
Sbjct: 162 IEKQILEGLRYLH-AQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 457 AGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
AGT APE + K+D++S GIV+ E+++
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 288 GGFSQKNLIGQGASGVVYK-GTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL 346
G F + L+ + A+G Y L+ +VA ++ + E ++ RH L
Sbjct: 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA--------HTLTENRVLQNSRHPFL 57
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKII-LDVAKGL 405
+L+ + D R V ++ G L H+S R+++ R + ++ L
Sbjct: 58 TALKYSFQTHD-----RLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSAL 108
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
YLH + + +RD+K N++LD + K+ DFGL K+ ++ + + T GT YLAP
Sbjct: 109 DYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAP 165
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGR 493
E D + G+V+ E+M GR
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 48/213 (22%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 296 IGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
+G G++G+V+ D VAVK+I D + + + E++II ++ H N++ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 355 SS-----DDEKGKRRF----LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
S +D +V ++M + ++N L + L+ + + + +GL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-----DLANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAK---QSLEGQSHLTTRVAGTYG 461
Y+H + HRD+K N+ +++E + K+ DFGLA+ + +L+ + +
Sbjct: 128 KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183
Query: 462 YLAPEYALY-GQLTEKSDVYSFGIVILELMSGR 493
Y +P L T+ D+++ G + E+++G+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEF--INEVEIISKIRHRNLLSLRGC 352
+G+G+ VYKG +G LVA+K I+ + T+ F I E ++ ++H N++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 353 CVSSDDEKGKRRFLVYD---FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+ + ++ D +M G H N + + + +GLAY+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNV-----------RLFMFQLLRGLAYIH 120
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK-QSLEGQSHLTTRVAGTYGYLAPEYA 468
I HRD+K N+L+ + K+ADFGLA+ +S+ Q++ + V T Y P+
Sbjct: 121 ---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-V 174
Query: 469 LYGQLTEKS---DVYSFGIVILELMSGRKVLETSNSSF 503
L G T+ S D++ G + +E++ G+ + F
Sbjct: 175 LLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 71/262 (27%)
Query: 295 LIGQGASGVVYKGTL----EDGTLVAVKQI--TDLDTKGDEE-FINEVEIISKIRHRNLL 347
+IG+GA G V+ L + G + A+K + +D+ + E +I++ ++
Sbjct: 8 VIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD------- 400
L S DE+ +LV ++MP G L N L RK +
Sbjct: 65 KLY---YSFQDEE--HLYLVMEYMPGGDL----MNLLIRKD---------VFPEETARFY 106
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ---------------- 444
+A+ + L K HRDIK NIL+D++ K+ADFGL K+
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 445 ------------SLEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILEL 489
+ + GT Y+APE YG D +S G+++ E+
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE---CDWWSLGVILYEM 223
Query: 490 MSGRKVL--ETSNSSFLLITDW 509
+ G +T ++ I +W
Sbjct: 224 LYGFPPFYSDTLQETYNKIINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 332 INEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAW 391
+ E ++ RH L +L+ + D R V ++ G L H+S R+++
Sbjct: 43 LTESRVLQNTRHPFLTALKYSFQTHD-----RLCFVMEYANGGELFFHLS----RERVFS 93
Query: 392 PQRKKII-LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450
R + ++ L YLH + +RD+K N++LD + K+ DFGL K+ + +
Sbjct: 94 EDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA 150
Query: 451 HLTTRVAGTYGYLAPEY---ALYGQLTEKSDVYSFGIVILELMSGR 493
+ T GT YLAPE YG+ D + G+V+ E+M GR
Sbjct: 151 TMKT-FCGTPEYLAPEVLEDNDYGRAV---DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 296 IGQGASGVVYKG--TLEDGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLSLRGC 352
+G+G VYKG L D LVA+K+I +G I EV ++ ++H N+++L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 353 CVSSDDEKGKRRFLVYDFMPSG--SLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
+ K LV++++ D N++ + K + + +GL Y H
Sbjct: 73 IHTE-----KSLTLVFEYLDKDLKQYLDDCGNSINMHNV-----KLFLFQLLRGLNYCH- 121
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK-QSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ + HRD+K N+L++ + K+ADFGLA+ +S+ +++ V T Y P+ L
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILL 177
Query: 470 -YGQLTEKSDVYSFGIVILELMSGRKVLETS 499
+ + D++ G + E+ +GR + S
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 25/143 (17%)
Query: 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL-DVAK--------GLAYLH 409
+ G + +L+ +++ G L H+ +R+ I + D A L +LH
Sbjct: 70 QTGGKLYLILEYLSGGELFMHL------------EREGIFMEDTACFYLSEISLALEHLH 117
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ I +RD+K NILLD++ K+ DFGL K+S+ + +T GT Y+APE +
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILM 173
Query: 470 YGQLTEKSDVYSFGIVILELMSG 492
+ D +S G ++ ++++G
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 52/215 (24%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 323 LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN 382
L + + + EV ++ +++H+N++ ++ ++K +++ +F +G L +I
Sbjct: 51 LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQK 107
Query: 383 ALTRKQLAWPQRKKIILDVAK----GLAYLHYGLKPA-----IYHRDIKSTNILLDSEMK 433
++ + I+D+ + LAY H LK + HRD+K NI L + ++
Sbjct: 108 CY---KMFGKIEEHAIVDITRQLLHALAYCH-NLKDGPNGERVLHRDLKPQNIFLSTGIR 163
Query: 434 -----------------AKVADFGLAKQ-SLEGQSHLTTRVAGTYGYLAPEYALY--GQL 473
AK+ DFGL+K +E +H GT Y +PE L+
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY 220
Query: 474 TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITD 508
+KSD+++ G +I EL SG+ +N+ LI++
Sbjct: 221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255
|
Length = 1021 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLSLRGCC 353
+G+G+ VYKG + +G LVA+K I + +G I E ++ ++H N++ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 354 VSSDDEKGKRRFLVYD---FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
+ + ++ D +M G H N K + + +GL+Y+H
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENV-----------KLFLFQLLRGLSYIH- 120
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ I HRD+K N+L+ + K+ADFGLA+ SH + T Y P+ L
Sbjct: 121 --QRYILHRDLKPQNLLISDTGELKLADFGLARAK-SVPSHTYSNEVVTLWYRPPD-VLL 176
Query: 471 GQLTEKS---DVYSFGIVILELMSG 492
G TE S D++ G + +E++ G
Sbjct: 177 GS-TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI-----TDLDTKGDEEFINEVEIISKIRHRNLLS 348
+G GA G V G VA+K++ +++ K E+ ++ ++H N++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAK---RAYRELTLLKHMQHENVIG 78
Query: 349 LRGCCVSSDDEKGKRRF-LVYDFMP---SGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
L S+ + F LV +M +G +S + + ++ + G
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED---------KVQYLVYQMLCG 129
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
L Y+H I HRD+K N+ ++ + + K+ DFGLA+ + + +T V T Y A
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVV-TRWYRA 182
Query: 465 PEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
PE L + + D++S G ++ E+++G+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 296 IGQGASGVVYKGTLEDG---TLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLSLRG 351
IG G G V G + G V VK++ + ++ +F+ E + ++H NLL G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLAYLH 409
C LV +F P G L ++ + + + +++ ++A GL +LH
Sbjct: 63 QCTEVTP-----YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT-RVAGTYGYLAPEYA 468
K H D+ N LL +++ K+ D+GL+ + ++T ++ ++APE
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 469 --LYGQL-----TEKSDVYSFGIVILEL 489
++G L T++S+V+S G+ I EL
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 296 IGQGASGVVYKGTLED--------GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL 347
+GQG ++KG + T V +K + E F ++S++ H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
G CV D+ +V +++ GSL ++ ++W L+VAK LA+
Sbjct: 63 LNYGVCVCGDES-----IMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAW 111
Query: 408 -LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS-------HLTTRVAGT 459
LH+ + H ++ + N+LL E K + K S G S L R+
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-- 169
Query: 460 YGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSG 492
++ PE Q L+ +D +SFG + E+ SG
Sbjct: 170 --WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 37/223 (16%)
Query: 293 KNLIGQGASG-VVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
++G GA+G V+ + DG AVK + D E ++E + N
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVV-------DMEGMSEADK-------NRAQAEV 82
Query: 352 CCVSS-------------------DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWP 392
CC+ + + E LV D+ +G L I + + +
Sbjct: 83 CCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSR-AKTNRTFR 141
Query: 393 QRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL 452
+ + +L + LA H K I HRDIKS NILL S K+ DFG +K S
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMI-HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD 200
Query: 453 TTRV-AGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK 494
R GT Y+APE ++K+D++S G+++ EL++ ++
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 38/103 (36%), Positives = 50/103 (48%), Gaps = 19/103 (18%)
Query: 405 LAYLH-YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL--------EGQSHLTTR 455
L YLH YG I HRD+K N+L+ S K+ DFGL+K L EG TR
Sbjct: 114 LEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 456 ------VAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 492
V GT Y+APE L + D ++ GI++ E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQIT-DLDTKGDEEF-INEVEIISKIRHRNLLSLRGC 352
IG+G G V+K E +VA+K++ D D +G + E+ ++ +++H+N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
S K+ LV+++ L + + + K + + KGLA+ H
Sbjct: 68 LHSD-----KKLTLVFEYCDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCH--- 116
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443
+ HRD+K N+L++ + K+ADFGLA+
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 16/98 (16%)
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL-------EGQSHLT 453
VA+G+ +L K I HRD+ + N+LL AK+ DFGLA+ + +G + L
Sbjct: 221 VAQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 454 TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ ++APE T +SDV+S+GI++ E+ S
Sbjct: 278 VK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
G+ +LH I HRD+K +NI++ S+ K+ DFGLA+ + G S + T T Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 184
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
APE L E D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 8e-08
Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 20/136 (14%)
Query: 362 KRRFLVYDFMPSGSLGD--HISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHR 419
K L+ D++ G L D L+ ++ KKII + + L LH K I H
Sbjct: 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEV-----KKIIRQLVEALNDLH---KHNIIHN 133
Query: 420 DIKSTNILLDSEMK-AKVADFGLAKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKS 477
DIK N+L D + D+GL K + G S GT Y +PE + G + S
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSCYD----GTLDYFSPE-KIKGHNYDVS 186
Query: 478 -DVYSFGIVILELMSG 492
D ++ G++ EL++G
Sbjct: 187 FDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 22/148 (14%)
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
C DD K ++V ++MP G L + +SN ++ A K +V L +H
Sbjct: 110 CAFQDD---KYLYMVMEYMPGGDLVNLMSNYDVPEKWA----KFYTAEVVLALDAIH--- 159
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLA-KQSLEGQSHLTTRVAGTYGYLAPEY---- 467
+ HRD+K N+LLD K+ADFG K G T V GT Y++PE
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 468 ---ALYGQLTEKSDVYSFGIVILELMSG 492
YG+ + D +S G+ + E++ G
Sbjct: 219 GGDGYYGR---ECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 53/233 (22%), Positives = 97/233 (41%), Gaps = 51/233 (21%)
Query: 295 LIGQGASGVVYKGTLED---GTLVAVKQITDLDTKGDE----EFINEVEIISKIRHRNLL 347
LIG+G G VY D VA+K+I + D + F+ E +I + + H ++
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMP---SGSLGDHISNALTRKQLAWPQRKK-------- 396
+ C D VY MP +L + + ++ L+ +K
Sbjct: 66 PVYSICSDGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ------- 449
I + + Y+H + HRD+K NILL + + D+G A + +
Sbjct: 118 IFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAI-FKKLEEEDLLDI 173
Query: 450 ---------SHLTT--RVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
S +T ++ GT Y+APE L +E +D+Y+ G+++ ++++
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 296 IGQGASGVVYKGTLEDGTLVA---VKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
IG G G V + T VA VK++ + +K EF+ + + ++H N+L G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNA-LTRKQLAWPQRKKIILDVAKGLAYLHY 410
CV + LV+++ G L ++S R+ +++ ++A G+ ++H
Sbjct: 63 QCVEAIP-----YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH- 116
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT--RVAGTYGYLAPEY- 467
K H D+ N L S++ KV D+G+ + + ++ T +LAPE
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-EDYIETEDDKCVPLRWLAPELV 173
Query: 468 -ALYGQL-----TEKSDVYSFGIVILEL 489
+G L T+ S+V++ G+ + EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 334 EVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQ 393
E +++K++H N+++ + E ++V ++ G L I L R +L +P+
Sbjct: 48 EAVLLAKMKHPNIVAFK-----ESFEADGHLYIVMEYCDGGDLMQKIK--LQRGKL-FPE 99
Query: 394 RKKI--ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451
+ + + G+ ++H + + HRDIKS NI L K K+ DFG A+ ++
Sbjct: 100 DTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156
Query: 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILEL 489
T V GT Y+ PE KSD++S G ++ EL
Sbjct: 157 ACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 1/75 (1%)
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEK 476
HRD+KS NI L K+ DFG +KQ + S + + GT YLAPE + ++K
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251
Query: 477 SDVYSFGIVILELMS 491
+D++S G+++ EL++
Sbjct: 252 ADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 16/98 (16%)
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-------SLEGQSHLT 453
VAKG+++L K I HRD+ + NILL K+ DFGLA+ ++G + L
Sbjct: 223 VAKGMSFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 454 TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
+ ++APE T +SDV+S+GI++ E+ S
Sbjct: 280 VK------WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEF--INEVEIISKIRHRNLLSLRGC 352
+G+G+ VYKG + G LVA+K+I L+ + F I E ++ ++H N+++L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIREASLLKDLKHANIVTLH-- 69
Query: 353 CVSSDDEKGKRRF-LVYDFMPS--GSLGDHISNALTRKQLAWPQRKKIIL-DVAKGLAYL 408
D K+ LV++++ + D L+ ++ L + +GLAY
Sbjct: 70 ----DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLS------MHNVRLFLFQLLRGLAYC 119
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK-QSLEGQSHLTTRVAGTYGYLAPEY 467
H + + HRD+K N+L+ + K+ADFGLA+ +S+ +++ V T Y P+
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPD- 173
Query: 468 ALYGQLTEKS---DVYSFGIVILELMSGR 493
L G TE S D++ G + E+ +GR
Sbjct: 174 VLLGS-TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 62/212 (29%), Positives = 87/212 (41%), Gaps = 59/212 (27%)
Query: 312 GTLVAVKQITDLDTKGDEEF---INEVEIISKIRHRNLLSLRGC--------CVSSDDEK 360
GTLV V+ ITDL+ +E NEV + RH N+++ +S
Sbjct: 25 GTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRD 420
G L+ + P G +S AL I+ +GL YLH + HR+
Sbjct: 84 GSANSLLKTYFPEG-----MSEALIGN---------ILFGALRGLNYLH---QNGYIHRN 126
Query: 421 IKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRV----------------AGTYGYLA 464
IK+++IL+ + GL SL G SHL + V +L+
Sbjct: 127 IKASHILISGD--------GLV--SLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176
Query: 465 PEYA---LYGQLTEKSDVYSFGIVILELMSGR 493
PE LYG KSD+YS GI EL +GR
Sbjct: 177 PELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 296 IGQGASGVVYKGTLED-GTLVAVKQIT-DLDTKGDE--EFINEVEIISKIRHRNLLSLRG 351
+GQG G V+ +D G +VA+K++ L K +E + E +I++ + L+ L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-- 66
Query: 352 CCVSS--DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+ + DDE +L +++P G ++N + + + ++ + + LH
Sbjct: 67 --LYAFQDDEY---LYLAMEYVPGGDFRTLLNNLGVLSE---DHARFYMAEMFEAVDALH 118
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ HRD+K N L+D+ K+ DFGL+K + V G+ Y+APE L
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPE-VL 170
Query: 470 YGQLTEKS-DVYSFGIVILELMSG 492
G+ + + D +S G ++ E + G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 25/168 (14%)
Query: 333 NEVEIISKIRHRNLLSLRGCCVSSDDE---KGKRRFLVYDFMPSGSLGDHISNALTRKQL 389
NE+ + ++ H N+L + S + K F +Y FM + + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265
Query: 390 AWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449
Q + I+ + + Y+H + HRDIK NI L+ + K + DFG A E +
Sbjct: 266 LK-QTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKE 320
Query: 450 SHLTTRVAGTYGYL------APEYALYGQLTEKSDVYSFGIVILELMS 491
R A YG++ +PE E +D++S G+++L+++S
Sbjct: 321 -----REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 1/77 (1%)
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTE 475
+ +RD+K NILLD + + DFGL K +++ T GT YLAPE L T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMK-DDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 476 KSDVYSFGIVILELMSG 492
D ++ G+++ E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 23/138 (16%)
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL--DVAKGLAYLHYGLKPAIYHRDIK 422
++V ++MP G L + +SN ++ A +++L D + ++H RD+K
Sbjct: 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---------RDVK 169
Query: 423 STNILLDSEMKAKVADFGLA-KQSLEGQSHLTTRVAGTYGYLAPEY-------ALYGQLT 474
N+LLD K+ADFG K + EG T V GT Y++PE YG+
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR-- 226
Query: 475 EKSDVYSFGIVILELMSG 492
+ D +S G+ + E++ G
Sbjct: 227 -ECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 296 IGQGASGVVYKGTL-EDGTLVAVKQITD-------LDTKG--DEEFINEVEIISKIRHRN 345
+GQG +YKG L L V + L + F ++S++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
L+ L G CV ++ +V +++ G L + L W LDVAK L
Sbjct: 63 LVKLYGVCVRDENI------MVEEYVKFGPLDVFLHREKNNVSLHW------KLDVAKQL 110
Query: 406 AY-LHYGLKPAIYHRDIKSTNILLDSE-------MKAKVADFGLAKQSLEGQSHLTTRVA 457
A LHY + H ++ NIL+ K++D G+ ++ + R+
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-TVLSREERVERIP 169
Query: 458 GTYGYLAPEYALYGQ--LTEKSDVYSFGIVILELMS-GRKVLETSNSS 502
++APE GQ LT +D +SFG +LE+ S G + L T +SS
Sbjct: 170 ----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 57/235 (24%), Positives = 91/235 (38%), Gaps = 46/235 (19%)
Query: 290 FSQKNLIGQGASG----VVYKGTLEDGTLVAVKQITDLDTKGDEE---FINEVEIISKIR 342
F K+L+G+G G V K T G + A+K + E F E +I+S
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL-------GDHISNALTRKQLAWPQRK 395
+ L+ D+ +LV ++ P G L D + + LA
Sbjct: 60 SPWIPQLQYAFQDKDN-----LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA----- 109
Query: 396 KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR 455
++ + +H + HRDIK N+L+D K+ADFG A + + +
Sbjct: 110 ----ELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL 162
Query: 456 VAGTYGYLAPEY---------ALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501
GT Y+APE YG + D +S G++ E++ GR S
Sbjct: 163 PVGTPDYIAPEVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSPFHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 296 IGQGASGVVYKGTLEDGTL--VAVKQITD---LDTKGDEEFINEVEIISKIRHRNLLSLR 350
+G G+ G V T ++ VA+K+ + K + +E +I++ I H ++L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
G S DE +LV +F+ G R+ +P A+ + Y
Sbjct: 98 G---SFKDES--YLYLVLEFVIGGEF-----FTFLRRNKRFPNDVGCFY-AAQIVLIFEY 146
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
I +RD+K N+LLD + K+ DFG AK ++ + T + GT Y+APE L
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK-VVDTR---TYTLCGTPEYIAPEILLN 202
Query: 471 GQLTEKSDVYSFGIVILELMSG 492
+ +D ++ GI I E++ G
Sbjct: 203 VGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 399 LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE-------GQSH 451
VA+G+ +L + I HRD+ + NILL K+ DFGLA+ + G +
Sbjct: 180 FQVARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
L + ++APE T +SDV+SFG+++ E+ S
Sbjct: 237 LPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG-T 459
VA+G+ +L + I HRD+ + NILL K+ DFGLA+ + ++ A
Sbjct: 183 VARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
++APE T +SDV+SFG+++ E+ S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
VA+G+ +L HRD+ + N+LL K+ DFGLA+ + ++++ T+
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK--GSTF 300
Query: 461 ---GYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
++APE T SDV+S+GI++ E+ S
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG-T 459
VAKG+ +L HRD+ + NILL K+ DFGLA+ + ++ A
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
++APE T +SDV+SFG+++ E+ S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 42/211 (19%)
Query: 299 GASGVVYKGTL---EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRG---- 351
G+ G V+ T E V VK +T T G E++I+ I HR +++L
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRW 157
Query: 352 ----CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
C V K + ++ ++ S L +Q QR+ + + LAY
Sbjct: 158 KSTVCMVMP-----KYKCDLFTYV-------DRSGPLPLEQAITIQRR-----LLEALAY 200
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL---A 464
LH I HRD+K+ NI LD A + DFG A + T + G G L +
Sbjct: 201 LH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL--DAHPDTPQCYGWSGTLETNS 255
Query: 465 PEYALYGQLTEKSDVYSFGIVILELMSGRKV 495
PE K+D++S G+V+ E MS + V
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFE-MSVKNV 285
|
Length = 392 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 40/181 (22%), Positives = 74/181 (40%), Gaps = 42/181 (23%)
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424
+L+ +F+P G D ++ + + L + + I + + +H + HRDIK
Sbjct: 77 YLIMEFLPGG---DMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPD 130
Query: 425 NILLDSEMKAKVADFGL------------------------------AKQSLE----GQS 450
N+LLDS+ K++DFGL +K+ E +
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 451 HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL--ETSNSSFLLITD 508
L GT Y+APE + + D +S G+++ E++ G ET ++ + +
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN 250
Query: 509 W 509
W
Sbjct: 251 W 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 45/225 (20%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
F +IG+GA G V AV ++ + D + +N+ E++ +
Sbjct: 3 FEILKVIGRGAFGEV-----------AVVKLKNADKVFAMKILNKWEMLKRAETACFREE 51
Query: 350 RGCCVSSDD----------EKGKRRFLVYDFMPSGSL-------GDHISNALTRKQLAWP 392
R V+ D+ + +LV D+ G L D + + R LA
Sbjct: 52 RDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-- 109
Query: 393 QRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL 452
I +D L Y+H RDIK NIL+D ++ADFG + +E +
Sbjct: 110 -EMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159
Query: 453 TTRVAGTYGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSG 492
++ GT Y++PE G+ + D +S G+ + E++ G
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 59/264 (22%)
Query: 290 FSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN--L 346
F +IG+GA G V +D G + A+K + D + E E ++ IR L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD-------MLEKEQVAHIRAERDIL 55
Query: 347 LSLRGCCV-----SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDV 401
+ G V S D++ +L+ +F+P G D ++ + + L+ + I +
Sbjct: 56 VEADGAWVVKMFYSFQDKRN--LYLIMEFLPGG---DMMTLLMKKDTLSEEATQFYIAET 110
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL-------------------- 441
+ +H + HRDIK N+LLD++ K++DFGL
Sbjct: 111 VLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167
Query: 442 ----------AKQSLE----GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVIL 487
+K+ E + L GT Y+APE + + D +S G+++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 488 ELMSGRKVL--ETSNSSFLLITDW 509
E++ G ET ++ + +W
Sbjct: 228 EMLIGYPPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 29/96 (30%), Positives = 45/96 (46%), Gaps = 3/96 (3%)
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
V + + YLH + I HRDIK+ NI ++ + DFG A ++ ++ AGT
Sbjct: 191 VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL 496
APE D++S GIV+ E+ + L
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
VA G+ +L HRD+ + N+L+ K+ DFGLA+ + ++++ T+
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTF 302
Query: 461 ---GYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
++APE T SDV+SFGI++ E+ +
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 30/152 (19%), Positives = 58/152 (38%), Gaps = 16/152 (10%)
Query: 291 SQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
S L+ G + VY +D V +K + + EV I+ + + L +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYV-LKINPS--REKGADREREVAILQLLARKGLPVPK 57
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
V + E +L+ +++ +L + +++ I +A+ LA LH
Sbjct: 58 ---VLASGESDGWSYLLMEWIEGETLDEVSEE----------EKEDIAEQLAELLAKLHQ 104
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442
+ H D+ NIL+D + D+ A
Sbjct: 105 LPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 62/243 (25%), Positives = 97/243 (39%), Gaps = 65/243 (26%)
Query: 295 LIGQGASGVVY----KGTLEDGTLVAVKQIT-DLDTKGDE--EFINEVEIISKIRHRNLL 347
L+G+G G V+ KGT G L A+K + K ++ + E EI++ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK---- 403
+L + + LV D+ P G L L ++Q K + +VA+
Sbjct: 65 TLY-----ASFQTETYLCLVMDYCPGGEL-----FRLLQRQ----PGKCLSEEVARFYAA 110
Query: 404 ----GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS-------------- 445
L YLH L +Y RD+K NILL ++DF L+KQS
Sbjct: 111 EVLLALEYLH--LLGIVY-RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 446 ---LEGQSHLTTRVA-----------GTYGYLAPEY-ALYGQLTEKSDVYSFGIVILELM 490
S + + GT Y+APE + G D ++ GI++ E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEML 226
Query: 491 SGR 493
G
Sbjct: 227 YGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 47/188 (25%), Positives = 67/188 (35%), Gaps = 53/188 (28%)
Query: 290 FSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRH 343
F +G+GA GVVYK +L ++G V +K+ T+ VEI R
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATEY---------GAVEIWMNERV 183
Query: 344 RNLLSLRGC---CV--------SSDDEKGKRRFLV---------YDFMPSGSLGDHISNA 383
R R C C +K +LV D M S ++
Sbjct: 184 R-----RACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY 238
Query: 384 LTRK--QLA-WPQRKKIIL-----DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA- 434
L K L +R+ I+ + L LH I HRD+K NI+ +
Sbjct: 239 LLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEGSGSF 295
Query: 435 KVADFGLA 442
K+ D G A
Sbjct: 296 KIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 23/51 (45%), Positives = 32/51 (62%), Gaps = 3/51 (5%)
Query: 396 KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446
K I +VA L YLH + I HRD+K N+L+ +E K+ DFGL+K +L
Sbjct: 108 KYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 38/140 (27%), Positives = 63/140 (45%), Gaps = 24/140 (17%)
Query: 365 FLVYDFMPSGSL-------GDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIY 417
+LV D+ G L D + + R LA +++L + + L Y
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-----EMVLAI-DSVHQLGY------V 124
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY--AL---YGQ 472
HRDIK N+LLD ++ADFG + L + + GT Y++PE A+ G+
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 473 LTEKSDVYSFGIVILELMSG 492
+ D +S G+ + E++ G
Sbjct: 185 YGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL-----YGQ 472
HRDIK N+LLD ++ADFG + + + ++ GT Y++PE G+
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK 184
Query: 473 LTEKSDVYSFGIVILELMSG 492
+ D +S G+ + E++ G
Sbjct: 185 YGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 43/195 (22%), Positives = 75/195 (38%), Gaps = 58/195 (29%)
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLAYLHYGLKPAIYHRDIK 422
+ V D++P G + +L + +P+ + I ++ + +H K HRDIK
Sbjct: 77 YFVMDYIPGGDM-----MSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIK 128
Query: 423 STNILLDSEMKAKVADFGLA-------------------KQSLE---------------- 447
NIL+D + K+ DFGL + S+E
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188
Query: 448 -----------GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK-- 494
Q L + GT Y+APE L T+ D +S G+++ E++ G+
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
Query: 495 VLETSNSSFLLITDW 509
+ T + L + +W
Sbjct: 249 LAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 46/199 (23%), Positives = 77/199 (38%), Gaps = 66/199 (33%)
Query: 365 FLVYDFMPSGSLG------DHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYH 418
+L+ +F+P G L D S +TR +A + +L + +H K H
Sbjct: 77 YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-----ECVL----AIEAVH---KLGFIH 124
Query: 419 RDIKSTNILLDSEMKAKVADFGLA------------KQSLEG---QSHLTTR-------- 455
RDIK NIL+D K++DFGL+ ++ L+G ++ + R
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184
Query: 456 -----------------------VAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 492
GT Y+APE L ++ D +S G ++ E + G
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
Query: 493 RKVL--ETSNSSFLLITDW 509
E S+ ++ I +W
Sbjct: 245 WPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 38/135 (28%), Positives = 57/135 (42%), Gaps = 14/135 (10%)
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLAYLHYGLKPAIYHRDIK 422
FLV G L HIS K L P+ K+ ++ L LH + I RD+
Sbjct: 61 FLVLQHAEGGKLWSHIS-----KFLNIPEECVKRWAAEMVVALDALH---REGIVCRDLN 112
Query: 423 STNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSF 482
NILLD ++ F + + A Y APE + TE D +S
Sbjct: 113 PNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGISEETEACDWWSL 168
Query: 483 GIVILELMSGRKVLE 497
G ++ EL++G+ ++E
Sbjct: 169 GAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 29/131 (22%), Positives = 48/131 (36%), Gaps = 39/131 (29%)
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAK---------------QSLEGQSHLTTR------- 455
HRDIK N+LLD++ K++DFGL +L
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 456 ---------------VAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK--VLET 498
GT Y+APE L ++ D +S G+++ E++ G +
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDN 243
Query: 499 SNSSFLLITDW 509
++ I +W
Sbjct: 244 PQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 40/173 (23%), Positives = 68/173 (39%), Gaps = 52/173 (30%)
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLAYLHYGLKPAIYHRDIK 422
+ V D++P G + + L R + + + + I ++ + +H K HRDIK
Sbjct: 77 YFVMDYIPGGDM----MSLLIRLGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIK 128
Query: 423 STNILLDSEMKAKVADFGL---------AKQSLEGQSH---------------------- 451
NIL+D + K+ DFGL +K +G H
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL 188
Query: 452 -----------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
L + GT Y+APE L T+ D +S G+++ E++ G+
Sbjct: 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 29/85 (34%), Positives = 40/85 (47%), Gaps = 8/85 (9%)
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG---LAKQSLEGQSHLTTRVAGTYGYL 463
Y+H I HRDIK+ N+L++ + DFG A+ S H +AGT
Sbjct: 275 YIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG--IAGTVDTN 329
Query: 464 APEYALYGQLTEKSDVYSFGIVILE 488
APE T D++S G+VI E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 614 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.86 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.51 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.63 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.59 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.52 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.46 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.44 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.28 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.2 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.14 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.06 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.87 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.84 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.49 | |
| PLN02236 | 344 | choline kinase | 96.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.12 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.76 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.74 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.61 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.4 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.3 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.24 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.22 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.03 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.86 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.81 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.77 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.81 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.68 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.85 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 92.73 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.65 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 92.41 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=507.40 Aligned_cols=288 Identities=49% Similarity=0.799 Sum_probs=253.9
Q ss_pred CCcccChHHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccc
Q 036081 274 GAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353 (614)
Q Consensus 274 ~~~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~ 353 (614)
....|++.|+..||++|+..++||+||||.||+|.+++|+.||||++.....+...+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999998765443155699999999999999999999999
Q ss_pred cccCCCCCc-eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC
Q 036081 354 VSSDDEKGK-RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 354 ~~~~~~~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 432 (614)
.+ +. +++||||||+||+|.++|+..... .|+|.+|++||.++|+||+|||+.+.++||||||||+|||||+++
T Consensus 141 ~e-----~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~ 214 (361)
T KOG1187|consen 141 LE-----GGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF 214 (361)
T ss_pred ec-----CCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence 84 33 599999999999999999885333 899999999999999999999999999999999999999999999
Q ss_pred cEEEeeecccccccC-CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-cchhHHHHH
Q 036081 433 KAKVADFGLAKQSLE-GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS-SFLLITDWA 510 (614)
Q Consensus 433 ~~KL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~-~~~~l~~~~ 510 (614)
++||+|||+|+.... ........ .||.+|+||||+..+..+.|+|||||||+|+||+||+++.+.... ....+.+|+
T Consensus 215 ~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 215 NAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred CEEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 999999999976554 22221111 899999999999999999999999999999999999999886542 234588999
Q ss_pred HHHhhCCCchhhhhHHhh-hhCcH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 511 WMLANSGKVDEIFDEFIR-EEGSR-AVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
+..+..+++.+++|+.+. ..... +.++++..++..|++.+|..||+|.||+++|+...
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999999999987 44443 67889999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=404.98 Aligned_cols=252 Identities=35% Similarity=0.557 Sum_probs=205.0
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcc--hHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEec
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG--DEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~--~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
.+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.... ....+||||
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~iVtEy 121 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLCIVTEY 121 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceEEEEEe
Confidence 44599999999999999844449999997643222 568999999999999999999999997422 158999999
Q ss_pred CCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc-eEecCCCCCceeecCCC-cEEEeeecccccccCC
Q 036081 371 MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA-IYHRDIKSTNILLDSEM-KAKVADFGLAKQSLEG 448 (614)
Q Consensus 371 ~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~-ivHrDIKp~NILLd~~~-~~KL~DFGla~~~~~~ 448 (614)
|++|+|.++|+.. ....++|..+++++.|||+||.||| +.+ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999874 3578999999999999999999999 677 99999999999999998 9999999999865432
Q ss_pred CccccccccCCCCccchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 449 QSHLTTRVAGTYGYLAPEYAL--YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~--~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
. ...+...||+.|||||.+. ...|+.|+|||||||+||||+||+.||......+ .+......+.
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-----~~~~v~~~~~-------- 263 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-----VASAVVVGGL-------- 263 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHhcCC--------
Confidence 2 2334478999999999999 6699999999999999999999999998765411 1111111111
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
+...+......+..++..|++.||..||++.+++.+|+..
T Consensus 264 -Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 264 -RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred -CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 1111222445788888999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=393.89 Aligned_cols=251 Identities=31% Similarity=0.466 Sum_probs=211.8
Q ss_pred cceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 292 QKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
..+.||+|-||+||.|.++....||+|.++... ...+.|.+|+++|.+|+|+|||+++|+|. .+...+||||||
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~-----~~~piyIVtE~m 283 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCT-----KQEPIYIVTEYM 283 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEe-----cCCceEEEEEec
Confidence 467899999999999999977799999998753 34578999999999999999999999997 334689999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 451 (614)
++|+|.++|... .+..+...+.+.++.|||+|++||+ ++++|||||.++||||+++..+||+|||||+...++...
T Consensus 284 ~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 284 PKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred ccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999999873 4567899999999999999999999 999999999999999999999999999999965555444
Q ss_pred ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhh
Q 036081 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREE 530 (614)
Q Consensus 452 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 530 (614)
......-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+ +.+.++.-.+-.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---------------v~~~le~GyRlp 424 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---------------VLELLERGYRLP 424 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---------------HHHHHhccCcCC
Confidence 4444556779999999999999999999999999999999 888887654221 112222222223
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 531 GSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 531 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.+..++..+.+|+..|++.+|++|||...+...|+..
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 4555677888999999999999999999999888864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.67 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=206.2
Q ss_pred ccceeeeccCcEEEEEEEEc-CCcEEEEEEeec-CCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 291 SQKNLIGQGASGVVYKGTLE-DGTLVAVKQITD-LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~-~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+..+.||+|..|+|||++++ +++.+|+|.+.. .+....++..+|++++.+.+||+||.++|.|.... .+..++|
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~~isI~m 157 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----EEISICM 157 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----ceEEeeh
Confidence 34678999999999999987 688999999954 33444678999999999999999999999998421 2699999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
|||++|||++.+... +.+++...-+|+.+|++||.|||+ +++||||||||+|||++..|++||+|||.++.....
T Consensus 158 EYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999998763 568889999999999999999994 489999999999999999999999999999876443
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
.....+||..|||||.+.++.|+.++||||||+.++|+.+|+.|+....... ....++++....
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-------------~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-------------LDIFELLCAIVD 296 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-------------CCHHHHHHHHhc
Confidence 4566789999999999999999999999999999999999999997642211 122233333333
Q ss_pred hh---CcH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 529 EE---GSR-AVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 529 ~~---~~~-~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+. .+. ....++..++-.|++.||.+|||..|+++|
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 21 122 255678999999999999999999998765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=366.20 Aligned_cols=204 Identities=30% Similarity=0.540 Sum_probs=181.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|.||+||+|+++ ++..||||.+... ..+..+-...|+++|+.++|||||+|++++. ..+.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cCCe
Confidence 466888888999999999999987 5899999999765 4555677889999999999999999999998 4568
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC------CcEEEe
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE------MKAKVA 437 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~------~~~KL~ 437 (614)
.+||||||.+|+|.++|++ ++.+++...+.++.|||.||++|| +++||||||||+||||+.. -.+||+
T Consensus 84 i~lVMEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred EEEEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 9999999999999999986 468999999999999999999999 9999999999999999765 458999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF 503 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~ 503 (614)
|||+|+....+ ......+|++-|||||+++.++|+.|+|+||.|++|||+++|+.||+.....+
T Consensus 158 DFGfAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 158 DFGFARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred ccchhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 99999987643 33456799999999999999999999999999999999999999998765543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=379.37 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=208.8
Q ss_pred CCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..|...++||+|||+.+|+++. ..|+.||+|++.+. .....+...+||+|.++|+|||||+++++|. +.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE-----Ds~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE-----DSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee-----cCCc
Confidence 4588899999999999999997 78999999999763 3344567899999999999999999999998 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.|+|.|+|++|+|.++++. ++.+++++.+.+..||+.||.||| +.+|+|||||..|++|++++++||+|||||.
T Consensus 93 VYivLELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceee
Confidence 9999999999999998874 689999999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... ......+||+.|+|||++.....+..+||||+|||+|-|+.|++||+...- .+..
T Consensus 167 ~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------------------kety 227 (592)
T KOG0575|consen 167 QLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------------------KETY 227 (592)
T ss_pred eecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------------------HHHH
Confidence 865432 234457999999999999999999999999999999999999999986431 1222
Q ss_pred hHHhhhh--CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREE--GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.....+ .+........+++..+++.+|.+|||+++|+.+
T Consensus 228 ~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 228 NKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2111111 222344466788899999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=393.15 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=214.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
.+....+.||+|.||+||+|+.. +...||||.+++.... ...+|++|+++++.++|||||+|+|.|. +
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~ 560 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----E 560 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----c
Confidence 34455678999999999999853 3568999999987665 6789999999999999999999999998 5
Q ss_pred CceEEEEEecCCCCCcccccchhh-------h----ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNAL-------T----RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~-------~----~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
++..++|+|||..|+|.+||.... . ..+|+..+.+.||.|||.|+.||- +..+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence 677999999999999999996432 1 233788899999999999999999 99999999999999999
Q ss_pred CCCcEEEeeecccccccCCCccccc-cccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQSHLTT-RVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLIT 507 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~ 507 (614)
++..+||+||||+|.....+.+... +..-...|||||.+++++||++||||||||+||||++ |+.|+.....++.
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--- 714 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--- 714 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH---
Confidence 9999999999999976554443322 3344679999999999999999999999999999999 9999876544321
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
-.....+++. +.++..+.++..|++.|++.+|.+||++.||-..|+....
T Consensus 715 ---Ie~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 ---IECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ---HHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 1122333331 2355566789999999999999999999999999987654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=361.63 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=201.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc-------chHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK-------GDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-------~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
.+.|...+.||+|+||.|-+|..+ +|+.||||++++.... ......+|+++|++|+|||||++.+++..
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--- 247 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--- 247 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec---
Confidence 344667889999999999999854 7999999999653211 12335799999999999999999999973
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC---CcEE
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE---MKAK 435 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~K 435 (614)
....|+|||||++|+|.+.+-. ++.+.+..-.-++.|++.|+.||| +.||+||||||+|||+..+ ..+|
T Consensus 248 --~ds~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 248 --PDSSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred --CCceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEE
Confidence 4457999999999999999876 466888888999999999999999 9999999999999999765 7899
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCCC--C-chhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL--T-EKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM 512 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~--s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~ 512 (614)
|+|||+|+...+ .......+||+.|.|||++.++.+ + .|.|+||+||+||-+++|.+||.....+..+..
T Consensus 320 ItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----- 392 (475)
T KOG0615|consen 320 ITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----- 392 (475)
T ss_pred ecccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH-----
Confidence 999999997653 334566799999999999986543 3 488999999999999999999976544321111
Q ss_pred HhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 513 LANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 513 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....|+.... .....++.++..+++.+++..||++|||++|++++
T Consensus 393 QI~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 393 QILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1112221100 11233566788999999999999999999999764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=404.76 Aligned_cols=262 Identities=26% Similarity=0.494 Sum_probs=214.1
Q ss_pred hCCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
...|...++||+|+||.||+|+. .+|..||||+++..... ...|++++++++|||||+++|+|.. ....+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS-----EKGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc-----CCCCE
Confidence 45577888999999999999997 47899999998653322 2356889999999999999999973 45689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++|+|.++++ .++|.++.+|+.|||+||+|||+.++++|+||||||+||+++.++.+++. ||.....
T Consensus 760 lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999999999984 38999999999999999999998778899999999999999999998886 6665432
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.. .....+|+.|+|||++.++.++.|+|||||||++|||+||+.|++........+.+|++.........+.+|+
T Consensus 833 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 833 CT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred cc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 21 1223688999999999999999999999999999999999999965443334556677665555556666666
Q ss_pred Hhhhh--CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 526 FIREE--GSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 526 ~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
.+... ...+...++.+++.+|++.+|++||||.||+++|+....
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 65432 234455678899999999999999999999999997543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=361.37 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=202.8
Q ss_pred hCCCccceeeeccCcEEEEEEEE------cCCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~ 358 (614)
.++|...++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|++++.++ +||||++++|+|..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK--- 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence 45688889999999999999974 2356899999875432 2345789999999999 89999999998863
Q ss_pred CCCceEEEEEecCCCCCcccccchhhh-----------------------------------------------------
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALT----------------------------------------------------- 385 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~----------------------------------------------------- 385 (614)
.+...++||||+++|+|.+++.....
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 23458999999999999988864211
Q ss_pred ------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCccc-cccccC
Q 036081 386 ------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL-TTRVAG 458 (614)
Q Consensus 386 ------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~-~~~~~g 458 (614)
...+++...+.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++......... .....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 134778888999999999999999 8999999999999999999999999999998654332221 223456
Q ss_pred CCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHH
Q 036081 459 TYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVME 537 (614)
Q Consensus 459 t~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 537 (614)
+..|+|||++.+..++.++||||||++||||++ |+.||......... . .....+... ..+.....
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~----~-~~~~~~~~~---------~~~~~~~~ 304 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF----C-QRLKDGTRM---------RAPENATP 304 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH----H-HHHhcCCCC---------CCCCCCCH
Confidence 788999999999999999999999999999997 99999764322111 1 111111110 01112334
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 538 RFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 538 ~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.+.+++..|++.+|++|||+.|++++|+..
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=340.63 Aligned_cols=262 Identities=22% Similarity=0.356 Sum_probs=208.9
Q ss_pred CCccceeeeccCcEEEEEEE-EcCCcEEEEEEeec--CCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITD--LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~--~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|.+.++||+|.||+|||+. +.+|..+|.|.+.- .+.+.......|+.+|++|+|||||++++..... +....+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~---~~evln 96 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE---DNEVLN 96 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc---cchhhH
Confidence 46677899999999999998 45899999999863 3344456788999999999999999999854432 223489
Q ss_pred EEEecCCCCCcccccchhhh-ccCCCccchhHHHHHHHHHHHHHHhcC-CCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNALT-RKQLAWPQRKKIILDVAKGLAYLHYGL-KPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~-~~~l~~~~r~~Ia~~Ia~gL~yLH~~~-~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
|||||+..|+|...+....+ ++.+++...++++.|+++||..+|+.. +..|+||||||.||+|+++|.+||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999876543 456889999999999999999999422 1239999999999999999999999999999
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
.+.... ......+|||.||+||.+....|+.||||||+||++|||..-+.||...+ +... -.....++...+.
T Consensus 177 ~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L-~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 177 FLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSL-CKKIEQGDYPPLP 249 (375)
T ss_pred Hhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHH-HHHHHcCCCCCCc
Confidence 765443 34556799999999999999999999999999999999999999998752 1111 1223344433332
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
+ ....+.+..++..|+.+||+.||+.-..+..+..+.
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l 286 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSEL 286 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHh
Confidence 2 334567888999999999999999766666665543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=378.41 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=214.3
Q ss_pred CccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 290 FSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
..+.++||.|.||.||+|+++- ...||||.++....+ ...+|+.|..||.++.||||++|.|+.. ..+..
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-----ks~Pv 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-----KSKPV 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-----cCcee
Confidence 3456899999999999999862 357999999876544 4678999999999999999999999987 55678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++|.|||+||+|+.||+.. .++++|.+...+.++||.|+.||- +.++|||||.++|||++.+..+||+||||+|.
T Consensus 706 MIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceee
Confidence 9999999999999999874 577999999999999999999999 99999999999999999999999999999997
Q ss_pred ccCCCccccccccC--CCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 445 SLEGQSHLTTRVAG--TYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 445 ~~~~~~~~~~~~~g--t~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
..++.....+...| ...|.|||.+.+++++..||||||||++||.++ |.+|+-.+... ++..
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---------------dVIk 845 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------------DVIK 845 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---------------HHHH
Confidence 65544332332223 468999999999999999999999999999887 99998543321 1222
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIP 571 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~~~ 571 (614)
.++.-.+-..+.+.+..+.+|++.|+|.|..+||+..+++.+|.+..-.|
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 23333333456677889999999999999999999999999998865433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.38 Aligned_cols=242 Identities=25% Similarity=0.361 Sum_probs=199.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|+..++||+|+||+||.++.+ +++.+|+|++++.. ....+...+|..||.+++||.||.++-.+. +..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-----t~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ-----TEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc-----cCC
Confidence 456899999999999999999866 58999999997632 233566789999999999999999998887 567
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
.+|||+||+.||.|..+|.+ .+.+++....-++.+|+.||.||| +.+||||||||+|||||++|+++|+||||+
T Consensus 99 kLylVld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred eEEEEEeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccc
Confidence 89999999999999999976 467899999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+....... .+...+||+.|||||++....|+..+|.||+|+++|||++|.+||...+.. .+...... ++
T Consensus 173 k~~~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I~~-~k---- 241 (357)
T KOG0598|consen 173 KEDLKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKILK-GK---- 241 (357)
T ss_pred hhcccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHHhc-Cc----
Confidence 97544432 344579999999999999999999999999999999999999999765421 12211111 11
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRP 555 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 555 (614)
+ ...+.-......+++...+..+|++|-
T Consensus 242 ----~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ----L-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----C-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0 011222334667788888999999995
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.89 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=203.9
Q ss_pred cccChHHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcc---hHHHHHHHHHHHHccCCCccccccc
Q 036081 276 KWFRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG---DEEFINEVEIISKIRHRNLLSLRGC 352 (614)
Q Consensus 276 ~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~---~~~f~~Ei~il~~l~H~NIv~l~g~ 352 (614)
+.++.++++ ......||+|++|.||+|+++ |+.||||+++...... .+.|.+|++++.+++||||++++|+
T Consensus 13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDID-----KYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHcC-----CCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 334555552 233467999999999999994 8999999997643333 4678899999999999999999999
Q ss_pred ccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCC-CceEecCCCCCceeecCC
Q 036081 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK-PAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 353 ~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~ 431 (614)
+..... .....++||||+++|+|.+++.. .+.++|..+++++.+++.||.||| + .+++||||||+|||++++
T Consensus 87 ~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 87 IIDIVD-DLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTEN 159 (283)
T ss_pred EEeccc-CCCceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCC
Confidence 864211 23568999999999999999875 357899999999999999999999 5 478899999999999999
Q ss_pred CcEEEeeecccccccCCCccccccccCCCCccchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Q 036081 432 MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW 509 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~ 509 (614)
+.+||+|||+++...... ....|+..|+|||++.+ +.++.++|||||||++|||++|+.||....... .
T Consensus 160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-----~ 230 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-----I 230 (283)
T ss_pred CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-----H
Confidence 999999999988643221 23468899999999976 789999999999999999999999997654221 1
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.......+. . ...+....+.+.+++..|++.||++|||+.|+++.|+.
T Consensus 231 ~~~i~~~~~-~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 231 YDLIINKNN-S--------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHhcCC-C--------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111111110 0 00111234578889999999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=343.25 Aligned_cols=263 Identities=22% Similarity=0.380 Sum_probs=200.0
Q ss_pred CCCccceeeeccCcEEEEEEEEcC-----------------CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED-----------------GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSL 349 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l 349 (614)
++|...++||+|+||.||++.+++ +..||+|.+..... ....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999998642 34799999875432 235679999999999999999999
Q ss_pred cccccccCCCCCceEEEEEecCCCCCcccccchhh----------------hccCCCccchhHHHHHHHHHHHHHHhcCC
Q 036081 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL----------------TRKQLAWPQRKKIILDVAKGLAYLHYGLK 413 (614)
Q Consensus 350 ~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~----------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~ 413 (614)
++++.. ....++||||+++|+|.+++.... ....++|...++++.||+.||.||| +
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~ 156 (304)
T cd05096 85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---S 156 (304)
T ss_pred EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---H
Confidence 999873 456899999999999999885421 1134788889999999999999999 8
Q ss_pred CceEecCCCCCceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-
Q 036081 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS- 491 (614)
Q Consensus 414 ~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt- 491 (614)
.+|+||||||+|||++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++
T Consensus 157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 9999999999999999999999999999976533322 12233456789999999999999999999999999999997
Q ss_pred -CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 492 -GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 492 -G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
|..|+........ ...+............ ...+...+..+.+++..|++.+|.+|||+.+|.+.|++
T Consensus 237 ~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 237 CKEQPYGELTDEQV--IENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCCCCCcCCHHHH--HHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4566654432211 1111111111100000 00111233578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=345.13 Aligned_cols=260 Identities=29% Similarity=0.433 Sum_probs=204.9
Q ss_pred CCCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.+|...+.||+|.||+||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+.+|.....+. ..+.+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence 446778899999999999999764 89999999876433335668999999999999999999997553221 47899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-CCcEEEeeecccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-EMKAKVADFGLAKQS 445 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~KL~DFGla~~~ 445 (614)
.|||+++|+|.+++.+.. ..|+++..+.++.||++||+||| +++||||||||+||||+. ++.+||+|||+++..
T Consensus 94 ~mEy~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 999999999999998743 26999999999999999999999 999999999999999999 799999999999876
Q ss_pred cC--CCccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 446 LE--GQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 446 ~~--~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
.. ..........||+.|||||++.++.. ..++|||||||+++||+||++||..... ...+.-.........
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~----~~~~~~~ig~~~~~P-- 242 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE----EAEALLLIGREDSLP-- 242 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc----hHHHHHHHhccCCCC--
Confidence 53 22223445789999999999996433 3599999999999999999999975310 011111111111111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
..+........+++..|+..+|+.|||+++++++.--..
T Consensus 243 -------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 243 -------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 122234456778889999999999999999999865543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.77 Aligned_cols=267 Identities=30% Similarity=0.414 Sum_probs=201.9
Q ss_pred CccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHc--cCCCcccccccccccCCCCCceEEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKI--RHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l--~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
....++||+|+||.||||.+. ++.||||++.. +....|++|-+|.+.. +|+||+++++.-...+. .+.+++||
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLV 286 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLV 286 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEE
Confidence 345678999999999999997 69999999865 4566799999998864 89999999998654433 36689999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcC------CCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL------KPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~------~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
+||.++|+|.++|.. ..++|....+|+..+++||+|||++. +++|+|||||++||||.+|+++.|+||||
T Consensus 287 t~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999965 57999999999999999999999765 67899999999999999999999999999
Q ss_pred cccccCCCccc-cccccCCCCccchhhhccC-CCC-----chhhHHHHHHHHHHHHhCCCCCCCCC-ccc-h--------
Q 036081 442 AKQSLEGQSHL-TTRVAGTYGYLAPEYALYG-QLT-----EKSDVYSFGIVILELMSGRKVLETSN-SSF-L-------- 504 (614)
Q Consensus 442 a~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~-~~s-----~ksDVwSfGvvL~ELltG~~p~~~~~-~~~-~-------- 504 (614)
|..+..+.... ....+||..|||||++.+. .+. .+.||||+|.|||||++.-..+.... ++. .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99876544332 2337899999999998753 222 36899999999999999765543211 110 0
Q ss_pred --hHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 505 --LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 505 --~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
.+ +-++.++..++....+.....+. ..+..+.+.+..|++.|++.|-|+.=|-+.+.....
T Consensus 443 hPt~-e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 443 HPTL-EEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCH-HHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 01 11111111122222222222211 234467788899999999999999999888776543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=336.51 Aligned_cols=255 Identities=21% Similarity=0.338 Sum_probs=202.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|...+.||+|+||.||+|+++ .+..||+|.++.... ...+.|.+|+.++.+++||||++++|++. .+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 345788899999999999999864 367899999876432 33467899999999999999999999986 34
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++... ...++|.+++.++.|++.||+||| +.+++||||||+|||++.++.+|++|||.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcc
Confidence 5789999999999999998653 346899999999999999999999 89999999999999999999999999998
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+...............++..|+|||.+.++.++.++||||||+++||+++ |+.||....... .... ...+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-----~~~~-~~~~~~- 226 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-----VIKA-VEDGFR- 226 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHH-HHCCCC-
Confidence 76532222111222345678999999999999999999999999999875 999997543221 1111 111110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+...+..+.+++..|++.+|.+||++.++++.|+.
T Consensus 227 --------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 --------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01122334577889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.79 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=201.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+.|+...++|+|+||+|||++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.|+.+|. ....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-----rkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-----RKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-----hccee
Confidence 34667778999999999999987 499999999976433 23466789999999999999999999997 56789
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+||+||++..=|. .|.. ....++.....+++.|+++|+.|+| ++++|||||||+||||+.++.+||+|||.|+.
T Consensus 77 hLVFE~~dhTvL~-eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 77 HLVFEYCDHTVLH-ELER--YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFART 150 (396)
T ss_pred EEEeeecchHHHH-HHHh--ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHh
Confidence 9999999764443 3333 2456888899999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHH--------
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITDWAWML-------- 513 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~--l~~~~~~~-------- 513 (614)
... .....+..+.|.+|.|||.+.+ .+|....|||+.||++.||++|.+.|.+..+-+.+ +..-...+
T Consensus 151 L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 151 LSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred hcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 754 3445677889999999999987 79999999999999999999999988765543211 11111100
Q ss_pred hhCCCchhhhhHHhh-----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANSGKVDEIFDEFIR-----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+.+..+.-+... +..-.....-+++++..|++.||++|++-+|++.+
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 001110000000000 00011233467889999999999999999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=350.65 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=209.6
Q ss_pred CCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
.|....+||+|..|.||.+.- .+++.||||++........+-..+|+.+|+..+|+|||.++..+. .++++|+|
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLWVV 348 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELWVV 348 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeEEE
Confidence 356667899999999999974 468999999998766666778899999999999999999999887 45679999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
||||++|+|.+.+.. ..+++.++..|+++++.||+||| ..+|+|||||.+||||+.+|.+||+|||++.+...
T Consensus 349 MEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 999999999999865 45999999999999999999999 99999999999999999999999999999988766
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
.+. ....++||+.|||||.+....|.+|.||||||++++||+-|.+||-..+.-. -.+.....|... +
T Consensus 422 ~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-----AlyLIa~ng~P~------l 489 (550)
T KOG0578|consen 422 EQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATNGTPK------L 489 (550)
T ss_pred ccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-----HHHHHhhcCCCC------c
Confidence 554 4456789999999999999999999999999999999999999996543221 112222333221 1
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..++.+...+.++..+|++.|+++||++.|+|++
T Consensus 490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1233344577888899999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=378.58 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=208.8
Q ss_pred CCccceeeeccCcEEEEEEEEcC--Cc----EEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED--GT----LVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~--g~----~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
+....+.||+|.||.||+|...+ |. .||||.++.. +.+...+|++|..+|++++|||||+++|+|.. .
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~ 767 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S 767 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence 44566889999999999999763 44 4999999765 44557899999999999999999999999984 4
Q ss_pred ceEEEEEecCCCCCcccccchhh----hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEe
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL----TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVA 437 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~----~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~ 437 (614)
...++++|||++|+|..+|++.+ ....|+....+.++.|||+|+.||+ ++++|||||.++|+||++...+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEc
Confidence 56899999999999999998753 1346888889999999999999999 9999999999999999999999999
Q ss_pred eecccccccCCCcccc-ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhh
Q 036081 438 DFGLAKQSLEGQSHLT-TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 438 DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
|||||+.....+.... .+..-...|||||.+..+.++.|+|||||||+||||+| |..||......+... ....
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-----~~~~ 919 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-----DVLE 919 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-----HHHh
Confidence 9999995544333222 22233568999999999999999999999999999999 888987654322111 1112
Q ss_pred CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 516 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.++ | ..+..+++.+.+|++.|++.+|++||++..+++.++...
T Consensus 920 ggR--------L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 920 GGR--------L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCc--------c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 221 1 234556778889999999999999999999999877643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.38 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=200.8
Q ss_pred hCCCccceeeeccCcEEEEEEEE------cCCcEEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCcccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~ 358 (614)
.++|+..+.||+|+||.||+|++ .++..||||+++... ....+.+.+|++++..+ +||||++++|+|.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 34688889999999999999974 235689999986432 23346788999999999 8999999999987
Q ss_pred CCCceEEEEEecCCCCCcccccchhhh-----------------------------------------------------
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALT----------------------------------------------------- 385 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~----------------------------------------------------- 385 (614)
.+...++||||+++|+|.+++.....
T Consensus 110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 45568999999999999988864210
Q ss_pred -------------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 386 -------------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 386 -------------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
...++|..+++++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 124788889999999999999999 8999999999999999999999999999998654
Q ss_pred CCCccc-cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 447 EGQSHL-TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 447 ~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........ +.. ....+..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~----~~~~~~~----- 335 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYK----MIKEGYR----- 335 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHH----HHHhCcc-----
Confidence 332211 222345678999999999999999999999999999998 8888865432211 111 1111110
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+......+.+++..|++.+|++|||+.||+++|+.
T Consensus 336 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 ----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00111123467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=330.99 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=201.1
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+|...+.||+|+||.||++.++++..+|+|.++... ...+.|.+|++++++++||||+++++++. .....++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv~ 78 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIVT 78 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEEE
Confidence 467788999999999999999888899999886432 33567999999999999999999999986 345689999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++... ...++|..++.++.+++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 79 EFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 999999999988652 246899999999999999999999 899999999999999999999999999998765333
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-----~~~~i~~~~~~-------- 220 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-----VVEMISRGFRL-------- 220 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCCCCC--------
Confidence 2222223345678999999998899999999999999999999 899986543211 11111111110
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
..+......+.+++..|++.+|++||++.++++.|.
T Consensus 221 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 --YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001112346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=332.20 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=204.5
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+...+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEEE
Confidence 4577889999999999999998888899999986532 33568999999999999999999998876 34568999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ....+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 80 TEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999998653 2356889999999999999999999 89999999999999999999999999999986544
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
..........++..|+|||++..+.++.++||||||+++|||++ |+.||....... ..... ..+...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~-~~~~~~------ 223 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSAL-QRGYRM------ 223 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHH-HcCCCC------
Confidence 33222233446778999999999999999999999999999998 999986543221 11111 111100
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.........+.+++..|++.+|++||++++++++|+.
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.43 Aligned_cols=264 Identities=20% Similarity=0.289 Sum_probs=201.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||.||+++.+ +++.+|||+++... ....+.+.+|++++.+++|+||+++++++. .....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence 46888999999999999999986 58899999987532 233467889999999999999999999886 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||++++.|..+... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 76 YLVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 999999998777544322 346889999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH-----------HH
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW-----------ML 513 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~-----------~~ 513 (614)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .... ..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF-TIQKVLGPLPAEQMKLF 228 (287)
T ss_pred ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhhCCCCHHHHHhh
Confidence 54433333344578999999999999999999999999999999999999997644322110 0000 00
Q ss_pred hhCCCchhhhhHHh------hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANSGKVDEIFDEFI------REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~~~~~~~~d~~l------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...........+.. ...........+.+++..|++.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 000011133468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.29 Aligned_cols=252 Identities=25% Similarity=0.305 Sum_probs=199.7
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.|+..+.||+|+||.||++... +|+.||||.+.... ......+.+|++++.+++|+|++++.+++. .+...
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 3677889999999999999864 79999999986432 223456889999999999999999999886 45578
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 9999999999998887543 2346889999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ .... ........
T Consensus 152 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~-~~~~~~~~------ 221 (285)
T cd05631 152 IPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEV-DRRVKEDQ------ 221 (285)
T ss_pred cCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHH-HHHhhccc------
Confidence 53322 22345789999999999999999999999999999999999999976443211 0000 00000000
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
...+......+.+++..|++.+|.+||+ +++++++
T Consensus 222 ----~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 ----EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ----ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0112223456788999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.39 Aligned_cols=255 Identities=28% Similarity=0.408 Sum_probs=204.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.++|+..+.||+|++|.||+|..++++.||+|.++... ...+++.+|++++++++|+||+++++++. ..+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeee
Confidence 45688889999999999999998888899999986543 33567999999999999999999999886 3456899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++++|.+++.... ...++|..+.+++.+++.||.||| +.+|+||||||+||++++++.+||+|||+++...
T Consensus 79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 999999999999986532 346899999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
............+..|+|||++.+..++.++||||||+++|||++ |+.||....... .+ ........
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~-----~~~~~~~~------ 222 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VL-----QQVDQGYR------ 222 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HH-----HHHHcCCC------
Confidence 322221222233468999999999999999999999999999999 998986543211 11 11111100
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111233578889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=334.75 Aligned_cols=245 Identities=23% Similarity=0.257 Sum_probs=199.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.. +|+.||+|++.... .+..+.+.+|++++++++||||+++++++. ++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 36788899999999999999976 68999999986422 223456889999999999999999998876 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. .+.+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcch
Confidence 8999999999999999865 356889999999999999999999 8999999999999999999999999999988
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ..+..
T Consensus 150 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-----~~~~i-~~~~~---- 215 (291)
T cd05612 150 KLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-----IYEKI-LAGKL---- 215 (291)
T ss_pred hccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HhCCc----
Confidence 65322 223568999999999999899999999999999999999999997643221 11111 11110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
..+......+.+++..|++.||.+||+ +.|++++
T Consensus 216 ------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011112346778999999999999995 8888766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.35 Aligned_cols=242 Identities=21% Similarity=0.291 Sum_probs=194.8
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|++++.+++||||+++.+++. .+...++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence 36999999999999875 68999999987532 223456789999999999999999999886 4567899999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCC
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 449 (614)
|+++|+|.+++.. ...+++.+...++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLSR---ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence 9999999988865 357899999999999999999999 8999999999999999999999999999987532211
Q ss_pred ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhh
Q 036081 450 SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529 (614)
Q Consensus 450 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 529 (614)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ... . ..+..
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~---~-~~~~~---------- 212 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FEL---I-LMEEI---------- 212 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--HHH---H-HcCCC----------
Confidence 223345799999999999999999999999999999999999999965432111 000 0 11110
Q ss_pred hCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 530 EGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 530 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.||++|| ++.+++++
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 01122344677899999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=336.82 Aligned_cols=266 Identities=23% Similarity=0.376 Sum_probs=199.9
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|+||.||+|+.. +|+.||||+++... ......+.+|++++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999965 68999999986422 22345688999999999999999999988654433445689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++ ++|.+++.. ...+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688887754 346899999999999999999999 899999999999999999999999999999854
Q ss_pred cCCCc--cccccccCCCCccchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH--------
Q 036081 446 LEGQS--HLTTRVAGTYGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML-------- 513 (614)
Q Consensus 446 ~~~~~--~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~-------- 513 (614)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .......
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLITDLLGTPSPET 231 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCCHHH
Confidence 32221 12234579999999999875 6889999999999999999999999975432210 0111100
Q ss_pred ---hhCCCchhhhhHHhhhhC-c-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ---ANSGKVDEIFDEFIREEG-S-----RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ---~~~~~~~~~~d~~l~~~~-~-----~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+......+.++....... . ......+.+++..|++.+|++|||+.|++++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 001111111111000000 0 0122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.68 Aligned_cols=266 Identities=27% Similarity=0.368 Sum_probs=206.0
Q ss_pred CCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+.|+..++||+|.||.|||++. .+|+.||+|+++-.. .....-..+||.||++|.||||++|.+...+. .....
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence 4467778999999999999985 479999999997543 23345567999999999999999999998754 34679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
|||+|||++ +|.-++... .-.++..++..++.|++.||.|+| ..+|+|||||.+|||||.+|.+||+|||||+.
T Consensus 194 YlVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceee
Confidence 999999975 777776552 346999999999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh--HHH-------HHHHHh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITD-------WAWMLA 514 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~--l~~-------~~~~~~ 514 (614)
+........+..+-|.+|.|||.+++ ..|+...|+||.||||.||+.|++.+....+-+.+ +.. -.|...
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 77666655666677999999999986 58999999999999999999999999876543311 111 112211
Q ss_pred hCC-----CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NSG-----KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~~-----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.-. +...-....+.+. -.......++++..++..||.+|.|+.++++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 110 0111111222221 11223356778888999999999999998764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.88 Aligned_cols=258 Identities=23% Similarity=0.379 Sum_probs=200.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
++|...+.||+|+||.||+++.. ++..||||+++... ....+.+.+|+++++++ +|+||++++|+|.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~----- 112 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT----- 112 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec-----
Confidence 46788899999999999999742 24579999997543 22345688999999999 8999999999987
Q ss_pred CCceEEEEEecCCCCCcccccchhhh------------------------------------------------------
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALT------------------------------------------------------ 385 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~------------------------------------------------------ 385 (614)
.....++||||+++|+|.+++.....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 44578999999999999998854210
Q ss_pred -------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc-
Q 036081 386 -------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH- 451 (614)
Q Consensus 386 -------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~- 451 (614)
...++|.+.++|+.||++||+||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 124677888999999999999999 899999999999999999999999999999765433221
Q ss_pred ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhh
Q 036081 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREE 530 (614)
Q Consensus 452 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 530 (614)
......++..|+|||++.++.++.++|||||||++|||++ |+.||........ . ......+ ....
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~----~~~~~~~---------~~~~ 335 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-F----YKMVKRG---------YQMS 335 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-H----HHHHHcc---------cCcc
Confidence 1222345678999999999999999999999999999997 9999875432211 0 0111111 0000
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 531 GSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 531 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.+......+.+++..|++.+|++|||+.+|+++|++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=334.27 Aligned_cols=249 Identities=31% Similarity=0.519 Sum_probs=192.4
Q ss_pred cceeeeccCcEEEEEEEEc-----CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 292 QKNLIGQGASGVVYKGTLE-----DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~-----~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
..+.||.|.||.||+|.+. .+..|+||.++.... +..+.|.+|++.+.+++||||++++|++. .....+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 4578999999999999987 257899999965433 33678999999999999999999999998 334589
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|+||+++|+|.++|... ....+++.++.+|+.||++||.||| +.+++||||+++|||+++++.+||+|||+++..
T Consensus 78 lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 999999999999999774 2357899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 446 LEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 446 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .......+...|+|||.+....++.++||||||+++|||++ |+.|+...... ++.... ..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----~~~~~~-~~~~~~--- 224 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----EIIEKL-KQGQRL--- 224 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----HHHHHH-HTTEET---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccc-cccccc---
Confidence 32221 22233456789999999999999999999999999999999 67887654321 111111 111111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
..+......+..++..|++.+|++|||+.++++.|
T Consensus 225 ------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11122334678899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=350.05 Aligned_cols=265 Identities=29% Similarity=0.422 Sum_probs=207.0
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
++.+...+.+.....||+|.||+||+|+|. | .||||+++-.. .+..+.|++|+.++++-+|.||+-+.|||..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~--- 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN--- 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC---
Confidence 344445556677889999999999999997 3 49999997543 3346789999999999999999999999962
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
....+|..++++.+|+.+|+.. +..++..+.++||.|||+|+.||| .++|||||||+.||+|++++++||+|
T Consensus 460 ---p~~AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 460 ---PPLAIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred ---CceeeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEec
Confidence 3359999999999999999875 356888899999999999999999 99999999999999999999999999
Q ss_pred ecccccccC-CCccccccccCCCCccchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh
Q 036081 439 FGLAKQSLE-GQSHLTTRVAGTYGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA 514 (614)
Q Consensus 439 FGla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~ 514 (614)
|||+..... ........-.|...|||||+++. .+|+..+||||||+|+|||++|..||.....++.+ |. +
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi-----fm-V 605 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII-----FM-V 605 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE-----EE-e
Confidence 999864211 11112223357789999999973 47899999999999999999999999854433321 11 1
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
..|-+. .|... ...+....+.+|...|+..++++||...+++.+|+....
T Consensus 606 GrG~l~--pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 606 GRGYLM--PDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccccC--ccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 112111 11111 112234567788899999999999999999998887543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=328.64 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=202.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.+|...+.||+|+||.||+|..+ +++.||+|.++.. ....+++.+|++++.+++|+||+++++++. .....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEE
Confidence 34677889999999999999976 5889999998653 333567999999999999999999999986 3456899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
+|||+++++|.+++... ....++|..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++...
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 80 ITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 99999999999998653 2346899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
...........++..|+|||++.+..++.++||||||+++|||++ |+.|+....... . +.....+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~-~~~~~~~-------- 221 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----V-YELLEKG-------- 221 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----H-HHHHHCC--------
Confidence 332222222334678999999999999999999999999999998 888986533211 1 1111111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.....+......+.+++..|++.+|++|||+.+++++|+.
T Consensus 222 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 222 -YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 0011112233568889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=332.31 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=198.6
Q ss_pred CCccceeeeccCcEEEEEEEEc--CCcEEEEEEeecCCC--cchHHHHHHHHHHHHc---cCCCcccccccccccCCCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE--DGTLVAVKQITDLDT--KGDEEFINEVEIISKI---RHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l---~H~NIv~l~g~~~~~~~~~~ 361 (614)
+|+..+.||+|+||.||+++.. +|+.||||+++.... .....+.+|++++.++ +||||++++++|........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5788899999999999999863 478899999865322 2234567788888776 69999999999865443345
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||++ ++|.+++... ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 67899999996 6898888653 2345889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC--CCc
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS--GKV 519 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~ 519 (614)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ +.......... ...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhhc
Confidence 9765332 223445789999999999999999999999999999999999999976543321 11111100000 000
Q ss_pred h-------hhhhHHhh---hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 520 D-------EIFDEFIR---EEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 520 ~-------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
. ..+...-. .....+..+.+.+++..|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 00000000 0001123346678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.76 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=203.0
Q ss_pred ccceeeeccCcEEEEEEEE-----cCCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 291 SQKNLIGQGASGVVYKGTL-----EDGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
...+.||+|+||+||++.. .+++.||+|.++.... ...+.|.+|++++++++||||+++++++... .....
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~~ 83 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKGL 83 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCceE
Confidence 6778999999999988653 3578999999875432 3456789999999999999999999987642 23468
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++.. ..++|.+++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 999999999999998854 35999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 445 SLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 445 ~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
....... ......++..|+|||++..+.++.++||||||+++|||++|+.|+......................+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 5433221 11223456679999999989999999999999999999999999865432211111111000001111111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
++.......+......+.+++..|++.+|++|||+++++++|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 211111111223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.11 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=208.7
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+...+|...++||+|+||.||+|...++..+|+|.+..........+.+|+.++++++|+||+++++++. .....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 3445678889999999999999999889999999998765555678999999999999999999999886 44568
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++.+.. ...+++.+++.++.+++.||.||| +.+|+||||||+||++++++.+||+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred EEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhh
Confidence 99999999999999997642 346899999999999999999999 89999999999999999999999999999976
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... ......++..|+|||.+..+.++.++||||||+++|||++ |+.||......... ... .....
T Consensus 154 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~--~~~---~~~~~----- 222 (261)
T cd05148 154 IKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY--DQI---TAGYR----- 222 (261)
T ss_pred cCCccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH--HHH---HhCCc-----
Confidence 543221 2223346778999999998999999999999999999998 88998654322111 111 11000
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+....+.+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 -----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112233567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=337.59 Aligned_cols=242 Identities=22% Similarity=0.296 Sum_probs=193.7
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
+.||+|+||.||+++.. +|+.||+|+++.. .......+.+|++++.+++||||+++++++. .....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 46999999999999875 6899999998753 2233456788999999999999999999886 4557899999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCC
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 449 (614)
|+++|+|.+++.. ...+++...+.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence 9999999888754 356899999999999999999999 8999999999999999999999999999987532221
Q ss_pred ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhh
Q 036081 450 SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529 (614)
Q Consensus 450 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 529 (614)
.......||+.|+|||++.++.++.++|||||||++|||++|+.||...+.... ...... +..
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----~~~~~~-~~~---------- 212 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILM-EEI---------- 212 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHHhc-CCC----------
Confidence 122345799999999999999999999999999999999999999975432211 011111 110
Q ss_pred hCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 530 EGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 530 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.+|.+|| ++.+++++
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 01112234677889999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.21 Aligned_cols=255 Identities=26% Similarity=0.479 Sum_probs=202.7
Q ss_pred CCccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
+|...+.||+|+||.||+|.... ...||+|.++.... .....|.+|++++.+++||||+++++++. ..
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~ 80 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----KE 80 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----CC
Confidence 56778899999999999998653 25799999865332 33467899999999999999999999986 34
Q ss_pred ceEEEEEecCCCCCcccccchhhh-------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALT-------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL 428 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL 428 (614)
...+++|||+++|+|.+++..... ...+++...+.++.|++.||.||| +.+++||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEE
Confidence 568999999999999999865311 145788889999999999999999 8999999999999999
Q ss_pred cCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhH
Q 036081 429 DSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLI 506 (614)
Q Consensus 429 d~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l 506 (614)
++++.+||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |+.||....... +
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~ 235 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--V 235 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 9999999999999986533221 22334456889999999999999999999999999999998 999987543221 1
Q ss_pred HHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 507 TDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 507 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.. .+..+... ..+...+..+.+++..|++.+|.+||++.||+++|++
T Consensus 236 ~~----~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IE----MIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH----HHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 11111111 1122344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=356.23 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=201.4
Q ss_pred cceeeeccCcEEEEEEEEcC--C--cE-EEEEEeec---CCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 292 QKNLIGQGASGVVYKGTLED--G--TL-VAVKQITD---LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~~--g--~~-vAVK~l~~---~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..++||+|.||.||+|++.. + .. ||||..+. .......+|.+|.++|++++|||||+++|++. ....
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~-----~~~P 235 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV-----LEEP 235 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCc
Confidence 34899999999999998763 3 23 89999875 23455678999999999999999999999998 4556
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
+++|||+|+||+|.++|... .+.++..+++.++.+.|+||+||| ++++|||||.++|+|++.++.+||+||||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 89999999999999999874 336999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
....-.. ......-+..|+|||.+..+.|+.++|||||||++||+++ |..|+......+ +..++ ...+.
T Consensus 311 ~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~~kI---~~~~~---- 380 (474)
T KOG0194|consen 311 AGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VKAKI---VKNGY---- 380 (474)
T ss_pred CCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HHHHH---HhcCc----
Confidence 5431111 1101124578999999999999999999999999999999 888987654321 11111 01111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIP 571 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~~~ 571 (614)
+...+...+..+..+...|+..+|++||||.++.+.|+......
T Consensus 381 -----r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 381 -----RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred -----cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11112233446677778999999999999999999998755443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=340.26 Aligned_cols=245 Identities=21% Similarity=0.278 Sum_probs=199.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+|+.. +|+.||||.++... ....+.+.+|+.++.+++||||+++++++. .+..
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCCE
Confidence 56888899999999999999976 58999999986532 233457889999999999999999999887 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166 (329)
T ss_pred EEEEEcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence 9999999999999998865 356888889999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ....+...
T Consensus 167 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~-~i~~~~~~--- 233 (329)
T PTZ00263 167 KVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-----IYE-KILAGRLK--- 233 (329)
T ss_pred EcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-----HHH-HHhcCCcC---
Confidence 653322 23578999999999999999999999999999999999999996543211 111 11111110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
.+.....++.+++..|++.||.+||+ +.+++.+
T Consensus 234 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 -------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112346778999999999999996 7888765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=338.15 Aligned_cols=242 Identities=22% Similarity=0.292 Sum_probs=194.7
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|++++++++||||+++.+++. .....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence 46999999999999875 6899999999753 2233457889999999999999999998886 4567899999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCC
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 449 (614)
|+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~- 148 (328)
T cd05593 76 YVNGGELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD- 148 (328)
T ss_pred CCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-
Confidence 9999999888765 356899999999999999999999 899999999999999999999999999998753222
Q ss_pred ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhh
Q 036081 450 SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529 (614)
Q Consensus 450 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 529 (614)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... +..
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~~~~~~~-~~~---------- 212 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELILM-EDI---------- 212 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----HHHHhcc-CCc----------
Confidence 122334579999999999999999999999999999999999999997543221 1111100 100
Q ss_pred hCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 530 EGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 530 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.+|++|| ++.|++++
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 01112334677888999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=327.16 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=200.8
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+|...+.||+|+||.||+|++.++..+|||.++... ...++|.+|+.++.+++||||+++++++.. ....++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~ 78 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYIVT 78 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEEEE
Confidence 466778999999999999998877789999987533 335679999999999999999999999863 34579999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++... ...++|.++++++.||+.||+||| +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 79 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 79 EYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999999998653 236899999999999999999999 899999999999999999999999999998765433
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
.........++..|+|||++.++.++.++||||||+++|||++ |+.||....... ..... ..+...
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~-~~~~~~------- 220 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-----TVEKV-SQGLRL------- 220 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHH-hcCCCC-------
Confidence 2222222345678999999998899999999999999999999 999986544221 11111 111100
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
..+......+.+++..|++.+|.+||++.++++.|+
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112357788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.98 Aligned_cols=253 Identities=19% Similarity=0.278 Sum_probs=202.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++.+++||||+++++++. .+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 46888999999999999999986 58999999997532 223456889999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 9999999999999999865 356889999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............| . .....
T Consensus 150 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-~~~~~-- 219 (333)
T cd05600 150 GIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW---K-ETLQR-- 219 (333)
T ss_pred cccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc---c-ccccC--
Confidence 6533 233457999999999999999999999999999999999999999765432211000000 0 00000
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.. ..........+.+++..|++.+|++||++.+++++
T Consensus 220 -~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 -PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 00001234467788899999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=327.38 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=203.1
Q ss_pred CCCccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|+..+.||+|+||.||+|+++. ...||||.++... .....+|.+|+.++.+++|+||+++++++. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence 468888999999999999999752 4579999986533 233567899999999999999999999886 345
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++... ...++|..+++++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchh
Confidence 689999999999999998653 347899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 443 KQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 443 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +.+. ...+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~----~~~~~~~ 227 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKA----VEDGYRL 227 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHH----HHcCCCC
Confidence 87642221 12222345678999999999999999999999999999998 999986543211 1111 1111000
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+....+.+.+++..|++.+|++||++.||+++|+..
T Consensus 228 ---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=342.36 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=204.1
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC----CC-cchHHHHHHHHHHHHcc-CCCccccccccccc
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL----DT-KGDEEFINEVEIISKIR-HRNLLSLRGCCVSS 356 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~----~~-~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~ 356 (614)
....++|...+.||+|+||+|+.|+.. +|+.||+|.+... .. ...+...+|+.++++++ ||||++++.++..
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t- 91 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT- 91 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-
Confidence 345678899999999999999999865 6899999976542 12 23456668999999999 9999999999873
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-CcEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAK 435 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~K 435 (614)
....++||||+.+|+|.+++.+ .+.+.+....+++.|++.|++|+| +.+|+||||||+|||+|.+ +++|
T Consensus 92 ----~~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 92 ----PTKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred ----CCeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEE
Confidence 4459999999999999999976 467888999999999999999999 9999999999999999999 9999
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ-LT-EKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
|+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+... ..+.
T Consensus 162 l~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-----l~~k- 234 (370)
T KOG0583|consen 162 LSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-----LYRK- 234 (370)
T ss_pred EeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-----HHHH-
Confidence 99999998764 2223345578999999999999877 86 78999999999999999999998743211 1111
Q ss_pred hhCCCchhhhhHHhhhhCcHHH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 514 ANSGKVDEIFDEFIREEGSRAV-MERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
...+... .+... ...+..++..|+..+|..|+|+.++++
T Consensus 235 i~~~~~~----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 IRKGEFK----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HhcCCcc----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111110 11112 457788999999999999999999983
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=331.74 Aligned_cols=265 Identities=24% Similarity=0.390 Sum_probs=203.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-----CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-----DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
..|...+.||+|+||.||++..+ ++..||+|+++.......+.|.+|++++.+++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 45777889999999999999753 5789999998766555567899999999999999999999987533 234
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.+. ...++|..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 689999999999999998652 346899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccc--cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC--
Q 036081 443 KQSLEGQSHL--TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK-- 518 (614)
Q Consensus 443 ~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~-- 518 (614)
+......... .....++..|+|||++.++.++.++||||||+++|||++|..++...... +.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~ 229 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMMGNDKQGQ 229 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhcccccccc
Confidence 8654332211 12223455699999999999999999999999999999998765432211 1000000000
Q ss_pred -chhhhhHHhhh----hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 519 -VDEIFDEFIRE----EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 519 -~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...-+...+.. .........+.+++..|++.+|++|||+.||+++|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 00000011110 1112334578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=337.99 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=200.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCc----EEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGT----LVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.+|+..+.||+|+||.||+|++. +|+ .||+|.++... ....+++.+|+.+++.++||||++++|+|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 35888899999999999999864 343 48999987543 2345679999999999999999999999863
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++++||+++|+|.+++... ...+++...+.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccc
Confidence 2468999999999999998753 345889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccc-cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQSHL-TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.|++...... +... ...+..
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~ 229 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI----LEKGER 229 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----HhCCCC
Confidence 98764333221 122334678999999999999999999999999999998 999987543211 1111 111100
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
. ..+......+..++..|++.+|++||++.+++..|....
T Consensus 230 ~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 L---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred C---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 001112236778999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=325.74 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=200.0
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+|+..+.||+|+||.||+|.++++..+|+|.+.... ...+.|.+|++++++++|+||+++++++. .....++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEEE
Confidence 366778999999999999998877889999986433 23457899999999999999999999886 345689999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++++|.+++... ...++|..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 999999999998653 246899999999999999999999 899999999999999999999999999998765432
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
.........++..|+|||++.++.++.++||||||+++|||++ |+.||........ .... ..+.
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~-~~~~--------- 218 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-----VESV-SAGY--------- 218 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-----HHHH-HcCC---------
Confidence 2222222234568999999999999999999999999999999 7888865432211 1111 1110
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
....+...+..+.+++..|++.+|++|||+.|++++|.
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 00111123457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=329.37 Aligned_cols=256 Identities=23% Similarity=0.433 Sum_probs=203.9
Q ss_pred CCCccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
++|...+.||+|+||.||+|+..+ +..||||.++..... ..+.|.+|++++.+++|+||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~ 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT-----E 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----c
Confidence 456778899999999999998643 478999998765443 4578999999999999999999999987 3
Q ss_pred CceEEEEEecCCCCCcccccchhh-----------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNAL-----------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~-----------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
+...++||||+++|+|.+++.... ....+++.+...++.|++.||.||| +.+++||||||+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEc
Confidence 467899999999999999986532 1245788899999999999999999 89999999999999999
Q ss_pred CCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLIT 507 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~ 507 (614)
.++.+||+|||+++....... .......+++.|+|||++.++.++.++||||||+++|||++ |+.||.......
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---- 232 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---- 232 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 999999999999875432221 12233456788999999999999999999999999999998 999986543321
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.... ...+.... .+......+.+++..|++.+|++||++.||+++|++
T Consensus 233 -~~~~-~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 -VIEC-ITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHH-HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111 11111111 111233577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.72 Aligned_cols=262 Identities=28% Similarity=0.386 Sum_probs=205.5
Q ss_pred hCCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.+.|+....||.|..++||+|+. +.++.||||++.-..-+ ..+...+|+..++.++||||+..+..|+ .+..+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----eccee
Confidence 45688889999999999999984 46899999999643222 2578899999999999999999999888 56789
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
|+||.||.+||+.+.++... ...+++..+..|.+++++||.||| ++|.||||||+.|||||.+|.+||+|||..-.
T Consensus 100 WvVmpfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred EEeehhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 99999999999999998753 345888999999999999999999 99999999999999999999999999997654
Q ss_pred ccCCCccc--c-ccccCCCCccchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 445 SLEGQSHL--T-TRVAGTYGYLAPEYAL--YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 445 ~~~~~~~~--~-~~~~gt~~Y~APE~~~--~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
........ . ...+||+.|||||.++ ...|+.|+|||||||..+||.+|..||.....-..++... ......
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL----qn~pp~ 251 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL----QNDPPT 251 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh----cCCCCC
Confidence 43322211 1 4568999999999965 3579999999999999999999999998766543332211 111110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+ -..+..+........+.+++-.|++.||.+|||+++++++
T Consensus 252 ~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 252 LL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00 1111111122223367788899999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.10 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=203.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|+..+.||+|+||.||+++.. +|..+|+|.+.... ....+.+.+|++++.+++||||+++++++. .+...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 357888999999999999999976 58899999986532 233467999999999999999999999987 35578
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++.. ...+++..+..++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 999999999999999865 3568899999999999999999993 24699999999999999999999999999876
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC--------
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS-------- 516 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~-------- 516 (614)
.... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ..........
T Consensus 154 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 154 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred cccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccccCCccc
Confidence 5332 22345789999999999999999999999999999999999999965432211 0010000000
Q ss_pred ----------------------CCchhhhhHHhhhh----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 517 ----------------------GKVDEIFDEFIREE----GSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 517 ----------------------~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
....+..+...... ........+.+++.+|++.||++|||+.|++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00011111111111 0112345788999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=342.19 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=205.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchH-HHHHHHHHHHHcc-CCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDE-EFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~-~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...++||.|.||.||+|+-. +|..||||++++.-...++ .=++|++.|++|. ||||++|.+++.+.+ ..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence 345777889999999999999854 6999999999875443332 2468999999998 999999999987432 27
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
+++|||||+ -+|++++++. ++.+++..++.|+.||.+||+|+| ++|+.|||+||+|||+..+..+||+||||||
T Consensus 85 L~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccc
Confidence 999999996 5899998774 678999999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCccccccccCCCCccchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh-
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE- 521 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~- 521 (614)
...... ..+.++.|.+|.|||++. .+-|+.+.|+|++|||++||.+-++.|.+.++-+. +...... .......+
T Consensus 159 ev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~V-LGtP~~~~~ 234 (538)
T KOG0661|consen 159 EVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEV-LGTPDKDSW 234 (538)
T ss_pred ccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHH-hCCCccccc
Confidence 765433 356788999999999986 78899999999999999999999999876554321 1111100 01111111
Q ss_pred ----hhhHHhh------------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 ----IFDEFIR------------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ----~~d~~l~------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+-..+. .-.+ .....+++++..|+..||.+|||+.|.+++
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111 1111 245678899999999999999999999987
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.11 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=197.1
Q ss_pred CCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecC----CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDL----DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~----~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
+|+..+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|++++.++ +|+||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence 4778899999999999999753 5889999998642 122345678899999999 5999999998876
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
.....++||||+++|+|.+++.. +..+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeC
Confidence 45678999999999999998865 356899999999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+...... .
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~-~- 226 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK-C- 226 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc-C-
Confidence 99986544333334456799999999999865 478899999999999999999999965432211 1111111111 0
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
+. ..+......+.+++..|++.||++|| ++.+++++
T Consensus 227 -----~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 -----DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -----CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00 11112334677889999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.75 Aligned_cols=261 Identities=23% Similarity=0.281 Sum_probs=211.0
Q ss_pred CCCccceeeeccCcEEEEEEEEcCC-cEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccc-cccccCCCC-Cce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDG-TLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRG-CCVSSDDEK-GKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g-~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g-~~~~~~~~~-~~~ 363 (614)
.+.++.+.|.+|||+.||.+....+ ..+|+|++-..+++..+...+||++|++|+ |+|||.+++ ......... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4466788999999999999998765 999999998778888889999999999997 999999999 444332323 478
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.+|.||||++|+|-|++......+ |++.++++|+.|+++|+++|| .++++|||||||-+||||+.+++.||||||.|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 999999999999999998765444 999999999999999999999 568899999999999999999999999999986
Q ss_pred cccCCCccc--------cccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Q 036081 444 QSLEGQSHL--------TTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM 512 (614)
Q Consensus 444 ~~~~~~~~~--------~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~ 512 (614)
-........ .-...-|+.|.|||.+. +..+++|+|||+|||+||-|+....||+......
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--------- 265 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--------- 265 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence 432211100 00123589999999984 6689999999999999999999999998754321
Q ss_pred HhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 513 LANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 513 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
+++....-........++..|+..||+++|.+||++.+|++.+....
T Consensus 266 ---------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 266 ---------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ---------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 11111111112345678999999999999999999999998876643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.23 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=210.4
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcc-hHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG-DEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~-~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
.....++||+|-||.|.++....+..||||.++...... ..+|.+|+++|.+++||||++|+|+|.. ++.+++|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePicmI 613 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLCMI 613 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchHHH
Confidence 345568999999999999999888999999998755444 5899999999999999999999999984 4568999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
+|||++|+|.++|..... ..+.-..-.+|+.|||.||+||. +.++|||||.++|+|+|.++++||+|||+++.+..
T Consensus 614 ~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccccccc
Confidence 999999999999976421 22455666789999999999999 99999999999999999999999999999997665
Q ss_pred CCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 448 GQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS--GRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 448 ~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
++.+ ...+.+-+..|||||.+..+++++++|||+||+.|||+++ ..+||....+++ ..+-...+...+....+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~~-- 765 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQVV-- 765 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCccee--
Confidence 5544 3445667889999999999999999999999999999876 668887654332 11111111111111100
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
-..+.-.+..+.++++.|+..+-.+||+.+++...|.++.
T Consensus 766 ----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 ----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 0113334567889999999999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=342.74 Aligned_cols=247 Identities=27% Similarity=0.357 Sum_probs=207.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|...+.||+|.||.||||+-+ +.+.||+|.+.+.. .+..+...+|++|+++++|||||.+++.|. ...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-----t~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-----TSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-----ccceE
Confidence 46777889999999999999876 58899999986533 233456889999999999999999999997 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++|.||+.+ +|..+|.. .+.+++++...|+.++..||.||| +.+|.|||+||.||||+.+|.+|++|||+|+.
T Consensus 77 ~vVte~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARA 149 (808)
T ss_pred EEEehhhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhh
Confidence 999999976 99999976 467999999999999999999999 99999999999999999999999999999997
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
... .....+.+.||+-|||||.+.++.|+..+|.||+||+|||+++|++||-... +...+.....++.
T Consensus 150 m~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~d~v------ 217 (808)
T KOG0597|consen 150 MST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKSILKDPV------ 217 (808)
T ss_pred ccc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhcCCC------
Confidence 544 4456677899999999999999999999999999999999999999995421 2223322222111
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+..+....++.||..|-|-.+++.+
T Consensus 218 -----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1233455678889999999999999999998765
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=347.87 Aligned_cols=242 Identities=27% Similarity=0.454 Sum_probs=201.3
Q ss_pred ccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEec
Q 036081 291 SQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
+..+-||+|+.|.||+|+++ ++.||||+++.. -..+|+-|++|+|+||+.|.|+|. ....+++||||
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCt-----qsPcyCIiMEf 193 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCT-----QSPCYCIIMEF 193 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeec-----CCceeEEeeec
Confidence 44568999999999999998 788999987542 235889999999999999999998 45678999999
Q ss_pred CCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCc
Q 036081 371 MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450 (614)
Q Consensus 371 ~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 450 (614)
|+.|-|.+.|+. ...++-.....+..+||.|+.||| .+.|||||||+-||||..+..+||+|||-++...+.
T Consensus 194 Ca~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 194 CAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred cccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 999999999976 456777777899999999999999 999999999999999999999999999998865443
Q ss_pred cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhh
Q 036081 451 HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREE 530 (614)
Q Consensus 451 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 530 (614)
......+||..|||||++.+...++|+||||||||||||+||..||..-+... .+|. -| ...|.-.
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIwG---VG------sNsL~Lp 331 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIWG---VG------SNSLHLP 331 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEEe---cc------CCccccc
Confidence 22345689999999999999999999999999999999999999997644322 1111 11 1112122
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 531 GSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 531 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.+...++-+.-++.+|++..|..||++++++.+|+-.
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 3445667888899999999999999999999999854
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=328.76 Aligned_cols=258 Identities=20% Similarity=0.383 Sum_probs=201.4
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
.+++|+..+.||+|+||.||+|.+. ++..||||+++.... ....+|.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 4677899999999999999999754 256799999864322 23457899999999999999999999986
Q ss_pred CCCceEEEEEecCCCCCcccccchhhh-------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALT-------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 431 (614)
.+...++||||+++|+|.+++.+... ...++|..++.++.|++.||.||| +.+++||||||+||+++++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 155 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence 45578999999999999998865321 124677888999999999999999 8999999999999999999
Q ss_pred CcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHH
Q 036081 432 MKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDW 509 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~ 509 (614)
+.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ |+.||....... .
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-----~ 230 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-----V 230 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----H
Confidence 99999999998754332221 1122345778999999999999999999999999999999 688886543221 1
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
... ...+.... .+......+.+++.+|++.+|++|||+.|++++|++
T Consensus 231 ~~~-~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 LRF-VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHH-HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111 11111110 111223467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=339.79 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=202.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
++|...+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|++++.++ +|+||++++++|..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~---- 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK---- 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec----
Confidence 46788899999999999999642 257899999875332 2345678899999999 89999999998863
Q ss_pred CCceEEEEEecCCCCCcccccchhhh------------------------------------------------------
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALT------------------------------------------------------ 385 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~------------------------------------------------------ 385 (614)
.+...+++|||+++|+|.+++.....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 34568999999999999988753211
Q ss_pred ----ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCccc-cccccCCC
Q 036081 386 ----RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL-TTRVAGTY 460 (614)
Q Consensus 386 ----~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~-~~~~~gt~ 460 (614)
...++|..+.+++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 236899999999999999999999 8999999999999999999999999999998754333222 22345677
Q ss_pred CccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHH
Q 036081 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERF 539 (614)
Q Consensus 461 ~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 539 (614)
.|+|||++.+..++.++|||||||+||||++ |+.||......+. + +.....+... ..+......+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----~-~~~~~~~~~~---------~~~~~~~~~~ 305 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----F-CRRLKEGTRM---------RAPEYATPEI 305 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----H-HHHHhccCCC---------CCCccCCHHH
Confidence 8999999999999999999999999999998 9999865332211 1 1111111100 0112233578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 540 VRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 540 ~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.+++..|++.+|++||++.|++++|+..
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.94 Aligned_cols=254 Identities=30% Similarity=0.429 Sum_probs=203.4
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|+..++||+|+||.||+|+++++..||+|+++... ...+.|.+|++++++++|+||+++++++. ....++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEEE
Confidence 4588889999999999999998877789999987533 23567999999999999999999998763 2347899
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ....++|..++.++.+++.||+||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999999998653 2345789999999999999999999 89999999999999999999999999999976543
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
..........++..|+|||+..++.++.++||||||+++|||++ |+.||........ .... ..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-----~~~~-~~~~-------- 220 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQV-ERGY-------- 220 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-----HHHH-hcCC--------
Confidence 33222223456778999999999999999999999999999999 7888865432211 1111 1110
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
......+....+.+++..|++.+|++||++.+++++|+..
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011223445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=329.26 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=198.4
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCc----EEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGT----LVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+|+..+.||+|+||.||+|++. +|+ .+++|.+..... ....++..|+.++++++||||++++|++. +.
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~~ 81 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------GA 81 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------CC
Confidence 4667789999999999999974 354 477787754332 22457788899999999999999999874 33
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++++||+++|+|.+++... ...++|..++.++.||+.||+||| +.+++||||||+|||+++++.+||+|||++
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 468999999999999998652 356899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 443 KQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 443 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+....... .......++..|+|||++.++.++.++||||||+++|||++ |+.|+....... +.++ ...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~ 230 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDL----LEKGERL 230 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----HHCCCcC
Confidence 86543322 22334567789999999999999999999999999999998 999986543211 1111 1111111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
. . +......+.+++..|++.+|+.|||+.|++++|+...
T Consensus 231 ~--~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 231 A--Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred C--C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0 0 0011234567888999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.25 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=197.4
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCC
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMP 372 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~ 372 (614)
++||+|+||.||+|...+++.+|+|.++.... .....|.+|++++++++||||+++++++. .....++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECCC
Confidence 36999999999999988899999999875433 22457899999999999999999999986 3456899999999
Q ss_pred CCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCccc
Q 036081 373 SGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL 452 (614)
Q Consensus 373 ~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 452 (614)
+|+|.+++... ...++|..++.++.+++.||.||| +.+++||||||+||+++.++.+||+|||++..........
T Consensus 76 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 76 GGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccccc
Confidence 99999988652 346889999999999999999999 8999999999999999999999999999987543322222
Q ss_pred cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhC
Q 036081 453 TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531 (614)
Q Consensus 453 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 531 (614)
.....++..|+|||++..+.++.++||||||+++|||++ |..||....... . . .....+.. ...
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~---~-~~~~~~~~---------~~~ 215 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--A---R-EQVEKGYR---------MSC 215 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--H---H-HHHHcCCC---------CCC
Confidence 222344678999999999999999999999999999999 999986543211 0 0 11111110 011
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 532 SRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
+......+.+++..|++.+|++||++.|++++|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1123457888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=330.76 Aligned_cols=259 Identities=24% Similarity=0.420 Sum_probs=206.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|...+.||+|+||.||+|+.. ++..+++|.++.......+.+.+|++++++++|+||+++++++. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 35677889999999999999753 35679999987655555678999999999999999999999987 34
Q ss_pred ceEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL 428 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL 428 (614)
...++||||+++++|.+++.... ....++|..+++++.||+.||+||| +.+|+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence 56899999999999999986532 1235889999999999999999999 8999999999999999
Q ss_pred cCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhH
Q 036081 429 DSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLI 506 (614)
Q Consensus 429 d~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l 506 (614)
+.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 233 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--- 233 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999975433221 12233456788999999999999999999999999999999 999986543221
Q ss_pred HHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 507 TDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 507 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
. ......+...+. ....+..+.+++.+|++.+|.+|||+.+|+++|+....
T Consensus 234 --~-~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 --V-IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --H-HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1 111122221111 11123467899999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.07 Aligned_cols=253 Identities=29% Similarity=0.436 Sum_probs=201.8
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|...+.||+|+||.||++..+++..+|+|.++.... ..+.|.+|++++++++|+|++++++++. ....+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEEE
Confidence 35677889999999999999988888999999875433 3567999999999999999999998874 2347899
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++++|.+++... ....+++.+++.++.+++.||.||| +.+|+||||||+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999998653 2345899999999999999999999 88999999999999999999999999999976543
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||....... ...........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~------- 222 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-----VLEQVERGYRM------- 222 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCCCC-------
Confidence 32222222345678999999998999999999999999999999 888886543211 11111111010
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..+......+.+++..|++.+|++|||+.++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112233568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=335.72 Aligned_cols=240 Identities=21% Similarity=0.280 Sum_probs=192.0
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 296 IGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 296 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
||+|+||.||+++.. +++.||+|+++.. .......+.+|++++.+++||||+++++++. .....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 699999999999976 5889999998642 2233456889999999999999999999886 456789999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 451 (614)
++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 76 ~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 148 (312)
T cd05585 76 NGGELFHHLQR---EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-D 148 (312)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-C
Confidence 99999998865 356899999999999999999999 8999999999999999999999999999987543222 2
Q ss_pred ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhC
Q 036081 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531 (614)
Q Consensus 452 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 531 (614)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ +.. ..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~-~~~----------~~ 212 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQ-EPL----------RF 212 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHc-CCC----------CC
Confidence 234467999999999999999999999999999999999999999754321 11111111 110 01
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 036081 532 SRAVMERFVRVGILCAHVMVALRPT---IADALKM 563 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RPt---m~eVl~~ 563 (614)
+......+.+++..|++.+|.+||+ +.|++.+
T Consensus 213 ~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 213 PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1223346778899999999999986 4555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=327.91 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=197.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence 467888999999999999999976 689999999865432 22456789999999999999999999987 34578
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||++ ++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EEEEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence 99999995 6787777542 356888899999999999999999 89999999999999999999999999999875
Q ss_pred ccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc----
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV---- 519 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---- 519 (614)
..... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........+....... .....
T Consensus 153 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (303)
T cd07869 153 KSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL-GTPNEDTWP 230 (303)
T ss_pred ccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh-CCCChhhcc
Confidence 42221 22233568999999999875 4688999999999999999999999976443221111111110 00000
Q ss_pred -----hhh--------hhHHhhhh-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 -----DEI--------FDEFIREE-GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 -----~~~--------~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... ....+... ........+.+++..|++.||.+|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 00000000 000012356788999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.84 Aligned_cols=245 Identities=27% Similarity=0.339 Sum_probs=192.6
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHH---HHccCCCcccccccccccCCCCCc
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEII---SKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il---~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
|...+.||+|+||.||++... +|+.||||+++... ....+.+.+|++++ .+++||||+++++++. .+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 556789999999999999876 68999999997532 22234567777665 4567999999999986 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|..++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLC 148 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCC
Confidence 79999999999999887743 46999999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....... +..
T Consensus 149 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-----~~~~i~~-~~~--- 218 (324)
T cd05589 149 KEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-----VFDSIVN-DEV--- 218 (324)
T ss_pred ccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh-CCC---
Confidence 7532221 22334679999999999999999999999999999999999999997644221 1111111 100
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.+|.+|| ++.+++++
T Consensus 219 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 -------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 01112334677899999999999999 56676654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.84 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=203.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHcc-CCCcccccccccccC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKIR-HRNLLSLRGCCVSSD 357 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~ 357 (614)
..++|...++||+|+||.||+|+.. .+..||||+++.... ...+.|.+|++++.++. ||||++++|++.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--- 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--- 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc---
Confidence 3567888899999999999999853 134799999965433 23467999999999996 999999999997
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhh----------------------------------------------------
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALT---------------------------------------------------- 385 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------- 385 (614)
.....++||||+++|+|.++|.....
T Consensus 112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 --KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred --cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 44568999999999999988764210
Q ss_pred -----------------------------------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 036081 386 -----------------------------------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424 (614)
Q Consensus 386 -----------------------------------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~ 424 (614)
...++|.++++++.||++||+||| ..+|+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChH
Confidence 124778888999999999999999 899999999999
Q ss_pred ceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 036081 425 NILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSS 502 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~ 502 (614)
|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999999865432221 1223456788999999999999999999999999999997 88998654321
Q ss_pred chhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 503 FLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 503 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
... ......+.. ...+......+.+++..|++.+|++|||+.+|+++|+..
T Consensus 347 ~~~-----~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 347 STF-----YNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHH-----HHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 111 111111110 001122345788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.83 Aligned_cols=255 Identities=22% Similarity=0.428 Sum_probs=199.5
Q ss_pred CCccceeeeccCcEEEEEEEE-----cCCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTL-----EDGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+|+..+.||+|+||.||+|++ .++..+|+|.++.... +....|.+|++++++++|+||+++++++. .+.
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~ 80 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QEQ 80 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cCC
Confidence 467778999999999999985 2467899999975332 33467899999999999999999999886 345
Q ss_pred eEEEEEecCCCCCcccccchhh--------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL--------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL 428 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~--------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL 428 (614)
..++||||+++|+|.+++.... ....+++.+.+.++.|++.||.||| +.+++||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili 157 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILI 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEE
Confidence 6899999999999999885321 1234788888999999999999999 8999999999999999
Q ss_pred cCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhH
Q 036081 429 DSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLI 506 (614)
Q Consensus 429 d~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l 506 (614)
++++.+||+|||+++....... .......++..|+|||++.++.++.++||||||+++|||++ |..||...... .+
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~ 235 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EV 235 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 9999999999999976533221 22233445778999999998899999999999999999999 88888653321 11
Q ss_pred HHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 507 TDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 507 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.... ...... ..+......+.+++..|++.+|++||++.+++++|.+
T Consensus 236 ~~~~----~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMV----RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 111111 0111233467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.38 Aligned_cols=245 Identities=26% Similarity=0.406 Sum_probs=195.4
Q ss_pred eeeccCcEEEEEEEEc---CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 295 LIGQGASGVVYKGTLE---DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
.||+|+||.||+|.++ ++..+|+|+++.... ...+++.+|+.++++++|+||++++|++. +...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 5899999999999753 578999999864332 23567999999999999999999999874 345789999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCC
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 449 (614)
|+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 9999999999864 346899999999999999999999 8999999999999999999999999999998654333
Q ss_pred ccc--cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 450 SHL--TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 450 ~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
... .....++..|+|||.+....++.++||||||+++|||++ |+.||...... .+.... ..+...
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~i-~~~~~~------ 217 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----EVTQMI-ESGERM------ 217 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH-HCCCCC------
Confidence 221 122334678999999988889999999999999999998 99999754321 111111 111110
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..+......+.+++..|++.+|++||++++|.++|++
T Consensus 218 ---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 ---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 0111233567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=321.22 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=203.7
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|...++||+|+||.||+|..++++.+|+|.+.... ...+.|.+|++++++++|+|++++++++. ....+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEEE
Confidence 4577789999999999999999889999999987543 33567999999999999999999998763 2357999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ....+++.++..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999988653 2346899999999999999999999 89999999999999999999999999999976543
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
..........++..|+|||++..+.++.++||||||+++|||++ |+.||....... ..... ..+...
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~-~~~~~~------ 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNL-ERGYRM------ 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHH-HcCCCC------
Confidence 32222233456778999999998999999999999999999999 999997543221 11111 111000
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.........+.+++.+|++.+|++|||++++++.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111223468889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.70 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=205.1
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
+.-++|...+.||+|+|++|++++.. .++++|||++.+. ..+..+-...|-++|.+| .||.|++|+-.|.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ----- 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ----- 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee-----
Confidence 34456888899999999999999865 6999999998642 223345577899999999 8999999998887
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
+...+|+|+||++||+|.++|.+. +.+++.-.+.++.+|+.||+||| +.|||||||||+|||||+||++||+||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeec
Confidence 556799999999999999999873 67999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCcc---------c---cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHH
Q 036081 440 GLAKQSLEGQSH---------L---TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLIT 507 (614)
Q Consensus 440 Gla~~~~~~~~~---------~---~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~ 507 (614)
|.|+.+...... . ....+||..|++||.+..+..+..+|+|+|||+||+|+.|++||...++- ++.
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--liF 296 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LIF 296 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HHH
Confidence 999976432211 1 13478999999999999999999999999999999999999999875531 110
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
..+++- .-..++...+...+|+...+-.||.+|+|..++-++.
T Consensus 297 ------------qkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 297 ------------QKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ------------HHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 111110 1112333335667788888999999999999997763
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=325.81 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=197.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|++++++++||||+++++++. .....+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence 45888899999999999999876 68999999986533 233456889999999999999999999886 345789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++ |+|.+++... ...+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 80 lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred EEEeCCC-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 9999997 5888887542 345788899999999999999999 899999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH-------HhhCC
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM-------LANSG 517 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~-------~~~~~ 517 (614)
.... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..... .+..-
T Consensus 154 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 154 SVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH-LIFRLLGTPTEETWPGI 231 (288)
T ss_pred cCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChHHhhcc
Confidence 3222 12233468999999999875 568999999999999999999999997654332110 00000 00000
Q ss_pred CchhhhhHHh----hh----hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 KVDEIFDEFI----RE----EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l----~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+.+...+ .. ...........+++..|++.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 00 0001123467789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=340.23 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=201.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.. +|+.||||+++... ......+.+|++++..++|+||+++++++. ++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 46888999999999999999976 68999999987532 233567889999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... ..+++...+.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 99999999999999998752 57899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCC----------------------------ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 036081 444 QSLEGQ----------------------------SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 495 (614)
Q Consensus 444 ~~~~~~----------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p 495 (614)
...... ........||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence 654332 1122345799999999999999999999999999999999999999
Q ss_pred CCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 036081 496 LETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT-IADALKM 563 (614)
Q Consensus 496 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-m~eVl~~ 563 (614)
|........ ......-. ..+...........+..++..|++ +|.+||+ +.+++++
T Consensus 230 f~~~~~~~~-----~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 230 FYSDTLQET-----YNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCHHHH-----HHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 976542211 11111100 000000001123467778888997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=320.10 Aligned_cols=253 Identities=30% Similarity=0.451 Sum_probs=201.5
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|.....||+|+||.||++.++++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. ....++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEEE
Confidence 3477788999999999999998877789999876433 33567899999999999999999998874 2347899
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ....++|..+..++.+++.||.||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 9999999999998653 2345889999999999999999999 89999999999999999999999999999976543
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
..........++..|+|||+..++.++.++||||||+++|||++ |+.||....... .. .+ .......
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~-~~---~~~~~~~------- 222 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VL-EQ---VERGYRM------- 222 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HH-HH---HHcCCCC-------
Confidence 32222223346778999999999999999999999999999999 888986543221 11 11 1111000
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..+...+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112234578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.02 Aligned_cols=258 Identities=23% Similarity=0.427 Sum_probs=204.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.+|...+.||+|+||.||++... ++..+|+|.+........+.+.+|++++.+++|+||+++++++. .+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 45778889999999999999852 34679999987655555678999999999999999999999987 35
Q ss_pred ceEEEEEecCCCCCcccccchhh----------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL----------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~----------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 431 (614)
...++||||+++++|.+++.... ....++|.++++++.|++.||+||| +.+++||||||+|||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence 67899999999999999886432 1235899999999999999999999 8999999999999999999
Q ss_pred CcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHH
Q 036081 432 MKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDW 509 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~ 509 (614)
+.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... .
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~ 231 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----V 231 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----H
Confidence 9999999999986533221 11223445788999999999999999999999999999999 888886543221 1
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
. .....+.... .+......+.+++..|++.+|.+|||+.+|++.|+...
T Consensus 232 ~-~~i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 232 I-ECITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred H-HHHHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1 1111121111 01112346888999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=331.10 Aligned_cols=242 Identities=21% Similarity=0.325 Sum_probs=193.1
Q ss_pred eeeeccCcEEEEEEEEc----CCcEEEEEEeecC----CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 294 NLIGQGASGVVYKGTLE----DGTLVAVKQITDL----DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~----~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+.||+|+||.||+++.. +++.||||.++.. .......+.+|++++++++||||+++++++. .+...+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence 57999999999999853 5789999998752 1223356788999999999999999999886 455789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++|+|.+++.. .+.+.+.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 77 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 77 LILEYLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEeCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999999999998865 356788888899999999999999 899999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... .+..
T Consensus 151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~~~~~~-~~~~------ 217 (323)
T cd05584 151 IHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----TIDKIL-KGKL------ 217 (323)
T ss_pred ccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----HHHHHH-cCCC------
Confidence 32222 2334579999999999998899999999999999999999999997643211 111111 1110
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.+|++|| ++.+++++
T Consensus 218 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 ----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 01112234677899999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=332.88 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=190.3
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
+|+..++||+|+||.||+++.. +|+.||||++..... ...+.+.+|++++++++|+||+++++++. .++..++
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 149 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD-----HNGEIQV 149 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec-----cCCeEEE
Confidence 3455678999999999999976 689999999865432 23467899999999999999999999886 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+.. ...+.....++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++...
T Consensus 150 v~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 150 LLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred EEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 99999999987542 3456677889999999999999 8999999999999999999999999999998653
Q ss_pred CCCccccccccCCCCccchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
... .......||..|+|||++.. ...+.++|||||||++|||++|+.||........ ...........
T Consensus 220 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~---- 292 (353)
T PLN00034 220 QTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--ASLMCAICMSQ---- 292 (353)
T ss_pred ccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhccC----
Confidence 322 12234579999999998743 2345689999999999999999999974332211 00000000000
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...........+.+++..|++.+|++|||+.|++++
T Consensus 293 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112233568889999999999999999999986
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=332.90 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=201.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|+..++||+|+||.||++... +|..+|+|.+.... ....+.+.+|++++.+++|+||+++++++. ..+..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 367888999999999999999976 58889999886532 233467899999999999999999999987 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++.. .+.+++.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 999999999999999865 3468888899999999999999993 24799999999999999999999999999875
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh---------
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN--------- 515 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~--------- 515 (614)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ........
T Consensus 154 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 154 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAESETS 228 (333)
T ss_pred hhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccccccC
Confidence 4322 123356899999999999989999999999999999999999999754322110 00000000
Q ss_pred ---------------C----CCchhhhhHHhhhhCc----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 ---------------S----GKVDEIFDEFIREEGS----RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 ---------------~----~~~~~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. .......+.......+ ......+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0 0000111111111100 0123467899999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=319.87 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=194.4
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
+.||+|+||.||+|+.. +|+.+|+|.+.... .+....|.+|++++++++|+||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 36999999999999975 68999999876432 334567999999999999999999999987 345689999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 451 (614)
++++|.+++... ...++|..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 999999998652 346899999999999999999999 899999999999999999999999999998754322111
Q ss_pred cc-ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhh
Q 036081 452 LT-TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529 (614)
Q Consensus 452 ~~-~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 529 (614)
.. .....+..|+|||.+.++.++.++||||||+++|||++ |..|+....... ... ..... ...
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~-~~~~~---------~~~ 215 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TRE-AIEQG---------VRL 215 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHH-HHHcC---------CCC
Confidence 11 11123457999999999999999999999999999998 888886433211 000 01110 000
Q ss_pred hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 530 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
..+......+.+++..|++.+|++|||+.+++++|+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111223457888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=317.95 Aligned_cols=259 Identities=18% Similarity=0.309 Sum_probs=205.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||.||+|+.. +++.||||.++... .+....+.+|++++++++||||+++++++. ..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 57888999999999999999975 68999999875422 233456899999999999999999999886 3457
Q ss_pred EEEEEecCCCCCcccccchhhh-ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALT-RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~-~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
.++|+||+++|+|.+++..... ...+++...+.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 8999999999999988864322 345788889999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+........ ++.... ......
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~~-~~~~~~-- 226 (267)
T cd08228 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKI-EQCDYP-- 226 (267)
T ss_pred eeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---HHHHHH-hcCCCC--
Confidence 76543221 12234688899999999988999999999999999999999999865432211 111111 111100
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..........+.+++..|++.+|++||++.+|++.|++.
T Consensus 227 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 ------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011122345688899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=339.97 Aligned_cols=241 Identities=26% Similarity=0.418 Sum_probs=205.6
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~ 360 (614)
..++|...++||+|.||+|+++.++ +++.+|||.+++.. .+..+..+.|.+|+... +||.|++|+.++. .
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ-----T 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ-----T 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc-----c
Confidence 4567899999999999999999987 58899999998753 23346677899998887 5999999999998 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
..+.|+||||..+|++..+.+ ...+++.....++..|+.||.||| +++||+||||.+|||||.+|++||+|||
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccc
Confidence 567999999999999665554 357999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
|++..... ...+...+||+.|||||++.+..|+..+|.|||||+||||+.|..||..+++ .
T Consensus 514 lcKe~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------------e 574 (694)
T KOG0694|consen 514 LCKEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------------E 574 (694)
T ss_pred cccccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH------------------H
Confidence 99975432 3356778999999999999999999999999999999999999999986553 3
Q ss_pred hhhhHHhhhh--CcHHHHHHHHHHHHHccccCCCCCCCH
Q 036081 521 EIFDEFIREE--GSRAVMERFVRVGILCAHVMVALRPTI 557 (614)
Q Consensus 521 ~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPtm 557 (614)
+++|..+.++ ++.....+.+.|+...+..+|++|--+
T Consensus 575 e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 4455555433 455566788889999999999999876
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.96 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=198.3
Q ss_pred ccceeeeccCcEEEEEEEEcC-Cc--EEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCceE
Q 036081 291 SQKNLIGQGASGVVYKGTLED-GT--LVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGKRR 364 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~-g~--~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~~~ 364 (614)
...+.||+|+||.||+|++.+ +. .+|+|.++.. .....+.|.+|++++++++|+||+++++++..... ......
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999764 33 6899988653 22335678999999999999999999998754322 123467
Q ss_pred EEEEecCCCCCcccccchhh---hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNAL---TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
+++|||+++|+|.+++.... ....++|.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 99999999999998874321 2245789999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccc-cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQSHL-TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++......... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||....... + ......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~----~~~~~~~~~ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--I----YDYLRQGNR 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHHcCCC
Confidence 98654322211 122345678999999999999999999999999999999 788886533211 1 111112211
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.. ........+.+++..|++.+|++|||+.++++.|+.
T Consensus 233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 233 LK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 111233467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=349.38 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=200.6
Q ss_pred CCccceeeeccCcEEEEEEEEc-C-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-D-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.|...+.||+|+||.||++... + ++.||+|.+..........+.+|+.++++++||||+++++++. .+...+|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 3788899999999999999854 3 6788888775544444567888999999999999999999987 4567999
Q ss_pred EEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 367 VYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
||||+++|+|.++|.+.. ....+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999999999886532 2346888889999999999999999 899999999999999999999999999999865
Q ss_pred cCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 446 LEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 446 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... .......||++|+|||++.+..++.++|||||||++|||++|+.||....... ....... +...
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----~~~~~~~-~~~~---- 289 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----IMQQVLY-GKYD---- 289 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh-CCCC----
Confidence 43322 22344679999999999999999999999999999999999999996543211 1111111 1110
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
..+......+.+++..|++.+|++||++.+++.
T Consensus 290 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011123346788999999999999999999864
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=335.49 Aligned_cols=266 Identities=25% Similarity=0.321 Sum_probs=199.9
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+.......+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 68999999986532 22346788999999999999999999998754322234789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|+||+. ++|.+.+.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 577776643 356899999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh-
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF- 523 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 523 (614)
............++..|+|||++.+. .++.++|||||||++|||++|+.||........ +. ............+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~-~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LD-LITDLLGTPSLEAMRS 231 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HH-HHHHHcCCCCHHHHHH
Confidence 43333333445689999999999864 579999999999999999999999976543211 10 010000111110000
Q ss_pred ------hHHhhh-----------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 ------DEFIRE-----------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 ------d~~l~~-----------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+.. .......+.+.+++..|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 0011123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=350.46 Aligned_cols=266 Identities=22% Similarity=0.288 Sum_probs=208.2
Q ss_pred hHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCccccccccccc
Q 036081 280 ESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSS 356 (614)
Q Consensus 280 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~ 356 (614)
..+.+...++|...+.||+|+||+||+++.. +|+.||||++.... ......+.+|+.++..++|+|++++.+.+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 3445556678999999999999999999864 69999999986532 33345788999999999999999988876543
Q ss_pred CC---CCCceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC
Q 036081 357 DD---EKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 357 ~~---~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 432 (614)
+. ......++||||+++|+|.+++.... ....+++.....++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCC
Confidence 22 12234789999999999999986532 2346888889999999999999999 89999999999999999999
Q ss_pred cEEEeeecccccccCCC-ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Q 036081 433 KAKVADFGLAKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~ 511 (614)
.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~ 255 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMH 255 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHH
Confidence 99999999998654322 12234467999999999999999999999999999999999999999754321 1111
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... .+... ..+......+.+++..|++.+|.+||++.+++++
T Consensus 256 ~~~-~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTL-AGRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHh-cCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 11111 0122234568889999999999999999999875
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=316.23 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=202.9
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|++|.||+++.+ +|+.|++|.+... .....+.+.+|++++++++|||++++++++. ..+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 4677889999999999999976 6899999998643 3344667999999999999999999999987 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++++|.+++... ....+++.+++.++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++..
T Consensus 76 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 999999999999998763 2356889999999999999999999 899999999999999999999999999998865
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
..... ......|++.|+|||+..++.++.++||||||+++|||++|+.||....... ..... ..+...
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~~----- 219 (256)
T cd08529 152 SDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-----LILKI-IRGVFP----- 219 (256)
T ss_pred cCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HcCCCC-----
Confidence 43322 2233568899999999999999999999999999999999999997544211 11111 111111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.........+.+++..|++.+|++||++.+++++
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111234578889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.47 Aligned_cols=258 Identities=21% Similarity=0.220 Sum_probs=195.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|...+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++. .....++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEE
Confidence 56889999999999999999875 68899999753 235789999999999999999999886 3456899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
|+|++. ++|.+++.. ...+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 161 v~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 161 ILPRYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEecCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999985 788877754 356899999999999999999999 8899999999999999999999999999997543
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc------chhHHHHHHHHhhC----
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSS------FLLITDWAWMLANS---- 516 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~------~~~l~~~~~~~~~~---- 516 (614)
...........||+.|+|||++.+..++.++|||||||++|||++|+.|+-..... ...+..........
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 32222334467999999999999999999999999999999999999876432110 01111111110000
Q ss_pred -CCchhhhhHHh----hh-----------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 -GKVDEIFDEFI----RE-----------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 -~~~~~~~d~~l----~~-----------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
......++... .. .........+..++..|++.||.+|||+.|++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000111100 00 0001234567889999999999999999999864
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=320.17 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=200.9
Q ss_pred CccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCc
Q 036081 290 FSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGK 362 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~ 362 (614)
|...+.||+|+||.||+|++.. +..||+|+++... ....+.+.+|++.+++++|+|++++++++...+. ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998752 3679999987532 2234678999999999999999999998865432 2334
Q ss_pred eEEEEEecCCCCCcccccchhh---hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL---TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
..++++||+++|+|..++.... ....+++.....++.|++.||.||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 5799999999999998885532 2246888899999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCccc-cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 440 GLAKQSLEGQSHL-TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 440 Gla~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|+++......... .....++..|+|||++....++.++||||||+++|||++ |..||....... +.++. . .+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~---~-~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYL---R-HG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH---H-cC
Confidence 9998654332221 122335678999999988899999999999999999999 888886543221 11111 1 11
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
... ..+......+.+++..|++.+|++|||+.|+++.|+.
T Consensus 232 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 232 NRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 100 0112234578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=324.58 Aligned_cols=258 Identities=27% Similarity=0.401 Sum_probs=200.2
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
.+++|...+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--- 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence 45678889999999999999998753 5679999886433 2334679999999999999999999998863
Q ss_pred CCCceEEEEEecCCCCCcccccchhhh----ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC--
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALT----RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-- 432 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-- 432 (614)
....++||||+++|+|.+++..... ...++|..+++++.||+.||+||| +.+++||||||+||+++.++
T Consensus 81 --~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 81 --RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCC
Confidence 3457999999999999999865321 125889999999999999999999 88999999999999998765
Q ss_pred -cEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHH
Q 036081 433 -KAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDW 509 (614)
Q Consensus 433 -~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~ 509 (614)
.+||+|||+++........ .......+..|+|||++.++.++.++|||||||++|||++ |+.||....... .
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~ 230 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----V 230 (277)
T ss_pred cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----H
Confidence 5999999999865322111 1112234568999999999999999999999999999997 999987543221 1
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
........+. ..+......+.+++..|++.+|++||++.+|+++|+.
T Consensus 231 ~~~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 231 MEFVTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1111111110 1112233577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.79 Aligned_cols=241 Identities=23% Similarity=0.332 Sum_probs=189.3
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+|+.. +++.||||.++.. .....+.+..|.+++..+ +||||+++++++. .+...++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 36999999999999976 5789999998752 122344566777777765 8999999999886 456799999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. ...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~gg~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence 99999999988865 346888999999999999999999 899999999999999999999999999999764332
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ..+.... ..
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~~-~~---------- 212 (316)
T cd05592 150 E-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-----LFDSILN-DR---------- 212 (316)
T ss_pred C-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHc-CC----------
Confidence 2 22344679999999999999999999999999999999999999997644321 1111111 00
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIA-DALK 562 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~-eVl~ 562 (614)
...+......+.+++..|++.+|.+||++. ++++
T Consensus 213 ~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 213 PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 001112234567888999999999999976 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.48 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=193.8
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++.++ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 46999999999999976 5889999999753 223345678899998887 7999999999886 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|..++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 E~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence 99999999888754 356899999999999999999999 899999999999999999999999999998753221
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc---hhHHHHHHHHhhCCCchhhhhH
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF---LLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....+..........
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 222 (329)
T cd05618 150 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 222 (329)
T ss_pred C-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------
Confidence 1 12234579999999999999999999999999999999999999996322111 1111222222211111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPT------IADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt------m~eVl~~ 563 (614)
..+......+.+++..|++.||.+||+ +.+++++
T Consensus 223 ----~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 ----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 012223346778999999999999998 5677554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=318.75 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=202.6
Q ss_pred HHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 282 ELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 282 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
|++.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++. .
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 76 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----E 76 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----c
Confidence 34567788888889999999999999965 57889999987665556678999999999999999999999987 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCC--CccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-CCcEEEe
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQL--AWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-EMKAKVA 437 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l--~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~KL~ 437 (614)
+...++|+||+++++|.+++.... ..+ ++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~ 151 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKIS 151 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEe
Confidence 567899999999999999987532 334 77888899999999999999 899999999999999986 6799999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
|||++........ ......|+..|+|||++..+. ++.++||||||+++|||++|+.|+.......... +......
T Consensus 152 dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~~~~ 228 (268)
T cd06624 152 DFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVGMFK 228 (268)
T ss_pred cchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhhhhc
Confidence 9999875433222 223345889999999987643 7899999999999999999999986533211110 1000000
Q ss_pred CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ....+....+.+..++..|++.+|++|||+.|++++
T Consensus 229 ---~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ---I--------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---c--------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 001122234567889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=335.17 Aligned_cols=251 Identities=20% Similarity=0.306 Sum_probs=195.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||.||+++.. +|+.||||+++... ......+.+|++++..++|+||+++++++. .+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCe
Confidence 46888999999999999999976 58999999997532 223456788999999999999999999887 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccce
Confidence 9999999999999999865 356899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcc-------------------------------------ccccccCCCCccchhhhccCCCCchhhHHHHHHHH
Q 036081 444 QSLEGQSH-------------------------------------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVI 486 (614)
Q Consensus 444 ~~~~~~~~-------------------------------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL 486 (614)
........ .....+||+.|+|||++....++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 54221100 01124699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccchhHHHHHHHHhh-CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 036081 487 LELMSGRKVLETSNSSFLLITDWAWMLAN-SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT---IADALK 562 (614)
Q Consensus 487 ~ELltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt---m~eVl~ 562 (614)
|||++|+.||......... ..... ...+. +. ......+.+.+++..|+. +|.+|++ +.|+++
T Consensus 230 ~el~~G~~Pf~~~~~~~~~-----~~i~~~~~~~~--~~------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETY-----RKIINWKETLQ--FP------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHhhcCCCCCCCCCHHHHH-----HHHHcCCCccC--CC------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999999999765432111 00100 00000 00 000112345566777776 8999998 988877
Q ss_pred H
Q 036081 563 M 563 (614)
Q Consensus 563 ~ 563 (614)
+
T Consensus 296 h 296 (364)
T cd05599 296 H 296 (364)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=339.18 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=193.4
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++.+++|+||+++++++. +....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 5778899999999999999865 58899999996532 233457889999999999999999999987 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++.. ...+++.....++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 999999999999999865 346888888999999999999999 89999999999999999999999999999753
Q ss_pred ccCCC----------------------------------------------ccccccccCCCCccchhhhccCCCCchhh
Q 036081 445 SLEGQ----------------------------------------------SHLTTRVAGTYGYLAPEYALYGQLTEKSD 478 (614)
Q Consensus 445 ~~~~~----------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksD 478 (614)
..... ........||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence 21100 00112357999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHH--ccccCCCCCCC
Q 036081 479 VYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGIL--CAHVMVALRPT 556 (614)
Q Consensus 479 VwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPt 556 (614)
||||||++|||++|+.||..............| ..... + .........+.+++.. |...++..||+
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~----~~~~~------~--~~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINW----ENTLH------I--PPQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc----ccccC------C--CCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 999999999999999999765432211100000 00000 0 0000112234445543 66777778999
Q ss_pred HHHHHHH
Q 036081 557 IADALKM 563 (614)
Q Consensus 557 m~eVl~~ 563 (614)
+.|++.+
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.30 Aligned_cols=237 Identities=24% Similarity=0.341 Sum_probs=185.1
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHH-HHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVE-IISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~-il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
++||+|+||.||+++.. +|+.||+|++.... ......+..|.. +++.++||||+++++++. ..+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 36999999999999976 58899999986432 122334555554 577889999999998886 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|..++.. ...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence 99999999888754 356888888999999999999999 899999999999999999999999999998753222
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... ....... +..
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~-~~~--------- 213 (321)
T cd05603 150 -EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----MYDNILH-KPL--------- 213 (321)
T ss_pred -CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----HHHHHhc-CCC---------
Confidence 122344578999999999999999999999999999999999999997643211 1111111 110
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIA 558 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~ 558 (614)
..+......+.+++..|++.+|.+||+..
T Consensus 214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 -QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01111234677899999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=323.55 Aligned_cols=260 Identities=22% Similarity=0.388 Sum_probs=206.1
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcC-----CcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLED-----GTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~-----g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
..++|...+.||+|+||.||+|.+.+ +..|++|+++... ....+.+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 34678888999999999999999875 6889999987543 23356788999999999999999999988642
Q ss_pred CCceEEEEEecCCCCCcccccchhhhc-----cCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcE
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTR-----KQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA 434 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~-----~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 434 (614)
+...++++||+++|+|.+++...... ..+++.+++.++.+++.||+||| +.+++||||||+||++++++.+
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcE
Confidence 35679999999999999998653222 46889999999999999999999 8999999999999999999999
Q ss_pred EEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHH
Q 036081 435 KVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWM 512 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~ 512 (614)
||+|||+++........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... .+..+
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~--- 231 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAY--- 231 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHH---
Confidence 99999999865433322 1223346778999999998899999999999999999999 99999654321 11111
Q ss_pred HhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 513 LANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 513 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
...+.. + .......+.+.+++..|++.+|+.|||+.+++++|+..
T Consensus 232 -~~~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 232 -LKDGYR-------L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred -HHcCCC-------C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111100 0 00111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=321.74 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=202.8
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCC-C
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE-K 360 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~-~ 360 (614)
+.+++.|+..+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.++.++ +|+|++++++++...+.. .
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 356778888999999999999999876 58899999986543 3456788999999999 699999999998754322 2
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....++||||+++|+|.+++... ....++|..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCC
Confidence 35689999999999999998753 2346889999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
+++...... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+......... . ....
T Consensus 157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~----~-~~~~ 230 (272)
T cd06637 157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----F-LIPR 230 (272)
T ss_pred Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH----H-HHhc
Confidence 987643222 1233457899999999986 346888999999999999999999999643321111 0 0011
Q ss_pred CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. .... ........+.+++..|++.+|.+|||+.|++++
T Consensus 231 ~~-~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NP-APRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CC-CCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 10 0000 111223467889999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=335.44 Aligned_cols=246 Identities=22% Similarity=0.250 Sum_probs=198.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEcC--CcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLED--GTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~--g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|...+.||+|+||.||+|++++ +..||+|++... .....+.+.+|++++..++||||+++++++. .+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eC
Confidence 3468889999999999999998653 368999998642 2233457889999999999999999999987 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++.. .+.+++..+..++.|++.||.||| +.+|+||||||+|||++.++++||+|||+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCC
Confidence 679999999999999999865 356889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+...
T Consensus 178 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~~~~~- 246 (340)
T PTZ00426 178 AKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILEGIIY- 246 (340)
T ss_pred CeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhcCCCC-
Confidence 9865322 234579999999999999899999999999999999999999997543211 11111111110
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
.+......+.+++..|++.+|.+|+ ++.+++++
T Consensus 247 ---------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 ---------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111234567889999999999995 89998876
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=325.13 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=200.2
Q ss_pred CCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
+|...+.||+|+||.||+|+.. ....+++|.+..... ...+.+.+|+.++++++||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 3667789999999999999853 235789998865432 23467899999999999999999999886 34
Q ss_pred ceEEEEEecCCCCCcccccchhh---------------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecC
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL---------------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRD 420 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrD 420 (614)
...++++||+++|+|.+++.... ....++|..++.++.|++.||.||| +.+|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence 56899999999999999875421 1235788899999999999999999 89999999
Q ss_pred CCCCceeecCCCcEEEeeecccccccCCCccc-cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 036081 421 IKSTNILLDSEMKAKVADFGLAKQSLEGQSHL-TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLET 498 (614)
Q Consensus 421 IKp~NILLd~~~~~KL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~ 498 (614)
|||+|||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999998653332211 222345678999999998899999999999999999998 9999865
Q ss_pred CCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 499 SNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 499 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
..... .+.....+. ....+......+.+++..|++.+|++||++.+++++|++..
T Consensus 233 ~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 233 IAPER------LFNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCHHH------HHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 43211 111111110 00111223347888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.25 Aligned_cols=264 Identities=25% Similarity=0.272 Sum_probs=201.4
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc--chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK--GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|...++||+|.||.||+|+.. +|+.||||+++..+.. ......+||+.|+.++|+||+.|++++. ......
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~-----~~~~l~ 77 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP-----HKSNLS 77 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc-----CCCceE
Confidence 4666789999999999999854 7999999999764332 2456889999999999999999999997 445689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
||+|||+ .+|+..+++. ...++-.+...++.++.+||+|+| .+.|+||||||.|+|++++|.+||+|||+|+.+
T Consensus 78 lVfEfm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 78 LVFEFMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFF 151 (318)
T ss_pred EEEEecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence 9999996 5888888763 567888899999999999999999 999999999999999999999999999999987
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH-------HhhC-
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM-------LANS- 516 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~-------~~~~- 516 (614)
.......+ ..+-|..|.|||.+.+ ..|+...||||.||++.||+-|.+-|.+.++-+.+ ...... .|.+
T Consensus 152 ~~p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL-~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 152 GSPNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL-SKIFRALGTPTPDQWPEM 229 (318)
T ss_pred CCCCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH-HHHHHHcCCCCcccCccc
Confidence 65443333 3367999999999985 68999999999999999999998777665443211 111000 0000
Q ss_pred CCchhhhhHHhh-----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 517 GKVDEIFDEFIR-----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 517 ~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
..+.+..+-..- ...-..+....+++...++..||.+|.|+.|+++|=-
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 011111110000 0001122345688999999999999999999998743
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.87 Aligned_cols=258 Identities=20% Similarity=0.326 Sum_probs=204.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||.||++... +|+.+|||.+.... .....++.+|++++++++|+||+++++++. .++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 45777889999999999999964 78999999886432 223457899999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 364 RFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
.+++|||+++++|.+++.... ....++|..++.++.+|+.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 899999999999999886422 2346899999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
........ ......|+..|+|||++.+..++.++||||||+++|||++|+.||.....+.. .+.... ....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~-~~~~---- 224 (267)
T cd08229 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKI-EQCD---- 224 (267)
T ss_pred hccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH---HHhhhh-hcCC----
Confidence 76543222 22334688999999999998999999999999999999999999864332211 111100 0000
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.+ ........+.+.+++..|++.+|++||||.+|++++++
T Consensus 225 -~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 225 -YP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred -CC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 00 00112344578889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.00 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=194.1
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCC-CcccccccccccCCCCCce
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHR-NLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~-NIv~l~g~~~~~~~~~~~~ 363 (614)
+|+..+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|++++..++|+ +|+++++++. ..+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence 4778899999999999999976 4789999998752 223346688899999999765 5778888776 3457
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 8999999999999988865 356889999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ....
T Consensus 150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-----~~~i~-~~~~---- 218 (324)
T cd05587 150 ENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-----FQSIM-EHNV---- 218 (324)
T ss_pred ecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHHH-cCCC----
Confidence 532211 123345799999999999999999999999999999999999999975442211 11111 1110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTI-----ADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm-----~eVl~~ 563 (614)
..+......+.+++..|++.+|.+||+. .++.++
T Consensus 219 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 ------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111233467789999999999999976 565543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=336.67 Aligned_cols=253 Identities=21% Similarity=0.245 Sum_probs=199.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||+||+++.. +|+.||+|+++... .+..+.+.+|+.++..++|+||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence 46888999999999999999876 68999999997532 233456889999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... ...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred EEEEECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence 89999999999999998653 356899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYAL------YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
..............||+.|+|||++. ...++.++|||||||++|||++|+.||........ ........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~ 225 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQ 225 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCC
Confidence 66443333334457899999999987 45678999999999999999999999976443211 11111111
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... .........+..++..|++ +|.+|||+.+++++
T Consensus 226 ~~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 RFLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 10000 0011223456778888887 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=319.56 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=201.7
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CC---cEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DG---TLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g---~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.++... ....+.+.+|++++.+++|+|++++.+++. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence 346788899999999999999975 33 379999986542 233567899999999999999999999986 34
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++++|.+++... ...++|.++..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcc
Confidence 5689999999999999998652 356899999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCccc--cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 442 AKQSLEGQSHL--TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 442 a~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
+.......... ......+..|+|||++.++.++.++||||||+++|||++ |+.||...... ++.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i~~~~~ 228 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAINDGFR 228 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHhcCCC
Confidence 87654322211 112233567999999999999999999999999999998 99998654321 11111111100
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ....+....+.+++..|++.+|++||+|.+|++.|++.
T Consensus 229 ~----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 L----------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 11112335678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.40 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=199.6
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+|+..++||+|+||.||++... +++.||||++.... ......+.+|+.++++++|+||+++++++. .+...
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 4778899999999999999975 68999999986532 122356788999999999999999999886 34579
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||+++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 9999999999999887653 2346899999999999999999999 89999999999999999999999999999876
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
...... .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ....+... ....
T Consensus 152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~------- 220 (285)
T cd05605 152 IPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERR-VKED------- 220 (285)
T ss_pred cCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHH-hhhc-------
Confidence 533221 223468999999999999999999999999999999999999997543221 11111100 0000
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
....+......+.+++..|++.||.+|| ++.+++++
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 ---QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111223445678899999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=313.10 Aligned_cols=259 Identities=21% Similarity=0.337 Sum_probs=206.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||.||+|... +|+.+|+|.++.. .....+.+.+|++++++++|+|++++++++. ..+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 57888999999999999999987 7999999988632 2233567899999999999999999999987 3457
Q ss_pred EEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 364 RFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
.++||||+++|+|.+++.+.. ....+++.+++.++.+++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEecccee
Confidence 899999999999999886532 2345889999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+....... ......++..|+|||++.+..++.++||||||+++|||++|+.|+...... ..++.... ..+....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-~~~~~~~- 227 (267)
T cd08224 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI-EKCDYPP- 227 (267)
T ss_pred eeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhhh-hcCCCCC-
Confidence 76433221 123346889999999999999999999999999999999999998654321 11111110 1111110
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.........+.+++..|++.+|++|||+.+++++|++.
T Consensus 228 -------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 -------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 01113345678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=335.12 Aligned_cols=202 Identities=23% Similarity=0.375 Sum_probs=173.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||+||+++.. +|+.||||+++... ......+.+|++++.+++|+||+++++.+. +...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence 46888999999999999999876 58999999996532 223356788999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. .+.+++.....++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 8999999999999999865 357899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCc----------------------------------cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHH
Q 036081 444 QSLEGQS----------------------------------HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILEL 489 (614)
Q Consensus 444 ~~~~~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~EL 489 (614)
....... ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 5422110 011235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 036081 490 MSGRKVLETSN 500 (614)
Q Consensus 490 ltG~~p~~~~~ 500 (614)
++|+.||....
T Consensus 230 l~G~~Pf~~~~ 240 (363)
T cd05628 230 LIGYPPFCSET 240 (363)
T ss_pred HhCCCCCCCCC
Confidence 99999997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=316.50 Aligned_cols=255 Identities=30% Similarity=0.463 Sum_probs=204.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.++|...+.||+|+||.||++..++++.+|||.+.... ...+++.+|++++++++|+||+++++++. .....++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence 45788889999999999999998888899999987533 34567999999999999999999999876 3456899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++++|.+++.... ...+++.++..++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++...
T Consensus 79 v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 999999999999986632 246899999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
...........++..|+|||.+.++.++.++||||||+++|||++ |+.||....... .+. .... +
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~----~~~~-~-------- 220 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLE----QVER-G-------- 220 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH----HHHc-C--------
Confidence 322222222335678999999999999999999999999999999 999986543211 111 1101 0
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.....+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 -YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0001111223578889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=330.45 Aligned_cols=242 Identities=21% Similarity=0.297 Sum_probs=193.3
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
+.||+|+||.||+++.. +|+.||+|.++.. .......+.+|++++.+++||||+++.+++. .....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEe
Confidence 36999999999999865 6899999999753 2223456788999999999999999998886 4567899999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCC-CceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK-PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
|+++|+|.+++.. ...+++..+..++.||+.||.||| + .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 76 YANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 149 (325)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence 9999999888764 356899999999999999999999 6 79999999999999999999999999998754322
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
.. ......||+.|+|||++.++.++.++|||||||++|||++|+.||........ ... . ..+..
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~~~---i-~~~~~--------- 213 (325)
T cd05594 150 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FEL---I-LMEEI--------- 213 (325)
T ss_pred Cc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--HHH---H-hcCCC---------
Confidence 21 22345699999999999999999999999999999999999999975432211 000 0 00100
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.||++|+ ++.+++++
T Consensus 214 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 -RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01112234677889999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.96 Aligned_cols=254 Identities=19% Similarity=0.247 Sum_probs=198.8
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
..++|+..+.||+|+||.||+++.. +|+.+|+|++... .....+.+.+|+++++.++||||+++++++. .+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 4567889999999999999999976 5889999998642 1223445789999999999999999998886 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++.+ ..+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 679999999999999998854 35778888899999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
++..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ + .......
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----~-~~i~~~~ 263 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----Y-SKIMDHK 263 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH----H-HHHHcCC
Confidence 986543322223345799999999998643 478999999999999999999999976442111 1 1111100
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL--RPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~eVl~~ 563 (614)
.. +.-.........+.+++..|++.+|.+ |||+.|++.+
T Consensus 264 ~~-------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 NS-------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred Cc-------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 000001112346778889999989987 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.83 Aligned_cols=247 Identities=24% Similarity=0.289 Sum_probs=193.7
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 296 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
||+|+||+||++... +|+.+|+|.+..... ...+.+..|++++++++|+||+++.+++. .....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence 699999999999875 689999999864321 23356788999999999999999998876 345789999999
Q ss_pred CCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCc
Q 036081 372 PSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450 (614)
Q Consensus 372 ~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 450 (614)
++|+|.+++.... ....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 9999988775422 2356899999999999999999999 89999999999999999999999999999976543322
Q ss_pred cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhh
Q 036081 451 HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREE 530 (614)
Q Consensus 451 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 530 (614)
......||+.|+|||++.++.++.++||||||+++|||++|+.||......... ....... ..+.. .
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~----------~ 219 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRI-LNDSV----------T 219 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhh-cccCC----------C
Confidence 223457899999999999999999999999999999999999999754322110 0000000 00000 1
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 531 GSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 531 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
.+......+.+++..|++.+|++|| |+++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1122345678899999999999999 77888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=317.73 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=194.4
Q ss_pred eeeccCcEEEEEEEEc---CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEec
Q 036081 295 LIGQGASGVVYKGTLE---DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
.||+|+||.||+|++. ++..||+|.+..... ...+.|.+|+.++++++|+||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 3899999999999864 356799999875433 23467999999999999999999999874 2357999999
Q ss_pred CCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCc
Q 036081 371 MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450 (614)
Q Consensus 371 ~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 450 (614)
+++|+|.+++... ...+++..+++++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 9999999988642 456899999999999999999999 88999999999999999999999999999875543322
Q ss_pred cc--cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 451 HL--TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 451 ~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
.. .....++..|+|||++....++.++||||||+++|||++ |+.||....... +. .....+..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~-~~~~~~~~-------- 216 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----VM-SFIEQGKR-------- 216 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----HH-HHHHCCCC--------
Confidence 21 122234578999999998899999999999999999996 999997543221 11 11111110
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+....+.+.+++..|++.+|++||++.+|.+.|+.
T Consensus 217 -~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 217 -LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 01112233567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.65 Aligned_cols=249 Identities=31% Similarity=0.447 Sum_probs=202.3
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|+..+.||+|+||.||++... |+.||+|.++.... ..+.+.+|+.++.+++|+||+++++++. .+...++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEEE
Confidence 46778899999999999999986 88999999976543 4667999999999999999999999987 34568999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++++|.+++.... ...++|..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 99999999999986532 236899999999999999999999 89999999999999999999999999999986532
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
... ...++..|+|||++..+.++.++||||||+++|||++ |+.||....... +. .....+..
T Consensus 155 ~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~----~~~~~~~~------- 217 (256)
T cd05039 155 GQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV----PHVEKGYR------- 217 (256)
T ss_pred ccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HH----HHHhcCCC-------
Confidence 221 2345678999999998999999999999999999997 999986543211 11 11111100
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+...+..+.+++..|+..+|++|||+.|++++|+.
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 --MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01111234577889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=315.48 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=200.6
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
.+|+..+.||+|+||.||++.+.+++.+|+|.++... .....|.+|++++++++|||++++++++. .....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEE
Confidence 3567788999999999999998878899999886433 23467999999999999999999999876 34568999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++++|.+++... ...++|+.++.++.+++.||+||| +.+++||||||+||+++.++.+||+|||+++....
T Consensus 78 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 9999999999988652 345889999999999999999999 88999999999999999999999999999876533
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
..........++.+|+|||++.++.++.++||||||+++|||++ |+.||...... ............ ..
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~---~~-- 222 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETINAGFRL---YK-- 222 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHhCCCCC---CC--
Confidence 22211222335678999999999999999999999999999998 99998654321 111111110000 00
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
+....+.+.+++..|++.+|++|||+.+++++|.
T Consensus 223 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 -----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112357888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.05 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=199.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-----cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-----KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-----~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|...+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|++++.+++||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 57888999999999999999865 689999999864321 12346889999999999999999999987 34
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++|+||+++++|.+++.. ...+++....+++.+++.||.||| +.+|+||||||+||++++++++||+|||+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 579999999999999998865 356888999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccc--ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQSHLT--TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++.......... ....|+..|+|||++.+..++.++||||||+++|||++|+.||........ ..+ .......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~-~~~~~~~ 225 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA----IFK-IATQPTN 225 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH----HHH-HhccCCC
Confidence 876533221111 334678899999999998999999999999999999999999865432111 111 1111100
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+......+.+++..|++.+|++|||+.|++++
T Consensus 226 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ---------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01112233467789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=322.77 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=201.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++...++||+|+||.||++... ++..+|+|.+........+.|.+|++++.+++|+||+++++++. .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence 34566789999999999999642 36689999987766566678999999999999999999999886 34
Q ss_pred ceEEEEEecCCCCCcccccchhhh------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALT------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
...+++|||+++|+|.+++..... ...++|..++.++.|++.||+||| +.+++||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence 568999999999999999865321 135889999999999999999999 89999999999999999
Q ss_pred CCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLIT 507 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~ 507 (614)
+++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--- 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---
Confidence 999999999999875433221 11223345788999999999999999999999999999998 8899865432211
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.... ..+... ..+......+.+++..|++.+|++||++.||++.|+.
T Consensus 234 --~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 --IECI-TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --HHHH-HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111 011000 0111223467789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=324.95 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=198.5
Q ss_pred CCCccceeeeccCcEEEEEEEEcC-Cc--EEEEEEeecC-CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED-GT--LVAVKQITDL-DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~vAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|+..+.||+|+||.||+|+.++ |. .+++|.++.. .....+.|.+|++++.++ +||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 467888999999999999998763 33 4788888743 233456789999999999 7999999999886 345
Q ss_pred eEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
..++|+||+++|+|.+++.... ....+++..++.++.|++.||+||| +.+|+||||||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence 6899999999999999986421 1134788899999999999999999 89999999999999999
Q ss_pred CCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITD 508 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~ 508 (614)
+++.+||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |+.||.......
T Consensus 154 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----- 226 (297)
T cd05089 154 ENLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----- 226 (297)
T ss_pred CCCeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 9999999999998642211 11111223567999999999999999999999999999998 999996543221
Q ss_pred HHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 509 WAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 509 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
..... ..+. ....+......+.+++..|++.+|.+|||+.+++++|+....
T Consensus 227 ~~~~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 227 LYEKL-PQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHHH-hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111 1110 001111233467889999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.65 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=203.7
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCcccccccccc
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVS 355 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~ 355 (614)
+...++|...+.||+|+||.||++...+ ...+|+|.+.... .+...++.+|++++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT- 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc-
Confidence 3445568888999999999999998642 3689999987532 23345688999999999 8999999999986
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchh-------------hhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCC
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNA-------------LTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIK 422 (614)
.+...+++|||+++|+|.+++... .....++|..+++++.|++.||+||| +.+|+|||||
T Consensus 87 ----~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlk 159 (293)
T cd05053 87 ----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLA 159 (293)
T ss_pred ----CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccc
Confidence 345689999999999999998642 12346889999999999999999999 8999999999
Q ss_pred CCceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 036081 423 STNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSN 500 (614)
Q Consensus 423 p~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~ 500 (614)
|+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+....
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 99999999999999999999865432221 1222345678999999999999999999999999999998 888886543
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.... . .....+... ..+......+.+++..|++.+|++|||+.|+++.|+..
T Consensus 240 ~~~~-----~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 VEEL-----F-KLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHH-----H-HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 2111 0 111111100 11112334788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=328.84 Aligned_cols=242 Identities=25% Similarity=0.346 Sum_probs=192.7
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
++||+|+||.||+++.+ +++.||||+++.. .....+.+..|++++..+ +||||+++++++. .....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence 36999999999999976 5889999998642 223345678899999887 6999999999886 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 Ey~~~g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQK---SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence 99999999988865 356899999999999999999999 899999999999999999999999999998754222
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ..+..
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i-~~~~~--------- 213 (320)
T cd05590 150 G-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFEAI-LNDEV--------- 213 (320)
T ss_pred C-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHH-hcCCC---------
Confidence 2 22334579999999999999999999999999999999999999997654321 11111 11110
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTI------ADALKM 563 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm------~eVl~~ 563 (614)
..+......+.+++..|++.||.+||++ .+++++
T Consensus 214 -~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 -VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0111223467789999999999999998 565543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=322.95 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=198.4
Q ss_pred CccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 290 FSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
|...+.||+|+||.||+|+..+ +..||+|+++..... ..+.|.+|+.++.+++||||+++++++. ...
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~ 81 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KEQ 81 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CCC
Confidence 5567789999999999998642 578999999754332 2466889999999999999999999987 345
Q ss_pred eEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
..++++||+++++|.+++.... .+..+++..+++++.|++.||.||| +.+|+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEec
Confidence 6899999999999998874311 1234788888999999999999999 89999999999999999
Q ss_pred CCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLIT 507 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~ 507 (614)
+++.+||+|||+++....... .......+++.|+|||++.++.++.++||||||+++|||++ |..|+......
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----- 233 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----- 233 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 999999999999886533221 12233456789999999999999999999999999999998 77887653321
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
++.... ..+... ..+.+..+.+..++..|++.+|.+||++.+|++.|+.
T Consensus 234 ~~~~~i-~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMI-RNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHH-HcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 111111 1112234567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.13 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=200.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCc----EEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGT----LVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.+|...++||+|+||+||+|++. +|+ .||+|.++.... ...+++.+|+.++..++|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------ 80 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------ 80 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence 45777899999999999999864 454 489999865332 335678999999999999999999999863
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++++||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCc
Confidence 3468999999999999998652 346899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccc-cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQSHL-TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++......... .....++..|+|||...++.++.++||||||+++|||++ |+.|+...... .+..+. ..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~----~~~~~ 229 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLL----EKGER 229 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH----HCCCc
Confidence 98654322211 122345678999999999999999999999999999998 88998654321 111111 11111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.. .+......+.+++..|++.+|+.||++.++++.|+...
T Consensus 230 ~~---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 LP---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00 01112346778999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=329.11 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=193.2
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
++||+|+||.||+|+.. +|+.||||+++.. .....+.+..|.+++..+ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 36999999999999976 5789999998753 223345678899999876 7999999999987 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+.+.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 E~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence 99999999988865 356899999999999999999999 899999999999999999999999999998754322
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...... +..
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-----~~~i~~-~~~--------- 213 (321)
T cd05591 150 G-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-----FESILH-DDV--------- 213 (321)
T ss_pred C-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-----HHHHHc-CCC---------
Confidence 2 223345789999999999999999999999999999999999999976543211 111111 110
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRP-------TIADALKM 563 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-------tm~eVl~~ 563 (614)
..+......+.+++..|++.+|++|| ++.+++++
T Consensus 214 -~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 -LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01111234677889999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=331.58 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=199.3
Q ss_pred CCCccceeeeccCcEEEEEEEE------cCCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
++|...+.||+|+||.||+|+. .+++.||||+++.... .....+.+|++++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---- 82 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---- 82 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec----
Confidence 4688889999999999999973 3478999999975332 2345688999999999 68999999998863
Q ss_pred CCceEEEEEecCCCCCcccccchhh-------------------------------------------------------
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNAL------------------------------------------------------- 384 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~------------------------------------------------------- 384 (614)
.+...++||||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 3446799999999999998875421
Q ss_pred ---------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc-ccc
Q 036081 385 ---------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH-LTT 454 (614)
Q Consensus 385 ---------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~ 454 (614)
....++|.++.+++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 0124678888999999999999999 899999999999999999999999999998765332221 122
Q ss_pred cccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcH
Q 036081 455 RVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSR 533 (614)
Q Consensus 455 ~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 533 (614)
...++..|+|||.+.+..++.++||||||+++|||++ |..|+........ ... ....+.... .+.
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~-~~~~~~~~~---------~~~ 305 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCR-RLKEGTRMR---------APD 305 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HHH-HHhccCCCC---------CCC
Confidence 2345678999999999999999999999999999997 8888865332111 111 111111000 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 534 AVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 534 ~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.....+.+++..|++.+|++|||+.|++++|+..
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1223678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.99 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=194.6
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
++||+|+||.||+++.. +++.||||+++... ....+.+..|..++.++ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence 36999999999999976 68899999997532 22345688999999998 7999999999886 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. .+.+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQR---QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence 99999999888754 357999999999999999999999 899999999999999999999999999998753221
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc---hhHHHHHHHHhhCCCchhhhhH
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF---LLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||+...... ....++.......+...
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 223 (329)
T cd05588 150 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----- 223 (329)
T ss_pred C-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-----
Confidence 1 22334679999999999999999999999999999999999999996422111 11112222221111110
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPT------IADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt------m~eVl~~ 563 (614)
.+......+.+++..|++.+|.+||+ +.+++++
T Consensus 224 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 -----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11123346788999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.77 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=203.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.++|...+.||+|+||.||++..+++..+|+|.++... ...+.|.+|++++++++|+|++++.+++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence 35678889999999999999998888889999886532 235678999999999999999999998753 45799
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
+|||+++|+|.+++... ....++|.+++.++.+++.||.||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999999998653 2345789999999999999999999 8899999999999999999999999999997654
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
...........++..|+|||++..+.++.++||||||+++|||++ |+.||....... +..+ ...+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~----~~~~~~~----- 222 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRA----LERGYRM----- 222 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHH----HhCCCCC-----
Confidence 333222233345678999999999999999999999999999999 888986543211 1111 1111100
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.........+.+++.+|++.+|++||++.++.++|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111233467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=338.25 Aligned_cols=256 Identities=19% Similarity=0.233 Sum_probs=196.9
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
....++|+..+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~----- 113 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ----- 113 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----
Confidence 344567999999999999999999976 5889999998642 2223456889999999999999999999886
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
.+...++||||+++|+|.+++.. ..+++.....++.||+.||+||| +.+|+||||||+|||+++++.+||+||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEec
Confidence 45679999999999999998854 35788889999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
|+++..............||+.|+|||.+... .++.++|||||||++|||++|+.||....... .. .....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~----~~i~~ 261 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TY----SKIMD 261 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HH----HHHHh
Confidence 99986543322223356799999999999753 37899999999999999999999997543211 11 11111
Q ss_pred CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 036081 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVA--LRPTIADALKM 563 (614)
Q Consensus 516 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~--~RPtm~eVl~~ 563 (614)
.... +.-.........+..++..|+..++. .|||+.|++++
T Consensus 262 ~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1000 00000112234556677777775554 38999999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.96 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=199.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|+..+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.++.+++|+||+++++++. .+...++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence 46888899999999999999974 68899999987655455567889999999999999999999986 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++++|.+++.. ...+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 84 CMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999999998864 356889999999999999999999 8999999999999999999999999999988653
Q ss_pred CCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
... .......|+..|+|||.+. ...++.++||||||+++|||++|+.|+.......... .+ ......
T Consensus 158 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~-----~~~~~~--- 227 (267)
T cd06646 158 ATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LM-----SKSNFQ--- 227 (267)
T ss_pred ccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-ee-----ecCCCC---
Confidence 221 1122346889999999884 4557889999999999999999999985432211000 00 000000
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.+... ........+.+++..|++.+|++|||+++++++|
T Consensus 228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 0112334678899999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.46 Aligned_cols=237 Identities=24% Similarity=0.342 Sum_probs=186.5
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHH-HHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVE-IISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~-il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||+||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++. .....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 36999999999999976 68999999986422 122344555555 457789999999998886 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. ...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence 99999999988865 356888999999999999999999 899999999999999999999999999998753222
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....... +..
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~-~~~--------- 213 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-----MYDNILN-KPL--------- 213 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-----HHHHHHc-CCC---------
Confidence 222344579999999999999999999999999999999999999997543211 1111111 110
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIA 558 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~ 558 (614)
.........+.+++..|++.+|.+||++.
T Consensus 214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 -RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 01112234678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.87 Aligned_cols=263 Identities=22% Similarity=0.376 Sum_probs=198.5
Q ss_pred CCCccceeeeccCcEEEEEEEEcC---------------CcEEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED---------------GTLVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRG 351 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~---------------g~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g 351 (614)
++|+..+.||+|+||.||+++..+ ...||+|.++.. .....+.|.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467888999999999999987642 235899998653 2233467999999999999999999999
Q ss_pred cccccCCCCCceEEEEEecCCCCCcccccchhhh---------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCC
Q 036081 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALT---------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422 (614)
Q Consensus 352 ~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~---------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIK 422 (614)
++. .....++||||+++++|.+++..... ...++|..++.++.|++.||+||| +.+++|||||
T Consensus 85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlk 156 (295)
T cd05097 85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLA 156 (295)
T ss_pred EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccC
Confidence 987 34568999999999999998854211 124688899999999999999999 8999999999
Q ss_pred CCceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 036081 423 STNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS--GRKVLETS 499 (614)
Q Consensus 423 p~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt--G~~p~~~~ 499 (614)
|+||++++++.+||+|||++........ .......++..|+|||++.++.++.++||||||+++|||++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999876533221 11223345778999999999999999999999999999998 55666543
Q ss_pred CccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 500 NSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 500 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.... .+.... ......... .....+......+.+++..|++.+|++||+|++|++.|+.
T Consensus 237 ~~~~-~~~~~~-~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 237 SDEQ-VIENTG-EFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ChHH-HHHHHH-Hhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 3221 111111 111110000 0000111123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.58 Aligned_cols=247 Identities=27% Similarity=0.440 Sum_probs=196.6
Q ss_pred eeeeccCcEEEEEEEEcC----CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLED----GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+++++++.|+|++++++++. +...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 469999999999998542 26899999875443 24567999999999999999999999874 34579999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++... ..++|..+..++.|++.||+||| ..+++||||||+|||++.++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 999999999998753 36899999999999999999999 889999999999999999999999999999866443
Q ss_pred Ccccc--ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 449 QSHLT--TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 449 ~~~~~--~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
..... ....++..|+|||.+.++.++.++||||||+++|||++ |+.||....... +..+. ......
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~----~~~~~~----- 217 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAML----ESGERL----- 217 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH----HcCCcC-----
Confidence 32221 11224568999999999999999999999999999998 999987543221 11111 111100
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+......+.+++..|++.+|++||++.++++.|++.
T Consensus 218 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 ----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11112334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.77 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=212.7
Q ss_pred ChHHHHHHhCCCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccC
Q 036081 279 RESELDQATGGFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357 (614)
Q Consensus 279 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~ 357 (614)
+.+|+++ .+....++||-|-||.||.|+|+. .-.||||.++... -..++|+.|..+|+.++|||+|+|+|+|.
T Consensus 260 DkWEmeR--tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT--- 333 (1157)
T KOG4278|consen 260 DKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 333 (1157)
T ss_pred chhhccc--hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhc---
Confidence 3444443 344557899999999999999984 6679999998644 34678999999999999999999999998
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEe
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVA 437 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~ 437 (614)
.+...|||.|||.+|+|.++|+.- ++..++--..+.++.||+.|+.||. .+++|||||.++|+|+.++..+||+
T Consensus 334 --~EpPFYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 334 --HEPPFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred --cCCCeEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEee
Confidence 456789999999999999999864 4556777778899999999999999 9999999999999999999999999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhC
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
||||++....+.........-.+.|.|||-+.+..++.|+|||+|||+||||.| |..|+...+ +.
T Consensus 408 DFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lS--------- 473 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LS--------- 473 (1157)
T ss_pred ccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HH---------
Confidence 999999876544322222334678999999999999999999999999999998 778876532 21
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.+.++++.-.+-..++.++..+.+++..||+.+|.+||++.|+-+.+|.
T Consensus 474 -qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 474 -QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred -HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 1223344444444566677789999999999999999999988766554
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.80 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=202.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~ 358 (614)
.++|...+.||+|+||.||+++.. ++..+|||.++.... ...+.+.+|+++++++ +|+||+++++++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---- 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT---- 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe----
Confidence 356888999999999999999742 345799999875432 3346789999999999 7999999999986
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
..+..++||||+++|+|.+++.... ...+++.++..++.+++.||+||| +.+|+|+||||+|||++.++.+||+|
T Consensus 110 -~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 110 -IGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred -cCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECC
Confidence 3456899999999999999986522 234899999999999999999999 89999999999999999999999999
Q ss_pred ecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhC
Q 036081 439 FGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 439 FGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.||......... ... ...
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~-~~~----~~~ 259 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF-YKL----IKE 259 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH-HHH----HHc
Confidence 9999865433221 1222345778999999999999999999999999999998 99998654322111 011 111
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
+. ....+....+.+.+++..|++.+|++|||+.|+++.|+.
T Consensus 260 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 260 GY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 10 000111223578889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=320.74 Aligned_cols=267 Identities=25% Similarity=0.400 Sum_probs=203.9
Q ss_pred CCccceeeeccCcEEEEEEEEc-----CCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-----DGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.|...+.||+|+||.||++++. ++..+|||.++..... ..+.|.+|++++++++|+||+++++++... .+.
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~~ 81 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GGR 81 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CCC
Confidence 4566789999999999999864 3689999999764443 467899999999999999999999988632 245
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++... ...++|..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 689999999999999998653 335999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 443 KQSLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 443 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
......... ......++..|+|||......++.++||||||+++|||++|+.|+......... +... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~-~~~~~~~ 232 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGI-AQGQMIV 232 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---cccc-ccccccH
Confidence 876432221 112234566799999999889999999999999999999999987643222100 0000 0000011
Q ss_pred hhhhHHhh----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 521 EIFDEFIR----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 521 ~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+...+. ...+......+.+++.+|++.+|++||||.||+++|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111 111122335788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.30 Aligned_cols=239 Identities=24% Similarity=0.324 Sum_probs=186.9
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHH-HHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEI-ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~i-l~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+++.. +|+.+|+|++... .......+..|..+ ++.++||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 36999999999999875 6899999998643 22233455666654 66789999999998886 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|..++.. ...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence 99999999888764 356899999999999999999999 899999999999999999999999999998753221
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
........||+.|+|||++.++.++.++|||||||++|||++|+.||....... ....... +.. .
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~~~~-~~~------~-- 214 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----MYDNILH-KPL------V-- 214 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----HHHHHHc-CCc------c--
Confidence 122344679999999999999999999999999999999999999997543211 1111111 110 0
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIADA 560 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eV 560 (614)
........+.+++..|++.+|.+||++.+.
T Consensus 215 --~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 215 --LRPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred --CCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 011123466788999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.07 Aligned_cols=256 Identities=22% Similarity=0.397 Sum_probs=202.0
Q ss_pred CCCccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
++|...+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.++..++|+||+++++++. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~ 80 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----T 80 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----C
Confidence 467788999999999999998652 36899999865432 33457889999999999999999999987 3
Q ss_pred CceEEEEEecCCCCCcccccchhhh-------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALT-------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK 433 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 433 (614)
+...++||||+++|+|.+++..... ...++|..++.++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCC
Confidence 4668999999999999999865321 224788899999999999999999 899999999999999999999
Q ss_pred EEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHH
Q 036081 434 AKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 434 ~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~ 511 (614)
+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||....... ...+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~-- 233 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKF-- 233 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHH--
Confidence 99999999876543221 12233456789999999998999999999999999999998 888886543221 1111
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+.... .+......+.+++..|++.+|++|||+.++++.|+.
T Consensus 234 --~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 --VIDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --HhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111111 111123577889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.94 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=198.8
Q ss_pred CCccceeeeccCcEEEEEEEEcC-C---cEEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED-G---TLVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~-g---~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+|...+.||+|+||.||+|.+.. | ..||||.++.. .....++|..|+.++++++||||+++.+++. .+..
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCCc
Confidence 46678899999999999999753 3 36999998654 2333568999999999999999999999886 4456
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... .+.+++.+++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 80 VMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred eEEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccc
Confidence 89999999999999988653 356899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccc--ccccc--CCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 444 QSLEGQSHL--TTRVA--GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 444 ~~~~~~~~~--~~~~~--gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
......... ..... .+..|+|||++.++.++.++||||||+++|||++ |+.||....... ...+.. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~---~~~~ 229 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIE---QDYR 229 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHH---cCCc
Confidence 654322211 11111 2457999999999999999999999999999887 999986543211 111110 0000
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ..+.+.+..+.+++..|++.+|++||++.+++.+|+..
T Consensus 230 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 L----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01122334677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.76 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=194.5
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCce
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+|...+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++..+ +|++|+++.+++. ..+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence 4778899999999999999876 57899999987532 22234567788888887 5889999998886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence 8999999999999988864 356899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... .......||+.|+|||++.++.++.++|||||||++|||++|+.||........ ..... ....
T Consensus 150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-----~~~i~-~~~~---- 218 (323)
T cd05616 150 ENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIM-EHNV---- 218 (323)
T ss_pred ecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-----HHHHH-hCCC----
Confidence 543221 223346799999999999999999999999999999999999999976443211 11111 1110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTI-----ADALK 562 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm-----~eVl~ 562 (614)
..+......+.+++..|++.+|++|++. .++.+
T Consensus 219 ------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 219 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 0112233567889999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.39 Aligned_cols=266 Identities=23% Similarity=0.296 Sum_probs=198.1
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHc---cCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKI---RHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l---~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+|+..+.||+|+||.||+++.. +|+.||+|.++.... .....+.+|++++.++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999876 689999999865322 2234566788887766 699999999998755444556
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||++ ++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 7899999997 5888877643 2345899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh-
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE- 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~- 521 (614)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ +...... .......+
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~-~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDL-IGLPPEDDW 231 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHH-hCCCChhhC
Confidence 7653221 22345689999999999999999999999999999999999999965443221 1111100 00000000
Q ss_pred ---------hhhHHh---hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 ---------IFDEFI---REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ---------~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+.. ......+..+.+.+++..|++.||++|||+.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 000111234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=323.87 Aligned_cols=242 Identities=25% Similarity=0.370 Sum_probs=193.8
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+++.. +++.||||+++.. .....+.+..|++++..+ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999976 5789999999753 223345678899999888 6999999999886 456799999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.+ ...+++.++..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence 99999999888765 346999999999999999999999 899999999999999999999999999998753222
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .....
T Consensus 150 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-----~~~~i-~~~~~--------- 213 (318)
T cd05570 150 G-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-----LFQSI-LEDEV--------- 213 (318)
T ss_pred C-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-----HHHHH-HcCCC---------
Confidence 2 12234568999999999999999999999999999999999999997543221 11111 11110
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTI-----ADALKM 563 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm-----~eVl~~ 563 (614)
..+......+.+++..|++.+|.+||++ .+++++
T Consensus 214 -~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 -RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0111233467889999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.82 Aligned_cols=248 Identities=30% Similarity=0.407 Sum_probs=198.1
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+|...+.||+|+||.||++... |..+|+|.++.. ...+.|.+|+.++++++|+|++++++++.. .+...++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~ 79 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT 79 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence 5777889999999999999876 788999998643 234579999999999999999999998653 334689999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++... ....++|..+++++.+++.||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999998653 2235889999999999999999999 899999999999999999999999999998754322
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... +..... ..+...
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-----~~~~~~-~~~~~~------- 218 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRV-EKGYKM------- 218 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH-hcCCCC-------
Confidence 1 22345678999999999999999999999999999998 99888643211 111111 111000
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.........+.+++..|++.+|++|||+.+++++|+.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 --DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0111233467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.59 Aligned_cols=264 Identities=22% Similarity=0.365 Sum_probs=202.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEcC-----------------CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCccc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLED-----------------GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLS 348 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~ 348 (614)
.++|+..+.||+|+||.||+++..+ +..||+|.+..... ...+.+.+|++++.+++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3567888999999999999998653 24689999875432 34567899999999999999999
Q ss_pred ccccccccCCCCCceEEEEEecCCCCCcccccchhh--------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecC
Q 036081 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL--------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRD 420 (614)
Q Consensus 349 l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~--------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrD 420 (614)
+++++. .+...+++|||+++++|.+++.+.. ....+++..++.++.|++.||+||| +.+|+|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence 999987 3457899999999999999986532 1126889999999999999999999 89999999
Q ss_pred CCCCceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 036081 421 IKSTNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS--GRKVLE 497 (614)
Q Consensus 421 IKp~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt--G~~p~~ 497 (614)
|||+||+++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ |..|+.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999876533321 22334456789999999998899999999999999999998 667775
Q ss_pred CCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 498 TSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 498 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...... ...........+....... .+......+.+++..|++.+|++|||+.|+++.|+.
T Consensus 236 ~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 236 HLTDQQ--VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CcChHH--HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 433211 1111111111111111000 111223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=304.77 Aligned_cols=269 Identities=25% Similarity=0.290 Sum_probs=214.6
Q ss_pred HHhCCCccceeeeccCcEEEEEEE-EcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
...++|++.+.||+|||..||.++ ..++..+|+|++.-.+.+..+..++|++..++++|||++++++++.........+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345679999999999999999998 5578999999998777777888999999999999999999999998665545678
Q ss_pred EEEEEecCCCCCcccccchhhh-ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALT-RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~-~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
.||+++|...|+|.+.+....- ...+++.+.+.|+.+|.+||++||. ..++++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 9999999999999999876543 3468999999999999999999993 2456999999999999999999999999998
Q ss_pred ccccCCCc---c-----ccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Q 036081 443 KQSLEGQS---H-----LTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 443 ~~~~~~~~---~-----~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~ 511 (614)
......-. . .-.....|..|.|||.+. +...++++|||||||+||+|+.|..||+.....+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-------- 248 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-------- 248 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--------
Confidence 76432111 0 011235689999999986 5567899999999999999999999997543221
Q ss_pred HHhhCCCchh-hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 512 MLANSGKVDE-IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 512 ~~~~~~~~~~-~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
+.+.- +....+.........+.+.+++.+|++.||..||++.+++..++..
T Consensus 249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111 1111111111122567889999999999999999999999998753
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.22 Aligned_cols=260 Identities=24% Similarity=0.436 Sum_probs=201.4
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
..++|+..+.||+|+||.||+|..++ +..||+|.+..... .....+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS---- 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 45678889999999999999997542 45899998864332 23456889999999999999999999876
Q ss_pred CCCceEEEEEecCCCCCcccccchhhh-------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALT-------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 431 (614)
.....++||||+++|+|.+++..... ...+++....+++.|++.||.||| +++|+||||||+|||++++
T Consensus 80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCC
Confidence 34468999999999999999965321 233566778899999999999999 8999999999999999999
Q ss_pred CcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHH
Q 036081 432 MKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDW 509 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~ 509 (614)
+.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||...... ++
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~ 230 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QV 230 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HH
Confidence 9999999999875433221 11222345678999999999999999999999999999999 77888653321 11
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.......+... .+......+.+++..|++.+|++|||+.++++.|++..
T Consensus 231 ~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 LKFVMDGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111111100 11122357889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.88 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=200.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-C---CcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-D---GTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~---g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|...+.||+|+||.||+|++. + +..+|+|.++... ....+.|.+|+.++.+++||||+++++++. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence 45777899999999999999864 2 3479999986532 233567899999999999999999999986 345
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 689999999999999998653 346899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccc--ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 443 KQSLEGQSHLT--TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 443 ~~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
+.......... ....++..|+|||++.++.++.++||||||+++||+++ |+.||....... ..... ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~----~~~~- 226 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAI----EEGY- 226 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHH----hCCC-
Confidence 86544332221 12233568999999999999999999999999999887 999986543221 10111 1110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
........+..+.+++..|++.+|++||+|.++++.|+.
T Consensus 227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 227 --------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 000111233467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=320.91 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=190.2
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 36999999999999976 47899999987531 22345567788888765 8999999999987 345789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. ...+++.+...++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ey~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence 99999999998864 356889999999999999999999 899999999999999999999999999998753222
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .... ..
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~i-~~~~------~~-- 214 (316)
T cd05619 150 D-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-----LFQSI-RMDN------PC-- 214 (316)
T ss_pred C-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HhCC------CC--
Confidence 2 12334578999999999999999999999999999999999999997543221 11110 1000 00
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIA-DALK 562 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~-eVl~ 562 (614)
.+......+.+++..|++.+|++||++. ++.+
T Consensus 215 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 --YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1111234567889999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=321.94 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=200.8
Q ss_pred CCccceeeeccCcEEEEEEEE-----cCCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTL-----EDGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.|...+.||+|+||.||++++ .++..||+|.++... ....+.+.+|++++++++|+|++++.+++... .+.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 467788999999999999984 247889999987543 33346799999999999999999999988642 235
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++... ...++|..+..++.+++.||+||| +.+++||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence 689999999999999998652 346899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc----------hhHHHHH
Q 036081 443 KQSLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF----------LLITDWA 510 (614)
Q Consensus 443 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~----------~~l~~~~ 510 (614)
+........ ......++..|+|||++.++.++.++||||||+++|||++++.|........ .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 865432221 1223456778999999998899999999999999999999887653221100 0000000
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
. ....+. ...........+.+++..|++.+|++|||+.++++.|+.
T Consensus 237 ~-~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 237 R-VLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred H-HHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 0 000110 001112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.61 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=198.2
Q ss_pred eeeeccCcEEEEEEEEcC--C--cEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLED--G--TLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~--g--~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++|+||+++++++.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 368999999999998753 3 3699999977555 456789999999999999999999998862 5789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.+... ..++|...+.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccc
Confidence 99999999999876422 46899999999999999999999 899999999999999999999999999999876442
Q ss_pred Ccc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 449 QSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 449 ~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+....... ............
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~----- 220 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-----ILKKIDKEGERL----- 220 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhcCCcC-----
Confidence 221 1223457789999999999999999999999999999999 999986543221 111111111000
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
..+...+..+.+++..|++.+|++||++.++++.|.
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123346888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.54 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=178.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.+|+..+.||.|+||.|.+.+.+ +|..+|+|++.+... +..+...+|..+|+.+.||.++++.+.+. +...
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-----d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-----DNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-----cCCe
Confidence 45778899999999999999976 689999999976332 33456789999999999999999999887 5678
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.+|||||+++|-|..+|++ .+.++++..+.+|.+|+.||+||| ...|++|||||+|||||.+|.+||.|||.|+
T Consensus 119 lymvmeyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred EEEEEeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence 9999999999999999986 467999999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~ 501 (614)
..... +-..+||+.|+|||.++...+...+|.|+|||++|||+.|..||...+.
T Consensus 193 ~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 193 RVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred EecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 76432 4567999999999999999999999999999999999999999977654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=322.95 Aligned_cols=255 Identities=21% Similarity=0.269 Sum_probs=193.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++. .+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 46888999999999999999976 5899999998642 2223456889999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.+. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence 99999999999999998652 346888999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
..............||+.|+|||++.. +.++.++|||||||++|||++|+.||....... ..........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-----~~~~i~~~~~ 225 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKE 225 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-----HHHHHHcCCC
Confidence 654433333334569999999999873 467889999999999999999999997543211 1111111111
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGIL--CAHVMVALRPTIADALKM 563 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPtm~eVl~~ 563 (614)
... +... .....+.+..++.. |...++..||++.+++++
T Consensus 226 ~~~-~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 HFQ-FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccc-CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 0000 00122344455555 445555568999999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=323.39 Aligned_cols=248 Identities=21% Similarity=0.319 Sum_probs=193.5
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+++.. +++.+|+|+++... ....+.+.+|+.++.++ +|+||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence 46999999999999976 57899999997532 22345688999999998 6999999999886 456799999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. .+.+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQR---QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence 99999999888754 356999999999999999999999 899999999999999999999999999998753221
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc-hhHHHHHHHHhhCCCchhhhhHHh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF-LLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....++..........
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 220 (327)
T cd05617 150 G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-------- 220 (327)
T ss_pred C-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--------
Confidence 1 22334679999999999999999999999999999999999999996432211 1111222222111110
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPT------IADALKM 563 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt------m~eVl~~ 563 (614)
..+......+.+++..|++.||.+||+ +.+++++
T Consensus 221 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 --RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 011122346778999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=335.24 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=192.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||.||+++.. +|+.||||.+.... ......+.+|++++.+++|+||+++++.+. +++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCE
Confidence 36888999999999999999975 58999999986422 223456889999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. .+.+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 9999999999999999865 346788888899999999999999 8999999999999999999999999999975
Q ss_pred cccCC------------------------------------------CccccccccCCCCccchhhhccCCCCchhhHHH
Q 036081 444 QSLEG------------------------------------------QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYS 481 (614)
Q Consensus 444 ~~~~~------------------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS 481 (614)
..... .........||+.|+|||++.+..++.++||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 229 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence 32100 000012347999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC---CHH
Q 036081 482 FGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRP---TIA 558 (614)
Q Consensus 482 fGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---tm~ 558 (614)
|||++|||++|+.||..............| . .... + .........+.+++..|+ .+|.+|+ |+.
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~---~-~~~~--~------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINW---E-TTLH--I------PSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhcc---C-cccc--C------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 999999999999999765432211100000 0 0000 0 000011223444555554 4999999 889
Q ss_pred HHHHH
Q 036081 559 DALKM 563 (614)
Q Consensus 559 eVl~~ 563 (614)
|++++
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 98876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.05 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=201.1
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCc-chHHHHHHHHHHHHcc-CCCcccccccccccC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTK-GDEEFINEVEIISKIR-HRNLLSLRGCCVSSD 357 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~ 357 (614)
..++|...++||+|+||.||+|++. .++.||||+++..... ..+.+.+|++++.++. ||||++++|+|..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 3445777889999999999999864 2468999999754322 2357889999999997 9999999999873
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhh----------------------------------------------------
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALT---------------------------------------------------- 385 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------- 385 (614)
....++||||+++|+|.++++....
T Consensus 113 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 113 ---GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ---CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 4568999999999999998864211
Q ss_pred -------------------------------------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCC
Q 036081 386 -------------------------------------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422 (614)
Q Consensus 386 -------------------------------------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIK 422 (614)
...++|...++|+.||+.||+||| +.+|+|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCC
Confidence 123667778899999999999999 8999999999
Q ss_pred CCceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 036081 423 STNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSN 500 (614)
Q Consensus 423 p~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~ 500 (614)
|+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999986433222 11223457889999999999999999999999999999998 888986543
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.... .......+. ....+......+.+++..|++.+|+.||+++|+++.|+..
T Consensus 347 ~~~~-----~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 347 MNEQ-----FYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred chHH-----HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2211 111111110 0001112335778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.08 Aligned_cols=250 Identities=27% Similarity=0.408 Sum_probs=202.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.+|...+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|+.+++.++|+|++++++++. .+...++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence 46788899999999999999864 68999999997655555678999999999999999999999887 3567999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++++|.+++.+ ..+++.++..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 95 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred eecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 9999999999998853 45889999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.... ......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... . ....+.. .
T Consensus 168 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~----~-~~~~~~~-~----- 235 (296)
T cd06654 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY----L-IATNGTP-E----- 235 (296)
T ss_pred cccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH----H-HhcCCCC-C-----
Confidence 3221 1223468899999999998889999999999999999999999997544221111 0 1111110 0
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+ ..+......+.+++.+|++.+|++|||+.+++++
T Consensus 236 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred C--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 0122334567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.50 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=191.9
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 296 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
||+|+||.||+++.+ +|+.+|+|++.... ......+..|++++.+++||||+++.+++. .+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence 699999999999876 58999999986422 122345667999999999999999998886 456789999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 451 (614)
++|+|.+++... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~g~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 149 (277)
T cd05607 76 NGGDLKYHIYNV-GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-- 149 (277)
T ss_pred CCCCHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--
Confidence 999999887543 2345889999999999999999999 8999999999999999999999999999987654322
Q ss_pred ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhC
Q 036081 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531 (614)
Q Consensus 452 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 531 (614)
......|+..|+|||++.++.++.++|||||||++|||++|+.||........ .......... +... ..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~---------~~ 218 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLE-DEVK---------FE 218 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhc-cccc---------cc
Confidence 22345689999999999999999999999999999999999999965432111 1111111111 0000 00
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 532 SRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.......+.+++..|++.+|++||++.|+++.+
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 112334678899999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=310.55 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=201.5
Q ss_pred eeeeccCcEEEEEEEEcC----CcEEEEEEeecCCCcc-hHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLED----GTLVAVKQITDLDTKG-DEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~~~-~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||++...+ +..+++|.++...... .+.+.+|++++.+++|+|++++++++.. +...++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 469999999999999764 7889999987644333 6789999999999999999999999873 56789999
Q ss_pred ecCCCCCcccccchhhh------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 369 DFMPSGSLGDHISNALT------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
||+++++|.+++..... ...+++.++..++.+++.||+||| +.+++||||||+||+++.++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 99999999999876321 367899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 443 KQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 443 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||....... ..... ..+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~-~~~~~- 225 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----VLEYL-RKGYR- 225 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHH-HcCCC-
Confidence 87644321 22334567889999999998899999999999999999999 689987653211 11111 11110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
...+......+.+++..|++.+|++|||+.|++++|+
T Consensus 226 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 --------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0112223457888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.52 Aligned_cols=250 Identities=30% Similarity=0.445 Sum_probs=191.9
Q ss_pred eeeeccCcEEEEEEEEc----CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE----DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+|++. ++..+|+|++.... ....+.+.+|+.+++.++|||++++++++... +...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 46899999999999864 24579999985432 23356788999999999999999999987632 33578999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.+. ...+.+..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 999999999998653 334677888999999999999999 899999999999999999999999999998754332
Q ss_pred Cc---cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 449 QS---HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR-KVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 449 ~~---~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
.. .......++..|+|||++....++.++||||||+++|||++|+ .|+..... ..+.... ......
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~---~~~~~~----- 221 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYL---LQGRRL----- 221 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---hcCCCC-----
Confidence 11 1112345677899999999899999999999999999999965 55543321 1111111 111100
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+...+..+.+++..|++.+|++||++.|++++|+..
T Consensus 222 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00112234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=311.27 Aligned_cols=248 Identities=28% Similarity=0.450 Sum_probs=197.2
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCC
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMP 372 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~ 372 (614)
++||+|+||.||++...+++.||+|.++..... ..+.+.+|++++++++|+||+++++++. .....++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcCC
Confidence 369999999999999877999999998764433 4568999999999999999999999887 4456899999999
Q ss_pred CCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCccc
Q 036081 373 SGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL 452 (614)
Q Consensus 373 ~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 452 (614)
+++|.+++... ...+++...+.++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++.........
T Consensus 76 ~~~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 76 GGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence 99999998653 345788899999999999999999 8999999999999999999999999999987653222111
Q ss_pred c-ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhh
Q 036081 453 T-TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREE 530 (614)
Q Consensus 453 ~-~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 530 (614)
. ....++..|+|||.+.++.++.++||||||+++|||++ |..||....... .... ...+. ...
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~----~~~~~---------~~~ 215 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRER----IESGY---------RMP 215 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHH----HhcCC---------CCC
Confidence 1 12234667999999998999999999999999999999 788886543211 1111 11100 001
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 531 GSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 531 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.+......+.+++..|++.+|++|||+.|+++.|+.
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 112234578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.66 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=201.2
Q ss_pred CCCccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|...+.||+|+||.||+|++.+ ...||||...... .+..+.+.+|+.++++++|+||+++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 346778899999999999998653 2468999886544 3445689999999999999999999998852 3
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++... ...++|..++.++.+++.||+||| +.+++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCcee
Confidence 468999999999999998652 345899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+..........+...++..|+|||.+....++.++||||||+++|||++ |+.||........ .... ..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-----~~~~-~~~~~~- 227 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-----IGRI-ENGERL- 227 (270)
T ss_pred eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHH-HcCCcC-
Confidence 8654433222333345678999999988899999999999999999996 9999965432211 1111 111100
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+......+.+++..|+..+|++|||+.+++++|++.
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01112334778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=335.98 Aligned_cols=201 Identities=24% Similarity=0.347 Sum_probs=170.7
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.|+..++||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++|+||+++++.+. ++...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 5788899999999999999875 68899999986532 223456889999999999999999999987 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++.+ ...+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 999999999999998865 346788888999999999999999 89999999999999999999999999999753
Q ss_pred ccCCC----------------------------------------------ccccccccCCCCccchhhhccCCCCchhh
Q 036081 445 SLEGQ----------------------------------------------SHLTTRVAGTYGYLAPEYALYGQLTEKSD 478 (614)
Q Consensus 445 ~~~~~----------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksD 478 (614)
..... ........||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 21000 00112347999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCC
Q 036081 479 VYSFGIVILELMSGRKVLETSN 500 (614)
Q Consensus 479 VwSfGvvL~ELltG~~p~~~~~ 500 (614)
||||||+||||++|+.||....
T Consensus 231 iwSlGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred EEechHHHHHHHhCCCCCCCCC
Confidence 9999999999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.85 Aligned_cols=258 Identities=23% Similarity=0.385 Sum_probs=201.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc--------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCccccccccccc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE--------DGTLVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSS 356 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~ 356 (614)
.++|...+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+.++..+ +|+||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence 345777899999999999999741 24579999986532 23356789999999999 8999999999986
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCC
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKS 423 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp 423 (614)
.....++||||+++|+|.+++.... ....++|.+++.++.||+.||.||| +.+|+||||||
T Consensus 92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp 165 (304)
T cd05101 92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAA 165 (304)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence 3456899999999999999986531 1235788889999999999999999 89999999999
Q ss_pred CceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 036081 424 TNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNS 501 (614)
Q Consensus 424 ~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~ 501 (614)
+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999865433222 1223346778999999999899999999999999999998 7788754332
Q ss_pred cchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 502 SFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 502 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ++.... ..+... ..+......+.+++..|++.+|++|||+.|+++.|+..
T Consensus 246 ~-----~~~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 246 E-----ELFKLL-KEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred H-----HHHHHH-HcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1 111111 111100 01112345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.70 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=200.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc--------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCcccccccccccC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE--------DGTLVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSD 357 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~ 357 (614)
++|...+.||+|+||.||+++.. ++..+|+|.++... .....++.+|++++.++ +|+||+++++++.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--- 94 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--- 94 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence 56888899999999999999753 23579999987532 23345788999999999 7999999999986
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhh-------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALT-------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~ 424 (614)
.....++||||+++|+|.+++..... ...++|.++++++.|++.||+||| +.+++||||||+
T Consensus 95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~ 169 (307)
T cd05098 95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 169 (307)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHH
Confidence 34568999999999999999865321 135889999999999999999999 899999999999
Q ss_pred ceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 036081 425 NILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSS 502 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~ 502 (614)
||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.|+......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999999999999999998765332211 1122234568999999999999999999999999999998 88888643321
Q ss_pred chhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 503 FLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 503 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
+..... ..+.. ...+......+.+++..|++.+|++||||.+|++.|+..
T Consensus 250 -----~~~~~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 250 -----ELFKLL-KEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -----HHHHHH-HcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 11110 011122335777899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.18 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=201.9
Q ss_pred CCCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|+..+.||+|+||.||+|+..+ ++.+++|.++.... .+++.+|++++++++|+|++++++++. .....++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEE
Confidence 568888999999999999999875 88999999865432 678999999999999999999999987 3467899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
++||+++++|.+++... ...++|..+..++.|++.||.||| +.+++||||+|+||+++.++.+||+|||++....
T Consensus 76 ~~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 76 VMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 99999999999998642 456899999999999999999999 8899999999999999999999999999988654
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.... ......++..|+|||++.+..++.++||||||+++|||++|+.|+........... ...... . .
T Consensus 151 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~-~----~ 218 (256)
T cd06612 151 DTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPNKPP-P----T 218 (256)
T ss_pred cCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hccCCC-C----C
Confidence 3221 22334588999999999999999999999999999999999999975432211100 000000 0 0
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+ ..+......+.+++..|++.+|++|||+.||+++
T Consensus 219 ~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 L--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred C--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0 0112233567889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.97 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=197.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCc--EEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGT--LVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~--~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|+..+.||+|+||.||+|.++ +|. .+|+|.++... ....+.+.+|++++.++ +|+||+++++++. .+.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CCC
Confidence 46778899999999999999975 454 46888776432 23456788999999999 8999999999986 345
Q ss_pred eEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
..++||||+++|+|.+++.... ....+++.+++.++.|++.||+||| +.+++||||||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEec
Confidence 6899999999999999986532 1235788899999999999999999 89999999999999999
Q ss_pred CCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITD 508 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~ 508 (614)
.++.+||+|||+++..... .......++..|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----- 231 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 231 (303)
T ss_pred CCCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----
Confidence 9999999999998642111 11112234668999999988889999999999999999998 999986543221
Q ss_pred HHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 509 WAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 509 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..... ..+. ....+......+.+++..|++.+|++||++.+++++|+..
T Consensus 232 ~~~~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 232 LYEKL-PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHHH-hcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 1110 0001111234678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.23 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=203.8
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.|+..+.||+|.||.||||... .++.||+|++.-.. ....++.++|+.++.+++++||.+++|.+. .+..+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-----~g~~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-----KGTKLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-----ecccHHH
Confidence 3666688999999999999965 58999999996533 334578899999999999999999999998 5778999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
+|||+.+|++.+.|.. ...+.+....-|..++..||.||| ..+.+|||||+.|||+..+|.+||+|||++-+..
T Consensus 89 iMey~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeee
Confidence 9999999999999875 344588888899999999999999 8999999999999999999999999999998776
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
...... ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+...+. ..... .-+.
T Consensus 163 ~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------lIpk~----~PP~ 230 (467)
T KOG0201|consen 163 NTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------LIPKS----APPR 230 (467)
T ss_pred chhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------eccCC----CCCc
Confidence 544433 56789999999999998899999999999999999999999997654422110 00011 1112
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.+ .....+.+++..|++.+|+.||++.+++++
T Consensus 231 L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 222 223357778889999999999999999775
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.59 Aligned_cols=251 Identities=20% Similarity=0.262 Sum_probs=193.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++.+++||||+++++++. +...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 46888899999999999999865 68999999986421 223456889999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. .+.+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999999999998865 356888889999999999999999 8999999999999999999999999999986
Q ss_pred cccCCCc------------c----------------------------------ccccccCCCCccchhhhccCCCCchh
Q 036081 444 QSLEGQS------------H----------------------------------LTTRVAGTYGYLAPEYALYGQLTEKS 477 (614)
Q Consensus 444 ~~~~~~~------------~----------------------------------~~~~~~gt~~Y~APE~~~~~~~s~ks 477 (614)
....... . ......||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 3211000 0 00124699999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh-CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCC---
Q 036081 478 DVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN-SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL--- 553 (614)
Q Consensus 478 DVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--- 553 (614)
|||||||++|||++|+.||......... ..... ...+. +.. .......+.+++..|++ +|.+
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~-----~~i~~~~~~~~------~p~--~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETY-----RKIINWRETLY------FPD--DIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHH-----HHHHccCCccC------CCC--CCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 9999999999999999999764432111 01100 00000 000 00122355667777886 5655
Q ss_pred CCCHHHHHHH
Q 036081 554 RPTIADALKM 563 (614)
Q Consensus 554 RPtm~eVl~~ 563 (614)
||++.|++++
T Consensus 296 r~~~~~~l~h 305 (377)
T cd05629 296 RGGAHEIKSH 305 (377)
T ss_pred CCCHHHHhcC
Confidence 5699998886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=335.86 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=208.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+-|...+.||.|+-|.|-.|++. +|+.+|||.+.+.. ........+||-+|+-+.|||+++|++++. +..+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe-----~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE-----NKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-----cCce
Confidence 45778889999999999999975 79999999997642 122345778999999999999999999987 5678
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
+|||.||+++|-|.++|.. ++.|.+.+..+++.||..|+.|+| ..+|+||||||+|+|||.++++||+|||+|.
T Consensus 87 lylvlEyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred EEEEEEecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceee
Confidence 9999999999999999876 578999999999999999999999 9999999999999999999999999999997
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
.-.+ .......+|.+.|.|||++++..|. .++||||.|||||.|+||+.||++++-...++ .+..|.++
T Consensus 161 Le~~--gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLl------KV~~G~f~-- 230 (786)
T KOG0588|consen 161 LEVP--GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLL------KVQRGVFE-- 230 (786)
T ss_pred cccC--CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHH------HHHcCccc--
Confidence 5333 2334456899999999999999885 68999999999999999999998544221111 12223222
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGDID 569 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~~~~ 569 (614)
.+..+..+..+++..|+.+||++|-|+.||+++ |.+...
T Consensus 231 --------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 231 --------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred --------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 123445577889999999999999999999997 444433
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=337.52 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=195.3
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccC---CCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD---DEKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~---~~~~ 361 (614)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+|+.++++++|+||+++++++.... ....
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999975 58899999885422 23457999999999999999998865321 1123
Q ss_pred ceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeee
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADF 439 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DF 439 (614)
...++||||+++ +|.+++.... ....+++...+.++.||+.||+||| +.+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 357799999984 6766664322 3456889999999999999999999 89999999999999999665 6999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +....... ....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~-~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQVL-GTPT 291 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh-CCCC
Confidence 99986543322 2335689999999998754 689999999999999999999999976543221 11111100 0000
Q ss_pred c---------------hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 519 V---------------DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 519 ~---------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. .......+....+......+.+++..|++.+|.+|||+.|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 00000011111111223568899999999999999999999865
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.97 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=201.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
.++|+..+.||+|+||.||++... ++..+|+|.+.... .+...+|.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 456888899999999999999864 46789999986533 233567999999999999999999999887
Q ss_pred CCceEEEEEecCCCCCcccccchhh-------------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecC
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNAL-------------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRD 420 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~-------------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrD 420 (614)
.+...++||||+++|+|.+++.... ....+++.+++.++.|++.||.||| +.+++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence 3456899999999999999986421 1134778888999999999999999 89999999
Q ss_pred CCCCceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 036081 421 IKSTNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLET 498 (614)
Q Consensus 421 IKp~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~ 498 (614)
|||+||++++++.+||+|||+++....... ........+..|+|||.+.++.++.++|||||||++|||++ |..||..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875433221 11222345678999999999999999999999999999998 8888854
Q ss_pred CCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 499 SNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 499 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.... ++... ...+.... .+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 236 ~~~~-----~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 236 MAHE-----EVIYY-VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCHH-----HHHHH-HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 3321 11111 11121110 111233578889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.14 Aligned_cols=269 Identities=25% Similarity=0.350 Sum_probs=208.5
Q ss_pred cChHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccc
Q 036081 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVS 355 (614)
Q Consensus 278 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~ 355 (614)
+..+.+..+.++|+..+.||+|+||.||+++.. +++.+|+|.+.... ...+++.+|+.++.++ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334666778899999999999999999999875 58899999876432 2346788999999999 69999999999875
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcE
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA 434 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 434 (614)
.....+...++||||+++++|.+++.... ....+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence 54445678999999999999998876432 2346888889999999999999999 8999999999999999999999
Q ss_pred EEeeecccccccCCCccccccccCCCCccchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Q 036081 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW 509 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~ 509 (614)
||+|||+++...... .......|++.|+|||++.. ..++.++|||||||++|||++|+.|+........ +..+
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~ 241 (286)
T cd06638 164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKI 241 (286)
T ss_pred EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhc
Confidence 999999987653322 12233468999999999853 4578899999999999999999999875432111 1000
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.........+ +......+.+++..|++.+|++|||+.|++++.
T Consensus 242 -----~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 -----PRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -----cccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000000000 111224678899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.13 Aligned_cols=258 Identities=25% Similarity=0.346 Sum_probs=203.9
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--------------cchHHHHHHHHHHHHccCCC
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--------------KGDEEFINEVEIISKIRHRN 345 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--------------~~~~~f~~Ei~il~~l~H~N 345 (614)
.+-.+..+.|+..+.||+|.||.|-++... +++.||||++.+... ...+...+||.+|++++|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 333445677899999999999999999865 799999999854211 11257889999999999999
Q ss_pred cccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCc
Q 036081 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTN 425 (614)
Q Consensus 346 Iv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~N 425 (614)
||+|+.+..+. .....|||+|||..|.+.+.=.+ ...|+..+.++++.++..||+||| .++||||||||+|
T Consensus 170 VV~LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsN 240 (576)
T KOG0585|consen 170 VVKLIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSN 240 (576)
T ss_pred eeEEEEeecCc---ccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhh
Confidence 99999987543 45679999999998887654322 233999999999999999999999 8999999999999
Q ss_pred eeecCCCcEEEeeecccccccCC----CccccccccCCCCccchhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCC
Q 036081 426 ILLDSEMKAKVADFGLAKQSLEG----QSHLTTRVAGTYGYLAPEYALYGQ----LTEKSDVYSFGIVILELMSGRKVLE 497 (614)
Q Consensus 426 ILLd~~~~~KL~DFGla~~~~~~----~~~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwSfGvvL~ELltG~~p~~ 497 (614)
+||+++|++||+|||.+.....+ ......+.+||+.|+|||....+. .+.+.||||+||+||-|+.|+.||-
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 99999999999999998765322 112234478999999999998643 3458899999999999999999996
Q ss_pred CCCccchhHHHHHHHHhhCCCchhhhhHHhh----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 498 TSNSSFLLITDWAWMLANSGKVDEIFDEFIR----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 498 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
.... .++.|+.+. -...+++.+++.++++.+++.||+.|.+..+|..+.-
T Consensus 321 ~~~~------------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 321 DDFE------------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred cchH------------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 5321 122222222 1122345678889999999999999999999988763
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.50 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=198.4
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCC-CCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~ 361 (614)
..++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 58899999986532 2334578899999999999999999998764322 133
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 468999999964 5655553 34888889999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC-----
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS----- 516 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~----- 516 (614)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........ ...........
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence 9754322 223345789999999999999999999999999999999999999975432111 11011000000
Q ss_pred ----CCchhhhh---------------HHhh---hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 ----GKVDEIFD---------------EFIR---EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 ----~~~~~~~d---------------~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
......++ ..+. ..........+.+++..|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0000 00011123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.30 Aligned_cols=240 Identities=23% Similarity=0.306 Sum_probs=189.6
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+++.+ +|+.||+|.++... ....+.+..|..++... +||||+++++++. ..+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence 46999999999999976 58899999987531 22345567788888765 8999999999886 456799999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. ...+++.+...++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence 99999999988865 356889999999999999999999 899999999999999999999999999998753222
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ...+. .
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-----~~~-~~~~~------~--- 213 (316)
T cd05620 150 D-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FES-IRVDT------P--- 213 (316)
T ss_pred C-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHH-HHhCC------C---
Confidence 2 223446799999999999999999999999999999999999999975432211 100 01110 0
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIA-DAL 561 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~-eVl 561 (614)
..+......+.+++..|++.||++||++. +++
T Consensus 214 -~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 -HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01111234567889999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.66 Aligned_cols=241 Identities=23% Similarity=0.344 Sum_probs=190.4
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCce
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+|+..+.||+|+||.||+++.. +|+.||+|+++.. .....+.+..|+.++..+. |++|+++.+++. ..+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCE
Confidence 3677889999999999999875 6899999998753 1233456788999998886 567778888776 3457
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEecccccc
Confidence 8999999999999988864 356899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... .......||+.|+|||++.++.++.++|||||||++|||++|+.||....... ....... ...
T Consensus 150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~~~i~~-~~~---- 218 (323)
T cd05615 150 EHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-----LFQSIME-HNV---- 218 (323)
T ss_pred ccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh-CCC----
Confidence 532221 12334568999999999999999999999999999999999999997644221 1111111 110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTI 557 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm 557 (614)
..+......+.+++..|++.+|.+|++.
T Consensus 219 ------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0112233467788999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.50 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=192.1
Q ss_pred eeeeccCcEEEEEEEEcC-Cc--EEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLED-GT--LVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~-g~--~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+|++++ |. .+++|.++... ....+.+.+|++++.++ +||||+++++++.. ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 368999999999999864 43 47888887532 33456789999999999 79999999999863 45689999
Q ss_pred ecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEE
Q 036081 369 DFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~K 435 (614)
||+++|+|.+++.... ....+++.+++.++.|++.||+||| +.+++||||||+|||+++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence 9999999999986532 1134788999999999999999999 89999999999999999999999
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHh
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLA 514 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~ 514 (614)
|+|||++...... ........+..|+|||++....++.++||||||+++|||++ |+.||....... .....
T Consensus 153 l~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~- 224 (270)
T cd05047 153 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKL- 224 (270)
T ss_pred ECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHHHH-
Confidence 9999998632211 11111233567999999998899999999999999999997 999986533211 11111
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+... ..+......+.+++..|++.+|.+|||+.+++.+|+..
T Consensus 225 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 PQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred hCCCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 111000 01112234678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.96 Aligned_cols=264 Identities=20% Similarity=0.293 Sum_probs=198.3
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~ 361 (614)
..++|...+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++..... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4577999999999999999999865 5889999998653 22334578899999999999999999998764321 233
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 568999999964 6666553 34788889999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+.... ....... ... ...+
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~-~~~-~~~~ 247 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQ-LGT-PCPE 247 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-cCC-CCHH
Confidence 9764322 223345789999999999999999999999999999999999999975443211 0000000 000 0000
Q ss_pred h---hh-------------------HHhh-------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 I---FD-------------------EFIR-------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~---~d-------------------~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. +. .... ..........+.+++..|++.||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00 0000 00001112367889999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.51 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=203.5
Q ss_pred ccceeeeccCcEEEEEEEE-cCC----cEEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 291 SQKNLIGQGASGVVYKGTL-EDG----TLVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~-~~g----~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
...++||+|+||+||||.| .+| -+||+|++... ..+...++++|+-+|.+++|||+++|+|+|..+ ..
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------TL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------hH
Confidence 3467899999999999986 344 47999998654 344568899999999999999999999999743 37
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
.||.+|||.|+|.++++.. +..+.-...+.+..|||+||.||| +++++||||.++|||+.+-.++||.|||+++.
T Consensus 773 qlvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 8999999999999999873 567888888999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCcccccc-ccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 445 SLEGQSHLTTR-VAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 445 ~~~~~~~~~~~-~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
...+....... ..-.+.|||-|.+....|+.++|||||||.+||++| |.+|++....++ +.+.
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------I~dl 912 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------IPDL 912 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------------hhHH
Confidence 76554433322 233568999999999999999999999999999999 999987654321 1111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
+..-.+-..++.....+..++..||..|+..||+++++...+.+..
T Consensus 913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 1111111123334456777889999999999999999988776643
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=316.34 Aligned_cols=268 Identities=27% Similarity=0.367 Sum_probs=209.5
Q ss_pred cChHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccc
Q 036081 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVS 355 (614)
Q Consensus 278 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~ 355 (614)
+...++..++++|...+.||+|+||.||+++.. +++.+|+|.+.... ...+.+.+|+.++.++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445667778999999999999999999999975 68899999986532 2346788999999999 79999999999876
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcE
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA 434 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 434 (614)
.+...+...++||||+++|+|.+++.... ....++|..++.++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence 54444567899999999999999886432 2356899999999999999999999 8899999999999999999999
Q ss_pred EEeeecccccccCCCccccccccCCCCccchhhhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Q 036081 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ-----LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW 509 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-----~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~ 509 (614)
||+|||+++....... ......|+..|+|||.+..+. ++.++|||||||++|||++|+.||........ +..+
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~ 245 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKI 245 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHH
Confidence 9999999876433221 122346889999999986443 68899999999999999999999875432111 1111
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+...... .+......+.+++..|++.+|++||++.|++++
T Consensus 246 -----~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 -----PRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----hcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 011111100 011233467889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=317.15 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=194.8
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
+|...++||+|+||.||+|+.. +++.+|+|.+... .....+++.+|++++.+++||||+++++++. ..+..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEEE
Confidence 5677889999999999999864 6899999998643 2334567999999999999999999999987 3456899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|..+ ..+++.....++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||++....
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence 9999999998644 24678888899999999999999 8999999999999999999999999999987543
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHHhhCCCchhhhh
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d 524 (614)
.. ......||..|+|||++.+..++.++||||||+++|||++|+.||........ ....+.... .... .
T Consensus 147 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~-----~ 217 (279)
T cd06619 147 NS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-VDED-----P 217 (279)
T ss_pred cc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-hccC-----C
Confidence 22 22335789999999999999999999999999999999999999965332211 000111000 0000 0
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+ ..........+.+++..|++.+|++||++.|++++
T Consensus 218 ~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 P---VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C---CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 00011123467889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=315.28 Aligned_cols=257 Identities=22% Similarity=0.360 Sum_probs=201.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
++|.....||+|+||.||+|+.+ +.+.+++|.+.....+ ..+++.+|++++++++|+||+++++++. +
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence 46778889999999999999864 2467999988654433 3567999999999999999999999886 3
Q ss_pred CceEEEEEecCCCCCcccccchhhhc------cCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcE
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTR------KQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA 434 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~------~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 434 (614)
....++||||+++|+|.+++...... ..++|..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcE
Confidence 45679999999999999998754311 26899999999999999999999 8899999999999999999999
Q ss_pred EEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHH
Q 036081 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~ 513 (614)
||+|||+++..............++..|+|||.+.++.++.++||||||+++|||++ |..||....... ... .
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-----~~~-~ 230 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-----VLN-R 230 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-----HHH-H
Confidence 999999987543322222333456778999999998889999999999999999999 778885433211 111 1
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+..... ........+.+++..|++.+|++|||+.|++++|.+
T Consensus 231 ~~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 231 LQAGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HHcCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111111100 111233478889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.04 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=197.3
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|++|.||+|+.. +|+.||+|+++... ....+.+.+|+.++.+++|||++++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 4677889999999999999976 68999999986432 223467889999999999999999999987 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++ ++|.+++........+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 9999997 688888765433457899999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH-------HhhCC
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM-------LANSG 517 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~-------~~~~~ 517 (614)
.... .......+++.|+|||.+.+. .++.++||||||+++|||+||+.||........... .... .|...
T Consensus 152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 152 GIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILGTPTEDVWPGV 229 (285)
T ss_pred CCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCChhhhhcc
Confidence 3221 122334578899999988754 578999999999999999999999975432211110 0000 00000
Q ss_pred CchhhhhHHhhh-------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 KVDEIFDEFIRE-------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
............ .........+.+++..|++.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 0011133467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.90 Aligned_cols=266 Identities=23% Similarity=0.329 Sum_probs=197.8
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~ 361 (614)
..++|...+.||+|+||.||+++.. +|+.||||++... .......+.+|+.++..++||||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999875 5899999998643 22335678899999999999999999998864332 123
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 467999999975 5555542 34788888999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH---------
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM--------- 512 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~--------- 512 (614)
++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.... +......
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCcHHHH
Confidence 9754322 223345789999999999999999999999999999999999999976532210 0000000
Q ss_pred ---------HhhC-CC-----chhhhhHHhhh---hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 513 ---------LANS-GK-----VDEIFDEFIRE---EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 513 ---------~~~~-~~-----~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.... .. ..+........ .........+.+++..|++.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00 00000000000 0001122457889999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.82 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=196.9
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
|+..+.||+|+||+||+++.. +|+.+|+|.+..... .....+.+|++++.+++|+|++.+.+++. .+...+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence 667789999999999999875 689999999865322 22345788999999999999999998876 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred EEEEeccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 999999999999888653 2346999999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ...+... ..... .
T Consensus 153 ~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~-~~~~~--~---- 222 (285)
T cd05632 153 PEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRR-VLETE--E---- 222 (285)
T ss_pred CCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-hhccc--c----
Confidence 3222 12345789999999999999999999999999999999999999975432211 1111111 11110 0
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
.........+.+++..|++.+|++||+ +.+++.+
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 011223345678899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.64 Aligned_cols=260 Identities=19% Similarity=0.232 Sum_probs=200.4
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCccccccccccc
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSS 356 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~ 356 (614)
.++....++|...+.||+|+||.||+++.+ +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-- 113 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-- 113 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--
Confidence 345556688999999999999999999976 5889999998642 1223456789999999999999999999886
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV 436 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL 436 (614)
.+...++||||+++|+|.+++.. ..++...+..++.||+.||.||| +.+|+||||||+|||++.++++||
T Consensus 114 ---~~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 114 ---DDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred ---cCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEE
Confidence 45679999999999999998854 35788888899999999999999 899999999999999999999999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM 512 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~ 512 (614)
+|||+++..............||+.|+|||++... .++.++|||||||++|||++|+.||...+... ....
T Consensus 184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~ 258 (371)
T cd05622 184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSK 258 (371)
T ss_pred EeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-----HHHH
Confidence 99999986543333233456799999999998753 37899999999999999999999997643211 1111
Q ss_pred HhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHh
Q 036081 513 LANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL--RPTIADALKML 564 (614)
Q Consensus 513 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~eVl~~L 564 (614)
.......... .........+..++..|+...+.+ ||++.|++++.
T Consensus 259 i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 259 IMNHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHcCCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111110000 001123346677888888744433 78999998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=314.98 Aligned_cols=246 Identities=27% Similarity=0.385 Sum_probs=197.5
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++. .+...++|
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 80 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWII 80 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEEE
Confidence 556678999999999999875 57899999886433 233457899999999999999999999987 45678999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++++|.+++.. ..+++..+..++.|+++||.||| +.+++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 81 MEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999999999988753 46889999999999999999999 89999999999999999999999999999876543
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
.. .......|+..|+|||++.+..++.++||||||+++|||++|+.|+........ ... ...+.. +
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~-~~~~~~-----~-- 219 (277)
T cd06642 154 TQ-IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----LFL-IPKNSP-----P-- 219 (277)
T ss_pred cc-hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----Hhh-hhcCCC-----C--
Confidence 22 122234678899999999999999999999999999999999999865432211 100 011100 0
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.........+.+++..|++.+|++||+|.+++++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 --TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1111233467889999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.20 Aligned_cols=238 Identities=24% Similarity=0.337 Sum_probs=190.0
Q ss_pred eeeeccCcEEEEEEEE----cCCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 294 NLIGQGASGVVYKGTL----EDGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~----~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
+.||+|+||.||+++. .+|+.+|+|+++... ......+.+|++++.+++||||+++++++. .+...++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 5799999999999875 358999999997532 123345778999999999999999999886 45678999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++.. ...+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 999999999998864 356899999999999999999999 89999999999999999999999999999876433
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... ...
T Consensus 151 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~i~~-~~~-------- 215 (318)
T cd05582 151 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-----TMTMILK-AKL-------- 215 (318)
T ss_pred CC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-----HHHHHHc-CCC--------
Confidence 21 22334578999999999998899999999999999999999999997543211 1111111 110
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIAD 559 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~e 559 (614)
..+......+.+++..|++.||++||++.+
T Consensus 216 --~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 --GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011122346778899999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=317.10 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=197.4
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
|+..+.||+|+||.||++... +++.+|||.+..... +..+.+.+|+.++++++|+|++.+.+.+. .+...+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence 667789999999999999876 689999999865322 22346788999999999999999999886 345789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++|+|.+++... ....+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 77 lv~e~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred EEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 999999999999988543 2345889999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
..... .....|+..|+|||.+.++.++.++||||||+++|||++|+.||......... .. ..... +.
T Consensus 153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~-~~~~~---------~~ 219 (285)
T cd05630 153 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EE-VERLV---------KE 219 (285)
T ss_pred CCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HH-HHhhh---------hh
Confidence 33222 12347899999999999999999999999999999999999999754322100 00 00000 00
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
............+.+++..|++.+|++||| +.|++++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 000111223345778899999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=319.04 Aligned_cols=263 Identities=21% Similarity=0.316 Sum_probs=196.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++|+||+++++++. .++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 45888899999999999999876 588999999875432 23456889999999999999999999987 345789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++ +|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred EEEeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence 99999974 787777542 345788899999999999999999 899999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH-------hhCC
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML-------ANSG 517 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~-------~~~~ 517 (614)
.... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +....... |..-
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 155 SVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred CCCc-cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhh
Confidence 3222 12223467899999999865 5689999999999999999999999976543221 11111000 0000
Q ss_pred -CchhhhhHHhhh-------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 -KVDEIFDEFIRE-------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 -~~~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+..+..... .........+.+++..|++.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000 0001233467789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=311.79 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=198.8
Q ss_pred CCccceeeeccCcEEEEEEEEcC--CcEEEEEEeecCC----------CcchHHHHHHHHHHHH-ccCCCcccccccccc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED--GTLVAVKQITDLD----------TKGDEEFINEVEIISK-IRHRNLLSLRGCCVS 355 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~--g~~vAVK~l~~~~----------~~~~~~f~~Ei~il~~-l~H~NIv~l~g~~~~ 355 (614)
+|...+.||+|+||.||+|..+. ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 46778899999999999999865 6889999885321 1123457789998876 69999999999987
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcE
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA 434 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 434 (614)
.+...+++|||+++++|.+++.... ....+++..+++++.|++.||.|||. ..+++||||||+||+++.++.+
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcE
Confidence 4567899999999999998875422 23468888999999999999999992 2689999999999999999999
Q ss_pred EEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh
Q 036081 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA 514 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~ 514 (614)
||+|||++....... ......|+..|+|||.+.++.++.++||||||+++|||++|+.||....... .....
T Consensus 154 ~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-----~~~~~- 225 (269)
T cd08528 154 TITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-----LATKI- 225 (269)
T ss_pred EEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-----HHHHH-
Confidence 999999998654332 2344568999999999999999999999999999999999999986543211 11111
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
..+..... ........+.+++.+|++.+|++||++.||.++++
T Consensus 226 ~~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111100 01112346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.80 Aligned_cols=251 Identities=21% Similarity=0.343 Sum_probs=200.5
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|++|.||+++.+ +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 4778899999999999999976 57899999986432 2334578899999999999999999987642 234679
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
++|||+++++|.+++... ....+++.+++.++.+++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 999999999999998753 2345899999999999999999999 899999999999999999999999999998765
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.... .......+++.|+|||++.++.++.++||||||++++||++|+.||...+.. ....... .+...
T Consensus 153 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~-~~~~~----- 220 (257)
T cd08223 153 ENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRII-EGKLP----- 220 (257)
T ss_pred cccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH-hcCCC-----
Confidence 3322 2233456889999999999999999999999999999999999998654321 1111111 11111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.+|++|||+.+++++
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112234578889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=309.49 Aligned_cols=251 Identities=31% Similarity=0.467 Sum_probs=198.3
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchH--HHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDE--EFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~--~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
|+..+.||+|+||+||+++.. +++.+|+|.+......... ....|+.++.+++|+||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 456789999999999999987 4678999999875443322 34569999999999999999999873 567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++++|.+++.. ...+++..+..++.|+++||.||| +.+|+||||||+||++++++.++|+|||.+....
T Consensus 76 v~~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred cccccccccccccccc---cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999999873 467899999999999999999999 8899999999999999999999999999987541
Q ss_pred CCCccccccccCCCCccchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
..........++..|+|||.+. +..++.++||||+|+++|+|++|+.|+........ . ... ......
T Consensus 150 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~-~~~---------~~~~~~ 217 (260)
T PF00069_consen 150 -ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-L-EII---------EKILKR 217 (260)
T ss_dssp -STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-H-HHH---------HHHHHT
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhh-h-hhh---------hhcccc
Confidence 2222344567899999999998 88999999999999999999999999986521110 0 000 000000
Q ss_pred HhhhhC--cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEG--SRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+.... .......+.+++..|++.+|++|||+.+++++
T Consensus 218 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 218 PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00112588899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.36 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=188.6
Q ss_pred eeeccCcEEEEEEEEcC---CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEec
Q 036081 295 LIGQGASGVVYKGTLED---GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~---g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
.||+|+||.||+|++.+ +..+|+|.++.... .....|.+|+.++++++||||++++|++.+ ....++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEEC
Confidence 58999999999998653 45799998865432 334578999999999999999999998863 3457999999
Q ss_pred CCCCCcccccchhhh--ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 371 MPSGSLGDHISNALT--RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 371 ~~~gsL~~~L~~~~~--~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
+++|+|.+++..... ...+++..++.++.|+++||+||| +.+++||||||+||+++.++++||+|||+++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 999999999865321 234667788899999999999999 899999999999999999999999999998754332
Q ss_pred Ccc-ccccccCCCCccchhhhccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 449 QSH-LTTRVAGTYGYLAPEYALYG-------QLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 449 ~~~-~~~~~~gt~~Y~APE~~~~~-------~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
... ......++..|+|||++... .++.++||||||+++|||++ |+.||......... .+. ... ..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~~---~~~-~~ 227 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYT---VRE-QQ 227 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HHH---hhc-cc
Confidence 221 12234578899999998642 35789999999999999996 99999654432211 111 111 11
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
....++.+.. ...+.+.+++..|+ .+|++|||++||++.|+
T Consensus 228 ~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111111 12235667788898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=316.46 Aligned_cols=263 Identities=20% Similarity=0.362 Sum_probs=198.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-----------------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-----------------DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSL 349 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-----------------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l 349 (614)
++|+..+.||+|+||.||++... ++..+|+|+++... ......|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998543 23469999987542 2335679999999999999999999
Q ss_pred cccccccCCCCCceEEEEEecCCCCCcccccchhhh--------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCC
Q 036081 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALT--------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDI 421 (614)
Q Consensus 350 ~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~--------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDI 421 (614)
++++. .+...++||||+++|+|.+++..... ...+++.+.+.++.|++.||+||| +.+|+||||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl 156 (296)
T cd05095 85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL 156 (296)
T ss_pred EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccC
Confidence 99986 34568999999999999998865321 124677889999999999999999 899999999
Q ss_pred CCCceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 036081 422 KSTNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS--GRKVLET 498 (614)
Q Consensus 422 Kp~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt--G~~p~~~ 498 (614)
||+|||++.++.+||+|||+++........ ......++..|+|||....+.++.++||||||+++|||++ |..|+..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999998765332211 1222345678999999998999999999999999999998 6677764
Q ss_pred CCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 499 SNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 499 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...... +. ............... ..+......+.+++.+|++.+|.+||+|.||++.|+.
T Consensus 237 ~~~~~~-~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 237 LSDEQV-IE-NTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred cChHHH-HH-HHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 332211 10 011111110000000 0111223578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=324.24 Aligned_cols=255 Identities=21% Similarity=0.242 Sum_probs=194.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++. ..+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 46888999999999999999976 5889999998642 1223445888999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEecccee
Confidence 89999999999999998652 346888899999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCccccccccCCCCccchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
..............||+.|+|||++.+ +.++.++||||||++||||++|+.||....... ..........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~ 225 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHEE 225 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-----HHHHHHcCCC
Confidence 654433333334579999999999875 568899999999999999999999997543211 1111111110
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL--RPTIADALKM 563 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~eVl~~ 563 (614)
... +...+ .+..+.+.+++..|+...+++ |+++++++++
T Consensus 226 ~~~-~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQ-FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccc-CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 01100 112345666777776654443 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.87 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=200.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+++.. +|..+|+|.++.... ...+++.+|++++.+++||||+++++++. .++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 36888999999999999999876 588899998864322 23456889999999999999999999987 456799
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++++|.+++.. .+.+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++...
T Consensus 76 lv~ey~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 76 ICMEHMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150 (308)
T ss_pred EEeeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence 99999999999999865 3568899999999999999999993 258999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC--------
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG-------- 517 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~-------- 517 (614)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ..+........
T Consensus 151 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 225 (308)
T cd06615 151 IDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL--EAMFGRPVSEGEAKESHRP 225 (308)
T ss_pred ccc---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH--HHhhcCccccccccCCccc
Confidence 322 12335688999999999888899999999999999999999999864432111 00000000000
Q ss_pred ------------CchhhhhHHhhhh----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 ------------KVDEIFDEFIREE----GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ------------~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+..+...... ........+.+++.+|++.+|++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111111110 001133468899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=314.40 Aligned_cols=239 Identities=21% Similarity=0.341 Sum_probs=186.3
Q ss_pred eeeccCcEEEEEEEEcC-------------------------CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccc
Q 036081 295 LIGQGASGVVYKGTLED-------------------------GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~-------------------------g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l 349 (614)
.||+|+||.||+|++.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998531 13588998865444445678999999999999999999
Q ss_pred cccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 350 ~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
+|+|. .....++||||+++|+|..++... .+.+++..++.++.||++||+||| +.+|+||||||+|||++
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLA 151 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEe
Confidence 99997 345689999999999999888652 456899999999999999999999 89999999999999997
Q ss_pred CCC-------cEEEeeecccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCC
Q 036081 430 SEM-------KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELM-SGRKVLETSN 500 (614)
Q Consensus 430 ~~~-------~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELl-tG~~p~~~~~ 500 (614)
.++ .+|++|||++...... ....++..|+|||++.+ ..++.++||||||+++|||+ +|+.|+....
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred ccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 654 3799999987643221 12357788999998875 56899999999999999995 6888886543
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
.... ..+.. .... .+......+.+++..|++.+|++|||+.++++.|+
T Consensus 227 ~~~~--~~~~~---~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 PSEK--ERFYE---KKHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hHHH--HHHHH---hccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 2211 01100 0000 01111236788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=314.74 Aligned_cols=199 Identities=26% Similarity=0.407 Sum_probs=161.2
Q ss_pred ceeeeccCcEEEEEEEEc---CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 293 KNLIGQGASGVVYKGTLE---DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
.++||+|+||.||+|+.. +++.+|+|.++... ....+.+|++++++++||||+++++++... .+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence 468999999999999865 46789999986532 234678999999999999999999988543 2456899999
Q ss_pred cCCCCCcccccchhh------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee----cCCCcEEEeee
Q 036081 370 FMPSGSLGDHISNAL------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL----DSEMKAKVADF 439 (614)
Q Consensus 370 y~~~gsL~~~L~~~~------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~KL~DF 439 (614)
|+. ++|.+++.... ....+++.....++.||+.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 986 57777664321 1235788889999999999999999 8999999999999999 46678999999
Q ss_pred cccccccCCCc--cccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 036081 440 GLAKQSLEGQS--HLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSN 500 (614)
Q Consensus 440 Gla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~ 500 (614)
|+++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99986543221 12334678999999999986 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.89 Aligned_cols=238 Identities=23% Similarity=0.357 Sum_probs=188.0
Q ss_pred eeeeccCcEEEEEEEEcCCc-----------EEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 294 NLIGQGASGVVYKGTLEDGT-----------LVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~-----------~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+.||+|+||.||+|++.+.. .+++|.+...... ...|.+|+.++++++|+||++++|++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 36999999999999986432 5788877654333 6789999999999999999999999863 3
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-------cEE
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-------KAK 435 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-------~~K 435 (614)
..++||||+++|+|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+|
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEE
Confidence 469999999999999998763 236899999999999999999999 89999999999999999888 799
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHH
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG--QLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWM 512 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~ 512 (614)
|+|||++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+....... .. .+
T Consensus 149 l~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~-~~--- 218 (259)
T cd05037 149 LSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KE-RF--- 218 (259)
T ss_pred eCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-HH-HH---
Confidence 999999876433 2233567789999999876 78999999999999999999 466775543211 00 00
Q ss_pred HhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 513 LANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 513 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
+..... +. . + ....+.+++..|++.+|++|||+.++++.|+
T Consensus 219 -~~~~~~-------~~-~-~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 -YQDQHR-------LP-M-P--DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -HhcCCC-------CC-C-C--CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000000 00 0 0 0147788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=351.18 Aligned_cols=259 Identities=19% Similarity=0.287 Sum_probs=199.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..++||+|+||.||+|+.. +|+.||+|+++.... ...+.|.+|++++++++||||+++++++. +++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 57888999999999999999976 589999999865322 22457999999999999999999999986 4567
Q ss_pred EEEEEecCCCCCcccccchhhh--------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEE
Q 036081 364 RFLVYDFMPSGSLGDHISNALT--------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~--------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~K 435 (614)
.++||||+++|+|.+++..... ...+++..+++++.||++||+||| +.+|+||||||+|||++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence 8999999999999998864221 134566778899999999999999 89999999999999999999999
Q ss_pred EeeecccccccCCC-----------------ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 036081 436 VADFGLAKQSLEGQ-----------------SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLET 498 (614)
Q Consensus 436 L~DFGla~~~~~~~-----------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~ 498 (614)
|+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 99999998652110 0011235799999999999999999999999999999999999999975
Q ss_pred CCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcC
Q 036081 499 SNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRP-TIADALKMLEGD 567 (614)
Q Consensus 499 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-tm~eVl~~L~~~ 567 (614)
........ . .... ++. ......+.+..+.+++..|++.+|++|| +++++++.|+..
T Consensus 234 ~~~~ki~~-----~----~~i~---~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 234 KKGRKISY-----R----DVIL---SPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred cchhhhhh-----h----hhcc---Chh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 33211100 0 0000 000 0000112334677899999999999996 566677766654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.10 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=200.2
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
..++|+....||+|+||.||+++-+ +|..+|+|++++... ...+..+.|-++|....++.||+|+-.|. +.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ-----D~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ-----DK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec-----CC
Confidence 4578999999999999999999866 599999999987543 23456788999999999999999998887 56
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
..+||||||+|||++..+|.+ ...|++.....++.+++.|+.-|| +.|||||||||+|+|||..|++||+||||
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccc
Confidence 679999999999999999976 467999999999999999999999 99999999999999999999999999999
Q ss_pred cccccC----------------------CCcc-----c-------------------cccccCCCCccchhhhccCCCCc
Q 036081 442 AKQSLE----------------------GQSH-----L-------------------TTRVAGTYGYLAPEYALYGQLTE 475 (614)
Q Consensus 442 a~~~~~----------------------~~~~-----~-------------------~~~~~gt~~Y~APE~~~~~~~s~ 475 (614)
+.-... .... . ....+|||.|||||++.+..|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 852110 0000 0 11247999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCC
Q 036081 476 KSDVYSFGIVILELMSGRKVLETSNSSFL--LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL 553 (614)
Q Consensus 476 ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~ 553 (614)
.+|.||+|||+|||+.|-+||...+..+. .+..|...+.... ......+..+++..|+. ||++
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHH
Confidence 99999999999999999999988776542 2333332121111 11111355667777777 9999
Q ss_pred CCC---HHHHHHH
Q 036081 554 RPT---IADALKM 563 (614)
Q Consensus 554 RPt---m~eVl~~ 563 (614)
|-- ..||-+|
T Consensus 433 RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 433 RLGSKGAEEIKKH 445 (550)
T ss_pred hcCcccHHHHhcC
Confidence 975 5555443
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.59 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=193.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-----cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-----KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-----~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.+|...+.||+|+||.||++... +|+.||+|++..... +..+.+.+|+.++++++|+||+++++++... .+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 46888999999999999999875 589999998864321 2235688999999999999999999987632 24
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++++||+++++|.+++.+ ...+++...+.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~ 152 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA 152 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCC
Confidence 568999999999999999865 345889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc--cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQS--HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++....... .......++..|+|||++.+..++.++||||||+++|||++|+.||........ .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----~~~~~~~~~- 226 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----IFKIATQPT- 226 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----HHHHhcCCC-
Confidence 875432111 112234588999999999998999999999999999999999999975432110 000101110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+ ..+....+.+..++ .|+..+|++||+++||+++
T Consensus 227 ----~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 ----NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00 01111222333343 6888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.68 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=202.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|...+.||+|+||.||+++.. +|+.||+|.+........+.+.+|+.+++.++|+|++++++++. .+...++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEEE
Confidence 56888899999999999999964 69999999997655555677899999999999999999999987 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++++|.+++.+ ..+++.++..++.+++.||.||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 94 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred eecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 9999999999998853 45888999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||........... ....+.. .
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~~~-~----- 234 (297)
T cd06656 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGTP-E----- 234 (297)
T ss_pred CCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCCCC-C-----
Confidence 3322 12334688999999999999999999999999999999999999965433211110 0000100 0
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+ ..+......+.+++..|++.+|++||++.+++++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 L--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0112233456788899999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.05 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=197.1
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc---------chHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK---------GDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~---------~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
+|.....||+|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 3666789999999999999875 5889999988653222 1246889999999999999999999986
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.....++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~d 149 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISD 149 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecc
Confidence 34578999999999999999865 356889999999999999999999 89999999999999999999999999
Q ss_pred ecccccccCCCcc-----ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 439 FGLAKQSLEGQSH-----LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 439 FGla~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
||+++........ ......|+..|+|||.+.++.++.++||||||+++|||++|+.||......... ...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~ 224 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-----FKI 224 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-----HHH
Confidence 9998865422111 112245788999999999999999999999999999999999999754321100 000
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... .....+....+.+.+++..|++.+|++||++.|++++
T Consensus 225 -~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 -GEN---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -hcc---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 000 0011122234567889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.56 Aligned_cols=240 Identities=20% Similarity=0.342 Sum_probs=186.7
Q ss_pred eeeeccCcEEEEEEEEcC-------------CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 294 NLIGQGASGVVYKGTLED-------------GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~-------------g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.++..++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 368999999999998642 23588998766544455678999999999999999999999873
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc-------
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK------- 433 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~------- 433 (614)
....++||||+++|+|..++... ...+++..+++++.||++||+||| +.+|+||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCce
Confidence 34579999999999998887642 346899999999999999999999 899999999999999987664
Q ss_pred EEEeeecccccccCCCccccccccCCCCccchhhhc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCccchhHHHHHH
Q 036081 434 AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELM-SGRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 434 ~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSfGvvL~ELl-tG~~p~~~~~~~~~~l~~~~~ 511 (614)
+|++|||++...... ....++..|+|||++. +..++.++||||||+++|||+ +|+.|+....... ...
T Consensus 151 ~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~ 220 (262)
T cd05077 151 IKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KER 220 (262)
T ss_pred eEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HHH
Confidence 899999998654321 2245788999999987 567899999999999999998 5777775432111 000
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
... +... . .....+.+.+++..|++.+|.+||++.++++.++
T Consensus 221 -~~~-~~~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 -FYE-GQCM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -HHh-cCcc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 001 1000 0 0011246778999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=322.69 Aligned_cols=255 Identities=20% Similarity=0.245 Sum_probs=193.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...++||+|+||.||+++.+ +++.+|+|.+.+. .......+.+|+.++..++|+||+++.+++. ....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 46888899999999999999976 4788999998642 1222345889999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.+. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence 89999999999999999652 346889999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
..............||+.|+|||++. .+.++.++|||||||++|||++|+.||....... ..........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~ 225 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKE 225 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-----HHHHHhCCCc
Confidence 65443333334457999999999986 3568899999999999999999999997543211 1111111110
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHcc--ccCCCCCCCHHHHHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCA--HVMVALRPTIADALKM 563 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl--~~~p~~RPtm~eVl~~ 563 (614)
... +.. ........+.+++..|+ ..++..||++.|++++
T Consensus 226 ~~~-~p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQ-FPA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccc-CCC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 000 00112234455555555 4445557899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.65 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=198.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||.||+|..+ +++.+|+|++..... ...+.+.+|++++++++|+||+++++++. .+...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 46788899999999999999986 589999998864322 23467889999999999999999999986 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++++|.++... ...++|.+++.++.||+.||+||| +.+++||||+|+||++++++.+||+|||++..
T Consensus 76 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred EEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 999999999988876543 245899999999999999999999 88999999999999999999999999999886
Q ss_pred ccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh--
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE-- 521 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-- 521 (614)
..... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ......+ ..+.+.+
T Consensus 150 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~---~~~~~~~~~ 224 (286)
T cd07846 150 LAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIK---CLGNLIPRH 224 (286)
T ss_pred ccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHH---HhCCCchhh
Confidence 54332 22334567899999999875 457889999999999999999999986543211 1111110 0001000
Q ss_pred --hhh------HHhh---------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 --IFD------EFIR---------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 --~~d------~~l~---------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+ .... ..........+.+++..|++.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 0000 00011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=311.71 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=195.3
Q ss_pred eeeeccCcEEEEEEEEcC-------CcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 294 NLIGQGASGVVYKGTLED-------GTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~-------g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+.||+|+||.||+|+..+ +..+|+|.+.... .....+|.+|++++++++||||+++++++. .....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 369999999999998753 2579999886533 234567999999999999999999999986 344689
Q ss_pred EEEecCCCCCcccccchhhh----ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-----cEEE
Q 036081 366 LVYDFMPSGSLGDHISNALT----RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-----KAKV 436 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-----~~KL 436 (614)
+||||+++|+|.+++.+... ...++|.+++.++.|++.||.||| +.+++|+||||+||+++.++ .+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEE
Confidence 99999999999999875321 234788999999999999999999 89999999999999999887 8999
Q ss_pred eeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHh
Q 036081 437 ADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLA 514 (614)
Q Consensus 437 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~ 514 (614)
+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ |+.||....... ......
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~ 227 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-----VLQHVT 227 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-----HHHHHh
Confidence 999998765332211 1222345778999999999999999999999999999998 999986543211 111111
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..... .........+.+++..|++.+|++||++++++++|+.
T Consensus 228 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 228 AGGRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cCCcc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11100 1112234577889999999999999999999999873
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.00 Aligned_cols=266 Identities=20% Similarity=0.290 Sum_probs=195.9
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCC------Ccccccccc
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHR------NLLSLRGCC 353 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~------NIv~l~g~~ 353 (614)
+++...+++|...++||+|+||+||+++.. .++.||||+++... ...+++..|++++.+++|. +++.+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 345556789999999999999999999875 57899999986532 2344567788888888655 477888877
Q ss_pred cccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCC-CceEecCCCCCceeecCCC
Q 036081 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK-PAIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 354 ~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~ 432 (614)
.. +....++|||++ +++|.+++.+ ...+++..+..|+.||+.||.||| . .+||||||||+|||++.++
T Consensus 201 ~~----~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 201 QN----ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSD 269 (467)
T ss_pred Ec----CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCC
Confidence 53 335689999988 6788888764 357999999999999999999999 6 5999999999999998765
Q ss_pred ----------------cEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 036081 433 ----------------KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL 496 (614)
Q Consensus 433 ----------------~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~ 496 (614)
.+||+|||++.... ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999876422 2234568999999999999999999999999999999999999999
Q ss_pred CCCCccch--hHH--------HHHHHHhhCCCchhhhh----------H-----HhhhhC--cHHHHHHHHHHHHHcccc
Q 036081 497 ETSNSSFL--LIT--------DWAWMLANSGKVDEIFD----------E-----FIREEG--SRAVMERFVRVGILCAHV 549 (614)
Q Consensus 497 ~~~~~~~~--~l~--------~~~~~~~~~~~~~~~~d----------~-----~l~~~~--~~~~~~~l~~l~~~Cl~~ 549 (614)
........ .+. .|.... ......++++ + ...... .......+.+++..|++.
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRC-GTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhc-cchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 76543221 110 011000 0000000000 0 000000 000123577899999999
Q ss_pred CCCCCCCHHHHHHH
Q 036081 550 MVALRPTIADALKM 563 (614)
Q Consensus 550 ~p~~RPtm~eVl~~ 563 (614)
||.+|||+.|++++
T Consensus 425 dP~~R~ta~e~L~H 438 (467)
T PTZ00284 425 DRQKRLNARQMTTH 438 (467)
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999874
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=311.98 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=200.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|+..+.||.|+||.||+|+.. +|+.+|+|.+.... ......+.+|++++++++|+|++++++++. ++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 35777889999999999999976 58999999986543 333467889999999999999999999887 446789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|+||+++++|.+++.. ..+++.....++.|++.||.||| +.+++||||+|+||++++++.++|+|||+++..
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred EEEEeeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999998864 37899999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.... .......++..|+|||++.+..++.++||||||+++|||++|+.||....... ..... ..+....
T Consensus 149 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~~-~~~~~~~---- 217 (274)
T cd06609 149 TSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFLI-PKNNPPS---- 217 (274)
T ss_pred cccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHHh-hhcCCCC----
Confidence 4332 22233568889999999999899999999999999999999999997543211 11110 1111100
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+... .....+.+++..|++.+|++|||+++++++
T Consensus 218 -~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 -LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0000 033467788999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.22 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=198.9
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-----CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-----TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+|...+.||+|+||.||+|+.. +++.|++|.+.... .+..+.+.+|++++++++|+|++++.+++. .+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 3667789999999999999987 78999999986533 223467899999999999999999999886 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++++||+++++|.+++.+ ...+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 78999999999999999865 346889999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCccccccccCCCCccchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
....... ......|+..|+|||.+.... ++.++|+||||+++|||++|+.||...... ...+..........
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 222 (258)
T cd06632 150 KQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AAVFKIGRSKELPP 222 (258)
T ss_pred eeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HHHHHHHhcccCCC
Confidence 7643322 223456889999999998776 899999999999999999999999754321 11111111011110
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+......+.+++..|++.+|++||++.+++++
T Consensus 223 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 ---------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111223467788999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.60 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=198.2
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC------cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT------KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~------~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+|...+.||+|+||.||+|...+|+.+|||.++.... +..+.+.+|++++++++|+||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cCC
Confidence 3667789999999999999988899999998864321 12346889999999999999999999987 346
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++.+ ...+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 149 (265)
T cd06631 76 TISIFMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCA 149 (265)
T ss_pred eEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhh
Confidence 78999999999999999865 346889999999999999999999 889999999999999999999999999998
Q ss_pred ccccCCC-----ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 443 KQSLEGQ-----SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 443 ~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
....... ........|+..|+|||++.+..++.++||||||+++|||++|+.||........ ........+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~ 225 (265)
T cd06631 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----MFYIGAHRG 225 (265)
T ss_pred HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH----HHHhhhccC
Confidence 7542211 1112335689999999999998999999999999999999999999975432111 100000001
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
... ..+....+.+.+++..|++.+|++||++.|+++
T Consensus 226 ~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMP---------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 110 011123356788999999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=310.04 Aligned_cols=248 Identities=28% Similarity=0.421 Sum_probs=197.6
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|...+.||+|+||.||+|.. +++.+|+|.++.. ...+.+.+|+.++.+++|+|++++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEEE
Confidence 3477789999999999999986 4788999998643 234678999999999999999999998752 236899
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ....+++..+++++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++....
T Consensus 77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 77 MELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred EECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 9999999999998653 2345889999999999999999999 89999999999999999999999999999875432
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.. .....+..|+|||++.++.++.++||||||+++|||++ |+.||....... +.... ..+.
T Consensus 153 ~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~-~~~~-------- 214 (254)
T cd05083 153 GV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECV-EKGY-------- 214 (254)
T ss_pred cC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHH-hCCC--------
Confidence 21 12234568999999999999999999999999999998 999986543211 11111 1111
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
........+..+.+++..|++.+|+.||++.++++.|+.+
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 254 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence 0011122345678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.61 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=187.2
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHH-HHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVE-IISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~-il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+++.. +++.+|+|++.... ......+..|.. +++.++|+||+++++++. .....++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 36999999999999976 57889999986422 122334444544 567789999999999886 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. ...+.+.....++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence 99999999998865 345778888899999999999999 899999999999999999999999999998754322
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ...
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~-~~~--------- 213 (325)
T cd05602 150 N-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNILN-KPL--------- 213 (325)
T ss_pred C-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHHHHh-CCc---------
Confidence 2 22344579999999999999999999999999999999999999997543221 1111111 100
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.........+.+++..|++.+|.+||++.+.+..
T Consensus 214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 214 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 0111233467788899999999999988754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.00 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=200.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc--------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCcccccccccccC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE--------DGTLVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSD 357 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~ 357 (614)
.+|...+.||+|+||.||++... ++..||+|.++... ....+++.+|++++.++ +|+||+++++++.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence 35778899999999999999742 12368999886432 23356789999999999 7999999999987
Q ss_pred CCCCceEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~ 424 (614)
.+...+++|||+++|+|.+++.... ....++|.+++.++.|++.||+||| +.+|+||||||+
T Consensus 89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~ 163 (334)
T cd05100 89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR 163 (334)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence 3456899999999999999986521 1235788899999999999999999 899999999999
Q ss_pred ceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 036081 425 NILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSS 502 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~ 502 (614)
|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999765432211 1222334568999999999999999999999999999998 88888654321
Q ss_pred chhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 503 FLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 503 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
++.... ..+... ..+......+.+++..|++.+|.+|||+.|+++.|+...
T Consensus 244 -----~~~~~~-~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 -----ELFKLL-KEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -----HHHHHH-HcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111111 111100 011122346788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=319.85 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=199.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc--------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCcccccccccccC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE--------DGTLVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSD 357 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~ 357 (614)
++|...+.||+|+||.||+++.. ++..+|+|.++... .....++.+|++++.++ +||||+++++++.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--- 88 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc---
Confidence 45778899999999999999742 24579999987532 23346788999999999 6999999999986
Q ss_pred CCCCceEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~ 424 (614)
.....++||||+++|+|.+++.... ....++|.++.+++.|++.||.||| +.+|+||||||+
T Consensus 89 --~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~ 163 (314)
T cd05099 89 --QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR 163 (314)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccce
Confidence 3456899999999999999986532 1235888899999999999999999 899999999999
Q ss_pred ceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 036081 425 NILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSS 502 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~ 502 (614)
|||++.++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999865432221 1122234567999999999999999999999999999999 88888653321
Q ss_pred chhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 503 FLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 503 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
. .... ...+...+ .+......+.+++..|++.+|++|||+.|+++.|+...
T Consensus 244 ~-----~~~~-~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 E-----LFKL-LREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred H-----HHHH-HHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1 1111 11111100 11122346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.09 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=203.9
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|+||.||++... +|+.+|+|.+.... ....+.+.+|++++++++|+|++++++++... .+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 4677889999999999999865 68899999986432 23346788999999999999999999987642 345689
Q ss_pred EEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcC--CCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 366 LVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGL--KPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~--~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
++|||+++++|.+++.... ....+++...+.++.+++.||.|||... ..+++||||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999999986532 2457899999999999999999999543 678999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
......... .....++..|+|||.+....++.++||||||+++++|++|+.|+...... .+... ...+...
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~-- 228 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----QLASK-IKEGKFR-- 228 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----HHHHH-HhcCCCC--
Confidence 875443321 23346899999999999989999999999999999999999999764321 11111 1111111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.+|++|||+.+|+++
T Consensus 229 -------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122334578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.93 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=202.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.+|...+.||.|+||.||+|+.. +|+.|++|.+........+.+.+|+++++.++|+|++++++++. .+...++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 45888899999999999999864 68999999997655555678899999999999999999999986 4567999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
|+||+++++|.+++.. ..++|.++..++.+++.||+||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 94 VMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 9999999999998754 45899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.... ......++..|+|||.+.++.++.++|||||||++|||++|+.||.......... . ...... ..
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~--~---~~~~~~-~~----- 234 (296)
T cd06655 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L---IATNGT-PE----- 234 (296)
T ss_pred cccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H---HHhcCC-cc-----
Confidence 3322 1233468899999999998899999999999999999999999997654321110 0 001000 00
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+ ..+......+.+++..|++.+|++|||+.+++.+
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 L--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred c--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 0112233467788999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=318.55 Aligned_cols=263 Identities=20% Similarity=0.305 Sum_probs=196.8
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCC-CCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~ 361 (614)
..++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3567888899999999999999865 68899999986432 2234567899999999999999999998864321 223
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 5679999988 7788777643 46899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..+... ......
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~--~~~~~~ 237 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEV--VGTPSP 237 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHH--hCCCCH
Confidence 9865332 233568999999999876 578999999999999999999999996543221 11111100 000001
Q ss_pred hhhhHH-----------hhhhCcH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEF-----------IREEGSR-------AVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~-----------l~~~~~~-------~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+..... +...... .....+.+++..|++.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111000 0000000 012246789999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.98 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=198.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|++++++++|+|++++++++. .+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 46788899999999999999986 58999999986432 223456889999999999999999999987 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++++|..++.. ...++|..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 76 ~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 76 HLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARI 149 (286)
T ss_pred EEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECcccccee
Confidence 999999999888777643 346899999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH----------
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML---------- 513 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~---------- 513 (614)
...... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... .......
T Consensus 150 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 150 LTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL-YLIRKTLGDLIPRHQQI 227 (286)
T ss_pred cCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChHHhhh
Confidence 543321 1223457889999999876 56889999999999999999999999754432211 1111000
Q ss_pred hhCCCc-hhhhhHHhhh-----hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANSGKV-DEIFDEFIRE-----EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~~~~-~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+..... .....+.... .........+.+++..|++.+|++|||+.|++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000 0000000000 0001223567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.75 Aligned_cols=192 Identities=23% Similarity=0.361 Sum_probs=163.5
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
...+|...+.||+|+||.||+|+.. +++.||+|.... .....|+.++++++|+||+++++++. .+...
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEE-----eCCee
Confidence 3457999999999999999999976 477899997432 23457999999999999999999987 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++|+||+. ++|.+++.. ....++|..++.|+.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EEEEEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 99999994 688888765 2457899999999999999999999 89999999999999999999999999999875
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL 496 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~ 496 (614)
..... ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 207 PVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 32221 223456899999999999999999999999999999999976554
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=297.64 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=207.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
-++|+..+.||+|.||.||.|+.+ ++..||+|++.+.. .+-..++.+|++|-+.|+||||++++|++. +..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-----d~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-----DSK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-----ccc
Confidence 356889999999999999999965 68899999986532 233567899999999999999999999998 567
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..||++||.++|+|...|... ..+++++.....++.|+|.||.|+| .+++|||||||+|+|++.++..||+|||-+
T Consensus 96 riyLilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eeEEEEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 899999999999999999753 2456888999999999999999999 999999999999999999999999999988
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
...+ .......+||..|.+||...+..++.+.|+|++|++.||++.|.+||+....++. .....
T Consensus 172 V~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-YkrI~------------ 235 (281)
T KOG0580|consen 172 VHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-YKRIR------------ 235 (281)
T ss_pred eecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-HHHHH------------
Confidence 6543 3334567899999999999999999999999999999999999999987552221 11000
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.- +-..+..+.....+++..|+..+|.+|.+..||+.+
T Consensus 236 -k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 -KV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -Hc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 00 011223344567789999999999999999999875
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.36 Aligned_cols=255 Identities=27% Similarity=0.343 Sum_probs=201.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|+..+.||+|+||+||++... +|+.+|+|++.... ....+.+.+|++++..++||||+++++++. .....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence 45677789999999999999875 58899999886533 334578999999999999999999999987 346789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++|+|.+++.. .+.+++.....++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++...
T Consensus 80 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred EEEecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 99999999999988765 3568999999999999999999993 358999999999999999999999999998654
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc------hhHHHHHHHHhhCCCc
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF------LLITDWAWMLANSGKV 519 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~------~~l~~~~~~~~~~~~~ 519 (614)
... ......|+..|+|||++.++.++.++|||||||++|||++|+.||....... ..+.++.........
T Consensus 155 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd06620 155 INS---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP- 230 (284)
T ss_pred hhh---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-
Confidence 221 1224578999999999998899999999999999999999999997544321 011111111111000
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
...........+.+++..|++.+|++|||+.|++++.
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 --------PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --------CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0001112345678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=307.52 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=186.3
Q ss_pred eeeccCcEEEEEEEEcC---CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEec
Q 036081 295 LIGQGASGVVYKGTLED---GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~---g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
.||+|+||.||+|...+ ...+|+|.+..... .....|.+|+++++.++|+||+++++.+. .....++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEEe
Confidence 58999999999997643 35788888764332 33457889999999999999999999887 34568999999
Q ss_pred CCCCCcccccchhhh--ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 371 MPSGSLGDHISNALT--RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 371 ~~~gsL~~~L~~~~~--~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
+++|+|.+++..... ....++...+.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccc
Confidence 999999999876422 223467778899999999999999 899999999999999999999999999998753322
Q ss_pred Ccc-ccccccCCCCccchhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 449 QSH-LTTRVAGTYGYLAPEYALY-------GQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 449 ~~~-~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
... ......++..|+|||++.. ..++.++||||||+++|||++ |+.||........ + ......+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~----~~~~~~~~- 227 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-L----KQVVREQD- 227 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-H----HHHhhccC-
Confidence 211 1223346778999999753 356889999999999999999 7788865432211 1 11111111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
....++.+ +......+.++...|+ .+|++|||++||+++|.
T Consensus 228 ~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111111 1122345566777787 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.00 Aligned_cols=254 Identities=27% Similarity=0.345 Sum_probs=202.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|...+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++. .+...++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEEE
Confidence 56888899999999999999975 57889999997655556678999999999999999999999886 4567999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
+|||+++++|.+++... ...+++.+...++.|++.||.||| +.+|+||||||+||++++++.+||+|||++....
T Consensus 78 ~~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 78 VMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhh
Confidence 99999999999988652 356889999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCccccccccCCCCccchhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYG---QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
... .......++..|+|||.+... .++.++||||||+++|||++|+.|+.......... . ....+ ..
T Consensus 153 ~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~----~~~~~-~~--- 222 (262)
T cd06613 153 ATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-L----ISKSN-FP--- 222 (262)
T ss_pred hhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-H----HHhcc-CC---
Confidence 321 122335688899999999776 88999999999999999999999986543221110 0 00000 00
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+ .........+.+++.+|++.+|..|||+.+|+.+
T Consensus 223 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 223 PPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred Cccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0122334578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.28 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=197.2
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+|++++++++. .+...++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence 455678999999999999976 47888999987655555677999999999999999999999987 356789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.+. ...++|..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 82 EFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 999999998887542 356899999999999999999999 899999999999999999999999999998754322
Q ss_pred CccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
. .......++..|+|||++. +..++.++|||||||++|||++|+.||.......... .. ...... ...
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~----~~~~~~-~~~ 229 (282)
T cd06643 157 I-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL-KI----AKSEPP-TLA 229 (282)
T ss_pred c-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH-HH----hhcCCC-CCC
Confidence 1 1223356899999999984 4567889999999999999999999986543221111 01 000000 000
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.+......+.+++..|++.+|++||++.+++++-
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 230 -------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 1112334678899999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=318.00 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=197.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCc----EEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGT----LVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|...+.||+|+||.||+|++. +|. .+|+|.+..... ....++.+|+.++++++||||++++|++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------ 80 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------ 80 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence 45667789999999999999864 444 478888765332 224478899999999999999999999863
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++++||+++|+|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccc
Confidence 2357999999999999988652 345889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.|+....... ..++. ..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~----~~~~~ 229 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLL----EKGER 229 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HCCCC
Confidence 9865432221 1223345778999999999999999999999999999997 889986543211 11111 11110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.. .+......+..++..|+..+|++||++.+++++|+..
T Consensus 230 ~~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 LP---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 0111223567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.93 Aligned_cols=253 Identities=25% Similarity=0.326 Sum_probs=198.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|...+.||+|+||.||+++.. +++.||+|.++.........+.+|+.+++.++||||+++++.+. .+...++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 46777889999999999999865 58999999987655445567889999999999999999999886 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++++|.+++.. .+.+++.+.+.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 84 CMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred EEeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 9999999999998864 356899999999999999999999 8899999999999999999999999999987553
Q ss_pred CCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
.. ........|+..|+|||++. .+.++.++|||||||++|||++|+.|+......... .............
T Consensus 158 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-----~~~~~~~~~~~~~ 231 (267)
T cd06645 158 AT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----FLMTKSNFQPPKL 231 (267)
T ss_pred Cc-ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-----HhhhccCCCCCcc
Confidence 22 12223457899999999974 556889999999999999999999998654322111 0000100000000
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. . .....+.+.+++..|++.+|++|||+++++++
T Consensus 232 ~----~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 K----D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c----c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 0 00123457789999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=331.64 Aligned_cols=260 Identities=21% Similarity=0.236 Sum_probs=194.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
..+|...+.||+|+||.||+++.. .++.||||... ...+.+|++++++++|+|||++++++. .+...+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEE
Confidence 457899999999999999999976 47899999632 234678999999999999999999886 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|||++. ++|.+++... ...++|.+++.|+.||++||.||| +.+|+||||||+||||+.++.+||+|||+++..
T Consensus 237 lv~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 9999994 7888887542 346999999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc-c-----hhHHHHHHHHh-hCC
Q 036081 446 LEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSS-F-----LLITDWAWMLA-NSG 517 (614)
Q Consensus 446 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~-~-----~~l~~~~~~~~-~~~ 517 (614)
..... .......||..|+|||++.+..++.++|||||||+||||++|..++-..... . ..+...+.... ...
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43222 1223457999999999999999999999999999999999988665322111 0 11111111100 000
Q ss_pred Cch-----hhhhHHhhh-------hCc-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 KVD-----EIFDEFIRE-------EGS-------RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ~~~-----~~~d~~l~~-------~~~-------~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... .+....... ... ......+.+++..|++.||.+|||+.|++++
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000000000 000 0112356789999999999999999999976
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.56 Aligned_cols=250 Identities=20% Similarity=0.265 Sum_probs=199.9
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
+|...+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++|+|++++++.+. .+...++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence 4677899999999999999876 6889999998643 2334567889999999999999999999886 4567999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++... ....+++...+.++.+++.||.||| +.+|+|+||||+||++++++.++|+|||+++...
T Consensus 76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeec
Confidence 99999999999887542 2345788889999999999999999 8999999999999999999999999999987653
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... ....... .+....
T Consensus 152 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~-~~~~~~----- 219 (255)
T cd08219 152 SPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKVC-QGSYKP----- 219 (255)
T ss_pred ccc-cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHHh-cCCCCC-----
Confidence 322 1223456889999999999889999999999999999999999999754321 1111111 111111
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+......+.+++..|++.+|++|||+.+++..
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ----LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223467788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.20 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=201.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||.||+|+.+ +++.||+|+++.. .....+.+.+|++++++++|+||+++++++. .++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 46888899999999999999976 5889999988643 2333567899999999999999999999987 35678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||++++.|..++.. ...+++.++..++.+|+.||.||| +.+++||||+|+||++++++.+||+|||++..
T Consensus 76 ~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 76 YLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 999999998777655433 345899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH----------
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML---------- 513 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~---------- 513 (614)
.............++..|+|||++... .++.++||||||+++|||++|+.||.......... ......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY-LIQKCLGPLPPSHQEL 228 (288)
T ss_pred cCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCHHHhhh
Confidence 654433233446788999999999888 88999999999999999999999987543221110 000000
Q ss_pred h-hCCC-----chhhhhH-HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 A-NSGK-----VDEIFDE-FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~-~~~~-----~~~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+ .... ..+..+. .+....+......+.+++..|++.+|++|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0000 0000000 01111122235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=316.04 Aligned_cols=272 Identities=23% Similarity=0.340 Sum_probs=203.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+++|...++||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++.+++|+||+++++++...........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999865 68999999986432 2334568899999999999999999998865544445678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++|+||++ ++|.+.+. ...+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999997 47766653 356899999999999999999999 89999999999999999999999999999876
Q ss_pred ccCCCcc--ccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 445 SLEGQSH--LTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 445 ~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
....... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+... ... .......... .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~-~~~~~~~~~~-~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLN-LILGVLGTPS-QE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHHHcCCCC-HH
Confidence 5332211 1233568999999998764 568999999999999999999999996543211 110 0111111100 01
Q ss_pred hhhHHhh-----------hh-------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCCC
Q 036081 522 IFDEFIR-----------EE-------GSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGDID 569 (614)
Q Consensus 522 ~~d~~l~-----------~~-------~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~~~~ 569 (614)
.++.... .. ........+.+++..|++.+|++|||+.|++++ ++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 1110000 00 001123468899999999999999999999997 665544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=328.01 Aligned_cols=202 Identities=23% Similarity=0.383 Sum_probs=173.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||.||+++.. +|+.||+|+++... ......+.+|++++.+++|+||+++++.+. ....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 36888899999999999999876 58999999986422 233456888999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.+ ...+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 9999999999999999865 356899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCc----------------------------------cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHH
Q 036081 444 QSLEGQS----------------------------------HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILEL 489 (614)
Q Consensus 444 ~~~~~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~EL 489 (614)
....... ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 5422110 011235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 036081 490 MSGRKVLETSN 500 (614)
Q Consensus 490 ltG~~p~~~~~ 500 (614)
++|+.||....
T Consensus 230 ~tG~~Pf~~~~ 240 (360)
T cd05627 230 LIGYPPFCSET 240 (360)
T ss_pred ccCCCCCCCCC
Confidence 99999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.63 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=200.1
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++. .+...++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence 3566788999999999999976 58899999987533 234567899999999999999999999987 4567999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++.. ..+++.+...++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence 9999999999998854 45888899999999999999999 8999999999999999999999999999997654
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
... .......++..|+|||++.+..++.++||||||+++|||++|+.|+......... ... ..+.
T Consensus 153 ~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~~~-~~~~-------- 217 (277)
T cd06640 153 DTQ-IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----FLI-PKNN-------- 217 (277)
T ss_pred CCc-cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----hhh-hcCC--------
Confidence 322 1223346888999999999889999999999999999999999998754322110 000 0010
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...........+.+++..|++.+|++||++.+++++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 -PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 011222345578889999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.48 Aligned_cols=266 Identities=24% Similarity=0.303 Sum_probs=200.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cc-hHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KG-DEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~-~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.|++|.||.||+|+.+ +++.||+|+++-... .+ .-..++||.+|.+.+|||||.+..+.+.++ .+..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---ccee
Confidence 45778899999999999999976 689999999974321 12 234689999999999999999999887543 4569
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
|+||||++. +|...+.+. ..++...+..-+..|+++||+||| ...|+|||||++|+|++..|.+||+|||||+.
T Consensus 153 y~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhh
Confidence 999999974 788888764 357888889999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHH----HHhhC-
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LITDWAW----MLANS- 516 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~~~~~----~~~~~- 516 (614)
+... ....+..+-|..|.|||.+.+ ..|++..|+||+|||+.||+++++.|.+..+-.. .+..... ..|..
T Consensus 227 ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 227 YGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 7544 334566777999999999986 5799999999999999999999998876543221 1111100 00000
Q ss_pred --------CCchhhhhHHhhhhCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 --------GKVDEIFDEFIREEGSRA-VMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 --------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
-...+..-..++...... ..+.-.++....+..||.+|-|+.|.+++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000000011111111111 33455677778889999999999998865
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=304.14 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=198.9
Q ss_pred ccceeeeccCcEEEEEEEEcC-----CcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 291 SQKNLIGQGASGVVYKGTLED-----GTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~-----g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
...+.||+|+||.||+++..+ +..||+|.++..... ..+.+.+|++++.+++|+||+++++++.. ....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCee
Confidence 456789999999999999764 388999999765433 46789999999999999999999999873 4578
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+++|||+++++|.+++.... ...+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCcee
Confidence 99999999999999987532 122899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
.............++..|+|||.+.+..++.++||||||++++||++ |+.|+....... .... ...+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~-~~~~~~~--- 223 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-----VLEY-LKKGYRL--- 223 (258)
T ss_pred cccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH-HhcCCCC---
Confidence 65443322222347789999999988899999999999999999999 788876532211 1111 1111111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.........+.+++..|+..+|++|||+.|++++|
T Consensus 224 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111345788899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.21 Aligned_cols=260 Identities=21% Similarity=0.228 Sum_probs=196.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc---CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE---DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..+|...+.||+|+||.||++... .+..||||.+... +.+.+|++++++++||||+++++++. ....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR-----WKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe-----eCCE
Confidence 456899999999999999999754 3578999987542 34568999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++|||++. ++|.+++.. ...++|..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 161 ~~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEEEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 899999995 688888733 467999999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHHhhC----
Q 036081 444 QSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF--LLITDWAWMLANS---- 516 (614)
Q Consensus 444 ~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~~l~~~~~~~~~~---- 516 (614)
....... .......||+.|+|||++....++.++|||||||++|||++|+.||....... ..+..........
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 6543322 22234679999999999999999999999999999999999999996543221 1111111110000
Q ss_pred --CC---chhhhhHHh---hhh--Cc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 --GK---VDEIFDEFI---REE--GS-----RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 --~~---~~~~~d~~l---~~~--~~-----~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. +.+.+.... +.. .+ ......+..++..|++.+|++|||+.|++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000 000 00 0112356778899999999999999999987
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=303.72 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=202.3
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|+||.||.++.. +++.+++|.+... +....+++.+|++++++++|+||+++++++. +....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 4778899999999999999864 5889999987643 2344567899999999999999999999987 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
++|||+++|+|.+++.... ...+++.++..++.|++.||.||| +.+++||||||+||++++++.+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 9999999999999986532 346889999999999999999999 889999999999999999999999999998865
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... +...... .+.....
T Consensus 152 ~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~-~~~~~~~--- 221 (256)
T cd08221 152 GSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIV-QGNYTPV--- 221 (256)
T ss_pred ccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHH-cCCCCCC---
Confidence 43332 233456899999999999888999999999999999999999998654321 1111111 1111111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.......+.+++..|++.+|++||++.++++++
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 122334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.84 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=194.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-----CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-----TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.+|...+.||+|+||.||+|... +|+.||||.+.... .+..+.+.+|+.++.+++|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 46888999999999999999975 58999999885321 12235688899999999999999999987532 23
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++++|.+++.+ ...+++...++++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~ 152 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGA 152 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcc
Confidence 467899999999999998864 345788889999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc--cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQS--HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... . ... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~---~~~-~~~~~~- 226 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-A---IFK-IATQPT- 226 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-H---HHH-HhcCCC-
Confidence 875432111 11233568899999999998889999999999999999999999986532111 0 100 000000
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....+......+..++..|+. +|+.||+++|++++
T Consensus 227 --------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 --------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011122333456667777774 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.38 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=191.7
Q ss_pred ceeeecc--CcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 293 KNLIGQG--ASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 293 ~~~LG~G--~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
.++||+| +||+||+++.+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++. .++..++|
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~lv 77 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWVV 77 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEEE
Confidence 4679999 78999999875 68999999986532 223456778999999999999999999987 45678999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++++|||.......
T Consensus 78 ~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 78 TSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 99999999999986532 345899999999999999999999 89999999999999999999999999986543321
Q ss_pred CCcc------ccccccCCCCccchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 448 GQSH------LTTRVAGTYGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 448 ~~~~------~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||............. .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~------~~~~ 227 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL------NGTV 227 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh------cCCc
Confidence 1110 1122356788999999976 468999999999999999999999997543222111100 0110
Q ss_pred hhhhh-------------------HHh-----------------hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFD-------------------EFI-----------------REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d-------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...++ ..+ ...........+.+++..|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000 000 000111233467899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=303.99 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=200.2
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|+||.||+++.. +|+.+|+|++... .....+++.+|++++++++|+||+++++++. .....+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence 4778899999999999999865 6899999998643 2233467899999999999999999999886 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++++|.+++... ....+++.++++++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 999999999999988652 1235788899999999999999999 899999999999999999999999999998765
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
..... ......|++.|+|||++.++.++.++||||||++++||++|+.|+...... +.+..... +...
T Consensus 152 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~-~~~~----- 219 (256)
T cd08218 152 NSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKIIR-GSYP----- 219 (256)
T ss_pred Ccchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHhc-CCCC-----
Confidence 33221 123346889999999999999999999999999999999999998653321 11111111 1110
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.+|++||+|.+|+++
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 ----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0112233467889999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=308.48 Aligned_cols=262 Identities=24% Similarity=0.270 Sum_probs=197.1
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc-----chHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK-----GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-----~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+|...+.||+|+||.||+|... +|+.||||+++..... ....+.+|++++.+++|+||+++++++. ...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 3677789999999999999975 6899999999754322 2345778999999999999999999987 356
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+ +|+|.+++... ...+++..++.++.||++||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~ 149 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLA 149 (298)
T ss_pred EEEEEEccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceee
Confidence 789999999 99999998653 236899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH-------h
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML-------A 514 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~-------~ 514 (614)
+....... ......++..|+|||.+.+ ..++.++||||||+++|||++|..+|....... .+....... +
T Consensus 150 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 150 RSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENW 227 (298)
T ss_pred eeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhh
Confidence 86543321 1223356788999999864 467899999999999999999987776543221 111110000 0
Q ss_pred -hCCCchhhhhHHhh-----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 -NSGKVDEIFDEFIR-----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 -~~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.............. ..........+.+++..|++.+|++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 00011224578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.41 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=203.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|+..+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+. .+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 46888999999999999999965 68899999986432 234567999999999999999999999886 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|+||+++++|.+++........+++.....++.|++.||+||| +.+++||||||+||++++++.+||+|||++...
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 99999999999999876433356899999999999999999999 899999999999999999999999999998765
Q ss_pred cCCCcc---ccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 446 LEGQSH---LTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 446 ~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
...... ......|+..|+|||++... .++.++||||||+++|||++|+.||........ ..... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~----~~~~--- 224 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTL----QNDP--- 224 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHh----cCCC---
Confidence 433222 22345689999999999877 789999999999999999999999975433211 11111 1100
Q ss_pred hhhHHhhhh-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREE-GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+... ......+.+.+++..|++.+|++|||+.+++++
T Consensus 225 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 ---PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ---CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001000 012334577899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.16 Aligned_cols=261 Identities=27% Similarity=0.405 Sum_probs=204.5
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCC-CCC
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDD-EKG 361 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~-~~~ 361 (614)
.++++|+..+.||+|++|.||+|..+ +++.+++|.+..... ..+.+.+|+++++++ +|+||+++++++..... ..+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46788999999999999999999985 578999999875433 356799999999999 69999999999875443 346
Q ss_pred ceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
...++||||+++++|.+++.... ....+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 67899999999999999886532 2356899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
++....... .......|+..|+|||++.. ..++.++||||||++++||++|+.||........ +... .
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~-----~ 231 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFKI-----P 231 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHHh-----h
Confidence 987543222 12233468899999998853 3467899999999999999999999964322111 1110 1
Q ss_pred CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+.... + .......+.+.+++.+|+..||++|||+.+++++
T Consensus 232 ~~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RNPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ccCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111100 0 0112234578889999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.28 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=194.6
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|...+.||+|+||.||+++.. +|+.+|+|+++... ......+.+|++++++++|+||+++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence 4677889999999999999976 68999999986432 222356788999999999999999999986 455789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|+||++ ++|.+++... ...+++...+.++.||++||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 76 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAF 149 (284)
T ss_pred EEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence 9999997 5777776542 356899999999999999999999 899999999999999999999999999998865
Q ss_pred cCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH----------HHHHh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW----------AWMLA 514 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~----------~~~~~ 514 (614)
..... ......++..|+|||++.+. .++.++||||||+++|||++|+.|+.........+... .|...
T Consensus 150 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 150 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred CCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 33221 12234678899999998764 47899999999999999999998864433222111100 00000
Q ss_pred hC-CCc--hhhhhHHhh-hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NS-GKV--DEIFDEFIR-EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~-~~~--~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ... ......... ........+.+.+++..|++.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 000 000000000 00111234567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.10 Aligned_cols=265 Identities=27% Similarity=0.394 Sum_probs=205.1
Q ss_pred ChHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCccccccccccc
Q 036081 279 RESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSS 356 (614)
Q Consensus 279 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~ 356 (614)
+..++..+.+.|+..+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +|+|++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45666677889999999999999999999975 58899999886533 3345788999999999 699999999998643
Q ss_pred CC-CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEE
Q 036081 357 DD-EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 357 ~~-~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~K 435 (614)
.. ..+...+++|||+++|+|.+++.... ...+++..+..++.||+.||.||| +.+|+||||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 22 23567899999999999999886532 345788888999999999999999 89999999999999999999999
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA 510 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~ 510 (614)
|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||..........
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 999999875432211 123356899999999986 3467889999999999999999999996533211100
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....... . ..........+.+++..|++.+|.+|||+.|++++
T Consensus 237 -~~~~~~~------~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 -LIPRNPP------P---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -hHhhCCC------C---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0000000 0 00111234578889999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=310.30 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=198.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|+..+.||+|+||.||+|+.. +++.+++|.+...+....+.+.+|++++++++|+|++++++++. .+...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 45777889999999999999976 48999999997665555678999999999999999999999886 3457899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++++|..++.+. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 87 MIEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred EEecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999998877542 356899999999999999999999 8999999999999999999999999999987532
Q ss_pred CCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
.. ........++..|+|||++. ...++.++|||||||++|||++|+.|+........ ...... .....
T Consensus 162 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~-~~~~~ 234 (292)
T cd06644 162 KT-LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAK-SEPPT 234 (292)
T ss_pred cc-ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-----HHHHhc-CCCcc
Confidence 22 11123346888999999985 34578899999999999999999999865432111 111111 10000
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ..+......+.+++..|++.+|++||++.+++++
T Consensus 235 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 L-------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C-------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0111233467889999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=314.26 Aligned_cols=199 Identities=26% Similarity=0.413 Sum_probs=160.6
Q ss_pred ceeeeccCcEEEEEEEEcC---CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 293 KNLIGQGASGVVYKGTLED---GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~---g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
..+||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++... .+...++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEe
Confidence 3689999999999999753 5789999986532 234678999999999999999999988643 3456899999
Q ss_pred cCCCCCcccccchhh------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee----cCCCcEEEeee
Q 036081 370 FMPSGSLGDHISNAL------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL----DSEMKAKVADF 439 (614)
Q Consensus 370 y~~~gsL~~~L~~~~------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~KL~DF 439 (614)
|+++ +|.+++.... ....+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9874 7766654211 1235788889999999999999999 8999999999999999 56779999999
Q ss_pred cccccccCCCc--cccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 036081 440 GLAKQSLEGQS--HLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSN 500 (614)
Q Consensus 440 Gla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~ 500 (614)
|+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 99986543221 12234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.39 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=197.3
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
+|+..+.||+|+||.||++..+ +|..+|+|.++.. .....+.+.+|++++.+++|+||+++++++. ..+..++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence 5677889999999999999986 6899999988653 2233467899999999999999999999887 3567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++++|..++........+++..+..++.+++.||.|||+ +.+|+||||||+||+++.++.+||+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999998888653223478999999999999999999993 3589999999999999999999999999987543
Q ss_pred CCCccccccccCCCCccchhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYG------QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
.. ......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ . ..... ...+..
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-~~~~~-~~~~~~- 227 (286)
T cd06622 155 AS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-F-AQLSA-IVDGDP- 227 (286)
T ss_pred CC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-H-HHHHH-HhhcCC-
Confidence 22 22334688899999998644 358899999999999999999999965332110 0 00000 000110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+......+..++..|++.+|++||++.+++.+
T Consensus 228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 --------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 01122244567789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=305.15 Aligned_cols=254 Identities=27% Similarity=0.370 Sum_probs=201.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|+..+.||+|+||.||++..+ +++.+|+|++.... ....+++.+|++++++++||||+++++.+. .....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence 35677789999999999999986 68999999987643 244567899999999999999999999987 346799
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCC-CceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK-PAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+++||+++++|.+++... ...+++.....++.+++.||+||| + .+++||||||+||++++++.+||+|||.+..
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 76 ICMEYMDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred EEEEecCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence 999999999999998753 256888899999999999999999 7 8999999999999999999999999999875
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.|+...........+.......... ..
T Consensus 151 ~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~--- 223 (265)
T cd06605 151 LVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-PR--- 223 (265)
T ss_pred hHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-CC---
Confidence 432211 12568899999999999999999999999999999999999997543211111111111111100 00
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.........+.+++..|+..+|++|||+.+++.+
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 -----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0011134568889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.20 Aligned_cols=269 Identities=23% Similarity=0.342 Sum_probs=204.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeec--CCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITD--LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~--~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
...|...+.||+|+||.|.+++.. +|+.||||++.+ .+.-..+.-.+|+++|+.++|+||+.+.+.........-+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 344555688999999999999876 689999999974 23333567789999999999999999999987644446778
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.|+|+|+| ..+|...++. ++.|+......+.+||++||.|+| +.+++||||||+|+|++.+...||+|||||+
T Consensus 101 vYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccccee
Confidence 99999999 5677777754 344999999999999999999999 9999999999999999999999999999999
Q ss_pred cccCC-CccccccccCCCCccchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHH-------H
Q 036081 444 QSLEG-QSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF--LLITDWAW-------M 512 (614)
Q Consensus 444 ~~~~~-~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~~l~~~~~-------~ 512 (614)
..... .....+..+.|..|.|||.+. ...|+...||||.|||+.||++|+..|.+.+.-. .++.+... .
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 76543 122346678899999999986 5789999999999999999999999997654322 11111110 0
Q ss_pred HhhCCCchhhhhHHhh-------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 513 LANSGKVDEIFDEFIR-------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 513 ~~~~~~~~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.....+....+...-. ...+ ......+++...|+..||.+|+|++|.+++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0011111111110000 0000 122366788899999999999999999876
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=310.76 Aligned_cols=239 Identities=21% Similarity=0.346 Sum_probs=186.7
Q ss_pred eeeccCcEEEEEEEEcC--------CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 295 LIGQGASGVVYKGTLED--------GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~--------g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.||+|+||.||+|.... ...+|+|.+........+.+.+|+.++..++|||++++++++.. +...++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcEE
Confidence 69999999999998642 23488888765544555788999999999999999999999873 456799
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc--------EEEee
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK--------AKVAD 438 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--------~KL~D 438 (614)
||||+++|+|.+++... ...++|..+++++.||+.||+||| +.+|+||||||+||+++.++. +|++|
T Consensus 77 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 77 VQEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEecCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999999998753 346899999999999999999999 899999999999999987765 59999
Q ss_pred ecccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCCccchhHHHHHHHHhhC
Q 036081 439 FGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGR-KVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 439 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~-~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
||++..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+....... ........
T Consensus 152 ~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-----~~~~~~~~ 221 (258)
T cd05078 152 PGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-----KLQFYEDR 221 (258)
T ss_pred cccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-----HHHHHHcc
Confidence 998865432 123467889999999986 45899999999999999999995 5544322110 00000000
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
. ..+......+.+++..|++.+|++|||++++++.|+
T Consensus 222 ~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 H------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 011112246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.37 Aligned_cols=261 Identities=20% Similarity=0.343 Sum_probs=196.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.++++++|+||+++++++. .....+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEE
Confidence 45788899999999999999876 58899999986433 233456789999999999999999999986 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++ ++|.+++... ...+++.....++.||+.||.||| +.+|+||||||+||++++++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred EEEeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 9999997 5888877652 346888999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +. ........ ...+...
T Consensus 155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~-~~~~~~~~-~~~~~~~ 230 (301)
T cd07873 155 SIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LH-FIFRILGT-PTEETWP 230 (301)
T ss_pred CCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHcCC-CChhhch
Confidence 32221 1223457889999999875 4578899999999999999999999976543211 00 00000000 0000000
Q ss_pred HHhh-----------------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIR-----------------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~-----------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+. ..........+.+++..|++.||.+|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 00011223467789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.84 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=200.1
Q ss_pred CCCccceeeeccCcEEEEEEEEcC-Cc----EEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED-GT----LVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|...+.||+|+||.||+|.+++ |. .+|+|.+..... ....++.+|+.++.+++|+||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 346777899999999999998653 33 589998865433 334678999999999999999999999863
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++.+. ...+++...+.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcc
Confidence 4689999999999999998753 345899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccc-ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQSHLT-TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~~~~-~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++.......... ....++..|+|||.+..+.++.++||||||+++|||++ |+.||....... +.... ..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~-~~~~~ 229 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLL-EKGER 229 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHH-hCCCC
Confidence 986543322211 11224568999999998899999999999999999999 999987643221 11111 11110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ..+......+.+++..|+..+|+.||++.++++.|+..
T Consensus 230 ~---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 L---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 00111223567888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=307.50 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=196.5
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---c-------chHHHHHHHHHHHHccCCCcccccccccccC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---K-------GDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~-------~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~ 357 (614)
+|...+.||+|+||.||+|... +|+.+|+|.++.... . ..+.+.+|++++.+++|+|++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 3566789999999999999865 689999998853211 1 1246788999999999999999999886
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEe
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVA 437 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~ 437 (614)
.....++||||+++|+|.+++.+. ..+++..+..++.||+.||.||| +.+++||||||+||+++.++.+||+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~ 150 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKIS 150 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEe
Confidence 456789999999999999998763 56899999999999999999999 8899999999999999999999999
Q ss_pred eecccccccCCCcc-ccccccCCCCccchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh
Q 036081 438 DFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA 514 (614)
Q Consensus 438 DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~ 514 (614)
|||+++........ ......|+..|+|||.+.... ++.++||||||+++||+++|+.|+........ .....
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~ 225 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-----MFKLG 225 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----HHHhh
Confidence 99998764322111 123456889999999987654 88999999999999999999999864332110 11111
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ......+... ........+.+++..|++.+|+.|||+.+|+++
T Consensus 226 ~-~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 N-KRSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-cccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 1111111111 111234577889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.57 Aligned_cols=269 Identities=26% Similarity=0.341 Sum_probs=201.6
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHH--ccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISK--IRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~--l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+.....+.||+|.||.||+|.|+ |+.||||++.. ..++.+.+|.+|++. |+|+||+.+++.-..+++ .-.+++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g-s~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNG-SWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCC-ceEEEE
Confidence 44567789999999999999998 99999999865 335568889998886 499999999998765443 457899
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcC-----CCceEecCCCCCceeecCCCcEEEeeec
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL-----KPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~-----~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
||.||.++|||+|+|.. ..++-...+++++.+|.||++||.+. ++.|.|||||+.|||+..++.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999964 57999999999999999999999543 7889999999999999999999999999
Q ss_pred ccccccCCCcc---ccccccCCCCccchhhhccCC----C--CchhhHHHHHHHHHHHHhCC----------CCCCCCCc
Q 036081 441 LAKQSLEGQSH---LTTRVAGTYGYLAPEYALYGQ----L--TEKSDVYSFGIVILELMSGR----------KVLETSNS 501 (614)
Q Consensus 441 la~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~~----~--s~ksDVwSfGvvL~ELltG~----------~p~~~~~~ 501 (614)
||......... ..+..+||..|||||++...- + -..+||||||.|+||+.-.- .||...-+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99876544222 245568999999999986431 2 13699999999999996521 34432211
Q ss_pred cchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 502 SFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 502 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
.+....++. +.+-..++...++. ...+.+.+..+.+++..|+..+|..|-|+--+-+.|.+...
T Consensus 442 ~DPs~eeMr-kVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEMR-KVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHHh-cceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 111111110 00011111111111 11234567788999999999999999999998888876543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=307.31 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=195.3
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|++|.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 4778899999999999999875 68999999886432 223457889999999999999999999986 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++ ++|.+++... ....+++..+..++.|++.||+||| +.+++||||+|+||+++.++.+||+|||+++..
T Consensus 76 ~v~e~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 76 LVFEFLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred EEeeccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999995 6888877543 2356899999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC-CCc----
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS-GKV---- 519 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~-~~~---- 519 (614)
..... ......++..|+|||++.+.. ++.++||||||+++|||+||+.||......... .......-.. ...
T Consensus 151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 151 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL-FRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred ccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCChhhhhhh
Confidence 33221 122345688999999887644 688999999999999999999999754432111 1111100000 000
Q ss_pred ----------hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 ----------DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ----------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.......+.. ........+.+++..|++.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 001123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.42 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=200.0
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++|+||+++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 4677889999999999999975 68999999987543 233567999999999999999999999986 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+ +++|.+++... ...+++.++++++.||++||+||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 76 ~v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred EEeccc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 999999 99999988653 356899999999999999999999 899999999999999999999999999998865
Q ss_pred cCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC------
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK------ 518 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~------ 518 (614)
............|+..|+|||++.+. .++.++||||||++++||++|+.+|........ + ...........
T Consensus 150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-L-AIVFRTLGTPNEETWPG 227 (286)
T ss_pred cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-H-HHHHHHcCCCChHHHhh
Confidence 44332223345689999999998754 468999999999999999999887765432211 1 01111000000
Q ss_pred ---chhh---hh-----HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 519 ---VDEI---FD-----EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 519 ---~~~~---~d-----~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+... .. ..+.. ...+..+.+.+++..|++.+|++|||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcchhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00 00000 001223578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=312.41 Aligned_cols=253 Identities=25% Similarity=0.287 Sum_probs=199.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc---chHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK---GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||++... +++.+|+|.+...... ..+.+.+|++++.+++|+||+++++.+. .+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 36788899999999999999976 4899999998754322 3457889999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++++|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 89999999999999988643 2356899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCc----------------------------cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 036081 444 QSLEGQS----------------------------HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 495 (614)
Q Consensus 444 ~~~~~~~----------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p 495 (614)
....... .......||..|+|||++.+..++.++||||||+++|||++|+.|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 5432111 011234688999999999998999999999999999999999999
Q ss_pred CCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 036081 496 LETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT----IADALKM 563 (614)
Q Consensus 496 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt----m~eVl~~ 563 (614)
|...+.... +.. ... .. ..-.........+.+++..|++.+|++||| +.|++.+
T Consensus 232 f~~~~~~~~----~~~-~~~-~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 232 FKGSNRDET----FSN-ILK-KE--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCchHHH----HHH-Hhc-CC--------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 975443211 110 000 00 000011113457889999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=305.93 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=184.9
Q ss_pred eeeccCcEEEEEEEEcCC---cEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEec
Q 036081 295 LIGQGASGVVYKGTLEDG---TLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~g---~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
.||+|+||.||+|...++ ..+++|.++... ....+.|.+|+++++.++||||+++++.+. .....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence 599999999999986543 346677665433 234578999999999999999999999987 34568999999
Q ss_pred CCCCCcccccchhhh-ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCC
Q 036081 371 MPSGSLGDHISNALT-RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449 (614)
Q Consensus 371 ~~~gsL~~~L~~~~~-~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 449 (614)
+++|+|.+++.+... ...+.+...+.++.||++||+||| +.+++||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence 999999999875321 234566677899999999999999 8999999999999999999999999999986422211
Q ss_pred -ccccccccCCCCccchhhhcc-------CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 450 -SHLTTRVAGTYGYLAPEYALY-------GQLTEKSDVYSFGIVILELMSG-RKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 450 -~~~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSfGvvL~ELltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
........++..|+|||++.. ..++.++||||||+++|||+++ ..|+....... ........ ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~-~~~ 227 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-----VLNHVIKD-QQV 227 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhh-ccc
Confidence 112234567889999998753 2457899999999999999974 66775433211 11111111 111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
...++.+... ...++.+++..|+ .+|++||++.+|++.|.
T Consensus 228 ~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1222222111 2245667778898 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=312.90 Aligned_cols=246 Identities=23% Similarity=0.325 Sum_probs=203.1
Q ss_pred CCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCc---chHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 289 GFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTK---GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+|++.+.||+|.||.|-++.. ..|+.||||.+++...+ ..-...+||+||+.|+||||++++.+|. +....
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-----NkdKI 128 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-----NKDKI 128 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-----CCceE
Confidence 466677899999999999985 57999999999764333 3345779999999999999999999997 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
.+||||..+|.|++++.. ++.|++.+...++.||..|+.|.| +++++|||||.+|||||.|+++||+||||+..
T Consensus 129 vivMEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhh
Confidence 999999999999999976 578999999999999999999999 99999999999999999999999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
+..+. ..+..+|++-|.+||++.+..|. +..|-||+||+||-|+.|..||++.+.. .++++ ...|...+--
T Consensus 203 y~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----~lvrQ-Is~GaYrEP~ 274 (668)
T KOG0611|consen 203 YADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----RLVRQ-ISRGAYREPE 274 (668)
T ss_pred hcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----HHHHH-hhcccccCCC
Confidence 65433 34567999999999999998885 6899999999999999999999875421 12221 1222222111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.+ ....-++.+|+..+|++|.|+.+|..+-
T Consensus 275 -------~P----SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 -------TP----SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CC----chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11 1334578899999999999999998873
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=302.76 Aligned_cols=251 Identities=28% Similarity=0.442 Sum_probs=198.8
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc--chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK--GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|...+.||+|+||.||+|+.. +++.+++|.++..... ..+.+.+|++++++++|+||+++++++. .....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 4677889999999999999875 6899999998765443 4678999999999999999999999876 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|+||+++++|.+++.. ...+++..+..++.+++.||.||| +.+++|+||+|+||++++++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence 99999999999999865 345889999999999999999999 899999999999999999999999999998865
Q ss_pred cCCCccccc---cccCCCCccchhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 446 LEGQSHLTT---RVAGTYGYLAPEYALYGQ---LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 446 ~~~~~~~~~---~~~gt~~Y~APE~~~~~~---~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
......... ...++..|+|||++.... ++.++||||||+++|||++|+.||........ ...... .+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~----~~~~~~-~~~- 223 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----IMFHVG-AGH- 223 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH----HHHHHh-cCC-
Confidence 433222111 346788999999998766 88999999999999999999999965432111 110000 010
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
.+.+.. .......+.+++..|++.+|++|||+.|++.
T Consensus 224 ----~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ----KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 1112346678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=310.50 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=196.0
Q ss_pred ceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 293 KNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
...||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++.+. .++..++||||+
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~e~~ 101 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVMEFL 101 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEEeCC
Confidence 356999999999999875 58899999987655555677999999999999999999999886 456789999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 451 (614)
++++|.+++.. ..+++.+...++.+|+.||+||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 99999988743 45899999999999999999999 88999999999999999999999999999875433221
Q ss_pred ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhC
Q 036081 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531 (614)
Q Consensus 452 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 531 (614)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ +. .. .. .+...+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~----~~-~~-----~~~~~~~~-- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MR----RI-RD-----NLPPRVKD-- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH----HH-Hh-----cCCCcccc--
Confidence 22335689999999999988999999999999999999999999865432111 00 00 00 00111100
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 532 SRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.......+..++..|++.+|++|||+.|++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11123456778889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.48 Aligned_cols=263 Identities=25% Similarity=0.313 Sum_probs=202.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++... .....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence 46788899999999999999985 588999999875332 3456799999999999999999999988642 245689
Q ss_pred EEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+||||+++++|.+++.... ....+++.....++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 9999999999998876432 2345788889999999999999999 89999999999999999999999999999875
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+...... ...... +.
T Consensus 155 ~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~-~~ 229 (287)
T cd06621 155 LVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPE-LK 229 (287)
T ss_pred ccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchh-hc
Confidence 43221 12345788999999999999999999999999999999999999765321111111111111 111111 10
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... .......+.+.+++..|++.+|.+|||+.|++++
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 0011234578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=306.46 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=198.2
Q ss_pred CccceeeeccCcEEEEEEEEc----CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCC-CCc
Q 036081 290 FSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE-KGK 362 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~-~~~ 362 (614)
|...+.||+|+||.||+|.+. +++.||||+++.. .....+++.+|++++++++||||+++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999864 3688999998653 223456789999999999999999999988654321 122
Q ss_pred eEEEEEecCCCCCcccccchhh---hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL---TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
..++++||+++|+|.+++.... ....+++...++++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 4578999999999988875321 1224788889999999999999999 889999999999999999999999999
Q ss_pred cccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 440 GLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 440 Gla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|+++........ ......++..|++||.+..+.++.++||||||+++|||++ |+.|+...... .+..+.. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~---~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI---KGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH---cCC
Confidence 998865433221 1223345678999999999999999999999999999999 88888654321 1111111 111
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
... .+......+.+++..|++.+|++||++.++++.|++
T Consensus 233 ~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 233 RLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 110 011223578889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=310.43 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=196.2
Q ss_pred ceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 293 KNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
...||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++++++++. .+...++|+||+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~e~~ 100 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLMEFL 100 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEEecC
Confidence 346999999999999875 68999999987655555677899999999999999999999987 456789999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 451 (614)
++++|.+++.. ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....... .
T Consensus 101 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~ 172 (297)
T cd06659 101 QGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-P 172 (297)
T ss_pred CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-c
Confidence 99999887643 46899999999999999999999 8999999999999999999999999999987543322 1
Q ss_pred ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhC
Q 036081 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531 (614)
Q Consensus 452 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 531 (614)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ .... ....... .. .
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~-~~~~~~~-----~~--~ 239 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRL-RDSPPPK-----LK--N 239 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH-hccCCCC-----cc--c
Confidence 22335689999999999988999999999999999999999999865432111 1111 1110000 00 0
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 532 SRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.......+.+++..|++.+|++||++.+++++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11123457788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.54 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=200.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||.||+++.. ++..+|+|.+........+.|.+|++++++++|+|++++++.+. .+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 345778889999999999999975 68999999987655555678999999999999999999999987 355789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++++|.+++... ...+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 79 ILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred EEeeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 999999999999988653 356899999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
..... ......++..|+|||.+. ...++.++||||||+++|||++|+.||........ +..+ ..+...
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~~~-----~~~~~~ 226 (280)
T cd06611 154 KSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LLKI-----LKSEPP 226 (280)
T ss_pred ccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HHHH-----hcCCCC
Confidence 32221 223356899999999985 34577899999999999999999999975432211 1111 111000
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+ ..+......+.+++..|++.+|.+||++.+++++
T Consensus 227 -----~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 -----TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 0011223467788999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=303.77 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=198.7
Q ss_pred CCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCC------cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDT------KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~------~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
+|+..+.||+|+||.||+++. .+|+.+|+|.+..... ...+.+.+|++++++++|+||+++++++. ++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 477788999999999999986 4689999999864321 12457889999999999999999999986 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeeec
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFG 440 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DFG 440 (614)
+..++||||+++++|.+++.+ ...+++..+..++.|++.||.||| +.+++||||||+||+++.++ .+||+|||
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence 678999999999999999865 356889999999999999999999 89999999999999998876 59999999
Q ss_pred ccccccCCCc---cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 441 LAKQSLEGQS---HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 441 la~~~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
++........ .......|+..|+|||.+.+..++.++||||+|++++||++|+.||......... ..........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~ 227 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--ALIFKIASAT 227 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--HHHHHHhccC
Confidence 9876543211 1122356889999999998889999999999999999999999998643321110 1111100000
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ....+......+.+++..|++.+|+.|||+.+++++
T Consensus 228 ~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 T---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred C---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0 011222344578889999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=323.15 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=207.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeec--CCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITD--LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~--~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|...+.+|+|+||.++..+++ +++.+++|.+.- ......+...+|+.++++++|||||.+.+.+++ ++...
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----DGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----CCceE
Confidence 45777889999999999999876 688999998854 233344578899999999999999999999874 34449
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+|||+|++||+|.+.+.... ...+++++...++.|+..|+.||| +..|+|||||+.||+++.+..+||+|||+|+.
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhh
Confidence 99999999999999997743 456788888999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... .....++||+.||.||.+.+.+|..|+|||||||++|||.+-+++|...+.... +.+. ..
T Consensus 156 l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----i~ki---------~~ 220 (426)
T KOG0589|consen 156 LNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----ILKI---------NR 220 (426)
T ss_pred cCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----HHHH---------hh
Confidence 76544 245568999999999999999999999999999999999999999976543221 1110 00
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. +....+......+..++..|++.+|..||++.+++.+
T Consensus 221 ~-~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 G-LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred c-cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 0 0111233344578889999999999999999999876
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=302.58 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=204.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|+..+.||+|++|.||+++.. +|+.++||++..... ...+.+.+|++.+.+++|+|++++++++. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 36788899999999999999987 499999999876543 34678999999999999999999999987 446799
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCC-CceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK-PAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+||||+++++|.+++... ..+++..++.++.|+++||+||| + .+++||||+|+||+++.++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred EEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 999999999999998652 56899999999999999999999 8 9999999999999999999999999999886
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
....... .....++..|+|||.+..+.++.++||||||+++|||++|+.|+....... ..+....... ....
T Consensus 150 ~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~-~~~~---- 221 (264)
T cd06623 150 LENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAICD-GPPP---- 221 (264)
T ss_pred cccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHHhc-CCCC----
Confidence 5433322 224467899999999999999999999999999999999999997654211 0011111111 1000
Q ss_pred HHhhhhCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRA-VMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+.. ..+.+.+++..|++.+|++||++.+++++
T Consensus 222 -----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 -----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111 34578889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=300.65 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=198.3
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|+||.||++... +++.+|||.+... .....+.+.+|++++++++|+|++++++.+. .+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 4778899999999999999875 6889999998653 2334567899999999999999999999876 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-CcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~KL~DFGla~~ 444 (614)
+||||+++++|.+++.... ...+++..+.+++.+++.||+||| +.+++||||||+||+++.+ +.+||+|||++..
T Consensus 76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI 151 (256)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence 9999999999999986532 345889999999999999999999 8999999999999999865 4689999999986
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+... ....... +....
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~-~~~~~--- 220 (256)
T cd08220 152 LSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKIMS-GTFAP--- 220 (256)
T ss_pred cCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHHHh-cCCCC---
Confidence 54322 1223568899999999998889999999999999999999999986543221 1111101 11111
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+......+.+++..|++.+|++|||+.|++++
T Consensus 221 ------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111233467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.98 Aligned_cols=265 Identities=21% Similarity=0.311 Sum_probs=195.5
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++++|...+.||+|+||.||+|... +|+.+|+|++..... .....+.+|++++++++|+||+++.+++. .+..
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence 4578999999999999999999865 689999999865432 22346789999999999999999999886 4457
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||++ ++|.+++... ...+.+.++..++.|++.||.||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred EEEEEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecccccc
Confidence 899999996 6777666432 345788889999999999999999 8899999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC----
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK---- 518 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~---- 518 (614)
...... .......++..|+|||++.+. .++.++||||||+++|||++|+.||+........+.. .|.......
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (291)
T cd07870 152 AKSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK-IWTVLGVPTEDTW 229 (291)
T ss_pred ccCCCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HHHHcCCCChhhh
Confidence 543221 112234578999999998754 5789999999999999999999999754432111111 111100000
Q ss_pred -----chhhhhHHhhhh---------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 519 -----VDEIFDEFIREE---------GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 519 -----~~~~~d~~l~~~---------~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.....+...... ........+.+++..|++.+|.+|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000 000012356788999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=307.52 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=192.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHH-HHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEI-ISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~i-l~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||.||+++.. +|+.||+|+++... .+....+..|+.+ ++.++|+|++++++++. .....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 46888899999999999999976 69999999987532 2334566677776 45568999999999986 34568
Q ss_pred EEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCC-ceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 365 FLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKP-AIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
+++|||++ |+|.+++.... ....+++...+.++.||+.||+||| +. +++||||||+||+++.++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999996 78887775432 2346899999999999999999999 65 9999999999999999999999999998
Q ss_pred ccccCCCccccccccCCCCccchhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALY----GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
+...... ..+...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.........+... .. +.
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~-~~ 224 (283)
T cd06617 152 GYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV----VE-EP 224 (283)
T ss_pred ccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH----Hh-cC
Confidence 8653321 2233468899999998864 456889999999999999999999986433211111111 00 00
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... + ......+.+.+++..|++.+|++||++.+++++
T Consensus 225 ~~~-----~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 225 SPQ-----L---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCC-----C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 011233567889999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.53 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=198.3
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
|+..+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++.+++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 456789999999999999976 48999999997653 233457889999999999999999999987421 367999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++ +|.+++... ...+++..++.++.+|++||+||| +.+++|+||||+||++++++.+||+|||++....
T Consensus 78 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 78 VFEYMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred Eeccccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 9999974 888877552 246899999999999999999999 8899999999999999999999999999998664
Q ss_pred CCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh-----------
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA----------- 514 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~----------- 514 (614)
.......+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +........
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccc
Confidence 433222334467889999998764 4678999999999999999999999976543221 111000000
Q ss_pred -----hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 -----NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 -----~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
............+...........+.+++..|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000111111111111124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.51 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=201.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|...+.||+|+||.||+|... ++..+|+|.+........+.+.+|+.++++++|||++++++++. .....++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence 56888899999999999999864 68899999986555555677899999999999999999999987 3456899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
|+||+++++|.+++.+ ..+++.++..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 94 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred EEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 9999999999998854 35889999999999999999999 8999999999999999999999999999887544
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.... ......|++.|+|||.+..+.++.++||||||+++||+++|+.||.......... .....+...
T Consensus 167 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~~~~------ 234 (293)
T cd06647 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGTPE------ 234 (293)
T ss_pred cccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCCCCC------
Confidence 3322 2233468889999999998889999999999999999999999997543321110 000111100
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..........+.+++..|++.+|++||++++++.+
T Consensus 235 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00112233467789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.57 Aligned_cols=267 Identities=20% Similarity=0.255 Sum_probs=197.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.++.+++ |+||+++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999976 689999998764322 23457889999999995 699999999887544433445
Q ss_pred EEEEEecCCCCCcccccchhhh--ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-CCcEEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALT--RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-EMKAKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~--~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~KL~DFG 440 (614)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78888765321 246899999999999999999999 899999999999999998 8999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
+++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||.......... .... ......
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~-~~~~~~- 232 (295)
T cd07837 157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFK-LLGTPT- 232 (295)
T ss_pred cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHH-HhCCCC-
Confidence 987543221 11223356889999998865 457999999999999999999999997543322111 1100 000000
Q ss_pred hhhh----------------hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIF----------------DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~----------------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+.. ...+. ...+.....+.+++..|++.+|.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00000 0111234568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.26 Aligned_cols=256 Identities=21% Similarity=0.281 Sum_probs=200.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||++... .++.|++|.+..... ...+.+.+|++++..++|+||+++++.+. .+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 46888899999999999999976 578999999865432 23457889999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++++|.+++.. ...+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 8999999999999999865 356899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCC--------------CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Q 036081 444 QSLEG--------------QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW 509 (614)
Q Consensus 444 ~~~~~--------------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~ 509 (614)
..... .........++..|+|||++.+..++.++||||||+++|||++|+.||...... ++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~ 224 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----EL 224 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH
Confidence 42110 001112345788999999999889999999999999999999999998643321 11
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
...... +... .+. ........+.+++..|++.+|++||++.++.+.|+..
T Consensus 225 ~~~~~~-~~~~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 225 FGQVIS-DDIE---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHHh-cccC---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 111111 0000 000 0012334678899999999999999987777777763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.51 Aligned_cols=262 Identities=26% Similarity=0.340 Sum_probs=198.7
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
.|...+++|.|.||.||+|++. +++.||||+.-.... .-..|+.+|++++|||||+|+-++....+.+.-...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667789999999999999976 578999999754222 22369999999999999999998876655434567799
Q ss_pred EecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-CcEEEeeecccccc
Q 036081 368 YDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQS 445 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~KL~DFGla~~~ 445 (614)
|||||. +|.+.++... .+..++.....-+..||.+||+||| ..+|+||||||.|+|+|.+ |.+||+|||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999985 7887776421 2456888888999999999999999 8999999999999999987 89999999999987
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..+... ....-|.-|.|||.+.+ ..|+.+.||||.|||+.||+-|+..|.+..... .+......+ ... ..+.+.
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d-QL~eIik~l-G~P-t~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD-QLVEIIKVL-GTP-TREDIK 251 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH-HHHHHHHHh-CCC-CHHHHh
Confidence 665544 33456889999999985 689999999999999999999999997744322 222222111 100 011111
Q ss_pred -----------HHhhhh-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 -----------EFIREE-----GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 -----------~~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.+... .........+++...+++.+|.+|-+..|++.+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111110 112233467889999999999999999999865
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.25 Aligned_cols=274 Identities=22% Similarity=0.332 Sum_probs=203.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|+||.||+++.. +|+.||||.+... .......+.+|+.++.+++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 456888999999999999999865 6899999998653 2233456788999999999999999999887543333356
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+. ++|.+++.. ...+++.....++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 899999996 688877754 356899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHH-------HHH
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LITDWA-------WML 513 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~~~~-------~~~ 513 (614)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...+.... .+.... +..
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 654322 12233467889999998875 5689999999999999999999999965432110 000000 000
Q ss_pred hhCCCchhhhhHHhh------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCC
Q 036081 514 ANSGKVDEIFDEFIR------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGDI 568 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~~~ 568 (614)
...+.....++.... ..........+.+++..|++.+|++|||+.|++++ ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 001111111110000 00011234578899999999999999999999988 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.69 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=197.7
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
|...+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++.+++|+||+++++++. .+...++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEEE
Confidence 566788999999999999865 68899999876433 233467889999999999999999999987 45678999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++++|.+++.+ ..+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 81 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 999999999988854 46899999999999999999999 89999999999999999999999999999876533
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
.. .......++..|+|||++.+..++.++||||||+++|||++|+.|+...... ...... ..+...
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~~------- 219 (277)
T cd06641 154 TQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLI-PKNNPP------- 219 (277)
T ss_pred ch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHH-hcCCCC-------
Confidence 22 1223346788999999999889999999999999999999999998653321 111111 111100
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.........+.+++..|++.+|.+||++.+++++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 --TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111233467789999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.53 Aligned_cols=262 Identities=21% Similarity=0.338 Sum_probs=194.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|+..+.||+|++|.||+|+.+ +++.||||.+..... .....+.+|++++++++|+||+++++++. .....+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeEE
Confidence 56888899999999999999976 689999999865332 22346788999999999999999999986 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++ ++|.+++... ...+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 80 lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred EEEecCC-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 9999998 4898887653 346888999999999999999999 899999999999999999999999999998753
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh-
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF- 523 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 523 (614)
.... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.........+. ..+....... .+..
T Consensus 154 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~ 230 (291)
T cd07844 154 SVPS-KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH-KIFRVLGTPT-EETWP 230 (291)
T ss_pred CCCC-ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH-HHHHhcCCCC-hhhhh
Confidence 2211 11122346889999999875 4589999999999999999999999965442111111 0111110000 0000
Q ss_pred -----------------hHHhhhhC-cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 -----------------DEFIREEG-SRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 -----------------d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+.... .......+.+++..|++.+|++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000 00111466789999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.99 Aligned_cols=241 Identities=25% Similarity=0.317 Sum_probs=185.5
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHc---cCCCcccccccccccCCCCCceEEEEE
Q 036081 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKI---RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 296 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l---~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
||+|+||+||+|+.. +|+.||||++..... .....+..|..++.+. +||||+++++++. .....++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-----~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-----TDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-----cCCeEEEEE
Confidence 699999999999976 589999999864221 2223456677777766 6999999998886 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. ...+++.....++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence 99999999988864 456899999999999999999999 899999999999999999999999999998754322
Q ss_pred CccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
. .......||..|+|||++.+. .++.++|||||||++|||++|+.||....... ... ....+... +
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~~-~i~~~~~~------~ 216 (330)
T cd05586 150 N-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MYR-NIAFGKVR------F 216 (330)
T ss_pred C-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HHH-HHHcCCCC------C
Confidence 2 223345799999999998764 48999999999999999999999996543211 111 11111110 0
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRP----TIADALKM 563 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP----tm~eVl~~ 563 (614)
. .......+.+++..|++.+|++|| ++.+++++
T Consensus 217 ~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 217 P---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred C---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 011234567889999999999998 56666553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.09 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=196.7
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHcc---CCCcccccccccccCCCCCce
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIR---HRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~---H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.|+..+.||+|+||.||+|+.. +|+.+|+|.++... ....+++.+|++++++++ |+|++++++++. .+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 4667789999999999999974 68999999986532 334567889999999997 999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++++|.+++.. ..+++...+.++.+++.||.||| +.+|+||||+|+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 8999999999999988754 36899999999999999999999 8999999999999999999999999999988
Q ss_pred cccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
....... ......|+..|+|||++..+ .++.++||||||+++|||++|+.||....... ..... .....
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~-~~~~~--- 219 (277)
T cd06917 150 LLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLI-PKSKP--- 219 (277)
T ss_pred ecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhcc-ccCCC---
Confidence 6544332 22334689999999998754 46899999999999999999999997543211 11000 00000
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.+.. ......+.+++..|++.+|++||++.|++++
T Consensus 220 --~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 --PRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --CCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 01111 1133467789999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=294.12 Aligned_cols=250 Identities=30% Similarity=0.435 Sum_probs=202.5
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
+|+..+.||+|++|.||+++.. +++.+++|++........+.+.+|++++++++|+|++++++++. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 3667789999999999999986 68999999997655545678999999999999999999999886 34678999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
+||+++++|.+++... ...+++..+..++.+++.||.||| ..+++||||+|+||++++++.+||+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence 9999999999988653 257899999999999999999999 89999999999999999999999999999876544
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
... .....++..|+|||++....++.++||||||++++||++|+.|+.......... .... ........
T Consensus 151 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~-~~~~~~~~--- 219 (253)
T cd05122 151 TKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-----KIAT-NGPPGLRN--- 219 (253)
T ss_pred ccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-----HHHh-cCCCCcCc---
Confidence 332 334568899999999998889999999999999999999999987543211110 0000 11111000
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.......+.+++..|++.+|++|||+.|++++
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 ----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11113568889999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=301.28 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=198.0
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
+|+..+.||+|++|.||+|+.. +|+.||||+++..... ..+.+.+|++++++++|+||+++++++. .....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 4778899999999999999986 6899999998754332 3466789999999999999999999987 3456899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++ +|.+++........+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++....
T Consensus 76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 9999984 88888765433456899999999999999999999 8899999999999999999999999999987543
Q ss_pred CCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH---------HHHhhC
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA---------WMLANS 516 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~---------~~~~~~ 516 (614)
.... ......++..|++||.+.+. .++.++||||||+++|||++|+.||.............. |..+..
T Consensus 152 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 152 IPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred CCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 2211 12234578899999998754 578999999999999999999999976543321110000 000000
Q ss_pred -CCch----hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 -GKVD----EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 -~~~~----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.... ...+... ..........+.+++..|++.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 231 LPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 0000000 00111234567889999999999999999999854
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.33 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=198.8
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|+||.||+|..+ +|..+|+|.+... .....+.+.+|++++++++|+|++++++.+. .+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence 4778899999999999999976 5889999998643 2234567889999999999999999999886 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DFGla~~ 444 (614)
+|+||+++++|.+++... ....++|..+.+++.+++.||.||| +.+++|+||||+||++++++ .+||+|||.+..
T Consensus 76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151 (257)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchh
Confidence 999999999999988653 2235799999999999999999999 88999999999999999886 469999999876
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... .......|++.|+|||+..+..++.++||||||+++|||++|+.|+...... ++...... +....
T Consensus 152 ~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~--- 221 (257)
T cd08225 152 LNDSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQ-GYFAP--- 221 (257)
T ss_pred ccCCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhc-ccCCC---
Confidence 54322 1223346889999999999889999999999999999999999998653321 22222111 11111
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
........+.+++.+|++.+|++|||+.|++++
T Consensus 222 ------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011223467788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.36 Aligned_cols=249 Identities=28% Similarity=0.422 Sum_probs=206.9
Q ss_pred ccceeeeccCcEEEEEEEEcC---C--cEEEEEEeec-CCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 291 SQKNLIGQGASGVVYKGTLED---G--TLVAVKQITD-LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~---g--~~vAVK~l~~-~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
...++||+|-||.||+|++.+ | -.||||..+. ......+.|+.|..+|++++||||++|+|+|. ....
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~------e~P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV------EQPM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee------ccce
Confidence 345789999999999998643 3 3589999876 45566788999999999999999999999996 3568
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
|+|||.++.|.|..+|... +..|+......++.||..+|+||| +.++|||||.++|||+....-+||+||||++.
T Consensus 466 WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 9999999999999999873 456888888899999999999999 99999999999999999999999999999998
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...+.....++..-+..|||||.+...+++.++|||-|||.+|||++ |.+||..-...+ +...+
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---------------VI~~i 605 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---------------VIGHI 605 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------eEEEe
Confidence 87776666666666789999999999999999999999999999988 999997543221 11111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
+..-+-..++.++..+..+...|+..+|.+||+..++...|+
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 111111234556678889999999999999999998876654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.88 Aligned_cols=262 Identities=25% Similarity=0.325 Sum_probs=195.3
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
|+..+.||+|++|.||+|..+ +|+.||+|++.... ....+.+.+|++++++++|+|++++++++. .+...++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 456789999999999999875 79999999986433 223457889999999999999999999987 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
+|||++ ++|.+++.... ...+++..+++++.|+++||+||| +.+++||||+|+||+++.++.+||+|||+++...
T Consensus 76 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred EEeccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 999995 68988876532 236899999999999999999999 8899999999999999999999999999987543
Q ss_pred CCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC--------
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG-------- 517 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~-------- 517 (614)
.... ......++..|+|||++.++ .++.++||||||+++|||++|+.||.......... ..........
T Consensus 151 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 151 VPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred CCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChHHhhhhh
Confidence 2221 12223568899999988754 57899999999999999999999997544321111 1111000000
Q ss_pred CchhhhhHHhh------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 KVDEIFDEFIR------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+....... ..........+.+++..|++.+|++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 00011223467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.45 Aligned_cols=245 Identities=28% Similarity=0.362 Sum_probs=198.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||++... +++.+|+|.++... .+..+.+.+|++++++++||||+++++++. .+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 46788899999999999999976 58999999986532 233467889999999999999999999886 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||+|+|||++.++.+||+|||+++
T Consensus 76 ~~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 149 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK 149 (290)
T ss_pred EEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence 8999999999999999865 356899999999999999999999 8999999999999999999999999999988
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .....|++.|+|||.+.++..+.++||||||+++|||++|+.||....... .......+..
T Consensus 150 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~---- 215 (290)
T cd05580 150 RVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKILEGKV---- 215 (290)
T ss_pred ccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCc----
Confidence 65433 234568999999999998889999999999999999999999986543211 0111111111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.+|.+|| ++.|++++
T Consensus 216 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 ------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 01112235778899999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.87 Aligned_cols=254 Identities=29% Similarity=0.411 Sum_probs=203.6
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..+++|+..+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|++++.+++|+|++++++++. ....
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL-----VGDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCE
Confidence 45667888889999999999999987 689999999976443 4667899999999999999999999987 3467
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++|+||+++++|.+++... ...+++..+..++.+++.||+||| +.+|+|+||+|+||+++.++.+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 89999999999999998763 137999999999999999999999 8999999999999999999999999999876
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
....... ......++..|+|||++.+..++.++||||||+++|||++|+.|+........ .. .... .......
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~----~~~~-~~~~~~~ 237 (286)
T cd06614 165 QLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LF----LITT-KGIPPLK 237 (286)
T ss_pred hhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HH----HHHh-cCCCCCc
Confidence 5432211 22234578899999999988899999999999999999999999865432211 10 0001 1110000
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
........+.+++..|++.+|..|||+.+++++
T Consensus 238 -------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 -------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111133567889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=304.06 Aligned_cols=268 Identities=21% Similarity=0.283 Sum_probs=196.0
Q ss_pred CCccceeeeccCcEEEEEEEEcC---CcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED---GTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~---g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+|...+.||+|+||.||+|+..+ ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++... .+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 36778899999999999999753 7899999987632 33346778999999999999999999998743 236
Q ss_pred eEEEEEecCCCCCcccccchhhh--ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC----CCcEEE
Q 036081 363 RRFLVYDFMPSGSLGDHISNALT--RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS----EMKAKV 436 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~--~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~----~~~~KL 436 (614)
..++||||+++ +|.+++..... ...+++...+.++.||+.||.||| +.+|+||||||+||+++. ++.+||
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence 79999999974 67666643221 235788889999999999999999 899999999999999999 999999
Q ss_pred eeecccccccCCCc--cccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--------hh
Q 036081 437 ADFGLAKQSLEGQS--HLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSF--------LL 505 (614)
Q Consensus 437 ~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--------~~ 505 (614)
+|||+++....... .......++..|+|||.+.+. .++.++||||||++++||++|+.||....... ..
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 99999886533221 122345678999999988764 58899999999999999999999997554322 00
Q ss_pred HHHHHHHHhh-----------CCCchhhhhH---------HhhhhCcH--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 506 ITDWAWMLAN-----------SGKVDEIFDE---------FIREEGSR--AVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 506 l~~~~~~~~~-----------~~~~~~~~d~---------~l~~~~~~--~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+..+...+.. ........+. .+...... .....+.+++..|++.+|++|||+.|++++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111110000 0000000000 00000000 223468889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.53 Aligned_cols=247 Identities=30% Similarity=0.410 Sum_probs=194.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..|...+.||+|+||.||+|+.. +|+.||+|.+..... +..+++.+|++++++++|||++++.+++. ....
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCe
Confidence 44777889999999999999975 689999999864332 22356889999999999999999999997 3456
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||++ |+|.+.+... ...+++..+..++.|++.||.||| ..+|+||||+|+||+++.++.+||+|||++.
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcce
Confidence 899999997 6776666432 346899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
..... ....++..|+|||.+. .+.++.++||||||+++|||++|+.|+........ ......... .
T Consensus 164 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~-~ 232 (307)
T cd06607 164 LVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNDS-P 232 (307)
T ss_pred ecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----HHHHhcCCC-C
Confidence 54322 2346788999999874 46788999999999999999999999865432111 000001000 0
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
. .......+.+..++..|++.+|++||++.+++.+.
T Consensus 233 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 233 T--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred C--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 01122345688899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.57 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=198.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||.||+|+.+ +++.+|+|.++.... .....+.+|++++.+++||||+++++++... +....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 46778889999999999999986 588999999874332 2234578899999999999999999988643 23679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||++ ++|.+++... ...+++..++.++.||+.||+||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred EEEehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 99999997 5888887652 246899999999999999999999 88999999999999999999999999999886
Q ss_pred ccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh--HHHH-------HHHHh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITDW-------AWMLA 514 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~--l~~~-------~~~~~ 514 (614)
...... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......... +... .|..+
T Consensus 156 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 156 YGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred ccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 543321 12334578899999998754 4689999999999999999999999754432210 0000 01000
Q ss_pred hC------CCchhhhhHHhhhhCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NS------GKVDEIFDEFIREEGSRA-VMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ..........+....+.. ..+.+.+++..|++.+|++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000011111111111111 24567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.53 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=198.4
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+|++++++++. .+...++|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEEE
Confidence 444579999999999999864 68999999987655555667899999999999999999999886 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++++|.+++.. ..+++..+..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 99999999998865 45889999999999999999999 899999999999999999999999999988754332
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+... ....... +.. +.+.
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-----~~~~~~~-~~~-----~~~~ 236 (285)
T cd06648 169 VP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-----AMKRIRD-NLP-----PKLK 236 (285)
T ss_pred Cc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-----HHHHHHh-cCC-----CCCc
Confidence 21 2233468999999999998889999999999999999999999986533211 1111111 100 0000
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. .......+.+++.+|++.+|++|||+.+++++
T Consensus 237 ~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 N--LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred c--cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0 11133578899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.47 Aligned_cols=271 Identities=23% Similarity=0.283 Sum_probs=200.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cc-hHHHHHHHHHHHHccCCC-cccccccccccCC-CCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KG-DEEFINEVEIISKIRHRN-LLSLRGCCVSSDD-EKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~-~~~f~~Ei~il~~l~H~N-Iv~l~g~~~~~~~-~~~~ 362 (614)
..|...++||+|.||+||+|+.+ +|+.||+|+++-... ++ .....+|+.++.+++|+| ||.|.+++...+. ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34556678999999999999865 689999999976433 22 345689999999999999 9999999975442 2334
Q ss_pred eEEEEEecCCCCCcccccchhhhc-cCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTR-KQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~-~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
..++|+||+. -+|..++...... ..++-.....++.||.+||+||| +++|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 5888888764321 34555778999999999999999 99999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHH----HHh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITDWAW----MLA 514 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~--l~~~~~----~~~ 514 (614)
|+..... ....++.++|..|.|||.+.+. .|+...||||+||++.||++++..|....+...+ +.+... ..|
T Consensus 167 Ara~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9965422 2235567889999999999876 7999999999999999999999888766543211 111110 000
Q ss_pred hCCCchhhhhHHhhhhC-c-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NSGKVDEIFDEFIREEG-S-------RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~-~-------~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.-....-.+....... + +.......+++..|++.+|.+|.|+..+++|
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00000000000000000 0 0111367789999999999999999999987
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=341.59 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=198.6
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
+...++|...+.||+|+||+||+++.. ++..+|+|.+... .......|..|+.++.+++|||||++++++... .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---A 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---C
Confidence 345578999999999999999999976 5778999988643 223356789999999999999999999987632 2
Q ss_pred CceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcC----CCceEecCCCCCceeecCC----
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGL----KPAIYHRDIKSTNILLDSE---- 431 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~----~~~ivHrDIKp~NILLd~~---- 431 (614)
....+|||||+++|+|.++|.... ....+++...+.|+.||+.||.|||... ..+||||||||+||||+.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 356899999999999999987532 2346899999999999999999999321 1469999999999999642
Q ss_pred -------------CcEEEeeecccccccCCCccccccccCCCCccchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 036081 432 -------------MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVL 496 (614)
Q Consensus 432 -------------~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSfGvvL~ELltG~~p~ 496 (614)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 348999999997653221 2234579999999999864 45899999999999999999999999
Q ss_pred CCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 497 ETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 497 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
....... .+.........+ ........+.+++..|++.+|.+||++.|++.
T Consensus 244 ~~~~~~~----qli~~lk~~p~l-----------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNFS----QLISELKRGPDL-----------PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcHH----HHHHHHhcCCCC-----------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 7543211 111111111000 00111246778999999999999999999984
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=292.19 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=203.7
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|...+.||+|++|.||+|+.. +++.+++|++..... ...+.+.+|++++++++|+||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4677889999999999999987 689999999865442 34678999999999999999999999887321 26789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|+||+++++|.+++.+. ..++|..+..++.++++||+||| +.+++|+||+|+||+++.++.+||+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 999999999999998753 37999999999999999999999 899999999999999999999999999998866
Q ss_pred cCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 446 LEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 446 ~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
...... ......++..|+|||.+.....+.++||||||++++||++|+.||....... ...+.....+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~---- 223 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AALYKIGSSGEPP---- 223 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHhccccCCCc----
Confidence 443321 1233568899999999998889999999999999999999999997654111 1111111101111
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++.+|++.+|++||++.+++.+
T Consensus 224 -----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 -----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1122224578889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.33 Aligned_cols=266 Identities=22% Similarity=0.313 Sum_probs=199.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~ 361 (614)
..++|...+.||+|+||.||+++.. +|+.||+|.+... .....+.+.+|++++.+++|+||+++++++..... .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3477899999999999999999975 6899999998642 22334567889999999999999999998764322 133
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+. ++|.+.+.. .+++.....++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 46799999996 577776643 3888889999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH---------
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM--------- 512 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~--------- 512 (614)
++...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+.... .......
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence 98653322 12334678999999999999999999999999999999999999975432110 0000000
Q ss_pred ---------HhhCC------CchhhhhHHhh----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 513 ---------LANSG------KVDEIFDEFIR----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 513 ---------~~~~~------~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... ...+.....+. ..........+.+++..|++.||++|||+.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00011100000 00011234467899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.33 Aligned_cols=247 Identities=25% Similarity=0.306 Sum_probs=199.5
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+|...+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++. .+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence 4778899999999999999976 58999999986532 234568999999999999999999999886 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++|+||+++++|.+++.. ...+++.....++.|+++||.||| +.+++|+||||+||++++++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 999999999999999865 247889999999999999999999 88999999999999999999999999999876
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... ......|+..|+|||.+....++.++||||||+++|+|++|+.|+....... .+........
T Consensus 150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~-------- 216 (258)
T cd05578 150 VTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIRAKQET-------- 216 (258)
T ss_pred cCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHHHHhcc--------
Confidence 54332 2233568889999999998889999999999999999999999997654321 1111111110
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTI--ADAL 561 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm--~eVl 561 (614)
.....+......+.+++..|++.+|.+||+. .|++
T Consensus 217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011122233577889999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=306.83 Aligned_cols=249 Identities=30% Similarity=0.406 Sum_probs=195.2
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
|...+.||+|+||.||+++.. +|..+|+|++..... +..+.+.+|++++++++|+|++++++++. .+...+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeEE
Confidence 566788999999999999975 689999999864322 22356889999999999999999999987 345689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++ |+|.+.+... ...++|.++..++.+++.||.||| +.+|+||||+|+||+++.++.+||+|||++...
T Consensus 102 lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 102 LVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred EEEeCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 9999996 5777776542 456899999999999999999999 899999999999999999999999999998654
Q ss_pred cCCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
.. .....|+..|+|||++. .+.++.++||||||+++|||++|+.||....... .+..+. ..+..
T Consensus 176 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~----~~~~~--- 242 (317)
T cd06635 176 SP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA----QNESP--- 242 (317)
T ss_pred CC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH----hccCC---
Confidence 32 22346888999999984 4678999999999999999999999986533211 111111 11100
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
..........+.+++..|++.+|.+||++.++++++--..
T Consensus 243 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 243 ------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0011123346788999999999999999999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.23 Aligned_cols=266 Identities=24% Similarity=0.347 Sum_probs=198.2
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~ 361 (614)
..++|+..+.||+|+||.||+|... +|+.+|+|++... .......+.+|+.++.++ +|+||+++++++... ++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence 3467888899999999999999976 5889999988542 223345678899999999 999999999988532 34
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||++ ++|.+++.. ..++|..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred ceEEEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 56899999997 588877754 36889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc----cccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH---
Q 036081 442 AKQSLEGQS----HLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML--- 513 (614)
Q Consensus 442 a~~~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~--- 513 (614)
++....... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||........ ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~ 232 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPP 232 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Confidence 986543322 12334578999999998764 5678999999999999999999999965432211 11000000
Q ss_pred -------hhCCCchhhhhHHhhh------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 -------ANSGKVDEIFDEFIRE------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 -------~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+......+.++..... .........+.+++..|++.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000011100000 0001123567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.36 Aligned_cols=258 Identities=24% Similarity=0.262 Sum_probs=192.9
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
|+..+.||+|+||.||+|+.. +++.+|+|+++... ........+|+.++.++. |+|++++++++.+. ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 456788999999999999965 68999999987532 222334568999999995 99999999998743 2256899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||++ |+|.+++.+. ...++|.++..++.|++.||+||| +.+++||||||+||+++. +.+||+|||+++...
T Consensus 78 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 78 VFELMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEecCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 999996 6888777542 356899999999999999999999 899999999999999999 999999999998654
Q ss_pred CCCccccccccCCCCccchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.... .....++..|+|||++. .+.++.++|||||||++|||++|+.||...+.... ..+..... +...+.+..
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~--~~~~~~~~--~~~~~~~~~ 224 (282)
T cd07831 151 SKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ--IAKIHDVL--GTPDAEVLK 224 (282)
T ss_pred cCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH--HHHHHHHc--CCCCHHHHH
Confidence 3222 12345789999999875 45678999999999999999999999976443211 01111100 110000000
Q ss_pred Hhh-----------------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIR-----------------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~-----------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... ..........+.+++..|++.+|++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000 00011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=301.95 Aligned_cols=270 Identities=26% Similarity=0.336 Sum_probs=200.1
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCC---
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD--- 358 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~--- 358 (614)
...++|+..+.||+|+||.||+|+.+ +|+.||+|+++.... .....+.+|++++++++|||++++++++....+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678889999999999999999986 589999999865332 233567889999999999999999998875431
Q ss_pred --CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEE
Q 036081 359 --EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV 436 (614)
Q Consensus 359 --~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL 436 (614)
......++|+||+++ +|.+.+... ...+++..++.++.||+.||+||| +.+|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence 123478999999976 666666542 346899999999999999999999 899999999999999999999999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +.. ......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~-~~~-~~~~~~ 235 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ-LEL-ISRLCG 235 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHH-HHHHhC
Confidence 9999998654433222233456788999998864 4578999999999999999999999975433211 111 111100
Q ss_pred CCC---chhh--------hh------HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 SGK---VDEI--------FD------EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 ~~~---~~~~--------~d------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... ..++ .+ ..+... .......+.+++..|++.+|.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0000 00 000000 01124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=293.74 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=201.6
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|+||.||+++.. +|+.+|+|.+.... .....++.+|++++++++|+||+++++++. .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 4777889999999999999865 68899999986532 233457889999999999999999999887 346799
Q ss_pred EEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+||||+++++|.+++.+.. ....+++..++.++.+++.||+||| +.+++||||+|+||++++++.+||+|||+++.
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999999999886532 2356889999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
.... ......++..|+|||++.+..++.++|+||||+++|||++|+.||...+... .... ...+....
T Consensus 153 ~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~~~--- 220 (256)
T cd08530 153 LKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRYK-VQRGKYPP--- 220 (256)
T ss_pred hccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH-HhcCCCCC---
Confidence 5443 2223467889999999999999999999999999999999999997543211 1111 11111111
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+......+..++..|++.+|++|||+.+++++
T Consensus 221 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 ------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=297.29 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=195.6
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 296 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
||+|+||.||+++.. +|+.+++|.+..... ...+.+.+|++++.+++|+||+++++.+. .+...+++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 689999999999987 499999999865433 34567889999999999999999998876 456789999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCc-
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS- 450 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~- 450 (614)
++++|.+++.+. ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.+||+|||++........
T Consensus 76 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLENV---GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence 999999998653 46899999999999999999999 89999999999999999999999999999875433211
Q ss_pred ------cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 451 ------HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 451 ------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
.......++..|+|||.......+.++||||||+++|||++|+.||....... ....... +...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~-~~~~---- 219 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQNILN-GKIE---- 219 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhc-CCcC----
Confidence 12234567889999999998889999999999999999999999997543221 1111111 1110
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..........+.+++..|++.+|.+|||+.++.+.|+.
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 ----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00000124577889999999999999999777766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=313.10 Aligned_cols=251 Identities=26% Similarity=0.333 Sum_probs=207.7
Q ss_pred hCCCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCc---chHHHHHHHHHHHHcc-CCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTK---GDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~---~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~ 361 (614)
...|...+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+.. .
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-----~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-----P 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-----C
Confidence 4457777899999999999999875 999999999764433 3468999999999998 9999999999974 4
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC----CcEEEe
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE----MKAKVA 437 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~----~~~KL~ 437 (614)
...++|||++.+|.|.+.+... .+++.....++.+|+.++.||| ..+|+||||||+|+|+... +.+|++
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEe
Confidence 5799999999999999998764 3889999999999999999999 8999999999999999543 579999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|||++..... .......+||+.|+|||.+....|+..+||||.||++|.|++|..||.......... ....+
T Consensus 182 DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~ 253 (382)
T KOG0032|consen 182 DFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG 253 (382)
T ss_pred eCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC
Confidence 9999998765 344566899999999999999999999999999999999999999998765443221 11122
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+. ......-....+..-+++..++..||.+|+|+.+++++
T Consensus 254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22 11112223345567788899999999999999999996
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=309.41 Aligned_cols=268 Identities=22% Similarity=0.337 Sum_probs=201.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++.+++|+||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 367888899999999999999865 69999999987532 233456788999999999999999999876543 24567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+. |+|.+++.. ...+++.....++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 899999995 688888754 345899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCc---cccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH------
Q 036081 444 QSLEGQS---HLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML------ 513 (614)
Q Consensus 444 ~~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~------ 513 (614)
....... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||...+.... +.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~~~~~~~g~~~~~ 234 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LKLILSVLGSPSEE 234 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HHHHHHHhCCChhH
Confidence 6433221 11234578899999999865 5689999999999999999999999965432211 00000000
Q ss_pred ----hhCCCchhhhhHHhhh-hC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ----ANSGKVDEIFDEFIRE-EG-----SRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ----~~~~~~~~~~d~~l~~-~~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.....+.+..+..-.. .. .......+.+++..|++.+|++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000011111100000 00 11234578899999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=297.00 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=197.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC-----CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL-----DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-----~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.+|+..+.||+|+||.||+|... +|+.+|+|.+... ..+....+.+|++++++++|+||+++++++... .+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 46888999999999999999975 5899999987532 122345788999999999999999999987532 24
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++++||+++++|.+++.. ...+++...++++.+++.||.||| +.+++||||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 152 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA 152 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccc
Confidence 568899999999999998864 345888899999999999999999 89999999999999999999999999999
Q ss_pred cccccCCC--ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQ--SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++...... ........++..|+|||++.+..++.++||||||++++||++|+.||....... .. .. ....+ .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~---~~-~~~~~-~ 226 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AI---FK-IATQP-T 226 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HH---HH-HHcCC-C
Confidence 98643211 111233568999999999998889999999999999999999999996542211 11 00 00000 0
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ...+....+.+.+++..|++ +|..||+..+++.+
T Consensus 227 ~--------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 K--------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred C--------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0 11223344567888899999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.24 Aligned_cols=260 Identities=25% Similarity=0.312 Sum_probs=198.0
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc--chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK--GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
|...+.||+|++|.||+++.. +|+.+++|++...... ....+.+|++++++++|+||+++++++. .+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 455678999999999999975 6899999998654322 3567889999999999999999999987 3467899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
|+||+++ +|.+++... ...+++..+..++.+++.||.||| +.+|+|+||||+||+++.++.+||+|||.+....
T Consensus 76 v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~ 149 (283)
T cd05118 76 VFEFMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFG 149 (283)
T ss_pred EEeccCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence 9999975 888877652 257899999999999999999999 8999999999999999999999999999987664
Q ss_pred CCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC------Cc
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG------KV 519 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~------~~ 519 (614)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.... +.... ...... ..
T Consensus 150 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~ 226 (283)
T cd05118 150 SPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIF-RTLGTPDPEVWPKF 226 (283)
T ss_pred CCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HHcCCCchHhcccc
Confidence 433 122334678899999999876 789999999999999999999999865443211 00000 000000 00
Q ss_pred hhhhhH---Hhh-------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDE---FIR-------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~---~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+.... ... ..........+.+++..|++.+|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 000 01112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.86 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=196.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378888999999999999999965 68999999986432 2223568899999999999999999999864332 1334
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++|+||+.. +|..++ ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 67999999963 555443 235889999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +..... .. .....+
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~-~~-~~~~~~ 237 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILK-VT-GVPGPE 237 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hc-CCCCHH
Confidence 754321 223467889999999876 4689999999999999999999999975432111 111000 00 000000
Q ss_pred hhhHH-----------hh----hhC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCC
Q 036081 522 IFDEF-----------IR----EEG---SRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGDI 568 (614)
Q Consensus 522 ~~d~~-----------l~----~~~---~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~~~ 568 (614)
..+.. +. ... .......+.+++..|++.+|.+||++.+++.+ +++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000 00 000 00123467889999999999999999999966 65543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.93 Aligned_cols=245 Identities=26% Similarity=0.378 Sum_probs=199.4
Q ss_pred eeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCC
Q 036081 294 NLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMP 372 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~ 372 (614)
-+||+|.||+||-|+..+ ...+|||.+...+.+...-..+||.+-++++|+|||+.+|.+. +++..-+.||-+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCC
Confidence 379999999999999764 5679999998777666667889999999999999999999986 4568889999999
Q ss_pred CCCcccccchhhhccCC--CccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec-CCCcEEEeeecccccccCCC
Q 036081 373 SGSLGDHISNALTRKQL--AWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD-SEMKAKVADFGLAKQSLEGQ 449 (614)
Q Consensus 373 ~gsL~~~L~~~~~~~~l--~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd-~~~~~KL~DFGla~~~~~~~ 449 (614)
+|+|.++|+.. =+++ ++...-.+..||.+||.||| +..|||||||-+|||++ -.|.+||+|||-++.... -
T Consensus 656 GGSLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-i 729 (1226)
T KOG4279|consen 656 GGSLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-I 729 (1226)
T ss_pred CCcHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc-C
Confidence 99999999763 2445 66677788999999999999 99999999999999996 468899999999887543 3
Q ss_pred ccccccccCCCCccchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 450 SHLTTRVAGTYGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 450 ~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
...+....||..|||||++..| .|...+|||||||.+.||.|||+||......+.-.. .+..+ +.+
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-kVGmy----KvH------- 797 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-KVGMY----KVH------- 797 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-hhcce----ecC-------
Confidence 3445567899999999999865 578899999999999999999999976554321000 00000 111
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
...+.+...+...+++.|..++|.+||++.++++
T Consensus 798 -P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 -PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1235566678889999999999999999999875
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.16 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=195.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCC---CC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD---EK 360 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~---~~ 360 (614)
-++|+..+.||+|+||.||+++.. +|+.||||.+..... .....+.+|++++++++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888999999999999999976 689999999864322 223456789999999999999999998865432 13
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....++||||+. ++|.+.+... ...+++.+.+.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 356799999996 4777776542 346899999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCc---cccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh-
Q 036081 441 LAKQSLEGQS---HLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN- 515 (614)
Q Consensus 441 la~~~~~~~~---~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~- 515 (614)
++........ .......++..|+|||++.+. .++.++||||||+++|||++|+.|+........ + ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~-~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-L-TLISQLCGS 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHhCC
Confidence 9976533221 112234578899999998764 478899999999999999999999875443211 0 11111100
Q ss_pred -------CCCchhhhhH---------Hhhhh-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 -------SGKVDEIFDE---------FIREE-GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 -------~~~~~~~~d~---------~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.....+..+. ..... ........+.+++..|++.+|.+|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000 00000 000012356689999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=300.53 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=193.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|++|.||+|+.+ +|+.||+|.+..... ...+.+.+|++++++++|+||+++++++. .+...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 46888899999999999999976 689999999864322 23467889999999999999999999987 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-CCcEEEeeecccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-EMKAKVADFGLAK 443 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~KL~DFGla~ 443 (614)
++||||++ ++|.+++... ....+++.....++.||+.||+||| +.+++||||||+||+++. ++.+||+|||++.
T Consensus 77 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~ 151 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (294)
T ss_pred EEEEeccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEccccccc
Confidence 99999996 5787776442 1223567777899999999999999 889999999999999985 5679999999997
Q ss_pred cccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC-----
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG----- 517 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~----- 517 (614)
...... ...+...+++.|+|||++.+ ..++.++||||||+++|||+||+.||.......... ..... ....
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~ 228 (294)
T PLN00009 152 AFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRI-LGTPNEETW 228 (294)
T ss_pred ccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHH-hCCCChhhc
Confidence 543221 11233467889999999876 457899999999999999999999997644322111 11000 0000
Q ss_pred ----CchhhhhHHh--h----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 ----KVDEIFDEFI--R----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ----~~~~~~d~~l--~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+.+...... . ........+.+.+++..|++.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 0 00011233467889999999999999999999874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=299.99 Aligned_cols=242 Identities=20% Similarity=0.266 Sum_probs=185.5
Q ss_pred eeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHH---ccCCCcccccccccccCCCCCceEEEE
Q 036081 295 LIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISK---IRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~---l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
+||+|+||.||++... +|+.+|+|.+..... .....+.+|..++.. .+|+|++.+.+++. .++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999975 589999998865322 222344555544444 36999999998886 34578999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++.. .+.++|.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence 999999999988864 356999999999999999999999 89999999999999999999999999999875432
Q ss_pred CCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.. .....|+..|+|||.+.. ..++.++||||||+++|||++|+.||.......... .......
T Consensus 150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~---------- 213 (279)
T cd05633 150 KK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLT---------- 213 (279)
T ss_pred cC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhhc----------
Confidence 21 223468999999999874 568999999999999999999999997543221110 0000000
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
.....+......+.+++..|++.+|.+|| ++.|++++
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00111222345778889999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.98 Aligned_cols=258 Identities=20% Similarity=0.228 Sum_probs=182.7
Q ss_pred CCCccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCCCcch-----------HHHHHHHHHHHHccCCCccccccc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLDTKGD-----------EEFINEVEIISKIRHRNLLSLRGC 352 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~~~~-----------~~f~~Ei~il~~l~H~NIv~l~g~ 352 (614)
++|...++||+|+||.||+|...+ +..+|+|.......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578889999999999999999764 34566665332221110 011223344455689999999997
Q ss_pred ccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC
Q 036081 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 353 ~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 432 (614)
+..... .....++++|+.. .++.+.+.. ....++.....|+.|++.||+||| +.+|+||||||+|||++.++
T Consensus 92 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRC-RMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecC-CceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 653322 2234577888764 345444432 223567788899999999999999 89999999999999999999
Q ss_pred cEEEeeecccccccCCCcc------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhH
Q 036081 433 KAKVADFGLAKQSLEGQSH------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLI 506 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l 506 (614)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999865432211 1123469999999999999999999999999999999999999997653322111
Q ss_pred ----HHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 507 ----TDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 507 ----~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
.++.... ..++ +. .......+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~~~~~~~-~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRL-HEGK--------IK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHh-hhhh--------hc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111111 1110 00 1112356788999999999999999999998764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.27 Aligned_cols=266 Identities=26% Similarity=0.345 Sum_probs=196.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|+.++.+++|+|++++++++... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence 457888999999999999999975 589999999864322 2233567899999999999999999988642 2346
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+. ++|.+++... ...+++.++..++.||+.||+||| +.+++||||||+||++++++.+||+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred EEEEEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceee
Confidence 899999996 5788877652 356899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh--HHHH-------HHHH
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITDW-------AWML 513 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~--l~~~-------~~~~ 513 (614)
...... ...+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..... +.++ .|..
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 157 TYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred ecCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 654322 12223345788999999875 56789999999999999999999999754432211 0000 0000
Q ss_pred hhCCCchhhhh------HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANSGKVDEIFD------EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.........+. ..+... .......+.+++..|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 000000 01123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.86 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=198.5
Q ss_pred CCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecCC----CcchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLD----TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~----~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
+|...+.||+|+||.||+++.. +++.+|||.++... ....+.+.+|++++.++ +|+||+++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~----- 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ----- 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-----
Confidence 3677889999999999999753 57889999986432 22345688999999999 5999999998875
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
.+...++||||+++|+|.+++.. ...+++.....++.|+++||.||| ..+++||||||+||+++.++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEEC
Confidence 45678999999999999998864 346888899999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|+++..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||....... ....+........
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~ 228 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKSK 228 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHccC
Confidence 998865443333333456899999999987665 7889999999999999999999986432211 1111111111100
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+......+.+++..|++.+|++|||+.+|.+.|+.
T Consensus 229 -----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 -----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01112223467788999999999999999999888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.37 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=194.9
Q ss_pred CCccceeeeccCcEEEEEEEE----cCCcEEEEEEeecCC----CcchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTL----EDGTLVAVKQITDLD----TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~----~~g~~vAVK~l~~~~----~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
+|+..+.||+|+||.||+++. .+|+.||+|+++... ....+.+.+|++++.++ +|+||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----- 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence 467788999999999999986 368999999987532 22346788999999999 5999999998876
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
.+...++||||+++++|.+++.. ...+++.....++.|+++||.||| +.+++||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeC
Confidence 34578999999999999999865 356888888999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|+++..............|+..|+|||++..+ .++.++||||||+++|||++|+.|+....... ....+........
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~ 228 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE 228 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhccC
Confidence 99986544332233345689999999998753 46789999999999999999999986432211 1111111111110
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
. ..+......+..++..|++.+|++|| +..+++.+
T Consensus 229 ~-----------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 P-----------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred C-----------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 01122334677899999999999997 66666554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=291.62 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=203.1
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC----Ccc----hHHHHHHHHHHHHc-cCCCcccccccc
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD----TKG----DEEFINEVEIISKI-RHRNLLSLRGCC 353 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~----~~~----~~~f~~Ei~il~~l-~H~NIv~l~g~~ 353 (614)
+...++|...++||.|..++|-++.++ +|...|+|++.... .+. .++-..|+.||+++ -||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 444567788889999999999998866 68899999985421 111 23456799999999 599999999999
Q ss_pred cccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc
Q 036081 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK 433 (614)
Q Consensus 354 ~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 433 (614)
. .....++|+|.|+.|.|.|+|.. .-.+++....+|+.|+.+|+.||| ...||||||||+|||+|++++
T Consensus 93 e-----s~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 93 E-----SDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMN 161 (411)
T ss_pred c-----CcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccc
Confidence 7 45578999999999999999975 456899999999999999999999 999999999999999999999
Q ss_pred EEEeeecccccccCCCccccccccCCCCccchhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHH
Q 036081 434 AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL------YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLIT 507 (614)
Q Consensus 434 ~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~ 507 (614)
+||+|||.++....+. .....+||++|+|||.+. ...|+...|+|+.||++|.|+.|.+||-.... .
T Consensus 162 i~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--m--- 234 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--M--- 234 (411)
T ss_pred eEEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--H---
Confidence 9999999999876654 345689999999999985 34688899999999999999999999843221 0
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..-++..+|+.. +....-.+......+++..|++.||.+|-|..|++++
T Consensus 235 -lMLR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 235 -LMLRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -HHHHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111122223221 0111123445577889999999999999999999764
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.93 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=200.3
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|+..+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 4677889999999999999876 578999999976543 34567999999999999999999999886 356789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
++|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence 999999999999988653 57899999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
...... .....++..|+|||......++.++||||||+++|||++|+.|+....... ..+.... ....
T Consensus 150 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~-~~~~----- 217 (254)
T cd06627 150 NDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----ALFRIVQ-DDHP----- 217 (254)
T ss_pred CCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhc-cCCC-----
Confidence 443321 233568899999999988889999999999999999999999986543211 1111111 1000
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
..+....+.+..++..|++.+|++|||+.+++.
T Consensus 218 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 ----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111223457788999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=295.70 Aligned_cols=242 Identities=25% Similarity=0.294 Sum_probs=192.8
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 296 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++|+||+++++++. .+...++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 689999999999986 48999999986532 233467999999999999999999999876 456789999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 451 (614)
++++|.+++.+ ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++......
T Consensus 76 ~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-- 147 (262)
T cd05572 76 LGGELWTILRD---RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-- 147 (262)
T ss_pred CCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence 99999999865 345889999999999999999999 8999999999999999999999999999998654332
Q ss_pred ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhC
Q 036081 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531 (614)
Q Consensus 452 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 531 (614)
......++..|+|||.+....++.++|+||||+++|||++|+.|+.....+.. +....... +. .....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~-~~--------~~~~~ 215 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYNDILK-GN--------GKLEF 215 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHHHHhc-cC--------CCCCC
Confidence 22334688999999999888899999999999999999999999976542111 11111110 00 00011
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 036081 532 SRAVMERFVRVGILCAHVMVALRPT-----IADALK 562 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~ 562 (614)
+......+.+++..|++.+|++||+ +.|+++
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2222457889999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.35 Aligned_cols=268 Identities=26% Similarity=0.342 Sum_probs=197.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc--chHHHHHHHHHHHHccCCCcccccccccccCC---CC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK--GDEEFINEVEIISKIRHRNLLSLRGCCVSSDD---EK 360 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~---~~ 360 (614)
.++|+..+.||+|+||.||+|+.. +++.+|||++...... ....+.+|++++++++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999976 6899999998653322 23467899999999999999999998764332 23
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....++|+||+.. +|...+.. ....+++..+..++.|+++||.||| +.+|+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 4568999999964 56665544 2346899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCc----------cccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Q 036081 441 LAKQSLEGQS----------HLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW 509 (614)
Q Consensus 441 la~~~~~~~~----------~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~ 509 (614)
+++....... ...+...+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~- 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHL- 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-
Confidence 9975433221 112234678899999988654 589999999999999999999999975443211 110
Q ss_pred HHHHhhCC---------Cchhh--------hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 510 AWMLANSG---------KVDEI--------FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 510 ~~~~~~~~---------~~~~~--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+...... .+... ....+... .....+.+.+++..|++.+|.+|||+.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11100000 00000 00001000 01122467889999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.15 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=192.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCC-cchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDT-KGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~ 363 (614)
-++|...+.||+|+||.||+|++++ |+.||||+++.... ....++..|+.++.+.. |+||+++++++. .+..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence 3567788999999999999999875 89999999975432 23456777888787775 999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||++ ++|.+++... ...+++..+.+++.+++.||+|||. ..+|+||||+|+||++++++.+||+|||++.
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EEEEeeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 899999985 4666665442 3478999999999999999999993 2589999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
....... .....++..|+|||++... .++.++||||||+++|||++|+.||......... .........
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~- 236 (296)
T cd06618 164 RLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV----LTKILQEEP- 236 (296)
T ss_pred hccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH----HHHHhcCCC-
Confidence 6533222 2234578899999998754 3889999999999999999999999653321111 111111110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. +. ......+.+.+++..|++.+|++||++.+++++
T Consensus 237 ~~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PS-----LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-----CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00 001133568889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.91 Aligned_cols=267 Identities=20% Similarity=0.313 Sum_probs=196.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCC-------
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE------- 359 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~------- 359 (614)
++|...+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67888999999999999999875 5899999999776666667899999999999999999999887643221
Q ss_pred --CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-CCcEEE
Q 036081 360 --KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-EMKAKV 436 (614)
Q Consensus 360 --~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~KL 436 (614)
+....++||||++ ++|.+++.. ..+++...+.++.||+.||.||| +.+|+||||||+||+++. ++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEE
Confidence 1235799999997 588776643 46889999999999999999999 899999999999999974 567899
Q ss_pred eeecccccccCCCcc--ccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 437 ADFGLAKQSLEGQSH--LTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 437 ~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
+|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......... ....+..
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~~~ 235 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILESV 235 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhc
Confidence 999998764322111 1123467889999998764 56888999999999999999999999755432111 0011000
Q ss_pred hhC-----CCchhhhhHHhh----------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANS-----GKVDEIFDEFIR----------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~-----~~~~~~~d~~l~----------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... ......+...+. ..........+.+++..|++.+|.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 000000000000 00001123467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=292.92 Aligned_cols=247 Identities=22% Similarity=0.221 Sum_probs=189.1
Q ss_pred HHHHhCCCccceee--eccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCC
Q 036081 283 LDQATGGFSQKNLI--GQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 283 l~~at~~f~~~~~L--G~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~ 358 (614)
+....++|...+.+ |+|+||.||+++.+ ++..+|+|.+....... .|+.....+ +|+|++++++++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~---- 79 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT---- 79 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe----
Confidence 33344566666665 99999999999865 68889999986532211 123332223 6999999999987
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEe
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVA 437 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~ 437 (614)
..+..++||||+++|+|.+++.. ...++|.++..++.|+++||.||| +.+++||||||+||+++.++ .++|+
T Consensus 80 -~~~~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 80 -TLKGHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred -cCCeeEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEe
Confidence 34579999999999999999865 247999999999999999999999 89999999999999999998 99999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||...........++.... ..
T Consensus 153 dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~ 225 (267)
T PHA03390 153 DYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QK 225 (267)
T ss_pred cCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cc
Confidence 99998754322 223688999999999999999999999999999999999999975443322222332221 00
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT-IADALK 562 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-m~eVl~ 562 (614)
. .. ........+.+++..|++.+|.+||+ ++|+++
T Consensus 226 ~-~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 K-LP---------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred c-CC---------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 00 11123356788899999999999996 688875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.71 Aligned_cols=251 Identities=28% Similarity=0.377 Sum_probs=202.9
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|...+.||+|+||.||++... +++.+++|++..... ...+.+.+|++++++++|+|++++.+.+. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 4777889999999999999976 689999999875433 44567899999999999999999999886 346789
Q ss_pred EEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+|+||+++++|.+++.... ....+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceee
Confidence 9999999999999987632 1367899999999999999999999 88999999999999999999999999999876
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... .......|++.|+|||......++.++||||||+++++|++|+.|+...... +....... .....
T Consensus 153 ~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~--- 222 (258)
T cd08215 153 LSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILK-GQYPP--- 222 (258)
T ss_pred cccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhc-CCCCC---
Confidence 54432 2233356888999999999889999999999999999999999998654321 11111111 11111
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+......+.+++..|++.+|++|||+.|++++
T Consensus 223 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 ------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111233567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.84 Aligned_cols=244 Identities=26% Similarity=0.376 Sum_probs=194.6
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCC
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMP 372 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~ 372 (614)
.+||+|+||.||++..+ +|+.||||++........+.+.+|+.++++++|+|++++++++. .++..++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEecCC
Confidence 57999999999999875 68999999986555555677999999999999999999999987 4567899999999
Q ss_pred CCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCccc
Q 036081 373 SGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL 452 (614)
Q Consensus 373 ~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 452 (614)
+++|.+++.. ..+++.....++.|++.||+||| +.+++||||||+||++++++.++|+|||++....... ..
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~ 172 (292)
T cd06657 101 GGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 172 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cc
Confidence 9999987743 45889999999999999999999 8899999999999999999999999999987543322 12
Q ss_pred cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCc
Q 036081 453 TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGS 532 (614)
Q Consensus 453 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 532 (614)
.....|+..|+|||++....++.++||||||+++|||++|+.||........ .. .. ... ....+.. .
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-~~-~~----~~~-----~~~~~~~--~ 239 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MK-MI----RDN-----LPPKLKN--L 239 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HH----Hhh-----CCcccCC--c
Confidence 2335688999999999888899999999999999999999999865332110 00 00 000 0000000 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 533 RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 533 ~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
......+.+++.+|++.+|.+||++.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1123356778899999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=292.64 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=197.2
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHc---cCCCcccccccccccCCCCCce
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKI---RHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l---~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
|+..+.||+|+||.||+|+.+ +++.+|+|+++.... .....+.+|++++.++ +|+|++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556789999999999999987 489999999864322 2234577888888777 5999999999998654434445
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.+++|||++ ++|.+++.... ...++|..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 57888876532 235899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc----
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV---- 519 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---- 519 (614)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||....... .+..+..........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCC
Confidence 6533221 223457889999999999999999999999999999999999987544321 111111100000000
Q ss_pred -----hhhhhHHhh---hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 -----DEIFDEFIR---EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 -----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
......... .....+....+.+++..|++.+|.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 01112334577889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=317.59 Aligned_cols=244 Identities=31% Similarity=0.443 Sum_probs=198.8
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcc---hHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKG---DEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~---~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
|+..+.||.|+||.||-++.. +.+.||||++.....+. ..+++.||..|.+++|||++.+.|||. .....|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchHH
Confidence 566678999999999999864 68899999997644433 356889999999999999999999998 566789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
|||||| -||-.|+|.- .++++.+-++..|..+.+.||+||| +.+.||||||+.||||++.|.+||+|||.|...
T Consensus 103 LVMEYC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence 999999 5677777754 3578999999999999999999999 999999999999999999999999999998765
Q ss_pred cCCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
.. ....+||+.|||||++. .|+|+-|+||||+||...||.-.++|+-.++.-..+ .....+.
T Consensus 177 ~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-----YHIAQNe----- 241 (948)
T KOG0577|consen 177 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNE----- 241 (948)
T ss_pred Cc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-----HHHHhcC-----
Confidence 43 34568999999999986 689999999999999999999999997554431111 0111111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+.+ ...+....+.+++-.|++.-|++|||..+++++
T Consensus 242 -sPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 -SPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -CCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 0111 133455678889999999999999999998776
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=321.14 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=202.2
Q ss_pred ccceeeeccCcEEEEEEEEc--CCc--EEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 291 SQKNLIGQGASGVVYKGTLE--DGT--LVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~--~g~--~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
...++||+|.||.|++|.|. +|+ .||||.++..... ...+|++|+.+|.+|+|+|+++|+|+.. +....
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl------~qp~m 186 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL------DQPAM 186 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec------cchhh
Confidence 34578999999999999986 344 5899999865443 5678999999999999999999999986 35679
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|+|+++.|+|.+.|++ ..+..|-....-.++.|||.||.||. .+++|||||.++|+||-..-.+||+||||.+.+
T Consensus 187 MV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 99999999999999987 34556777777799999999999999 999999999999999999999999999999987
Q ss_pred cCCCcccc--ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 446 LEGQSHLT--TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 446 ~~~~~~~~--~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
..+..+.. ....-...|.|||.+.++.++.++|||+|||.||||+| |..||-...... +.+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---------------IL~~ 327 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---------------ILKN 327 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---------------HHHh
Confidence 66554321 11223568999999999999999999999999999999 678886644321 1222
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+|+.-+-..++.+.+++.++++.||..+|++|||+..+.+.
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 33222222355677899999999999999999999999643
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=300.86 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=191.4
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|...+.||+|+||.||+++.. +|+.+|+|.+.... ......+.+|+.++.++. |+||+++++++. .....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence 3445678999999999999975 58999999986433 234567899999999996 999999999886 345679
Q ss_pred EEEecCCCCCcccccchh--hhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNA--LTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~--~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
++|||++ ++|.++.... .....+++....+++.+++.||+|||+ ..+++||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 9999986 4555433211 123568899999999999999999993 3589999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYG---QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
...... ......|+..|+|||++... .++.++||||||+++|||++|+.||...... ......... +..
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~~~- 228 (288)
T cd06616 157 QLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQVVK-GDP- 228 (288)
T ss_pred HhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhhcC-CCC-
Confidence 643322 12334688999999999866 6899999999999999999999998654311 011111111 100
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.+...........+.+++..|++.+|++|||+.+|+++
T Consensus 229 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 ----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112244578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.88 Aligned_cols=244 Identities=23% Similarity=0.292 Sum_probs=189.7
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 296 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
||+|+||+||++..+ +|+.+|+|.+.... ......+.+|++++++++|||++++++.+. ..+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence 689999999999865 68999999986432 223456788999999999999999998886 345789999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 451 (614)
++++|.+++.+.. ...+++..++.++.|++.||.||| +.+++||||+|+||++++++.+||+|||++.......
T Consensus 76 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 149 (277)
T cd05577 76 NGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-- 149 (277)
T ss_pred CCCcHHHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--
Confidence 9999999987532 236889999999999999999999 8999999999999999999999999999987653321
Q ss_pred ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhC
Q 036081 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531 (614)
Q Consensus 452 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 531 (614)
......++..|+|||++.++.++.++||||||++++||++|+.||........ ...... ..... ....
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----~~~~~------~~~~ 217 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKR-----RTLEM------AVEY 217 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHh-----ccccc------cccC
Confidence 12234678899999999988899999999999999999999999975443110 000000 00000 0011
Q ss_pred cHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 036081 532 SRAVMERFVRVGILCAHVMVALRP-----TIADALK 562 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~ 562 (614)
+......+.+++..|++.+|.+|| +..+++.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 112234677899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.04 Aligned_cols=260 Identities=21% Similarity=0.257 Sum_probs=190.6
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
+.+|.|+++.||+++. +|+.||||+++.. .....+.+.+|++++++++|+||+++++++. .....+++|||+
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~ 81 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLM 81 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEecc
Confidence 3455556666666665 5999999998754 3344568999999999999999999999887 455689999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCc-
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS- 450 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~- 450 (614)
++|+|.+++.+.. ...+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 82 AYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 9999999987532 245788889999999999999999 89999999999999999999999999998875432211
Q ss_pred -----cccccccCCCCccchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH---Hhh-----
Q 036081 451 -----HLTTRVAGTYGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM---LAN----- 515 (614)
Q Consensus 451 -----~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~---~~~----- 515 (614)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||.........+...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 11233457889999999875 358899999999999999999999997643322111110000 000
Q ss_pred --CCCchh----hhhHHh----hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 --SGKVDE----IFDEFI----REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 --~~~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...... ..+... ...........+.+++..|++.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000000 011222344578889999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=323.71 Aligned_cols=266 Identities=18% Similarity=0.243 Sum_probs=185.4
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcC--CcEEEEEEe--------------e---cCCCcchHHHHHHHHHHHHccCCCc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLED--GTLVAVKQI--------------T---DLDTKGDEEFINEVEIISKIRHRNL 346 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~--g~~vAVK~l--------------~---~~~~~~~~~f~~Ei~il~~l~H~NI 346 (614)
..++|...+.||+|+||+||++.++. +...++|.+ . .........+.+|++++.+++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999987642 222222211 0 0111234568899999999999999
Q ss_pred ccccccccccCCCCCceEEEEEecCCCCCcccccchhhh--ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 036081 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALT--RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424 (614)
Q Consensus 347 v~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~--~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~ 424 (614)
+++++++. .....++|+|++. ++|.+++..... .......+...|+.||+.||.||| +.+|+||||||+
T Consensus 226 v~l~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~ 296 (501)
T PHA03210 226 LKIEEILR-----SEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLE 296 (501)
T ss_pred CcEeEEEE-----ECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 99999987 3456899999984 567666543210 112234456789999999999999 899999999999
Q ss_pred ceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCccc
Q 036081 425 NILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV-LETSNSSF 503 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p-~~~~~~~~ 503 (614)
|||++.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.+ +.......
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 99999999999999999987654433333446799999999999999999999999999999999998854 43322111
Q ss_pred -hhHHHHHHHHh-hCCC-------chhhh------------hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 504 -LLITDWAWMLA-NSGK-------VDEIF------------DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 504 -~~l~~~~~~~~-~~~~-------~~~~~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
..+........ .... +.+.+ ...+... .....+..++.+|++.||.+|||+.|++.
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL---GLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc---CCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111111000 0000 00000 0111110 11234667788999999999999999987
Q ss_pred H
Q 036081 563 M 563 (614)
Q Consensus 563 ~ 563 (614)
+
T Consensus 454 h 454 (501)
T PHA03210 454 L 454 (501)
T ss_pred C
Confidence 5
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.30 Aligned_cols=271 Identities=24% Similarity=0.332 Sum_probs=204.1
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|...+.||+|+||.||+|+.. +|+.+|||++.... ....+.+.+|++++++++|+||+++.+++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677889999999999999976 48999999987643 33456789999999999999999999998765433445789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++ ++|.+++.+ ...+++..++.++.+++.||+||| ..+|+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 578887754 347999999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCc--cccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHH-------HHH
Q 036081 446 LEGQS--HLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITDWA-------WML 513 (614)
Q Consensus 446 ~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~--l~~~~-------~~~ 513 (614)
..... .......++..|+|||++.+. .++.++||||||+++|||++|+.||......... +.... +..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44321 123345678899999999887 8999999999999999999999999765432210 00000 000
Q ss_pred hhCCCchhhhhHHhh------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 036081 514 ANSGKVDEIFDEFIR------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEG 566 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~ 566 (614)
.......+.+...-. ..........+.+++..|++.+|.+|||+.+++.+ +++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 000011111110000 00011133567889999999999999999999985 444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=293.56 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=200.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|...+.||+|+||.||+++.. +|+.+|+|++... .....+.+.+|++++.+++ |+||+++++++. .+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCc
Confidence 46788899999999999999976 6999999998652 2233467889999999998 999999999886 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++.+ ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~ 149 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTA 149 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccc
Confidence 78999999999999999865 347999999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCc-------------------cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 036081 443 KQSLEGQS-------------------HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF 503 (614)
Q Consensus 443 ~~~~~~~~-------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~ 503 (614)
........ .......++..|+|||......++.++||||||++++|+++|+.|+.......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 76533221 11223467899999999998889999999999999999999999997644211
Q ss_pred hhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 036081 504 LLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTI----ADALKM 563 (614)
Q Consensus 504 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm----~eVl~~ 563 (614)
.. ..... .....+....+.+.+++..|++.+|.+||++ .+++++
T Consensus 230 -~~----~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 -TF----QKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -HH----HHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 00 00000 0011122234578899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=289.85 Aligned_cols=245 Identities=25% Similarity=0.305 Sum_probs=188.0
Q ss_pred eeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHH-HccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIIS-KIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~-~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+|+.. +|+.||||.++.... .....+..|..++. ..+|+|++++++++. .+...++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 46899999999999875 589999999865322 12233455555544 458999999999986 456799999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence 99999999998865 346889999999999999999999 89999999999999999999999999999875432
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .... ...+... ..
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~-----~~~~~~~--~~---- 213 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDN-----ILSRRIN--WP---- 213 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHH-----HHhcccC--CC----
Confidence 223468889999999998889999999999999999999999996543221 1110 1111100 00
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..........+.+++..|++.+|++||++.++.+.|..
T Consensus 214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 00111233577889999999999999988766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=292.54 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=194.6
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
|...+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+.+++ |+|++++++++.. +...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 456788999999999999986 478999999865332 22334567999999999 9999999999873 567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+ +|+|.+++.... ...++|.++..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 76 v~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR 150 (283)
T ss_pred EEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence 99999 889988886532 246899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCccccccccCCCCccchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhH-----------HHHHHHHh
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLI-----------TDWAWMLA 514 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l-----------~~~~~~~~ 514 (614)
.... .....++..|+|||++. ...++.++||||||++++||++|+.||.......... ..|.....
T Consensus 151 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 151 SRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred CCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 3222 23346788999999875 4567999999999999999999999986543221100 00110000
Q ss_pred hCCCchhhhh----HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NSGKVDEIFD----EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~~~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
........+. ..+....+ .....+.+++..|++.+|++|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00000001 113578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.53 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=190.0
Q ss_pred eeeecc--CcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQG--ASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G--~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
..||+| +||+||+++.. +|+.||+|.+.... .+..+.+.+|+.+++.++||||+++++++. .+...++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 346666 99999999975 69999999986432 223467889999999999999999999987 455789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.+.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence 9999999999887642 235888888999999999999999 899999999999999999999999999865432211
Q ss_pred Cccc------cccccCCCCccchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh------
Q 036081 449 QSHL------TTRVAGTYGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA------ 514 (614)
Q Consensus 449 ~~~~------~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~------ 514 (614)
.... .....++..|+|||++.++ .++.++||||||+++|||++|+.||..................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 1100 1112356679999999763 5789999999999999999999999764332211110000000
Q ss_pred ---------hC----------------CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 ---------NS----------------GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ---------~~----------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. .......+..+...........+.+++..|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 00000001111111123345578899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=302.50 Aligned_cols=269 Identities=22% Similarity=0.314 Sum_probs=200.4
Q ss_pred hHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCccccccccccc
Q 036081 280 ESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSS 356 (614)
Q Consensus 280 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~ 356 (614)
..++...+++|...+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|++++.+++|+||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3556678899999999999999999999864 68999999986532 22345688999999999999999999987643
Q ss_pred CC-CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEE
Q 036081 357 DD-EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 357 ~~-~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~K 435 (614)
.. ......++++|++ +++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence 22 1224568888887 7788777643 46899999999999999999999 89999999999999999999999
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA 514 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~ 514 (614)
|+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+........
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG 235 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 9999998764321 233467899999999876 568899999999999999999999986543221 1111111000
Q ss_pred hCCCchhhhh-----------HHhhhhCc-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NSGKVDEIFD-----------EFIREEGS-------RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~~~~~~~~d-----------~~l~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ...+... ..+..... ......+.+++..|++.+|.+||++.+++.+
T Consensus 236 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 T--PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred C--CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0000000 00000000 0112357889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=300.68 Aligned_cols=262 Identities=25% Similarity=0.308 Sum_probs=193.4
Q ss_pred CCCcc-ceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcc--------------hHHHHHHHHHHHHccCCCcccccc
Q 036081 288 GGFSQ-KNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKG--------------DEEFINEVEIISKIRHRNLLSLRG 351 (614)
Q Consensus 288 ~~f~~-~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~--------------~~~f~~Ei~il~~l~H~NIv~l~g 351 (614)
++|.. .+.||+|+||.||+|+.. +|+.||||.++...... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34443 467999999999999965 68999999986532211 125789999999999999999999
Q ss_pred cccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC
Q 036081 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 352 ~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 431 (614)
++. .+...++||||++ |+|.+++.. ...+++.....++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 88 ~~~-----~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 88 VYV-----EGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSK 155 (335)
T ss_pred EEe-----cCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCC
Confidence 987 4567899999996 688888754 346889999999999999999999 8999999999999999999
Q ss_pred CcEEEeeecccccccCCC-------------ccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 036081 432 MKAKVADFGLAKQSLEGQ-------------SHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLE 497 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~ 497 (614)
+.+||+|||+++...... ........++..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999987643110 1111223468899999998764 47899999999999999999999997
Q ss_pred CCCccchhHHHHHHHHhhCCC---chhh------------hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 498 TSNSSFLLITDWAWMLANSGK---VDEI------------FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 498 ~~~~~~~~l~~~~~~~~~~~~---~~~~------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
..+...... .......... .... ........ .......+.+++..|++.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 236 GENEIDQLG--RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCHHHHHH--HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 654332111 1111111000 0000 00000000 0112346788999999999999999999997
Q ss_pred Hh
Q 036081 563 ML 564 (614)
Q Consensus 563 ~L 564 (614)
+-
T Consensus 313 ~~ 314 (335)
T PTZ00024 313 HE 314 (335)
T ss_pred Cc
Confidence 54
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=301.53 Aligned_cols=242 Identities=26% Similarity=0.312 Sum_probs=201.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+.|+.-++||+||||.||-++.+ +|+.+|.|++.+. ..+++...++|-.+|.+++.+.||.+--.+. ....
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe-----Tkd~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE-----TKDA 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec-----CCCc
Confidence 45788899999999999999866 6999999988542 3345667889999999999999999877776 3456
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
++||+..|.+|+|.-||.+..+ ..+++...+.++.+|+.||++|| +.+||.|||||+|||||+.|+++|+|.|||.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEE
Confidence 8999999999999999988643 57999999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...+++.... .+||.||||||++.++.|+...|.||+||+||||+-|+.||...... .-.+-+
T Consensus 336 ei~~g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---------------vk~eEv 398 (591)
T KOG0986|consen 336 EIPEGKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---------------VKREEV 398 (591)
T ss_pred ecCCCCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---------------hhHHHH
Confidence 8877765432 38999999999999999999999999999999999999999754321 112234
Q ss_pred hHHhh---hhCcHHHHHHHHHHHHHccccCCCCCC
Q 036081 524 DEFIR---EEGSRAVMERFVRVGILCAHVMVALRP 555 (614)
Q Consensus 524 d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RP 555 (614)
|.+.. .+.+....+....+-...++.||.+|-
T Consensus 399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhc
Confidence 44333 123445556677777788899999886
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=299.70 Aligned_cols=246 Identities=30% Similarity=0.411 Sum_probs=192.2
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
|...+.||+|+||.||+|+.. +++.+|+|.+... ......++.+|++++++++|+|++++.+++. .....+
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 91 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTAW 91 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCeeE
Confidence 556678999999999999975 5889999998642 2223456889999999999999999999987 345789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+. |+|.+.+... ...+++.++..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 92 lv~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 92 LVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 9999996 6887776542 345889999999999999999999 889999999999999999999999999998754
Q ss_pred cCCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
... ....++..|+|||++. .+.++.++||||||+++|||++|+.|+....... ....... +...
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~-~~~~-- 232 (308)
T cd06634 166 APA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQ-NESP-- 232 (308)
T ss_pred cCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-----HHHHHhh-cCCC--
Confidence 322 2346888999999985 4568899999999999999999999986533211 1111111 1100
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
..........+.+++..|++.+|++||++.+++++..
T Consensus 233 ------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 ------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0011123346778999999999999999999997744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=292.80 Aligned_cols=242 Identities=21% Similarity=0.266 Sum_probs=185.1
Q ss_pred eeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHH---HccCCCcccccccccccCCCCCceEEEE
Q 036081 295 LIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIIS---KIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~---~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
.||+|+||.||++... +|+.||+|.+..... .....+.+|..++. ...||||+.+.+++. .....++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence 4899999999999875 588999999865322 22233555554444 347999999998886 34578999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++.. ...++|..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence 999999999988754 356999999999999999999999 89999999999999999999999999999875432
Q ss_pred CCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.. .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.......... ........ .
T Consensus 150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~------~-- 215 (278)
T cd05606 150 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLTM------A-- 215 (278)
T ss_pred cC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---HHHHhhcc------C--
Confidence 21 2234689999999999754 68999999999999999999999997543221100 00000000 0
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
...+......+.+++..|++.+|.+|| ++.+++++
T Consensus 216 --~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 --VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 011112235778889999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=295.34 Aligned_cols=268 Identities=23% Similarity=0.321 Sum_probs=197.8
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
+....++|...+.||+|+||.||++... +|..||||++.... ....+.+.+|++++++++|+||+++++++......
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3345678999999999999999999865 68999999985422 22345688999999999999999999988643321
Q ss_pred -CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 360 -KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 360 -~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.....++||||+ +++|.+++.. ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence 223579999999 6788777643 46899999999999999999999 89999999999999999999999999
Q ss_pred ecccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHH----------
Q 036081 439 FGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLIT---------- 507 (614)
Q Consensus 439 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~---------- 507 (614)
||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9998754322 223457889999999876 4688999999999999999999999975442211100
Q ss_pred HHHHHHhhCCCchhhhhHH--hh----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 508 DWAWMLANSGKVDEIFDEF--IR----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~--l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+... ............. .. ..........+.+++..|++.+|++|||+.+++.+
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQK-LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHh-hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000000 00 00001223357889999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=297.16 Aligned_cols=244 Identities=31% Similarity=0.455 Sum_probs=190.6
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
|...+.||+|+||.||+|+.. +|+.|++|++..... ...+.+.+|++++++++|+|++++++++. ++...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence 455677999999999999975 688999999864322 22356889999999999999999999987 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+. |+|.+++... ...++|.++..++.||+.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 98 lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 98 LVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred EEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 9999996 6777776542 356899999999999999999999 889999999999999999999999999998643
Q ss_pred cCCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
.. .....|+..|+|||++. .+.++.++||||||+++|||++|+.|+...+... ......... ....
T Consensus 172 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~~-~~~~ 240 (313)
T cd06633 172 SP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQND-SPTL 240 (313)
T ss_pred CC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcC-CCCC
Confidence 22 22356889999999984 4678899999999999999999999986543211 111111111 0000
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
........+.+++..|++.+|.+||++.+++.+
T Consensus 241 --------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 --------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122357789999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=289.96 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=196.8
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+.+|++++++++|+|++++++++. .....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 455678999999999999976 48999999987643 233467889999999999999999999987 3467899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||++ ++|.+++... ...+++..++.++.+++.||+||| +.+|+||||+|+||++++++.+||+|||+++...
T Consensus 76 v~e~~~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~ 149 (282)
T cd07829 76 VFEYCD-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFG 149 (282)
T ss_pred EecCcC-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccC
Confidence 999998 5899988753 246899999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhH--H-------HHHHHHhhC
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLI--T-------DWAWMLANS 516 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l--~-------~~~~~~~~~ 516 (614)
.... ......++..|+|||.+... .++.++||||||+++|||++|+.||.......... . ...|..+..
T Consensus 150 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 150 IPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred CCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 3221 22234567889999999876 88999999999999999999999986644221100 0 000100000
Q ss_pred CC-chhhhhHHhh---hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 GK-VDEIFDEFIR---EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 ~~-~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
-. ....+..... ..........+.+++..|++.+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 0000000000 00011124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.61 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=198.2
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~ 361 (614)
..++|...+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|+|++++++++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4677889999999999999999986 5889999998642 22234567889999999999999999998764332 233
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++|+||+ +++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 4589999998 5688887754 46899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH---------
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW--------- 511 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~--------- 511 (614)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +.....
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHH
Confidence 8865332 233467889999999865 4678999999999999999999999965432211 100000
Q ss_pred -HHhhCCCchhhhhHHhhh------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 512 -MLANSGKVDEIFDEFIRE------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 512 -~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+........+...... .........+.+++..|++.+|++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000010000000 0000124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=325.23 Aligned_cols=261 Identities=23% Similarity=0.402 Sum_probs=206.0
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEcC--------CcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccc
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLED--------GTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCC 353 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~~--------g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~ 353 (614)
+...++....+.||+|.||.|++|.... ...||||.++.... ...+.+..|+++|..+ +|+|++.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3344445556699999999999998541 35799999976433 4467899999999999 699999999999
Q ss_pred cccCCCCCceEEEEEecCCCCCcccccchhh-----hc--------cCCCccchhHHHHHHHHHHHHHHhcCCCceEecC
Q 036081 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNAL-----TR--------KQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRD 420 (614)
Q Consensus 354 ~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-----~~--------~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrD 420 (614)
.. ....++|.||++.|+|.++|+..+ .. ..|+....+.++.|||.|++||+ +.++||||
T Consensus 372 t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRD 443 (609)
T KOG0200|consen 372 TQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRD 443 (609)
T ss_pred cc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchh
Confidence 84 566899999999999999998743 00 23778889999999999999999 89999999
Q ss_pred CCCCceeecCCCcEEEeeecccccccCCCccccccccC--CCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 036081 421 IKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG--TYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLE 497 (614)
Q Consensus 421 IKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~ 497 (614)
|.++|||+.++..+||+|||+|+..............| ...|||||.+....|+.|+|||||||+||||+| |..|+.
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 99999999999999999999999755544443333333 346999999999999999999999999999999 778886
Q ss_pred CCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 498 TSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 498 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..... .+. +.+.+.|.-. ..+.....++..++..|++.+|++||+..++++.++.
T Consensus 524 ~~~~~----~~l-~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 524 GIPPT----EEL-LEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CCCcH----HHH-HHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 52211 112 2233333211 1233345577899999999999999999999999987
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=326.54 Aligned_cols=260 Identities=27% Similarity=0.356 Sum_probs=190.8
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCC-
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK- 360 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~- 360 (614)
.+-..+|++..+||+||||.|||++.+ ||+.+|||++.... ........+|+.++++|+|||+|+++..+++.....
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345677999999999999999999987 89999999997543 233456788999999999999998876443211000
Q ss_pred --------------------------------------------------------------------------------
Q 036081 361 -------------------------------------------------------------------------------- 360 (614)
Q Consensus 361 -------------------------------------------------------------------------------- 360 (614)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHH
Q 036081 361 -------------------------G--------KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407 (614)
Q Consensus 361 -------------------------~--------~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~y 407 (614)
. ..+|+=||||+.-+|.+++++..-. -.-...++++.+|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHH
Confidence 0 3467888999887777777653111 0345668999999999999
Q ss_pred HHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc-----------------CCCccccccccCCCCccchhhhcc
Q 036081 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL-----------------EGQSHLTTRVAGTYGYLAPEYALY 470 (614)
Q Consensus 408 LH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~-----------------~~~~~~~~~~~gt~~Y~APE~~~~ 470 (614)
+| +.+||||||||.||+||++..+||+|||+|.... .......+..+||.-|+|||.+.+
T Consensus 713 IH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99 8999999999999999999999999999998611 011123456789999999999975
Q ss_pred C---CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHcc
Q 036081 471 G---QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCA 547 (614)
Q Consensus 471 ~---~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 547 (614)
. .|+.|+|+||+||||+||+. ||...-+....+. ..+.+.+... ... ....+..-..++.+++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~-----~LR~g~iP~~-~~f-----~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILT-----NLRKGSIPEP-ADF-----FDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH-----hcccCCCCCC-ccc-----ccccchHHHHHHHHHh
Confidence 4 59999999999999999985 4554321111111 1234444333 011 1111224467889999
Q ss_pred ccCCCCCCCHHHHHH
Q 036081 548 HVMVALRPTIADALK 562 (614)
Q Consensus 548 ~~~p~~RPtm~eVl~ 562 (614)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.00 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=197.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeec--CCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITD--LDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~--~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~ 363 (614)
...|++.++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|++.|.+|+ |.+|++|++|-. .+..
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----~d~~ 434 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----TDGY 434 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----cCce
Confidence 345788899999999999999998889999998754 34455678999999999996 999999999987 4678
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
+|+||||= +-+|..+|.... .....| .++.+..|++.++.++| +.+|||.||||.|.|+ -.|.+||+|||+|.
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIAN 507 (677)
T ss_pred EEEEeecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence 99999986 468888887632 233445 77899999999999999 9999999999999999 57889999999999
Q ss_pred cccCCCccc-cccccCCCCccchhhhccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Q 036081 444 QSLEGQSHL-TTRVAGTYGYLAPEYALYGQ-----------LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 444 ~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~-----------~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~ 511 (614)
....+.+.. ....+||+.||+||.+.... .+.++||||+|||||+|+.|+.||... ...|..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~aK 581 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIAK 581 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHHH
Confidence 876665443 34468999999999986332 567999999999999999999999642 223333
Q ss_pred HHhhCCCchhhhhHHhhhhCcH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 512 MLANSGKVDEIFDEFIREEGSR-AVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ..+.|+.-.-+++. .....+++++..|++.||.+|||+.|+|++
T Consensus 582 l-------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 L-------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred H-------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2 22233211101110 001138999999999999999999999875
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.51 Aligned_cols=198 Identities=25% Similarity=0.364 Sum_probs=168.8
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CC-----CcccccccccccCCCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HR-----NLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~-----NIv~l~g~~~~~~~~~~ 361 (614)
+|+..++||+|.||.|-|+... +++.||||++++.. .-..+-..|+.+|..|+ |. |+|++++|+. ..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-----fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-----FR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-----cc
Confidence 6888999999999999999865 69999999998643 22455678999999997 43 8999999998 46
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC--cEEEeee
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM--KAKVADF 439 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~--~~KL~DF 439 (614)
++.+||+|.+ ..+|+++|+... -..++....+.|+.||+.||.+|| +.+|||+||||+||||.+-. .+||+||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEec
Confidence 7799999999 469999998753 456899999999999999999999 99999999999999996543 6999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~ 501 (614)
|.++.....- ....-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.++
T Consensus 336 GSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 336 GSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9998643321 145678899999999999999999999999999999999887766543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.98 Aligned_cols=250 Identities=20% Similarity=0.316 Sum_probs=192.2
Q ss_pred CCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecC-----CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDL-----DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~-----~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+|...+.||+|+||.||+++... +..+++|.++.. .......+..|+.++++++|||++++++++. ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 36778899999999999998753 445666665432 1223345778999999999999999999986 345
Q ss_pred eEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
..++||||+++++|.+++.... ....++|.+++.++.|++.||.||| +.+++|+||||+||+++. +.+||+|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCc
Confidence 6899999999999998886532 2456899999999999999999999 899999999999999975 5699999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
++...... .......|+..|+|||+..+..++.++||||||+++|+|++|+.|+...... ...... ..+...
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~- 223 (260)
T cd08222 152 SRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRI-VEGPTP- 223 (260)
T ss_pred eeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHH-HcCCCC-
Confidence 87653322 2223356788999999998888999999999999999999999998643211 111111 111111
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.+|++||++.|++++
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 --------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1122334467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=294.85 Aligned_cols=264 Identities=22% Similarity=0.327 Sum_probs=197.2
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
+...+++|+..+.||+|+||.||++... +|+.||||++... .....+.+.+|++++.+++||||+++.+++..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 80 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS---- 80 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----
Confidence 3457888999999999999999999865 7899999987542 22334678899999999999999999998863
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
.+...++++||+ +++|.+++.. ..+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 81 PLEDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred CCCcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcc
Confidence 234689999998 5688777643 45788888899999999999999 899999999999999999999999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--hHHHH-------
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LITDW------- 509 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~~~------- 509 (614)
|++...... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||........ .+.++
T Consensus 153 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd07856 153 GLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228 (328)
T ss_pred ccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 998753221 123457889999998765 5789999999999999999999999965432110 11111
Q ss_pred -HHHHhhCCCchhhhhHHhh-hhCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 510 -AWMLANSGKVDEIFDEFIR-EEGS-----RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 510 -~~~~~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.... ..+...+.+..... ...+ ......+.+++..|++.+|++|||+.+++.+
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTI-CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhc-cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000011100000 0000 1123578889999999999999999999776
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=285.73 Aligned_cols=252 Identities=27% Similarity=0.372 Sum_probs=197.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEee--cCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQIT--DLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~--~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+++|+..+.||+|.|+.||+.... .|+.+|+|.+. +....+.++..+|++|.+.|+|||||+|..... ....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-----~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-----ccce
Confidence 345677788999999999999765 68999998874 234446778899999999999999999998775 5678
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---CCcEEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~KL~DFG 440 (614)
.+||+|+|.+++|..-+-. +.-.++...-..++||+++|.|.| .++|||||+||+|+||-. .--+||+|||
T Consensus 85 ~ylvFe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred eEEEEecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccc
Confidence 9999999999999766644 344667777889999999999999 999999999999999943 3358999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+|.... ........+||++|||||++...+|+..+|||+-||+||-|+.|..||-..+... +... ...+...
T Consensus 159 vAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~-----I~~g~yd 230 (355)
T KOG0033|consen 159 LAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQ-----IKAGAYD 230 (355)
T ss_pred eEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHH-----HhccccC
Confidence 999876 2233445689999999999999999999999999999999999999997633221 1100 1111110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
++ ...-..+.+...+++.+|+..||.+|-|+.|.+.+
T Consensus 231 --~~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 --YP----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred --CC----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 00 11112344566788889999999999999998754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.79 Aligned_cols=208 Identities=28% Similarity=0.404 Sum_probs=179.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccC-CCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD-DEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~-~~~~~~~ 364 (614)
..|...+.||+||||.||+|+.+ .|+.||||.++... ....+....|++++++++|+|||++++.-.... .......
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34556678999999999999965 69999999997643 344677889999999999999999998765332 1224678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee--cCCCc--EEEeeec
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL--DSEMK--AKVADFG 440 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL--d~~~~--~KL~DFG 440 (614)
.+|||||.+|||...|.+..+...|++.+.+.+..+++.||.||| +++|+||||||.||++ .++|+ .||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999999999888889999999999999999999999 9999999999999999 34444 7999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLETSN 500 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~ 500 (614)
.|+...++. ..+..+||..|.+||.+. .+.|+..+|.|||||++||.+||..||....
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 999876544 556789999999999998 5899999999999999999999999997543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.76 Aligned_cols=252 Identities=24% Similarity=0.259 Sum_probs=201.2
Q ss_pred CCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.|+..+.||.|.-|+||++.+.+ +...|+|++.+.. .+.....+.|-+||+.+.||.+..|++.+. ..+..
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-----t~~~~ 152 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-----TDKYS 152 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee-----cccee
Confidence 35567889999999999999874 5899999996533 233456778999999999999999999997 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+||||||+||+|...+++. ..+.+++...+.++.+|.-||+||| -.|||.|||||+||||.++|++-|+||.|+..
T Consensus 153 cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999887664 4567999999999999999999999 99999999999999999999999999998753
Q ss_pred ccC---------------------------------CCc----------------------cccccccCCCCccchhhhc
Q 036081 445 SLE---------------------------------GQS----------------------HLTTRVAGTYGYLAPEYAL 469 (614)
Q Consensus 445 ~~~---------------------------------~~~----------------------~~~~~~~gt~~Y~APE~~~ 469 (614)
... ... ......+||..|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 000 0011247999999999999
Q ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHcccc
Q 036081 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHV 549 (614)
Q Consensus 470 ~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 549 (614)
+...+.++|+|+|||+||||+.|+.||.+.+..+.+. .++-.-+.-.....+...+.+++...+-.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~--------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR--------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH--------------HHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence 9999999999999999999999999998876544221 11111111111123455778889999999
Q ss_pred CCCCCCC----HHHHHHH
Q 036081 550 MVALRPT----IADALKM 563 (614)
Q Consensus 550 ~p~~RPt----m~eVl~~ 563 (614)
||++|-. +.||-++
T Consensus 375 dP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ChhhhhccccchHHhhcC
Confidence 9999997 7777654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=291.90 Aligned_cols=266 Identities=23% Similarity=0.301 Sum_probs=193.5
Q ss_pred CCccceeeeccCcEEEEEEEEc-C--CcEEEEEEeecCC--CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-D--GTLVAVKQITDLD--TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~--g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+|...+.||+|+||.||+++.. . +..+|+|++.... ....+.+.+|++++.++ +|+||+++++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 4677889999999999999976 3 7799999986422 22345688999999999 5999999998765322 1335
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++++||+. ++|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 6789999986 688888754 356899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc---ccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH-----
Q 036081 443 KQSLEGQSH---LTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML----- 513 (614)
Q Consensus 443 ~~~~~~~~~---~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~----- 513 (614)
+........ ......||..|+|||++.+ ..++.++||||||+++|||++|+.||...+... .+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 231 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDE 231 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCH
Confidence 865432211 1233578999999998865 468999999999999999999999987544221 111111000
Q ss_pred -----hhCCCchhhhhHHhh------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 -----ANSGKVDEIFDEFIR------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 -----~~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+............-. ..........+.+++..|++.+|.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 00000113467889999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=292.12 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=203.2
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
|....+||+|+||.|||+.++ .|+.+|||++.-. ....+...|+.++++.+.|++|+++|.+. ....+++||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEeeh
Confidence 667789999999999999876 6999999998542 23567899999999999999999999887 445689999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
|||..|+..+.++. .+++|++.++..+..+.++||+||| ...-||||||+.||||+.+|.+||+|||.|.++...
T Consensus 108 EYCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 108 EYCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hhcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 99999999999876 4688999999999999999999999 788899999999999999999999999999876432
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 528 (614)
. .....+.||+.|||||++..-.|+.++||||+|+...||.-|++|+.....-... + ....+.. +.++
T Consensus 183 M-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---F----MIPT~PP----PTF~ 250 (502)
T KOG0574|consen 183 M-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---F----MIPTKPP----PTFK 250 (502)
T ss_pred H-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---E----eccCCCC----CCCC
Confidence 2 2345688999999999999999999999999999999999999999653321100 0 0000100 0111
Q ss_pred hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 529 EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 529 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.++.-...+.+++..|+-..|+.|-|+.+++++
T Consensus 251 --KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 --KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 133445578889999999999999999988775
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=279.00 Aligned_cols=236 Identities=25% Similarity=0.327 Sum_probs=190.5
Q ss_pred eeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 296 IGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 296 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
||+|+||.||+++.. +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+. .+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 689999999999976 589999999875432 23457899999999999999999998886 456789999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 451 (614)
++++|.+++... ..+++.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....... .
T Consensus 76 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~ 148 (250)
T cd05123 76 PGGELFSHLSKE---GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-S 148 (250)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-C
Confidence 999999998652 46899999999999999999999 8999999999999999999999999999987654322 1
Q ss_pred ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhC
Q 036081 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531 (614)
Q Consensus 452 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 531 (614)
......++..|++||...+...+.++|+||||+++|||++|+.||...... ........ .. ...
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~-~~----------~~~ 212 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-----EIYEKILK-DP----------LRF 212 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHhc-CC----------CCC
Confidence 233456889999999999888999999999999999999999999654321 11111111 10 011
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHH
Q 036081 532 SRAVMERFVRVGILCAHVMVALRPTIAD 559 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~e 559 (614)
+......+.+++..|+..+|++||++.+
T Consensus 213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 213 PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1122356788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.25 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=207.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+-|...+.||+|.|..|-++++- .|..||||++.+.. .-....+.+|++.|+-++|||||+|+.+.. ....+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccceE
Confidence 44666788999999999999743 69999999996543 333457889999999999999999999875 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee-cCCCcEEEeeecccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL-DSEMKAKVADFGLAK 443 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL-d~~~~~KL~DFGla~ 443 (614)
|||+|+-.+|+|++++-+. ...+.+....+++.||..|+.|.| +..+|||||||+||.+ ..-|-+||.|||.+.
T Consensus 93 yLiLELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEEecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 9999999999999999764 467999999999999999999999 9999999999999877 556889999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTE-KSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~-ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
.+..+.. .+..+|+..|-|||++.+..|+. ..||||+|||||-|++|+.||+..++.+. +..+
T Consensus 168 kf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmI 231 (864)
T KOG4717|consen 168 KFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMI 231 (864)
T ss_pred cCCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhh
Confidence 7766543 34568999999999999999975 78999999999999999999998765432 2223
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+|-.. ..+..+..++.+++..|+..||.+|.+.+|++..
T Consensus 232 mDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 232 MDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 33221 2355567789999999999999999999998764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.06 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=198.9
Q ss_pred CccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
|.+...||.|+||.|||++.++ +-..|.|++.-.+.+..++|+-||+||+...||+||+|++.|. ..+.+++..
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwili 108 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWILI 108 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEEEE
Confidence 3445679999999999999875 4456778887777777889999999999999999999999887 456789999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
|||.||-.+..+... ...|++.++.-++++++.||.||| +.+|||||||+.|||++-+|.++|+|||.+.....
T Consensus 109 EFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~- 182 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS- 182 (1187)
T ss_pred eecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh-
Confidence 999999998887653 467999999999999999999999 99999999999999999999999999998754321
Q ss_pred CccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 449 QSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
.........||+.|||||+++ ..+|+.++||||||+.|.||.-+.+|....+.-..++ +..... ...++
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll-----KiaKSe-PPTLl 256 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-----KIAKSE-PPTLL 256 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH-----HHhhcC-CCccc
Confidence 112233468999999999986 5689999999999999999999999976544321111 111111 11111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. +......+-++...|+..||..||+..+++++
T Consensus 257 q-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 Q-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred C-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1 22334567888999999999999999998765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=314.00 Aligned_cols=145 Identities=28% Similarity=0.389 Sum_probs=128.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...++||+|+||.||+|... +++.||||+++.... .....+..|+.++..++|+||+++++++. ....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECCE
Confidence 57888999999999999999976 689999999875322 22367889999999999999999998876 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++++|.+++.. ...+++...++|+.||+.||.||| ..+|+||||||+||||+.++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999865 346888899999999999999999 8899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.06 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=195.6
Q ss_pred ceeeeccCcEEEEEEEEc-CCcEEEEEEe--ec--CCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 293 KNLIGQGASGVVYKGTLE-DGTLVAVKQI--TD--LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l--~~--~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
..+||+|.|-+||||... +|-.||=-.+ .+ .+.+..+.|..|+.+|+.|+|+||++++.++.+.. .+..-+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~i 121 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINFI 121 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeeee
Confidence 457999999999999875 4767763222 22 23334578999999999999999999999987653 3678899
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-CcEEEeeeccccccc
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQSL 446 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~KL~DFGla~~~~ 446 (614)
.|.|..|+|..++.+. +.++.....++++||++||.|||. ..++|||||||-+||+|+.+ |.+||+|+|||....
T Consensus 122 TEL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999998763 567888889999999999999995 58999999999999999765 899999999998754
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.. + ...+.|||.|||||... ..|++..||||||+.++||+|+..||....... -+.+.+..|.....+.+.
T Consensus 198 ~s--~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-----QIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 198 KS--H-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-----QIYKKVTSGIKPAALSKV 268 (632)
T ss_pred cc--c-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-----HHHHHHHcCCCHHHhhcc
Confidence 32 2 34489999999999876 789999999999999999999999997654321 122333445444333322
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+ ..+.+++..|+.. ...|||+.|+|+.
T Consensus 269 ----~d----Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 ----KD----PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----CC----HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 12 2566788999999 9999999999874
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=276.72 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=194.3
Q ss_pred cceeeeccCcEEEEEEEEc-CCcEEEEEEeecC-CCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEEEEE
Q 036081 292 QKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL-DTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
....||.|..|.|++.++. .|..+|||.+... +.+..+..+..++++.+-+ .|.||+-+||+.. ....++.|
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-----n~dV~IcM 170 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-----NTDVFICM 170 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-----CchHHHHH
Confidence 3557999999999999977 5899999999764 3344567888888887765 8999999999984 34578999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
|.|. ..++.+|... .+++++...-++...+..||.||.+ +++|+|||+||+|||+|+.|++|++|||++-...+
T Consensus 171 elMs-~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd- 244 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD- 244 (391)
T ss_pred HHHH-HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec-
Confidence 9983 3455555442 4567777777899999999999996 78999999999999999999999999999876544
Q ss_pred CccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 449 QSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
+...++..|-+.|||||.+. ...|+.++|||||||.|+||.||+.||...+.+...++..+. +. .+
T Consensus 245 -SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln----~e------PP 313 (391)
T KOG0983|consen 245 -SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN----EE------PP 313 (391)
T ss_pred -ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh----cC------CC
Confidence 33445678999999999986 457899999999999999999999999887655433332221 11 12
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.|... ......+.++...|++.|+.+||...+++++
T Consensus 314 ~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22211 1134578889999999999999999998765
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=298.03 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=203.0
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.-++.|.....||+|.|++|..+++. .|..||||.+.+..- .....+.+|+++|..++|||||+++.+.. ..
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-----t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-----TE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-----ec
Confidence 34677889999999999999999976 699999999876432 22345889999999999999999999987 35
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
..+|+||||..+|.++++|.+. ..........++.|+.++++|+| .+.|||||||++||||+.++++||+|||+
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeecccc
Confidence 6799999999999999999874 44556888899999999999999 99999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+..+..+ ......+|++.|.|||.+.+.+| .+++|+||+|++||-|+.|..||+...-.
T Consensus 202 S~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------------------ 261 (596)
T KOG0586|consen 202 STFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------------------ 261 (596)
T ss_pred ceeeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc------------------
Confidence 9876533 33445689999999999998776 57899999999999999999999864321
Q ss_pred hhhhHHhhhh--CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREE--GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
++-++.+.+. .+......+.+++...+-.+|.+|++++++.+.
T Consensus 262 ~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 262 ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1112222211 122233467788888999999999999998764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=305.56 Aligned_cols=265 Identities=19% Similarity=0.217 Sum_probs=172.6
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-C----CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccC-CC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-D----GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD-DE 359 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~----g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~-~~ 359 (614)
..++|...+.||+|+||.||+|++. + +..||||++..... .+.+.+| .+.+..+.+++.+...+.... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999976 4 68999999764221 1112221 122223334443333222111 13
Q ss_pred CCceEEEEEecCCCCCcccccchhhhc-----------------cCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCC
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTR-----------------KQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~-----------------~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIK 422 (614)
.+...++||||+++++|.+++...... ....+.....++.||+.||.||| +.+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 456799999999999999888642100 00112234579999999999999 8999999999
Q ss_pred CCceeecC-CCcEEEeeecccccccCCCccccccccCCCCccchhhhccC----------------------CCCchhhH
Q 036081 423 STNILLDS-EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG----------------------QLTEKSDV 479 (614)
Q Consensus 423 p~NILLd~-~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----------------------~~s~ksDV 479 (614)
|+|||++. ++.+||+|||+++....+.........+|+.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987654444445567889999999966422 24456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHH----------HHHHHHHHHHHcccc
Q 036081 480 YSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRA----------VMERFVRVGILCAHV 549 (614)
Q Consensus 480 wSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~----------~~~~l~~l~~~Cl~~ 549 (614)
|||||+||||+++..+.+... ..+...+...+.-...+...+......+ ......+++..|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999876643211 1111111111100000000000000000 012345789999999
Q ss_pred CCCCCCCHHHHHHH
Q 036081 550 MVALRPTIADALKM 563 (614)
Q Consensus 550 ~p~~RPtm~eVl~~ 563 (614)
||.+|||+.|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-34 Score=324.88 Aligned_cols=258 Identities=27% Similarity=0.373 Sum_probs=201.8
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
...+-+|...++||.|.||.||.+.. ++|...|+|-++-.. ....+...+|+.++..++|||+|+.+|+-+ .
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-----H 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-----H 1305 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-----c
Confidence 34456788889999999999999985 469999999876433 233456789999999999999999999877 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....+|.||||++|+|.+.+... ..+++....-+..|++.|++||| +.+||||||||.||+||.+|.+|++|||
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeeccc
Confidence 55689999999999999998652 34566666678899999999999 9999999999999999999999999999
Q ss_pred ccccccCCC---ccccccccCCCCccchhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH-
Q 036081 441 LAKQSLEGQ---SHLTTRVAGTYGYLAPEYALYG---QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML- 513 (614)
Q Consensus 441 la~~~~~~~---~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~- 513 (614)
.|....... ........||+.|||||.+.+. ...-+.||||+|||++||+||++||...+.+ |+-.+
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~ 1453 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYH 1453 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhH
Confidence 998764332 1223457899999999999753 3456899999999999999999999765542 33222
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
+..|.... .+......-.+++..|++.||.+|-++.|++++--++
T Consensus 1454 V~~gh~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1454 VAAGHKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HhccCCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 12222221 1222334455677899999999999998888876544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=268.65 Aligned_cols=238 Identities=28% Similarity=0.381 Sum_probs=191.4
Q ss_pred CcEEEEEEEEc-CCcEEEEEEeecCCCcc-hHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCCCCCcc
Q 036081 300 ASGVVYKGTLE-DGTLVAVKQITDLDTKG-DEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLG 377 (614)
Q Consensus 300 ~fG~Vykg~~~-~g~~vAVK~l~~~~~~~-~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~ 377 (614)
+||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++. .....++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence 68999999987 48999999997655444 678999999999999999999999987 346789999999999999
Q ss_pred cccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcccccccc
Q 036081 378 DHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457 (614)
Q Consensus 378 ~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~ 457 (614)
+++... ..+++..++.++.+++++|.||| +.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 76 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 147 (244)
T smart00220 76 DLLKKR---GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFV 147 (244)
T ss_pred HHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--cccccc
Confidence 988652 23889999999999999999999 8899999999999999999999999999988654432 233456
Q ss_pred CCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHH
Q 036081 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVME 537 (614)
Q Consensus 458 gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 537 (614)
++..|++||.+....++.++||||||++++||++|+.|+....... .+.++. ..+..... ........
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~----~~~~~~~~-------~~~~~~~~ 215 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKI----GKPKPPFP-------PPEWKISP 215 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHH----hccCCCCc-------cccccCCH
Confidence 8889999999998899999999999999999999999986532211 111111 11111000 00000335
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 036081 538 RFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 538 ~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
.+.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 7888999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=299.19 Aligned_cols=267 Identities=20% Similarity=0.240 Sum_probs=183.3
Q ss_pred HhCCCccceeeeccCcEEEEEEEE-----------------cCCcEEEEEEeecCCCcchHH--------------HHHH
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTL-----------------EDGTLVAVKQITDLDTKGDEE--------------FINE 334 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~-----------------~~g~~vAVK~l~~~~~~~~~~--------------f~~E 334 (614)
..++|+..++||+|+||.||+|.+ .+++.||||+++.......++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235789999986533222233 3457
Q ss_pred HHHHHHccCCCc-----ccccccccccCC---CCCceEEEEEecCCCCCcccccchhh---------------------h
Q 036081 335 VEIISKIRHRNL-----LSLRGCCVSSDD---EKGKRRFLVYDFMPSGSLGDHISNAL---------------------T 385 (614)
Q Consensus 335 i~il~~l~H~NI-----v~l~g~~~~~~~---~~~~~~~LV~Ey~~~gsL~~~L~~~~---------------------~ 385 (614)
+.++.+++|.++ ++++++|..... ......+|||||+++|+|.++|+... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877665 678888864321 12356899999999999999886421 0
Q ss_pred ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccch
Q 036081 386 RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465 (614)
Q Consensus 386 ~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~AP 465 (614)
...++|..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....+.........+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123567788899999999999999 88999999999999999999999999999976543322222223458899999
Q ss_pred hhhccCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCCccchhHH-----HHHHHHhhCC
Q 036081 466 EYALYGQL----------------------TEKSDVYSFGIVILELMSGRK-VLETSNSSFLLIT-----DWAWMLANSG 517 (614)
Q Consensus 466 E~~~~~~~----------------------s~ksDVwSfGvvL~ELltG~~-p~~~~~~~~~~l~-----~~~~~~~~~~ 517 (614)
|.+..... ..+.||||+||+++||++|.. |+.....-...+. .-.|......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98864321 235799999999999999975 6543211000000 0112222222
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMV---ALRPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPtm~eVl~~ 563 (614)
...- . ......+...+++..++..+| .+|+|+.|+++|
T Consensus 460 ~~~~--~------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYDF--S------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCCc--c------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1110 0 011122456667777777655 689999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-34 Score=277.58 Aligned_cols=252 Identities=26% Similarity=0.326 Sum_probs=193.7
Q ss_pred ceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEEe
Q 036081 293 KNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
...||.|.||+|+|-.++ .|+.+|||+++.... ..+.+++.|.+...+- +.||||+++|.+. .++..|+.||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCceeeeHH
Confidence 457999999999999876 699999999986544 5567899999987766 6999999999987 4566899999
Q ss_pred cCCCCCcccccchh--hhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 370 FMPSGSLGDHISNA--LTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 370 y~~~gsL~~~L~~~--~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
.|. .||+.+-... ..+..+++...-+|..-+.+||.||-+ ...|||||+||+|||||..|.+||+|||++-++..
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 994 5665543221 134568888888899999999999996 67899999999999999999999999999876532
Q ss_pred CCccccccccCCCCccchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYAL--YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~--~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
+...+..+|-..|||||.+. ...|+.+|||||+|+.|+|+.||+.|+...++....+. .. ..|....+..+
T Consensus 221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~----~V-v~gdpp~l~~~ 293 (361)
T KOG1006|consen 221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC----QV-VIGDPPILLFD 293 (361)
T ss_pred --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH----HH-HcCCCCeecCc
Confidence 33445668999999999986 33589999999999999999999999976543211111 11 11221111111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....+....+..++..|+-.|...||...++.++
T Consensus 294 ----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 ----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1112344578889999999999999999998654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=272.90 Aligned_cols=220 Identities=22% Similarity=0.219 Sum_probs=174.1
Q ss_pred cCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCCCCCcc
Q 036081 299 GASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLG 377 (614)
Q Consensus 299 G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~ 377 (614)
|.+|.||+++.. +|+.+|+|+++... .+..|...+....|||++++++++. .....++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence 899999999975 68999999986532 3445666666678999999999887 456789999999999999
Q ss_pred cccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcccccccc
Q 036081 378 DHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457 (614)
Q Consensus 378 ~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~ 457 (614)
+++.. ...+++.....++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+...... .....
T Consensus 74 ~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~ 143 (237)
T cd05576 74 SHISK---FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEA 143 (237)
T ss_pred HHHHH---hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCC
Confidence 98865 345899999999999999999999 899999999999999999999999999987654321 12234
Q ss_pred CCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHH
Q 036081 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVME 537 (614)
Q Consensus 458 gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 537 (614)
++..|+|||+...+.++.++||||+|+++|||++|+.|+....... ... .. + ..+.....
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~-~~--~------~~~~~~~~ 203 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTH-TT--L------NIPEWVSE 203 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccc-cc--c------CCcccCCH
Confidence 5778999999988889999999999999999999998865322100 000 00 0 01112234
Q ss_pred HHHHHHHHccccCCCCCCCHH
Q 036081 538 RFVRVGILCAHVMVALRPTIA 558 (614)
Q Consensus 538 ~l~~l~~~Cl~~~p~~RPtm~ 558 (614)
.+.+++..|++.||++||++.
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCC
Confidence 677889999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=269.97 Aligned_cols=259 Identities=25% Similarity=0.332 Sum_probs=196.3
Q ss_pred hHHHHHHhCCCccceeeeccCcEEEEEEE-EcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccC
Q 036081 280 ESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSD 357 (614)
Q Consensus 280 ~~el~~at~~f~~~~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~ 357 (614)
++++-+.|+ +.||+|+|+.|-.++ +.+|.++|||++.+..........+|++++.+.+ |+||++|+.++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE--- 146 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE--- 146 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc---
Confidence 456666553 579999999999987 6689999999998877777888999999999985 999999999997
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc---E
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK---A 434 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~ 434 (614)
++...|||||-|.+|+|..++.+ ++.+++.+..++..+||.||.||| .++|.||||||+|||-..-.. +
T Consensus 147 --dd~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPv 218 (463)
T KOG0607|consen 147 --DDTRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPV 218 (463)
T ss_pred --ccceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCce
Confidence 56679999999999999999976 578999999999999999999999 999999999999999965543 7
Q ss_pred EEeeecccccccCC--Cc----cccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 036081 435 KVADFGLAKQSLEG--QS----HLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF 503 (614)
Q Consensus 435 KL~DFGla~~~~~~--~~----~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~ 503 (614)
||+||.|+...... -+ ......+|+..|||||++. ...|+.+.|.||||||||-|++|-.||.+.=...
T Consensus 219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d 298 (463)
T KOG0607|consen 219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD 298 (463)
T ss_pred eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence 99999987643211 11 1223357888999999874 3468899999999999999999999997542221
Q ss_pred hhHHHHHHHHhhCCCc----hhhhhHHhhh---hCc----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 504 LLITDWAWMLANSGKV----DEIFDEFIRE---EGS----RAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 504 ~~l~~~~~~~~~~~~~----~~~~d~~l~~---~~~----~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
-- |..|.. ++.+-+.+.+ +.+ ..+..+..+++...+-.++..|-++.+|+.
T Consensus 299 -----CG---WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 299 -----CG---WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -----CC---ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 00 112211 1111111111 111 122334445555566689999999888876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=280.10 Aligned_cols=264 Identities=20% Similarity=0.313 Sum_probs=211.1
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCcc-hHHHHHHHHHHHHccCCCcccccccc
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTKG-DEEFINEVEIISKIRHRNLLSLRGCC 353 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~-~~~f~~Ei~il~~l~H~NIv~l~g~~ 353 (614)
.|+.....+++...++.+|.||.||.|.|. +.+.|-||.+++...+. ...++.|--.+..+.|||+..+.|++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 455555667888888999999999999664 34567788887644433 45788999999999999999999999
Q ss_pred cccCCCCCceEEEEEecCCCCCcccccc-----hhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee
Q 036081 354 VSSDDEKGKRRFLVYDFMPSGSLGDHIS-----NALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL 428 (614)
Q Consensus 354 ~~~~~~~~~~~~LV~Ey~~~gsL~~~L~-----~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL 428 (614)
.+ +....+++|.++.-|+|+.+|. +......++-.+...++.|++.|++||| +.++||.||.++|.++
T Consensus 357 ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 357 IE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVI 429 (563)
T ss_pred ee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhccee
Confidence 86 4567899999999999999997 3333345667778899999999999999 9999999999999999
Q ss_pred cCCCcEEEeeecccccccCCCccccc-cccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhH
Q 036081 429 DSEMKAKVADFGLAKQSLEGQSHLTT-RVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLI 506 (614)
Q Consensus 429 d~~~~~KL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l 506 (614)
|+..++||+|=.++|.....+.+... ....+..||+||.+.+..|+..+|||||||+||||+| |+.|+..-++.+.
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-- 507 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-- 507 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--
Confidence 99999999999999987666555332 2345678999999999999999999999999999999 8899876543221
Q ss_pred HHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 507 TDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 507 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
. .+..+|. +-..+.+.+.++..++.-||..+|++||+.+|++.-|.+
T Consensus 508 ---~-~ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 ---E-HYLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ---H-HHHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1 1112221 111234566789999999999999999999999987764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=267.87 Aligned_cols=203 Identities=27% Similarity=0.388 Sum_probs=174.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcch---HHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGD---EEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~---~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...++||+|.||.|-+++-+ .|+.+|+|++++.-.-.. ..-+.|-++|...+||.+..|--.+. ...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-----t~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ-----TQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc-----cCc
Confidence 367888999999999999999866 699999999976432222 33457889999999999998876665 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
++++||||..+|.|.-||.+ .+.+++...+.+-.+|..||.||| ..+||.||||.+|.|||.||++||+||||+
T Consensus 242 rlCFVMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLC 315 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLC 315 (516)
T ss_pred eEEEEEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccc
Confidence 79999999999999999976 457888888899999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~ 501 (614)
+.-... ...+...+||+.|+|||++....|....|.|.+||++|||++||.||...+.
T Consensus 316 KE~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 316 KEEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred hhcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 864332 2345568999999999999999999999999999999999999999976543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=276.27 Aligned_cols=240 Identities=24% Similarity=0.364 Sum_probs=189.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.+|....+||+|+||.|.++.-+ ..+.+|||++++.-. ...+--..|-++|+.. +-|.+++|..++. ..+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ-----TmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ-----TMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-----hhh
Confidence 35788899999999999999866 467899999976321 1122234677777766 6889999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
++|+||||+.+|+|-.++.+. +.+.++....+|.+||-||-+|| +.+||.||||.+|||||.+|++||+|||+.
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred heeeEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccc
Confidence 799999999999999998763 56888999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+...-+ ...+...+||+.|+|||++.+.+|+..+|.|||||+||||+.|+.||+..++++... .+
T Consensus 498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~--------------aI 562 (683)
T KOG0696|consen 498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--------------AI 562 (683)
T ss_pred cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------------HH
Confidence 864332 234556799999999999999999999999999999999999999998766543211 11
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRP 555 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 555 (614)
.+... .++.....+.+.+...-+...|.+|-
T Consensus 563 ~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 563 MEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11111 13333444556666667777888774
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=294.04 Aligned_cols=266 Identities=27% Similarity=0.397 Sum_probs=215.0
Q ss_pred ChHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCccccccccccc
Q 036081 279 RESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSS 356 (614)
Q Consensus 279 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~ 356 (614)
.++.+...++.|++.+.||+|.+|.||+++.. +|+.+|||++.. +...+++...|.++++.. .|||++.++|++...
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34445556777889999999999999999854 689999998754 445567788899999988 599999999999888
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV 436 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL 436 (614)
+...++++|||||||.+||..|++.+.. ...+.|+.+..|+.++++||.+|| +..++|||||-.||||+.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence 8778899999999999999999998865 667999999999999999999999 999999999999999999999999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~ 511 (614)
.|||++.+..... ......+||+.|||||++.. ..|+.++|+||+|++..||--|.+|+..+-....++
T Consensus 165 vDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF----- 238 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF----- 238 (953)
T ss_pred eeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-----
Confidence 9999998764322 23344689999999999863 357789999999999999999999986543321110
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+.. .+.+. .+..-.+++.+++..|+..|-++||++.+++++
T Consensus 239 ~IpRNP------PPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 LIPRNP------PPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cCCCCC------Ccccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 000111 01111 133455789999999999999999999987653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=306.45 Aligned_cols=207 Identities=25% Similarity=0.343 Sum_probs=182.2
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCccccccccccc
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSS 356 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~ 356 (614)
.+++-..++|.+.++||+|+||.|..++++ .++.+|.|++.+.. .....-|..|-++|..-..+-|++|.-.|.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-- 145 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ-- 145 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc--
Confidence 455566778999999999999999999986 58999999997732 233456899999999999999999988887
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV 436 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL 436 (614)
+..++|+|||||+||+|..+|.+. ..+++...+.++..|.-||.-|| +.|+|||||||+|||||..|++||
T Consensus 146 ---D~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikL 216 (1317)
T KOG0612|consen 146 ---DERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKL 216 (1317)
T ss_pred ---CccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEee
Confidence 567899999999999999999774 26888889999999999999999 999999999999999999999999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL----Y-GQLTEKSDVYSFGIVILELMSGRKVLET 498 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~----~-~~~s~ksDVwSfGvvL~ELltG~~p~~~ 498 (614)
+|||.+-....+........+|||.|++||++. + +.|+..+|.||+||++|||+.|..||..
T Consensus 217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 999998777666665566679999999999996 3 6899999999999999999999999964
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=288.58 Aligned_cols=240 Identities=23% Similarity=0.313 Sum_probs=192.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+..|.....+|.|+|+.|-++... +++..+||++.+.. .+-.+|+.++.+. +|+||+++.+.+. ++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~-----~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE-----DGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceec-----CCcee
Confidence 455666777999999999999865 68899999997642 2345678777776 6999999999987 67889
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee-cCCCcEEEeeecccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL-DSEMKAKVADFGLAK 443 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL-d~~~~~KL~DFGla~ 443 (614)
++|||++.+|-|.+.+.. .+... ..+..|+.+|+.++.||| .+++|||||||+|||+ ++.++++|+|||.++
T Consensus 392 ~~v~e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeehhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 999999999888777654 22233 677789999999999999 8999999999999999 699999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... ....+-|..|.|||.+....|++.+|+||||++||||++|+.||.....+.... .....++
T Consensus 465 ~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~-----~~i~~~~----- 530 (612)
T KOG0603|consen 465 ELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH-----TRIQMPK----- 530 (612)
T ss_pred hCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH-----HhhcCCc-----
Confidence 76544 122355889999999999999999999999999999999999998765431111 1111222
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....+.+...+++.+|++.||.+||+|.++..+
T Consensus 531 -------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 -------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -------cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 224455567788999999999999999998764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=283.89 Aligned_cols=243 Identities=27% Similarity=0.372 Sum_probs=188.8
Q ss_pred ceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 293 KNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
.+.||+|-||+||-|+++ +|+.||||++.+. ..+.+....+|+.||++++||.||.|.-.|. ..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E-----T~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE-----TPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec-----CCceEEEEeh
Confidence 468999999999999975 7999999999653 3455678999999999999999999988776 3457899999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC---CcEEEeeeccccccc
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE---MKAKVADFGLAKQSL 446 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~KL~DFGla~~~~ 446 (614)
-+ +|+..+.+-.. +.+.|++..-..++.||+.||.||| .++|+|+||||+||||... -++||+|||.|+...
T Consensus 644 Kl-~GDMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 644 KL-HGDMLEMILSS-EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred hh-cchHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 99 56666665443 3567888888899999999999999 8999999999999999543 479999999999876
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
+.. ....++||+.|+|||+++++.|...-|+||.||++|--++|..||..+.+-...+..-+ .+...
T Consensus 719 Eks--FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-FMyPp---------- 785 (888)
T KOG4236|consen 719 EKS--FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-FMYPP---------- 785 (888)
T ss_pred hhh--hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-cccCC----------
Confidence 543 35568999999999999999999999999999999999999999976543221111100 00111
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADAL 561 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl 561 (614)
..-.++....++++...+|..-.+|-|.++-+
T Consensus 786 ---~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 ---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 11223334555666666677777777766543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=260.14 Aligned_cols=203 Identities=28% Similarity=0.415 Sum_probs=166.6
Q ss_pred CCccceeeeccCcEEEEEEEEcC-----CcEEEEEEeecCCC-cc-hHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED-----GTLVAVKQITDLDT-KG-DEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~-----g~~vAVK~l~~~~~-~~-~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.|+....||+|.||.|||++-++ ...+|+|+++.... .+ .....+|+.+++.++|+|++.|..++... +
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----d 100 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----D 100 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----C
Confidence 46778899999999999996432 23799999975422 12 34678999999999999999999998842 5
Q ss_pred ceEEEEEecCCCCCcccccchhh--hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC----CcEE
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL--TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE----MKAK 435 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~--~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~----~~~K 435 (614)
...+|++||.+. +|...++-.. ..+.++-.....|..||..|+.||| ++-|+||||||.|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 679999999975 7777765432 2356777788899999999999999 8999999999999999877 8999
Q ss_pred EeeecccccccCCCcc--ccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 036081 436 VADFGLAKQSLEGQSH--LTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETS 499 (614)
Q Consensus 436 L~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~ 499 (614)
|+|||+++.+...-.. ....++-|..|.|||.+.+ ..||.+.|||+.|||+.||+|-++.|...
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999987543222 3445778999999999986 57999999999999999999998887543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=251.32 Aligned_cols=214 Identities=27% Similarity=0.406 Sum_probs=172.2
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeec-CCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITD-LDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~-~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
++...+.......||+|++|.|-+-++. +|+..|||+++. .+.+..+..++|+++..+- ..|.+|.++|...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~----- 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF----- 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh-----
Confidence 3444445555678999999999888764 799999999965 3445667888999988775 6999999999776
Q ss_pred CCceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.....++.||.|. .||+.+-.... .....++...-+||..+.+||.|||+ +..+||||+||+|||++.+|++|++|
T Consensus 116 regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcc
Confidence 4567899999994 57776654432 34567888888999999999999997 78999999999999999999999999
Q ss_pred ecccccccCCCccccccccCCCCccchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhH
Q 036081 439 FGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLI 506 (614)
Q Consensus 439 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l 506 (614)
||++-.+.. +-..+-..|-..|||||.+. ...|+.|+||||||+.+.||.+++.|++........+
T Consensus 193 FGIsG~L~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 193 FGISGYLVD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred cccceeehh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 999876533 22233356888999999985 3479999999999999999999999998766554333
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=259.51 Aligned_cols=257 Identities=22% Similarity=0.259 Sum_probs=197.8
Q ss_pred hCCCccc-eeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQK-NLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
|++|++. ++||-|-.|.|-.+..+ .|+.+|+|++.+. ....+|+++--+. .|||||.++++|..+-. ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~-~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQ-GRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc-Ccee
Confidence 4445433 57999999999999876 6899999998652 3456788876666 59999999999975443 5678
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---CCcEEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~KL~DFG 440 (614)
+.+|||.|++|.|...+.+.. ...+++.+.-.|+.||+.|+.||| ..+|.||||||+|+|... |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999987642 346899999999999999999999 999999999999999954 4568999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
.|+..... ......+-|+.|.|||++...+|+...|+||+||++|-|++|-+||....... .-..+ ......|...
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-ispgM-k~rI~~gqy~ 285 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGM-KRRIRTGQYE 285 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CChhH-HhHhhccCcc
Confidence 99975432 22334577999999999999999999999999999999999999997543211 10011 1111111110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+....-..+.+...+++...+..+|.+|-|+.+++.+
T Consensus 286 ------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 286 ------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0011123456677788889999999999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-31 Score=258.32 Aligned_cols=271 Identities=22% Similarity=0.339 Sum_probs=195.8
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeec-CCCcc-hHHHHHHHHHHHHccCCCcccccccccccCC---CCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITD-LDTKG-DEEFINEVEIISKIRHRNLLSLRGCCVSSDD---EKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~-~~~~~-~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~---~~~~ 362 (614)
.|+..++||+|.||.||+++.+ .|+.||+|+.-- ...++ ....++|+++|..++|+|++.++..|..... ....
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3556778999999999999866 578889886532 12222 3457899999999999999999999975432 2345
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..+|||++++. +|...|.+. ...++..++.+++.++..||.|+| +..|+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 68999999964 677777653 345888899999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCc---cccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHH----
Q 036081 443 KQSLEGQS---HLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSF--LLITDWAWM---- 512 (614)
Q Consensus 443 ~~~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~~l~~~~~~---- 512 (614)
+.+..... ...+..+-|..|.+||.+.+ .+|+++.|||.-||++.||+||.+-++...... ..+......
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76533221 12233455999999999985 589999999999999999999998887665443 122222111
Q ss_pred HhhCCCchhhhhHH----hhhhCc---HHHH------HHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 513 LANSGKVDEIFDEF----IREEGS---RAVM------ERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 513 ~~~~~~~~~~~d~~----l~~~~~---~~~~------~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
.|.+-.-.++.... +.+..- ++.. ....+++..++..||.+|+..++++.+--
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 11111111111111 000000 0111 14567778889999999999999987643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=236.15 Aligned_cols=211 Identities=36% Similarity=0.549 Sum_probs=181.4
Q ss_pred eeccCcEEEEEEEEcC-CcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCCC
Q 036081 296 IGQGASGVVYKGTLED-GTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPS 373 (614)
Q Consensus 296 LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~ 373 (614)
||+|++|.||++...+ |+.+++|++...... ..+.+.+|++.+++++|++++++++++.. ....++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence 6899999999999864 899999998764332 34679999999999999999999999873 3678999999999
Q ss_pred CCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-CCcEEEeeecccccccCCCccc
Q 036081 374 GSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-EMKAKVADFGLAKQSLEGQSHL 452 (614)
Q Consensus 374 gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~KL~DFGla~~~~~~~~~~ 452 (614)
++|.+++... ...+++..+..++.+++++|.||| +.+++|+||+|.||+++. +++++|+|||.+........ .
T Consensus 76 ~~l~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~ 149 (215)
T cd00180 76 GSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-L 149 (215)
T ss_pred CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-h
Confidence 9999988652 146899999999999999999999 889999999999999999 89999999999876543321 2
Q ss_pred cccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhC
Q 036081 453 TTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531 (614)
Q Consensus 453 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 531 (614)
.....+...|++||..... ..+.+.|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2335678899999999877 888999999999999998
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 532 SRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4677888999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=260.89 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=199.1
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc--CC----CcccccccccccCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR--HR----NLLSLRGCCVSSDD 358 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~--H~----NIv~l~g~~~~~~~ 358 (614)
.+++|.+...+|+|.||.|-++... .+..||||+++....- .+..+-|++++.++. .| .+|++.+++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd---- 161 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFD---- 161 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh----
Confidence 4788999999999999999999865 4789999999865432 455678999999994 22 3678878776
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec---------
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD--------- 429 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd--------- 429 (614)
..++.++|+|.+ +-|++++|.+. +..+++..+.+.|+.|++++++||| +.+++|-||||+|||+-
T Consensus 162 -yrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 162 -YRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred -ccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEec
Confidence 456789999998 56999999874 3456888899999999999999999 99999999999999992
Q ss_pred -----------CCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 036081 430 -----------SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLET 498 (614)
Q Consensus 430 -----------~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~ 498 (614)
.+..+||.|||.|....+.. ..++.|..|.|||++++-.++.++||||+||||.|+.||...|+.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 13458999999998654433 456789999999999999999999999999999999999999987
Q ss_pred CCccchh-HH---------HH-----HHHHhhCCCch-----------hhhhHH--hh--hhCcHHHHHHHHHHHHHccc
Q 036081 499 SNSSFLL-IT---------DW-----AWMLANSGKVD-----------EIFDEF--IR--EEGSRAVMERFVRVGILCAH 548 (614)
Q Consensus 499 ~~~~~~~-l~---------~~-----~~~~~~~~~~~-----------~~~d~~--l~--~~~~~~~~~~l~~l~~~Cl~ 548 (614)
.+..+.+ .. .. ..+....+++. .+.+.- +. .........++++++..++.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 7644311 00 00 01111111110 001100 00 01112333479999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 036081 549 VMVALRPTIADALKM 563 (614)
Q Consensus 549 ~~p~~RPtm~eVl~~ 563 (614)
.||.+|+|..|++.+
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=270.56 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=201.8
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCc-EEEEEEeec---CCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGT-LVAVKQITD---LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~-~vAVK~l~~---~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++.....||-||||.|=+...+... .+|+|.+++ .+.+.++....|-.||...+.|.||+|+.-+. +.+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr-----d~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR-----DSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc-----cchh
Confidence 34555667999999999999877433 388888865 34455677889999999999999999998886 5678
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.|+.||-|-+|.|+..|++ ++.++......++..+.+|++||| +++||.|||||+|.+||.+|-+||.|||.|+
T Consensus 495 vYmLmEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred hhhhHHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHH
Confidence 8999999999999999986 578999999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
....+. .+-..+||+.|+|||++.++..+..+|.||+|+++|||++|++||...++-... ...-.| +
T Consensus 569 ki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY------n~ILkG-----i 635 (732)
T KOG0614|consen 569 KIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY------NLILKG-----I 635 (732)
T ss_pred HhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH------HHHHhh-----h
Confidence 875443 345679999999999999999999999999999999999999999875532110 000001 1
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
|. -..+..+.....+++...+..+|.+|-- +.++-++
T Consensus 636 d~---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 636 DK---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hh---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 11 1234455566777888888889999874 7777655
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=252.31 Aligned_cols=200 Identities=25% Similarity=0.430 Sum_probs=174.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|...++||+|+|.+|..++++ ..+.+|+|++++. +.+..+-.+.|-.+..+. +||.+|.|..++. .+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq-----te 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ-----TE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc-----cc
Confidence 467888999999999999999976 5788999998752 233345577888888877 6999999999987 46
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
..+++|.||+++|+|--++.+ ...|+++..+.+..+|..||.||| +.+||.||||.+|||||.+|++||.|+|+
T Consensus 324 srlffvieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred ceEEEEEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccch
Confidence 689999999999999888865 456999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLET 498 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~ 498 (614)
.+.... ....+...+||+.|.|||++.+..|....|.|++||+++||+.||.||+-
T Consensus 398 cke~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 398 CKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred hhcCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 986433 23345678999999999999999999999999999999999999999973
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=283.39 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=186.1
Q ss_pred CccceeeeccCcE-EEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEE
Q 036081 290 FSQKNLIGQGASG-VVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 290 f~~~~~LG~G~fG-~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
|...+++|.|.-| .||+|.+. |+.||||++-. +..+-..+||..|+.- +|||||++++.-. +....|+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~-----d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQ-----DRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeecc-----CCceEEEE
Confidence 5566789999886 57999997 89999999854 2344567899999888 5999999876543 56789999
Q ss_pred EecCCCCCcccccchh-hhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---C--CcEEEeeecc
Q 036081 368 YDFMPSGSLGDHISNA-LTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---E--MKAKVADFGL 441 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~-~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~--~~~KL~DFGl 441 (614)
.|.|. -+|.+++... .......-..-+.+..|++.||++|| ..+||||||||.||||+. + .+++|+|||+
T Consensus 582 lELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 582 LELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred ehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 99995 5899998763 11111121445788999999999999 899999999999999965 3 4799999999
Q ss_pred cccccCCCccc--cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 442 AKQSLEGQSHL--TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSG-RKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 442 a~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG-~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
++....+.+.. .....||-||+|||++....-+..+||||+|||+|..++| .+||+.....+..+. .....
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl------~~~~~ 731 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL------TGNYT 731 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh------cCccc
Confidence 99887665543 3457899999999999998888899999999999999996 899986543221110 00111
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.. +... .. ....+++..|++.+|..||++.+|+.+
T Consensus 732 L~~-----L~~~-~d---~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVH-----LEPL-PD---CEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eee-----eccC-ch---HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 100 0000 11 156778899999999999999999643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=266.45 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=192.2
Q ss_pred HhCCCccceeeeccCcEEEEEEE-EcCCcEEEEEEeec---CCCc----chHHHHHHHHHHHHccCCCcccccccccccC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITD---LDTK----GDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~---~~~~----~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~ 357 (614)
..++|-..++||+|||+.|||+. +...+.||||+-.- +..+ -.+...+|.+|-+.|.||.||++++++..
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-- 538 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-- 538 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee--
Confidence 34557778899999999999997 45688999997532 1111 12346789999999999999999999864
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec---CCCcE
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD---SEMKA 434 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd---~~~~~ 434 (614)
+.+..+-|+||+++.+|+-+|.. .+.+++.+.+.|+.||+.||.||. +.+++|||=||||.||||- .-|.+
T Consensus 539 --DtdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 539 --DTDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred --ccccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCccccee
Confidence 34568999999999999999876 467899999999999999999999 4589999999999999994 45789
Q ss_pred EEeeecccccccCCCc------cccccccCCCCccchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCccch
Q 036081 435 KVADFGLAKQSLEGQS------HLTTRVAGTYGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLETSNSSFL 504 (614)
Q Consensus 435 KL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~ 504 (614)
||.||||++....+.. ..+....||.+|++||.+.-+ .++.|+||||.|||+|..+.|++||+.......
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 9999999997654322 235567899999999998643 578899999999999999999999987654432
Q ss_pred hHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 036081 505 LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADA 560 (614)
Q Consensus 505 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eV 560 (614)
.+. ...+...-+-.+ ...+.+......++..|++..-++|-..-++
T Consensus 693 ILq--------eNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 693 ILQ--------ENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred HHh--------hhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 221 111110000000 0111222345567778888888877655554
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=267.08 Aligned_cols=213 Identities=24% Similarity=0.353 Sum_probs=174.3
Q ss_pred hHHHHHHh---CCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCccccccc
Q 036081 280 ESELDQAT---GGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGC 352 (614)
Q Consensus 280 ~~el~~at---~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~ 352 (614)
|-.|+++. .-|-..+.||-|+||+|.++.- +....+|.|.+++.+. +.....+.|-+||+....+-||+|+-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44455553 3477788999999999999974 4467899999876442 233457789999999999999999988
Q ss_pred ccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC
Q 036081 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 353 ~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 432 (614)
|. +...+|+||||+++|++-.+|-+ .+.+.+...+.++.++..|+++.| +.|+|||||||+|||||.+|
T Consensus 698 FQ-----DkdnLYFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdG 766 (1034)
T KOG0608|consen 698 FQ-----DKDNLYFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDG 766 (1034)
T ss_pred ec-----cCCceEEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCC
Confidence 87 45569999999999999998876 356777888889999999999999 99999999999999999999
Q ss_pred cEEEeeecccccc---------cCCCc--------------------------------cccccccCCCCccchhhhccC
Q 036081 433 KAKVADFGLAKQS---------LEGQS--------------------------------HLTTRVAGTYGYLAPEYALYG 471 (614)
Q Consensus 433 ~~KL~DFGla~~~---------~~~~~--------------------------------~~~~~~~gt~~Y~APE~~~~~ 471 (614)
++||.||||+.-+ .++.. ......+||+.|+|||++...
T Consensus 767 HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~ 846 (1034)
T KOG0608|consen 767 HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART 846 (1034)
T ss_pred ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc
Confidence 9999999997421 11100 001124799999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 036081 472 QLTEKSDVYSFGIVILELMSGRKVLETSNSSF 503 (614)
Q Consensus 472 ~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~ 503 (614)
.|+..+|.||.|||||||+.|+.||......+
T Consensus 847 g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 847 GYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred CccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 99999999999999999999999998766544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=237.83 Aligned_cols=199 Identities=33% Similarity=0.497 Sum_probs=170.8
Q ss_pred CccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 4567889999999999999875 899999999765444 5678999999999999999999999886 34578999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
+||+++++|.+++... ...+++.....++.+++++|.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 76 MEYCEGGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHR 150 (225)
T ss_pred EeccCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence 9999999999988653 112889999999999999999999 88999999999999999999999999999887654
Q ss_pred CCccccccccCCCCccchhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 036081 448 GQSHLTTRVAGTYGYLAPEYA-LYGQLTEKSDVYSFGIVILELMSGRKVLET 498 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwSfGvvL~ELltG~~p~~~ 498 (614)
..........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 321122345678899999998 667788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-30 Score=251.07 Aligned_cols=270 Identities=25% Similarity=0.321 Sum_probs=201.1
Q ss_pred ccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 291 SQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
+..+.||-|+||.||..+.. +|+.||.|++.+.- -...+.+.+|+++|..++|.|++..+++..-....--.+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44678999999999999975 79999999987532 2335678899999999999999998887653333233457889
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
.|.|. .+|...+.. ...|+-....-+.+||.+||.||| ..+|.||||||.|.|++.|-..||+|||+++--..
T Consensus 136 TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 99884 577777654 356888888889999999999999 99999999999999999999999999999997666
Q ss_pred CCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHH-------HHhhCC
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSF--LLITDWAW-------MLANSG 517 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~~l~~~~~-------~~~~~~ 517 (614)
++....+..+-|..|.|||++++ ..|+...||||.||++.||+-.|..|+..+.-+ .++++... +..-+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 66555666677999999999986 579999999999999999999888887655433 23333321 001111
Q ss_pred CchhhhhHHhh--------h-hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 518 KVDEIFDEFIR--------E-EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 518 ~~~~~~d~~l~--------~-~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.-..++....+ . ..+......-+.+..++++.+|+.|-+..+.+.++..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 11111111000 0 00111222456677788999999999999998887554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=227.14 Aligned_cols=199 Identities=24% Similarity=0.391 Sum_probs=162.7
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+|...++||+|.||+||||+.. .++.||+|+++-.+ ..-....++|+-+++.++|+|||++++... .++..-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence 3455678999999999999965 58899999986432 222457889999999999999999999876 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+|+||+. .+|..+...- ++.++-+....++.|+.+||.+.| .+++.|||+||.|.|++.+|+.|++|||+++.+
T Consensus 78 lvfe~cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 78 LVFEFCD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred EeHHHhh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence 9999994 4676665442 456888888999999999999999 999999999999999999999999999999976
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMS-GRKVLETS 499 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~ 499 (614)
...- ......+-|..|.+|.++.+ +-|++..|+||-||++.|+.. |++.|...
T Consensus 152 gipv-rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 152 GIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred CCce-EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 4322 12233456899999999986 468999999999999999988 55555443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=243.23 Aligned_cols=136 Identities=24% Similarity=0.380 Sum_probs=114.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-----C---CCcccccccccccC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-----H---RNLLSLRGCCVSSD 357 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-----H---~NIv~l~g~~~~~~ 357 (614)
.++|...++||.|.|++||++... +.+.||+|+.+.. ..-.+..+.||++|++++ | ..||+|+++|..+.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 367889999999999999999864 6789999998652 233567789999999994 3 35999999997655
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL 428 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL 428 (614)
. +|.+.++|+|++ +-+|..+|... ..+.++.....+|++||+.||.|||. +.+|||-||||+||||
T Consensus 156 p-NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 P-NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred C-CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 4 789999999998 56777777664 34679999999999999999999997 5699999999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=226.84 Aligned_cols=258 Identities=17% Similarity=0.308 Sum_probs=193.7
Q ss_pred hCCCccceeeeccCcEEEEEEE-EcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|+..+++|+|.|+.||.|. ..+.+.++||.++.. ..+...+|++||..|+ ||||++|++...+. .....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccCc
Confidence 3568888999999999999998 456889999999763 3567889999999997 99999999988643 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeeecccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAK 443 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DFGla~ 443 (614)
.||+||+.|.+...+. ..|+...+...+.+++.||.|+| +.||+|||+||.|+++|... ..+|.|+|||.
T Consensus 111 aLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHh
Confidence 8999999987765543 35788888999999999999999 99999999999999999764 69999999999
Q ss_pred cccCCCccccccccCCCCccchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHH------------HH
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITD------------WA 510 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~------------~~ 510 (614)
....+.... -.+.+.-|--||.+. ...|+..-|+|||||+|.+|+..+.||-...+....+.. ++
T Consensus 182 FYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 182 FYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 876554332 224567788999986 567888999999999999999999998544433222222 22
Q ss_pred HHHhhCCCchhhhhHHhh------------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 511 WMLANSGKVDEIFDEFIR------------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+... .+...++..+. .+...-...+.++++-..+.-|-++|||+.|...+
T Consensus 260 ~KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11110 11111222111 11111122466778888889999999999998654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-27 Score=247.70 Aligned_cols=195 Identities=25% Similarity=0.355 Sum_probs=164.0
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--------cchHHHHHHHHHHHHcc---CCCccccccccccc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--------KGDEEFINEVEIISKIR---HRNLLSLRGCCVSS 356 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--------~~~~~f~~Ei~il~~l~---H~NIv~l~g~~~~~ 356 (614)
+|...+.+|+|+||.|+.++++ +...|+||.+.+... ...-..-.||.||..++ |+||++++.++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE-- 639 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE-- 639 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee--
Confidence 4777899999999999999987 467789998754211 11123557999999997 999999999997
Q ss_pred CCCCCceEEEEEecCC-CCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEE
Q 036081 357 DDEKGKRRFLVYDFMP-SGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~-~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~K 435 (614)
+.+.+||+||-.. +-+|.+++.. ++.+++.+..-|+.||+.|+++|| ..+|||||||-+||.+|.+|-+|
T Consensus 640 ---ddd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 640 ---DDDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred ---cCCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEE
Confidence 5667999999864 5688888865 567999999999999999999999 99999999999999999999999
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCC
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLE 497 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSfGvvL~ELltG~~p~~ 497 (614)
|.|||.+.....+.. ...+||.+|.|||.+.+..|- ..-|||++|++||.++....||.
T Consensus 711 lidfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999876544332 235799999999999988774 45799999999999999888874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=231.30 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=190.7
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeec--CCCcchHHHHHHHHHHHHccCCCcccccccccccC-CCCCceE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITD--LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD-DEKGKRR 364 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~--~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~-~~~~~~~ 364 (614)
+|.....+|.|.- .|-.+... .++.||+|++.. .+....+...+|..++..++|+|+++++.++.-.. .++..+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555667888877 44444332 488999998753 22344567889999999999999999999886322 2245678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
|+|||||. .+|...+. ..++-.....|..|+..|++||| +.+|+||||||+||++..+..+||.|||+|+.
T Consensus 97 y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence 99999994 67777664 24666778899999999999999 99999999999999999999999999999985
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh---
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE--- 521 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--- 521 (614)
-. .....+..+.|..|.|||.+.+..+.+.+||||.||++.||++|+..|.+.+ .+.+|-...-..|...+
T Consensus 168 e~--~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 ED--TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cC--cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch----HHHHHHHHHHHhcCCCHHHH
Confidence 43 3346777889999999999998889999999999999999999998886322 22233222111111110
Q ss_pred ------------------------hhhHHh-hh--hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 522 ------------------------IFDEFI-RE--EGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 522 ------------------------~~d~~l-~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.+...+ .. +.+..-......++..|+-.+|++|-++++++++=
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 000000 00 01111122456678899999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=271.50 Aligned_cols=201 Identities=14% Similarity=0.163 Sum_probs=140.8
Q ss_pred HccC-CCcccccccccccC--CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCce
Q 036081 340 KIRH-RNLLSLRGCCVSSD--DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAI 416 (614)
Q Consensus 340 ~l~H-~NIv~l~g~~~~~~--~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~i 416 (614)
.++| +||+++++++.... .......++++||+ .++|.++|... ...+++.+++.++.||++||.||| +.+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAH---SQGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 3456 68888888873322 11234567888987 56999999652 356899999999999999999999 8999
Q ss_pred EecCCCCCceeecC-------------------CCcEEEeeecccccccCCC---------------ccccccccCCCCc
Q 036081 417 YHRDIKSTNILLDS-------------------EMKAKVADFGLAKQSLEGQ---------------SHLTTRVAGTYGY 462 (614)
Q Consensus 417 vHrDIKp~NILLd~-------------------~~~~KL~DFGla~~~~~~~---------------~~~~~~~~gt~~Y 462 (614)
+||||||+||||+. ++.+||+|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666777665321100 0001124588899
Q ss_pred cchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHH
Q 036081 463 LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRV 542 (614)
Q Consensus 463 ~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 542 (614)
||||++.+..++.++|||||||+||||++|..|+..... ....+... .+.+... . .......+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~---------~~~~~~~----~-~~~~~~~~ 244 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHR---------VLPPQIL----L-NWPKEASF 244 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHh---------hcChhhh----h-cCHHHHHH
Confidence 999999999999999999999999999999887643211 11111100 0111000 0 11234567
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 036081 543 GILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 543 ~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+..|++.+|.+||+|.|++++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 788999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=214.25 Aligned_cols=166 Identities=22% Similarity=0.196 Sum_probs=125.7
Q ss_pred CCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcccc
Q 036081 374 GSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLT 453 (614)
Q Consensus 374 gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 453 (614)
|+|.+++... ...++|.+++.|+.||++||.||| +.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888652 356999999999999999999999 554 999999999999999 99987653322
Q ss_pred ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcH
Q 036081 454 TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSR 533 (614)
Q Consensus 454 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 533 (614)
..||+.|||||++.++.++.++|||||||++|||++|+.||.........+..+.......... + .....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~----~~~~~ 133 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR----D----RSNLE 133 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc----c----cccHH
Confidence 2589999999999999999999999999999999999999965433222222222111111000 0 00111
Q ss_pred HHHH--HHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 534 AVME--RFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 534 ~~~~--~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+ .+.+++..|++.+|.+||++.|+++++..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 2222 68899999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=223.38 Aligned_cols=254 Identities=19% Similarity=0.328 Sum_probs=188.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+.|.+.+.||+|.||.+-++.++ ..+.+++|.+.... ...++|.+|...--.| .|.||+.-++.-.. ..+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t~d~Yv 98 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----TSDAYV 98 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh----cCceEE
Confidence 45788899999999999999987 57789999876432 2357899998876666 59999988776543 344789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee-cC-CCcEEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL-DS-EMKAKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL-d~-~~~~KL~DFGla~ 443 (614)
+++||+|.|+|.+.+.. ..+.+..-.+++.|++.||.|+| +.++||||||.+|||+ +. ..++||+|||+.+
T Consensus 99 F~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999999988755 45777788899999999999999 9999999999999999 33 3479999999987
Q ss_pred cccCCCccccccccCCCCccchhhhcc---C--CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALY---G--QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~---~--~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
.... ......-+..|.+||.... + ...+.+|||.||++++.++||+.|++..... ...-|.|..|..++
T Consensus 172 k~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~--d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 172 KVGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM--DKPYWEWEQWLKRK 245 (378)
T ss_pred ccCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc--CchHHHHHHHhccc
Confidence 5321 1223345678999998753 2 3467899999999999999999999843322 22335555555554
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
...+-+.+ .. ..++..++-..-+..++++|=-+.++.++..
T Consensus 246 ~~~~P~~F--~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 246 NPALPKKF--NP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred CccCchhh--cc----cCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 33222211 11 2235556666778889988866667666543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-26 Score=246.39 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=195.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
..+|+....+|+|.||.|||++.. .++..|||.++-.......-.++|+-+++.-+|+||+.++|-+. .....+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-----r~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-----RRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-----hhcCcE
Confidence 346777889999999999999965 68999999998766566667788999999999999999999987 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
++|||+.+|+|.+.-+- .++|++.++-...++..+||+||| ..+-+|||||-.|||+++.|.+|++|||.+-+.
T Consensus 89 icMEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhh
Confidence 99999999999998765 467999999999999999999999 899999999999999999999999999988654
Q ss_pred cCCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
... -.......||+.|||||+.. .+.|..++|||+.|+...|+---+.|.-..-....+ +. ....+
T Consensus 163 tat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l---~L--mTkS~----- 231 (829)
T KOG0576|consen 163 TAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL---FL--MTKSG----- 231 (829)
T ss_pred hhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH---HH--hhccC-----
Confidence 321 11233468999999999874 678999999999999999997666654221110000 00 00111
Q ss_pred hhH-HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036081 523 FDE-FIREEGSRAVMERFVRVGILCAHVMVALRPTIADAL 561 (614)
Q Consensus 523 ~d~-~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl 561 (614)
+++ .+++ ...-.+-+.+++..|+-.+|.+|||....+
T Consensus 232 ~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 232 FQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111 1111 112234678899999999999999987754
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=233.86 Aligned_cols=267 Identities=20% Similarity=0.233 Sum_probs=201.3
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc------CCCccccccccccc
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR------HRNLLSLRGCCVSS 356 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~------H~NIv~l~g~~~~~ 356 (614)
+...++|......|+|-|++|.+|... -|..||||++.+.. -..+.=+.|++||.+|+ --+.++|+-.|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~-- 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK-- 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--
Confidence 344567888888999999999999865 48899999997643 22445578999999995 347888888776
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAK 435 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~K 435 (614)
..++++||+|-+ ..+|.+.|......-.|.......++.|+.-||..|- +.+|+|.||||+|||+++.- ..|
T Consensus 505 ---hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 505 ---HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred ---hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceee
Confidence 567899999987 5689999988777778999999999999999999999 99999999999999998764 579
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh--HHH----H
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITD----W 509 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~--l~~----~ 509 (614)
|||||.|....+.. .+.+.-+..|.|||++.+-.|+...|+||.||.||||.||+..|.+.....++ ..+ +
T Consensus 578 LCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 578 LCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 99999987654432 23334456799999999999999999999999999999999998765544321 111 1
Q ss_pred HHHHhhCCCch-h--------------------------------hhhHHhhh-----hCcHHHHHHHHHHHHHccccCC
Q 036081 510 AWMLANSGKVD-E--------------------------------IFDEFIRE-----EGSRAVMERFVRVGILCAHVMV 551 (614)
Q Consensus 510 ~~~~~~~~~~~-~--------------------------------~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p 551 (614)
..++++.+.+. . -+...|.. .........+..+.-.|+..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 11112211110 0 01111111 1122344567778889999999
Q ss_pred CCCCCHHHHHHH
Q 036081 552 ALRPTIADALKM 563 (614)
Q Consensus 552 ~~RPtm~eVl~~ 563 (614)
++|-|..+.|++
T Consensus 735 ~KRit~nqAL~H 746 (752)
T KOG0670|consen 735 EKRITVNQALKH 746 (752)
T ss_pred hhcCCHHHHhcC
Confidence 999999998875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=225.68 Aligned_cols=264 Identities=26% Similarity=0.366 Sum_probs=193.5
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCC
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDD 358 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~ 358 (614)
....+.|...++||+|.|++||++++. ..+.||+|.+...+. .....+|+++|..+. +.||+++.+++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~r---- 105 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFR---- 105 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhc----
Confidence 334566888999999999999999854 367899999865433 345889999999995 999999999886
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-CcEEEe
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVA 437 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~KL~ 437 (614)
.++...+|+||++.-...+++. .++..+...++..+..||+++| ..|||||||||+|+|.+.. ++-.|.
T Consensus 106 -nnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 106 -NNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred -cCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEE
Confidence 5678999999999877777664 3778888999999999999999 9999999999999999764 567899
Q ss_pred eecccccccC--------C-----Ccc------------------------------ccccccCCCCccchhhhc-cCCC
Q 036081 438 DFGLAKQSLE--------G-----QSH------------------------------LTTRVAGTYGYLAPEYAL-YGQL 473 (614)
Q Consensus 438 DFGla~~~~~--------~-----~~~------------------------------~~~~~~gt~~Y~APE~~~-~~~~ 473 (614)
|||||..... . ... ......||+||.|||++. .+.-
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 9999861100 0 000 001146999999999986 5677
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH----HHH-----HhhCCC-----------chhhhhH-------H
Q 036081 474 TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW----AWM-----LANSGK-----------VDEIFDE-------F 526 (614)
Q Consensus 474 s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~----~~~-----~~~~~~-----------~~~~~d~-------~ 526 (614)
+++.||||-|||++-+++++.||-...++...+.+. -+. ..-.|. +.+.... .
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 899999999999999999999996555443211111 110 011122 1111110 0
Q ss_pred hhh---------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IRE---------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~---------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.. ...+.....++++.-+|++.||.+|-|++|.|++
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 0111122367889999999999999999999876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=222.65 Aligned_cols=167 Identities=17% Similarity=0.160 Sum_probs=129.9
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc--CCcEEEEEEeecC-----CCcchHHHHHHHHHHHHccCCCccccccccccc
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE--DGTLVAVKQITDL-----DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSS 356 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~-----~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~ 356 (614)
....++|...+.||+|+||+||+|.+. +++.+|||++... .....+.|.+|++++.+++|+|++..+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 445677999999999999999999875 5788899987532 112345689999999999999998533211
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCC-CCCceeecCCCcEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDI-KSTNILLDSEMKAK 435 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDI-Kp~NILLd~~~~~K 435 (614)
...++||||+++++|... .. . ....++.+++++|.||| +.+|+|||| ||+|||++.++++|
T Consensus 91 -----~~~~LVmE~~~G~~L~~~-~~---~------~~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHLA-RP---H------GDPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred -----CCcEEEEEccCCCCHHHh-Cc---c------chHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEE
Confidence 236999999999999622 11 0 11467899999999999 899999999 99999999999999
Q ss_pred EeeecccccccCCCcc-------ccccccCCCCccchhhhccC
Q 036081 436 VADFGLAKQSLEGQSH-------LTTRVAGTYGYLAPEYALYG 471 (614)
Q Consensus 436 L~DFGla~~~~~~~~~-------~~~~~~gt~~Y~APE~~~~~ 471 (614)
|+|||+++........ ..+...+++.|+|||++...
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999876443211 12456789999999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=198.76 Aligned_cols=259 Identities=27% Similarity=0.357 Sum_probs=193.3
Q ss_pred CccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCc---chHHHHHHHHHHHHccCC-CcccccccccccCCCCCceEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTK---GDEEFINEVEIISKIRHR-NLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~-NIv~l~g~~~~~~~~~~~~~~ 365 (614)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+++. .....+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEEE
Confidence 556788999999999999987 78999998654332 367899999999999988 7999999884 233479
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DFGla~~ 444 (614)
+++||+.+++|.+++........+.......+..+++.++.|+| ..+++||||||+||+++..+ .+++.|||+++.
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 99999999999966544211125788889999999999999999 88999999999999999998 799999999985
Q ss_pred ccCCCcc-----ccccccCCCCccchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc--chhHHHHHHHHh
Q 036081 445 SLEGQSH-----LTTRVAGTYGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLETSNSS--FLLITDWAWMLA 514 (614)
Q Consensus 445 ~~~~~~~-----~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~--~~~l~~~~~~~~ 514 (614)
....... ......||..|+|||.+.. ..++...|+||+|++++++++|+.|+...... ........+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 5443322 2356789999999999987 68899999999999999999999997654431 111111111111
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. .......... .......+.+++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSN----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccc----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 0000000000 01112356778888899999999999987764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-21 Score=202.88 Aligned_cols=261 Identities=18% Similarity=0.205 Sum_probs=189.8
Q ss_pred CCccceeeeccCcEEEEEEEEcCC--cEEEEEEeecCCCcchHHHHHHHHHHHHccC----CCcccccccccccCCCCCc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDG--TLVAVKQITDLDTKGDEEFINEVEIISKIRH----RNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g--~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H----~NIv~l~g~~~~~~~~~~~ 362 (614)
+|...++||+|+||.||++...+. ..+|+|............+..|+.++..+.+ +++..+++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 789999999999999999997643 4788888765433333378899999999973 46666666553 1355
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-----CcEEEe
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-----MKAKVA 437 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-----~~~KL~ 437 (614)
..++||+.. +.+|.++..... .+.++-.+.+.|+.|+..+|.+|| +.+++||||||.|+++... ..+.|.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 789999987 779998765543 467999999999999999999999 9999999999999999765 468999
Q ss_pred eecccc--cccCCCc----cc---cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Q 036081 438 DFGLAK--QSLEGQS----HL---TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITD 508 (614)
Q Consensus 438 DFGla~--~~~~~~~----~~---~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~ 508 (614)
|||+++ ....... .. .....||..|.+++...+...+.+.|+||++.++.|++.|..|+........ ...
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~ 248 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSK 248 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHH
Confidence 999998 3222111 11 1234599999999999999999999999999999999999999865443211 000
Q ss_pred HHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 509 WAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 509 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
... ..............+..+..+...+-..+...+|....+...|+....
T Consensus 249 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 249 FEK----------DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHH----------HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 000 000000000011122345555556666899999999999888766543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-23 Score=201.85 Aligned_cols=245 Identities=21% Similarity=0.346 Sum_probs=182.4
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEee--cCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEec
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQIT--DLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~--~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
..+|.+...|..|+|+|+ |..+++|+++ .......++|..|.-.|+-+.||||+.++|.|.. .....++..|
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~isq~ 268 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVIISQY 268 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceEeeee
Confidence 346888999999999998 5556677764 3344455789999999999999999999999974 3568999999
Q ss_pred CCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEe--eecccccccCC
Q 036081 371 MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVA--DFGLAKQSLEG 448 (614)
Q Consensus 371 ~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~--DFGla~~~~~~ 448 (614)
||.|+|+..|+.. ..-..+-.+..+++++||+|++|||+ .++-|.---|.+..|++|++.+++|+ |--.+.+
T Consensus 269 mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred ccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 9999999999874 23346778899999999999999994 34444455689999999999998885 2211111
Q ss_pred CccccccccCCCCccchhhhccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQL---TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~---s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.....-.+.||+||.++..+- -..+|+|||.++||||.|...||.....-+... .+.-+
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------------kiale 404 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------------KIALE 404 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------------hhhhc
Confidence 111234688999999986543 347999999999999999999997654322100 01111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.++-..++.....+.+++.-|+..||.+||..+.|+-.||+.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 122223334445667788889999999999999999998863
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=187.52 Aligned_cols=177 Identities=11% Similarity=0.141 Sum_probs=136.6
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHH---------HHHHHHHHHHccCCCcccccccccc
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEE---------FINEVEIISKIRHRNLLSLRGCCVS 355 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~---------f~~Ei~il~~l~H~NIv~l~g~~~~ 355 (614)
...++|...++||.|+||.||.... ++..+|||.+.......... +.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468899999999999999999655 57789999997543333222 6789999999999999999888664
Q ss_pred cCCC---CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC
Q 036081 356 SDDE---KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 356 ~~~~---~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 432 (614)
.+.. .....+|||||+++.+|.++.. ++ .....+++.+|..+| +.+++||||||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~----~~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------IS----EDVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------cc----HHHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC
Confidence 3211 1346899999999999977631 11 135669999999999 99999999999999999988
Q ss_pred cEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHH
Q 036081 433 KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELM 490 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELl 490 (614)
++|.|||......+.... ..++....+..++|+|+||+.+.-..
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754322111 11455566778999999999987653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=182.53 Aligned_cols=138 Identities=17% Similarity=0.230 Sum_probs=107.5
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCCc--c-------hHHH-----------------HHHHHHHHHccCCCcc
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTK--G-------DEEF-----------------INEVEIISKIRHRNLL 347 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--~-------~~~f-----------------~~Ei~il~~l~H~NIv 347 (614)
..||+|+||.||+|...+|+.||||+++..... . ...| ..|++++.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999999753211 1 1122 3499999999888774
Q ss_pred cccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHH-HhcCCCceEecCCCCCce
Q 036081 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-HYGLKPAIYHRDIKSTNI 426 (614)
Q Consensus 348 ~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yL-H~~~~~~ivHrDIKp~NI 426 (614)
....+.. ...+|||||+++++|...+.. ...+++....+++.|++.+|.|+ | ..+|+||||||+||
T Consensus 83 ~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NI 149 (190)
T cd05147 83 CPEPILL-------KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNL 149 (190)
T ss_pred CCcEEEe-------cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHE
Confidence 4332211 123899999998877654322 34688889999999999999999 6 78999999999999
Q ss_pred eecCCCcEEEeeecccccc
Q 036081 427 LLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 427 LLd~~~~~KL~DFGla~~~ 445 (614)
|++ ++.++|+|||++...
T Consensus 150 li~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEE-CCcEEEEEccccccC
Confidence 998 578999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=176.57 Aligned_cols=140 Identities=18% Similarity=0.167 Sum_probs=109.9
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcc--------------------------hHHHHHHHHHHHHccCCCc
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG--------------------------DEEFINEVEIISKIRHRNL 346 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~--------------------------~~~f~~Ei~il~~l~H~NI 346 (614)
...||+|+||.||+|+..+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999998889999999987542110 1123578999999999987
Q ss_pred ccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCC-CceEecCCCCCc
Q 036081 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK-PAIYHRDIKSTN 425 (614)
Q Consensus 347 v~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~-~~ivHrDIKp~N 425 (614)
.....+.. ...+|||||++++++...... ...++.....+++.+++.+|.++| . .+|+||||||+|
T Consensus 82 ~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~N 148 (190)
T cd05145 82 PVPEPILL-------KKNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYN 148 (190)
T ss_pred CCceEEEe-------cCCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhh
Confidence 54444322 124899999998865433211 245777888999999999999999 6 899999999999
Q ss_pred eeecCCCcEEEeeeccccccc
Q 036081 426 ILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 426 ILLd~~~~~KL~DFGla~~~~ 446 (614)
||++ +++++|+|||++....
T Consensus 149 Ill~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 149 ILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEE-CCCEEEEEcccceecC
Confidence 9999 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-20 Score=213.53 Aligned_cols=252 Identities=20% Similarity=0.209 Sum_probs=180.7
Q ss_pred cceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcch----HHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 292 QKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGD----EEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~----~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
..+++|.|.+|.|+..+.. .....+.|..... ..... ..+..|+-+-..++|+|++..+..+.+. ...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~~ 396 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DGI 396 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----ccc
Confidence 4578999999977777643 3333444433210 11111 1255677777788999998888777643 233
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
.-+|||++. +|..++... ..+.-.++-.++.|+.+|++|+| ..+|.|||||++|+++..+|.+||+|||.+..
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCccee
Confidence 444999999 999888652 36788888999999999999999 99999999999999999999999999999876
Q ss_pred ccCCC---ccccccccCCCCccchhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 445 SLEGQ---SHLTTRVAGTYGYLAPEYALYGQLTE-KSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 445 ~~~~~---~~~~~~~~gt~~Y~APE~~~~~~~s~-ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+.... .......+|+..|+|||.+...+|.+ ..||||.|+++..|++|+.||...........+-.. ....+..
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--~~~~~~~ 547 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--SDQRNIF 547 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc--ccccccc
Confidence 54332 25566788999999999999999987 589999999999999999999754433211100000 0000000
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
.-.. ......+++...++-.+++.+|.+|-||.+|++
T Consensus 548 ~~~~-----~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPN-----RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChH-----HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0001 112234557778888999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.2e-20 Score=199.71 Aligned_cols=213 Identities=28% Similarity=0.373 Sum_probs=160.2
Q ss_pred HHccCCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCce-E
Q 036081 339 SKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAI-Y 417 (614)
Q Consensus 339 ~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~i-v 417 (614)
+.+.|.|+.+++|.+. ++...+.|.+|+..|+|.|.+.+ ....++|..+..++.+|+.||+||| ..+| .
T Consensus 2 ~~l~h~n~~~f~g~~~-----~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~ 71 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASV-----DGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLH---NSPIGY 71 (484)
T ss_pred cccchhhhhhheeeEe-----cCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHh---cCccee
Confidence 5678999999999998 45779999999999999999987 3567999999999999999999999 4444 9
Q ss_pred ecCCCCCceeecCCCcEEEeeecccccccCC-CccccccccCCCCccchhhhccC-------CCCchhhHHHHHHHHHHH
Q 036081 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEG-QSHLTTRVAGTYGYLAPEYALYG-------QLTEKSDVYSFGIVILEL 489 (614)
Q Consensus 418 HrDIKp~NILLd~~~~~KL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~~~~~-------~~s~ksDVwSfGvvL~EL 489 (614)
|+.++++|.++|....+||+|||+....... ............-|.|||.+... ..+.+.||||||++++||
T Consensus 72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999999998765321 11111122245679999998753 247789999999999999
Q ss_pred HhCCCCCCCCCccch--hHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 490 MSGRKVLETSNSSFL--LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 490 ltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
++.+.||........ .+...+.. .+ ...+.+.+.... +..+.+..++..|+..+|.+||++.+|-..++..
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~---~~--~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKK---GG--SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred HhccCccccccccCChHHHHHHHHh---cC--CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999999987543332 22222211 01 111111111111 3334788899999999999999999998888764
Q ss_pred C
Q 036081 568 I 568 (614)
Q Consensus 568 ~ 568 (614)
.
T Consensus 225 ~ 225 (484)
T KOG1023|consen 225 N 225 (484)
T ss_pred c
Confidence 3
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=168.75 Aligned_cols=187 Identities=12% Similarity=0.045 Sum_probs=140.5
Q ss_pred ccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcc----hHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEE
Q 036081 291 SQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG----DEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~----~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.....|++|+||+||.+.- ++..++.+.+.....-. ...|.+|+++|.++. |+++.+++++. ..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence 3457899999999997765 57888877775432211 125789999999995 57888888752 259
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCC-CCCceeecCCCcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDI-KSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDI-Kp~NILLd~~~~~KL~DFGla~~ 444 (614)
++|||+.+.+|...+.. ....++.+++++|.++| +.+|+|||| ||+|||++.++.++|+|||++..
T Consensus 75 lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred EEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 99999998888654311 11357889999999999 999999999 79999999999999999999985
Q ss_pred ccCCCcc----c--------cccccCCCCccchhhhccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 036081 445 SLEGQSH----L--------TTRVAGTYGYLAPEYALYG-QLT-EKSDVYSFGIVILELMSGRKVLETSN 500 (614)
Q Consensus 445 ~~~~~~~----~--------~~~~~gt~~Y~APE~~~~~-~~s-~ksDVwSfGvvL~ELltG~~p~~~~~ 500 (614)
....... . ......++.|+.|+...-- ..+ ...+.++-|.-+|.++|++.+.-.++
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 4432210 0 1112368889999876432 334 67899999999999999998764433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.5e-19 Score=172.16 Aligned_cols=202 Identities=22% Similarity=0.318 Sum_probs=162.1
Q ss_pred hCCCccceeeeccCcEEEEEEE-EcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccC-CCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRH-RNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H-~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...++||+|+||.+|.|. ..+|..||||.-+.. ....+...|.++...|+| ..|..+.-|.. ++..-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~-----e~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGT-----EKDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcc-----ccccc
Confidence 4678999999999999999997 568999999985432 334567889999999975 45655555554 45566
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC---CcEEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE---MKAKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~KL~DFGl 441 (614)
.+|||.. +-||++++.- . ...++..+.+-++-|+..-++|+| ..++|||||||+|.|..-+ .++-++||||
T Consensus 87 vlVMdLL-GPsLEdLfnf-C-~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNF-C-SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeeeecc-CccHHHHHHH-H-hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccc
Confidence 8999998 6788876532 2 345888889999999999999999 9999999999999999644 4688999999
Q ss_pred cccccCCCc--c----ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 036081 442 AKQSLEGQS--H----LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501 (614)
Q Consensus 442 a~~~~~~~~--~----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~ 501 (614)
|+.+....+ + ......||..|.+-....+-+-+.+-|+=|+|.+|...--|..||+....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 997644322 1 23346799999998888888888999999999999999999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=170.81 Aligned_cols=140 Identities=21% Similarity=0.246 Sum_probs=107.7
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-----cCCCcccccccccccCCCCCce
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-----RHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-----~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+...+.||+|+||.||. ++ ++.. +||++........+.+.+|++++.++ .||||++++|++.+..+ .+..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEE
Confidence 34567899999999996 44 3444 79988765445567899999999999 57999999999875432 1233
Q ss_pred EEEEEec--CCCCCcccccchhhhccCCCccchhHHHHHHHHHH-HHHHhcCCCceEecCCCCCceeecC----CCcEEE
Q 036081 364 RFLVYDF--MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL-AYLHYGLKPAIYHRDIKSTNILLDS----EMKAKV 436 (614)
Q Consensus 364 ~~LV~Ey--~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL-~yLH~~~~~~ivHrDIKp~NILLd~----~~~~KL 436 (614)
..+|+|| +++|+|.+++.+ ..+++. ..++.++..++ +||| +.+|+||||||+|||++. +++++|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 4489999 668999999954 234444 35678888888 9999 999999999999999974 347999
Q ss_pred eeeccc
Q 036081 437 ADFGLA 442 (614)
Q Consensus 437 ~DFGla 442 (614)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 996544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-19 Score=201.60 Aligned_cols=251 Identities=25% Similarity=0.254 Sum_probs=180.1
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC-CcchHHHHHHHHH--HHHccCCCcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD-TKGDEEFINEVEI--ISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~-~~~~~~f~~Ei~i--l~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++...+.||++.|=+|.+++.++|. |+||++-+.+ .-..+.|.++++- ...++|||.+++.-.-. ..+..|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~-----t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV-----TDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH-----hhHHHH
Confidence 5666788999999999999999887 8899986544 3334555554444 44458999998876644 345568
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc-
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ- 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~- 444 (614)
||=+|.. -+|+|.|.. +.-|...+.+-|+.|+..||.-.| +.+|+|||||.+||||+.=.-+.|+||..-+.
T Consensus 98 lvRqyvk-hnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 98 LVRQYVK-HNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHh-hhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCc
Confidence 8888885 478888754 455777788889999999999999 99999999999999999888899999987653
Q ss_pred -ccCCCcccccccc----CCCCccchhhhccC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHH
Q 036081 445 -SLEGQSHLTTRVA----GTYGYLAPEYALYG-----------QLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLIT 507 (614)
Q Consensus 445 -~~~~~~~~~~~~~----gt~~Y~APE~~~~~-----------~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~ 507 (614)
.+++.....+-.. .-..|+|||.+... ..+++.||||.||++.||++ |+++|+..
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------- 242 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------- 242 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------
Confidence 2333322211111 22369999988531 26789999999999999998 67777532
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
+... ++.+. .......+.+-.+ ..+.++++.|++.||.+|-++++.++.-.+.
T Consensus 243 QL~a--Yr~~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 243 QLLA--YRSGN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHHh--HhccC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1111 12222 2222222222111 2677889999999999999999999885553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-18 Score=174.70 Aligned_cols=237 Identities=20% Similarity=0.185 Sum_probs=147.7
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccC----------CCcccccccccc
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRH----------RNLLSLRGCCVS 355 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H----------~NIv~l~g~~~~ 355 (614)
+...+.||.|+++.||.++.. +|+.+|||++.-.. ....+++.+|.-....+.+ -.++.-++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445788999999999999987 48999999875332 2234566666655444322 112211111110
Q ss_pred c-CC------CCCc-----eEEEEEecCCCCCcccccchhhh----ccCCCccchhHHHHHHHHHHHHHHhcCCCceEec
Q 036081 356 S-DD------EKGK-----RRFLVYDFMPSGSLGDHISNALT----RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHR 419 (614)
Q Consensus 356 ~-~~------~~~~-----~~~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHr 419 (614)
. .. .+.. ..+++|+-+ .++|.+++.--.. ...+....|+.+..|+.+.+++|| ..+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 0 00 0011 236777777 5788777542111 123445567788899999999999 8999999
Q ss_pred CCCCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccC--------CCCchhhHHHHHHHHHHHHh
Q 036081 420 DIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG--------QLTEKSDVYSFGIVILELMS 491 (614)
Q Consensus 420 DIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--------~~s~ksDVwSfGvvL~ELlt 491 (614)
||||+|++++.+|.++|+||+.......... . ...+..|.+||..... .++.+.|.|++|+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE--G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee--c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987765432111 1 2345789999987542 47889999999999999999
Q ss_pred CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCC
Q 036081 492 GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALR 554 (614)
Q Consensus 492 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R 554 (614)
|+.||+........ .. .+.. .. +.++.+..++...++.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~--------------~~----~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADP--------------EW----DFSR-CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTS--------------GG----GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccc--------------cc----cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence 99999865432110 00 1222 23 677788899999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=192.47 Aligned_cols=200 Identities=22% Similarity=0.246 Sum_probs=158.3
Q ss_pred HHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc---CCCcccccccccccCC
Q 036081 282 ELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR---HRNLLSLRGCCVSSDD 358 (614)
Q Consensus 282 el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~---H~NIv~l~g~~~~~~~ 358 (614)
+.+.....|.+.+.||+|+||+||+|+..+|+.||+|+-+..+ .-+|.--.+++.||+ -+-|..+..++..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~--- 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVF--- 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHcc---
Confidence 3444556788899999999999999999889999999865432 234554555666666 2334444444442
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec-------CC
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD-------SE 431 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd-------~~ 431 (614)
.+.-+||+||.+.|+|.+++.. .+.++|.....++.++++-+..|| ..+|||+||||+|.||. ++
T Consensus 766 --~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 766 --QNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred --CCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcc
Confidence 2346899999999999999873 578999999999999999999999 99999999999999993 23
Q ss_pred CcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 036081 432 MKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 495 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p 495 (614)
..++|+|||-+-...--.. ..-...++|-++-.+|...+..++...|.|.|+.+++-|+.|+..
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 4589999998865322111 233456889999999999999999999999999999999999854
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=168.77 Aligned_cols=201 Identities=20% Similarity=0.309 Sum_probs=162.9
Q ss_pred CCCccceeeeccCcEEEEEEE-EcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
-+|...++||+|.||.++.|+ +-+++.||||.-...+. ..++..|.+..+.|. .++|...+-|-. ++.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGq-----eG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQ-----EGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeecc-----ccchhh
Confidence 358889999999999999998 44799999997543222 345778888888884 677777665544 567779
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-----CcEEEeeec
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-----MKAKVADFG 440 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-----~~~KL~DFG 440 (614)
||+|.+ +-||+|++.- . ...++..+..-||.|+..-++|+| .+.+|.|||||+|.||..- ..+.|.|||
T Consensus 101 LVidLL-GPSLEDLFD~-C-gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDL-C-GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhhhh-CcCHHHHHHH-h-cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 999998 6788877543 1 346889999999999999999999 9999999999999999643 348999999
Q ss_pred ccccccCCCcc------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 036081 441 LAKQSLEGQSH------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501 (614)
Q Consensus 441 la~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~ 501 (614)
+|+...+..+. ......||..||+=.-..+.+-+.+-|.=|+|-++...+-|..||+....
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 99987543322 12335799999999999999999999999999999999999999986543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=160.81 Aligned_cols=143 Identities=20% Similarity=0.156 Sum_probs=110.2
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCc----------------------chHHHHHHHHHHHH
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTK----------------------GDEEFINEVEIISK 340 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~----------------------~~~~f~~Ei~il~~ 340 (614)
+.+....|...+.||+|+||.||++..++|+.||||++...... ....+..|..++.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333346677899999999999999888999999987542200 11236778999999
Q ss_pred ccCCCc--ccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEe
Q 036081 341 IRHRNL--LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYH 418 (614)
Q Consensus 341 l~H~NI--v~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivH 418 (614)
+.|+++ ...++. ...++||||+++++|.+.... .....++.+++.++.++| +.+|+|
T Consensus 90 l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H 148 (198)
T cd05144 90 LYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIH 148 (198)
T ss_pred HHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCc
Confidence 988753 333321 235899999999998765421 345678999999999999 899999
Q ss_pred cCCCCCceeecCCCcEEEeeeccccccc
Q 036081 419 RDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 419 rDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
|||||+||+++++++++|+|||++....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.8e-19 Score=191.31 Aligned_cols=185 Identities=29% Similarity=0.393 Sum_probs=152.3
Q ss_pred eeccCcEEEEEEE----EcCCcEEEEEEeecCCCcc--hHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEEEEE
Q 036081 296 IGQGASGVVYKGT----LEDGTLVAVKQITDLDTKG--DEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 296 LG~G~fG~Vykg~----~~~g~~vAVK~l~~~~~~~--~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+|+|.||.|+... .+.|..+|.|.+++..... ......|..++..++ ||.+|++.-.+. .....+++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq-----t~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ-----TDGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec-----cccchhHhh
Confidence 7899999998764 2347888999886533211 114567888999997 999999987776 345689999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
+|..+|.|..++.+ ....++.........+|-+++++| +.+|+|||+|++||+++.+|++|+.|||+++..-+.
T Consensus 77 d~~rgg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSK---EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhcccchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 99999999988865 344566666777888999999999 999999999999999999999999999999876443
Q ss_pred CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 036081 449 QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLET 498 (614)
Q Consensus 449 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~ 498 (614)
.. .+||..|||||++. .....+|.||||++.+||+||-.||..
T Consensus 151 ~~-----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 151 KI-----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hh-----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 22 18999999999998 567789999999999999999999975
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=162.95 Aligned_cols=134 Identities=23% Similarity=0.344 Sum_probs=110.8
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCCc--------chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTK--------GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--------~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+.||+|++|.||+|.+ +|..++||+....... ....+.+|++++..++|+++.....++.. ....+
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENFI 75 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCCE
Confidence 5799999999999998 5778999986543221 12357889999999999998877776652 33568
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+||||+++++|.+.+... .+ .+..++.+++.+|.++| +.+++|||++|.|||++ ++.++|+|||+++.
T Consensus 76 lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999887541 12 78899999999999999 89999999999999999 78999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=166.51 Aligned_cols=141 Identities=17% Similarity=0.134 Sum_probs=108.3
Q ss_pred CCccceeeeccCcEEEEEEE--EcCCcEEEEEEeecCCCc------------------------chHHHHHHHHHHHHcc
Q 036081 289 GFSQKNLIGQGASGVVYKGT--LEDGTLVAVKQITDLDTK------------------------GDEEFINEVEIISKIR 342 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~--~~~g~~vAVK~l~~~~~~------------------------~~~~f~~Ei~il~~l~ 342 (614)
.|...+.||+|+||.||+|+ ..+|+.||||.++..... ....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36677899999999999998 568999999998643210 0123568999999997
Q ss_pred CCC--cccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc-eEec
Q 036081 343 HRN--LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA-IYHR 419 (614)
Q Consensus 343 H~N--Iv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~-ivHr 419 (614)
+.. +.+++++ ...++||||+++++|...... ...+...+...++.+|+.+|.+|| ..+ |+||
T Consensus 109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~ 173 (237)
T smart00090 109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLY---KEGELVHG 173 (237)
T ss_pred hcCCCCCeeeEe---------cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeC
Confidence 643 2233321 124899999999888765432 233455556799999999999999 888 9999
Q ss_pred CCCCCceeecCCCcEEEeeecccccc
Q 036081 420 DIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 420 DIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
||||+||+++ +++++|+|||.+...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 889999999998743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.4e-17 Score=159.31 Aligned_cols=130 Identities=25% Similarity=0.403 Sum_probs=104.4
Q ss_pred eeeccCcEEEEEEEEcCCcEEEEEEeecCCCc--------chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 295 LIGQGASGVVYKGTLEDGTLVAVKQITDLDTK--------GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--------~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.||+|+||.||+|.+. |..+++|+....... ..+.+.+|++++..++|+++.....++.. ....++
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCEE
Confidence 4899999999999964 788999986542211 12457789999999998876555544442 234689
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
||||+++++|.+.+.... . .++.+++.+|.+|| +.+++|||++|.||+++ ++.+++.|||+++.
T Consensus 75 v~e~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN----D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEECCccHHHHHhhcH----H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999988765421 1 88999999999999 89999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-18 Score=185.06 Aligned_cols=123 Identities=25% Similarity=0.452 Sum_probs=109.0
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++.|+++...+|.++|.........+|...+.++.|++.|+.| ++.+|||+||.||+...+.++||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 589999999999999999866566678899999999999999999 68999999999999999999999999998
Q ss_pred ccccCCC-----ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh
Q 036081 443 KQSLEGQ-----SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491 (614)
Q Consensus 443 ~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt 491 (614)
....... ....+..+||..||+||.+.+..|+.|+||||||++|+|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7654433 223455689999999999999999999999999999999987
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.9e-17 Score=183.97 Aligned_cols=137 Identities=22% Similarity=0.326 Sum_probs=108.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEE-eecC-CC------cchHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQ-ITDL-DT------KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~-l~~~-~~------~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
...|...++||+|+||+||+|.+.+.. +++|+ ..+. .. ...+.+.+|++++.+++|++++....++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe---
Confidence 344566789999999999999987443 44443 2221 11 112468899999999999999887766653
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
....++||||+++++|.+++. .+..++.+++++|.||| +.+++||||||+|||+ +++.++|+|
T Consensus 408 --~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 408 --PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred --CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEe
Confidence 234689999999999988774 34679999999999999 8999999999999999 678999999
Q ss_pred eccccc
Q 036081 439 FGLAKQ 444 (614)
Q Consensus 439 FGla~~ 444 (614)
||+++.
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-16 Score=148.56 Aligned_cols=135 Identities=21% Similarity=0.267 Sum_probs=97.3
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcc--hHHH----------------------HHHHHHHHHccCCC--c
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG--DEEF----------------------INEVEIISKIRHRN--L 346 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~--~~~f----------------------~~Ei~il~~l~H~N--I 346 (614)
.+.||+|+||.||+++..+|+.||||+++...... ...+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36799999999999998889999999986532211 1111 24555555554432 2
Q ss_pred ccccccccccCCCCCceEEEEEecCCCCCcccc-cchhhhccCCCccchhHHHHHHHHHHHHHHhcCC-CceEecCCCCC
Q 036081 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDH-ISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK-PAIYHRDIKST 424 (614)
Q Consensus 347 v~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~-L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~-~~ivHrDIKp~ 424 (614)
.+.+++ ...++||||++++.+... +... ... .+...++.+++.++.++| . .+|+||||||+
T Consensus 82 ~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~ 144 (187)
T cd05119 82 PKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEY 144 (187)
T ss_pred CceEec---------CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChh
Confidence 222222 235899999999655432 2211 111 667899999999999999 7 99999999999
Q ss_pred ceeecCCCcEEEeeecccccc
Q 036081 425 NILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~ 445 (614)
||+++ ++.++|+|||.+...
T Consensus 145 Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 145 NILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred hEEEE-CCcEEEEECcccccc
Confidence 99999 999999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=138.48 Aligned_cols=135 Identities=19% Similarity=0.207 Sum_probs=111.3
Q ss_pred cceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccC--CCcccccccccccCCCCCceEEEEEe
Q 036081 292 QKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRH--RNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H--~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
+.+.||+|.++.||+++..+ ..+++|....... ...+.+|+.++..++| .++.+++++.. ..+..+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEE
Confidence 35689999999999999864 7899999865332 4679999999999987 48888877665 2356899999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
|++++.+..+ ++.....++.+++++|++||.....+++|+|++|+||+++.++.+++.|||.++.
T Consensus 74 ~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9998777644 4456678999999999999954446899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.1e-15 Score=152.87 Aligned_cols=202 Identities=21% Similarity=0.240 Sum_probs=136.2
Q ss_pred cCCCcccccccccccCC----------------------CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHH
Q 036081 342 RHRNLLSLRGCCVSSDD----------------------EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL 399 (614)
Q Consensus 342 ~H~NIv~l~g~~~~~~~----------------------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~ 399 (614)
+|||||++.++|.++-. .++...|+||.-.+ -+|.++|.. ...+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999998764311 13567788887774 367777754 3466667778899
Q ss_pred HHHHHHHHHHhcCCCceEecCCCCCceee--cCCC--cEEEeeecccccccCC--C---ccccccccCCCCccchhhhcc
Q 036081 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILL--DSEM--KAKVADFGLAKQSLEG--Q---SHLTTRVAGTYGYLAPEYALY 470 (614)
Q Consensus 400 ~Ia~gL~yLH~~~~~~ivHrDIKp~NILL--d~~~--~~KL~DFGla~~~~~~--~---~~~~~~~~gt~~Y~APE~~~~ 470 (614)
|+.+|+.||| +++|.|||+|++|||| |+|+ ...|+|||.+--.... + ........|...-||||+...
T Consensus 349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999 9999999999999999 4444 4688999975422110 1 011112346778999999863
Q ss_pred C--C----CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHH
Q 036081 471 G--Q----LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGI 544 (614)
Q Consensus 471 ~--~----~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 544 (614)
. + --.|+|.|+.|.+-||+++...||....+-...... ..+.--+.+ +..++..+.+++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----------Yqe~qLPal----p~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----------YQESQLPAL----PSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----------hhhhhCCCC----cccCChHHHHHHH
Confidence 2 2 235999999999999999999999763321111111 111111111 2223345667788
Q ss_pred HccccCCCCCCCHHHHHHHhh
Q 036081 545 LCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 545 ~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
..++.||.+||+.+-....|+
T Consensus 492 ~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHhcCCccccCCccHHHhHHH
Confidence 889999999998766544443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=173.31 Aligned_cols=169 Identities=30% Similarity=0.460 Sum_probs=122.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
..+|...+.|..|+||.||..+++. .+..|.|. .+.+ .. -+||..+.| ..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----li-----------lRnilt~a~-----------npf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LI-----------LRNILTFAG-----------NPF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hh-----------hhccccccC-----------Ccc
Confidence 3568889999999999999999874 56777743 2211 11 122333322 123
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
.| |+-...+.+ .+.++. +++.+++||| +.+|+|||+||+|.||..-|++|+.|||+.+..
T Consensus 134 vv------gDc~tllk~---~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 134 VV------GDCATLLKN---IGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ee------chhhhhccc---CCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence 33 333333332 122322 2378999999 999999999999999999999999999998753
Q ss_pred cCCC--------------ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 036081 446 LEGQ--------------SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF 503 (614)
Q Consensus 446 ~~~~--------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~ 503 (614)
.... ......++||+.|.|||++....|...+|+|++|+|+||.+-|+.||.....++
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 2211 112345789999999999999999999999999999999999999998765543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=146.43 Aligned_cols=139 Identities=16% Similarity=0.196 Sum_probs=106.0
Q ss_pred ceeee-ccCcEEEEEEEEcCCcEEEEEEeecCC-------------CcchHHHHHHHHHHHHccCCCc--cccccccccc
Q 036081 293 KNLIG-QGASGVVYKGTLEDGTLVAVKQITDLD-------------TKGDEEFINEVEIISKIRHRNL--LSLRGCCVSS 356 (614)
Q Consensus 293 ~~~LG-~G~fG~Vykg~~~~g~~vAVK~l~~~~-------------~~~~~~f~~Ei~il~~l~H~NI--v~l~g~~~~~ 356 (614)
...|| .||.|+||+.... +..++||++.... ......+.+|++++.+++|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999886 7789999875311 1123467889999999998885 6666664432
Q ss_pred CCCCCceEEEEEecCCC-CCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEE
Q 036081 357 DDEKGKRRFLVYDFMPS-GSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~K 435 (614)
.. .....++|+||+++ .+|.+++.+ ..++. ..+.+|+.+|.+|| +.+|+||||||.|||++.++.++
T Consensus 115 ~~-~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~----~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HG-LFYRADILIERIEGARDLVALLQE----APLSE----EQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cC-cceeeeEEEEecCCCCCHHHHHhc----CCCCH----HHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEE
Confidence 11 11234699999997 688877643 23332 34678999999999 99999999999999999999999
Q ss_pred Eeeeccccc
Q 036081 436 VADFGLAKQ 444 (614)
Q Consensus 436 L~DFGla~~ 444 (614)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-13 Score=149.54 Aligned_cols=145 Identities=20% Similarity=0.256 Sum_probs=104.1
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcc----------------------------------------h
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG----------------------------------------D 328 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~----------------------------------------~ 328 (614)
.|. .+.||.|++|.||+|++++|+.||||+.+....+. +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 36899999999999999999999999985421100 0
Q ss_pred HHHHHHHHHHHHcc----CCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHH-
Q 036081 329 EEFINEVEIISKIR----HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK- 403 (614)
Q Consensus 329 ~~f~~Ei~il~~l~----H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~- 403 (614)
-+|.+|.+.+.+++ |.+-+.+-..+.+ .....+|||||+++++|.+..... .... .+.+++..+++
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARS 268 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHH
Confidence 02455666565552 3333444444432 123469999999999999876431 1112 45678887777
Q ss_pred HHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 404 gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
.+..+| ..+++|+|+||.||+++.++++++.|||++....
T Consensus 269 ~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 478888 8999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-14 Score=163.86 Aligned_cols=253 Identities=22% Similarity=0.251 Sum_probs=182.2
Q ss_pred CCccceeeeccCcEEEEEEEEcC--CcEEEEEEeecCC--CcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCce
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED--GTLVAVKQITDLD--TKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~--g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.|...+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++... ....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-----~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-----SPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-----CCcc
Confidence 35556679999999998877543 4556777664432 222233345777777776 999999999876 4567
Q ss_pred EEEEEecCCCCCccccc-chhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeeecc
Q 036081 364 RFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGL 441 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L-~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DFGl 441 (614)
.+++.||..+|++.+.+ ... ....+......+..|+..++.|+|. ..++.||||||+|.+++..+ ..|++|||+
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred cccccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchh
Confidence 89999999999999888 332 2256667778899999999999995 67899999999999999999 999999999
Q ss_pred cccccC--CCccccccccC-CCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 442 AKQSLE--GQSHLTTRVAG-TYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 442 a~~~~~--~~~~~~~~~~g-t~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|..... +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|.... +
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~ 248 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---G 248 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---c
Confidence 987655 33333445677 9999999999874 556789999999999999999999876554332222222110 0
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADAL 561 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl 561 (614)
.... ............+...++..+|..|.+.+++-
T Consensus 249 ~~~~--------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 RFTQ--------LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccc--------CccccCChhhhhcccccccCCchhcccccccc
Confidence 0000 01112223455566677778999999888763
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-13 Score=138.56 Aligned_cols=210 Identities=20% Similarity=0.226 Sum_probs=147.0
Q ss_pred HHHHHHccCCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCC
Q 036081 335 VEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLK 413 (614)
Q Consensus 335 i~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~ 413 (614)
..-|-++.|.|||+++.|+.+...++..+..++.|||..|+|..+|++.. ..+.+....-.+++.||..||.||| .+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccC
Confidence 34455668999999999998777767788999999999999999998754 2345666666789999999999999 568
Q ss_pred CceEecCCCCCceeecCCCcEEEeeeccccc---ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHH
Q 036081 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQ---SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELM 490 (614)
Q Consensus 414 ~~ivHrDIKp~NILLd~~~~~KL~DFGla~~---~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELl 490 (614)
++|+|+++.-+-|++..++-+||+----... .............+-++|.+||+-...+.+..+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999999888852210000 0000111122335678999999988888889999999999999998
Q ss_pred hCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 491 SGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 491 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
-|..-.....+... .+.. +...+..... .+-...+..|++..|+.||+|++.+.+
T Consensus 277 ilEiq~tnseS~~~----------~ee~----ia~~i~~len----~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE----------VEEN----IANVIIGLEN----GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceee----------hhhh----hhhheeeccC----ccccCcCcccccCCCCCCcchhhhhcC
Confidence 88643222211110 0001 1111100000 011234567999999999999998665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.9e-12 Score=118.15 Aligned_cols=127 Identities=18% Similarity=0.108 Sum_probs=95.7
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCccc-ccccccccCCCCCceEEEEEecC
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS-LRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~-l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
.+.|+.|.++.||+++.. |..+++|....... ....+..|++++..+.+.++++ ++++. ....++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEec
Confidence 356889999999999976 77899998754321 2345788999999997666543 33322 12347999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc-----eEecCCCCCceeecCCCcEEEeeecccc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA-----IYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~-----ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
++.++.+. ......++.+++++|+.|| ..+ ++|+|++|.||+++ ++.+++.|||.+.
T Consensus 74 ~G~~l~~~-----------~~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE-----------DFSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc-----------cccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99887643 0112356789999999999 555 69999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-11 Score=137.62 Aligned_cols=148 Identities=16% Similarity=0.180 Sum_probs=95.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCc----------------------------------chH--
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTK----------------------------------GDE-- 329 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~----------------------------------~~~-- 329 (614)
...|+. +.||+|++|.||+|++++ |+.||||+++..-.+ -.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999987 999999998642100 011
Q ss_pred ----HHHHHHHHHHHcc----CCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHH
Q 036081 330 ----EFINEVEIISKIR----HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDV 401 (614)
Q Consensus 330 ----~f~~Ei~il~~l~----H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~I 401 (614)
+|.+|+..+.+++ +.+.+.+-.++.+ -....+|||||++++.+.+.-.- ..... .+..++...
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l--~~~g~---d~~~la~~~ 268 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAAL--RAAGT---DMKLLAERG 268 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHH--HhcCC---CHHHHHHHH
Confidence 2344444444442 3344444343332 13457899999999999764211 01111 123344333
Q ss_pred HHH-HHHHHhcCCCceEecCCCCCceeecCCC----cEEEeeecccccccC
Q 036081 402 AKG-LAYLHYGLKPAIYHRDIKSTNILLDSEM----KAKVADFGLAKQSLE 447 (614)
Q Consensus 402 a~g-L~yLH~~~~~~ivHrDIKp~NILLd~~~----~~KL~DFGla~~~~~ 447 (614)
++. +.-++ ..+++|+|+||.||+++.++ ++++.|||+.....+
T Consensus 269 v~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 332 22333 78999999999999999988 999999999876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.1e-11 Score=133.21 Aligned_cols=246 Identities=25% Similarity=0.267 Sum_probs=172.4
Q ss_pred Cccceeeec--cCcEEEEEEEE--c-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCC
Q 036081 290 FSQKNLIGQ--GASGVVYKGTL--E-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 290 f~~~~~LG~--G~fG~Vykg~~--~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~ 361 (614)
|.....+|. |.+|.||.+.. . ++..+|+|+-+..- ......=.+|+..-.+++ |+|.++....+. .+
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e-----~~ 190 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE-----GS 190 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc-----cC
Confidence 555678999 99999999987 3 68889999854322 222333456777777774 999999666554 55
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHH----HHHHHHhcCCCceEecCCCCCceeecCC-CcEEE
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK----GLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKV 436 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~----gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~KL 436 (614)
+..++-.|++. .+|..+.+.. ...+.....+.+..+... ||.++| ..+++|-|+||.||++..+ ...++
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred Ccceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeec
Confidence 67788888874 6777776553 233566667777777777 999999 9999999999999999999 88999
Q ss_pred eeecccccccCCCcc----ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Q 036081 437 ADFGLAKQSLEGQSH----LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM 512 (614)
Q Consensus 437 ~DFGla~~~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~ 512 (614)
+|||+...+..+.-. ...+..|...|++||.. .+.++.+.|+|++|.+.+|-.+|-......... .|.
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~ 336 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWS 336 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Ccc
Confidence 999998876554421 12233677889999965 467889999999999999999988766443111 121
Q ss_pred HhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 513 LANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 513 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
..+.+.+. ++.... .. .++..+..++++.+|-.|++...+..
T Consensus 337 ~~r~~~ip---~e~~~~-~s----~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLRQGYIP---LEFCEG-GS----SSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccccCc---hhhhcC-cc----hhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 12222111 111111 11 12333777899999999998887654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.8e-10 Score=110.63 Aligned_cols=145 Identities=19% Similarity=0.255 Sum_probs=109.5
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCC--CcccccccccccCCCCCceEEEEEec
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHR--NLLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~--NIv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
+.|+.|..+.||+++..+|+.+++|....... .....+..|++++..+++. ++.+++.+..... ..+..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEE
Confidence 56899999999999988778999998754322 2355789999999999764 4566666654321 12346899999
Q ss_pred CCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhc---------------------------------------
Q 036081 371 MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG--------------------------------------- 411 (614)
Q Consensus 371 ~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~--------------------------------------- 411 (614)
+++.++.+.+.. ..++..++..++.++++.|.+||..
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999888876531 2466677778888888888888832
Q ss_pred --------------CCCceEecCCCCCceeecC--CCcEEEeeeccccc
Q 036081 412 --------------LKPAIYHRDIKSTNILLDS--EMKAKVADFGLAKQ 444 (614)
Q Consensus 412 --------------~~~~ivHrDIKp~NILLd~--~~~~KL~DFGla~~ 444 (614)
....++|+|+++.||+++. ++.+.|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-09 Score=105.84 Aligned_cols=135 Identities=16% Similarity=0.184 Sum_probs=95.6
Q ss_pred eeeeccCcEEEEEEEEcC-------CcEEEEEEeecC-------------C---------CcchHHHH----HHHHHHHH
Q 036081 294 NLIGQGASGVVYKGTLED-------GTLVAVKQITDL-------------D---------TKGDEEFI----NEVEIISK 340 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~-------g~~vAVK~l~~~-------------~---------~~~~~~f~----~Ei~il~~ 340 (614)
..||.|--+.||.|.-.+ +..+|||..+-. + ....+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998553 479999986421 0 01122333 79999999
Q ss_pred ccC--CCcccccccccccCCCCCceEEEEEecCCCCCccc-ccchhhhccCCCccchhHHHHHHHHHHHHH-HhcCCCce
Q 036081 341 IRH--RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGD-HISNALTRKQLAWPQRKKIILDVAKGLAYL-HYGLKPAI 416 (614)
Q Consensus 341 l~H--~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~-~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yL-H~~~~~~i 416 (614)
+.. -++..++++. ..+|||||+.++.+.. .+.+ ..++..+...+..+++.+|..| | +.+|
T Consensus 83 l~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H---~~gl 146 (197)
T cd05146 83 MQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYK---ECNL 146 (197)
T ss_pred HHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 853 4555555431 3589999997654422 2221 2233345567889999999999 7 8899
Q ss_pred EecCCCCCceeecCCCcEEEeeecccccc
Q 036081 417 YHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 417 vHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
|||||++.|||++ ++.+.|+|||.+...
T Consensus 147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999999997 568999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-09 Score=120.54 Aligned_cols=166 Identities=17% Similarity=0.189 Sum_probs=122.4
Q ss_pred EcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccC
Q 036081 309 LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQ 388 (614)
Q Consensus 309 ~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~ 388 (614)
..++.+|.|...+..+....+...+-++.|+.+|||||++++.... ..+..|||+|-+. -|...+.+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-----~~~~~ylvTErV~--Pl~~~lk~------ 100 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-----EEGTLYLVTERVR--PLETVLKE------ 100 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-----ccCceEEEeeccc--cHHHHHHH------
Confidence 3468889998887665544556778889999999999999998876 3457899999873 45555543
Q ss_pred CCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhh
Q 036081 389 LAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468 (614)
Q Consensus 389 l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~ 468 (614)
+.....--.+.||+.||.|||+ +.+++|++|.-..|++++.|+.||++|-++........ ......--..|..|+.+
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI 177 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence 2234445577899999999986 67899999999999999999999999988765432111 01111122346667654
Q ss_pred ccCCCCchhhHHHHHHHHHHHHhC
Q 036081 469 LYGQLTEKSDVYSFGIVILELMSG 492 (614)
Q Consensus 469 ~~~~~s~ksDVwSfGvvL~ELltG 492 (614)
.... -..|.|-||++++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 3222 456999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-10 Score=124.79 Aligned_cols=257 Identities=17% Similarity=0.151 Sum_probs=173.2
Q ss_pred ccChHH-HHHHhCCCccceeeeccCcEEEEEEEEc--CCcEEEEEEeecCCCcch--HHHHHHHHHHHHc-cCCCccccc
Q 036081 277 WFRESE-LDQATGGFSQKNLIGQGASGVVYKGTLE--DGTLVAVKQITDLDTKGD--EEFINEVEIISKI-RHRNLLSLR 350 (614)
Q Consensus 277 ~f~~~e-l~~at~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~~~~~~--~~f~~Ei~il~~l-~H~NIv~l~ 350 (614)
.|...+ ....+.+|.....||.|.|+.|++...+ ++..+++|.+.+...... ..-..|+-+...+ .|.+.++..
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 344444 4455678999999999999999998754 578899998865432221 1224566666665 477777755
Q ss_pred ccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC
Q 036081 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS 430 (614)
Q Consensus 351 g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~ 430 (614)
.-+. .....++--||++++++...+. ....++...++++..+++.++.++| ++.++|+|+||+||++..
T Consensus 333 ~~W~-----~~r~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 333 SSWS-----QLRQGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISN 401 (524)
T ss_pred CCcc-----ccccccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeecc
Confidence 4443 2334678889999998876652 2345788889999999999999999 999999999999999987
Q ss_pred C-CcEEEeeecccccccCCCccccccccCCCCc-cchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Q 036081 431 E-MKAKVADFGLAKQSLEGQSHLTTRVAGTYGY-LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITD 508 (614)
Q Consensus 431 ~-~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y-~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~ 508 (614)
+ +.-+++|||.+..+.-.. ......+..| .+++......+..+.|+||||.-+.|.++|.........
T Consensus 402 ~~~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------- 471 (524)
T KOG0601|consen 402 DGFFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------- 471 (524)
T ss_pred chhhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------
Confidence 6 788999999886421111 1111122233 355555677888999999999999999998755433221
Q ss_pred HHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 509 WAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 509 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
|. ....+.+.. .+.. .+.+..+...+...++..||...+...+.+-
T Consensus 472 ~~--~i~~~~~p~---------~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 472 SL--TIRSGDTPN---------LPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ce--eeecccccC---------CCch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11 111111110 0111 1345556666788889999988877665543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.4e-08 Score=109.27 Aligned_cols=172 Identities=20% Similarity=0.275 Sum_probs=130.6
Q ss_pred EEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCCC-CCcccc
Q 036081 302 GVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPS-GSLGDH 379 (614)
Q Consensus 302 G~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~-gsL~~~ 379 (614)
.+.||+..+ ||..|.+|+++....+....-..-++.++++.|.|+|++..++..... ....+++||+|.|+ ++|.+.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHHH
Confidence 688999865 899999999954333333334556889999999999999999874333 45678999999985 677765
Q ss_pred cchhh------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 380 ISNAL------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 380 L~~~~------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
-+... +....++...|.++.|+..||.++| +.|+.-+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 1224567788999999999999999 88999999999999999999999998887665443
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 495 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p 495 (614)
+.. |-+.. -.+-|.=-||.+++-|.||...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 331 11111 1356888999999999999754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-08 Score=97.44 Aligned_cols=132 Identities=27% Similarity=0.390 Sum_probs=96.1
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEE-eecCC--Ccc-----hHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQ-ITDLD--TKG-----DEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~-l~~~~--~~~-----~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
..+++|+-..+|.+.+. |..+.+|. +++.- ++- .+.-.+|..++.+++--.|....=+.+ +.....
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-----D~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-----DPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-----cCCCCE
Confidence 35789999999999886 44566664 22211 111 134568999999986444332222233 234568
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
++|||+++-.|.+.+... +..++..+-+-+.-|| ..+|+|+||.++||++..+. +.+.||||+...
T Consensus 76 I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999998888887542 4678889999999999 99999999999999997665 999999998743
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.2e-08 Score=102.88 Aligned_cols=144 Identities=16% Similarity=0.120 Sum_probs=101.8
Q ss_pred eeeccCcEEEEEEEEcCCcEEEEEEeecCCC-----------cchHHHHHHHHHHHHccCCCc--ccccccccccCCCCC
Q 036081 295 LIGQGASGVVYKGTLEDGTLVAVKQITDLDT-----------KGDEEFINEVEIISKIRHRNL--LSLRGCCVSSDDEKG 361 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-----------~~~~~f~~Ei~il~~l~H~NI--v~l~g~~~~~~~~~~ 361 (614)
.+-+.....|++..+. |+.+.||+...... .....+.+|...+.++...+| ..++++.........
T Consensus 29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3444444557777774 78899997743221 111247899999999964444 344555543222223
Q ss_pred ceEEEEEecCCCC-CcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-------CCc
Q 036081 362 KRRFLVYDFMPSG-SLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-------EMK 433 (614)
Q Consensus 362 ~~~~LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-------~~~ 433 (614)
...+||+|++++- +|.+++.+.. ....+...+..++.+++..+.-|| ..+|+|+|++++|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 4578999999876 7888875321 233445567789999999999999 999999999999999975 468
Q ss_pred EEEeeecccc
Q 036081 434 AKVADFGLAK 443 (614)
Q Consensus 434 ~KL~DFGla~ 443 (614)
+.++||+.++
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.6e-08 Score=93.72 Aligned_cols=142 Identities=21% Similarity=0.313 Sum_probs=101.1
Q ss_pred cceeeeccCcEEEEEEEEcCCcEEEEEE-eecCCC-------cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 292 QKNLIGQGASGVVYKGTLEDGTLVAVKQ-ITDLDT-------KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~-l~~~~~-------~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
...+|-+|+-+.|+++.+. |+...||. +.+.-. -....-.+|++++.+++--.|....=++.+ ...
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-----~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-----TYG 84 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-----cCC
Confidence 4568999999999999997 78777774 322111 112456789999999875554433333432 223
Q ss_pred EEEEEecCCC-CCcccccchhhhccCCCccch-hHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC---cEEEee
Q 036081 364 RFLVYDFMPS-GSLGDHISNALTRKQLAWPQR-KKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM---KAKVAD 438 (614)
Q Consensus 364 ~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~r-~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~---~~KL~D 438 (614)
-.|+|||+++ .++.+++..... .-..+.. ..++..|-+.+.-|| ...|||+||..+||+|..++ .+.+.|
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEe
Confidence 4799999976 477777765432 2223333 688999999999999 99999999999999996554 358999
Q ss_pred eccccc
Q 036081 439 FGLAKQ 444 (614)
Q Consensus 439 FGla~~ 444 (614)
||++..
T Consensus 160 fgls~~ 165 (229)
T KOG3087|consen 160 FGLSSV 165 (229)
T ss_pred ecchhc
Confidence 999764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2e-09 Score=123.64 Aligned_cols=205 Identities=20% Similarity=0.266 Sum_probs=142.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
..+.|.+.+-+-+|.++.++..+-. .|...+.|..... ..+..+....+-.++-..+||-++...--+. -.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-----~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-----CR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-----CC
Confidence 3456677777888999998877633 2333333333211 1111222222333333334555554433311 34
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...+||++|..+++|...|++. ..++.+-....+..+..+++||| ...+.|||++|.|+|...+++.+++|||.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccc
Confidence 5679999999999999998874 34665566677778889999999 77799999999999999999999999984
Q ss_pred cccccC---------------------C---------CccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh
Q 036081 442 AKQSLE---------------------G---------QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491 (614)
Q Consensus 442 a~~~~~---------------------~---------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt 491 (614)
...... . .........||+.|.+||...+......+|.|++|+.++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 321100 0 0011223578999999999999999999999999999999999
Q ss_pred CCCCCCCCCc
Q 036081 492 GRKVLETSNS 501 (614)
Q Consensus 492 G~~p~~~~~~ 501 (614)
|..||.....
T Consensus 1031 g~pp~na~tp 1040 (1205)
T KOG0606|consen 1031 GIPPFNAETP 1040 (1205)
T ss_pred CCCCCCCcch
Confidence 9999976543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.4e-08 Score=93.74 Aligned_cols=125 Identities=25% Similarity=0.322 Sum_probs=83.0
Q ss_pred EEEEEEEcCCcEEEEEEeecCC-------------Cc--------c-----hHHHHHHHHHHHHccCC--Cccccccccc
Q 036081 303 VVYKGTLEDGTLVAVKQITDLD-------------TK--------G-----DEEFINEVEIISKIRHR--NLLSLRGCCV 354 (614)
Q Consensus 303 ~Vykg~~~~g~~vAVK~l~~~~-------------~~--------~-----~~~f~~Ei~il~~l~H~--NIv~l~g~~~ 354 (614)
.||.|...+|..+|||..+... .. . .....+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999874210 00 0 12356899999999765 455555432
Q ss_pred ccCCCCCceEEEEEecCC--CCCcccccchhhhccCCCccchhHHHHHHHHHHHH-HHhcCCCceEecCCCCCceeecCC
Q 036081 355 SSDDEKGKRRFLVYDFMP--SGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY-LHYGLKPAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 355 ~~~~~~~~~~~LV~Ey~~--~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~y-LH~~~~~~ivHrDIKp~NILLd~~ 431 (614)
.-.|||||++ +..+.. |.+ ..++......++.++...+.. +| ..+|+|+||.+.|||++++
T Consensus 80 --------~~~ivME~I~~~G~~~~~-l~~----~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~ 143 (188)
T PF01163_consen 80 --------RNVIVMEYIGEDGVPLPR-LKD----VDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG 143 (188)
T ss_dssp --------TTEEEEE--EETTEEGGC-HHH----CGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT
T ss_pred --------CCEEEEEecCCCccchhh-HHh----ccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc
Confidence 2379999998 434433 332 122355667888888886666 57 8999999999999999888
Q ss_pred CcEEEeeecccccc
Q 036081 432 MKAKVADFGLAKQS 445 (614)
Q Consensus 432 ~~~KL~DFGla~~~ 445 (614)
.+.|.|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 9999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-08 Score=113.70 Aligned_cols=151 Identities=24% Similarity=0.296 Sum_probs=101.9
Q ss_pred HHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCc--------cccccccCCCCccchhhhccC
Q 036081 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS--------HLTTRVAGTYGYLAPEYALYG 471 (614)
Q Consensus 400 ~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~--------~~~~~~~gt~~Y~APE~~~~~ 471 (614)
+++.||.|+|. +.++||++|.|++|.+++++..||+.|+.+........ ...--......|.|||++.+.
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34489999996 78999999999999999999999999998764333111 011112345689999999998
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCC-CCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccC
Q 036081 472 QLTEKSDVYSFGIVILELMSGRKVL-ETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVM 550 (614)
Q Consensus 472 ~~s~ksDVwSfGvvL~ELltG~~p~-~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~ 550 (614)
..+.++|+||+|+++|.+..|+++. ...+.. +..... ...+..-......+++.++.+=+.+.+..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~--~~~~~~----------~~~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGL--LSYSFS----------RNLLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCc--chhhhh----------hcccccccccccccCcHHHHHHHHHHhcCC
Confidence 8999999999999999999555443 322111 000000 001111111122344556666677788999
Q ss_pred CCCCCCHHHHHHHh
Q 036081 551 VALRPTIADALKML 564 (614)
Q Consensus 551 p~~RPtm~eVl~~L 564 (614)
+..||++.++....
T Consensus 253 ~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 253 SAVRPTLDLLLSIP 266 (700)
T ss_pred cccCcchhhhhccc
Confidence 99999888875543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=6e-07 Score=88.37 Aligned_cols=143 Identities=18% Similarity=0.165 Sum_probs=105.8
Q ss_pred eeccCcEEEEEEEEcCCcEEEEEEeecC---C---CcchHHHHHHHHHHHHccCCC--cccccccccccCCCCCceEEEE
Q 036081 296 IGQGASGVVYKGTLEDGTLVAVKQITDL---D---TKGDEEFINEVEIISKIRHRN--LLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 296 LG~G~fG~Vykg~~~~g~~vAVK~l~~~---~---~~~~~~f~~Ei~il~~l~H~N--Iv~l~g~~~~~~~~~~~~~~LV 367 (614)
-|+||-+.|++-.++ |..+-+|+-.+. + +.+...|.+|...+.++...+ +.+.. ++........-+.+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888999998876 557999987521 1 346778999999999996443 34444 3322222234567999
Q ss_pred EecCCC-CCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc--EEEeeeccccc
Q 036081 368 YDFMPS-GSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK--AKVADFGLAKQ 444 (614)
Q Consensus 368 ~Ey~~~-gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--~KL~DFGla~~ 444 (614)
+|-+++ -+|.+++.+. ...+.+...+..+..+++..++-|| ..++.|+|+.+.|||++.++. +++.||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997763 5788777542 1234566778899999999999999 999999999999999986667 99999976553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.7e-07 Score=90.28 Aligned_cols=110 Identities=23% Similarity=0.350 Sum_probs=86.0
Q ss_pred hHHHHHHHHHHHHccCC--CcccccccccccCCCCCceEEEEEecCCCC-CcccccchhhhccCCCccchhHHHHHHHHH
Q 036081 328 DEEFINEVEIISKIRHR--NLLSLRGCCVSSDDEKGKRRFLVYDFMPSG-SLGDHISNALTRKQLAWPQRKKIILDVAKG 404 (614)
Q Consensus 328 ~~~f~~Ei~il~~l~H~--NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~g 404 (614)
.....+|...+.+++.. .....+++....... ....+||+|++++. +|.+++.+. ..++...+..++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHH
Confidence 34678899999988644 445666666543332 24568999999874 788887652 225666788999999999
Q ss_pred HHHHHhcCCCceEecCCCCCceeecCCC---cEEEeeeccccc
Q 036081 405 LAYLHYGLKPAIYHRDIKSTNILLDSEM---KAKVADFGLAKQ 444 (614)
Q Consensus 405 L~yLH~~~~~~ivHrDIKp~NILLd~~~---~~KL~DFGla~~ 444 (614)
++-|| ..+|+|+|+++.|||++.+. .+.++||+.++.
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 99999999999999998887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.7e-07 Score=89.45 Aligned_cols=132 Identities=20% Similarity=0.179 Sum_probs=95.8
Q ss_pred ccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC----------------------CcchHHHHHHHHHHHHccCC--Cc
Q 036081 291 SQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD----------------------TKGDEEFINEVEIISKIRHR--NL 346 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~----------------------~~~~~~f~~Ei~il~~l~H~--NI 346 (614)
...+.||-|--+.||.|..++|.++|||.-+... .-......+|.++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3457899999999999999999999999542100 00112456899999998654 56
Q ss_pred ccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCce
Q 036081 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNI 426 (614)
Q Consensus 347 v~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NI 426 (614)
.+.+++ +...+||||+++--|... .++-+..-.|+..|.+-+.-+- ..||||+|+.+-||
T Consensus 174 P~P~~~---------nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNI 233 (304)
T COG0478 174 PKPIAW---------NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNI 233 (304)
T ss_pred CCcccc---------ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheE
Confidence 555543 456899999988655433 1233344456666666666665 68999999999999
Q ss_pred eecCCCcEEEeeeccc
Q 036081 427 LLDSEMKAKVADFGLA 442 (614)
Q Consensus 427 LLd~~~~~KL~DFGla 442 (614)
++++||.+.+.||=-+
T Consensus 234 lV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 234 LVTEDGDIVVIDWPQA 249 (304)
T ss_pred EEecCCCEEEEeCccc
Confidence 9999999999999543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-06 Score=89.85 Aligned_cols=198 Identities=15% Similarity=0.150 Sum_probs=126.1
Q ss_pred cceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCccccccccccc--CCCCCceEEEEE
Q 036081 292 QKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSS--DDEKGKRRFLVY 368 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~--~~~~~~~~~LV~ 368 (614)
....||+||-+.+|-.--- +. -+.|+......... .+.++.|.+. .||-+..=+.+=... ....+...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4567999999999964321 11 23455543222221 2233444444 466443311111100 011233366777
Q ss_pred ecCCCCC-cccccch---hhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 369 DFMPSGS-LGDHISN---ALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 369 Ey~~~gs-L~~~L~~---~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
..+++.- ...++.. .......+|...++.+..+|.+.+-|| ..|.+-+|+.++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 7776542 1222211 112345789999999999999999999 89999999999999999999999987653322
Q ss_pred ccCCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSG-RKVLETS 499 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG-~~p~~~~ 499 (614)
... .......+|...|.+||.-. +-.-+...|-|.+||++++++.| ++||...
T Consensus 167 ~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 NAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 211 11223357889999999765 33457789999999999999987 8999753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.2e-07 Score=98.80 Aligned_cols=147 Identities=20% Similarity=0.260 Sum_probs=98.9
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCc---------------------c---------hH--------
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTK---------------------G---------DE-------- 329 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~---------------------~---------~~-------- 329 (614)
..|+. +.|+.++-|.||+|++++|+.||||+.+..-.+ + .+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34543 589999999999999999999999987531100 0 01
Q ss_pred --HHHHHHHHHHHcc----CCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHH
Q 036081 330 --EFINEVEIISKIR----HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403 (614)
Q Consensus 330 --~f~~Ei~il~~l~----H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~ 403 (614)
++..|..-+.+++ +..-+++-..+++ -.....|+|||++|..+.+...-. ....+ +..|+..+++
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we----~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d---~k~ia~~~~~ 275 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWE----YTTRRVLTMEWIDGIKISDIAALK--SAGID---RKELAELLVR 275 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehh----ccCCcEEEEEeeCCEecccHHHHH--hcCCC---HHHHHHHHHH
Confidence 1344555555542 2333344444442 234579999999999888874321 12233 4556666655
Q ss_pred H-HHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 404 G-LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 404 g-L~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
+ +..+- ..+++|.|..|.||+++.+++.-+.|||+.....+
T Consensus 276 ~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 276 AFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 4 22233 67999999999999999999999999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-05 Score=78.48 Aligned_cols=143 Identities=13% Similarity=0.173 Sum_probs=95.1
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHH---------HHHHHHHHHccCCCc---ccccccc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEF---------INEVEIISKIRHRNL---LSLRGCC 353 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f---------~~Ei~il~~l~H~NI---v~l~g~~ 353 (614)
..++|...+++-......|.+-..+ |..+.+|..+......++.| .+++..+.+++...+ +.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4567777778877777777776665 78899998866443333322 345555555543322 2222222
Q ss_pred cccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc
Q 036081 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK 433 (614)
Q Consensus 354 ~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 433 (614)
.-.........+|+|||++|..|.+... ++. .++..++.++.-|| +.|++|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-
Confidence 2222222345679999999988876531 111 35667888899999 99999999999999998554
Q ss_pred EEEeeeccccc
Q 036081 434 AKVADFGLAKQ 444 (614)
Q Consensus 434 ~KL~DFGla~~ 444 (614)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=7.7e-06 Score=90.95 Aligned_cols=145 Identities=19% Similarity=0.250 Sum_probs=95.9
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcc-------------------------------------hHHH
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG-------------------------------------DEEF 331 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~f 331 (614)
.|+ .+.||.-+.|.||++++++|+.||||+-+..-.+. +-+|
T Consensus 163 ~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 163 EFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred hcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 344 35899999999999999999999999865311100 0125
Q ss_pred HHHHHHHHHc----cCCC---cccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHH
Q 036081 332 INEVEIISKI----RHRN---LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404 (614)
Q Consensus 332 ~~Ei~il~~l----~H~N---Iv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~g 404 (614)
.+|.+-..+. +|-+ -|.+-.++++ -...+.|+||||+|..+.|.-.- .+..++-. .|+..+.++
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~----~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~---~i~~~l~~~ 312 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWD----LSTKRVLTMEYVDGIKINDLDAI--DKRGISPH---DILNKLVEA 312 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhh----cCcceEEEEEecCCccCCCHHHH--HHcCCCHH---HHHHHHHHH
Confidence 5666655554 4666 2334444443 23468999999999988776321 12233332 455444444
Q ss_pred HHHHHhcCCCceEecCCCCCceeecC----CCcEEEeeecccccc
Q 036081 405 LAYLHYGLKPAIYHRDIKSTNILLDS----EMKAKVADFGLAKQS 445 (614)
Q Consensus 405 L~yLH~~~~~~ivHrDIKp~NILLd~----~~~~KL~DFGla~~~ 445 (614)
|++.-...|++|+|-.|.||+++. ++++.+-|||+....
T Consensus 313 --~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 313 --YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred --HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 222223678999999999999983 678999999998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.6e-06 Score=81.34 Aligned_cols=103 Identities=25% Similarity=0.313 Sum_probs=83.5
Q ss_pred HHHHHHHHHccC-CCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHh
Q 036081 332 INEVEIISKIRH-RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410 (614)
Q Consensus 332 ~~Ei~il~~l~H-~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~ 410 (614)
.+|.-++..+++ +++.+++|+|- .++|.||.+.+++...-.....--..+|..|.+||.++++.+.+|++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 458888889976 69999999995 48899999887765321000011246899999999999999999997
Q ss_pred cCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 411 ~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.....+.-.|++++|+-+++++++|+.|...+.
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 766778889999999999999999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.6e-05 Score=75.80 Aligned_cols=150 Identities=19% Similarity=0.216 Sum_probs=99.2
Q ss_pred ChHHHHHHhCCCccceeee---ccCcEEEEEEEEcCCcEEEEEEeecCCCc---------chH---------------HH
Q 036081 279 RESELDQATGGFSQKNLIG---QGASGVVYKGTLEDGTLVAVKQITDLDTK---------GDE---------------EF 331 (614)
Q Consensus 279 ~~~el~~at~~f~~~~~LG---~G~fG~Vykg~~~~g~~vAVK~l~~~~~~---------~~~---------------~f 331 (614)
+...|.....+..+....| .|--..||+|.-.++..+|||+.+..... +.. -.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 4455666666665555555 56677899999888999999998532111 111 12
Q ss_pred HHHHHHHHHcc--CCCcccccccccccCCCCCceEEEEEecCCCC-CcccccchhhhccCCCccchhHHHHHHHHHHHHH
Q 036081 332 INEVEIISKIR--HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSG-SLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408 (614)
Q Consensus 332 ~~Ei~il~~l~--H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yL 408 (614)
..|..-|.++. +-.+.+.+++. .-.|||||+... .-.-.|.+ -++...+...+..++.+++.-|
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHH
Confidence 35666666663 44444444443 248999999643 11222222 1222224667788888888888
Q ss_pred HhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 409 H~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
-. ..++||+||..-|||+. ++.+.|+|||-|..
T Consensus 183 ~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 183 YK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HH--hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence 72 48999999999999999 88999999997754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.7e-05 Score=78.36 Aligned_cols=146 Identities=20% Similarity=0.259 Sum_probs=86.2
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC--cccccccccccCCCCCceEEEEEec
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN--LLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N--Iv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
.+.|+.|..+.||+....+ ..+++|..... .......+|.+++..+.... +.+++.+..... .....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~--~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE--FNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE--ETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc--ccccceEEEEE
Confidence 3678999999999999986 68999986543 34567889999999986443 445555432211 23457999999
Q ss_pred CCCCCccc----------------ccc---hhh-hccCCCccc---------hhH------------HHHHHHH-HHHHH
Q 036081 371 MPSGSLGD----------------HIS---NAL-TRKQLAWPQ---------RKK------------IILDVAK-GLAYL 408 (614)
Q Consensus 371 ~~~gsL~~----------------~L~---~~~-~~~~l~~~~---------r~~------------Ia~~Ia~-gL~yL 408 (614)
+++..+.. .+. ... ......+.. ... ....+.+ .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99887776 110 000 000111100 000 0112222 33333
Q ss_pred Hh----cCCCceEecCCCCCceeec-CCCcEEEeeecccc
Q 036081 409 HY----GLKPAIYHRDIKSTNILLD-SEMKAKVADFGLAK 443 (614)
Q Consensus 409 H~----~~~~~ivHrDIKp~NILLd-~~~~~KL~DFGla~ 443 (614)
+. .....++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 2467899999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.6e-07 Score=98.78 Aligned_cols=189 Identities=19% Similarity=0.116 Sum_probs=133.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC-cccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN-LLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N-Iv~l~g~~~~~~~~~~~~~~ 365 (614)
+.-+..-+-+++|+++++||.+-...+...++.+.. .....-++++|.+++||| .++.++-+. .+...+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~-----~E~~~~ 310 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYD-----GEDYLW 310 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCC-----cccccc
Confidence 333344456889999999998854344444665533 244567899999999999 444333332 456789
Q ss_pred EEEecCCCC-CcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 366 LVYDFMPSG-SLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++++++..| +-...... ....+...+...+...-.++|+||| +..=+||| ||+..+ +..|..||+....
T Consensus 311 i~~~i~s~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred hhhhhhcCCccccccCCh--hhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcc
Confidence 999999877 22221111 1223444455667777889999999 55558998 887755 6789999998876
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLE 497 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~ 497 (614)
+.... ..+...+|+.|+|||....+.+..+.|+|+.|+--.++--|-+|-.
T Consensus 381 L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 381 LTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 65433 3455679999999999999999999999999987777777766543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.3e-05 Score=75.54 Aligned_cols=139 Identities=17% Similarity=0.174 Sum_probs=80.3
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCc--ccccccccccCCCCCceEEEEEecC
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL--LSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NI--v~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
..||+|..+.||+.. |..+++|...... ......+|.+++..+..-.+ .+.+++.. .++...+|||++
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-----~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVE-----DGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEe-----cCCeeeeeeeec
Confidence 578999999999842 4457788875422 33457889999999865444 44455443 234467899999
Q ss_pred CCCC-cccccchh-----------------hhc---cCCCccchhH-HHH----------HHHH-HHHHHHh-cCCCceE
Q 036081 372 PSGS-LGDHISNA-----------------LTR---KQLAWPQRKK-IIL----------DVAK-GLAYLHY-GLKPAIY 417 (614)
Q Consensus 372 ~~gs-L~~~L~~~-----------------~~~---~~l~~~~r~~-Ia~----------~Ia~-gL~yLH~-~~~~~iv 417 (614)
+|.+ +...+... ... .......+.. +.. .+.+ ...+|.. .....++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8863 22111100 000 0001000000 000 0011 1122221 1244678
Q ss_pred ecCCCCCceeecCCCcEEEeeecccc
Q 036081 418 HRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 418 HrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
|+|+.|.||++++++ +.|.||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00016 Score=73.10 Aligned_cols=139 Identities=16% Similarity=0.108 Sum_probs=81.0
Q ss_pred eeccCc-EEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEEEEEecCCC
Q 036081 296 IGQGAS-GVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPS 373 (614)
Q Consensus 296 LG~G~f-G~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~ 373 (614)
|-.|.. ..||+.... +..+.||+..... ......|++++..+. +--+.+++++.. .++..++|||++++
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEEeeCC
Confidence 444555 788999765 5778888875432 345778999998885 333445555443 12357899999998
Q ss_pred CCcccccc---hh------------hhcc---CCCcc----chhHHHH--------------------HHHHHHHHHH--
Q 036081 374 GSLGDHIS---NA------------LTRK---QLAWP----QRKKIIL--------------------DVAKGLAYLH-- 409 (614)
Q Consensus 374 gsL~~~L~---~~------------~~~~---~l~~~----~r~~Ia~--------------------~Ia~gL~yLH-- 409 (614)
.+|..... .. .... ..... .+..... .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 87764321 00 0000 00000 0000000 0111122221
Q ss_pred --hcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 410 --YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 410 --~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
....+.++|+|+.|.|||++++....|.||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1124669999999999999998778999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00038 Score=70.06 Aligned_cols=78 Identities=10% Similarity=0.137 Sum_probs=46.5
Q ss_pred eeeeccCcE-EEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCC---CcccccccccccCCCCCceEEEEEe
Q 036081 294 NLIGQGASG-VVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHR---NLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 294 ~~LG~G~fG-~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~---NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
+.|+.||.. .||+. +..+++|..+. ......+.+|.+++..+... .+.+.++.... .+.....+++||
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~--~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEP--GEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCC--ccCCCcceEEEE
Confidence 467777776 58875 23466776543 22345788999999988632 22233332211 111234588999
Q ss_pred cCCCCCcccc
Q 036081 370 FMPSGSLGDH 379 (614)
Q Consensus 370 y~~~gsL~~~ 379 (614)
++++.++.+.
T Consensus 75 ~i~G~~l~~~ 84 (235)
T cd05155 75 WLEGETATAA 84 (235)
T ss_pred eecCCCCCcc
Confidence 9999887543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00033 Score=83.36 Aligned_cols=83 Identities=10% Similarity=0.218 Sum_probs=57.5
Q ss_pred ceeeeccCcEEEEEEEEcCC---cEEEEEEeecCC-CcchHHHHHHHHHHHHcc-CCCc--ccccccccccCCCCCceEE
Q 036081 293 KNLIGQGASGVVYKGTLEDG---TLVAVKQITDLD-TKGDEEFINEVEIISKIR-HRNL--LSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g---~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~-H~NI--v~l~g~~~~~~~~~~~~~~ 365 (614)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++++|.+.. .....|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCce
Confidence 46788999999999887654 367777754322 123456889999999996 6665 66666665322 224578
Q ss_pred EEEecCCCCCcc
Q 036081 366 LVYDFMPSGSLG 377 (614)
Q Consensus 366 LV~Ey~~~gsL~ 377 (614)
+||||+++..+.
T Consensus 121 lVME~v~G~~~~ 132 (822)
T PLN02876 121 YIMEYLEGRIFV 132 (822)
T ss_pred EEEEecCCcccC
Confidence 999999976543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0011 Score=69.48 Aligned_cols=81 Identities=10% Similarity=0.028 Sum_probs=57.7
Q ss_pred ccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccC---CCcccccccccccCCCCCceEEEE
Q 036081 291 SQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRH---RNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H---~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
...+.||.|..+.||+-...+|+ +.+|..+. ......|..|.+.++.+.. -.+.+++++|.... ..+..+||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LV 91 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLL 91 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEE
Confidence 34567999999999999876664 66676432 1123578999999999953 35677777764321 23557999
Q ss_pred EecCCCCCc
Q 036081 368 YDFMPSGSL 376 (614)
Q Consensus 368 ~Ey~~~gsL 376 (614)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998776
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00021 Score=68.25 Aligned_cols=127 Identities=20% Similarity=0.278 Sum_probs=87.5
Q ss_pred cceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecC
Q 036081 292 QKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
..+.|++|++|.||+|.+. |..+|+|+-+..+ ....+..|+++|..++-.++.+=+-++- .-++.|||.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg--------~~~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG--------EDFIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec--------hhhhhhhhh
Confidence 4567999999999999998 6688999865432 3567889999999998777654332221 135669999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCC-C-CceeecCCCcEEEeeecccc
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK-S-TNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIK-p-~NILLd~~~~~KL~DFGla~ 443 (614)
.+-.|.+.-.. . . .+-...+++.---|. ..+|-|+.|. | .||++ .+..+.|+||.-|.
T Consensus 95 ~G~~L~~~~~~------~---~-rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At 154 (201)
T COG2112 95 DGRPLGKLEIG------G---D-RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLV-NDRDVYIIDFDSAT 154 (201)
T ss_pred cCcchhhhhhc------c---c-HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEe-cCCcEEEEEccchh
Confidence 88777655321 0 1 233445555544455 7788888886 4 45555 45599999999876
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00033 Score=68.69 Aligned_cols=130 Identities=25% Similarity=0.411 Sum_probs=94.1
Q ss_pred CCCccceeeeccCc-EEEEEEEEcCCcEEEEEEeecCC---C------------------cchHHHHHHHHHHHHcc---
Q 036081 288 GGFSQKNLIGQGAS-GVVYKGTLEDGTLVAVKQITDLD---T------------------KGDEEFINEVEIISKIR--- 342 (614)
Q Consensus 288 ~~f~~~~~LG~G~f-G~Vykg~~~~g~~vAVK~l~~~~---~------------------~~~~~f~~Ei~il~~l~--- 342 (614)
.+++..+.||.|.- |.|||.++. |+.+|+|.++... . .-..-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 999999997 8899999943210 0 01135889999999985
Q ss_pred CCCc--ccccccccccC-------------CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHH
Q 036081 343 HRNL--LSLRGCCVSSD-------------DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407 (614)
Q Consensus 343 H~NI--v~l~g~~~~~~-------------~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~y 407 (614)
+.++ |+-+||..-+. ......+.+|.||++... ....+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4455 88888874331 112335577888776422 1223456678888889
Q ss_pred HHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 408 LH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
+| ..+|+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 99 999999999999976 3489999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00084 Score=69.75 Aligned_cols=147 Identities=18% Similarity=0.165 Sum_probs=87.1
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC--cccccccccccC-CCCCceEEEEEe
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN--LLSLRGCCVSSD-DEKGKRRFLVYD 369 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N--Iv~l~g~~~~~~-~~~~~~~~LV~E 369 (614)
.+.|..|-...+|+....+ ..+++|+... ...+....|++++..+.+.+ +.+++....... ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567777778999987654 4688888754 23455777899998886443 334433211000 012345689999
Q ss_pred cCCCCCcccc----c----------chhhhc--------cCCCccchh----------HHHHHHHHHHHHHHh----cCC
Q 036081 370 FMPSGSLGDH----I----------SNALTR--------KQLAWPQRK----------KIILDVAKGLAYLHY----GLK 413 (614)
Q Consensus 370 y~~~gsL~~~----L----------~~~~~~--------~~l~~~~r~----------~Ia~~Ia~gL~yLH~----~~~ 413 (614)
|+++..+... . +..... ....|.... .....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776430 0 110000 011222111 111223344555542 234
Q ss_pred CceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 414 ~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.+++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 679999999999999998778899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00026 Score=83.49 Aligned_cols=200 Identities=18% Similarity=0.154 Sum_probs=129.9
Q ss_pred HHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcC
Q 036081 333 NEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412 (614)
Q Consensus 333 ~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~ 412 (614)
-|.+.+.+++|+|++.+++|-.+... .+-...+..|+++.-++...+.. -..++....+.+..+...||+|+|
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~-~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h--- 303 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLF-RGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLH--- 303 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhc-chHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHH---
Confidence 46667778899999999888764332 11122344577777777776654 345777788889999999999999
Q ss_pred CCceEecCCCCC---ceeecCCCcEEEe--eecccccccCCCccccccccCCCCccchhhhccCCCCch--hhHHHHHHH
Q 036081 413 KPAIYHRDIKST---NILLDSEMKAKVA--DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEK--SDVYSFGIV 485 (614)
Q Consensus 413 ~~~ivHrDIKp~---NILLd~~~~~KL~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~k--sDVwSfGvv 485 (614)
.....|.-+..+ +-..+.++...++ ||+..+........ ....-+..|.+||.........+ .|+|.+|..
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 444444444444 4445666777777 88877655432211 11233556888888776655544 799999999
Q ss_pred HHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 486 ILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 486 L~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
+..+..|..+-..... ...+++. .... ........|...++++|++..+++.+.-
T Consensus 382 ~~~~~~~~~i~~~~~~-----------------~~~~l~~----~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV-----------------PVSLLDV----LSTS----ELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred HhhhhhcCcccccccc-----------------hhhhhcc----ccch----hhhhhhhhhcchhhhhccchhhhhhchh
Confidence 9999988755432110 0111111 1110 2344556799999999999999988764
Q ss_pred c
Q 036081 566 G 566 (614)
Q Consensus 566 ~ 566 (614)
.
T Consensus 437 ~ 437 (1351)
T KOG1035|consen 437 L 437 (1351)
T ss_pred c
Confidence 4
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0015 Score=64.15 Aligned_cols=134 Identities=17% Similarity=0.229 Sum_probs=87.1
Q ss_pred ccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC----------------CcchHHHHHHHHHHHHcc------CCCccc
Q 036081 291 SQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD----------------TKGDEEFINEVEIISKIR------HRNLLS 348 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~----------------~~~~~~f~~Ei~il~~l~------H~NIv~ 348 (614)
+....||+|+.-.||.- ++.....||++.... ....+++.+|+.-...+. +..|.+
T Consensus 4 ~~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 34568999999998864 445557788876543 123567788888887776 788999
Q ss_pred ccccccccCCCCCceEEEEEecCCC--CCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCce
Q 036081 349 LRGCCVSSDDEKGKRRFLVYDFMPS--GSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNI 426 (614)
Q Consensus 349 l~g~~~~~~~~~~~~~~LV~Ey~~~--gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NI 426 (614)
++|+..++. -.-+|+|.+.+ |++..-|........++. .+...+-+-..||- +..|+.+|++|.||
T Consensus 82 ~~G~veT~~-----G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~---~~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 82 FYGFVETNL-----GLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLL---DHHIVIRDLNPHNI 149 (199)
T ss_pred EeEEEecCC-----ceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHH---HcCCeecCCCcccE
Confidence 999987433 35788888653 443333332222344544 33333334455666 77899999999999
Q ss_pred eecCCC----cEEEee
Q 036081 427 LLDSEM----KAKVAD 438 (614)
Q Consensus 427 LLd~~~----~~KL~D 438 (614)
++..+. .+.|.|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 995332 455655
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0028 Score=63.42 Aligned_cols=74 Identities=18% Similarity=0.191 Sum_probs=47.8
Q ss_pred eeeeccCcEEEEEEEEcC--CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc-cccccccccCCCCCceEEEEEec
Q 036081 294 NLIGQGASGVVYKGTLED--GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL-SLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~--g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv-~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
+.|..|-...+|+....+ +..+++|....... ..-...+|+.++..+...+++ ++++... ..++|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---------~~~l~e~ 73 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ---------NGLIYEF 73 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC---------CcEEEEe
Confidence 457777778999998764 67888887653221 112334799999998644443 3333221 1479999
Q ss_pred CCCCCcc
Q 036081 371 MPSGSLG 377 (614)
Q Consensus 371 ~~~gsL~ 377 (614)
+++.++.
T Consensus 74 i~G~~l~ 80 (235)
T cd05157 74 IPGRTLE 80 (235)
T ss_pred eCCCcCC
Confidence 9987764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0015 Score=66.52 Aligned_cols=138 Identities=12% Similarity=0.102 Sum_probs=77.0
Q ss_pred eeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc-cccccccccCCCCCceEEEEEecCCCC
Q 036081 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL-SLRGCCVSSDDEKGKRRFLVYDFMPSG 374 (614)
Q Consensus 296 LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv-~l~g~~~~~~~~~~~~~~LV~Ey~~~g 374 (614)
+..|-.+.+|+... +|..+++|..........-...+|.++++.+....++ ++++... .++||||+++.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~---------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE---------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC---------CEEEEEeccCc
Confidence 44566788998874 4677888875433222112357899999998654443 2333221 26899999987
Q ss_pred Ccccc-------c----------chhh-hccCCCccchh-HHH---------HHHHHHHHHHHh-----cCCCceEecCC
Q 036081 375 SLGDH-------I----------SNAL-TRKQLAWPQRK-KII---------LDVAKGLAYLHY-----GLKPAIYHRDI 421 (614)
Q Consensus 375 sL~~~-------L----------~~~~-~~~~l~~~~r~-~Ia---------~~Ia~gL~yLH~-----~~~~~ivHrDI 421 (614)
.+... + +... ....++...+. ... ..+.+-+..+-. .....++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 76532 1 1100 00011111100 100 011111222211 11346899999
Q ss_pred CCCceeecCCCcEEEeeeccccc
Q 036081 422 KSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 422 Kp~NILLd~~~~~KL~DFGla~~ 444 (614)
.|.||++++++ +.|.||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0046 Score=65.04 Aligned_cols=143 Identities=17% Similarity=0.219 Sum_probs=78.8
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCc--ccccccccccCC----CCCceEEEE
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL--LSLRGCCVSSDD----EKGKRRFLV 367 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NI--v~l~g~~~~~~~----~~~~~~~LV 367 (614)
+.|+.|....+|+....+| .+++|+... ...+....|++++..|...++ .+.+.. .++ ...+..+++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~---~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVAR---RDGAALGELAGKPAAI 100 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeC---CCCCEeeeeCCEEEEE
Confidence 4566677789999887655 588888752 123344557777777743332 222211 111 123457899
Q ss_pred EecCCCCCcccc----c----------chhhhc--------cCCCc-cchhH------------HH-HHHHHHHHHHHh-
Q 036081 368 YDFMPSGSLGDH----I----------SNALTR--------KQLAW-PQRKK------------II-LDVAKGLAYLHY- 410 (614)
Q Consensus 368 ~Ey~~~gsL~~~----L----------~~~~~~--------~~l~~-~~r~~------------Ia-~~Ia~gL~yLH~- 410 (614)
+||+++..+... . +..... ..+.| ..... .. ..+...+..+..
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 999998765321 1 110000 01112 11110 11 111112233321
Q ss_pred ---cCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 411 ---GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 411 ---~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
....+++|+|+.+.|||++.+...-|.||+.+.
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 135689999999999999876656899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0082 Score=62.94 Aligned_cols=148 Identities=19% Similarity=0.187 Sum_probs=84.5
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC--ccccccccccc-CCCCCceEEEEEe
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN--LLSLRGCCVSS-DDEKGKRRFLVYD 369 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N--Iv~l~g~~~~~-~~~~~~~~~LV~E 369 (614)
.+.++.|-...+|+....+| .+++|+..... ..++...|++++..|.... +.+++...... ....++..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34566666689999876655 56788764421 2345667888888885333 33443321100 0012356789999
Q ss_pred cCCCCCcccc--------------cchhhhc--c-------CCCccchh------------HHHHHHHHHHHHHHh----
Q 036081 370 FMPSGSLGDH--------------ISNALTR--K-------QLAWPQRK------------KIILDVAKGLAYLHY---- 410 (614)
Q Consensus 370 y~~~gsL~~~--------------L~~~~~~--~-------~l~~~~r~------------~Ia~~Ia~gL~yLH~---- 410 (614)
|+++..+... ++..... . .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998665321 1110000 0 01111100 111223345555542
Q ss_pred cCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 411 ~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
....+++|+|+++.||+++.++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 235789999999999999998877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0071 Score=65.73 Aligned_cols=76 Identities=16% Similarity=0.098 Sum_probs=52.8
Q ss_pred ceeeeccCcEEEEEEEEcCC-cEEEEEEeecC-----C--CcchHHHHHHHHHHHHcc---CCCcccccccccccCCCCC
Q 036081 293 KNLIGQGASGVVYKGTLEDG-TLVAVKQITDL-----D--TKGDEEFINEVEIISKIR---HRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g-~~vAVK~l~~~-----~--~~~~~~f~~Ei~il~~l~---H~NIv~l~g~~~~~~~~~~ 361 (614)
.+.||.|.+..||+....+| +.+.||.-... . .-..+.+..|.+.|..+. ..++.+++.+..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-------
Confidence 35789999999999999877 48999984311 1 123456778888888863 234556665532
Q ss_pred ceEEEEEecCCCCC
Q 036081 362 KRRFLVYDFMPSGS 375 (614)
Q Consensus 362 ~~~~LV~Ey~~~gs 375 (614)
...++||||+++..
T Consensus 104 ~~~~lVME~L~~~~ 117 (401)
T PRK09550 104 ELAVTVMEDLSDHK 117 (401)
T ss_pred CCCEEEEecCCCcc
Confidence 34689999998743
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0068 Score=63.22 Aligned_cols=140 Identities=26% Similarity=0.310 Sum_probs=82.0
Q ss_pred eeeeccCcEEEEEEEEcC-------CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc-cccccccccCCCCCceEE
Q 036081 294 NLIGQGASGVVYKGTLED-------GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL-SLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~-------g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv-~l~g~~~~~~~~~~~~~~ 365 (614)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+....+. ++++++. -.
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~---------~~ 73 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP---------NG 73 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC---------CC
Confidence 345556667899988765 4788899865432 2233567899999888644443 3444332 13
Q ss_pred EEEecCCCCCcccc-c----------------chhhhcc-C-------CCccchhH------------------------
Q 036081 366 LVYDFMPSGSLGDH-I----------------SNALTRK-Q-------LAWPQRKK------------------------ 396 (614)
Q Consensus 366 LV~Ey~~~gsL~~~-L----------------~~~~~~~-~-------l~~~~r~~------------------------ 396 (614)
+|+||++|..+... + ++..... . .-|....+
T Consensus 74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (302)
T cd05156 74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL 153 (302)
T ss_pred chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence 58999998776531 1 1100000 0 00100000
Q ss_pred --HHHHHHHHHHHHHh------cCCCceEecCCCCCceeecCC----CcEEEeeecccc
Q 036081 397 --IILDVAKGLAYLHY------GLKPAIYHRDIKSTNILLDSE----MKAKVADFGLAK 443 (614)
Q Consensus 397 --Ia~~Ia~gL~yLH~------~~~~~ivHrDIKp~NILLd~~----~~~KL~DFGla~ 443 (614)
+...+..-+.+|.. .....++|+|+.+.|||++++ +.+++.||..+.
T Consensus 154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 11122222334431 246789999999999999985 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.018 Score=59.58 Aligned_cols=31 Identities=26% Similarity=0.484 Sum_probs=25.6
Q ss_pred CceEecCCCCCceeecCCCc-EEEeeeccccc
Q 036081 414 PAIYHRDIKSTNILLDSEMK-AKVADFGLAKQ 444 (614)
Q Consensus 414 ~~ivHrDIKp~NILLd~~~~-~KL~DFGla~~ 444 (614)
..++|+|+++.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997565 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.004 Score=64.85 Aligned_cols=130 Identities=18% Similarity=0.148 Sum_probs=88.7
Q ss_pred CccceeeeccCcEEEEEEEEcCCcEEEEEEeec-------C-----------CCcc----hHHHHHHHHHHHHccC-C-C
Q 036081 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITD-------L-----------DTKG----DEEFINEVEIISKIRH-R-N 345 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~-------~-----------~~~~----~~~f~~Ei~il~~l~H-~-N 345 (614)
++..+.||-|--+.||.+...+|++.++|.-+- . +..+ .-...+|...|+.|.. . -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567789999999999999999999999984311 0 0000 1124568888888753 2 2
Q ss_pred cccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCc
Q 036081 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTN 425 (614)
Q Consensus 346 Iv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~N 425 (614)
+.+.+++ ...++|||++.+-.|...-+- .+- -.+...+..-+.-|- +.|+||+|..--|
T Consensus 174 VPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v------~d~---~~ly~~lm~~Iv~la---~~GlIHgDFNEFN 232 (465)
T KOG2268|consen 174 VPKPIDH---------NRHCVVMELVDGYPLRQVRHV------EDP---PTLYDDLMGLIVRLA---NHGLIHGDFNEFN 232 (465)
T ss_pred CCCcccc---------cceeeHHHhhcccceeeeeec------CCh---HHHHHHHHHHHHHHH---HcCceecccchhe
Confidence 3333433 357899999988777654211 111 233333434444455 8899999999999
Q ss_pred eeecCCCcEEEeeec
Q 036081 426 ILLDSEMKAKVADFG 440 (614)
Q Consensus 426 ILLd~~~~~KL~DFG 440 (614)
|++++++.++++||=
T Consensus 233 imv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 233 IMVKDDDKIVVIDFP 247 (465)
T ss_pred eEEecCCCEEEeech
Confidence 999999999999995
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.00054 Score=82.56 Aligned_cols=162 Identities=12% Similarity=0.022 Sum_probs=112.3
Q ss_pred HHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhc-cCCCccchhHHHHHHHHHHHHHH
Q 036081 331 FINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTR-KQLAWPQRKKIILDVAKGLAYLH 409 (614)
Q Consensus 331 f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~-~~l~~~~r~~Ia~~Ia~gL~yLH 409 (614)
...|.+.++..+|+++.....-.. +.+..+.+.+++|+..|.+.+.|-+..++ ..++..-......+...+..-.|
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~---ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIP---PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCC---CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 445666666778998876544322 22445678999999999999988664332 22332222222222234444444
Q ss_pred --hcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHH
Q 036081 410 --YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVIL 487 (614)
Q Consensus 410 --~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ 487 (614)
+....--+|+++|+-|.+|..+.++|++++|+.+.... .........+++-|+.|++...-.++.++|+|..|+.+|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 22245578999999999999999999999999983222 122233456788999999999999999999999999999
Q ss_pred HHHhCCCCC
Q 036081 488 ELMSGRKVL 496 (614)
Q Consensus 488 ELltG~~p~ 496 (614)
+.--|..++
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 998877665
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.04 Score=58.96 Aligned_cols=140 Identities=15% Similarity=0.165 Sum_probs=78.6
Q ss_pred eeeccCcEEEEEEEEcC-----CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc-cccccccccCCCCCceEEEEE
Q 036081 295 LIGQGASGVVYKGTLED-----GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL-SLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~-----g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv-~l~g~~~~~~~~~~~~~~LV~ 368 (614)
.|-.|-.-.+|+..+.+ ++.+.+|.......... .-.+|..++..+...++. ++++++. . ..|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~-----~----g~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFP-----N----GRVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEEC-----C----ceEE
Confidence 44446667889887642 36788888755332222 236799999988655443 4445442 1 2589
Q ss_pred ecCCCCCcccc-c----------------chhh-h-cc-CCCccchhHHHH-----------------HHHHHHHHH---
Q 036081 369 DFMPSGSLGDH-I----------------SNAL-T-RK-QLAWPQRKKIIL-----------------DVAKGLAYL--- 408 (614)
Q Consensus 369 Ey~~~gsL~~~-L----------------~~~~-~-~~-~l~~~~r~~Ia~-----------------~Ia~gL~yL--- 408 (614)
||+++.+|... + ++.. . .. ...|.+..++.. .+..-+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987676421 1 1100 0 00 111221111111 111112222
Q ss_pred -Hh-cCCCceEecCCCCCceeecC-CCcEEEeeeccccc
Q 036081 409 -HY-GLKPAIYHRDIKSTNILLDS-EMKAKVADFGLAKQ 444 (614)
Q Consensus 409 -H~-~~~~~ivHrDIKp~NILLd~-~~~~KL~DFGla~~ 444 (614)
.. .....++|+|+++.|||+++ ++.+.+.||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 22457899999999999986 46899999988753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.079 Score=55.87 Aligned_cols=130 Identities=17% Similarity=0.202 Sum_probs=76.7
Q ss_pred EEEEEEEcCCcEEEEEEee-cCCCcchHHHHHHHHHHHHccC--CCcccccccccccCCCCCceEEEEEecCCCCCcccc
Q 036081 303 VVYKGTLEDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIRH--RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDH 379 (614)
Q Consensus 303 ~Vykg~~~~g~~vAVK~l~-~~~~~~~~~f~~Ei~il~~l~H--~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~ 379 (614)
.+|..... ++.+++++-. ...........+|.++++.+.- --....+++|.+.. -...+.||+|.++..+.+.
T Consensus 40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~pf~v~~~veGe~~~~~ 115 (321)
T COG3173 40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTPFYVMEWVEGEVVWSA 115 (321)
T ss_pred ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCceEEEEEecceeccCc
Confidence 34444433 7778887221 1222334456678888887743 22334455665321 2457999999988555443
Q ss_pred cchhhhccCCCccchhHHH-HHHHHHHHHHH-------------------------------------------------
Q 036081 380 ISNALTRKQLAWPQRKKII-LDVAKGLAYLH------------------------------------------------- 409 (614)
Q Consensus 380 L~~~~~~~~l~~~~r~~Ia-~~Ia~gL~yLH------------------------------------------------- 409 (614)
+.... .. .+++ ..+++.|+-||
T Consensus 116 ~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 116 LPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred CCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 32110 00 1122 24444444444
Q ss_pred -hc-----CCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 410 -YG-----LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 410 -~~-----~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
.. ....++|+|+.+.|++++.+...-|.||+++..
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 11 135699999999999999988899999999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.043 Score=57.21 Aligned_cols=69 Identities=13% Similarity=0.219 Sum_probs=42.1
Q ss_pred EEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCC----CCCceEEEEEecCCCCCcc
Q 036081 303 VVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD----EKGKRRFLVYDFMPSGSLG 377 (614)
Q Consensus 303 ~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~----~~~~~~~LV~Ey~~~gsL~ 377 (614)
.||+....+| .+++|+... ..+....|+..+..|....+ ++.......++ ..++..++++||++|..+.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~-~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGF-NIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCC-CCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4888876555 578888742 23446668888888854443 33332222211 1245689999999986654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.17 Score=53.73 Aligned_cols=144 Identities=21% Similarity=0.320 Sum_probs=86.1
Q ss_pred eeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc------cccccccccCCCCCceEEEEE
Q 036081 295 LIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL------SLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv------~l~g~~~~~~~~~~~~~~LV~ 368 (614)
.|.+ .-..+|+....+|+. ++|..+.. ....+...|++.+..+.-..+. .+-|-....-. .+...+-++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~-~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALS-GGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhcc-CCceeEEEE
Confidence 3444 456889999887776 78876553 4456677888888888533322 22221111100 114788999
Q ss_pred ecCCCCCccc-cc--------------chhh---------hccCCCcc-------------chhHHHHHHHHHHHHHHhc
Q 036081 369 DFMPSGSLGD-HI--------------SNAL---------TRKQLAWP-------------QRKKIILDVAKGLAYLHYG 411 (614)
Q Consensus 369 Ey~~~gsL~~-~L--------------~~~~---------~~~~l~~~-------------~r~~Ia~~Ia~gL~yLH~~ 411 (614)
+|++|..+.. .. +... ......|. .......++...+..+...
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988873 11 1000 01123443 1112334444455555422
Q ss_pred C----CCc---eEecCCCCCceeecCCCc-EEEeeecccc
Q 036081 412 L----KPA---IYHRDIKSTNILLDSEMK-AKVADFGLAK 443 (614)
Q Consensus 412 ~----~~~---ivHrDIKp~NILLd~~~~-~KL~DFGla~ 443 (614)
. ... +||+|+.|.||++|.+.. ..+.|||-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 223 999999999999999885 8999998664
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.042 Score=58.35 Aligned_cols=135 Identities=20% Similarity=0.268 Sum_probs=89.8
Q ss_pred eeeccCcEEEEEEEEcCCcEEEEEEeecC-------C--Ccch-------------H----HHHHHHHHHHHccCCCccc
Q 036081 295 LIGQGASGVVYKGTLEDGTLVAVKQITDL-------D--TKGD-------------E----EFINEVEIISKIRHRNLLS 348 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~g~~vAVK~l~~~-------~--~~~~-------------~----~f~~Ei~il~~l~H~NIv~ 348 (614)
-|..|--..||.++-.+|..+|||+.+-. . ..++ + ....|++-|.+|+.-.|..
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 46678889999999999999999987421 0 0011 1 1235777777776544332
Q ss_pred ccccccccCCCCCceEEEEEecCCC-CCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCcee
Q 036081 349 LRGCCVSSDDEKGKRRFLVYDFMPS-GSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNIL 427 (614)
Q Consensus 349 l~g~~~~~~~~~~~~~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NIL 427 (614)
.--+. -....|||+|+.. |=-...|. .-.++......+-.++++-+.-|-. ..++||.||.--|+|
T Consensus 231 PePIl-------Lk~hVLVM~FlGrdgw~aPkLK----d~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 231 PEPIL-------LKNHVLVMEFLGRDGWAAPKLK----DASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLL 297 (520)
T ss_pred CCcee-------eecceEeeeeccCCCCcCcccc----cccCChHHHHHHHHHHHHHHHHHHH--Hhceeccchhhhhhe
Confidence 21111 1234799999852 11111222 2346666777888888888888875 568999999999999
Q ss_pred ecCCCcEEEeeecccc
Q 036081 428 LDSEMKAKVADFGLAK 443 (614)
Q Consensus 428 Ld~~~~~KL~DFGla~ 443 (614)
+ .+|.+.|+|.+-+.
T Consensus 298 y-hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 298 Y-HDGKLYIIDVSQSV 312 (520)
T ss_pred E-ECCEEEEEEccccc
Confidence 9 56789999998654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.14 Score=62.41 Aligned_cols=148 Identities=20% Similarity=0.352 Sum_probs=82.4
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc--CCC-----ccccc-cccc-ccCCCCC-ce
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR--HRN-----LLSLR-GCCV-SSDDEKG-KR 363 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~--H~N-----Iv~l~-g~~~-~~~~~~~-~~ 363 (614)
+.|+ |..-.+|+....+|..+++|+.+... .......|.+.+..|. ++. +++-. |-.. .....++ ..
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 45678899888888889999987532 2334455666776663 222 22211 1111 0011122 25
Q ss_pred EEEEEecCCCCCccccc-----------------chhh-------hccCCCccch-----------------hHHHHHHH
Q 036081 364 RFLVYDFMPSGSLGDHI-----------------SNAL-------TRKQLAWPQR-----------------KKIILDVA 402 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L-----------------~~~~-------~~~~l~~~~r-----------------~~Ia~~Ia 402 (614)
.+-+++|+++..|.+.. +... ....+.|..+ ..++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 67789999987775411 0000 1123455432 12222332
Q ss_pred HHHHH----HHhcCCCceEecCCCCCceeecCCC--cEE-Eeeeccccc
Q 036081 403 KGLAY----LHYGLKPAIYHRDIKSTNILLDSEM--KAK-VADFGLAKQ 444 (614)
Q Consensus 403 ~gL~y----LH~~~~~~ivHrDIKp~NILLd~~~--~~K-L~DFGla~~ 444 (614)
+...- .......++||+|+.+.|||++.+. ++. |.|||-+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22211 1123467899999999999999875 554 999997753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.082 Score=55.46 Aligned_cols=33 Identities=15% Similarity=0.242 Sum_probs=29.1
Q ss_pred CCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 412 ~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
...+++|+|+.+.|||+++++.+.|.||..+..
T Consensus 194 ~~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 194 WRTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred cceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 356899999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.041 Score=60.68 Aligned_cols=49 Identities=16% Similarity=0.274 Sum_probs=36.8
Q ss_pred HHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCCCCCcccccch
Q 036081 329 EEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN 382 (614)
Q Consensus 329 ~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~ 382 (614)
.+.+-...+++.+.|+|+...+.+.... -....+|+|++ +.||++.+..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCc----cceEEEEehhh-ccchHHHHHh
Confidence 4566677888889999999888766432 23478999998 6788888754
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.27 Score=52.13 Aligned_cols=77 Identities=16% Similarity=0.127 Sum_probs=46.7
Q ss_pred cCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC--cccccccccccCCCCCceEEEEEecCCCCCc
Q 036081 299 GASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN--LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL 376 (614)
Q Consensus 299 G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N--Iv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL 376 (614)
+.-..||+...++|..+++|..+. ......+...|++.+..|.... ++.....--..-...++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 445789999988888899998743 2234566778999988884322 2222210000000123467889999987654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.064 Score=55.89 Aligned_cols=140 Identities=21% Similarity=0.256 Sum_probs=70.5
Q ss_pred cceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc---CCCcccccccccccCCCCCceEEEEE
Q 036081 292 QKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR---HRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~---H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
..+.++-|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++... ....+||+
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-----~~~~fLll 91 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-----DDDAFLLL 91 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE------SSCCEEEE
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-----cCCceEEE
Confidence 45678888889999988 568889999865 234557899999999984 3345566666542 22349999
Q ss_pred ecCCCCCcc--------c---ccchhhhcc---------------C----CCcc-----chhHHHHHHHH----------
Q 036081 369 DFMPSGSLG--------D---HISNALTRK---------------Q----LAWP-----QRKKIILDVAK---------- 403 (614)
Q Consensus 369 Ey~~~gsL~--------~---~L~~~~~~~---------------~----l~~~-----~r~~Ia~~Ia~---------- 403 (614)
||++.+... . .|+...... . -+|. +|+.-..+.+.
T Consensus 92 e~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~ 171 (288)
T PF03881_consen 92 EFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELE 171 (288)
T ss_dssp E--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHH
T ss_pred EeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHH
Confidence 999876111 1 112200000 1 1221 23222222221
Q ss_pred -HHHH----HH-hcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 404 -GLAY----LH-YGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 404 -gL~y----LH-~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
-++- |+ ....+.++||||.+.|++.+.++++.|.|=.
T Consensus 172 ~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 172 RLVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 1111 22 1225789999999999999999989998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.15 Score=54.58 Aligned_cols=73 Identities=12% Similarity=0.084 Sum_probs=46.0
Q ss_pred eeeccCcEEEEEEEEcCC-cEEEEEEeec----CC---CcchHHHHHHHHHHHHcc--CCC-cccccccccccCCCCCce
Q 036081 295 LIGQGASGVVYKGTLEDG-TLVAVKQITD----LD---TKGDEEFINEVEIISKIR--HRN-LLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~g-~~vAVK~l~~----~~---~~~~~~f~~Ei~il~~l~--H~N-Iv~l~g~~~~~~~~~~~~ 363 (614)
.||-|-...||++..++| +.|+||.-.. .. .-..+.-.-|.+.|.... -|. +.+++.| +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence 478888999999998755 5899997431 11 122334456777776653 343 3344443 2344
Q ss_pred EEEEEecCCCC
Q 036081 364 RFLVYDFMPSG 374 (614)
Q Consensus 364 ~~LV~Ey~~~g 374 (614)
..+|||+++..
T Consensus 75 ~~~vMEdL~~~ 85 (370)
T TIGR01767 75 AVTVMEDLSHH 85 (370)
T ss_pred ceehHhhCccc
Confidence 67999999753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.12 Score=51.00 Aligned_cols=31 Identities=29% Similarity=0.477 Sum_probs=22.0
Q ss_pred CceEecCCCCCceee-cCCCcEEEeeeccccc
Q 036081 414 PAIYHRDIKSTNILL-DSEMKAKVADFGLAKQ 444 (614)
Q Consensus 414 ~~ivHrDIKp~NILL-d~~~~~KL~DFGla~~ 444 (614)
..+.|+|+.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 568899999999999 8899999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.15 Score=50.87 Aligned_cols=152 Identities=20% Similarity=0.236 Sum_probs=94.8
Q ss_pred CcEEEEEEEEcCCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEecCCCCCccc
Q 036081 300 ASGVVYKGTLEDGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGD 378 (614)
Q Consensus 300 ~fG~Vykg~~~~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~ 378 (614)
|-.+.-+|+-+=| ...+|++....-. ...-|.++.+++++++ .|++|. ++ ++..+-++.|++-.-
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~------ND-n~~~yGvIlE~Cy~~---- 139 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK------ND-NNYKYGVILERCYKI---- 139 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee------cC-CCceeEEEEeeccCc----
Confidence 3344444443323 3557777654444 4567889999998875 245544 11 455678888987311
Q ss_pred ccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCccccccccC
Q 036081 379 HISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458 (614)
Q Consensus 379 ~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~g 458 (614)
+.. . ..++.-=...|.-.|.+ ..+.+|||-.|+||+-|.+|.+||.|=+.--. .
T Consensus 140 --------~i~---~-~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~ 193 (308)
T PF07387_consen 140 --------KIN---F-SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------N 193 (308)
T ss_pred --------ccc---h-hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------h
Confidence 000 0 12222223567777844 67899999999999999999999999864211 1
Q ss_pred CCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 036081 459 TYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK 494 (614)
Q Consensus 459 t~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~ 494 (614)
+..|.--| +...+.++.+=+|=.-+++++...+
T Consensus 194 ~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 194 QVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eeeEEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 11233322 3456788888888888888877554
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.28 Score=52.16 Aligned_cols=140 Identities=17% Similarity=0.190 Sum_probs=76.6
Q ss_pred eeeccCcEEEEEEEEcC----CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc-cccccccccCCCCCceEEEEEe
Q 036081 295 LIGQGASGVVYKGTLED----GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL-SLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 295 ~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv-~l~g~~~~~~~~~~~~~~LV~E 369 (614)
.|..|=...+|+....+ +..|.+|........ .-.-.+|..++..+...++. ++++++. . .+|.+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-----~----G~i~~ 90 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-----N----GMIQS 90 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-----C----cEeeh
Confidence 44445567888887653 237888887543322 22345799999999765554 4454432 1 15899
Q ss_pred cCCCCCcccc-------c----------chhh-h-cc-CCCccchhHHHH----------------------HHHHHHHH
Q 036081 370 FMPSGSLGDH-------I----------SNAL-T-RK-QLAWPQRKKIIL----------------------DVAKGLAY 407 (614)
Q Consensus 370 y~~~gsL~~~-------L----------~~~~-~-~~-~l~~~~r~~Ia~----------------------~Ia~gL~y 407 (614)
|+++..|... + +... . .. .--|....++.. .+.+-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 9977665321 1 1100 0 00 011222111111 11111222
Q ss_pred HHh-----cCCCceEecCCCCCceeecC-CCcEEEeeeccccc
Q 036081 408 LHY-----GLKPAIYHRDIKSTNILLDS-EMKAKVADFGLAKQ 444 (614)
Q Consensus 408 LH~-----~~~~~ivHrDIKp~NILLd~-~~~~KL~DFGla~~ 444 (614)
+.. ....-++|.|+.+.|||+++ ++.+++.||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 211 12345799999999999975 57899999988753
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.81 E-value=0.65 Score=46.63 Aligned_cols=118 Identities=19% Similarity=0.279 Sum_probs=70.2
Q ss_pred CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC---cccccccccccCCCCCceEEEEEecCCCCCcccc---------
Q 036081 312 GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN---LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDH--------- 379 (614)
Q Consensus 312 g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N---Iv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~--------- 379 (614)
...+-||+-. .+....|..|+.-|..+.--| +.+.+..-. .....|+|+||++-|.+...
T Consensus 39 ~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~-----~~~~sylVle~L~~~~~d~~~~~~~GqqL 110 (286)
T COG3001 39 TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGA-----SRDHSYLVLEYLPTGPLDAHSAFILGQQL 110 (286)
T ss_pred CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecC-----CCCeeEEEEeeccCCCCCchhHHHHHHHH
Confidence 5678888732 233467889999888886555 333333322 45678999999998877621
Q ss_pred --cchhhhc---------------cCCCcc---------chhHHHHHHH--------------HHHHHHHhcC--CCceE
Q 036081 380 --ISNALTR---------------KQLAWP---------QRKKIILDVA--------------KGLAYLHYGL--KPAIY 417 (614)
Q Consensus 380 --L~~~~~~---------------~~l~~~---------~r~~Ia~~Ia--------------~gL~yLH~~~--~~~iv 417 (614)
|+..... .+-.|. +|+-.-.++| ..+..+-..+ ++..+
T Consensus 111 A~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~elL~~hqpqPsLl 190 (286)
T COG3001 111 ARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQELLADHQPQPSLL 190 (286)
T ss_pred HHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHHHHhcCCCCccee
Confidence 1111111 112232 2322222222 2333333222 48899
Q ss_pred ecCCCCCceeecCCCcEEEee
Q 036081 418 HRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 418 HrDIKp~NILLd~~~~~KL~D 438 (614)
|+||...|.....+| +.+-|
T Consensus 191 HGDLW~gN~a~~~~G-Pv~fD 210 (286)
T COG3001 191 HGDLWSGNCAFGKDG-PVIFD 210 (286)
T ss_pred ecccccccccccCCC-Ceeec
Confidence 999999999999998 66654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.2 Score=53.29 Aligned_cols=105 Identities=19% Similarity=0.175 Sum_probs=70.5
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
++...|++|++. +++|.- .+.-.|++.+.|+.+.+.-+.-+.. +.+.=|||+.-.||||| +|++-|+||
T Consensus 297 e~~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred CceEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEe
Confidence 345567777765 344432 2346789999999998888888774 66788999999999999 999999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHH
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSF 482 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSf 482 (614)
-++|....+..-...+ .--|-.+. |.-+..-|||-+
T Consensus 366 klsRl~~~q~~isy~r------ldhp~lF~-G~dd~QFeIYrl 401 (488)
T COG5072 366 KLSRLSYSQGIISYNR------LDHPDLFN-GVDDYQFEIYRL 401 (488)
T ss_pred eeeecccCCceeeccc------cCchhhhc-CccceeeeHHHH
Confidence 9998543322111111 12233343 333566677764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.85 E-value=0.37 Score=52.32 Aligned_cols=74 Identities=16% Similarity=0.124 Sum_probs=48.3
Q ss_pred ceeeeccCcEEEEEEEEcC-CcEEEEEEeec---CC---CcchHHHHHHHHHHHHcc--CCC-cccccccccccCCCCCc
Q 036081 293 KNLIGQGASGVVYKGTLED-GTLVAVKQITD---LD---TKGDEEFINEVEIISKIR--HRN-LLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~---~~---~~~~~~f~~Ei~il~~l~--H~N-Iv~l~g~~~~~~~~~~~ 362 (614)
.+.||-|--..||++...+ ++.|+||.-.. .. .-..+...-|.+.|+... -|. +.+++.+ +..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-------D~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-------DSV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-------CcH
Confidence 4578999999999999853 56799996432 11 122345566788887763 343 4445544 234
Q ss_pred eEEEEEecCCC
Q 036081 363 RRFLVYDFMPS 373 (614)
Q Consensus 363 ~~~LV~Ey~~~ 373 (614)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 56889999965
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=92.73 E-value=1.2 Score=48.60 Aligned_cols=73 Identities=11% Similarity=0.091 Sum_probs=47.8
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeec----CCC---cchHHHHHHHHHHHHcc---CCCcccccccccccCCCCCc
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITD----LDT---KGDEEFINEVEIISKIR---HRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~----~~~---~~~~~f~~Ei~il~~l~---H~NIv~l~g~~~~~~~~~~~ 362 (614)
.+.||-|-...||+.... +..++||+-.. ... -..+.-..|.+.|..+. ..++.+++.++. .
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-------d 108 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-------T 108 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-------C
Confidence 467899999999998875 55688997541 111 12223344566666553 346777888775 2
Q ss_pred eEEEEEecCCC
Q 036081 363 RRFLVYDFMPS 373 (614)
Q Consensus 363 ~~~LV~Ey~~~ 373 (614)
..+++|||+++
T Consensus 109 ~~vlvME~L~~ 119 (418)
T PLN02756 109 MALIGMRYLEP 119 (418)
T ss_pred CCEEEEeecCC
Confidence 35889999976
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.65 E-value=0.99 Score=49.04 Aligned_cols=74 Identities=19% Similarity=0.275 Sum_probs=44.3
Q ss_pred eeeeccCcEEEEEEEEcCC--cE-----EEEEEeecCCCcchHHHHHHHHHHHHccCCCcc-cccccccccCCCCCceEE
Q 036081 294 NLIGQGASGVVYKGTLEDG--TL-----VAVKQITDLDTKGDEEFINEVEIISKIRHRNLL-SLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g--~~-----vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv-~l~g~~~~~~~~~~~~~~ 365 (614)
+.|..|=...+|+....++ .. |.++.... .....-.-.+|++++..+...++. ++++.+. -+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~---------~g 125 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG---------DF 125 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC---------CE
Confidence 3454577789999976543 22 44443211 111112235789999999766554 4444442 26
Q ss_pred EEEecCCCCCcc
Q 036081 366 LVYDFMPSGSLG 377 (614)
Q Consensus 366 LV~Ey~~~gsL~ 377 (614)
+++||+++.+|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 999999987765
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=92.41 E-value=0.065 Score=38.17 Aligned_cols=25 Identities=24% Similarity=0.347 Sum_probs=10.6
Q ss_pred EEEEhhHHHHHHHHHHHHHHHHHHH
Q 036081 222 IKIVVALLGALLGVLLAGGLIIMYR 246 (614)
Q Consensus 222 ~~i~i~v~~~~~~~l~~~~~~~~~~ 246 (614)
+..++++.++++++++.+++++|||
T Consensus 13 Ia~~VvVPV~vI~~vl~~~l~~~~r 37 (40)
T PF08693_consen 13 IAVGVVVPVGVIIIVLGAFLFFWYR 37 (40)
T ss_pred EEEEEEechHHHHHHHHHHhheEEe
Confidence 3334444444444444334443443
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 614 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-16 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 406 bits (1046), Expect = e-139
Identities = 124/307 (40%), Positives = 184/307 (59%), Gaps = 14/307 (4%)
Query: 275 AKWFRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDE-EFIN 333
K F EL A+ FS KN++G+G G VYKG L DGTLVAVK++ + T+G E +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 334 EVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWP 392
EVE+IS HRNLL LRG C+ R LVY +M +GS+ + ++ L WP
Sbjct: 77 EVEMISMAVHRNLLRLRGFCM-----TPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 393 QRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL 452
+R++I L A+GLAYLH P I HRD+K+ NILLD E +A V DFGLAK +H+
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 453 TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETS---NSSFLLITDW 509
TT V GT G++APEY G+ +EK+DV+ +G+++LEL++G++ + + N +++ DW
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569
L K++ + D ++ +E+ ++V +LC RP +++ ++MLEGD
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD-- 309
Query: 570 IPTLPER 576
L ER
Sbjct: 310 --GLAER 314
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-127
Identities = 114/311 (36%), Positives = 172/311 (55%), Gaps = 11/311 (3%)
Query: 263 RSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITD 322
+ S L + +L++AT F K LIG G G VYKG L DG VA+K+ T
Sbjct: 14 DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73
Query: 323 LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS- 381
++G EEF E+E +S RH +L+SL G C L+Y +M +G+L H+
Sbjct: 74 ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYG 128
Query: 382 NALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441
+ L ++W QR +I + A+GL YLH AI HRD+KS NILLD K+ DFG+
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 442 AKQSLEG-QSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
+K+ E Q+HL+T V GT GY+ PEY + G+LTEKSDVYSFG+V+ E++ R + S
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 501 SS-FLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIAD 559
+ + +WA N+G++++I D + ++ + +F + C + RP++ D
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 560 ALKMLEGDIDI 570
L LE + +
Sbjct: 306 VLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 356 bits (917), Expect = e-120
Identities = 101/314 (32%), Positives = 160/314 (50%), Gaps = 24/314 (7%)
Query: 266 KDSVLPNSGAKWFRESELDQATGGFSQK------NLIGQGASGVVYKGTLEDGTLVAVKQ 319
K + ++ F EL T F ++ N +G+G GVVYKG + + T VAVK+
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK 61
Query: 320 ITDLDTK----GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGS 375
+ + ++F E+++++K +H NL+ L G G LVY +MP+GS
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGS 116
Query: 376 LGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435
L D +S L+W R KI A G+ +LH + HRDIKS NILLD AK
Sbjct: 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAK 173
Query: 436 VADFGLAKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK 494
++DFGLA+ S + + +T+R+ GT Y+APE L G++T KSD+YSFG+V+LE+++G
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLP 232
Query: 495 VLETSNSSFLLITDWAW-MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL 553
++ LL+ D + +++ D+ + + +E V C H
Sbjct: 233 AVDEHREPQLLL-DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNK 290
Query: 554 RPTIADALKMLEGD 567
RP I ++L+
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 7e-79
Identities = 75/307 (24%), Positives = 120/307 (39%), Gaps = 31/307 (10%)
Query: 281 SELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISK 340
L + + +G G V+K L VAVK D + + EV +
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSLPG 74
Query: 341 IRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD 400
++H N+L G +L+ F GSL D L ++W + I
Sbjct: 75 MKHENILQFIGAEKRGTSVD-VDLWLITAFHEKGSLSDF----LKANVVSWNELCHIAET 129
Query: 401 VAKGLAYLH-------YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL- 452
+A+GLAYLH G KPAI HRDIKS N+LL + + A +ADFGLA + G+S
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 453 TTRVAGTYGYLAPEYA-----LYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLIT 507
T GT Y+APE + D+Y+ G+V+ EL S + ++L
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP- 248
Query: 508 DWAWMLANSGKVDEIFDEFIREEG---------SRAVMERFVRVGILCAHVMVALRPTIA 558
+ + ++++ + + ++ A M C R +
Sbjct: 249 -FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 559 DALKMLE 565
+ +
Sbjct: 308 CVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-68
Identities = 75/341 (21%), Positives = 119/341 (34%), Gaps = 42/341 (12%)
Query: 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI 337
SE LIG+G G VYKG+L D VAVK + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV---FSFANRQNFINEKNI 58
Query: 338 --ISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK 395
+ + H N+ + LV ++ P+GSL + L+ W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY----LSLHTSDWVSSC 114
Query: 396 KIILDVAKGLAYLH------YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK------ 443
++ V +GLAYLH KPAI HRD+ S N+L+ ++ ++DFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 444 -QSLEGQSHLTTRVAGTYGYLAPEYA-------LYGQLTEKSDVYSFGIVILELMSGRKV 495
+ + GT Y+APE ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 496 LETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL-- 553
L S + + N ++ + E R + L +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFED-MQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 554 ---------RPTIADALKMLEGDIDIPTLPERPLPLTHESF 585
R T A + + + I + P H
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHH 334
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-63
Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 10/200 (5%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQIT--DLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
IG G+ G V++ G+ VAVK + D + EF+ EV I+ ++RH N++ G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
+ +V +++ GSL + + R+QL +R + DVAKG+ YLH
Sbjct: 104 T-----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL 473
P I HR++KS N+L+D + KV DFGL++ + AGT ++APE
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 474 TEKSDVYSFGIVILELMSGR 493
EKSDVYSFG+++ EL + +
Sbjct: 217 NEKSDVYSFGVILWELATLQ 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-60
Identities = 70/244 (28%), Positives = 124/244 (50%), Gaps = 38/244 (15%)
Query: 267 DSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDT 325
S P S ++E++ + IG+G G+V+KG ++D ++VA+K + D+
Sbjct: 5 GSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 326 KGD-------EEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGD 378
+G+ +EF EV I+S + H N++ L G +V +F+P G L
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDLYH 110
Query: 379 HISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-----EMK 433
+ + + W + +++LD+A G+ Y+ P I HRD++S NI L S +
Sbjct: 111 RLLDK--AHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVC 167
Query: 434 AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL---TEKSDVYSFGIVILELM 490
AKVADFGL++Q H + + G + ++APE + + TEK+D YSF +++ ++
Sbjct: 168 AKVADFGLSQQ----SVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTIL 222
Query: 491 SGRK 494
+G
Sbjct: 223 TGEG 226
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 8e-60
Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQIT--DLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+ + SG ++KG G + VK + D T+ +F E + H N+L + G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
L+ +MP GSL + + T + Q K LD+A+G+A+LH L+
Sbjct: 77 Q---SPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL---- 469
P I + S ++++D +M A+++ + S + ++APE AL
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPE-ALQKKP 184
Query: 470 YGQLTEKSDVYSFGIVILELMSGR 493
+D++SF +++ EL++
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-59
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G+GA GVV K VA+KQI + + FI E+ +S++ H N++ L G C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
LV ++ GSL + + A L ++G+AYLH A
Sbjct: 72 ------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 416 IYHRDIKSTNILLDSEMK-AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLT 474
+ HRD+K N+LL + K+ DFG A T G+ ++APE +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 475 EKSDVYSFGIVILELMSGRK 494
EK DV+S+GI++ E+++ RK
Sbjct: 182 EKCDVFSWGIILWEVITRRK 201
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-59
Identities = 78/337 (23%), Positives = 122/337 (36%), Gaps = 48/337 (14%)
Query: 273 SGAKW-FRESELDQATGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEE 330
S FR S+L ++G+G G K T E G ++ +K++ D +
Sbjct: 1 SMPHRIFRPSDL-------IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT 53
Query: 331 FINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLA 390
F+ EV+++ + H N+L G K KR + +++ G+L I + Q
Sbjct: 54 FLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLNFITEYIKGGTLRGIIKSM--DSQYP 106
Query: 391 WPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA-------- 442
W QR D+A G+AYLH I HRD+ S N L+ VADFGLA
Sbjct: 107 WSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 443 -----KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLE 497
+ + V G ++APE EK DV+SFGIV+ E++
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-- 221
Query: 498 TSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT- 556
L + F+ F + + C + RP+
Sbjct: 222 -----------DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSF 270
Query: 557 --IADALKMLEGDIDIPTLPERPLPLTHESFKASPSR 591
+ L+ L + L F + R
Sbjct: 271 VKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRR 307
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-56
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI--ISKIRHRNLLSLRG 351
+G+G G V++G+ G VAVK + D ++ + E E+ +RH N+L
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH-- 409
++S + +L+ + GSL D+ L L +I+L +A GLA+LH
Sbjct: 70 SDMTSRH-SSTQLWLITHYHEMGSLYDY----LQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 410 ---YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK----QSLEGQSHLTTRVAGTYGY 462
KPAI HRD+KS NIL+ + +AD GLA + + RV GT Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 463 LAPE------YALYGQLTEKSDVYSFGIVILELMSG 492
+APE ++ D+++FG+V+ E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-56
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQI----TDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
IG G G VY+ G VAVK + ++ E E ++ + ++H N+++LRG
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
C+ K LV +F G L L+ K++ + +A+G+ YLH
Sbjct: 74 VCL-----KEPNLCLVMEFARGGPLNRV----LSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 412 LKPAIYHRDIKSTNILLDSEMK--------AKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
I HRD+KS+NIL+ +++ K+ DFGLA+ E AG Y ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWM 181
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
APE ++ SDV+S+G+++ EL++G
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-55
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI--ISKIRHRNLLSLRG 351
IG+G G V+ G G VAVK + + + E EI +RH N+L
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH-- 409
+ + +L+ D+ +GSL D+ L L K+ GL +LH
Sbjct: 99 ADIKGTGSW-TQLYLITDYHENGSLYDY----LKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 410 ---YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL---TTRVAGTYGYL 463
KPAI HRD+KS NIL+ +AD GLA + + + + GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 464 APEYALYGQL-------TEKSDVYSFGIVILELMSG 492
PE L L +D+YSFG+++ E+
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-55
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
IG G+ G VYKG G VAVK + T + + F NEV ++ K RH N+L G
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
+ +V + SL H+ + + + I A+G+ YLH
Sbjct: 90 ------TAPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAK-QSLEGQSHLTTRVAGTYGYLAPE---YAL 469
+I HRD+KS NI L + K+ DFGLA +S SH +++G+ ++APE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 470 YGQLTEKSDVYSFGIVILELMSGR 493
+ +SDVY+FGIV+ ELM+G+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-53
Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEI--ISKIRHRNLLSLRG 351
IG+G G V++G G VAVK + + + + E EI +RH N+L
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH-- 409
+ + +LV D+ GSL D+ L R + K+ L A GLA+LH
Sbjct: 104 ADNKDNGTW-TQLWLVSDYHEHGSLFDY----LNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 410 ---YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLT---TRVAGTYGYL 463
KPAI HRD+KS NIL+ +AD GLA + + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 464 APEYALYGQL-------TEKSDVYSFGIVILELMSG 492
APE L + +++D+Y+ G+V E+
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 9e-53
Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 28/216 (12%)
Query: 293 KNLIGQGASGVVYKGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
LIG+G G VY G G VA++ I + + F EV + RH N++
Sbjct: 38 GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
G C+ ++ +L + +A + L + ++I ++ KG+ YLH
Sbjct: 96 GACM-----SPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH- 147
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK----QSLEGQSHLTTRVAGTYGYLAPE 466
I H+D+KS N+ D K + DFGL + G +LAPE
Sbjct: 148 --AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 467 ---------YALYGQLTEKSDVYSFGIVILELMSGR 493
++ SDV++ G + EL +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-44
Identities = 69/320 (21%), Positives = 117/320 (36%), Gaps = 46/320 (14%)
Query: 250 KKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT- 308
++R + E + + + + ++ + IG+G+ VYKG
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDG--RFLKFDIE------------IGRGSFKTVYKGLD 47
Query: 309 LEDGTLVAVKQITDLDTKGDE--EFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366
E VA ++ D E F E E++ ++H N++ S+ K K L
Sbjct: 48 TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVL 106
Query: 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNI 426
V + M SG+L ++ K + + + KGL +LH P I HRD+K NI
Sbjct: 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNI 162
Query: 427 LLDSEM-KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIV 485
+ K+ D GLA ++ V GT ++APE + E DVY+FG+
Sbjct: 163 FITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMC 218
Query: 486 ILELMSGR---KVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRV 542
+LE+ + + + + +T + E I
Sbjct: 219 MLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE-------------- 264
Query: 543 GILCAHVMVALRPTIADALK 562
C R +I D L
Sbjct: 265 --GCIRQNKDERYSIKDLLN 282
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 61/259 (23%), Positives = 113/259 (43%), Gaps = 39/259 (15%)
Query: 296 IGQGASGVVYKGTLE-----DGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G+G G V + G VAVK + + + E+EI+ + H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL- 408
+G C ++ G L+ +F+PSGSL +++ + ++ Q+ K + + KG+ YL
Sbjct: 89 KGICT---EDGGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLG 143
Query: 409 --HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TY 460
Y + HRD+ + N+L++SE + K+ DFGL K + + T +
Sbjct: 144 SRQY-----V-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY- 196
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519
APE + + SDV+SFG+ + EL++ +I + + V
Sbjct: 197 ---APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 520 DEIFDEFIREEGSRAVMER 538
+ + +EG R +
Sbjct: 254 NTL------KEGKR--LPC 264
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 48/231 (20%), Positives = 92/231 (39%), Gaps = 22/231 (9%)
Query: 280 ESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVE 336
S + + IG G+ G K DG ++ K++ + + ++EV
Sbjct: 2 PSRAED----YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 57
Query: 337 IISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQL-----AW 391
++ +++H N++ + D ++V ++ G L I+ +Q
Sbjct: 58 LLRELKHPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 392 PQRKKIILDVAKGLAYLHY--GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449
+++ + L H + HRD+K N+ LD + K+ DFGLA+ L
Sbjct: 115 ----RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHD 169
Query: 450 SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
+ GT Y++PE EKSD++S G ++ EL + +
Sbjct: 170 TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 32/216 (14%)
Query: 293 KNLIGQGASGVVYKGTLEDG---TLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLS 348
+G G G V +G VA+K + + EE + E +I+ ++ + ++
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
L G C + + LV + G L + R+++ +++ V+ G+ YL
Sbjct: 75 LIGVC------QAEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYL 126
Query: 409 ---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------T 459
++ HRD+ + N+LL + AK++DFGL+K S+ T R AG
Sbjct: 127 EEKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
APE + + + +SDV+S+G+ + E +S G+K
Sbjct: 181 ----APECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 296 IGQGASGVVYKGTL-----EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
+G+G G V G LVAVKQ+ +F E++I+ + ++ R
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G + LV +++PSG L D + R +L + + KG+ YL
Sbjct: 91 GVSYGP---GRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS 145
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TYG 461
+ HRD+ + NIL++SE K+ADFGLAK + + R G
Sbjct: 146 RRC-----V-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-- 197
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILELMS 491
APE + +SDV+SFG+V+ EL +
Sbjct: 198 --APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 296 IGQGASGVVYKGTLE-----DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
+G+G G V + G +VAVK++ + +F E+EI+ ++H N++ +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G C S+ L+ +++P GSL D++ ++++ + + + KG+ YL
Sbjct: 78 GVCYSAGRR---NLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT 132
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TYG 461
Y I HRD+ + NIL+++E + K+ DFGL K + + + G
Sbjct: 133 KRY-----I-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-- 184
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILELMS 491
APE + + SDV+SFG+V+ EL +
Sbjct: 185 --APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 296 IGQGASGVVYKGTLED-----GTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G+G G V + G +VAVK + D + + E++I+ + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL- 408
+GCC + LV +++P GSL D+ L R + Q + +G+AYL
Sbjct: 99 KGCCEDAGAAS---LQLVMEYVPLGSLRDY----LPRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 409 --HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TY 460
HY I HRD+ + N+LLD++ K+ DFGLAK EG + R G
Sbjct: 152 AQHY-----I-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY- 204
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMS 491
APE + SDV+SFG+ + EL++
Sbjct: 205 ---APECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 296 IGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLSLRGCC 353
IG+G G V+ G L D TLVAVK + +F+ E I+ + H N++ L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
+ + ++V + + G + +L +++ D A G+ YL K
Sbjct: 182 T-----QKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLE--SK 232
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY----LAPEYAL 469
I HRD+ + N L+ + K++DFG++++ +G G APE
Sbjct: 233 CCI-HRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALN 288
Query: 470 YGQLTEKSDVYSFGIVILELMS 491
YG+ + +SDV+SFGI++ E S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 41/232 (17%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS 348
F + ++GQGA G V K D A+K+I + ++EV +++ + H+ ++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 349 LRGCCVSSDDEKGKRR--------FLVYDFMPSGSLGDHIS--NALTRKQLAWPQRKKII 398
+ + F+ ++ +G+L D I N ++ W ++
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLF 122
Query: 399 LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-------------- 444
+ + L+Y+H I HRD+K NI +D K+ DFGLAK
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 445 SLEGQSHLTTRVAGTYGYLAPE----YALYGQLTEKSDVYSFGIVILELMSG 492
+LT+ + GT Y+A E Y EK D+YS GI+ E++
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYN---EKIDMYSLGIIFFEMIYP 227
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
IG G G+V+ G + VA+K I + +E+FI E E++ K+ H L+ L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---H 409
C+ + LV +FM G L D++ R A + LDV +G+AYL
Sbjct: 72 CL-----EQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT---YGYLAPE 466
HRD+ + N L+ KV+DFG+ + L+ Q T GT + +PE
Sbjct: 125 V------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPE 175
Query: 467 YALYGQLTEKSDVYSFGIVILELMS-GRK 494
+ + + KSDV+SFG+++ E+ S G+
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 296 IGQGASGVVYKGTLE-----DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
+G+G G V + G +VAVK++ + +F E+EI+ ++H N++ +
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G C S+ L+ +++P GSL D++ ++++ + + + KG+ YL
Sbjct: 109 GVCYSAGRR---NLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT 163
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TYG 461
Y I HRD+ + NIL+++E + K+ DFGL K + + + + G
Sbjct: 164 KRY-----I-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-- 215
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILELMS 491
APE + + SDV+SFG+V+ EL +
Sbjct: 216 --APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G GVV G + VAVK I + + ++EF E + + K+ H L+ G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS- 73
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---HYGL 412
K ++V +++ +G L +++ + K L Q ++ DV +G+A+L +
Sbjct: 74 ----KEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT---YGYLAPEYAL 469
I HRD+ + N L+D ++ KV+DFG+ + L+ Q GT + APE
Sbjct: 126 ---I-HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFH 178
Query: 470 YGQLTEKSDVYSFGIVILELMS-GRK 494
Y + + KSDV++FGI++ E+ S G+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
+G G GVV G VA+K I + + ++EFI E +++ + H L+ L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---H 409
C K + F++ ++M +G L +++ R + Q ++ DV + + YL
Sbjct: 88 CT-----KQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT---YGYLAPE 466
+ + HRD+ + N L++ + KV+DFGL++ L+ + T G+ + PE
Sbjct: 141 F-----L-HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPE 191
Query: 467 YALYGQLTEKSDVYSFGIVILELMS 491
+Y + + KSD+++FG+++ E+ S
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 271 PNSGAKWF-RESELDQATGGFSQKNLIGQGASGVVYKGTLEDG-----TLVAVKQI-TDL 323
PN +E+E + ++G GA G VYKG VA+K++
Sbjct: 4 PNQALLRILKETEF-------KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 324 DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNA 383
K ++E ++E +++ + + ++ L G C++S L+ MP G L D++
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREH 110
Query: 384 LTRKQLAWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440
+ + + +AKG+ YL + HRD+ + N+L+ + K+ DFG
Sbjct: 111 --KDNIGSQYLLNWCVQIAKGMNYLEDRRL-----V-HRDLAARNVLVKTPQHVKITDFG 162
Query: 441 LAKQSLEGQSHLTTRVAG------TYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GR 493
LAK L + G A E L+ T +SDV+S+G+ + ELM+ G
Sbjct: 163 LAK-LLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 494 K 494
K
Sbjct: 218 K 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS 348
F + LIG G G V+K DG +K++ +E+ EV+ ++K+ H N++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVH 68
Query: 349 LRGC-----------CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKI 397
GC +S K K F+ +F G+L I ++L ++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALEL 127
Query: 398 ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457
+ KG+ Y+H + +RD+K +NI L + K+ DFGL L+ T
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKRTRSK- 182
Query: 458 GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK 494
GT Y++PE ++ D+Y+ G+++ EL+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 296 IGQGASGVVYKGTLEDG---TLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
+G G G V KG + VAVK + D +E + E ++ ++ + ++ +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G C + + LV + G L ++ + + +++ V+ G+ YL
Sbjct: 85 GIC------EAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TYG 461
++ HRD+ + N+LL ++ AK++DFGL+K +++ + G
Sbjct: 136 SNF------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-- 187
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
APE Y + + KSDV+SFG+++ E S G+K
Sbjct: 188 --APECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 51/219 (23%), Positives = 87/219 (39%), Gaps = 21/219 (9%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS 348
+ +G+G V L DG A+K+I + + EE E ++ H N+L
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK--KIILDVAKGLA 406
L C+ + +L+ F G+L + I + + + ++L + +GL
Sbjct: 91 LVAYCLR-ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLE 148
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK---------QSLEGQSHLTTRVA 457
+H HRD+K TNILL E + + D G + +
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR- 204
Query: 458 GTYGYLAPE---YALYGQLTEKSDVYSFGIVILELMSGR 493
T Y APE + + E++DV+S G V+ +M G
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 292 QKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
+ ++G+G G+VY G L + +A+K+I + D++ + E+ + ++H+N++
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 351 GCCVSSDDEKGKRRFLVYDFM---PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
G + + FM P GSL + + + + +GL Y
Sbjct: 86 GSFSENGF--------IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
LH I HRDIK N+L+++ K++DFG +K+ T GT Y+APE
Sbjct: 138 LH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE 193
Query: 467 YALYGQL--TEKSDVYSFGIVILELMSGR 493
G + +D++S G I+E+ +G+
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 35/238 (14%)
Query: 271 PNSGAKWF-RESELDQATGGFSQKNLIGQGASGVVYKGTL----EDGTLVAVKQI---TD 322
P E +L +G G+ GVV +G VAVK +
Sbjct: 7 PLQSLTCLIGEKDL-------RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL 59
Query: 323 LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN 382
+ ++FI EV + + HRNL+ L G + +V + P GSL D +
Sbjct: 60 SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL------TPPMKMVTELAPLGSLLDRLRK 113
Query: 383 ALTRKQLAWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439
+ + + VA+G+ YL + HRD+ + N+LL + K+ DF
Sbjct: 114 --HQGHFLLGTLSRYAVQVAEGMGYLESKRF------IHRDLAARNLLLATRDLVKIGDF 165
Query: 440 GLAKQSLEGQSHLTTRVAGTYGY--LAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
GL + + H + + APE + SD + FG+ + E+ + G++
Sbjct: 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 49/285 (17%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLL 347
+++ IGQGASG VY + G VA++Q+ +L + +E I NE+ ++ + ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIV 80
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIILDVAKGLA 406
+ + G ++V +++ GSL D + + Q+A + + + L
Sbjct: 81 NYLDSYL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALE 130
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+LH + HRDIKS NILL + K+ DFG Q QS +T V GT ++APE
Sbjct: 131 FLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPE 186
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGR---------KVLETSNSSFLLITDWAWMLANSG 517
K D++S GI+ +E++ G + L +L+ T+ L N
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGTPELQNPE 240
Query: 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
K+ IF +F+ C + V R + + L+
Sbjct: 241 KLSAIFRDFLN----------------RCLEMDVEKRGSAKELLQ 269
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 293 KNLIGQGASGVVYKGTLEDG----TLVAVKQI-TDLDTKGD-EEFINEVEIISKIRHRNL 346
++G+G G V +G L+ VAVK + D ++ + EEF++E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI--------SNALTRKQLAWPQRKKII 398
+ L G C+ + + ++ FM G L ++ + + L K +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL-----KFM 153
Query: 399 LDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR 455
+D+A G+ YL ++ + HRD+ + N +L +M VADFGL+K+ G +
Sbjct: 154 VDIALGMEYLSNRNF-----L-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY---- 203
Query: 456 VAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
G + A E T KSDV++FG+ + E+ +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 74/326 (22%), Positives = 127/326 (38%), Gaps = 61/326 (18%)
Query: 249 YKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT 308
+ HE+F + + V IG+G++G+V
Sbjct: 18 LYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK------------IGEGSTGIVCLAR 65
Query: 309 -LEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366
G VAVK + DL + E + NEV I+ +H N++ + + G+ ++
Sbjct: 66 EKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL-----VGEELWV 119
Query: 367 VYDFMPSGSLGDHISNA-LTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTN 425
+ +F+ G+L D +S L +Q+A + V + LAYLH + HRDIKS +
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEEQIA-----TVCEAVLQALAYLH---AQGVIHRDIKSDS 171
Query: 426 ILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIV 485
ILL + + K++DFG Q + + V GT ++APE + D++S GI+
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 486 ILELMSGR---------KVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVM 536
++E++ G + + L L NS KV + +F+
Sbjct: 231 VIEMVDGEPPYFSDSPVQAM------KRLRDSPPPKLKNSHKVSPVLRDFLE-------- 276
Query: 537 ERFVRVGILCAHVMVALRPTIADALK 562
R T + L
Sbjct: 277 --------RMLVRDPQERATAQELLD 294
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 57/240 (23%), Positives = 105/240 (43%), Gaps = 33/240 (13%)
Query: 272 NSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGD 328
+ G + +++ + + IG+G+ G EDG +K+I + + +K
Sbjct: 12 DLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 329 EEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQ 388
EE EV +++ ++H N++ R + ++V D+ G L I+ +K
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENG-----SLYIVMDYCEGGDLFKRINA---QKG 119
Query: 389 LAWPQRK--KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446
+ + + + + + L ++H I HRDIKS NI L + ++ DFG+A+ L
Sbjct: 120 VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV-L 175
Query: 447 EGQSHLTTRVAGTYGYLAPE------YALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
L GT YL+PE Y KSD+++ G V+ EL + + E +
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPY------NNKSDIWALGCVLYELCTLKHAFEAGS 229
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 69/215 (32%), Positives = 101/215 (46%), Gaps = 35/215 (16%)
Query: 294 NLIGQGASGVVYKGTLEDG----TLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLS 348
+IG+G G VY GTL D AVK + + G+ +F+ E I+ H N+LS
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI---SNALTRKQLAWPQRKKIILDVAKGL 405
L G C+ S+ +V +M G L + I ++ T K L L VAKG+
Sbjct: 91 LLGICLRSEG----SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGM 141
Query: 406 AYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
YL + HRD+ + N +LD + KVADFGLA+ + + + V G
Sbjct: 142 KYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGA 192
Query: 463 L------APEYALYGQLTEKSDVYSFGIVILELMS 491
A E + T KSDV+SFG+++ ELM+
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 293 KNLIGQGASGVVYKGTLEDG----TLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLL 347
+IG+G GVVY G D A+K ++ + E F+ E ++ + H N+L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
+L G + + ++ +M G L I + ++ L VA+G+ Y
Sbjct: 86 ALIGIMLPPEG----LPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEY 139
Query: 408 L---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL- 463
L + HRD+ + N +LD KVADFGLA+ L+ + + + L
Sbjct: 140 LAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREY--YSVQQHRHARLP 191
Query: 464 ----APEYALYGQLTEKSDVYSFGIVILELMS 491
A E + T KSDV+SFG+++ EL++
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD--EEFINEVEIISKIRHRNL 346
F++ IG+G+ G V+KG +VA+K I DL+ D E+ E+ ++S+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIILDVAKGL 405
G + K + +++ +++ GS D + L Q+A I+ ++ KGL
Sbjct: 83 TKYYGSYL-----KDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGL 132
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
YLH HRDIK+ N+LL + K+ADFG+A Q + Q T V GT ++AP
Sbjct: 133 DYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSG 492
E K+D++S GI +EL G
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARG 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-36
Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 296 IGQGASGVVYKGTLEDG---TLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
+G G G V +G VA+K + + EE + E +I+ ++ + ++ L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL--- 408
C + + LV + G L + R+++ +++ V+ G+ YL
Sbjct: 404 VC------QAEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TYGY 462
++ HR++ + N+LL + AK++DFGL+K S+ T R AG
Sbjct: 456 NF------VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY--- 506
Query: 463 LAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
APE + + + +SDV+S+G+ + E +S G+K
Sbjct: 507 -APECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-36
Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+GQG G V+ GT T VA+K + T E F+ E +++ K+RH L+ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---HY 410
+ ++V ++M GSL D + T K L PQ + +A G+AY+ +Y
Sbjct: 249 ------SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ HRD+++ NIL+ + KVADFGLA+ + + + APE ALY
Sbjct: 302 -----V-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 471 GQLTEKSDVYSFGIVILELMS 491
G+ T KSDV+SFGI++ EL +
Sbjct: 356 GRFTIKSDVWSFGILLTELTT 376
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 18/209 (8%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQIT--DLDTKGDEEFINEVEIISKI-RHRN 345
F + + +G G+ G V+K EDG L AVK+ K + EV K+ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
+ L E+G +L + SL H L Q + D L
Sbjct: 119 CVRLEQA-----WEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLAL 170
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
A+LH + H D+K NI L + K+ DFGL + L + G Y+AP
Sbjct: 171 AHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE-LGTAGAGEVQE-GDPRYMAP 225
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGRK 494
E L G +DV+S G+ ILE+ +
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 23/202 (11%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355
+G G G V+ G T VAVK + + + F+ E ++ +++H+ L+ L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---HYGL 412
+ +++ ++M +GSL D + + +L + + +A+G+A++ +Y
Sbjct: 79 -----QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT---YGYLAPEYAL 469
HRD+++ NIL+ + K+ADFGLA+ + + T G + APE
Sbjct: 131 ----IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAIN 183
Query: 470 YGQLTEKSDVYSFGIVILELMS 491
YG T KSDV+SFGI++ E+++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+GQG G V+ GT T VA+K + T E F+ E +++ K+RH L+ L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---HY 410
+ ++V ++M GSL D + T K L PQ + +A G+AY+ +Y
Sbjct: 332 S------EEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ HRD+++ NIL+ + KVADFGLA+ + + + APE ALY
Sbjct: 385 -----V-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 471 GQLTEKSDVYSFGIVILELMS 491
G+ T KSDV+SFGI++ EL +
Sbjct: 439 GRFTIKSDVWSFGILLTELTT 459
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 45/283 (15%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS 348
F +G+G+ G VYK E G +VA+KQ+ +++ +E I E+ I+ + +++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESD-LQEIIKEISIMQQCDSPHVVK 88
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
G K ++V ++ +GS+ D I L K L + I+ KGL YL
Sbjct: 89 YYGSYF-----KNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYL 141
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
H HRDIK+ NILL++E AK+ADFG+A Q + + T + GT ++APE
Sbjct: 142 H---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 469 LYGQLTEKSDVYSFGIVILELMSGR---------KVLETSNSSFLLITDWAWMLANSGKV 519
+D++S GI +E+ G+ + + F++ T+
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMIPTNPPPTFRKPELW 251
Query: 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
+ F +F++ C R T L+
Sbjct: 252 SDNFTDFVK----------------QCLVKSPEQRATATQLLQ 278
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 296 IGQGASGVVYKGTL----EDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
IG G SG V G L + VA+K + + +F++E I+ + H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G +G+ +V ++M +GSL + Q Q ++ V G+ YL
Sbjct: 117 GVVT-----RGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TYG 461
Y + HRD+ + N+L+DS + KV+DFGL++ + T G T
Sbjct: 170 LGY-----V-HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-- 221
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
APE + + SDV+SFG+V+ E+++ G +
Sbjct: 222 --APEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 68/214 (31%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 294 NLIGQGASGVVYKGTLEDG----TLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLS 348
+IG+G G VY GTL D AVK + + G+ +F+ E I+ H N+LS
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI---SNALTRKQLAWPQRKKIILDVAKGL 405
L G C+ S+ +V +M G L + I ++ T K L L VAKG+
Sbjct: 155 LLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGM 205
Query: 406 AYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
+L + HRD+ + N +LD + KVADFGLA+ + + T
Sbjct: 206 KFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAK 257
Query: 463 L-----APEYALYGQLTEKSDVYSFGIVILELMS 491
L A E + T KSDV+SFG+++ ELM+
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 54/262 (20%), Positives = 103/262 (39%), Gaps = 33/262 (12%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIRHRNLL 347
F +G+G GVV++ D A+K+I E+ + EV+ ++K+ H ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 348 SLRGCCVSSDDEKGKRR-------FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD 400
+ + + + ++ +L D ++ T ++ I L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-----------SLEGQ 449
+A+ + +LH + HRD+K +NI + KV DFGL +
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 450 SHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITD 508
T GT Y++PE ++G + K D++S G+++ EL+ T +TD
Sbjct: 184 YARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLYP---FSTQMERVRTLTD 239
Query: 509 WAWMLANSGKVDEIFDEFIREE 530
+ K +F + E
Sbjct: 240 -----VRNLKFPPLFTQKYPCE 256
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 296 IGQGASGVVYKGTL-----EDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
IG G G VYKG L + VA+K + K +F+ E I+ + H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL- 408
G K K ++ ++M +G+L + + + Q ++ +A G+ YL
Sbjct: 112 EGVIS-----KYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 409 --HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TY 460
+Y + HRD+ + NIL++S + KV+DFGL++ + T G T
Sbjct: 165 NMNY-----V-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT- 217
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
APE Y + T SDV+SFGIV+ E+M+ G +
Sbjct: 218 ---APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 64/292 (21%), Positives = 122/292 (41%), Gaps = 56/292 (19%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLL 347
+ +G GA G VYK E G L A K I + ++ + E++I E+EI++ H ++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHPYIV 79
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGD---HISNALTRKQLAWPQRKKIILDVAKG 404
L G + +++ +F P G++ + LT Q+ + + +
Sbjct: 80 KLLGAYY-----HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----VCRQMLEA 129
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
L +LH I HRD+K+ N+L+ E ++ADFG++ ++L+ + + GT ++A
Sbjct: 130 LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMA 185
Query: 465 PEYALYGQLTE-----KSDVYSFGIVILELMSGR---------KVLETSNSSFLLITDWA 510
PE + + + K+D++S GI ++E+ +VL +
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSDP 239
Query: 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
L K F +F++ + RP+ A L+
Sbjct: 240 PTLLTPSKWSVEFRDFLK----------------IALDKNPETRPSAAQLLE 275
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 35/218 (16%)
Query: 293 KNLIGQGASGVVYKGTLEDG-----TLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNL 346
++G G G V+KG V +K I + + + + I + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
+ L G C S LV ++P GSL DH+ R L + +AKG+
Sbjct: 78 VRLLGLCPGS------SLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMY 129
Query: 407 YL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG----- 458
YL HR++ + N+LL S + +VADFG+A L
Sbjct: 130 YLEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADL-LPPDDKQLLYSEAKTPIK 182
Query: 459 -TYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
A E +G+ T +SDV+S+G+ + ELM+ G +
Sbjct: 183 WM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 293 KNLIGQGASGVVYKGTLEDGTL-VAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
K+ +G G G VY+G + +L VAVK + + DT EEF+ E ++ +I+H NL+ L G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL--- 408
C + +++ +FM G+L D++ R++++ + ++ + YL
Sbjct: 77 VCT-----REPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL----- 463
++ I HRD+ + N L+ KVADFGL++ A
Sbjct: 131 NF-----I-HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWT 179
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMS 491
APE Y + + KSDV++FG+++ E+ +
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 293 KNLIGQGASGVVYKGTLEDG----TLVAVKQI-TDLDTKGD-EEFINEVEIISKIRHRNL 346
++G+G G V + L+ VAVK + D+ D EEF+ E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 347 LSLRGCCVSSDDEKGKRR-FLVYDFMPSGSLGDHI--------SNALTRKQLAWPQRKKI 397
L G + S + ++ FM G L + L + L +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV-----RF 142
Query: 398 ILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT 454
++D+A G+ YL ++ I HRD+ + N +L +M VADFGL+++ G +
Sbjct: 143 MVDIACGMEYLSSRNF-----I-HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY--- 193
Query: 455 RVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
G L A E T SDV++FG+ + E+M+
Sbjct: 194 -RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 296 IGQGASGVVYKGTLEDG-----TLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G GA G VYKG VA+K++ K ++E ++E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL- 408
G C++S L+ MP G L D++ + + + +AKG+ YL
Sbjct: 83 LGICLTS------TVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 409 --HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TY 460
HRD+ + N+L+ + K+ DFGLAK L + G
Sbjct: 135 DRRL------VHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHAEGGKVPIKWM- 186
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
A E L+ T +SDV+S+G+ + ELM+ G K
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-35
Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 294 NLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
+ +G G G VY+G + VAVK + + DT EEF+ E ++ +I+H NL+ L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
C + +++ +FM G+L D++ R++++ + ++ + YL
Sbjct: 285 CT-----REPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE--- 335
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ 472
K HR++ + N L+ KVADFGL++ + APE Y +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 473 LTEKSDVYSFGIVILELMS 491
+ KSDV++FG+++ E+ +
Sbjct: 396 FSIKSDVWAFGVLLWEIAT 414
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 32/211 (15%)
Query: 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
IG+G G V G G VAVK I + T + F+ E +++++RH NL+ L G
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---H 409
V ++V ++M GSL D++ + R L K LDV + + YL +
Sbjct: 83 IVEEKGGL----YIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL-----A 464
+ + HRD+ + N+L+ + AKV+DFGL K++ Q G L A
Sbjct: 138 F-----V-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---------TGKLPVKWTA 182
Query: 465 PEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
PE + + KSDV+SFGI++ E+ S GR
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-35
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
IG+G G V G G VAVK I + T + F+ E +++++RH NL+ L G
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL---H 409
V ++V ++M GSL D++ + R L K LDV + + YL +
Sbjct: 255 IVEEKGGL----YIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT---YGYLAPE 466
+ + HRD+ + N+L+ + AKV+DFGL K ++ + APE
Sbjct: 310 F-----V-HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPE 356
Query: 467 YALYGQLTEKSDVYSFGIVILELMS 491
+ + KSDV+SFGI++ E+ S
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 296 IGQGASGVVYKGTL----EDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
+G G G V G L + VA+K + K +F+ E I+ + H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G K K +V ++M +GSL + Q Q ++ +A G+ YL
Sbjct: 113 GVVT-----KSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG------TYG 461
Y HRD+ + NIL++S + KV+DFGL + + T G T
Sbjct: 166 MGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-- 217
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
+PE Y + T SDV+S+GIV+ E+MS G +
Sbjct: 218 --SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G G G V+ T T VAVK + + E F+ E ++ ++H L+ L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
+ +++ +FM GSL D + + + P+ +A+G+A++ +
Sbjct: 253 T------KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI--EQR 303
Query: 414 PAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGT---YGYLAPEYALY 470
I HRD+++ NIL+ + + K+ADFGLA+ + + T G + APE +
Sbjct: 304 NYI-HRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINF 359
Query: 471 GQLTEKSDVYSFGIVILELMS 491
G T KSDV+SFGI+++E+++
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQIT---DLDTKGDEEFINEVEIISKIRHRN 345
F + IG+G VY+ L DG VA+K++ +D K + I E++++ ++ H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK--KIILDVAK 403
++ + + +V + +G L I + +K+L P+R K + +
Sbjct: 94 VIKYYASFIEDN-----ELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCS 147
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
L ++H + HRDIK N+ + + K+ D GL + ++ + GT Y+
Sbjct: 148 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYM 203
Query: 464 APE------YALYGQLTEKSDVYSFGIVILELMSGR 493
+PE Y KSD++S G ++ E+ + +
Sbjct: 204 SPERIHENGY------NFKSDIWSLGCLLYEMAALQ 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 296 IGQGASGVVYKGTL----EDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
+G+G G VY+G + VAVK D E+F++E I+ + H +++ L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G + + +++ + P G LG ++ + L L + K +AYL
Sbjct: 80 GII------EEEPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES 131
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL---- 463
+ HRDI NIL+ S K+ DFGL++ + + + L
Sbjct: 132 INC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASV--TRLPIKW 180
Query: 464 -APEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
+PE + + T SDV+ F + + E++S G++
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 41/222 (18%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G+GA G V+ +D LVAVK + + ++F E E+++ ++H++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSL------------GDHISNALTRKQLAWPQRKKI 397
G C +G+ +V+++M G L + L Q +
Sbjct: 109 FGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 398 ILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT 454
VA G+ YL H+ HRD+ + N L+ + K+ DFG+++
Sbjct: 164 ASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YY 214
Query: 455 RVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
RV G L PE LY + T +SDV+SFG+V+ E+ +
Sbjct: 215 RV-GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLL 347
F L+G G G VYKG ++ G L A+K + D+ +EE E+ ++ K HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 348 SLRGCCVSSDDEKGKRR-FLVYDFMPSGSLGD----HISNALTRKQLAWPQRKKIILDVA 402
+ G + + + +LV +F +GS+ D N L + +A+ I ++
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREIL 139
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
+GL++LH + + HRDIK N+LL + K+ DFG++ Q T GT +
Sbjct: 140 RGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYW 195
Query: 463 LAPEYALYGQLTE-----KSDVYSFGIVILELMSG 492
+APE + + KSD++S GI +E+ G
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 293 KNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL 346
K +G+GA G V+ +D LVAVK + D ++F E E+++ ++H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSL-------------GDHISNALTRKQLAWPQ 393
+ G C G +V+++M G L + +L Q
Sbjct: 80 VKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 394 RKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450
I +A G+ YL H+ + HRD+ + N L+ + + K+ DFG+++
Sbjct: 135 MLHIASQIASGMVYLASQHF-----V-HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 451 HLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
+ G + L PE +Y + T +SDV+SFG+++ E+ +
Sbjct: 189 Y----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 39/220 (17%)
Query: 296 IGQGASGVVYKGTL--------EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL 347
+GQG ++KG T V +K + E F ++SK+ H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
G CV G LV +F+ GSL ++ + + + ++ +A + +
Sbjct: 76 LNYGVCV-----CGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHF 128
Query: 408 L---HYGLKPAIYHRDIKSTNILLDSEMK--------AKVADFGLAKQSLEGQSHLTTRV 456
L I H ++ + NILL E K++D G++ ++ + L R+
Sbjct: 129 LEENTL-----I-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-TVLPKDILQERI 181
Query: 457 AGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMS-GRK 494
PE + +D +SFG + E+ S G K
Sbjct: 182 PWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLL 347
+ +++GQGA+ V++G + G L A+K ++ + E E++ K+ H+N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
L ++ + + L+ +F P GSL + L + ++ DV G+ +
Sbjct: 71 KLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 408 LHYGLKPAIYHRDIKSTNILL----DSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
L + I HR+IK NI+ D + K+ DFG A++ LE + GT YL
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYL 182
Query: 464 APE--------YALYGQLTEKSDVYSFGIVILELMSGR 493
P+ + D++S G+ +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 22/210 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS 348
+ + +G+G+ G V++ + G AVK++ L+ EE + + + ++
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEE----LVACAGLSSPRIVP 114
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
L G +G + + + GSLG I L + + +GL YL
Sbjct: 115 LYGAVR-----EGPWVNIFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYL 166
Query: 409 HYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQSLEGQSHLTTR----VAGTYGYL 463
H I H D+K+ N+LL S+ +A + DFG A + + GT ++
Sbjct: 167 H---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
APE + K D++S ++L +++G
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 33/213 (15%)
Query: 296 IGQGASGVVYKGTLEDG----TLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
IG+G G V++G VA+K E+F+ E + + H +++ L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G +++ + G L + + L ++ LAYL
Sbjct: 83 GVI------TENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES 134
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL---- 463
+ HRDI + N+L+ S K+ DFGL++ + + + G L
Sbjct: 135 KRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASK--GKLPIKW 183
Query: 464 -APEYALYGQLTEKSDVYSFGIVILELMS-GRK 494
APE + + T SDV+ FG+ + E++ G K
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 37/218 (16%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLS 348
+G GA G VY+G + VAVK + ++ ++ DE +F+ E IISK H+N++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGD----HISNALTRKQLAWPQRKKIILDVAKG 404
G + + RF++ + M G L LA + D+A G
Sbjct: 98 CIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 405 LAYL---HYGLKPAIYHRDIKSTNILLDSE---MKAKVADFGLAKQSLEGQSHLTTRVAG 458
YL H+ I HRDI + N LL AK+ DFG+A+ R G
Sbjct: 153 CQYLEENHF-----I-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYRK-G 202
Query: 459 TYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
L PE + G T K+D +SFG+++ E+ S
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-33
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLS 348
F K+++G GA G + + D VAVK+I + EV+++ + H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLA 406
C D + +++ + +L +++ +K A ++ GLA
Sbjct: 83 YF--CTEKDRQF---QYIAIELCA-ATLQEYV----EQKDFAHLGLEPITLLQQTTSGLA 132
Query: 407 YLHYGLKPAIYHRDIKSTNILL-----DSEMKAKVADFGLAKQSLEGQSHLTTR--VAGT 459
+LH L I HRD+K NIL+ ++KA ++DFGL K+ G+ + R V GT
Sbjct: 133 HLH-SLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 460 YGYLAPEY---ALYGQLTEKSDVYSFGIVILELMSG 492
G++APE T D++S G V ++S
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 76/303 (25%), Positives = 127/303 (41%), Gaps = 62/303 (20%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD--EEFINEVEIISKIRHRNL 346
+ + +IG GA+ VV VA+K+I +L+ +E + E++ +S+ H N+
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSL----------GDHISNALTRKQLAWPQRKK 396
+S V +LV + GS+ G+H S L +A
Sbjct: 76 VSYYTSFV-----VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT----- 125
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR- 455
I+ +V +GL YLH K HRD+K+ NILL + ++ADFG++ G +
Sbjct: 126 ILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 456 ---VAGTYGYLAPE----YALYGQLTEKSDVYSFGIVILELMSGR---------KVLETS 499
GT ++APE Y K+D++SFGI +EL +G KVL
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYD---FKADIWSFGITAIELATGAAPYHKYPPMKVL--- 236
Query: 500 NSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIAD 559
L + + L + E+ ++ ++ + + LC RPT A+
Sbjct: 237 ---MLTLQNDPPSLETGVQDKEMLKKY-----GKSFRK-MIS---LCLQKDPEKRPTAAE 284
Query: 560 ALK 562
L+
Sbjct: 285 LLR 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLS 348
+GQG+ G+VY+G E T VA+K + + + + EF+NE ++ + +++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSL-------GDHISNALTRKQLAWPQRKKIILDV 401
L G +G+ ++ + M G L ++N + + ++ ++
Sbjct: 93 LLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 402 AKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
A G+AYL + HRD+ + N ++ + K+ DFG+ + E + G
Sbjct: 148 ADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKG 197
Query: 459 TYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
G L +PE G T SDV+SFG+V+ E+ +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLL 347
+ +++GQGA+ V++G + G L A+K ++ + E E++ K+ H+N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
L ++ + + L+ +F P GSL + L + ++ DV G+ +
Sbjct: 71 KLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 408 LHYGLKPAIYHRDIKSTNILL----DSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
L + I HR+IK NI+ D + K+ DFG A++ LE + GT YL
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYL 182
Query: 464 APE--------YALYGQLTEKSDVYSFGIVILELMSGR 493
P+ + D++S G+ +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 52/227 (22%), Positives = 98/227 (43%), Gaps = 43/227 (18%)
Query: 293 KNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRN 345
+G+ G VYKG L E VA+K + D EEF +E + ++++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL-------------GDHISNALTRKQLAWP 392
++ L G K + +++ + G L G + + L P
Sbjct: 74 VVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 393 QRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449
++ +A G+ YL H + H+D+ + N+L+ ++ K++D GL ++ +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHV-----V-HKDLATRNVLVYDKLNVKISDLGLFRE-VYAA 181
Query: 450 SHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
+ L APE +YG+ + SD++S+G+V+ E+ S
Sbjct: 182 DYYK---LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 46/223 (20%), Positives = 93/223 (41%), Gaps = 35/223 (15%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNL- 346
+S IG G S V++ E + A+K + + D + + + NE+ ++K++ +
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 347 -LSLRGCCVSSDDEKGKRRFLVYDFM--PSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403
+ L ++ +Y M + L + +K + +RK ++ +
Sbjct: 90 IIRLYDYEITDQY--------IYMVMECGNIDLNSWLKK---KKSIDPWERKSYWKNMLE 138
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK--QSLEGQSHLTTRVAGTYG 461
+ +H + I H D+K N L+ + K+ DFG+A Q ++V GT
Sbjct: 139 AVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVN 193
Query: 462 YLAPE-----------YALYGQLTEKSDVYSFGIVILELMSGR 493
Y+ PE +++ KSDV+S G ++ + G+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 48/225 (21%), Positives = 82/225 (36%), Gaps = 38/225 (16%)
Query: 290 FSQKNLIGQGAS--GVVYKGT-LEDGTLVAVKQITDLDTKGDEEF---INEVEIISKIRH 343
+ +IG+G V G V V++I +L+ +E E+ + H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNH 85
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGD----HISNALTRKQLAWPQRKKIIL 399
N++ R + ++V FM GS D H + + +A+ I+
Sbjct: 86 PNIVPYRATFI-----ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-----ILQ 135
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR---- 455
V K L Y+H HR +K+++IL+ + K ++ +
Sbjct: 136 GVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 456 --VAGTYGYLAPE-----YALYGQLTEKSDVYSFGIVILELMSGR 493
+L+PE Y KSD+YS GI EL +G
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYD---AKSDIYSVGITACELANGH 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 46/223 (20%), Positives = 93/223 (41%), Gaps = 35/223 (15%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNL- 346
+S IG G S V++ E + A+K + + D + + + NE+ ++K++ +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 347 -LSLRGCCVSSDDEKGKRRFLVYDFM--PSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403
+ L ++ +Y M + L + +K + +RK ++ +
Sbjct: 71 IIRLYDYEITDQY--------IYMVMECGNIDLNSWLKK---KKSIDPWERKSYWKNMLE 119
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK--QSLEGQSHLTTRVAGTYG 461
+ +H + I H D+K N L+ + K+ DFG+A Q ++V GT
Sbjct: 120 AVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVN 174
Query: 462 YLAPE-----------YALYGQLTEKSDVYSFGIVILELMSGR 493
Y+ PE +++ KSDV+S G ++ + G+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGC 352
++ +G VY+ + G A+K++ + + + I EV + K+ H N++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 353 CVSSDDEKGKRRFLVYDFM--PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
+E + G L + + +R L+ KI + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLA------------KQSLEGQSHLTTRVAG 458
KP I HRD+K N+LL ++ K+ DFG A Q TR
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN-T 212
Query: 459 TYGYLAPE-YALYGQL--TEKSDVYSFGIVILELMSGR 493
T Y PE LY EK D+++ G ++ L +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 37/218 (16%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGDE-EFINEVEIISKIRHRNLLS 348
+G GA G VY+G + VAVK + ++ ++ DE +F+ E IISK H+N++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGD----HISNALTRKQLAWPQRKKIILDVAKG 404
G + + RF++ + M G L LA + D+A G
Sbjct: 139 CIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 405 LAYL---HYGLKPAIYHRDIKSTNILLDSE---MKAKVADFGLAKQSLEGQSHLTTRVAG 458
YL H+ I HRDI + N LL AK+ DFG+A+ R G
Sbjct: 194 CQYLEENHF-----I-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---YYRK-G 243
Query: 459 TYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
L PE + G T K+D +SFG+++ E+ S
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 295 LIGQGASGVVYKGTLEDGTL---VAVKQITDLDTKGDEEFI----NEVEIISKIRHRNLL 347
+G G VY D L VA+K + + EE + EV S++ H+N++
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
S + DE+ +LV +++ +L ++I + L+ + G+ +
Sbjct: 75 S-----MIDVDEEDDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKH 126
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
H I HRDIK NIL+DS K+ DFG+AK E T V GT Y +PE
Sbjct: 127 AH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 468 ALYGQLTEKSDVYSFGIVILELMSGR 493
A E +D+YS GIV+ E++ G
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEE----FINEVEIISKIRHR 344
FS IG G+ G VY + + +VA+K++ K E I EV + K+RH
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
N + RGC + + +LV ++ GS D + + +K L + + +G
Sbjct: 115 NTIQYRGCYL-----REHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAVTHGALQG 166
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR--VAGTYGY 462
LAYLH + HRD+K+ NILL K+ DFG A + GT +
Sbjct: 167 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-------MAPANSFVGTPYW 216
Query: 463 LAPEYALYGQLTE---KSDVYSFGIVILELMSG 492
+APE L + K DV+S GI +EL
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 44/225 (19%)
Query: 293 KNLIGQGASGVVYKGTLEDG---TLVAVKQITDLDTKGD-EEFINEVEIISKI-RHRNLL 347
+++IG+G G V K ++ A+K++ + +K D +F E+E++ K+ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSL-------------GDHISNALTRKQLAWPQR 394
+L G C E +L ++ P G+L T L+ Q
Sbjct: 90 NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 395 KKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451
DVA+G+ YL + I HRD+ + NIL+ AK+ADFGL++
Sbjct: 145 LHFAADVARGMDYLSQKQF-----I-HRDLAARNILVGENYVAKIADFGLSRGQEV---- 194
Query: 452 LTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
V T G L A E Y T SDV+S+G+++ E++S
Sbjct: 195 ---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 45/223 (20%), Positives = 91/223 (40%), Gaps = 37/223 (16%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQI----------------TDLDTKGDEEFI-NEVEII 338
+ QG + +D A+K+ + K + NE++II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 339 SKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS-----NALTRKQLAWPQ 393
+ I++ L+ G + ++ +++Y++M + S+ + +
Sbjct: 98 TDIKNEYCLTCEG--IITNY---DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 394 RKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLT 453
K II V +Y+H I HRD+K +NIL+D + K++DFG ++ ++ +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIK 208
Query: 454 TRVAGTYGYLAPEYALYGQLT---EKSDVYSFGIVILELMSGR 493
GTY ++ PE + + K D++S GI + +
Sbjct: 209 G-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 11/215 (5%)
Query: 285 QATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIR 342
Q G + K +G G G V + + G VA+KQ +L K E + E++I+ K+
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 343 HRNLLSLRGCCVSSDD-EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDV 401
H N++S R L ++ G L +++ L + ++ D+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSE---MKAKVADFGLAKQSLEGQSHLTTRVAG 458
+ L YLH + I HRD+K NI+L + K+ D G AK+ L+ T V G
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEFV-G 185
Query: 459 TYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
T YLAPE + T D +SFG + E ++G
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 295 LIGQGASGVVYKGTLEDGTL---VAVKQITDLDTKGDEEFI----NEVEIISKIRHRNLL 347
++G G V+ D VAVK + D D F E + + + H ++
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 348 SL--RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
++ G ++ G ++V +++ +L D + T + + ++I D + L
Sbjct: 76 AVYDTG---EAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQAL 129
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT--RVAGTYGYL 463
+ H + I HRD+K NI++ + KV DFG+A+ + + +T V GT YL
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
+PE A + +SDVYS G V+ E+++G
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 45/223 (20%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNL- 346
+S IG G S V++ E + A+K + + D + + + NE+ ++K++ +
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 347 -LSLRGCCVSSDDEKGKRRFLVYDFM--PSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403
+ L ++ +Y M + L + +K + +RK ++ +
Sbjct: 118 IIRLYDYEITDQY--------IYMVMECGNIDLNSWLKK---KKSIDPWERKSYWKNMLE 166
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK--QSLEGQSHLTTRVAGTYG 461
+ +H + I H D+K N L+ + K+ DFG+A Q ++V G
Sbjct: 167 AVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GAVN 221
Query: 462 YLAPE-----------YALYGQLTEKSDVYSFGIVILELMSGR 493
Y+ PE +++ KSDV+S G ++ + G+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 53/230 (23%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKI-RHRNLL 347
+G+GA G V + VAVK + + T + ++E++I+ I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSL------------------GDHISNALTRKQL 389
+L G C + G ++ +F G+L D + LT + L
Sbjct: 95 NLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 390 AWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446
VAKG+ +L I HRD+ + NILL + K+ DFGLA+
Sbjct: 151 I-----CYSFQVAKGMEFLASRKC-----I-HRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 447 EGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
+ + V L APE T +SDV+SFG+++ E+ S
Sbjct: 200 KDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 52/304 (17%), Positives = 104/304 (34%), Gaps = 68/304 (22%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQIT--DLDTKGDEEFINEVEIISKI-RHRN 345
F + IG G G V+K DG + A+K+ + ++ + EV + + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS-NALTRKQLAWPQRKKIILDVAKG 404
++ + + ++ GSL D IS N + K ++L V +G
Sbjct: 73 VVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLD-------------------SEMKAKVADFGLAKQS 445
L Y+H ++ H DIK +NI + +++ K+ D G +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 446 LEGQSHLTTRVAGTYGYLAPE-------YALYGQLTEKSDVYSFGIVILELMSGRKVLET 498
Q G +LA E + K+D+++ + ++ +
Sbjct: 185 SSPQV-----EEGDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPLPRN 233
Query: 499 SNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIA 558
+ W G++ I +E ++ + H RP+
Sbjct: 234 GDQ---------WHEIRQGRLPRIPQVLSQE------FTELLK---VMIHPDPERRPSAM 275
Query: 559 DALK 562
+K
Sbjct: 276 ALVK 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 34/277 (12%), Positives = 66/277 (23%), Gaps = 42/277 (15%)
Query: 249 YKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT 308
Y + + V + +V P + S L Q + G VV+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVR 82
Query: 309 -LEDGTLVAVKQIT---DLDTKGDEEFINEVEIISKIRHRNLLSLRGCC----------- 353
+E A+K T + E +++ + R
Sbjct: 83 DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142
Query: 354 ----------VSSDDEKGKRRFLVYDFMPSGSLGDHIS----NALTRKQLAWPQRKKIIL 399
DD L+ S L S + R +
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 400 DVAKGLAYLH-YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
+ + A L G + H N+ + + + + D + +
Sbjct: 202 QLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWK----VGTRGPASSV 253
Query: 459 TYGYLAPEYAL--YGQLTEKSDVYSFGIVILELMSGR 493
Y E+ T + + G+ I +
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 46/230 (20%)
Query: 293 KNLIGQGASGVVYKGTL--------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKI-R 342
+G+GA G V ++ VAVK + D T+ D + ++E+E++ I +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL-------------GDHISNALTRKQL 389
H+N+++L G C + +++ ++ G+L + N + +Q+
Sbjct: 100 HKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 390 AWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446
+ +A+G+ YL I HRD+ + N+L+ K+ADFGLA+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC-----I-HRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 447 EGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
+ T G L APE T +SDV+SFG+++ E+ +
Sbjct: 209 NIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 294 NLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFIN-EVEIISKIRHRNLLSL 349
+G+G G VY + ++A+K + L+ G E + EVEI S +RH N+L L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G D R +L+ ++ P G++ + + + I ++A L+Y H
Sbjct: 75 YG--YFHDA---TRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH 126
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ HRDIK N+LL S + K+ADFG + + GT YL PE
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDL--CGTLDYLPPEMIE 180
Query: 470 YGQLTEKSDVYSFGIVILELMSGR 493
EK D++S G++ E + G+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 296 IGQGASGVVYKGTL-EDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G G GVV+K + G ++A K I ++ + I E++++ + ++ G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGD--HISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
S + + + M GSL + + + L K+ + V KGL YL
Sbjct: 101 YSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREK 150
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
K I HRD+K +NIL++S + K+ DFG++ Q ++ ++ + V GT Y++PE
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQGT 205
Query: 472 QLTEKSDVYSFGIVILELMSGR 493
+ +SD++S G+ ++E+ GR
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGR 227
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 51/232 (21%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLS 348
+G+G G V K T T VAVK + + + + + ++E ++ ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSL---------------------GDHISNALTRK 387
L G C + L+ ++ GSL + +
Sbjct: 91 LYGACS-----QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 388 QLAWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444
L +++G+ YL + HRD+ + NIL+ K K++DFGL++
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKL-----V-HRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 445 SLEGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
E S+ V + G + A E T +SDV+SFG+++ E+++
Sbjct: 200 VYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 62/290 (21%), Positives = 117/290 (40%), Gaps = 71/290 (24%)
Query: 243 IMYRKWYKKRKRNALHEEFVRSFKDSVLPNSGA-------KW--FRESELDQATGGFSQK 293
+ Y+ YK++ + + + + S++ + KW R +
Sbjct: 2 VDYK--YKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNN--------LQFG 51
Query: 294 NLIGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKI-RHRN 345
+G GA G V + T + VAVK + + E ++E++I+S + +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL----------------GDHISNALTRKQL 389
+++L G C G ++ ++ G L ++ + + L
Sbjct: 112 IVNLLGACT-----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 390 AWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446
VA+G+A+L + I HRD+ + N+LL + AK+ DFGLA+ +
Sbjct: 167 L-----HFSSQVAQGMAFLASKNC-----I-HRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 447 EGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
++ + L APE T +SDV+S+GI++ E+ S
Sbjct: 216 NDSNY----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 51/235 (21%)
Query: 293 KNLIGQGASGVVYKGTLEDG------TLVAVKQITDLDTKGD-EEFINEVEIISKIRHRN 345
IG+GA G V++ T+VAVK + + + +F E ++++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL---------------------GDHISNAL 384
++ L G C GK L++++M G L ++
Sbjct: 112 IVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 385 TRKQLAWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441
L+ ++ I VA G+AYL + + HRD+ + N L+ M K+ADFGL
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKF-----V-HRDLATRNCLVGENMVVKIADFGL 220
Query: 442 AKQSLEGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
++ + A + PE Y + T +SDV+++G+V+ E+ S
Sbjct: 221 SRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-30
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 32/209 (15%)
Query: 296 IGQGASGVVYKGTLEDG----TLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
IG+G G V++G VA+K E+F+ E + + H +++ L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL-- 408
G +++ + G L + + L ++ LAYL
Sbjct: 458 GVI------TENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLES 509
Query: 409 -HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL---- 463
+ HRDI + N+L+ S K+ DFGL++ +E ++ + G L
Sbjct: 510 KRF------VHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTY----YKASKGKLPIKW 558
Query: 464 -APEYALYGQLTEKSDVYSFGIVILELMS 491
APE + + T SDV+ FG+ + E++
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 54/230 (23%), Positives = 100/230 (43%), Gaps = 46/230 (20%)
Query: 293 KNLIGQGASGVVYKGTL--------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKI-R 342
+G+G G V ++ VAVK + D T+ D + ++E+E++ I +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL-------------GDHISNALTRKQL 389
H+N+++L G C + +++ ++ G+L + N + +Q+
Sbjct: 146 HKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 390 AWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446
+ +A+G+ YL I HRD+ + N+L+ K+ADFGLA+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC-----I-HRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 447 EGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
+ T G L APE T +SDV+SFG+++ E+ +
Sbjct: 255 NIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 29/210 (13%)
Query: 295 LIGQGASGVVYKGTLEDGTL---VAVKQITDLDTKGDEEFI----NEVEIISKIRHRNLL 347
L+G+G G VY+ ED VA+K + D F E +++ +++
Sbjct: 41 LVGRGGMGDVYEA--EDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 348 SL--RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
+ G E + ++ + L + + LA P+ I+ + L
Sbjct: 98 PIHDFG-------EIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSAL 147
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT--RVAGTYGYL 463
H HRD+K NIL+ ++ A + DFG+A + LT GT Y+
Sbjct: 148 DAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYM 202
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGR 493
APE T ++D+Y+ V+ E ++G
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGS 232
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 56/232 (24%)
Query: 296 IGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKI-RHRNLL 347
+G GA G V + T + VAVK + + E ++E++++S + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSL--------------------GDHISNALTRK 387
+L G C G ++ ++ G L + AL +
Sbjct: 91 NLLGACT-----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 388 QLAWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444
L VAKG+A+L + I HRD+ + NILL K+ DFGLA+
Sbjct: 146 DLL-----SFSYQVAKGMAFLASKNC-----I-HRDLAARNILLTHGRITKICDFGLARD 194
Query: 445 SLEGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
++ V L APE T +SDV+S+GI + EL S
Sbjct: 195 IKNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 46/230 (20%)
Query: 293 KNLIGQGASGVVYKGTL--------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKI-R 342
+G+GA G V T VAVK + T+ D + I+E+E++ I +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL-------------GDHISNALTRKQL 389
H+N+++L G C + +++ ++ G+L + + +QL
Sbjct: 134 HKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 390 AWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446
+ VA+G+ YL I HRD+ + N+L+ + K+ADFGLA+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKC-----I-HRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 447 EGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
+ T G L APE T +SDV+SFG+++ E+ +
Sbjct: 243 HIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDE--EFINEVEII-SKIRHRNLLSLRG 351
IG+GA G V K G ++AVK+I E + + +++++ ++ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLAYLH 409
D ++ + M S S + P+ KI L K L +L
Sbjct: 89 ALFREGD-----CWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE--- 466
LK I HRDIK +NILLD K+ DFG++ Q L S TR AG Y+APE
Sbjct: 143 ENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ-LV-DSIAKTRDAGCRPYMAPERID 198
Query: 467 -YALYGQLTEKSDVYSFGIVILELMSGR 493
A +SDV+S GI + EL +GR
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 295 LIGQGASGVVYKG-TLEDGTLVAVKQI--TDLDTKGDEEFIN-EVEIISKIRHRNLLSLR 350
+G+G G VY ++ ++A+K + + L+ +G E + E+EI S +RH N+L +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
D KR +L+ +F P G L + + + + ++A L Y H
Sbjct: 81 N--YFHDR---KRIYLMLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCH- 131
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ + HRDIK N+L+ + + K+ADFG + + S + GT YL PE
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLDYLPPEMIEG 186
Query: 471 GQLTEKSDVYSFGIVILELMSGR 493
EK D++ G++ E + G
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEE-FINEVEIISKIRHRNLLSLR 350
L+G+G+ VY+ + G VA+K I + G + NEV+I +++H ++L L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
S +LV + +G + ++ N K + + + + + G+ YLH
Sbjct: 78 NYFEDS-----NYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLH- 129
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA-- 468
I HRD+ +N+LL M K+ADFGLA Q T + GT Y++PE A
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATR 186
Query: 469 -LYGQLTEKSDVYSFGIVILELMSGR 493
+G +SDV+S G + L+ GR
Sbjct: 187 SAHG---LESDVWSLGCMFYTLLIGR 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 55/307 (17%), Positives = 106/307 (34%), Gaps = 78/307 (25%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLL 347
F +G+G GVV++ D A+K+I + + E + EV+ ++K+ H ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 348 SLRGCCVSSDDEKGKRR------------------------------------------- 364
+ + EK +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 365 ---------FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415
++ +L D ++ + + I + +A+ + +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKG 184
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAK------------QSLEGQSHLTTRVAGTYGYL 463
+ HRD+K +NI + KV DFGL + + T +V GT Y+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GTKLYM 243
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523
+PE + K D++S G+++ EL+ T +ITD + K +F
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITD-----VRNLKFPLLF 295
Query: 524 DEFIREE 530
+ +E
Sbjct: 296 TQKYPQE 302
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 56/240 (23%), Positives = 97/240 (40%), Gaps = 61/240 (25%)
Query: 293 KNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDTKGD-EEFINEVEIISKI-RHR 344
++G GA G V T VAVK + + + E ++E+++++++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSL-------------------------GDH 379
N+++L G C +L++++ G L +
Sbjct: 110 NIVNLLGACT-----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 380 ISNALTRKQLAWPQRKKIILDVAKGLAYL---HYGLKPAIYHRDIKSTNILLDSEMKAKV 436
N LT + L VAKG+ +L + HRD+ + N+L+ K+
Sbjct: 165 DLNVLTFEDLL-----CFAYQVAKGMEFLEFKSC-----V-HRDLAARNVLVTHGKVVKI 213
Query: 437 ADFGLAKQSLEGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
DFGLA+ + ++ V L APE G T KSDV+S+GI++ E+ S
Sbjct: 214 CDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 42/232 (18%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKI-RHRNLL 347
+ ++G G+SG V G VAVK++ + E++++++ H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLLTESDDHPNVI 72
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI----SNALTRKQLAWPQRKKIILDVAK 403
C + D ++ + +L D + + K ++ +A
Sbjct: 73 RYY--CSETTDRF---LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSE-------------MKAKVADFGLAKQSLEGQS 450
G+A+LH LK I HRD+K NIL+ + ++ ++DFGL K+ GQS
Sbjct: 127 GVAHLH-SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 451 HLTTR---VAGTYGYLAPE-------YALYGQLTEKSDVYSFGIVILELMSG 492
T +GT G+ APE +LT D++S G V ++S
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEE-FINEVEIISKIRHRNLLSLR 350
+G+G ++ + + + A K + + L E E+ I + H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
G +D F+V + SL + RK L P+ + + + G YLH
Sbjct: 108 GFFEDND-----FVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH- 158
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ + HRD+K N+ L+ +++ K+ DFGLA + + GT Y+APE L
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLS 214
Query: 471 GQL-TEKSDVYSFGIVILELMSGR 493
+ + + DV+S G ++ L+ G+
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-29
Identities = 65/246 (26%), Positives = 104/246 (42%), Gaps = 24/246 (9%)
Query: 258 HEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQK----NLIGQGASGVVYKGT-LEDG 312
H S ++++ + + G S+ +G GA G V
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62
Query: 313 TLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDF 370
A+K I T + T + + + EV ++ + H N++ L E + +LV +
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMEC 117
Query: 371 MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS 430
G L D I + R + II V G+ YLH K I HRD+K N+LL+S
Sbjct: 118 YKGGELFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLES 171
Query: 431 EMKA---KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVIL 487
+ K K+ DFGL+ + GT Y+APE L + EK DV+S G+++
Sbjct: 172 KEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILF 228
Query: 488 ELMSGR 493
L++G
Sbjct: 229 ILLAGY 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEE-FINEVEIISKIRHRNLLSLR 350
+G+G ++ + + + A K + + L E E+ I + H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
G +D F+V + SL + RK L P+ + + + G YLH
Sbjct: 82 GFFEDNDF-----VFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH- 132
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ + HRD+K N+ L+ +++ K+ DFGLA + + GT Y+APE L
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLS 188
Query: 471 GQL-TEKSDVYSFGIVILELMSGR 493
+ + + DV+S G ++ L+ G+
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 34/225 (15%), Positives = 68/225 (30%), Gaps = 30/225 (13%)
Query: 290 FSQKNLIGQGASGVVYKGT------LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRH 343
+L+G+GA VY+ T ++ +K + +E +
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS--NALTRKQLAWPQRKKIILDV 401
+ + + LV + G+L + I+ K + + +
Sbjct: 127 HMFMKFYSAHLFQN-----GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILL-----------DSEMKAKVADFGLAKQ-SLEGQ 449
+ +H I H DIK N +L D + D G + L +
Sbjct: 182 LYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 450 SHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGR 493
+ T T G+ E L + + D + + ++ G
Sbjct: 239 GTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQIT-DLDTKGDEEFINEVEII-SKIRHRNLLSLRGC 352
+G+GA GVV K + G ++AVK+I ++++ + + +++I + ++ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR--KKIILDVAKGLAYLHY 410
D ++ + M SL D + K P+ KI + + K L +LH
Sbjct: 75 LFREGD-----VWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE---- 466
L + HRD+K +N+L+++ + K+ DFG++ L AG Y+APE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGY-LV-DDVAKDIDAGCKPYMAPERINP 183
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGR 493
+ KSD++S GI ++EL R
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDE--EFINEVEIISK-IRHRNLLSLRG 351
+G G G V+K + G ++AVKQ+ +E + +++++ K ++ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGD--HISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+++ D F+ + M + + + + + L K+ + + K L YL
Sbjct: 92 TFITNTD-----VFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLK 141
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE--- 466
+ HRD+K +NILLD + K+ DFG++ + L R AG Y+APE
Sbjct: 142 EKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR-LV-DDKAKDRSAGCAAYMAPERID 197
Query: 467 --YALYGQLTEKSDVYSFGIVILELMSGR 493
++DV+S GI ++EL +G+
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 43/263 (16%), Positives = 76/263 (28%), Gaps = 40/263 (15%)
Query: 266 KDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLD 324
S+ ESEL + + ++GQ + T E G V +
Sbjct: 57 STSLWNTGQPFRV-ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE 115
Query: 325 TKGD---EEFINEVEIISKIRH----------------RNLLSLRGCCVSSDDEKGKRRF 365
++ EV + +R +L+ +R
Sbjct: 116 RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDM 175
Query: 366 LV---YDFMP--SGSLGDHISNALTRKQ----LAWPQRKKIILDVAKGLAYLH-YGLKPA 415
V + P +L L+ L R ++ L V + LA LH YG
Sbjct: 176 WVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---- 231
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ--- 472
+ H ++ +I+LD + F + R A +GQ
Sbjct: 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHP 291
Query: 473 --LTEKSDVYSFGIVILELMSGR 493
+T D ++ G+ I +
Sbjct: 292 TLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 48/270 (17%), Positives = 92/270 (34%), Gaps = 56/270 (20%)
Query: 268 SVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTK 326
+ L N+G + ESEL + + ++GQ + T E G V +
Sbjct: 53 TSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP 112
Query: 327 GDEE----------------------------FINEVEIISKIRHRNLLSLRGCCVSSDD 358
FI +++ + + ++ +R D
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL---DERD 169
Query: 359 EKGKRRFLVYDFMPS--GSLGDHISNALT-RKQLAWPQRKKIILDVAKGLAYLH-YGLKP 414
RF +Y M S + G+ + + + K L R ++ L V + LA LH YG
Sbjct: 170 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226
Query: 415 AIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY---- 470
+ H ++ +I+LD + F + +G +++ + G+ PE
Sbjct: 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVSS---VSRGFEPPELEARRATI 280
Query: 471 -------GQLTEKSDVYSFGIVILELMSGR 493
+T D ++ G+VI +
Sbjct: 281 SYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFI-NEVEIISKIRHRNLLS 348
+ ++G+G+ G V G AVK I + K D+E + EV+++ ++ H N++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
L E +LV + G L D I ++RK+ + +II V G+ Y+
Sbjct: 91 LYEFF-----EDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYM 142
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKA---KVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
H K I HRD+K N+LL+S+ K ++ DFGL+ + GT Y+AP
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAP 197
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGR 493
E L+G EK DV+S G+++ L+SG
Sbjct: 198 E-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 71/213 (33%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 290 FSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFIN-EVEIISKIRHRNLL 347
++ +IG G+ GVVY+ L + G LVA+K++ D+ F N E++I+ K+ H N++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 348 SLRGCCVSSDDEKGKRR-FLVYDFMPSGSLGDHISNALTRKQ-LAWPQRKKIILDVAKGL 405
LR SS ++K + LV D++P ++ + KQ L K + + + L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKA-KVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
AY+H I HRDIK N+LLD + K+ DFG AKQ + G+ + + Y Y A
Sbjct: 170 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRA 224
Query: 465 PEYAL----YGQLTEKSDVYSFGIVILELMSGR 493
PE Y T DV+S G V+ EL+ G+
Sbjct: 225 PELIFGATDY---TSSIDVWSAGCVLAELLLGQ 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 58/261 (22%), Positives = 96/261 (36%), Gaps = 33/261 (12%)
Query: 251 KRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQK----NLIGQGASGVVYK 306
K KR L+ + S + + +G GA G V
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 307 GT-LEDGTLVAVKQI--------TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357
+ VA++ I + + E+EI+ K+ H ++ ++ + D
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213
Query: 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIY 417
++V + M G L D + + K+L K + + YLH + I
Sbjct: 214 ------YYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLH---ENGII 261
Query: 418 HRDIKSTNILLDS---EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE---YALYG 471
HRD+K N+LL S + K+ DFG +K E + T GT YLAPE
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLC-GTPTYLAPEVLVSVGTA 319
Query: 472 QLTEKSDVYSFGIVILELMSG 492
D +S G+++ +SG
Sbjct: 320 GYNRAVDCWSLGVILFICLSG 340
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 43/205 (20%), Positives = 82/205 (40%), Gaps = 24/205 (11%)
Query: 295 LIGQGASGVVYKG--TLEDGTLVAVKQITDLDTKGDEE----FINEVEIISKIRHRNLLS 348
I G G +Y +G V +K L GD E + E + ++++ H +++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKG---LVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
+ +D ++V +++ SL ++L + +L++ L+YL
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYL 198
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
H + + D+K NI+L E + K+ D G + + GT G+ APE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NS---FGYLYGTPGFQAPEIV 249
Query: 469 LYGQLTEKSDVYSFGIVILELMSGR 493
T +D+Y+ G + L
Sbjct: 250 R-TGPTVATDIYTVGRTLAALTLDL 273
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
++G+G+ G V K AVK I K + EVE++ K+ H N++ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
E ++V + G L D I + RK+ + +II V G+ Y+H
Sbjct: 87 FEIL-----EDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKA---KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
K I HRD+K NILL+S+ K K+ DFGL+ + + R+ GT Y+APE
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIAPE 193
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGR 493
L G EK DV+S G+++ L+SG
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 37/232 (15%)
Query: 279 RESEL--DQATGGFSQK----NLIGQGASGVVYKGT-LEDGTLVAVKQI--------TDL 323
R++ L +T GF + ++G+G S VV + AVK I +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 324 DTKGDEEFI-NEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS 381
+ + E EV+I+ K+ H N++ L+ E FLV+D M G L D++
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYL- 115
Query: 382 NALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441
+ L+ + +KI+ + + + LH K I HRD+K NILLD +M K+ DFG
Sbjct: 116 --TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 442 AKQSLEGQSHLTTRVAGTYGYLAPE------YALYGQLTEKSDVYSFGIVIL 487
+ Q L+ L GT YLAPE + ++ D++S G VI+
Sbjct: 171 SCQ-LDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIM 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 287 TGGFSQK----NLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIIS 339
G F+++ ++G+G+ G V K AVK I K + EVE++
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 340 KIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL 399
K+ H N++ L E ++V + G L D I + RK+ + +II
Sbjct: 77 KLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIK 128
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADFGLAKQSLEGQSHLTTRV 456
V G+ Y+H K I HRD+K NILL+S + K+ DFGL+ + + R+
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI 184
Query: 457 AGTYGYLAPEYALYGQLTEKSDVYSFGIVIL 487
GT Y+APE L G EK DV+S G VIL
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAG-VIL 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQIT--DLDTKGDEEFINEVEIISKIRHRNLLSL 349
K +G+GA VV + G A K I L + ++ E I K++H N++ L
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
++ +LV+D + G L + I + R+ + I + + +AY H
Sbjct: 71 HDSI-----QEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCH 122
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKA---KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
I HR++K N+LL S+ K K+ADFGLA + + ++ GT GYL+PE
Sbjct: 123 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPE 177
Query: 467 ---YALYGQLTEKSDVYSFGIVIL 487
Y + D+++ G VIL
Sbjct: 178 VLKKDPYS---KPVDIWACG-VIL 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFIN-EVEIISKIRHRNLLS 348
++ +IG G+ GVV++ L + VA+K++ D+ F N E++I+ ++H N++
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVKHPNVVD 96
Query: 349 LRGCCVSSDDEKGKRR-FLVYDFMPSGSLGDHISNALTRKQ-LAWPQRKKIILDVAKGLA 406
L+ S+ D+K + LV +++P ++ + KQ + K + + + LA
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKA-KVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
Y+H I HRDIK N+LLD K+ DFG AK + G+ + + Y Y AP
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-NVSYICSRY-YRAP 210
Query: 466 EYALYG--QLTEKSDVYSFGIVILELMSGR 493
E ++G T D++S G V+ ELM G+
Sbjct: 211 E-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS 348
S+ ++G G G V+K G +A K I K EE NE+ +++++ H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI---SNALTRKQLAWPQRKKIILDVAKGL 405
L E LV +++ G L D I S LT + + +G+
Sbjct: 151 LYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-----LFMKQICEGI 200
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKA--KVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
++H + I H D+K NIL + K+ DFGLA++ + + L GT +L
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFL 255
Query: 464 APEYALYGQLTEKSDVYSFGIVIL-ELMSG 492
APE Y ++ +D++S G VI L+SG
Sbjct: 256 APEVVNYDFVSFPTDMWSVG-VIAYMLLSG 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
++G GA V+ G L A+K I D NE+ ++ KI+H N+++L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
E +LV + G L D I L R +I V + YLH
Sbjct: 74 IY-----ESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSAVKYLH-- 123
Query: 412 LKPAIYHRDIKSTNILLDS---EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
+ I HRD+K N+L + K + DFGL+K +E ++T GT GY+APE
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMST-ACGTPGYVAPEVL 179
Query: 469 LYGQLTEKSDVYSFGIVIL 487
++ D +S G VI
Sbjct: 180 AQKPYSKAVDCWSIG-VIT 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 18/198 (9%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEE-FINEVEIISKIRHRNLLSLRGCC 353
+G GA G V+ G +K I ++ E E+E++ + H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
E ++V + G L + I S K L+ +++ + LAY H
Sbjct: 90 -----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--- 141
Query: 413 KPAIYHRDIKSTNILLDS---EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ H+D+K NIL K+ DFGLA+ + H T GT Y+APE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAA-GTALYMAPE-VF 198
Query: 470 YGQLTEKSDVYSFGIVIL 487
+T K D++S G V++
Sbjct: 199 KRDVTFKCDIWSAG-VVM 215
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 30/233 (12%)
Query: 268 SVLPNSGAKWFRESELDQATGGFSQK----NLIGQGASGVVYKGT-LEDGTLVAVKQI-- 320
+ + + A+ FS +G+GA VV + G A K I
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 321 TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI 380
L + ++ E I K++H N++ L ++ +LV+D + G L + I
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDI 119
Query: 381 SNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA---KVA 437
+ R+ + I + + +AY H I HR++K N+LL S+ K K+A
Sbjct: 120 ---VAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPE---YALYGQLTEKSDVYSFGIVIL 487
DFGLA + + ++ GT GYL+PE Y + D+++ G VIL
Sbjct: 174 DFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKDPYS---KPVDIWACG-VIL 220
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 30/207 (14%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI--------TDLDTKGDEEFINEVEIISKIRHRNL 346
+G GA G V + VA+K I + + E+EI+ K+ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
+ ++ + D ++V + M G L D + + K+L K + +
Sbjct: 78 IKIKNFFDAED------YYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQ 128
Query: 407 YLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
YLH + I HRD+K N+LL S + K+ DFG +K E + T GT YL
Sbjct: 129 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYL 183
Query: 464 APE---YALYGQLTEKSDVYSFGIVIL 487
APE D +S G VIL
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLG-VIL 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQI------------TDLDTKGDEE-FINEVEII 338
+G GA G V + A+K I + + + E NE+ ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 339 SKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKII 398
+ H N++ L E K +LV +F G L + I + R + I+
Sbjct: 101 KSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIM 152
Query: 399 LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADFGLAKQSLEGQSHLTTR 455
+ G+ YLH K I HRDIK NILL++ + K+ DFGL+ + L R
Sbjct: 153 KQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDR 208
Query: 456 VAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
+ GT Y+APE L + EK DV+S G+++ L+ G
Sbjct: 209 L-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
IG+G+ G V A K+I + + F E+EI+ + H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF- 75
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP 414
E +LV + G L + + + ++ +I+ DV +AY H K
Sbjct: 76 ----EDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCH---KL 125
Query: 415 AIYHRDIKSTNILLDS---EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
+ HRD+K N L + + K+ DFGLA + G+ + T+V GT Y++P+ L G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQ-VLEG 182
Query: 472 QLTEKSDVYSFGIVIL 487
+ D +S G V++
Sbjct: 183 LYGPECDEWSAG-VMM 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQI--------TDLDTKGDEEFINEVEIISKIR- 342
K++IG+G S VV + G AVK + + + E E I+ ++
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
H ++++L E FLV+D M G L D++ + L+ + + I+ +
Sbjct: 159 HPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLL 210
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
+ +++LH I HRD+K NILLD M+ +++DFG + G+ L GT GY
Sbjct: 211 EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGY 265
Query: 463 LAPE---------YALYGQLTEKSDVYSFGIVIL 487
LAPE + YG ++ D+++ G VIL
Sbjct: 266 LAPEILKCSMDETHPGYG---KEVDLWACG-VIL 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 54/211 (25%), Positives = 83/211 (39%), Gaps = 32/211 (15%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQI-----TDLDTKGDEEFINEVEIISKIRHRNL 346
+IG+G VV + E G AVK + T E+ E I ++H ++
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWP----QRKKIILDVA 402
+ L ++V++FM L I + R + + +
Sbjct: 89 VELLETY-----SSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEAVASHYMRQIL 140
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA---KVADFGLAKQSLEGQSHLTTRVAGT 459
+ L Y H I HRD+K +LL S+ + K+ FG+A Q E RV GT
Sbjct: 141 EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 460 YGYLAPE---YALYGQLTEKSDVYSFGIVIL 487
++APE YG + DV+ G VIL
Sbjct: 197 PHFMAPEVVKREPYG---KPVDVWGCG-VIL 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 290 FSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFIN-EVEII---SKIRHR 344
F + + GQG G V G G VA+K++ D F N E++I+ + + H
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVLHHP 79
Query: 345 NLLSLRGCCVSSDDEKGKRRFL--VYDFMPSGSLGDHISNALTRKQ-LAWPQRKKIILDV 401
N++ L+ + + + +L V +++P +L N R+ K + +
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAKQSLEGQSHLTTRVAGTY 460
+ + LH + HRDIK N+L++ K+ DFG AK+ + + + Y
Sbjct: 139 IRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICSRY 196
Query: 461 GYLAPEYAL----YGQLTEKSDVYSFGIVILELMSGR 493
Y APE Y T D++S G + E+M G
Sbjct: 197 -YRAPELIFGNQHY---TTAVDIWSVGCIFAEMMLGE 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 36/216 (16%)
Query: 292 QKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSL 349
Q++++G+GA V L AVK I EVE++ + + HRN+L L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
E+ R +LV++ M GS+ HI R+ + ++ DVA L +LH
Sbjct: 77 IEFF-----EEEDRFYLVFEKMRGGSILSHI---HKRRHFNELEASVVVQDVASALDFLH 128
Query: 410 YGLKPAIYHRDIKSTNILLDSE---MKAKVADFGLAKQSLEGQSH-------LTTRVAGT 459
I HRD+K NIL + K+ DF L L T G+
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GS 184
Query: 460 YGYLAPE--------YALYGQLTEKSDVYSFGIVIL 487
Y+APE ++Y ++ D++S G VIL
Sbjct: 185 AEYMAPEVVEAFSEEASIYD---KRCDLWSLG-VIL 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
+G GA GVV++ G + K I NE+ I++++ H L++L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF- 117
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHI---SNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
E L+ +F+ G L D I ++ ++ + +GL ++H
Sbjct: 118 ----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI-----NYMRQACEGLKHMH-- 166
Query: 412 LKPAIYHRDIKSTNILLDSEMKA--KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ +I H DIK NI+ +++ + K+ DFGLA + L + T + APE
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK-LNPDEIVKVTT-ATAEFAAPEIVD 223
Query: 470 YGQLTEKSDVYSFGIVILELMSG 492
+ +D+++ G++ L+SG
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSG 246
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI-TDLDTKGDEEF----INEVEI---ISK 340
+ IG GA G VYK G VA+K + G + EV + +
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 341 IRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD 400
H N++ L C +S ++ + LV++ + L ++ L K ++
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIKDLMRQ 128
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
+GL +LH I HRD+K NIL+ S K+ADFGLA+ Q LT V T
Sbjct: 129 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPVVV-TL 183
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
Y APE L D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 46/210 (21%), Positives = 82/210 (39%), Gaps = 26/210 (12%)
Query: 291 SQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLS 348
+ +G+G+ + K + AVK I + + E+ + H N++
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVK 70
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
L FLV + + G L + I +K + + I+ + ++++
Sbjct: 71 LHEVF-----HDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHM 122
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKA---KVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
H + HRD+K N+L E K+ DFG A+ L T T Y AP
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAP 178
Query: 466 E---YALYGQLTEKSDVYSFGIVILELMSG 492
E Y E D++S G+++ ++SG
Sbjct: 179 ELLNQNGYD---ESCDLWSLGVILYTMLSG 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHRNLLSLR 350
IGQG G V+K + G VA+K++ ++ E F + E++I+ ++H N+++L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL-ME-NEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 351 GCCVSSDDEKGKRR---FLVYDFMPS--GSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
C + + + +LV+DF L ++ T + K+++ + GL
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL-----SEIKRVMQMLLNGL 137
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ----SLEGQSHLTTRVAGTYG 461
Y+H + I HRD+K+ N+L+ + K+ADFGLA+ + T RV T
Sbjct: 138 YYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLW 193
Query: 462 YLAPEYALYG--QLTEKSDVYSFGIVILELMSGR 493
Y PE L G D++ G ++ E+ +
Sbjct: 194 YRPPEL-LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 43/232 (18%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQI-------------------------TDLDTK 326
K+ IG+G+ GVV D T A+K + + +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 327 GDEEFI-NEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALT 385
G E + E+ I+ K+ H N++ L V D + ++V++ + G + + +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDH-LYMVFELVNQGPVMEVPT---- 130
Query: 386 RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445
K L+ Q + D+ KG+ YLHY I HRDIK +N+L+ + K+ADFG++ +
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTE----KSDVYSFGIVILELMSGR 493
+ L+ GT ++APE +L DV++ G+ + + G+
Sbjct: 188 KGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G+GA VV + + G A I L + ++ E I ++H N++ L
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+ +L++D + G L + I + R+ + I + + + + H
Sbjct: 76 HDSI-----SEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCH 127
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKA---KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+ + HR++K N+LL S++K K+ADFGLA + Q GT GYL+PE
Sbjct: 128 ---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183
Query: 467 ---YALYGQLTEKSDVYSFGIVIL 487
YG + D+++ G VIL
Sbjct: 184 VLRKDPYG---KPVDLWACG-VIL 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 281 SELDQATGGFSQ----KNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEV 335
+L + + F+ K IG G+ V + AVK I EE +
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66
Query: 336 EIISK-IRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR 394
EI+ + +H N+++L+ + GK ++V + M G L D I L +K + +
Sbjct: 67 EILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKI---LRQKFFSEREA 118
Query: 395 KKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA----KVADFGLAKQSLEGQS 450
++ + K + YLH + HRD+K +NIL E ++ DFG AKQ
Sbjct: 119 SAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 451 HLTTRVAGTYGYLAPE---YALYGQLTEKSDVYSFGIVIL 487
L T T ++APE Y D++S G V+L
Sbjct: 176 LLMTPC-YTANFVAPEVLERQGYD---AACDIWSLG-VLL 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
IG+G V + G VA+K I T L+ ++ EV I+ + H N++ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
+ +L+ ++ G + D++ ++ + + + + Y H
Sbjct: 83 IETEKT-----LYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCH--- 131
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ 472
+ I HRD+K+ N+LLD++M K+ADFG + + G L G Y APE G+
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPE-LFQGK 188
Query: 473 LTE--KSDVYSFGIVILELMSGR 493
+ + DV+S G+++ L+SG
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGS 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-24
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354
+G GA GVV++ T G A K + E E++ +S +RH L++L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 355 SSDDEKGKRRFLVYDFMPSGSLGDHI---SNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
E ++Y+FM G L + + N ++ + + + V KGL ++H
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-----EYMRQVCKGLCHMH-- 272
Query: 412 LKPAIYHRDIKSTNILLDSEMKA--KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ H D+K NI+ ++ K+ DFGL L+ + + GT + APE A
Sbjct: 273 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAE 329
Query: 470 YGQLTEKSDVYSFGIVILELMSG 492
+ +D++S G++ L+SG
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 28/210 (13%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI------TDLDTKGDEEFINEVEIISKIRHRNLLS 348
+G G +V K G A K I EE EV I+ ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI--SNALTRKQLAWPQRKKIILDVAKGLA 406
L E L+ + + G L D + +L+ ++ I + G+
Sbjct: 80 LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-----SFIKQILDGVN 129
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKA----KVADFGLAKQSLEGQSHLTTRVAGTYGY 462
YLH I H D+K NI+L + K+ DFGLA + +G GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF-GTPEF 184
Query: 463 LAPEYALYGQLTEKSDVYSFGIVILELMSG 492
+APE Y L ++D++S G++ L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 57/246 (23%), Positives = 102/246 (41%), Gaps = 26/246 (10%)
Query: 251 KRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQK----NLIGQGASGVVYK 306
L+ + + S S P + + S + +G+GA+ +VY+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71
Query: 307 GT-LEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364
A+K + D++ + E+ ++ ++ H N++ L+ E
Sbjct: 72 CKQKGTQKPYALKVL---KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEI 123
Query: 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424
LV + + G L D I + + + + + + +AYLH + I HRD+K
Sbjct: 124 SLVLELVTGGELFDRI---VEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPE 177
Query: 425 NILL---DSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYS 481
N+L + K+ADFGL+K +E Q + T V GT GY APE + D++S
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKI-VEHQVLMKT-VCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 482 FGIVIL 487
G +I
Sbjct: 236 VG-IIT 240
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 31/232 (13%)
Query: 274 GAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI------TDLDTK 326
G + F++ +++ + +G G +V K G A K I
Sbjct: 1 GMETFKQQKVEDF---YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 327 GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI--SNAL 384
EE EV I+ ++ H N+++L E L+ + + G L D + +L
Sbjct: 58 CREEIEREVSILRQVLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL 112
Query: 385 TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA----KVADFG 440
+ ++ I + G+ YLH I H D+K NI+L + K+ DFG
Sbjct: 113 SEEEAT-----SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 492
LA + +G GT ++APE Y L ++D++S G++ L+SG
Sbjct: 165 LAHEIEDGVE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 27/213 (12%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHRN 345
+ + +G+G GVVYK G +VA+K+I LD DE I E+ ++ ++ H N
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR-LD-AEDEGIPSTAIREISLLKELHHPN 80
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPS--GSLGDHISNALTRKQLAWPQRKKIILDVAK 403
++SL S + LV++FM + D L Q+ K + + +
Sbjct: 81 IVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQI-----KIYLYQLLR 130
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-SLEGQSHLTTRVAGTYGY 462
G+A+ H + I HRD+K N+L++S+ K+ADFGLA+ + +S T V T Y
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-YTHEVV-TLWY 185
Query: 463 LAPEYALYG--QLTEKSDVYSFGIVILELMSGR 493
AP+ L G + + D++S G + E+++G+
Sbjct: 186 RAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 29/205 (14%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI------TDLDTKGDEEFINEVEIISKIRHRNLLS 348
+G G +V K G A K I + EE EV I+ +IRH N+++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI--SNALTRKQLAWPQRKKIILDVAKGLA 406
L E L+ + + G L D + +LT + + + + G+
Sbjct: 73 LHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-----QFLKQILDGVH 122
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKA----KVADFGLAKQSLEGQSHLTTRVAGTYGY 462
YLH I H D+K NI+L + K+ DFG+A + G GT +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF-GTPEF 177
Query: 463 LAPEYALYGQLTEKSDVYSFGIVIL 487
+APE Y L ++D++S G VI
Sbjct: 178 VAPEIVNYEPLGLEADMWSIG-VIT 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHR 344
F Q +G G VYKG G VA+K++ LD+ +E I E+ ++ +++H
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDS--EEGTPSTAIREISLMKELKHE 63
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPS--GSLGDHISNALTRKQLAWPQRKKIILDVA 402
N++ L + + + LV++FM + D + T + L K +
Sbjct: 64 NIVRLYDVIHTEN-----KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-SLEGQSHLTTRVAGTYG 461
+GLA+ H + I HRD+K N+L++ + K+ DFGLA+ + + ++ V T
Sbjct: 119 QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-FSSEVV-TLW 173
Query: 462 YLAPEYALYG--QLTEKSDVYSFGIVILELMSGR 493
Y AP+ L G + D++S G ++ E+++G+
Sbjct: 174 YRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 44/203 (21%), Positives = 84/203 (41%), Gaps = 27/203 (13%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI-TDLDTKGDEEFI-NEVEIISKIRHR-NLLSLRG 351
+G+G VV + G A K + + I +E+ ++ + +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHI----SNALTRKQLAWPQRKKIILDVAKGLAY 407
E L+ ++ G + + ++ + ++I + +G+ Y
Sbjct: 97 VY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI-----RLIKQILEGVYY 146
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKA---KVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
LH + I H D+K NILL S K+ DFG++++ L + GT YLA
Sbjct: 147 LH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM-GTPEYLA 201
Query: 465 PEYALYGQLTEKSDVYSFGIVIL 487
PE Y +T +D+++ G +I
Sbjct: 202 PEILNYDPITTATDMWNIG-IIA 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 27/200 (13%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD--EEFINEVEIISKIRHRNLLSLRGC 352
+G+G G+V++ K + KG E+ I++ RHRN+L L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHI---SNALTRKQLAWPQRKKIILDVAKGLAYLH 409
E + ++++F+ + + I + L +++ + V + L +LH
Sbjct: 70 F-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIV-----SYVHQVCEALQFLH 119
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKA--KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
I H DI+ NI+ + + K+ +FG A+Q G + Y APE
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPEYYAPEV 174
Query: 468 ALYGQLTEKSDVYSFGIVIL 487
+ ++ +D++S G ++
Sbjct: 175 HQHDVVSTATDMWSLG-TLV 193
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI-TDLDTKGDEEF----INEVEIISKIRH 343
+ + + +G+G VYK +VA+K+I ++ + + E++++ ++ H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403
N++ L LV+DFM + L I + L K +L +
Sbjct: 72 PNIIGLLDAFGHKS-----NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQ 123
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
GL YLH + I HRD+K N+LLD K+ADFGLAK T +V T Y
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYR 179
Query: 464 APEYALYG--QLTEKSDVYSFGIVILELMSGR 493
APE L+G D+++ G ++ EL+
Sbjct: 180 APE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 50/236 (21%), Positives = 99/236 (41%), Gaps = 49/236 (20%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFIN-EVEIISKIRHRNLLSLRGCC 353
+G G+ G+V + +E G A+K++ D + N E++I+ + H N++ L
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 354 VSSDDEKGKRRF---------------------------------LVYDFMPSGSLGDHI 380
++ DE+ K ++ +++P +L +
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVL 128
Query: 381 SNALTRKQ-LAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVAD 438
+ + + + I + + + ++H I HRDIK N+L++S+ K+ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 439 FGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
FG AK+ + + + + Y APE L + T D++S G V EL+ G+
Sbjct: 186 FGSAKKLIPSEPS-VAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 59/254 (23%), Positives = 90/254 (35%), Gaps = 64/254 (25%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQI-----TDLDTKGDEEFINEVEIISKIRHRNL 346
K IGQG+ GVV + + A+K + ++ K E EV ++ K+ H N+
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR------------ 394
L E + LV + G L D ++ +
Sbjct: 91 ARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 395 -------------------------KKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429
I+ + L YLH I HRDIK N L
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFS 202
Query: 430 SEMKA--KVADFGLAK---QSLEGQSHLTTRVAGTYGYLAPE-----YALYGQLTEKSDV 479
+ K+ DFGL+K + G+ + T AGT ++APE YG K D
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG---PKCDA 259
Query: 480 YSFGIVILELMSGR 493
+S G+++ L+ G
Sbjct: 260 WSAGVLLHLLLMGA 273
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 25/203 (12%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLR 350
K ++G G +G V + G A+K + D + EV+ + +++ +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCIL 88
Query: 351 GCCVSSDDEKGKRRF-LVYDFMPSGSLGDHISNALTRKQLAWPQRK--KIILDVAKGLAY 407
V + GKR ++ + M G L I R A+ +R+ +I+ D+ + +
Sbjct: 89 D--VYENMHHGKRCLLIIMECMEGGELFSRI---QERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKA---KVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
LH I HRD+K N+L S+ K K+ DFG AK++ + L T T Y+A
Sbjct: 144 LH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVA 197
Query: 465 PEYALYGQLTEKSDVYSFGIVIL 487
PE + + D++S G VI+
Sbjct: 198 PEVLGPEKYDKSCDMWSLG-VIM 219
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHR 344
+ + IG+G G V+K E +VA+K++ LD DE + E+ ++ +++H+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD-DDDEGVPSSALREICLLKELKHK 61
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPS--GSLGDHISNALTRKQLAWPQRKKIILDVA 402
N++ L S K+ LV++F D + L + + K + +
Sbjct: 62 NIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIV-----KSFLFQLL 111
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-SLEGQSHLTTRVAGTYG 461
KGL + H + HRD+K N+L++ + K+A+FGLA+ + + + V T
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVV-TLW 166
Query: 462 YLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVL 496
Y P+ L+G + D++S G + EL + + L
Sbjct: 167 YRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 62/258 (24%), Positives = 107/258 (41%), Gaps = 30/258 (11%)
Query: 249 YKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQAT-GGFSQKNLIGQGASGVVY-- 305
+ L + + F DS+ +W + E F ++G+G G V+
Sbjct: 146 LLRAVLAHLGQAPFQEFLDSLYFLRFLQW-KWLEAQPMGEDWFLDFRVLGRGGFGEVFAC 204
Query: 306 --KGTLEDGTLVAVKQI--TDLDTKGDEEF-INEVEIISKIRHRNLLSLRGCCVSSDDEK 360
K T G L A K++ L + + + E +I++K+ R ++SL +
Sbjct: 205 QMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT--- 258
Query: 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKK-----IILDVAKGLAYLHYGLKPA 415
LV M G + HI N R I+ GL +LH +
Sbjct: 259 --DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GLEHLH---QRN 309
Query: 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTE 475
I +RD+K N+LLD + +++D GLA + GQ+ GT G++APE L +
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDF 368
Query: 476 KSDVYSFGIVILELMSGR 493
D ++ G+ + E+++ R
Sbjct: 369 SVDYFALGVTLYEMIAAR 386
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI------TDLDTKGDEEFINEVEIISKIRHRNLLS 348
+G G VV K G A K I + E+ EV I+ +I+H N+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI--SNALTRKQLAWPQRKKIILDVAKGLA 406
L E L+ + + G L D + +LT ++ + + + G+
Sbjct: 79 LHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT-----EFLKQILNGVY 128
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKA----KVADFGLAKQSLEGQSHLTTRVAGTYGY 462
YLH I H D+K NI+L K+ DFGLA + G GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF-GTPEF 183
Query: 463 LAPEYALYGQLTEKSDVYSFGIVILELMSG 492
+APE Y L ++D++S G++ L+SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 290 FSQKNLIGQGASGVVYKG--TLEDGTLVAVKQITDLDTKGDEEF----INEVEI---ISK 340
+ IG+GA G V+K G VA+K++ + G+E I EV + +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQ-TGEEGMPLSTIREVAVLRHLET 70
Query: 341 IRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD 400
H N++ L C S ++ + LV++ + L ++ + + K ++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
+ +GL +LH + HRD+K NIL+ S + K+ADFGLA+ Q LT+ V T
Sbjct: 129 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVV-TL 183
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
Y APE L D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 35/233 (15%)
Query: 271 PNSGAKWFRESELDQATGGFSQ-----KNLIGQGASGVVYKGT-LEDGTLVAVKQITDLD 324
P ++ +S L ++G G +G V + A+K + D
Sbjct: 40 PQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC- 98
Query: 325 TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRF-LVYDFMPSGSLGDHISN 382
+ EVE+ + + +++ + V + G++ +V + + G L I
Sbjct: 99 ----PKARREVELHWRASQCPHIVRIVD--VYENLYAGRKCLLIVMECLDGGELFSRI-- 150
Query: 383 ALTRKQLAWPQRK--KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA---KVA 437
R A+ +R+ +I+ + + + YLH I HRD+K N+L S+ K+
Sbjct: 151 -QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT 206
Query: 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPE---YALYGQLTEKSDVYSFGIVIL 487
DFG AK++ S LTT T Y+APE Y + D++S G VI+
Sbjct: 207 DFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKYD---KSCDMWSLG-VIM 253
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEE-----FINEVEIISKIRH 343
+ + + +G+G VYKG LVA+K+I L+ EE I EV ++ ++H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LE---HEEGAPCTAIREVSLLKDLKH 59
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPS--GSLGDHISNALTRKQLAWPQRKKIILDV 401
N+++L + K LV++++ D N + K + +
Sbjct: 60 ANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNIINM-----HNVKLFLFQL 109
Query: 402 AKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYG 461
+GLAY H + + HRD+K N+L++ + K+ADFGLA+ V T
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLW 165
Query: 462 YLAPEYALYG--QLTEKSDVYSFGIVILELMSGR 493
Y P+ L G + + D++ G + E+ +GR
Sbjct: 166 YRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHRN 345
+ IG+G GVVYK G A+K+I L+ K DE I E+ I+ +++H N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-LE-KEDEGIPSTTIREISILKELKHSN 61
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPS--GSLGDHISNALTRKQLAWPQRKKIILDVAK 403
++ L + KR LV++ + L D L K +L +
Sbjct: 62 IVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTA-----KSFLLQLLN 111
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
G+AY H + HRD+K N+L++ E + K+ADFGLA+ T + T Y
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYR 167
Query: 464 APEYALYG--QLTEKSDVYSFGIVILELMSGR 493
AP+ L G + + D++S G + E+++G
Sbjct: 168 APD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHR 344
+ L+G+G+ G+V K + G +VA+K+ L++ D+ + E++++ ++RH
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
NL++L C KR +LV++F+ ++ D + L + +K + + G
Sbjct: 85 NLVNLLEVCKKK-----KRWYLVFEFVDH-TILDDLEL--FPNGLDYQVVQKYLFQIING 136
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
+ + H I HRDIK NIL+ K+ DFG A+ VA T Y A
Sbjct: 137 IGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRA 192
Query: 465 PEYALYG--QLTEKSDVYSFGIVILELMSGR 493
PE L G + + DV++ G ++ E+ G
Sbjct: 193 PE-LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-22
Identities = 66/253 (26%), Positives = 108/253 (42%), Gaps = 23/253 (9%)
Query: 249 YKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGG-FSQKNLIGQGASGVVY-- 305
+ L + DS+ N +W + E T F Q ++G+G G V
Sbjct: 145 LTRLTHEYLSVAPFADYLDSIYFNRFLQW-KWLERQPVTKNTFRQYRVLGKGGFGEVCAC 203
Query: 306 --KGTLEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360
+ T G + A K++ KG+ +NE +I+ K+ R ++SL + D
Sbjct: 204 QVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--- 257
Query: 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRD 420
LV M G L HI + + + ++ GL LH + I +RD
Sbjct: 258 --ALCLVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLH---RERIVYRD 311
Query: 421 IKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVY 480
+K NILLD +++D GLA EGQ+ GT GY+APE + T D +
Sbjct: 312 LKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWW 369
Query: 481 SFGIVILELMSGR 493
+ G ++ E+++G+
Sbjct: 370 ALGCLLYEMIAGQ 382
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 8e-22
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD--EEFINEVEIISKIRHRNLLSLRG 351
+G+GA G V VAVK I D+ D E E+ I + H N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQ-RKK---IILDVAKGLAY 407
+ + +L ++ G L D I + P ++ ++ G+ Y
Sbjct: 73 HRREGNIQ-----YLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMA----GVVY 120
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS--HLTTRVAGTYGYLAP 465
LH I HRDIK N+LLD K++DFGLA L GT Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 466 EYALYGQL--TEKSDVYSFGIVILELMSGR 493
E L + E DV+S GIV+ +++G
Sbjct: 177 E-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-21
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 296 IGQGASGVVYKG---TLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
+G+G G VYK +D A+KQI E+ ++ +++H N++SL+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 353 CVSSDDEKGKRRFLVYDFMPS--GSLGDHISNALTRK---QLAWPQRKKIILDVAKGLAY 407
+S D K +L++D+ + + K QL K ++ + G+ Y
Sbjct: 87 FLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKA----KVADFGLAKQ---SLEGQSHLTTRVAGTY 460
LH + HRD+K NIL+ E K+AD G A+ L+ + L V T+
Sbjct: 144 LH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199
Query: 461 GYLAPEYALYG--QLTEKSDVYSFGIVILELMSGR 493
Y APE L G T+ D+++ G + EL++
Sbjct: 200 WYRAPEL-LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 52/210 (24%), Positives = 82/210 (39%), Gaps = 26/210 (12%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI--------TDLDTKGDEEFINEVEIISKIRHRNL 346
+G GA G V+ E V VK I ++ + E+ I+S++ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGS-LGDHISNALTRKQLAWPQRKKIILDVAKGL 405
+ + + + LV + SG L I +L P I + +
Sbjct: 92 IKVLD--IFENQGF---FQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAV 143
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
YL I HRDIK NI++ + K+ DFG A G+ T GT Y AP
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEYCAP 198
Query: 466 EYALYGQLTE--KSDVYSFGIVILELMSGR 493
E L G + +++S G+ + L+
Sbjct: 199 E-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFIN-EVEIISKIRHRNLLSLR 350
+G G G V G G VAVK + + + I E++ + RH +++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
+ D F+V +++ G L D+I ++ + +++ + + Y H
Sbjct: 78 QVISTPTD-----FFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCH- 128
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ + HRD+K N+LLD+ M AK+ADFGL+ +G+ L T G+ Y APE +
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNYAAPE-VIS 183
Query: 471 GQLTE--KSDVYSFGIVILELMSGR 493
G+L + D++S G+++ L+ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGT 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQI-TDLDTKGDEEF-INEVEIISKIRHRNLLSLRGC 352
IG+G+ GVV+K + G +VA+K+ D ++ + E+ ++ +++H NL++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL-- 68
Query: 353 CVSSDDEKGKRR-FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
+ + KRR LV+++ ++ + ++ + K I + + + H
Sbjct: 69 ----EVFRRKRRLHLVFEYCDH-TVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH-- 119
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
K HRD+K NIL+ K+ DFG A+ + VA T Y +PE L G
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE-LLVG 176
Query: 472 QLTEKS---DVYSFGIVILELMSGR 493
T+ DV++ G V EL+SG
Sbjct: 177 D-TQYGPPVDVWAIGCVFAELLSGV 200
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD--EEFINEVEIISKIRHRNLLSLRG 351
+G+GA G V VAVK I D+ D E E+ I + H N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQ-RKK---IILDVAKGLAY 407
+ + +L ++ G L D I + P ++ ++ G+ Y
Sbjct: 73 HRREGNIQ-----YLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMA----GVVY 120
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS--HLTTRVAGTYGYLAP 465
LH I HRDIK N+LLD K++DFGLA L GT Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 466 EYALYGQL--TEKSDVYSFGIVILELMSGR 493
E L + E DV+S GIV+ +++G
Sbjct: 177 E-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 28/212 (13%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFIN----EVEIISKIRHR--N 345
L+G G G VY G + D VA+K + + G+ EV ++ K+
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDF-MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
++ L D L+ + P L D I+ R L + V +
Sbjct: 110 VIRLLDWFERPDSF-----VLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEA 161
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
+ + H + HRDIK NIL+D + K+ DFG +L + T GT Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFD-GTRVYS 215
Query: 464 APEYALYGQLTE--KSDVYSFGIVILELMSGR 493
PE+ + + V+S GI++ +++ G
Sbjct: 216 PPEW-IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 296 IGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEE--FIN---------EVEIISKIRHR 344
I G+ G V G +G VA+K++ + + G + E+ +++ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL-DVAK 403
N+L LR V ++ + +LV + M + L I ++ + PQ + + +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---DQRIVISPQHIQYFMYHILL 145
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
GL LH + HRD+ NILL + DF LA+ ++ T V Y
Sbjct: 146 GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVT-HRWYR 200
Query: 464 APEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
APE + + T+ D++S G V+ E+ + +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 4e-21
Identities = 60/257 (23%), Positives = 105/257 (40%), Gaps = 29/257 (11%)
Query: 249 YKKRKRNALHEEFVRSFKDSVLPNSGAKWFRESELDQAT-GGFSQKNLIGQGASGVVY-- 305
Y + L + + F +S +W T FS +IG+G G VY
Sbjct: 149 YIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGC 208
Query: 306 --KGTLEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKI---RHRNLLSLRGCCVSSD 357
T G + A+K + +G+ +NE ++S + ++ + + D
Sbjct: 209 RKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265
Query: 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIY 417
+ + D M G L H+S + + ++ GL ++H +
Sbjct: 266 -----KLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVV 314
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKS 477
+RD+K NILLD +++D GLA + + H V GT+GY+APE G + S
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSS 371
Query: 478 -DVYSFGIVILELMSGR 493
D +S G ++ +L+ G
Sbjct: 372 ADWFSLGCMLFKLLRGH 388
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 36/212 (16%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
IG G GV LVAVK + DE E+ +RH N++ +
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK--------GL 405
++ ++ ++ G L + I N + D A+ G+
Sbjct: 86 LTPTH-----LAIIMEYASGGELYERICN-----------AGRFSEDEARFFFQQLLSGV 129
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDS--EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
+Y H I HRD+K N LLD + K+ DFG +K S+ S + V GT Y+
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYI 184
Query: 464 APEYALYGQLTE--KSDVYSFGIVILELMSGR 493
APE L Q + +DV+S G+ + ++ G
Sbjct: 185 APE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF----INEVEIISKIRHR 344
+ + +G+G G VYK VA+K+I L+ + +E I EV ++ +++HR
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHE-EEGVPGTAIREVSLLKELQHR 93
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
N++ L+ + R L++++ + L ++ ++ K + + G
Sbjct: 94 NIIELKSVIHHNH-----RLHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLING 144
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKA-----KVADFGLAKQ-SLEGQSHLTTRVAG 458
+ + H HRD+K N+LL + K+ DFGLA+ + + T +
Sbjct: 145 VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ-FTHEII- 199
Query: 459 TYGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGR 493
T Y PE L G + D++S + E++
Sbjct: 200 TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 40/221 (18%)
Query: 290 FSQKNLIGQGASGVVY----KGTLEDGTLVAVKQI--TDLDTKGDEEFIN-EVEIISKIR 342
F ++G+G+ V T A+K + + + ++ E +++S++
Sbjct: 32 FKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
H + L + + + + +G L +I
Sbjct: 89 HPFFVKLYFTFQDDE-----KLYFGLSYAKNGELLKYIRKI-----------GSFDETCT 132
Query: 403 K--------GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT 454
+ L YLH I HRD+K NILL+ +M ++ DFG AK
Sbjct: 133 RFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 455 R-VAGTYGYLAPEYALYGQLTEKS-DVYSFGIVILELMSGR 493
GT Y++PE L + KS D+++ G +I +L++G
Sbjct: 190 NSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 22/210 (10%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITD----LDTKGDEEFIN-EVEIISKIRHRNLLS 348
L+G+G+ G V + E AVK I E + E++++ ++RH+N++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGS--LGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
L V ++EK K ++V ++ G + D + K+ Q + GL
Sbjct: 71 LVD--VLYNEEKQKM-YMVMEYCVCGMQEMLDSVP----EKRFPVCQAHGYFCQLIDGLE 123
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL-AKQSLEGQSHLTTRVAGTYGYLAP 465
YLH I H+DIK N+LL + K++ G+ G+ + P
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 466 EYALYGQLTE--KSDVYSFGIVILELMSGR 493
E A K D++S G+ + + +G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 57/226 (25%), Positives = 84/226 (37%), Gaps = 50/226 (22%)
Query: 290 FSQKNLIGQGASGVVY----KGTLEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIR 342
F IG+G+ G V T + A+K + ++ E++I+ +
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
H L++L D+E F+V D + G L H+ Q +
Sbjct: 74 HPFLVNLWYS--FQDEED---MFMVVDLLLGGDLRYHLQ-----------QNVHFKEETV 117
Query: 403 K--------GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT 454
K L YL I HRD+K NILLD + DF +A T
Sbjct: 118 KLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT- 173
Query: 455 RVAGTYGYLAPE------YALYGQLTEKS-DVYSFGIVILELMSGR 493
+AGT Y+APE A Y + D +S G+ EL+ GR
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYS----FAVDWWSLGVTAYELLRGR 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFIN-EVEIISKIRHRNLLSLR 350
+G G G V G G VAVK + + + I E++ + RH +++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
+ D F+V +++ G L D+I +L + +++ + G+ Y H
Sbjct: 83 QVISTPSD-----IFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCH- 133
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ + HRD+K N+LLD+ M AK+ADFGL+ +G+ L T G+ Y APE +
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPE-VIS 188
Query: 471 GQLTE--KSDVYSFGIVILELMSGR 493
G+L + D++S G+++ L+ G
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFIN---------EVEIIS 339
+ IG GA G+V VA+K+++ F N E+ ++
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 116
Query: 340 KIRHRNLLSLRGC-CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKII 398
+ H+N++SL E+ + +LV + M + +L + + +L + ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NL-----CQVIQMELDHERMSYLL 170
Query: 399 LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
+ G+ +LH I HRD+K +NI++ S+ K+ DFGLA+ + +T V
Sbjct: 171 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVV- 225
Query: 459 TYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
T Y APE L E D++S G ++ E++ +
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLL 347
++ + IG+GA G+V + VA+K+I+ + + + E++I+ + RH N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIIL-DVAKGL 405
+ + E+ K ++V D M + L + + L+ L + +GL
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLS------NDHICYFLYQILRGL 141
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK---QSLEGQSHLTTRVAGTYGY 462
Y+H + HRD+K +N+LL++ K+ DFGLA+ + LT VA T Y
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWY 197
Query: 463 LAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
APE L T+ D++S G ++ E++S R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 30/214 (14%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFIN----EVEIISKIR----H 343
L+G+G G V+ G L D VA+K I + EV ++ K+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDF-MPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
++ L E LV + +P+ L D+I+ + L + V
Sbjct: 98 PGVIRLLD--WFETQEG---FMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVV 149
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAKQSLEGQSHLTTRVAGTYG 461
+ + H + HRDIK NIL+D AK+ DFG +L T GT
Sbjct: 150 AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDFD-GTRV 203
Query: 462 YLAPEYALYGQLTE--KSDVYSFGIVILELMSGR 493
Y PE+ + + V+S GI++ +++ G
Sbjct: 204 YSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFIN-EVEIISKIRHRNLLSLR 350
+G+G+ G V T + VA+K I L + E+ + +RH +++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
+ D +V ++ G L D+I +K++ + ++ + + Y H
Sbjct: 76 DVITTPTD-----IVMVIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCH- 125
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ I HRD+K N+LLD + K+ADFGL+ +G L T G+ Y APE +
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYAAPE-VIN 180
Query: 471 GQLTE--KSDVYSFGIVILELMSGR 493
G+L + DV+S GIV+ ++ GR
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITD-----LDTKGDEEFINEVEIISKIRHRNLLSL 349
IG GA G+V VA+K+++ K E+ ++ + H+N++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR---AYRELVLMKCVNHKNIIGL 89
Query: 350 RGC-CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
E+ + ++V + M + +L + + +L + ++ + G+ +L
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NL-----CQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
H I HRD+K +NI++ S+ K+ DFGLA+ + +T V T Y APE
Sbjct: 144 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVV-TRYYRAPEVI 198
Query: 469 LYGQLTEKSDVYSFGIVILELMSGR 493
L E D++S G ++ E++ G
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 52/263 (19%), Positives = 98/263 (37%), Gaps = 51/263 (19%)
Query: 253 KRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVY----KGT 308
++ +F++ + V+ + R+ F +IG+GA V K T
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQRDD--------FEILKVIGRGAFSEVAVVKMKQT 85
Query: 309 LEDGTLVAVKQI--TDLDTKGDEE-FINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365
G + A+K + D+ +G+ F E +++ R + L ++ +
Sbjct: 86 ---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDEN----YLY 137
Query: 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK--------GLAYLHYGLKPAIY 417
LV ++ G L +S ++I ++A+ + +H +
Sbjct: 138 LVMEYYVGGDLLTLLSK----------FGERIPAEMARFYLAEIVMAIDSVH---RLGYV 184
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKS 477
HRDIK NILLD ++ADFG + + + GT YL+PE +
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 478 DVY-------SFGIVILELMSGR 493
Y + G+ E+ G+
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQ 267
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 49/212 (23%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITD-----LDTKGDEEFINEVEIISKIRH 343
+ +G GA G V G VA+K+++ + K E+ ++ ++H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELLLLKHMQH 82
Query: 344 RNLLSLRGC-CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
N++ L +S +LV FM + L + + +++ + ++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKI-----QYLVYQML 136
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
KGL Y+H + HRD+K N+ ++ + + K+ DFGLA+ + + +T V T Y
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVV-TRWY 189
Query: 463 LAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
APE L + + D++S G ++ E+++G+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 53/264 (20%), Positives = 97/264 (36%), Gaps = 58/264 (21%)
Query: 253 KRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVY----KGT 308
++N + F+ +KD++ + E + +IG+GA G V K T
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAED--------YEVVKVIGRGAFGEVQLVRHKST 93
Query: 309 LEDGTLVAVKQI--TDLDTKGDEE-FINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365
+ A+K + ++ + D F E +I++ ++ L +
Sbjct: 94 ---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR-----YLY 145
Query: 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK--------GLAYLHYGLKPAIY 417
+V ++MP G L + + + A+ L +H
Sbjct: 146 MVMEYMPGGDLVNLM------------SNYDVPEKWARFYTAEVVLALDAIH---SMGFI 190
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE-------YALY 470
HRD+K N+LLD K+ADFG + + GT Y++PE Y
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 471 GQLTEKS-DVYSFGIVILELMSGR 493
G + D +S G+ + E++ G
Sbjct: 251 G----RECDWWSVGVFLYEMLVGD 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 50/261 (19%), Positives = 98/261 (37%), Gaps = 49/261 (18%)
Query: 253 KRNALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVY----KGT 308
+R E++ K + RE F +IG+GA G V K
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHRED--------FEILKVIGRGAFGEVAVVKLKNA 98
Query: 309 LEDGTLVAVKQI--TDLDTKGDEE-FINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365
+ A+K + ++ + + F E +++ + + +L + +
Sbjct: 99 ---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN-----NLY 150
Query: 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK--------GLAYLHYGLKPAIY 417
LV D+ G L +S ++ ++A+ + +H +
Sbjct: 151 LVMDYYVGGDLLTLLSKF----------EDRLPEEMARFYLAEMVIAIDSVH---QLHYV 197
Query: 418 HRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKS 477
HRDIK NIL+D ++ADFG + +E + ++ GT Y++PE + +
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 478 -----DVYSFGIVILELMSGR 493
D +S G+ + E++ G
Sbjct: 258 YGPECDWWSLGVCMYEMLYGE 278
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITD-----LDTKGDEEFINEVEIISKIRHRNLLSL 349
+G GA G V G VA+K++ L K E+ ++ +RH N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR---AYRELRLLKHMRHENVIGL 89
Query: 350 RGC-CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
+ +LV FM + D + + ++L + + ++ + KGL Y+
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQMLKGLRYI 144
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
H I HRD+K N+ ++ + + K+ DFGLA+Q+ S +T V T Y APE
Sbjct: 145 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVV-TRWYRAPEVI 197
Query: 469 L-YGQLTEKSDVYSFGIVILELMSGR 493
L + + T+ D++S G ++ E+++G+
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 295 LIGQGASGVVY----KGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLS 348
++GQG+ G V+ + L A+K + L + E +I+ ++ H ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK----- 403
L ++ + +L+ DF+ G L +S + + K
Sbjct: 91 LH-YAFQTEG----KLYLILDFLRGGDLFTRLS-----------KEVMFTEEDVKFYLAE 134
Query: 404 ---GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
L +LH I +RD+K NILLD E K+ DFGL+K+S++ GT
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSFCGTV 190
Query: 461 GYLAPEYALYGQLTEKS-DVYSFGIVILELMSGR 493
Y+APE + + +S D +SFG+++ E+++G
Sbjct: 191 EYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFI-NEVEIISKIRHRNLLSLRGCC 353
+G+GA GVV T G +VA+K+I D E++I+ +H N++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHIS-NALTRKQLAWPQRKKIIL-DVAKGLAYLHYG 411
E +++ + M + L IS L+ + + + + LH
Sbjct: 79 RPDSFENFNEVYIIQELMQT-DLHRVISTQMLS------DDHIQYFIYQTLRAVKVLHGS 131
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLA----------KQSLEGQSHLTTRVAGTYG 461
+ HRD+K +N+L++S KV DFGLA + QS + VA T
Sbjct: 132 ---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA-TRW 187
Query: 462 YLAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
Y APE L + + DV+S G ++ EL R
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 295 LIGQGASG----VVYKGTLEDGTLVAVKQITDLDTKGDEEF---INEVEIISKIRHRNLL 347
L+G+G G V K T G A+K + +E + E ++ RH L
Sbjct: 155 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
+L+ + D R V ++ G L H+S + + + + ++ L Y
Sbjct: 212 ALKYSFQTHD-----RLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDY 263
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
LH + +RD+K N++LD + K+ DFGL K+ ++ + + T GT YLAPE
Sbjct: 264 LHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEV 320
Query: 468 ALYGQLTEKSDVYSFGIVILELMSGR 493
D + G+V+ E+M GR
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 43/223 (19%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFIN---------EVEIISKIRHRN 345
+G G +G+V+ + VA+K+I + E++II ++ H N
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHDN 69
Query: 346 LLSL---------RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKK 396
++ + + + ++V ++M + L + + + +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DL-----ANVLEQGPLLEEHAR 123
Query: 397 IIL-DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLA---KQSLEGQSH 451
+ + + +GL Y+H + HRD+K N+ +++E + K+ DFGLA + H
Sbjct: 124 LFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 452 LTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
L+ + T Y +P L T+ D+++ G + E+++G+
Sbjct: 181 LSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 45/207 (21%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCC 353
+G+G V++ + + V VK + + K + E++I+ +R N+++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLA--D 98
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGD--HISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
+ D + + D + LT + + + ++ K L Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNT----DFKQLYQTLTDYDI-----RFYMYEILKALDYCH-- 147
Query: 412 LKPAIYHRDIKSTNILLDSEMKA-KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
I HRD+K N+++D E + ++ D+GLA+ GQ RVA Y + PE +
Sbjct: 148 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRY-FKGPELLVD 204
Query: 471 GQLTEKS-DVYSFGIVILELMSGRKVL 496
Q+ + S D++S G ++ ++ ++
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 44/198 (22%), Positives = 79/198 (39%), Gaps = 22/198 (11%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITD-----LDTKGDEEFINEVEIISKIRH 343
+ ++LIG G+ G V + + +VA+K+I +D K + E+ I++++ H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR---ILREIAILNRLNH 111
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403
+++ + + D EK ++V + S T L K ++ ++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR---TPVYLTELHIKTLLYNLLV 167
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA------KQSLEGQSHLTTRVA 457
G+ Y+H I HRD+K N L++ + KV DFGLA +
Sbjct: 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 458 GTYGYLAPEYALYGQLTE 475
L QLT
Sbjct: 225 MNLVTFPHTKNLKRQLTG 242
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITD-----LDTKGDEEFINEVEIISKIRHRNLLSL 349
+G GA G V + G VAVK+++ + K E+ ++ ++H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 93
Query: 350 RGC-CVSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIILDVAKGLAY 407
+ E+ +LV M + L + + LT + + +I + +GL Y
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF-----LIYQILRGLKY 147
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
+H I HRD+K +N+ ++ + + K+ DFGLA+ + +T VA T Y APE
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVA-TRWYRAPEI 200
Query: 468 AL-YGQLTEKSDVYSFGIVILELMSGR 493
L + + D++S G ++ EL++GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 21/205 (10%), Positives = 52/205 (25%), Gaps = 49/205 (23%)
Query: 295 LIGQGASGVVYKGTLEDGTL---VAVKQI---TDLDTKGDEEFINEVEIISKIRHRNLLS 348
G ++ D L VA+ + L +E ++ +S+I +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
V +V +++ GSL + + + + +A
Sbjct: 96 -----VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR-----AMQSLAAAADAA 145
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
H + + + + + + +A +
Sbjct: 146 H---RAGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-- 179
Query: 469 LYGQLTEKSDVYSFGIVILELMSGR 493
+ D+ G + L+ R
Sbjct: 180 -----NPQDDIRGIGASLYALLVNR 199
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 42/204 (20%), Positives = 80/204 (39%), Gaps = 47/204 (23%)
Query: 293 KNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLR 350
++G G +G V + A+K + D + EVE+ + + +++ +
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 77
Query: 351 GCCVSSDDEKGKRRF--LVYDFMPSGSLGDHISNALTRKQLAWPQRK--KIILDVAKGLA 406
++ R+ +V + + G L I R A+ +R+ +I+ + + +
Sbjct: 78 DVY---ENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKA---KVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
YLH I HRD+K N+L S+ K+ DFG AK++ Y
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------GEKYD-- 176
Query: 464 APEYALYGQLTEKSDVYSFGIVIL 487
+ D++S G VI+
Sbjct: 177 -----------KSCDMWSLG-VIM 188
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 22/206 (10%)
Query: 295 LIGQGASG----VVYKGTLEDGTLVAVKQITDLDTKGDEEF---INEVEIISKIRHRNLL 347
L+G+G G V K T G A+K + +E + E ++ RH L
Sbjct: 12 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
+L+ + D R V ++ G L H+S + + + ++ L Y
Sbjct: 69 ALKYAFQTHD-----RLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEY 120
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
LH + +RDIK N++LD + K+ DFGL K+ + GT YLAPE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEV 176
Query: 468 ALYGQLTEKSDVYSFGIVILELMSGR 493
D + G+V+ E+M GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 57/246 (23%), Positives = 99/246 (40%), Gaps = 50/246 (20%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITD-----LDTKGDEEFINEVEIISKIRH 343
+ K+LIG+G+ G VY VA+K++ +D K + E+ I+++++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLKS 84
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGD-----HISNALTRKQLAWPQRKKII 398
++ L + D K ++V + S D LT + + K I+
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS----DLKKLFKTPIFLTEEHI-----KTIL 135
Query: 399 LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA---------------- 442
++ G ++H I HRD+K N LL+ + KV DFGLA
Sbjct: 136 YNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 443 ------KQSLEGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKV 495
+ + LT+ V T Y APE L T+ D++S G + EL++ +
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 496 LETSNS 501
+
Sbjct: 252 HINDPT 257
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 4e-16
Identities = 46/215 (21%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 295 LIGQGASGVVY---KGTLED-GTLVAVKQI--TDLDTKGDEEF--INEVEIISKIRHRNL 346
++G+G G V+ K T + G + A+K + + + E I+ +++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK--- 403
+ L + + +L+ +++ G L + + + D A
Sbjct: 84 VDLI-YAFQTGG----KLYLILEYLSGGELFMQLE-----------REGIFMEDTACFYL 127
Query: 404 -----GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
L +LH + I +RD+K NI+L+ + K+ DFGL K+S+ +T G
Sbjct: 128 AEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCG 183
Query: 459 TYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
T Y+APE + D +S G ++ ++++G
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 295 LIGQGASGVVY----KGTLEDGTLVAVKQI--TDLDTKGD--EEFINEVEIISKIRHRN- 345
++G GA G V+ + G L A+K + + K E E +++ IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK-- 403
L++L ++ + L+ D++ G L H+S QR++ +
Sbjct: 121 LVTLH-YAFQTET----KLHLILDYINGGELFTHLS-----------QRERFTEHEVQIY 164
Query: 404 ------GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA 457
L +LH K I +RDIK NILLDS + DFGL+K+ + ++
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 458 GTYGYLAPE---YALYGQLTEKS-DVYSFGIVILELMSGR 493
GT Y+AP+ G +K+ D +S G+++ EL++G
Sbjct: 222 GTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 56/247 (22%), Positives = 99/247 (40%), Gaps = 33/247 (13%)
Query: 258 HEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVY----KGTLEDGT 313
+E V+ F + KW S+ F + +G G+ G V K + G
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES---GN 67
Query: 314 LVAVKQITD---LDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDF 370
A+K + + K E +NE I+ + L+ L + ++V ++
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----NLYMVMEY 122
Query: 371 MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS 430
+ G + H+ + + P + + YLH + +RD+K N+L+D
Sbjct: 123 VAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ 176
Query: 431 EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKS-DVYSFGIVI 486
+ +V DFG AK+ T + GT LAPE L Y K+ D ++ G++I
Sbjct: 177 QGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPEIILSKGYN----KAVDWWALGVLI 228
Query: 487 LELMSGR 493
E+ +G
Sbjct: 229 YEMAAGY 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 9e-16
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 295 LIGQGASGVV----YKGTLEDGTLVAVKQITDLDTKGDEEF---INEVEIISKI-RHRNL 346
++G+G+ G V KGT L AVK + D++ + E +++ + L
Sbjct: 348 VLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
L C + D R + V +++ G L HI + P ++A GL
Sbjct: 405 TQLHSCFQTMD-----RLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLF 456
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+L I +RD+K N++LDSE K+ADFG+ K+++ T GT Y+APE
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPE 512
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGR 493
Y + D ++FG+++ E+++G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 21/175 (12%)
Query: 322 DLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS 381
+ ++++ + + K R ++ S + S E+ + + P D
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF-- 189
Query: 382 NALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441
LT + L VAKG+ +L HRD+ + NILL + K+ DFGL
Sbjct: 190 --LTLEHLI-----CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 442 AKQSLEGQSHLTTRVAGTYGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 491
A+ + + V L APE T +SDV+SFG+++ E+ S
Sbjct: 240 ARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 35/184 (19%), Positives = 66/184 (35%), Gaps = 32/184 (17%)
Query: 270 LPNSGAKW--FRESELDQATGGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQIT 321
LP +KW R+ +G+GA G V + VAVK +
Sbjct: 10 LPYDASKWEFPRDR--------LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 61
Query: 322 DLDTKGD-EEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDH 379
+ T + ++E++I+ I H N+++L G C + G ++ +F G+L +
Sbjct: 62 EGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----TKPGGPLMVIVEFCKFGNLSTY 117
Query: 380 ISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439
+ +R + + KG + D+K + S + + F
Sbjct: 118 L----------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167
Query: 440 GLAK 443
K
Sbjct: 168 VEEK 171
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 49/223 (21%)
Query: 290 FSQKNLIGQGASGVVY----KGTLEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIR 342
F +G G+ G V+ + G A+K + + K E +E ++S +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
H ++ + G + + F++ D++ G L + + ++ VA
Sbjct: 65 HPFIIRMWGTFQDAQ-----QIFMIMDYIEGGELFSLLRKS-----------QRFPNPVA 108
Query: 403 K--------GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTT 454
K L YLH I +RD+K NILLD K+ DFG AK + T
Sbjct: 109 KFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TY 161
Query: 455 RVAGTYGYLAPEYAL---YGQLTEKS-DVYSFGIVILELMSGR 493
+ GT Y+APE Y KS D +SFGI+I E+++G
Sbjct: 162 TLCGTPDYIAPEVVSTKPYN----KSIDWWSFGILIYEMLAGY 200
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 295 LIGQGASGVV----YKGTLEDGTLVAVKQITDLDTKGDEEF---INEVEIISK-IRHRNL 346
++G+G+ G V +K T A+K + D++ + E ++S H L
Sbjct: 24 MLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
+ + + F V +++ G L HI + + + ++ GL
Sbjct: 81 THMFCTFQTKE-----NLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQ 132
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+LH I +RD+K NILLD + K+ADFG+ K+++ G + T GT Y+APE
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 188
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGR 493
L + D +SFG+++ E++ G+
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 295 LIGQGASGVVY----KGTLEDGTLVAVKQITDLDTKGDEEF---INEVEIISKI-RHRNL 346
++G+G+ G V K T G L AVK + D++ + E I+S H L
Sbjct: 30 VLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
L C + D R F V +F+ G L HI ++ + + ++ L
Sbjct: 87 TQLFCCFQTPD-----RLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALM 138
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+LH I +RD+K N+LLD E K+ADFG+ K+ + T GT Y+APE
Sbjct: 139 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTATFCGTPDYIAPE 194
Query: 467 ---YALYGQLTEKS-DVYSFGIVILELMSGR 493
LYG + D ++ G+++ E++ G
Sbjct: 195 ILQEMLYG----PAVDWWAMGVLLYEMLCGH 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 50/253 (19%)
Query: 295 LIGQGASG----VVYKGTLEDGTLVAVKQITDLDTKGDEEF---INEVEIISKI-RHRNL 346
+IG+G+ V K T + A+K + DE+ E + + H L
Sbjct: 16 VIGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK--- 403
+ L C ++ R F V +++ G L H+ +++K+ + A+
Sbjct: 73 VGLH-SCFQTES----RLFFVIEYVNGGDLMFHMQ-----------RQRKLPEEHARFYS 116
Query: 404 -----GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
L YLH + I +RD+K N+LLDSE K+ D+G+ K+ L T+ G
Sbjct: 117 AEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCG 172
Query: 459 TYGYLAPEYALYGQLTEKS-DVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517
T Y+APE L G+ S D ++ G+++ E+M+GR S F ++ N+
Sbjct: 173 TPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR-------SPFDIVGSSDNPDQNT- 223
Query: 518 KVDEIFDEFIREE 530
D +F + ++
Sbjct: 224 -EDYLFQVILEKQ 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 41/216 (18%)
Query: 295 LIGQGASGVVY----KGTLEDGTLVAVKQI---TDLDTKGDEEFINEVEIISK-IRHRNL 346
+IG+G+ G V K AVK + L K ++ ++E ++ K ++H L
Sbjct: 45 VIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK--- 403
+ L + D + + V D++ G L H+ + + + A+
Sbjct: 102 VGLH-FSFQTAD----KLYFVLDYINGGELFYHLQ-----------RERCFLEPRARFYA 145
Query: 404 -----GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
L YLH I +RD+K NILLDS+ + DFGL K+++E S T+ G
Sbjct: 146 AEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFCG 201
Query: 459 TYGYLAPEYALYGQLTEKS-DVYSFGIVILELMSGR 493
T YLAPE L+ Q +++ D + G V+ E++ G
Sbjct: 202 TPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 50/253 (19%)
Query: 295 LIGQGASG----VVYKGTLEDGTLVAVKQITDLDTKGDEEF---INEVEIISKI-RHRNL 346
+IG+G+ V K T + A++ + DE+ E + + H L
Sbjct: 59 VIGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK--- 403
+ L C ++ R F V +++ G L H+ +++K+ + A+
Sbjct: 116 VGLH-SCFQTES----RLFFVIEYVNGGDLMFHMQ-----------RQRKLPEEHARFYS 159
Query: 404 -----GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
L YLH + I +RD+K N+LLDSE K+ D+G+ K+ L T+ G
Sbjct: 160 AEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCG 215
Query: 459 TYGYLAPEYALYGQLTEKS-DVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517
T Y+APE L G+ S D ++ G+++ E+M+GR S F ++ N+
Sbjct: 216 TPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR-------SPFDIVGSSDNPDQNT- 266
Query: 518 KVDEIFDEFIREE 530
D +F + ++
Sbjct: 267 -EDYLFQVILEKQ 278
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 48/235 (20%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITD-----LDTKGDEEFINEVEIISKIR- 342
+ +G+GA G+V+K G +VAVK+I D D + E+ I++++
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELSG 67
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-SNALTRKQLAWPQRKKIIL-D 400
H N+++L + +D + +LV+D+M + L I +N L P K+ ++
Sbjct: 68 HENIVNLLNVLRADND---RDVYLVFDYMET-DLHAVIRANILE------PVHKQYVVYQ 117
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA------------------ 442
+ K + YLH G + HRD+K +NILL++E KVADFGL+
Sbjct: 118 LIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 443 ---KQSLEGQSHLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 493
+ + Q LT VA T Y APE L + T+ D++S G ++ E++ G+
Sbjct: 175 ENTENFDDDQPILTDYVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 295 LIGQGASGVV----YKGTLEDGTLVAVKQITDLDTKGDEEF---INEVEIISKI-RHRNL 346
++G+G+ G V KGT L AVK + D++ + E +++ + L
Sbjct: 27 VLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
L C + D R + V +++ G L HI + P ++A GL
Sbjct: 84 TQLHSCFQTMD-----RLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLF 135
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+L I +RD+K N++LDSE K+ADFG+ K+++ T GT Y+APE
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKTFCGTPDYIAPE 191
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGR 493
Y + D ++FG+++ E+++G+
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 4e-14
Identities = 41/213 (19%), Positives = 64/213 (30%), Gaps = 49/213 (23%)
Query: 286 ATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQI--------TDLDTKGDEEFINEVEI 337
T + IG+G G V++ D T VA+K I K EE + E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 338 ISKI---------RHRNLLSLRGCCV-------------------------SSDDEKGKR 363
++ R + L D K +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKS 423
F+V +F G + + K + K I+ + LA L+ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQM----RTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190
Query: 424 TNILLDSEMKAKVADFGLAKQSLEGQSHLTTRV 456
N+LL K+ K S L +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 56/267 (20%), Positives = 97/267 (36%), Gaps = 51/267 (19%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G G V+ + + T VA+K + D E +E++++ ++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDAD-------- 76
Query: 354 VSSDDEKGKRRF--LVYDFMPSGSLGDHI--------SN--ALTRKQ----LAWPQRKKI 397
+ +D G L+ F G G H+ N AL +K + K+I
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 398 ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA------KVADFGLAKQSLEGQSH 451
+ GL Y+H I H DIK N+L++ K+AD G A + +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHY 192
Query: 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW-- 509
T T Y +PE L +D++S +I EL++G + E D
Sbjct: 193 --TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
Query: 510 -----------AWMLANSGKVDEIFDE 525
+++L N F+
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNS 277
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 53/258 (20%), Positives = 98/258 (37%), Gaps = 53/258 (20%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFIN----EVEIISKIRHRNLLSL 349
+IG+G+ G V K + VA+K + + ++ F E+ I+ +R ++ +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDN- 157
Query: 350 RGCCVSSDDEKGKRRFL----------VYDFMPSGSLGDHISNALTRKQLAWPQRKKIIL 399
+ + R + +Y+ + + + P +K
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF----------QGFSLPLVRKFAH 207
Query: 400 DVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA--KVADFGLAKQSLEGQSHLT---T 454
+ + L LH K I H D+K NILL + ++ KV DFG + E Q T +
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQS 262
Query: 455 RVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITDW--- 509
R Y APE L + D++S G ++ EL++G +L + L + +
Sbjct: 263 RF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317
Query: 510 --AWMLANSGKVDEIFDE 525
+L S +
Sbjct: 318 PSQKLLDASKRAKNFVSS 335
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 60/284 (21%), Positives = 114/284 (40%), Gaps = 47/284 (16%)
Query: 284 DQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEF----INEVEII 338
++ + +LIG+G+ G V K + VA+K I K + F EV ++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLL 104
Query: 339 SKIRHRNLLSLRGCCVSSDDEKGKRRF-------LVYDFMPSGSLGDHISNALTRKQ-LA 390
+ + ++ V KR F LV++ + S +L D + N T + ++
Sbjct: 105 ELMNKHDT-EMKYYIV-----HLKRHFMFRNHLCLVFEML-SYNLYDLLRN--TNFRGVS 155
Query: 391 WPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA--KVADFGLAKQSLEG 448
+K + L +L + +I H D+K NILL + ++ K+ DFG + G
Sbjct: 156 LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLG 212
Query: 449 QSHLT---TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL 505
Q +R Y +PE L D++S G +++E+ +G + +N +
Sbjct: 213 QRIYQYIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267
Query: 506 --ITDW-----AWMLANSGKVDEIFDEFIREEGSRAVMERFVRV 542
I + A +L + K + F++ + + R
Sbjct: 268 NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKRE 311
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 52/273 (19%), Positives = 91/273 (33%), Gaps = 72/273 (26%)
Query: 296 IGQGASGVVYKG-TLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL-RGCC 353
+G G V+ ++ VA+K + E ++E+ ++ +R+ + R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 354 VSSDDE------KGKRRFLVYDFMPSGSLGDHISNALTR---KQLAWPQRKKIILDVAKG 404
V D+ G +V++ + G H+ + + + L P KKII V +G
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL-----GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSE--------------------------------- 431
L YLH + I H DIK NILL
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 432 ----------------MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTE 475
+K K+AD G A + + T Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272
Query: 476 KSDVYSFGIVILELMSGRKVLETSNSSFLLITD 508
+D++S + EL +G + E + +
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDE 305
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 1e-07
Identities = 63/456 (13%), Positives = 126/456 (27%), Gaps = 133/456 (29%)
Query: 189 ILNDPKDEATAACILGLPLSTSGSKNSSSNDRVIKIVVALLGALLGVLLAGGLIIMYRKW 248
I+ + + LS + +++ V +L +
Sbjct: 54 IIMSKDAVSGTLRLFWTLLS--------KQEEMVQKFV-------EEVLRINYKFLMSPI 98
Query: 249 YKKRKRNALHEEFVRSFKDSVLPNSG---AKWF--RESELDQATGGFSQ----KNLI--G 297
++++ ++ +D L N AK+ R + + KN++ G
Sbjct: 99 KTEQRQPSMMTRMYIEQRD-RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 298 QGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357
SG K + L K + ++ ++ C S +
Sbjct: 158 VLGSG---KTWV---ALDVCL-----SYKVQCKMDFKIFWLNL----------KNCNSPE 196
Query: 358 DEKGKRRFLVYDFMPSG-SLGDHISN---------ALTRKQLAWPQRKK--IILDVAKGL 405
+ L+Y P+ S DH SN A R+ L + ++L
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL----- 251
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
++++ A F L+ + L LTTR +L+
Sbjct: 252 --------------NVQNAKAW-----NA----FNLSCKIL-----LTTRFKQVTDFLSA 283
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF---------LLIT-------DW 509
+ L S + V L+ K L+ ++ D
Sbjct: 284 ATTTHISLDHHSMTLTPDEV-KSLLL--KYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 510 A-----WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564
W N K+ I + + + F R+ + + PT L ++
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI---PT--ILLSLI 395
Query: 565 EGDIDIPTLPERPLPLTHESFKAS-------PSRYS 593
D+ + + ++ K S S S
Sbjct: 396 WFDVI----KSDVMVVVNKLHKYSLVEKQPKESTIS 427
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-07
Identities = 53/360 (14%), Positives = 111/360 (30%), Gaps = 94/360 (26%)
Query: 320 ITDLDTKGDEEFIN------EVEIISKIRHRNLLSLRGC-CVSSDDEKGKRRFLV----- 367
+ + D K ++ E++ I + +LR + S E+ ++F+
Sbjct: 30 VDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI 89
Query: 368 -YDFM----------PSGSLGDHIS--NALTRKQLAWPQ----RKKIILDVAKGLAYLHY 410
Y F+ PS +I + L + + R + L + + L
Sbjct: 90 NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL----L 145
Query: 411 GLKPAIY---HRDI---KST---NILLDSEMKAKVADFGL----------AKQSLEGQSH 451
L+PA + K+ ++ L +++ K DF + + LE
Sbjct: 146 ELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK-MDFKIFWLNLKNCNSPETVLEMLQK 204
Query: 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511
L + + P + ++ S I ++ R + + LL+
Sbjct: 205 LLYQ-------IDPNWT---SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254
Query: 512 MLANSGKVDEIFDEFIREEGSRAVM-ERFVRV-----GILCAHVMVALRP---TIADALK 562
+ K F+ + ++ RF +V H+ + T +
Sbjct: 255 ----NAKAWNAFN-----LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 563 MLEG--DIDIPTLPERPL---PLTH----ESFKASPSRYSFLMTNERSIATSGMTSTISS 613
+L D LP L P ES + + + + + +T+ I S
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW----KHVNCDKLTTIIES 361
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 7e-07
Identities = 79/537 (14%), Positives = 144/537 (26%), Gaps = 184/537 (34%)
Query: 41 W-DRSQCLDPDGKLCCQTLTSL-VGIGLALYLRETSMFQLPNETAS-SSCLSDFQHNLA- 96
W + C P+ L + L L I R + S + L +
Sbjct: 186 WLNLKNCNSPETVL--EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 97 --ALSI-----NPSLVAACFPDKYQFVTRPSSCAGIVTTKDWRKLVGPTSALDSDCKNMT 149
L + N A F + SC ++TT+ K +T
Sbjct: 244 ENCLLVLLNVQNAKAWNA-F-N--------LSCKILLTTRF---------------KQVT 278
Query: 150 GFTQCSSCVEAGYKVNSQLVSIQQNSTKCFYFAILYAAGILN-DPKDEATAACILGLPLS 208
F + A + L T ++L L+ P+D P
Sbjct: 279 DF------LSAATTTHISLDHHSMTLTPDEVKSLL--LKYLDCRPQDLPREVL-TTNPR- 328
Query: 209 TSGSKNSSSNDRVIKIVVALLGALLGVLLAGGLIIMYRKW--YKKRKRNALHE------- 259
++++ + W +K + L
Sbjct: 329 ----------------RLSIIAES--------IRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 260 -----EFVRSFKD-SVLPNSGAK---------WFR--ESELDQATGGFSQKNLIGQGASG 302
E+ + F SV P S A WF +S++ + +L+ +
Sbjct: 365 VLEPAEYRKMFDRLSVFPPS-AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 303 VVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362
++ L +L K + NE + HR+++ D
Sbjct: 424 STI--SIPSIYL-------ELKVKLE----NEYAL-----HRSIV---------DHYNIP 456
Query: 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYH---- 418
+ F D +P LD Y H G +H
Sbjct: 457 KTFDSDDLIPP------------------------YLD---QYFYSHIG-----HHLKNI 484
Query: 419 ----RDIKSTNILLDSE-MKAKVADFGLAKQSLEGQSHLTTRVAGTY-GYLAPEYALYGQ 472
R + LD ++ K+ A + + ++ Y Y+ Y +
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK-FYKPYICDNDPKYER 543
Query: 473 LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
L + + F L + L S + LL +A + + IF+E ++
Sbjct: 544 LV--NAILDF------LPKIEENLICSKYTDLL------RIALMAEDEAIFEEAHKQ 586
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 31/182 (17%), Positives = 62/182 (34%), Gaps = 40/182 (21%)
Query: 296 IGQGASGVVYKGT---------LEDGTLVAVK----------QITDLDTKGDEEFINEVE 336
+ G++Y+ ++K + +N+ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 337 IISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSG-SLGDHISNALTRKQLAWPQRK 395
+ + + G V + K RFLV + G SL + + L+ +
Sbjct: 110 KLYSTPLLAIPTCMGFGV----HQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLS----E 158
Query: 396 KIILDVAK----GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV--ADFGLAKQSLEGQ 449
+ +L VA L +LH H ++ + NI +D E +++V A +G A +
Sbjct: 159 RSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 450 SH 451
H
Sbjct: 216 KH 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 39/180 (21%), Positives = 65/180 (36%), Gaps = 34/180 (18%)
Query: 295 LIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDE-----------EFINEVEIISKIRH 343
IGQG G +Y + V + + + + + E I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 344 RNLLSLRG-----CCVSSDDEKGKRRFLVYDFM-PS-GSLGDHISNALTRK---QLAWPQ 393
L G D RF++ D + + + +RK QL+ +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL-R 160
Query: 394 RKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV--ADFGLAKQSLEGQSH 451
ILD+ L Y+H + H DIK++N+LL+ + +V D+GLA + H
Sbjct: 161 ----ILDI---LEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 37/180 (20%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEI---------ISKIRHR 344
IG G G++Y A + ++ + + +E++ I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 345 NLLSLRG-----CCVSSDDEKGKRRFLVYDFMPSG-SLGDHI--SNALTRK---QLAWPQ 393
L G ++ + RF+V + + G L + + QL +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGI-R 159
Query: 394 RKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV--ADFGLAKQSLEGQSH 451
+LDV L Y+H + H DIK+ N+LL + +V AD+GL+ + +H
Sbjct: 160 ----MLDV---LEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 45/243 (18%), Positives = 80/243 (32%), Gaps = 78/243 (32%)
Query: 295 LIGQGASGVVYKG--TLEDGTLVAVKQITDLDTKGDEEFIN----EVEIISKIRHR---- 344
+G+G G V + + VA+K I + ++ E+ ++ KI+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 345 --NLLSLRGC-------CVSSDDEKGKRRFLVYDFMPSGS-LGDHISNALTR---KQLAW 391
+ + C++ + ++F+ + R QL
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEFLKENNFQP--YPLPHVRHMAYQLC- 133
Query: 392 PQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA----------------- 434
L +LH + + H D+K NIL +
Sbjct: 134 -----------HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 435 --KVADFGLAKQSLEGQSHLT---TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILEL 489
+VADFG A + + + H T TR Y PE L + DV+S G ++ E
Sbjct: 180 SIRVADFGSA--TFDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEY 232
Query: 490 MSG 492
G
Sbjct: 233 YRG 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 40/217 (18%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCC 353
IG G+ G +Y GT ++ VA+K + + + E +I ++ + ++R
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRK---KIILDVAK----GLA 406
V G LV D + SL D + RK K +L +A +
Sbjct: 73 VE-----GDYNVLVMDLLGP-SLEDL---------FNFCSRKLSLKTVLMLADQMINRVE 117
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAK---VADFGLAKQ--SLEGQSHLTTR----VA 457
++H + HRDIK N L+ +A + DFGLAK+ H+ R +
Sbjct: 118 FVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 458 GTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGR 493
GT Y A G + + + D+ S G V++ + G
Sbjct: 175 GTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 57/298 (19%), Positives = 102/298 (34%), Gaps = 90/298 (30%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFIN----EVEIISKIRHR----- 344
+G G G V +++ AVK + + +++ E +I+ KI++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 345 NLLSLRGC-------CVSSDDEKGKRRFLVYDFM-PSGSLGDHISNALTRKQLAWPQRKK 396
N++ G C+ + +Y+ + + G +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFE----PLGPSLYEIITRNNYNG--FHIEDIKL--------- 141
Query: 397 IILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA---------------------- 434
+++ K L YL K ++ H D+K NILLD
Sbjct: 142 YCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 435 ---KVADFGLAKQSLEGQSHLT---TRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIV 485
K+ DFG A + + H + TR Y APE L + SD++SFG V
Sbjct: 199 TGIKLIDFGCA--TFKSDYHGSIINTRQ-----YRAPEVILNLGWDV---SSDMWSFGCV 248
Query: 486 ILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVG 543
+ EL +G + T L A M + + + E ++ ++V
Sbjct: 249 LAELYTGSLLFRTHEHMEHL----AMMESIIQP----IPKNMLYEATKTNGSKYVNKD 298
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 43/220 (19%), Positives = 78/220 (35%), Gaps = 44/220 (20%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRH-RNLLSLRGCC 353
IG G G + G L VA+K + + ++ + E ++ + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ-LHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 354 VSSDDEKGKRRFLVYDFMPSG-SLGDHISNALTRKQLAWPQRK---KIILDVAK----GL 405
GK +V + + G SL D R K +L +A +
Sbjct: 75 PC-----GKYNAMVLELL--GPSLEDL---------FDLCDRTFSLKTVLMIAIQLISRM 118
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAK-----VADFGLAKQ--SLEGQSHLTTR--- 455
Y+H + +RD+K N L+ + DF LAK+ E + H+ R
Sbjct: 119 EYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 456 -VAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGR 493
+ GT Y G + + + D+ + G + + + G
Sbjct: 176 SLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 42/218 (19%)
Query: 296 IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRH-RNLLSLRGCC 353
IG G+ G +Y GT + G VA+K + + E +I ++ + ++R C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 354 VSSDDEKGKRRFLVYDFMPSG-SLGDHISNALTRKQLAWPQRK---KIILDVA----KGL 405
G +V + + G SL D + RK K +L +A +
Sbjct: 75 AE-----GDYNVMVMELL--GPSLEDL---------FNFCSRKFSLKTVLLLADQMISRI 118
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAK---VADFGLAKQ--SLEGQSHLTTR----V 456
Y+H HRD+K N L+ K + DFGLAK+ H+ R +
Sbjct: 119 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 457 AGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGR 493
GT Y A G + + + D+ S G V++ G
Sbjct: 176 TGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 614 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.94 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.06 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.7 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.7 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.88 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.76 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.17 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 90.76 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 90.39 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.02 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.91 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.23 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.24 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.17 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=459.35 Aligned_cols=259 Identities=24% Similarity=0.408 Sum_probs=205.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|...++||+|+||+||+|+++ +++.||||+++..+.+..++|.+|+++|++++|||||+++|+|. +.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 35667789999999999999874 47899999998766666788999999999999999999999997 45
Q ss_pred ceEEEEEecCCCCCcccccchhh------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
...+||||||++|+|.++|++.. ....++|.++++|+.|||+||+||| +.+||||||||+|||||
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence 56899999999999999987532 1246999999999999999999999 88999999999999999
Q ss_pred CCCcEEEeeecccccccCCC-ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLIT 507 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~ 507 (614)
+++++||+|||+++...... ....+...||+.|||||++.++.++.++|||||||+||||+| |+.||......+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---- 268 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---- 268 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH----
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH----
Confidence 99999999999998754433 233455789999999999999999999999999999999999 899997654321
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
..... ..+.. ...+...++.+.+++..|++.||++||||.||+++|+....
T Consensus 269 -~~~~i-~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 -AIDCI-TQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -HHHHH-HHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHHHH-HcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111 11110 01122334578889999999999999999999999987544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=452.29 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=208.4
Q ss_pred CccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 290 FSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
+...+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|. +..
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~~ 102 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----KDQ 102 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----ECC
Confidence 445678999999999999873 46889999997543 334578999999999999999999999997 345
Q ss_pred eEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
..+||||||++|+|.++|.... ....++|.++++|+.|||+||+||| +.+||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEEC
Confidence 6899999999999999996431 1346899999999999999999999 88999999999999999
Q ss_pred CCCcEEEeeecccccccCCC-ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLIT 507 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~ 507 (614)
+++++||+|||+++...... ....+...||+.|||||++.++.|+.++|||||||+||||+| |+.||......+
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---- 255 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---- 255 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH----
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998754432 233455689999999999999999999999999999999999 899997654321
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.... ...+... ..+.+.+..+.+++..|++.||++||||.||+++|+...
T Consensus 256 -~~~~-i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 256 -VVEM-IRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -HHHH-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -HHHH-HHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1111 1222211 112234457888999999999999999999999999753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-55 Score=453.77 Aligned_cols=257 Identities=23% Similarity=0.430 Sum_probs=210.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|...+.||+|+||+||+|++. +|+.||||+++..+.+..++|.+|++++++++|||||+++|+|. ++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence 45677889999999999999874 47889999998776666788999999999999999999999997 44
Q ss_pred ceEEEEEecCCCCCcccccchhh----------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL----------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~----------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 431 (614)
+..+||||||++|+|.++|+... ....++|.++++|+.|||+||+||| +++||||||||+||||+++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence 56899999999999999997532 2346999999999999999999999 8999999999999999999
Q ss_pred CcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHH
Q 036081 432 MKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDW 509 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~ 509 (614)
+++||+|||+|+........ ......||+.|||||++.++.|+.|+|||||||+||||+| |+.||......+ .
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-----~ 239 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----V 239 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----H
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----H
Confidence 99999999999865443322 2334579999999999999999999999999999999999 899997654321 1
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.... ..+... ..+...++.+.+++..|++.||++||||.||+++|++.
T Consensus 240 ~~~i-~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 240 IECI-TQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHH-HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-HcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 111111 11223445788899999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=446.41 Aligned_cols=258 Identities=29% Similarity=0.399 Sum_probs=201.7
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.+++...++||+|+||+||+|++++ .||||+++... .+..+.|.+|++++++++|||||+++|+|.. +..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~~ 106 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DNL 106 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------CeE
Confidence 3567788999999999999999763 59999987533 3345789999999999999999999999852 347
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+||||||++|+|.++|... ...++|.++++|+.|||+||+||| +.+||||||||+|||||+++++||+|||+|+.
T Consensus 107 ~iVmEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEEECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 9999999999999999753 457999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCC-ccccccccCCCCccchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 445 SLEGQ-SHLTTRVAGTYGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 445 ~~~~~-~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
..... ....+...||+.|||||++.+ +.|+.|+|||||||+||||+||+.||......... ......+...
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-----~~~~~~~~~~ 256 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-----IFMVGRGYAS 256 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-----HHHHHTTCCC
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-----HHHHhcCCCC
Confidence 54322 233455789999999999963 46999999999999999999999999765432211 1111111111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+. ..+.+.++.+.+++..|++.||++||||.||+++|+..
T Consensus 257 p~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 257 PDLS-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCST-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCcc-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0000 11222345788899999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=441.96 Aligned_cols=268 Identities=23% Similarity=0.343 Sum_probs=215.1
Q ss_pred cChHHHHHHhCCCccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCCCc-chHHHHHHHHHHHHccC-CCcccc
Q 036081 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLDTK-GDEEFINEVEIISKIRH-RNLLSL 349 (614)
Q Consensus 278 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H-~NIv~l 349 (614)
++..+.+...++|...+.||+|+||+||+|++.. ++.||||+++..... ..++|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444555556789999999999999999998652 368999999765433 35679999999999965 899999
Q ss_pred cccccccCCCCCceEEEEEecCCCCCcccccchhhh-------------ccCCCccchhHHHHHHHHHHHHHHhcCCCce
Q 036081 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALT-------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAI 416 (614)
Q Consensus 350 ~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~i 416 (614)
+|+|.. .+...+||||||++|+|.++|++... ...++|.+++.|+.|||+||+||| +++|
T Consensus 134 ~g~~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~i 206 (353)
T 4ase_A 134 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKC 206 (353)
T ss_dssp EEEECC----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred EEEEEe----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCe
Confidence 999864 23458999999999999999976422 245899999999999999999999 8999
Q ss_pred EecCCCCCceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCC
Q 036081 417 YHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494 (614)
Q Consensus 417 vHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~ 494 (614)
|||||||+||||++++.+||+|||+|+........ ..+...||+.|||||++.++.|+.++|||||||+||||+| |+.
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 99999999999999999999999999976544433 3445679999999999999999999999999999999998 999
Q ss_pred CCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 495 VLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 495 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
||.......... .....+... ..+......+.+++..|++.||++|||+.||+++|+.
T Consensus 287 Pf~~~~~~~~~~-----~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 287 PYPGVKIDEEFC-----RRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp SSTTCCCSHHHH-----HHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCHHHHHH-----HHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 997654332111 111111110 1122233567889999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=427.74 Aligned_cols=266 Identities=26% Similarity=0.313 Sum_probs=198.9
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHH--HHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFI--NEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~--~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++...+.||+|+||+||+|+++ |+.||||+++.. ..+++. .|+..+.+++|||||+++|+|...+. .....+|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~l 78 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL 78 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEE
Confidence 4566789999999999999985 899999999653 233343 45556678899999999999975432 2346899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhc-----CCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG-----LKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~-----~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
|||||++|+|.++|++ ..++|+.+.+|+.|+|+||+|||+. .+++||||||||+|||||.++++||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999964 4699999999999999999999943 134999999999999999999999999999
Q ss_pred cccccCCCcc---ccccccCCCCccchhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--------
Q 036081 442 AKQSLEGQSH---LTTRVAGTYGYLAPEYALYG------QLTEKSDVYSFGIVILELMSGRKVLETSNSSFL-------- 504 (614)
Q Consensus 442 a~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~-------- 504 (614)
|+........ .....+||+.|||||++.+. .++.|+|||||||+||||+||+.|+........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9876543322 22346899999999999754 467899999999999999999887754332210
Q ss_pred --hHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 505 --LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 505 --~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
....+. .....+.....+.. .....+..+.+.+++..|++.||++||||.||+++|+..
T Consensus 235 ~~~~~~~~-~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 235 DPSVEEMR-KVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHH-HHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHH-HHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111111 11111111111111 011234556788999999999999999999999999763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=418.21 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=198.1
Q ss_pred ccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 291 SQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
...++||+|+||+||+|++. ++..||||++... .....+.|.+|++++++++|||||++++++..... .....+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET-TEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC-CCcEEEEE
Confidence 45668999999999999976 5899999999653 22335679999999999999999999999864321 24568999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc--eEecCCCCCceeecC-CCcEEEeeeccccc
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA--IYHRDIKSTNILLDS-EMKAKVADFGLAKQ 444 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~-~~~~KL~DFGla~~ 444 (614)
||||++|+|.++|.+ ...+++..+..|+.||+.||+||| +.+ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999975 467999999999999999999999 666 999999999999984 79999999999985
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
... ......+||+.|||||++. +.|+.++|||||||+||||+||+.||........ .. .....+.....++
T Consensus 182 ~~~---~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~----~~-~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 182 KRA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IY-RRVTSGVKPASFD 252 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HH-HHHTTTCCCGGGG
T ss_pred CCC---CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH----HH-HHHHcCCCCCCCC
Confidence 432 2344578999999999886 5699999999999999999999999975433211 11 1122222111111
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ....+.+++..|++.||++|||+.|++++
T Consensus 253 ----~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 ----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----cc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 12357789999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=430.41 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=207.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
..|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++. +.+..||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 35788899999999999999986 69999999997665556677999999999999999999999997 4567999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++.+ ..+++.+...++.||+.||+||| +.+||||||||+||||+.++++||+|||+|+...
T Consensus 149 vmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 9999999999998854 46999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.... ..+..+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.... + ........ +.
T Consensus 222 ~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~----~~i~~~~~------~~ 289 (346)
T 4fih_A 222 KEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-M----KMIRDNLP------PR 289 (346)
T ss_dssp SSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H----HHHHHSSC------CC
T ss_pred CCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-H----HHHHcCCC------CC
Confidence 4332 34457899999999999999999999999999999999999999976443211 1 11111100 00
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+ .....+...+.+++..|++.||++|||+.|++++
T Consensus 290 ~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp C--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 0111233467889999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=430.51 Aligned_cols=252 Identities=20% Similarity=0.201 Sum_probs=204.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.+.|...++||+|+||+||+|+.. +|+.||||+++... .+.+|++++++++|||||++++++. +++..+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVR-----EGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 456778889999999999999976 69999999997532 2347999999999999999999987 456799
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DFGla~~ 444 (614)
|||||+++|+|.++|.+ .+.+++.+...++.||+.||+||| +.+||||||||+||||+.++ ++||+|||+|+.
T Consensus 127 ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp EEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred EEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 99999999999999975 457999999999999999999999 89999999999999999998 699999999987
Q ss_pred ccCCCcc----ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 445 SLEGQSH----LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 445 ~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
....... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.......... .. .......
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~i----~~~~~~~ 275 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KI----ASEPPPI 275 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-HH----HHSCCGG
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-HH----HcCCCCc
Confidence 6443211 1234679999999999999999999999999999999999999997654433211 11 1111100
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
...+..+...+.+++..|++.||.+|||+.|++++|...
T Consensus 276 --------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 --------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 011223345778899999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=432.87 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=200.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.|.+|++++++++|||||++++++. +.+..
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence 57999999999999999999975 69999999997543 233567999999999999999999999987 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
||||||+++|+|.++|... ....+++.+.+.|+.||+.||+||| +.+||||||||+||||+.++++||+|||+|+.
T Consensus 99 yiVmEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174 (350)
T ss_dssp EEEEECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence 9999999999999999653 2345688889999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... ...+..+||+.|||||++.+..|+.++|||||||+||||+||+.||...+... ....... +....
T Consensus 175 ~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~~~~i~~-~~~~~--- 244 (350)
T 4b9d_A 175 LNSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----LVLKIIS-GSFPP--- 244 (350)
T ss_dssp CCHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHH-TCCCC---
T ss_pred ecCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHHc-CCCCC---
Confidence 53321 22345689999999999999999999999999999999999999997654321 1111111 11110
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+......+.+++..|++.||++|||+.|++++
T Consensus 245 ------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 ------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112233467889999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=420.83 Aligned_cols=247 Identities=18% Similarity=0.256 Sum_probs=205.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||+||+++.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++. +.+.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 46899999999999999999975 6999999999642 2234567999999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.||||||+++|+|.+++.+ .+.+++.+...++.||+.||+||| +.+|+||||||+||||+.++++||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence 9999999999999999975 467999999999999999999999 8999999999999999999999999999999
Q ss_pred cccCCC-ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
...... .......+||+.|||||++.+..|+.++||||+||+||||++|+.||...+.... + ..... +..
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~----~~i~~-~~~--- 251 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-F----AKIIK-LEY--- 251 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H----HHHHH-TCC---
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H----HHHHc-CCC---
Confidence 765433 2334567899999999999999999999999999999999999999976443211 1 11111 111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADAL 561 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl 561 (614)
..+......+.+++..|++.||++|||+.|++
T Consensus 252 -------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 01122334678899999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=431.10 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=207.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
+.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++. .++..||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEEE
Confidence 45888999999999999999976 69999999998766666778999999999999999999999997 4567999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
|||||++|+|.+++.. ..+++.+...|+.||+.||+||| +.+||||||||+||||+.++++||+|||+|+...
T Consensus 226 VmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 9999999999998854 46999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.... ..+..+||+.|||||++.+..|+.++|||||||+||||++|+.||........ ......... +.
T Consensus 299 ~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-----~~~i~~~~~------~~ 366 (423)
T 4fie_A 299 KEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDNLP------PR 366 (423)
T ss_dssp SSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCC------CC
T ss_pred CCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----HHHHHcCCC------CC
Confidence 4332 34457899999999999999999999999999999999999999976442211 111111100 00
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+. ....+...+.+++..|++.||++|||+.|++++
T Consensus 367 ~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred Cc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 111233467889999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=407.29 Aligned_cols=246 Identities=21% Similarity=0.318 Sum_probs=189.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++. ..+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCE
Confidence 68999999999999999999975 69999999996532 233567999999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+ +|+|.+++.+ ++.+++.+...++.||+.||+||| +.+|+||||||+||||++++++||+|||+|+
T Consensus 88 ~~ivmEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN 160 (275)
T ss_dssp EEEEEECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred EEEEEeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCe
Confidence 99999999 6899998865 467999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
...... .....+||+.|||||++.+..+ +.++||||+||+||||+||+.||...+... ..... ..+...
T Consensus 161 ~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-----~~~~i-~~~~~~-- 230 (275)
T 3hyh_A 161 IMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-----LFKNI-SNGVYT-- 230 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-HHTCCC--
T ss_pred ecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHH-HcCCCC--
Confidence 654322 2344689999999999998776 579999999999999999999997643221 11111 111110
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+......+.+++..|++.||++|||+.|++++
T Consensus 231 --------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 --------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 112233467789999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=414.11 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=195.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|+..+.||+|+||+||+++.. .++.||||+++... ......+.+|++++++++|||||++++++. +.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence 46899999999999999999863 47899999996532 223456889999999999999999999987 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
+..++||||+++|+|.++|.+ .+.+++.+...++.||+.||+||| +.+|+||||||+|||++.++++||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccc
Confidence 679999999999999999975 457999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
|+...... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+..+. ...... +..
T Consensus 173 a~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----~~~i~~-~~~-- 243 (304)
T 3ubd_A 173 SKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----MTMILK-AKL-- 243 (304)
T ss_dssp EEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHH-CCC--
T ss_pred ceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-----HHHHHc-CCC--
Confidence 98654332 223456899999999999999999999999999999999999999976543221 111111 111
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
..+......+.+++..|++.||++||| ++|++++
T Consensus 244 --------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 --------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 011223346788999999999999998 5677653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=404.92 Aligned_cols=256 Identities=20% Similarity=0.305 Sum_probs=189.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCC------
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE------ 359 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~------ 359 (614)
++|+..+.||+|+||+||+|+.. +|+.||||+++....+ ..+.+.+|++++++++|||||++++++.+.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999976 6999999999754433 346789999999999999999999998754321
Q ss_pred -CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 360 -KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 360 -~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.....++||||+++|+|.+++..........+...+.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 23457999999999999999976433334556668899999999999999 89999999999999999999999999
Q ss_pred ecccccccCCCcc-----------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHH
Q 036081 439 FGLAKQSLEGQSH-----------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLIT 507 (614)
Q Consensus 439 FGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~ 507 (614)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||....+. .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---~- 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---V- 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---H-
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---H-
Confidence 9999876433211 1234579999999999999999999999999999999996 66432110 0
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... ............. ........++..|++.||++|||+.|++++
T Consensus 235 ~~~-~~~~~~~~p~~~~---------~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 235 RTL-TDVRNLKFPPLFT---------QKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH-HHHHTTCCCHHHH---------HHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH-HHHhcCCCCCCCc---------ccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001 1112222221111 112245678899999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=398.56 Aligned_cols=295 Identities=41% Similarity=0.697 Sum_probs=248.5
Q ss_pred CCCcccChHHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccc
Q 036081 273 SGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRG 351 (614)
Q Consensus 273 ~~~~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g 351 (614)
.....|+..++..++++|...+.||+|+||.||+|+..+|+.||||++..... .....+.+|++++.+++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567899999999999999999999999999999988899999999875432 23347899999999999999999999
Q ss_pred cccccCCCCCceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC
Q 036081 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS 430 (614)
Q Consensus 352 ~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~ 430 (614)
++. .....++||||+++|+|.+++.... ....++|..++.|+.|++.||.|||..+..+|+||||||+|||++.
T Consensus 95 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 95 FCM-----TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp EEC-----CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred EEe-----cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 997 3456799999999999999987643 2345999999999999999999999433349999999999999999
Q ss_pred CCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CccchhHH
Q 036081 431 EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETS---NSSFLLIT 507 (614)
Q Consensus 431 ~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~---~~~~~~l~ 507 (614)
++.+||+|||+++..............||+.|+|||.+.++.++.++||||||+++|||++|+.||+.. ........
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 999999999999876555555555667999999999999999999999999999999999999999632 12224555
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCC
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPT 572 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~~~~ 572 (614)
+|..............+..+.........+.+.+++..|++.+|.+|||+.||+++|++......
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~ 314 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER 314 (326)
T ss_dssp HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSS
T ss_pred HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhh
Confidence 67766666777777777777666777788899999999999999999999999999998654443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=393.39 Aligned_cols=283 Identities=39% Similarity=0.649 Sum_probs=239.3
Q ss_pred ccChHHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCccccccccccc
Q 036081 277 WFRESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSS 356 (614)
Q Consensus 277 ~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~ 356 (614)
.+...++..++++|...+.||+|+||.||+|++++|+.||||++........+.+.+|++++++++||||+++++++.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 105 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-- 105 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC--
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--
Confidence 345566777899999999999999999999998889999999988766666788999999999999999999999986
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~K 435 (614)
..+..++||||+++|+|.+++.... ....++|.+++.++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 106 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 106 ---ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp ---CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEE
T ss_pred ---CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEE
Confidence 4456899999999999999997532 1235899999999999999999999 88999999999999999999999
Q ss_pred EeeecccccccCCC-ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc-hhHHHHHHHH
Q 036081 436 VADFGLAKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF-LLITDWAWML 513 (614)
Q Consensus 436 L~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~-~~l~~~~~~~ 513 (614)
|+|||+++...... ........||+.|+|||.+.++.++.++||||||+++|||++|+.||....... .....|....
T Consensus 180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 99999998644322 223344568999999999999999999999999999999999999997654433 3445565555
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
...+.+...+++.+......+..+.+.+++..|++.||++|||+.||+++|+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 566666666666665556677888999999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=401.68 Aligned_cols=267 Identities=22% Similarity=0.331 Sum_probs=203.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccC-CCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSD-DEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~-~~~~~~ 363 (614)
++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.... ..+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 56899999999999999999975 699999999975432 23457889999999999999999999886432 224567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.|||||||+ |+|.+++.+ .+.+++.+...++.||+.||.||| +.+||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999995 789988865 467999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCC---ccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 444 QSLEGQ---SHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 444 ~~~~~~---~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
...... ....+..+||+.|||||++.+. .++.++||||+||++|||++|+.||...+.... +....... .....
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~-g~p~~ 284 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVL-GTPSP 284 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHH-CCCCG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhc-CCCCh
Confidence 654321 2234457899999999998875 569999999999999999999999976543321 11111110 00000
Q ss_pred hh-------hhhHHhhh---h--C-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DE-------IFDEFIRE---E--G-----SRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~-------~~d~~l~~---~--~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. .....+.. . . .......+.+++..|++.||.+|||+.|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000000 0 0 00123467889999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=391.58 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=199.0
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCC
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~ 358 (614)
....+.|...+.||+|+||+||+|+.+ .++.||||++... .....+.+|++++.++ +|||||++++++.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~---- 90 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFR---- 90 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE----
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEE----
Confidence 345678999999999999999999853 4688999998653 2345688999999998 6999999999987
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-CcEEEe
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVA 437 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~KL~ 437 (614)
..+..++||||+++|+|.+++. .+++.+...++.||+.||+||| +.+|+||||||+|||++.+ +.+||+
T Consensus 91 -~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 91 -KNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp -ETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred -ECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEEC
Confidence 4567999999999999999873 4889999999999999999999 8999999999999999877 799999
Q ss_pred eecccccccCCCc---------------------------cccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHH
Q 036081 438 DFGLAKQSLEGQS---------------------------HLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILEL 489 (614)
Q Consensus 438 DFGla~~~~~~~~---------------------------~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~EL 489 (614)
|||+|+....... ...+..+||+.|+|||++.+. .|+.++||||+||++|||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence 9999985433211 112345799999999999875 589999999999999999
Q ss_pred HhCCCCCCCCCccchhHHHHHHHH----------hh-----------CCCchhhhhHHh------------------hhh
Q 036081 490 MSGRKVLETSNSSFLLITDWAWML----------AN-----------SGKVDEIFDEFI------------------REE 530 (614)
Q Consensus 490 ltG~~p~~~~~~~~~~l~~~~~~~----------~~-----------~~~~~~~~d~~l------------------~~~ 530 (614)
++|+.||....++...+....... .. ........+... ...
T Consensus 241 l~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 241 LSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred HHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 999999965544322111111000 00 000001110000 000
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 531 GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 531 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
......+.+.+++..|++.||.+|||+.|++++
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011223467889999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=368.25 Aligned_cols=282 Identities=35% Similarity=0.561 Sum_probs=228.4
Q ss_pred CCcccChHHHHHHhCCCccc------eeeeccCcEEEEEEEEcCCcEEEEEEeecCC----CcchHHHHHHHHHHHHccC
Q 036081 274 GAKWFRESELDQATGGFSQK------NLIGQGASGVVYKGTLEDGTLVAVKQITDLD----TKGDEEFINEVEIISKIRH 343 (614)
Q Consensus 274 ~~~~f~~~el~~at~~f~~~------~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~----~~~~~~f~~Ei~il~~l~H 343 (614)
....|+..++..++++|... +.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999988 8999999999999997 48899999986532 2335679999999999999
Q ss_pred CCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCC
Q 036081 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKS 423 (614)
Q Consensus 344 ~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp 423 (614)
|||+++++++. .....++||||+++|+|.+++........++|..++.++.|++.||.||| +.+|+||||||
T Consensus 90 ~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp 161 (307)
T 2nru_A 90 ENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKS 161 (307)
T ss_dssp TTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred CCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCH
Confidence 99999999987 34568999999999999999876544567999999999999999999999 88999999999
Q ss_pred CceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc
Q 036081 424 TNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSS 502 (614)
Q Consensus 424 ~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~ 502 (614)
+|||++.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......
T Consensus 162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 999999999999999999986543322 22344679999999998764 5899999999999999999999999865443
Q ss_pred chhHHHHHHHHhh-CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 503 FLLITDWAWMLAN-SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 503 ~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
... ..+...... ...+.+.+++.+. .......+.+.+++..|++.+|.+|||+.+|+++|+..
T Consensus 241 ~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 241 QLL-LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SBT-THHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHH-HHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 321 122222211 2233344443332 23455667899999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=372.02 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=209.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|...+.||+|+||+||+++.. +|+.||+|++...+....+.|.+|++++.+++||||+++++++. ++...++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeEE
Confidence 56788899999999999999986 68999999997766666788999999999999999999999997 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++... ...++|.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 99999999999999763 457999999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCccc-------------cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 447 EGQSHL-------------TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 447 ~~~~~~-------------~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~-------- 231 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-------- 231 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT--------
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH--------
Confidence 322211 11457999999999999999999999999999999999999998654332110
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
........+....+......+.+++..|++.||++|||+.++++.|+..
T Consensus 232 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 232 -----FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -----SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0001111111111222334678899999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=406.28 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=207.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||.||+++.+ +|+.||+|++........+.+.+|+++|++++|||||++++++. +....+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence 357999999999999999999976 69999999998765555678899999999999999999999987 456899
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC--CcEEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE--MKAKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~--~~~KL~DFGla~ 443 (614)
||||||++|+|.++|.+. ...+++.+...++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus 231 iv~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EEEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EEEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeecccee
Confidence 999999999999988652 456899999999999999999999 8999999999999999854 899999999999
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh-CCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN-SGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~ 522 (614)
...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..... ..... .....+.
T Consensus 306 ~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-----~~i~~~~~~~~~~ 378 (573)
T 3uto_A 306 HLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-----RNVKSCDWNMDDS 378 (573)
T ss_dssp ECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----HHHHTTCCCCCSG
T ss_pred EccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----HHHHhCCCCCCcc
Confidence 765433 234468999999999999999999999999999999999999999765432211 11111 1111110
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....+.+.+.+++..|++.||.+|||+.|++++
T Consensus 379 --------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 --------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011223467789999999999999999999885
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=402.02 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=197.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHH---HHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINE---VEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E---i~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
++|+..++||+|+||+||+++.. +|+.||||++.+.. .+....+.+| +.++..++|||||++++++. +
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~-----~ 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-----E
Confidence 56889999999999999999976 69999999996421 2223334444 55556678999999999997 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....||||||+++|+|.++|.+ .+.+++.....++.||+.||.||| +.+||||||||+|||||.+|++||+|||
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFG 337 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 337 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccc
Confidence 5679999999999999999975 467999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
+|+...... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......... ........ ...
T Consensus 338 lA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~i~~-~~~ 411 (689)
T 3v5w_A 338 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT-MAV 411 (689)
T ss_dssp TCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHHHHH-CCC
T ss_pred eeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhhcC-CCC
Confidence 998764432 334689999999999975 57999999999999999999999999754332211 11111111 100
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
..+......+.+++..|++.||.+|++ +.||++|
T Consensus 412 ----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 112223456788999999999999998 6887653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=373.76 Aligned_cols=264 Identities=30% Similarity=0.412 Sum_probs=203.5
Q ss_pred HHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 282 ELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 282 el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
+++...++|...+.||+|+||+||+|+.. |+.||||++..... ...+.|.+|++++++++||||+++++++.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 104 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----- 104 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----
Confidence 33444567889999999999999999884 88999999875432 23467899999999999999999999987
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc--eEecCCCCCceeecCCCcEEEe
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA--IYHRDIKSTNILLDSEMKAKVA 437 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~~~~~KL~ 437 (614)
.....++||||+++|+|.+++........+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 34568999999999999999976544445999999999999999999999 778 9999999999999999999999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........
T Consensus 182 Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-----~~~~~~~~ 255 (309)
T 3p86_A 182 DFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-----VAAVGFKC 255 (309)
T ss_dssp CCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----HHHHHHSC
T ss_pred CCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcC
Confidence 999997543221 223346799999999999999999999999999999999999999976543211 11110011
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
... ..+......+.+++..|++.+|.+|||+.++++.|+....
T Consensus 256 ~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 256 KRL---------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 100 1112233467889999999999999999999999987644
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=360.87 Aligned_cols=267 Identities=25% Similarity=0.360 Sum_probs=207.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHH--ccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISK--IRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~--l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||+||+|++ +|+.||||++.. ...+.+..|.+++.. ++||||+++++++..... .....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~-~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRH-SSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET-TEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccC-CCcee
Confidence 46788999999999999999998 589999999864 345667788888887 789999999998764322 34678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcC-----CCceEecCCCCCceeecCCCcEEEeee
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL-----KPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~-----~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
++||||+++|+|.+++.. ..+++..+++++.||+.||+|||... +.+|+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999999954 46999999999999999999999432 679999999999999999999999999
Q ss_pred cccccccCCCccc---cccccCCCCccchhhhccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 036081 440 GLAKQSLEGQSHL---TTRVAGTYGYLAPEYALYG------QLTEKSDVYSFGIVILELMSG----------RKVLETSN 500 (614)
Q Consensus 440 Gla~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSfGvvL~ELltG----------~~p~~~~~ 500 (614)
|+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654433221 2334799999999999876 455799999999999999999 77876543
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
......................-. ..........+.+++..|++.||++|||+.||+++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 322222222221111111111111 11123455688999999999999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.91 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=213.5
Q ss_pred cccChHHHHHHhCC----------CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCC
Q 036081 276 KWFRESELDQATGG----------FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHR 344 (614)
Q Consensus 276 ~~f~~~el~~at~~----------f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~ 344 (614)
..++.++++.+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 35778888888764 666789999999999999987 7999999999876666678899999999999999
Q ss_pred CcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 036081 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424 (614)
Q Consensus 345 NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~ 424 (614)
||+++++++. .+...++||||+++|+|.+++.. ..++|..+..++.|++.||.||| +.+|+||||||+
T Consensus 103 niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~ 170 (321)
T 2c30_A 103 NVVEMYKSYL-----VGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSD 170 (321)
T ss_dssp TBCCEEEEEE-----ETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGG
T ss_pred CcceEEEEEE-----ECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHH
Confidence 9999999987 35678999999999999998854 46999999999999999999999 889999999999
Q ss_pred ceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch
Q 036081 425 NILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL 504 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~ 504 (614)
|||++.++.+||+|||+++....... ......||+.|+|||++.++.++.++||||||+++|||++|+.||.......
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~- 248 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ- 248 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred HEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99999999999999999986544322 2345679999999999999999999999999999999999999997543221
Q ss_pred hHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 505 LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 505 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.......... .. +. ........+.+++..|++.||++|||+.|++++
T Consensus 249 ----~~~~~~~~~~-~~-----~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 ----AMKRLRDSPP-PK-----LK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----HHHHHHHSSC-CC-----CT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHhcCCC-CC-----cC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111110 00 00 011123467789999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.89 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=206.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||+||+|... +|+.||||++........+.+.+|+.++++++||||+++++++. .+...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEEE
Confidence 357889999999999999999964 68999999997665566778999999999999999999999987 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++|+|.+++.+ ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 99999999999999864 46899999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......+...
T Consensus 167 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~~~~~~~~----- 235 (297)
T 3fxz_A 167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPE----- 235 (297)
T ss_dssp CSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHHCSCC-----
T ss_pred CCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhCCCCC-----
Confidence 44332 234467999999999999999999999999999999999999999765432111 1111111100
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+......+.+++..|++.||++|||+.|++++
T Consensus 236 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 ---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ---CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00112233467889999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=367.98 Aligned_cols=268 Identities=26% Similarity=0.348 Sum_probs=206.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.++|...++||+|+||+||+|++. ++.||||+++... .....+..|+.++.+++||||+++++++..... .....++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence 456888999999999999999987 8999999986532 234456679999999999999999999875432 2456899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCC----------ceEecCCCCCceeecCCCcEEE
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP----------AIYHRDIKSTNILLDSEMKAKV 436 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~----------~ivHrDIKp~NILLd~~~~~KL 436 (614)
||||+++|+|.+++.. ..++|..++.++.|++.||+||| +. +|+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 9999999999999864 45999999999999999999999 77 9999999999999999999999
Q ss_pred eeecccccccCCCcc-ccccccCCCCccchhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Q 036081 437 ADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYG-----QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA 510 (614)
Q Consensus 437 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~-----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~ 510 (614)
+|||+++........ ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.......... +.
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~ 250 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP--FE 250 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT--TH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc--hh
Confidence 999999865443322 23346799999999999863 55678999999999999999999997654332100 00
Q ss_pred HHHhhCCCchhhhhHHhh--------h-hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 511 WMLANSGKVDEIFDEFIR--------E-EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~--------~-~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..........+..+.... . .......+.+.+++..|++.||++|||+.||++.|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000011111111111110 0 0112345578999999999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=353.80 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=210.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.++|...+.||+|+||.||+|+++++..||||+++... ...+++.+|++++.+++||||+++++++. .....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceEE
Confidence 45688899999999999999999988899999997543 34567999999999999999999999986 4556899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 99999999999999763 346999999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
...........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ..........
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~~~~~~~------ 224 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-----VLKVSQGHRL------ 224 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHHHTTCCC------
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-----HHHHHcCCCC------
Confidence 544333444556778999999999999999999999999999999 9999976543211 1111111100
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
..+......+.+++..|++.+|.+|||+.|++++|+....
T Consensus 225 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 ----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0011123467889999999999999999999999997543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=357.75 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=208.3
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|...+.||+|+||.||+|++.+++.||+|++.... ...+++.+|++++.+++||||+++++++. +....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceEEE
Confidence 4678889999999999999999889999999997543 34567999999999999999999999987 34568999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999998653 456899999999999999999999 89999999999999999999999999999986544
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..... ..+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-----~~~~~-~~~~-------- 224 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDI-STGF-------- 224 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHH-HTTC--------
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHH-hcCc--------
Confidence 33333344567888999999999999999999999999999999 999997644321 11111 1110
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
....+......+.+++..|++.+|++|||+.|++++|+..
T Consensus 225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 225 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0011112234678899999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=387.04 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=213.6
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
.+.+...++|...+.||+|+||.||+|+++++..||||+++... ...+.|.+|++++++++||||+++++++.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------ 253 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------ 253 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------
Confidence 34455667788999999999999999999889999999997643 44678999999999999999999999985
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....++||||+++|+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred CCccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 235799999999999999997532 346889999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
+++..............+|..|+|||.+..+.++.++||||||++||||++ |+.||....... ..........
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i~~~~~- 403 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYR- 403 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHHHTCC-
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcCCC-
Confidence 998654322222233456789999999999999999999999999999999 999997644221 1111111101
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
...+....+.+.+++..|++.||++|||+.+|+++|+....
T Consensus 404 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 ---------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 01122234578889999999999999999999999998643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=373.28 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=207.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc--------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCccccccccccc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE--------DGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSS 356 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~ 356 (614)
.++|...+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|++++.++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 456888999999999999999862 356799999976433 2346799999999999 8999999999987
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhh-------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCC
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALT-------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKS 423 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp 423 (614)
.....++||||+++|+|.+++..... ...+++.+++.++.||++||+||| +.+|+||||||
T Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp 231 (370)
T 2psq_A 158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA 231 (370)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccch
Confidence 34568999999999999999976321 235889999999999999999999 89999999999
Q ss_pred CceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 036081 424 TNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNS 501 (614)
Q Consensus 424 ~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~ 501 (614)
+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999986544322 22334567889999999999999999999999999999999 9999976543
Q ss_pred cchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 502 SFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 502 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.... .. ...+.. ...+......+.+++..|++.+|.+|||+.|+++.|+..
T Consensus 312 ~~~~--~~----~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 312 EELF--KL----LKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GGHH--HH----HHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH--HH----HhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2211 11 111110 011222335788899999999999999999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=368.12 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=205.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|...+.||+|+||.||+|++. .+..||||+++... ....+.|.+|++++.+++||||+++++++. .+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RG 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 346778899999999999999985 35569999997643 334567999999999999999999999986 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++... ...+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred CccEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 5689999999999999998653 357999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 442 AKQSLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 442 a~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ..... ..+.
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~~-~~~~ 271 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----VISSV-EEGY 271 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHH-HTTC
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHH-HcCC
Confidence 9876443222 2233456788999999999999999999999999999999 999997644321 11111 1110
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
....+......+.+++..|++.+|.+|||+.|++++|+...
T Consensus 272 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 272 ---------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00112223457888999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=372.57 Aligned_cols=270 Identities=23% Similarity=0.334 Sum_probs=213.7
Q ss_pred ccChHHHHHHhCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCc-chHHHHHHHHHHHHc-cCCCccc
Q 036081 277 WFRESELDQATGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTK-GDEEFINEVEIISKI-RHRNLLS 348 (614)
Q Consensus 277 ~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l-~H~NIv~ 348 (614)
.+...+.+...++|...+.||+|+||.||+|++. +++.||||+++..... ..+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3456667777889999999999999999999842 4689999999764332 346799999999999 7999999
Q ss_pred ccccccccCCCCCceEEEEEecCCCCCcccccchhhh-------------------------------------------
Q 036081 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALT------------------------------------------- 385 (614)
Q Consensus 349 l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~------------------------------------------- 385 (614)
+++++.. .+...++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 91 LLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp EEEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred eeeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 9999874 23458999999999999999876421
Q ss_pred --------------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 386 --------------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 386 --------------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 112888899999999999999999 889999999999999999999999999999865
Q ss_pred cCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 446 LEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 446 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||........... ....+...
T Consensus 244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-----~~~~~~~~--- 315 (359)
T 3vhe_A 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-----RLKEGTRM--- 315 (359)
T ss_dssp TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-----HHHHTCCC---
T ss_pred cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH-----HHHcCCCC---
Confidence 43322 23344678999999999999999999999999999999998 9999976543321111 11111100
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+......+.+++..|++.+|.+|||+.|++++|+..
T Consensus 316 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 316 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11112234678899999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=366.27 Aligned_cols=267 Identities=23% Similarity=0.389 Sum_probs=205.5
Q ss_pred hCCCccceeeeccCcEEEEEEEE-----cCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL-----EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|+..+.||+|+||+||++++ .+|+.||||++........+.|.+|++++.+++||||+++++++... ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 35688899999999999999985 25889999999876655567899999999999999999999988642 22
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++++||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 4579999999999999999763 345899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc--cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQS--HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... +..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~ 234 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMRMIGNDKQG 234 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHHHHCTTCCT
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHhhhcCcccc
Confidence 987543322 1223345778899999999999999999999999999999999988643211 11111011000
Q ss_pred h----hhhhHHh---hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 520 D----EIFDEFI---REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 520 ~----~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ...+... ....+......+.+++..|++.+|++|||+.|++++|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 0011000 0111223445788999999999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.21 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=205.1
Q ss_pred HhCCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
..++|...+.||+|+||.||+|+. .+|+.||||++... +....+.+.+|++++++++||||+++++++. ...
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence 456899999999999999999997 47999999999653 2233567889999999999999999999986 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++++||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred EEEEEEECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 79999999999999999865 356999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+...... ......||+.|+|||.+.+..++ .++|||||||++|||++|+.||...+... ....... +...
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~-~~~~- 232 (328)
T 3fe3_A 162 NEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-----LRERVLR-GKYR- 232 (328)
T ss_dssp GGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCCC-
T ss_pred eecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh-CCCC-
Confidence 8654332 23456799999999999988875 79999999999999999999997654221 1111111 1110
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+......+.+++..|++.||.+|||+.|++++
T Consensus 233 ---------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 ---------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111123467789999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=356.19 Aligned_cols=262 Identities=25% Similarity=0.316 Sum_probs=206.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+++.. +++.||+|++..... ...+.|.+|+.++.+++||||+++++++. .+.
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCC
Confidence 467889999999999999999975 689999999864332 22467899999999999999999999986 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++++||+|||++
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred eEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 78999999999999999865 357999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+..............||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~-~~~~ 232 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----AIKHIQDS-VPNV 232 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----HHHHHSSC-CCCH
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhhcc-CCCc
Confidence 87654443344556799999999999999999999999999999999999999976543211 11111111 1111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCCCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRP-TIADALKMLEGDIDI 570 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-tm~eVl~~L~~~~~~ 570 (614)
.. ......++.+.+++..|++.||.+|| ++.++.+.|+.....
T Consensus 233 -~~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 233 -TT----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -HH----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -ch----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11 11222345788899999999999999 999999999876443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=376.46 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=196.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|...+.||+|+||.||+|++. ++..||||+++... ....+.|.+|++++.+++||||+++++++. ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence 357888999999999999999875 57789999997543 234567999999999999999999999987 34
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++... ...+++.+++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 5689999999999999999753 356999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCccc--cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 442 AKQSLEGQSHL--TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 442 a~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
++......... .....+|..|+|||++.++.++.++||||||+++|||++ |+.||....... .... ...+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----~~~~-i~~~- 266 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----VIKA-VDEG- 266 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----HHHH-HHTT-
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH-HHcC-
Confidence 98754432221 222345778999999999999999999999999999998 999996543221 1111 1111
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.....+......+.+++..|++.+|.+||++.+|+++|+...
T Consensus 267 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 267 --------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp --------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 111112223457888999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=356.59 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=206.5
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
..++|...+.||+|+||.||++++.++..||||+++... ...+++.+|++++.+++||||+++++++. .....+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeE
Confidence 345688889999999999999999988899999997543 33567999999999999999999999986 455689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++|+|.+++... ...+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 96 IITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred EEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 999999999999998663 456999999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....... +.
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~-~~------ 238 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIAQ-GL------ 238 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHHT-TC------
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-----HHHHHhc-cc------
Confidence 4333223334457788999999999999999999999999999998 999997654321 1111111 10
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
....+....+.+.+++..|++.+|.+|||+.|++++|+..
T Consensus 239 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 ---RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0011111234678899999999999999999999999753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=381.08 Aligned_cols=261 Identities=30% Similarity=0.418 Sum_probs=206.7
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+...++|...+.||+|+||.||+|+++++..||||+++... ...++|.+|++++++++||||+++++++.. ..
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 34456788899999999999999999988889999997543 345789999999999999999999999852 35
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... ....+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred eEEEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccce
Confidence 79999999999999999753 2346899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
..............++..|+|||.+.++.++.++||||||+++|||++ |+.||....... ..... ..+.
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i-~~~~---- 398 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQV-ERGY---- 398 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHH-HTTC----
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-HcCC----
Confidence 754433333334457889999999999999999999999999999999 999997543221 11111 1111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDI 570 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~~ 570 (614)
....+....+.+.+++..|++.+|++|||+.+++++|+.....
T Consensus 399 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 399 -----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 0011223345788899999999999999999999999986543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=380.40 Aligned_cols=264 Identities=19% Similarity=0.233 Sum_probs=210.3
Q ss_pred ChHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCccccccccc
Q 036081 279 RESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCV 354 (614)
Q Consensus 279 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~ 354 (614)
...+++..+++|...++||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.++.+++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45666777889999999999999999999987 47899999996521 122345899999999999999999999997
Q ss_pred ccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcE
Q 036081 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA 434 (614)
Q Consensus 355 ~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 434 (614)
+....++||||+++|+|.+++.+. ...+++..++.++.||+.||.||| +.+|+||||||+||||+.++++
T Consensus 145 -----~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~v 214 (437)
T 4aw2_A 145 -----DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHI 214 (437)
T ss_dssp -----CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred -----eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCE
Confidence 456799999999999999999752 356999999999999999999999 8999999999999999999999
Q ss_pred EEeeecccccccCCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Q 036081 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW 509 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~ 509 (614)
||+|||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+..... ...
T Consensus 215 kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~i 293 (437)
T 4aw2_A 215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-GKI 293 (437)
T ss_dssp EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHH
T ss_pred EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH-Hhh
Confidence 99999999876555544455578999999999997 567899999999999999999999999765432211 000
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL--RPTIADALKM 563 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~eVl~~ 563 (614)
...... -... .........+.+++..|+..+|++ ||++.|++++
T Consensus 294 ~~~~~~-~~~p---------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHKER-FQFP---------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHHHH-CCCC---------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhcccc-ccCC---------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 000000 0000 000112346777888888888887 9999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=375.58 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=205.7
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..++|...+.||+|+||.||+|++. +|+.||||.++.... ...+.|.+|++++++++||||++++|++. ....
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCC
Confidence 3456888899999999999999987 789999999875432 23457899999999999999999999996 3456
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 89999999999999999753 346899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccc-ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 444 QSLEGQSHLT-TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 444 ~~~~~~~~~~-~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
.......... ....++..|+|||.+.++.++.++||||||+++|||++ |+.||....... . ......+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~----~~~~~~~~~-- 333 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--T----REFVEKGGR-- 333 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--H----HHHHHTTCC--
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H----HHHHHcCCC--
Confidence 6433221111 12235778999999999999999999999999999998 999997654221 1 111111110
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+...+..+.+++..|++.+|++|||+.++++.|+.
T Consensus 334 -------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 334 -------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 01112233467889999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=367.89 Aligned_cols=271 Identities=24% Similarity=0.335 Sum_probs=211.7
Q ss_pred CCCccceeeeccCcEEEEEEEE-----cCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTL-----EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|...+.||+|+||.||++++ .+++.||||++........+.+.+|++++.+++|+||+++++++... +..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CCc
Confidence 4578889999999999999984 35889999999876656667899999999999999999999988642 346
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred eEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 789999999999999999763 346999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 443 KQSLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 443 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+........ ......||..|+|||.+.+..++.++||||||+++|||++|+.|+.......... +.. ........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~-~~~~~~~~ 251 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGC-ERDVPALS 251 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC-----CCHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--ccc-ccccccHH
Confidence 876433322 2334568888999999999999999999999999999999999986532211000 000 00000011
Q ss_pred hhhhHHh---hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 521 EIFDEFI---REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 521 ~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
...+... ....+....+.+.+++..|++.||++|||+.|++++|+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 111223344578899999999999999999999999998644
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=356.19 Aligned_cols=258 Identities=25% Similarity=0.386 Sum_probs=210.1
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
...++|...+.||+|+||.||+|+.+++..||||.++... ...+.+.+|++++.+++||||+++++++. .+..
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCc
Confidence 3446788899999999999999999888899999997543 34678999999999999999999999875 2347
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++++|.+++.... ...+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 99999999999999997532 236999999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
.............++..|+|||.+.++.++.++||||||+++|||++ |+.||....... ..... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~~-~~~~----- 227 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNL-ERGY----- 227 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHH-HTTC-----
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-----HHHHH-hccc-----
Confidence 65443333344567889999999999999999999999999999999 899987543221 11111 1110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
....+....+.+.+++..|++.+|++|||+.+++++|+...
T Consensus 228 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 228 ----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 00111223357888999999999999999999999998743
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.55 Aligned_cols=273 Identities=19% Similarity=0.275 Sum_probs=213.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++.+++||||+++++++... .....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceEE
Confidence 56888999999999999999987 48999999997533 23356788999999999999999999988643 234689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee----cCCCcEEEeeecc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL----DSEMKAKVADFGL 441 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~KL~DFGl 441 (614)
+||||+++|+|.+++........+++.+++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999987544445999999999999999999999 8899999999999999 8888999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYAL--------YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~--------~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
++....... .....||+.|+|||.+. +..++.++||||||+++|||++|+.||........... .....
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~ 239 (319)
T 4euu_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE-VMYKI 239 (319)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH-HHHHH
T ss_pred ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH-HHHHH
Confidence 987544332 23457999999999986 57889999999999999999999999975443321111 11111
Q ss_pred hhC---CCchhh---hh------HHh--hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 514 ANS---GKVDEI---FD------EFI--REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 514 ~~~---~~~~~~---~d------~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
... ...... .. ..+ ...........+..++..|++.||++|||++|++++...+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 110 000000 00 000 112345667788899999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.97 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=203.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++. .+...
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 467899999999999999999976 789999999865332 23467899999999999999999999987 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++.. ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence 999999999999999875 356999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCC-ccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 445 SLEGQ-SHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 445 ~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
..... ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+.. .......
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~----~~~~~~~ 230 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTYLNP 230 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT----TCTTSTT
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----ccccCCc
Confidence 54322 222345679999999999987775 77999999999999999999999765543322222211 1110000
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.......+.+++..|++.||.+|||+.|++++
T Consensus 231 ---------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ---------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11123466789999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=364.48 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=198.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCc----EEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGT----LVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|...+.||+|+||+||+|++. +|+ .||+|.++.. .....++|.+|+.++++++||||+++++++..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 88 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 88 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES------
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence 45888999999999999999965 344 3688887543 23446789999999999999999999999973
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++|+||+++|+|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++++||+|||+
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 89 STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp SSEEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred CCeEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 2378999999999999998763 456999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++....... .......+|+.|+|||++.++.++.++||||||+++|||++ |+.||....... +.... ..+.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~----~~~~- 236 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL----EKGE- 236 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH----HTTC-
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHH----HcCC-
Confidence 987543332 22334567889999999999999999999999999999999 999997654332 11111 1111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
....+......+.+++..|++.+|.+|||+.|++++|+..
T Consensus 237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011122334678899999999999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=384.89 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=211.9
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
...+|...+.||+|+||.||+|++++ +..||||.++... ...++|.+|++++.+++||||++++++|. .....
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~ 291 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 291 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcE
Confidence 45568888999999999999999874 8899999997543 34678999999999999999999999997 34568
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++... ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 292 ~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp EEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeeccccee
Confidence 9999999999999999753 2356899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
.............++..|+|||.+.++.++.++|||||||+||||++ |+.||........ ... ...+
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~~~----~~~~------ 435 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YEL----LEKD------ 435 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHH----HHTT------
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHH----HHcC------
Confidence 64433333334456789999999999999999999999999999999 9999976543221 111 1111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
.....+....+.+.+++..|++.+|++|||+.+++++|+....
T Consensus 436 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 436 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111122334578889999999999999999999999997643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=356.63 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=198.5
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|...+.||+|+||.||+|++. ++.||||++... ...+.|.+|++++++++||||+++++++.. ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEEE
Confidence 45778899999999999999986 789999998642 345679999999999999999999998852 36899
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc-EEEeeeccccccc
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK-AKVADFGLAKQSL 446 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~-~KL~DFGla~~~~ 446 (614)
|||+++|+|.+++........+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999976433345788889999999999999999332289999999999999998886 7999999997543
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.... +....
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~-~~~~~----- 224 (307)
T 2eva_A 158 TH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAVHN-GTRPP----- 224 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH---HHHHHHT-TCCCC-----
T ss_pred cc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH---HHHHHhc-CCCCC-----
Confidence 22 22346899999999999999999999999999999999999999754332211 1111111 11111
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
........+.+++..|++.+|++|||+.|++++|+....
T Consensus 225 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 225 ----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp ----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111223467889999999999999999999999987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.32 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=202.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcE----EEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTL----VAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~----vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|...+.||+|+||.||+|++. +|+. ||+|.+.... .+....+.+|+.++.+++||||+++++++. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence 46788899999999999999975 4443 7888875433 333467889999999999999999999884 3
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++++||+|||+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred CccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCc
Confidence 4589999999999999998753 457999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++....... .......||..|+|||.+.++.++.++||||||+++|||++ |+.||........ .... ..+..
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~----~~~~~ 235 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--PDLL----EKGER 235 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--HHHH----HTTCB
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--HHHH----HcCCC
Confidence 987644332 23345678889999999999999999999999999999999 9999976543221 1111 11110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
. ..+......+.+++..|++.+|.+|||+.|++++|+....
T Consensus 236 ~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 L---------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp C---------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred C---------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 0111122356778899999999999999999999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=358.57 Aligned_cols=257 Identities=19% Similarity=0.282 Sum_probs=200.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCC------
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD------ 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~------ 358 (614)
.++|+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999987 79999999997533 3345789999999999999999999998865321
Q ss_pred ----------------------------------------------CCCceEEEEEecCCCCCcccccchhhhccCCCcc
Q 036081 359 ----------------------------------------------EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWP 392 (614)
Q Consensus 359 ----------------------------------------------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~ 392 (614)
......++||||+++|+|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 1123489999999999999999775444556677
Q ss_pred chhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCc-----------cccccccCCCC
Q 036081 393 QRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS-----------HLTTRVAGTYG 461 (614)
Q Consensus 393 ~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~-----------~~~~~~~gt~~ 461 (614)
.++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999 89999999999999999999999999999987644321 12234579999
Q ss_pred ccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHH
Q 036081 462 YLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVR 541 (614)
Q Consensus 462 Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 541 (614)
|+|||.+.+..++.++||||||+++|||++|..|+.... .. ............. ......+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------~~-~~~~~~~~~~~~~---------~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------RI-ITDVRNLKFPLLF---------TQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------HH-HHHHHTTCCCHHH---------HHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------HH-HHHhhccCCCccc---------ccCChhHHH
Confidence 999999999999999999999999999999977642210 01 1111112211111 122235678
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 036081 542 VGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 542 l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
++..|++.||.+|||+.|++++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.20 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=203.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.+ +|+.||+|+++.. .....+.+.+|++++.+++||||+++++++. ....
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCCE
Confidence 56888999999999999999976 6999999999653 2234567889999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 80 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchh
Confidence 9999999999999998865 357899999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+... ....... +..
T Consensus 154 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~~-~~~---- 222 (337)
T 1o6l_A 154 EGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILM-EEI---- 222 (337)
T ss_dssp CSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCC----
T ss_pred hcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-----HHHHHHc-CCC----
Confidence 643222 22345679999999999999999999999999999999999999997643221 1111111 110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.||.+|| ++.|++++
T Consensus 223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 01112334678899999999999999 89999775
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=363.13 Aligned_cols=271 Identities=16% Similarity=0.197 Sum_probs=206.9
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCCCcc-----------hHHHHHHHHHHHHccCCCccc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLDTKG-----------DEEFINEVEIISKIRHRNLLS 348 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~~~-----------~~~f~~Ei~il~~l~H~NIv~ 348 (614)
..++|...+.||+|+||.||+|++.+ ++.||||++....... ...+..|+..+.+++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999864 4789999987543211 112334555566678999999
Q ss_pred ccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee
Q 036081 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL 428 (614)
Q Consensus 349 l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL 428 (614)
+++++..... .....++||||+ +|+|.+++... ...++|..++.|+.||+.||+||| +.+|+||||||+|||+
T Consensus 113 ~~~~~~~~~~-~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKN-GKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEET-TEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred EEeeeeeccC-CcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEE
Confidence 9999875322 235689999999 99999998752 457999999999999999999999 8899999999999999
Q ss_pred c--CCCcEEEeeecccccccCCCcc------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 036081 429 D--SEMKAKVADFGLAKQSLEGQSH------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500 (614)
Q Consensus 429 d--~~~~~KL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~ 500 (614)
+ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999865432211 1133459999999999999999999999999999999999999998643
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
...... ....... ...+.+.+++.+... ..+..+.+++..|++.+|.+||++.+++++|+...
T Consensus 266 ~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 266 KDPKYV-RDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp TCHHHH-HHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCHHHH-HHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 332211 1111111 123444444443211 22347788999999999999999999999987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=352.66 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=194.6
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
..++|...+.||+|+||.||+|+... +..||+|+++.... ...+.+.+|+.++.+++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence 34578889999999999999998753 45799999875433 33567999999999999999999999874
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCccEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccc
Confidence 23579999999999999998652 346899999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ . ... ..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-~----~~i-~~~~~ 235 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-I----GRI-ENGER 235 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-H----HHH-HTTCC
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-H----HHH-HcCCC
Confidence 998765443333444567889999999999999999999999999999997 9999976543321 1 111 11110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
. ..+......+.+++..|++.+|++|||+.|++++|+.
T Consensus 236 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 236 L---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0 0112233567889999999999999999999999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=362.88 Aligned_cols=264 Identities=24% Similarity=0.410 Sum_probs=210.9
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccc
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVS 355 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~ 355 (614)
+....++|...+.||+|+||.||+|+.. +++.||||+++.... ...+.|.+|++++.+++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~- 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA- 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-
Confidence 3445678999999999999999999975 348899999976433 33567999999999999999999999987
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhhh---------------------ccCCCccchhHHHHHHHHHHHHHHhcCCC
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALT---------------------RKQLAWPQRKKIILDVAKGLAYLHYGLKP 414 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~---------------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~ 414 (614)
.+...++||||+++|+|.+++..... ...+++.+++.++.||++||.||| +.
T Consensus 121 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~ 193 (343)
T 1luf_A 121 ----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ER 193 (343)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred ----cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 34568999999999999999876321 156899999999999999999999 88
Q ss_pred ceEecCCCCCceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-C
Q 036081 415 AIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-G 492 (614)
Q Consensus 415 ~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G 492 (614)
+|+||||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.++.++.++||||||+++|||++ |
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 999999999999999999999999999986533221 22334568899999999999999999999999999999999 9
Q ss_pred CCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 493 RKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 493 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
+.||....... .... ...+.... .+......+.+++..|++.+|++|||+.+++++|+....
T Consensus 274 ~~p~~~~~~~~-----~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 274 LQPYYGMAHEE-----VIYY-VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CCTTTTSCHHH-----HHHH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCcCCCCChHH-----HHHH-HhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 99997644221 1111 11221111 112233478889999999999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=348.34 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=207.3
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|...+.||+|+||.||+++..+++.||+|++.... ...+.+.+|++++.+++||||+++++++. .....++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeEEE
Confidence 4678889999999999999999889999999997643 33568999999999999999999999987 34568999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp ECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 9999999999998653 356899999999999999999999 88999999999999999999999999999986543
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~i-~~~~~------- 223 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDI-STGFR------- 223 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHH-HTTCC-------
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-----HHHHH-hcCCc-------
Confidence 22222334567889999999999999999999999999999999 899987643221 11111 11100
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
...+......+.+++..|++.+|++|||+.+++++|+..
T Consensus 224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 --LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001112234678899999999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.28 Aligned_cols=250 Identities=29% Similarity=0.398 Sum_probs=203.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.++|...+.||+|+||.||+|++. |+.||||+++... ..+.|.+|++++++++||||+++++++... ....++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceEE
Confidence 456888899999999999999986 7899999997543 456899999999999999999999998642 236899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++... ....+++..++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999763 2234789999999999999999999 8899999999999999999999999999998543
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.. .....++..|+|||.+.++.++.++||||||+++|||++ |+.||......... .. ...+.
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-----~~-i~~~~------- 403 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----PR-VEKGY------- 403 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-----HH-HHTTC-------
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HH-HHcCC-------
Confidence 21 122357889999999999999999999999999999999 99999765432211 11 11111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
....+......+.+++..|++.+|++|||+.++++.|+.
T Consensus 404 --~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 404 --KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011122234577889999999999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=360.22 Aligned_cols=263 Identities=22% Similarity=0.360 Sum_probs=207.9
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEE------cCCcEEEEEEeecCC-CcchHHHHHHHHHHHHc-cCCCcccccccccc
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITDLD-TKGDEEFINEVEIISKI-RHRNLLSLRGCCVS 355 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~ 355 (614)
+...++|...+.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++.++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34457889999999999999999996 246689999997532 33457899999999999 89999999999873
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhhh--------------------ccCCCccchhHHHHHHHHHHHHHHhcCCCc
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALT--------------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~--------------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ 415 (614)
....++||||+++|+|.+++..... ...++|..++.++.||+.||.||| +.+
T Consensus 121 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 192 (344)
T 1rjb_A 121 -----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKS 192 (344)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred -----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 4568999999999999999876321 124789999999999999999999 899
Q ss_pred eEecCCCCCceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CC
Q 036081 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GR 493 (614)
Q Consensus 416 ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~ 493 (614)
|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||+| |+
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999865443322 2334567889999999999999999999999999999998 99
Q ss_pred CCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 494 KVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 494 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.||.......... .....+.. ...+....+.+.+++..|++.||.+|||+.|++++|+...
T Consensus 273 ~p~~~~~~~~~~~-----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 273 NPYPGIPVDANFY-----KLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CSSTTCCCSHHHH-----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCcccCCcHHHHH-----HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 9997654332111 11111110 0111122357888999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.36 Aligned_cols=263 Identities=22% Similarity=0.340 Sum_probs=208.8
Q ss_pred HHHHHhCCCccceeeeccCcEEEEEEEEcC------CcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccc
Q 036081 282 ELDQATGGFSQKNLIGQGASGVVYKGTLED------GTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCC 353 (614)
Q Consensus 282 el~~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~ 353 (614)
+.+...++|...+.||+|+||.||+|+... +..||||.++.... ...+.+.+|++++.++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344556789999999999999999999752 24799999976433 3356799999999999 899999999998
Q ss_pred cccCCCCCceEEEEEecCCCCCcccccchhhh-----------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCC
Q 036081 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALT-----------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422 (614)
Q Consensus 354 ~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-----------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIK 422 (614)
. .+...++||||+++|+|.+++..... ...+++..++.++.||+.||.||| +.+|+|||||
T Consensus 120 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 191 (333)
T 2i1m_A 120 T-----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVA 191 (333)
T ss_dssp C-----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred e-----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcc
Confidence 7 34568999999999999999876421 245789999999999999999999 8899999999
Q ss_pred CCceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 036081 423 STNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSN 500 (614)
Q Consensus 423 p~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~ 500 (614)
|+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999999999865433322 2334557889999999999999999999999999999999 899997644
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..... .... ..+. ....+......+.+++..|++.+|.+|||+.|++++|+.
T Consensus 272 ~~~~~-~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 272 VNSKF-YKLV----KDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp SSHHH-HHHH----HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHH-HHHH----hcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 32211 1111 1110 000111123467889999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=373.34 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=206.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
.++|...+.||+|+||.||+|++. +++.||||+++... .+....+.+|+.++.+++||||+++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 356888999999999999999953 46789999996543 334567899999999999999999999987
Q ss_pred CCceEEEEEecCCCCCcccccchhhh----ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC---
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALT----RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM--- 432 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~--- 432 (614)
.....++||||+++|+|.+++..... ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCc
Confidence 34567999999999999999976421 235889999999999999999999 88999999999999999555
Q ss_pred cEEEeeecccccccCCC-ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHH
Q 036081 433 KAKVADFGLAKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWA 510 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~ 510 (614)
.+||+|||+++...... ........||+.|+|||.+.++.++.++|||||||++|||++ |+.||....... ..
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-----~~ 296 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VL 296 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HH
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH
Confidence 59999999998543221 222334568999999999999999999999999999999998 999997644221 11
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCC
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDI 570 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~~ 570 (614)
......... ..+......+.+++..|++.+|++|||+.+|+++|+.....
T Consensus 297 ~~i~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 297 EFVTSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHcCCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111111110 11122334678899999999999999999999999875443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=354.34 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=209.0
Q ss_pred HHhCCCccceeeeccCcEEEEEEEE------cCCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCccccccccccc
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSS 356 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~ 356 (614)
...++|...+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT-- 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe--
Confidence 3456788999999999999999985 2468999999975433 3356799999999999 9999999999987
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhh---------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCC
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALT---------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDI 421 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~---------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDI 421 (614)
.+...++||||+++|+|.+++..... ...+++..++.++.||+.||.||| +.+|+||||
T Consensus 98 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl 171 (313)
T 1t46_A 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDL 171 (313)
T ss_dssp ---SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ---cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCC
Confidence 34567999999999999999876421 124899999999999999999999 889999999
Q ss_pred CCCceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 036081 422 KSTNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETS 499 (614)
Q Consensus 422 Kp~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~ 499 (614)
||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999999876544322 2233457889999999999999999999999999999999 99999765
Q ss_pred CccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 500 NSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 500 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
....... ... ..+ .....+......+.+++..|++.||.+|||+.|++++|+..
T Consensus 252 ~~~~~~~-~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 252 PVDSKFY-KMI----KEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp CSSHHHH-HHH----HHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHHH-HHh----ccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 4332111 111 111 01111122335778899999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=351.81 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=197.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--------------------------cchHHHHHHHHHHH
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--------------------------KGDEEFINEVEIIS 339 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--------------------------~~~~~f~~Ei~il~ 339 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467889999999999999999975 689999999865321 11356899999999
Q ss_pred HccCCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEec
Q 036081 340 KIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHR 419 (614)
Q Consensus 340 ~l~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHr 419 (614)
+++||||+++++++... .+...++||||+++|+|.+++. ...+++.+++.++.||+.||+||| +.+|+||
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 161 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHR 161 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 99999999999998742 2467899999999999998764 357999999999999999999999 8899999
Q ss_pred CCCCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCC---CCchhhHHHHHHHHHHHHhCCCCC
Q 036081 420 DIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ---LTEKSDVYSFGIVILELMSGRKVL 496 (614)
Q Consensus 420 DIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSfGvvL~ELltG~~p~ 496 (614)
||||+|||++.++++||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999987544322 233457999999999998665 378999999999999999999999
Q ss_pred CCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 497 ETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 497 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...... .+...... .... ........+.+.+++..|++.||++|||+.|++++
T Consensus 241 ~~~~~~-----~~~~~~~~-~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 241 MDERIM-----CLHSKIKS-QALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCSSHH-----HHHHHHHH-CCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCccHH-----HHHHHHhc-ccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 754321 11111111 1100 00011233467889999999999999999999753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=357.21 Aligned_cols=260 Identities=24% Similarity=0.368 Sum_probs=208.4
Q ss_pred HHhCCCccceeeeccCcEEEEEEEE------cCCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccC
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~ 357 (614)
...++|...+.||+|+||.||+++. .+++.||||+++.... ...+.+.+|++++.+++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 96 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS--- 96 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe---
Confidence 3456788899999999999999986 2458899999975432 33467899999999999999999999986
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhh---------------------ccCCCccchhHHHHHHHHHHHHHHhcCCCce
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALT---------------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAI 416 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~---------------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~i 416 (614)
.....++||||+++|+|.+++..... ...+++.+++.++.||++||.||| +.+|
T Consensus 97 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i 171 (314)
T 2ivs_A 97 --QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKL 171 (314)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred --cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCC
Confidence 34568999999999999999976422 134888999999999999999999 8899
Q ss_pred EecCCCCCceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCC
Q 036081 417 YHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494 (614)
Q Consensus 417 vHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~ 494 (614)
+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999865443322 2334567889999999999999999999999999999999 999
Q ss_pred CCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 495 VLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 495 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
||........ ... ...+... ..+....+.+.+++..|++.||++|||+.|++++|+..
T Consensus 252 p~~~~~~~~~--~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 252 PYPGIPPERL--FNL----LKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp SSTTCCGGGH--HHH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHH--HHH----hhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9976543321 111 1111100 11122335788899999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=357.06 Aligned_cols=257 Identities=21% Similarity=0.298 Sum_probs=196.4
Q ss_pred hCCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCc---chHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTK---GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+++. .+|+.||||+++..... ....+.+|++++.+++||||+++++++..... .+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCc
Confidence 46788999999999999999997 47899999999764322 23578899999999999999999999864332 234
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. ...+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 56999999999999999865 357999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCc--cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 443 KQSLEGQS--HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 443 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~ 238 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPIP 238 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCCC
Confidence 86543322 22334579999999999999999999999999999999999999997654321 111222222111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
. ... .......+.+++..|++.||++||+..++++
T Consensus 239 ~---~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 P---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp H---HHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred c---ccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 000 1112346788999999999999997766554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.77 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=193.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..++||+|+||+||+|+.. +|+.||||++..... .....+..|+..+.++ +|+||+++++++. ++..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 56899999999999999999987 799999999865332 2234566677777666 8999999999997 4667
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+ +++|.+++... ...++|..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeee
Confidence 99999999 67998888653 456999999999999999999999 7899999999999999999999999999988
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... ......||++|+|||++.+ .++.++||||||+++|||++|+.++.... . +.....+.....
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-------~--~~~~~~~~~~~~- 272 (311)
T 3p1a_A 206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-------G--WQQLRQGYLPPE- 272 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-------H--HHHHTTTCCCHH-
T ss_pred ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-------H--HHHHhccCCCcc-
Confidence 654322 2344569999999998875 79999999999999999999987664321 1 111222222111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.. ...+.+.+++..|++.||++|||+.|++++
T Consensus 273 ---~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 ---FTA----GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---ccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111 123578889999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=347.39 Aligned_cols=250 Identities=28% Similarity=0.445 Sum_probs=193.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC----cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT----KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~----~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+|++. |+.||||+++.... ...+.+.+|++++++++||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KEP 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC-
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence 457888999999999999999986 89999999865322 23467899999999999999999999987 345
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc---eEecCCCCCceeecC--------C
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA---IYHRDIKSTNILLDS--------E 431 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~---ivHrDIKp~NILLd~--------~ 431 (614)
..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++. +
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred ceEEEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccC
Confidence 68999999999999988853 57899999999999999999999 566 999999999999986 7
Q ss_pred CcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Q 036081 432 MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~ 511 (614)
+.+||+|||+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ...
T Consensus 153 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~ 224 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAY 224 (271)
T ss_dssp CCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHH
T ss_pred cceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHH
Confidence 789999999997653322 224578999999999999999999999999999999999999997644221 111
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...... .. ...+....+.+.+++..|++.+|++|||+.|++++|+.
T Consensus 225 ~~~~~~-~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 225 GVAMNK-LA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHTSC-CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hhhcCC-CC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111111 10 01112233578889999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.81 Aligned_cols=270 Identities=25% Similarity=0.339 Sum_probs=199.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHH--HccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIIS--KIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~--~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||.||+|+. +|+.||||++... ....+..|.+++. .++|+||+++++.+...........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788899999999999999987 4899999998642 3345555555544 5799999999987654444355678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCC---------ceEecCCCCCceeecCCCcEE
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP---------AIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~---------~ivHrDIKp~NILLd~~~~~K 435 (614)
++||||+++|+|.+++.. ...+|..+..++.||++||.||| +. +|+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence 999999999999999854 45689999999999999999999 67 999999999999999999999
Q ss_pred EeeecccccccCCC-------ccccccccCCCCccchhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 036081 436 VADFGLAKQSLEGQ-------SHLTTRVAGTYGYLAPEYALY-------GQLTEKSDVYSFGIVILELMSGRKVLETSNS 501 (614)
Q Consensus 436 L~DFGla~~~~~~~-------~~~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~ 501 (614)
|+|||+++...... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998654321 112234579999999999986 4567799999999999999999877643322
Q ss_pred cchhHHHHHHHHhhCCCchhhhhHHhh---------h--hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 502 SFLLITDWAWMLANSGKVDEIFDEFIR---------E--EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 502 ~~~~l~~~~~~~~~~~~~~~~~d~~l~---------~--~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.......+.... ......+.+...+. . .........+.+++..|++.||++|||+.|+++.|+...
T Consensus 241 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEV-GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHH-CSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhccc-CCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 110000000000 00000111111000 0 011234567899999999999999999999999998744
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=349.07 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=202.2
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
..++|...+.||+|+||.||+|++.+ +..||||.++... ....+.|.+|++++.+++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 35678889999999999999998653 3469999987643 3345779999999999999999999998752
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
...++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccC
Confidence 3468999999999999999653 456899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~~~---~~~~~~ 233 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IGVL---EKGDRL 233 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HHHH---HHTCCC
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HHHH---hcCCCC
Confidence 998765443333444567889999999999999999999999999999998 9999975443221 1111 111100
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..+....+.+.+++..|++.+|++|||+.|++++|+.
T Consensus 234 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 234 ----------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 0111223467889999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=343.84 Aligned_cols=259 Identities=16% Similarity=0.198 Sum_probs=207.3
Q ss_pred hCCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|++++.++ +|+|++++++++. .+...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCcee
Confidence 46789999999999999999996 479999999986533 335688999999999 7999999999886 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc-----EEEeee
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK-----AKVADF 439 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~-----~KL~DF 439 (614)
++||||+ +++|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++. +||+||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 9999999 99999999753 346999999999999999999999 899999999999999987776 999999
Q ss_pred cccccccCCCcc------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHH
Q 036081 440 GLAKQSLEGQSH------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LITDWAW 511 (614)
Q Consensus 440 Gla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~~~~~ 511 (614)
|+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .+.....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 999876443221 23456799999999999999999999999999999999999999986543221 1111110
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.. ...... .+ .....+.+.+++..|++.+|++|||+.+|++.|+...
T Consensus 236 ~~-~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 236 KK-QSTPLR-----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HH-HHSCHH-----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hc-cCccHH-----HH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 00 000000 00 1123357888999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=365.94 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=208.5
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc--------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE--------DGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVS 355 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~ 355 (614)
..++|...+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|++++.++ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec-
Confidence 3467888999999999999999863 246799999976433 3346789999999999 9999999999987
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhhh-------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCC
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALT-------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIK 422 (614)
.....++||||+++|+|.+++..... ...+++.+++.|+.||+.||+||| +.+|+|||||
T Consensus 146 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk 218 (382)
T 3tt0_A 146 ----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLA 218 (382)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred ----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCC
Confidence 34568999999999999999876321 235899999999999999999999 8899999999
Q ss_pred CCceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 036081 423 STNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSN 500 (614)
Q Consensus 423 p~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~ 500 (614)
|+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986543322 22344567889999999999999999999999999999999 999997543
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
... .... ...+... ..+......+.+++..|++.+|++|||+.||+++|+...
T Consensus 299 ~~~-----~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 299 VEE-----LFKL-LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHH-----HHHH-HHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH-----HHHH-HHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 221 1111 1111110 111123346888999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.43 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=201.3
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..++|...+.||+|+||+||+++..+|+.||||+++.... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 93 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERC 93 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSC
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCE
Confidence 4567899999999999999999998899999999864322 23467899999999999999999999987 4557
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||++ |+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 899999997 5787777552 356899999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC---c
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK---V 519 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~ 519 (614)
...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +....... .... .
T Consensus 168 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~-~~~~~~~~ 244 (311)
T 3niz_A 168 AFGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSIL-GTPNPREW 244 (311)
T ss_dssp ETTSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHH-CCCCTTTS
T ss_pred ecCCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHH-CCCChHHh
Confidence 654322 22334578999999999876 5689999999999999999999999976554432 11111111 1110 0
Q ss_pred hhhhhH------Hh-------hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDE------FI-------REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~------~l-------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....+. .. ...........+.+++..|++.||.+|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 00 000001123467889999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=352.85 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=211.5
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
...++|...+.||+|+||.||+|++.+ +..||||.++.. ....+.+.+|++++++++||||+++++++. ....
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 83 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPP 83 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCC
Confidence 345678889999999999999999874 889999998753 334578999999999999999999999986 4556
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... ....+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence 89999999999999998653 2356899999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~~~~----~~~----- 228 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELL----EKD----- 228 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHH----HTT-----
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----hcc-----
Confidence 765444444445567889999999999999999999999999999999 9999876543221 1111 111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.....+....+.+.+++..|++.+|.+|||+.|++++|+..
T Consensus 229 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 ----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 01111222335788899999999999999999999998763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=349.13 Aligned_cols=270 Identities=25% Similarity=0.306 Sum_probs=203.3
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHc--cCCCcccccccccccCCCC
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKI--RHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l--~H~NIv~l~g~~~~~~~~~ 360 (614)
-....++|...+.||+|+||.||+|+.. |+.||||++... ....+..|.+++..+ +||||+++++++..... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG-S 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-G
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-C
Confidence 3445578999999999999999999987 899999998642 344566677776665 89999999999875322 2
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCC--------ceEecCCCCCceeecCCC
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP--------AIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~--------~ivHrDIKp~NILLd~~~ 432 (614)
....++||||+++|+|.+++.. ..+++..++.++.|++.||.||| .. +|+||||||+|||++.++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCC
Confidence 2678999999999999999954 46999999999999999999999 66 999999999999999999
Q ss_pred cEEEeeecccccccCCCccc---cccccCCCCccchhhhccCCCCch------hhHHHHHHHHHHHHhC----------C
Q 036081 433 KAKVADFGLAKQSLEGQSHL---TTRVAGTYGYLAPEYALYGQLTEK------SDVYSFGIVILELMSG----------R 493 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~s~k------sDVwSfGvvL~ELltG----------~ 493 (614)
.+||+|||+++......... .....||+.|+|||.+.+...+.+ +||||||+++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997654332221 224579999999999987766665 9999999999999999 5
Q ss_pred CCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 494 KVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 494 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.||............+... .........+... .......+.+.+++..|++.||++|||+.||+++|+...
T Consensus 260 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREI-VCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHH-HTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHH-HhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 5554432222111111111 1111111111111 112356678999999999999999999999999998743
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=357.86 Aligned_cols=268 Identities=24% Similarity=0.394 Sum_probs=206.2
Q ss_pred CccceeeeccCcEEEEEEEEc-----CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-----DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-----~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
|...+.||+|+||.||++.+. +|+.||||+++.... +..+.+.+|++++++++||||+++++++... ....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 378899999999999998753 588999999976432 3356799999999999999999999998743 2457
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 8999999999999999864 35999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCc--cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 444 QSLEGQS--HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 444 ~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||............+.........+.+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 7654332 12334568889999999999999999999999999999999999986532211000000000000000111
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.++.......+......+.+++..|++.+|.+|||+.|+++.|+..
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111112233445788999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.73 Aligned_cols=257 Identities=16% Similarity=0.185 Sum_probs=205.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++..... .+.+.+|++++.++ +||||+++++++. .+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence 467889999999999999999964 689999999875432 34689999999999 9999999999987 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc-----EEEeee
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK-----AKVADF 439 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~-----~KL~DF 439 (614)
++||||+ +++|.+++... ...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++. +||+||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred EEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 9999999 99999998753 457999999999999999999999 889999999999999999887 999999
Q ss_pred cccccccCCCcc------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHH
Q 036081 440 GLAKQSLEGQSH------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LITDWAW 511 (614)
Q Consensus 440 Gla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~~~~~ 511 (614)
|+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 999875433221 12456799999999999999999999999999999999999999986543321 1111110
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..... . .+.+.. ..+ .+.+++..|++.+|.+||+++++++.|+..
T Consensus 235 ~~~~~-~-----~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 235 TKRAT-P-----IEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHS-C-----HHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hhccC-C-----HHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00000 0 000000 122 788899999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=356.83 Aligned_cols=270 Identities=23% Similarity=0.326 Sum_probs=197.0
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEcC-C---cEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccC
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLED-G---TLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~~-g---~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~ 357 (614)
....++|...+.||+|+||.||+|++.. + ..||||+++.. .....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445679999999999999999999764 3 27999998753 3344678999999999999999999999987433
Q ss_pred CC-CCceEEEEEecCCCCCcccccchhhh---ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc
Q 036081 358 DE-KGKRRFLVYDFMPSGSLGDHISNALT---RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK 433 (614)
Q Consensus 358 ~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~---~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 433 (614)
.. .....++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence 21 11234999999999999999865421 125899999999999999999999 889999999999999999999
Q ss_pred EEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHH
Q 036081 434 AKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 434 ~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~ 511 (614)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----~ 250 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-----N 250 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----H
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-----H
Confidence 99999999986543322 12233456889999999999999999999999999999999 89999765433211 1
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIP 571 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~~~ 571 (614)
........ ..+......+.+++..|++.||++|||+.++++.|++....+
T Consensus 251 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 YLIGGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhcCCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111110 111223357888999999999999999999999999865444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=344.09 Aligned_cols=252 Identities=30% Similarity=0.493 Sum_probs=201.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcch-------HHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGD-------EEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~-------~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
.++|...+.||+|+||.||+|+.. +++.||||++........ +.+.+|++++.+++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 467888999999999999999975 789999999865332221 6789999999999999999999998531
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc--eEecCCCCCceeecCCCc---
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA--IYHRDIKSTNILLDSEMK--- 433 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~~~~--- 433 (614)
.++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.
T Consensus 96 -----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 96 -----PRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp -----TEEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred -----CeEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCc
Confidence 26999999999999888653 457999999999999999999999 778 999999999999988776
Q ss_pred --EEEeeecccccccCCCccccccccCCCCccchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Q 036081 434 --AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA--LYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW 509 (614)
Q Consensus 434 --~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~--~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~ 509 (614)
+||+|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||.............
T Consensus 166 ~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred eeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 99999999975432 23346799999999998 35567899999999999999999999997654432211111
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
. ...+.. ...+......+.+++..|++.||.+|||+.|+++.|++
T Consensus 242 ~---~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 I---REEGLR---------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H---HHSCCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H---hccCCC---------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 111110 01112233578889999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=368.72 Aligned_cols=260 Identities=18% Similarity=0.219 Sum_probs=208.3
Q ss_pred hHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccc
Q 036081 280 ESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355 (614)
Q Consensus 280 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~ 355 (614)
..+++...++|...+.||+|+||+||+++.. +|+.||+|+++.. .....+.+.+|++++..++||||+++++++.
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~- 139 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ- 139 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence 3455667788999999999999999999986 5899999998642 1223446889999999999999999999997
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEE
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~K 435 (614)
+....++||||+++|+|.+++.+ ..+++..+..++.||+.||.||| +.+|+||||||+||||+.++++|
T Consensus 140 ----~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 140 ----DDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp ----CSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred ----ECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEE
Confidence 45679999999999999998854 46899999999999999999999 89999999999999999999999
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ----LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~ 511 (614)
|+|||+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.... ......
T Consensus 209 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~ 287 (410)
T 3v8s_A 209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMN 287 (410)
T ss_dssp ECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHT
T ss_pred EeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HHHHHh
Confidence 9999999876554433445678999999999998655 88999999999999999999999976543211 111100
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL--RPTIADALKM 563 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~eVl~~ 563 (614)
... .+.-.........+.+++..|++.+|.+ ||++.||+++
T Consensus 288 ~~~-----------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKN-----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHH-----------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccc-----------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 0000000122346778899999999988 9999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=353.84 Aligned_cols=252 Identities=20% Similarity=0.246 Sum_probs=204.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||.||+++.. +|+.+|+|.++.. ....+.+.+|++++.+++||||+++++++. .....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence 467889999999999999999976 5889999998643 334567899999999999999999999987 456799
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC--CCcEEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS--EMKAKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~--~~~~KL~DFGla~ 443 (614)
+||||+++|+|.+++... ...+++.+++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++
T Consensus 78 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 999999999999998652 346899999999999999999999 889999999999999987 7899999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ........ ... .
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~-~~~--~ 222 (321)
T 1tki_A 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----IIENIMNA-EYT--F 222 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHT-CCC--C
T ss_pred ECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-----HHHHHHcC-CCC--C
Confidence 764433 2334578999999999998889999999999999999999999997654321 11111111 100 0
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.... ......+.+++..|++.||.+|||+.|++++
T Consensus 223 ~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 223 DEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Chhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00000 1123467889999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=383.66 Aligned_cols=260 Identities=30% Similarity=0.422 Sum_probs=211.2
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+...++|...+.||+|+||.||+|+++++..||||+++... ...++|.+|++++++++|+||+++++++.. ..
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 34456788899999999999999999988889999997643 345789999999999999999999999852 45
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.++|... ....+++.+++.|+.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred ceEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 79999999999999999753 2346899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
..............++..|+|||.+.++.++.++|||||||+||||++ |+.||......+ ..... ..+.
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----~~~~i-~~~~---- 481 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQV-ERGY---- 481 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----HHHHH-HTTC----
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-HcCC----
Confidence 654322222233456789999999999999999999999999999999 999997543221 11111 1111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
....+....+.+.+++..|++.+|++|||+.+|+++|+....
T Consensus 482 -----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 -----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 001122234577889999999999999999999999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=350.24 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=203.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc------chHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK------GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~------~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
++|...+.||+|+||.||+++.. +|+.||||.++..... ..+.+.+|++++.+++||||+++++++. .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 45888999999999999999986 6899999999754321 3567999999999999999999999987 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC----cEEE
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM----KAKV 436 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~KL 436 (614)
....++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .+||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 5679999999999999999865 456899999999999999999999 89999999999999999887 8999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +.... ...
T Consensus 160 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~---~~~ 233 (326)
T 2y0a_A 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVS---AVN 233 (326)
T ss_dssp CCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHH---HTC
T ss_pred EECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHH---hcC
Confidence 9999998754332 23345799999999999999999999999999999999999999976443211 11000 011
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... . ... .....+.+++..|++.||.+|||+.|++++
T Consensus 234 ~~~~~---~-~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YEFED---E-YFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCCH---H-HHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCcCc---c-ccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11110 0 001 123467789999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=356.33 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=204.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc------chHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK------GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~------~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
.+.|...+.||+|+||.||+++.. +|+.||||.++..... ..+.+.+|++++.+++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----- 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE----- 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence 456888999999999999999976 6899999999754322 2467999999999999999999999987
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC----cEE
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM----KAK 435 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~K 435 (614)
.....++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+|
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEE
Confidence 45679999999999999999865 457999999999999999999999 88999999999999998877 799
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
|+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ + ... .
T Consensus 160 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~----~~i-~ 231 (361)
T 2yab_A 160 LIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-L----ANI-T 231 (361)
T ss_dssp ECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-H----HHH-H
T ss_pred EEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-H----HHH-H
Confidence 99999998754432 23446799999999999999999999999999999999999999976543211 1 111 1
Q ss_pred CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+... +++.... ...+.+.+++..|++.||.+|||+.|++++
T Consensus 232 ~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 232 AVSYD--FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCCC--CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11110 0111111 123467789999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.34 Aligned_cols=264 Identities=22% Similarity=0.349 Sum_probs=204.6
Q ss_pred CCCccceeeeccCcEEEEEEEE-----cCCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTL-----EDGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
+.|...+.||+|+||.||++++ .+|+.||||+++... ....+.+.+|++++.+++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 3478889999999999999984 358999999997533 33457899999999999999999999998743 23
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccc
Confidence 5689999999999999999653 456999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc--cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQS--HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+ .........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~ 245 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LF-LKMIGPTHG 245 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HH-HHHHCSCCG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HH-hhccCCccc
Confidence 987654332 223345688899999999999999999999999999999999998643211 00 000000000
Q ss_pred ---hhhhhHHhh----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 520 ---DEIFDEFIR----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 520 ---~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+...+. ...+....+.+.+++..|++.||.+|||+.|++++|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 000111111 11122344578899999999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.67 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=198.7
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~ 360 (614)
..++|+..+.||+|+||.||+++.+ +|+.||||+++.. .....+.+.+|.+++.++ +||||+++++++. .
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----T 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----e
Confidence 3468999999999999999999976 5899999999752 223345688999999998 6999999999987 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+||||+.++++||+|||
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG 169 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFG 169 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEcccc
Confidence 5679999999999999999865 357999999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....... +..
T Consensus 170 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~~-~~~- 241 (353)
T 3txo_A 170 MCKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFEAILN-DEV- 241 (353)
T ss_dssp TCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCC-
T ss_pred ceeecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-----HHHHHHc-CCC-
Confidence 99854322 223445679999999999999999999999999999999999999997654321 1111111 110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTI------ADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm------~eVl~~ 563 (614)
..+......+.+++..|++.+|.+||++ .|++++
T Consensus 242 ---------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 ---------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ---------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 0111233467789999999999999998 777653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.85 Aligned_cols=269 Identities=23% Similarity=0.346 Sum_probs=212.9
Q ss_pred cChHHHHHHhCCCccceeeeccCcEEEEEEEE------cCCcEEEEEEeecCCCc-chHHHHHHHHHHHHc-cCCCcccc
Q 036081 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTL------EDGTLVAVKQITDLDTK-GDEEFINEVEIISKI-RHRNLLSL 349 (614)
Q Consensus 278 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l-~H~NIv~l 349 (614)
+...+.....++|...+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45556666678899999999999999999985 24689999999764332 346789999999999 79999999
Q ss_pred cccccccCCCCCceEEEEEecCCCCCcccccchhhh-------------ccCCCccchhHHHHHHHHHHHHHHhcCCCce
Q 036081 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALT-------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAI 416 (614)
Q Consensus 350 ~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~i 416 (614)
++++.. .+...++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +.+|
T Consensus 97 ~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i 169 (316)
T 2xir_A 97 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKC 169 (316)
T ss_dssp EEEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred EEEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 999864 23458999999999999999876321 122788899999999999999999 8899
Q ss_pred EecCCCCCceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCC
Q 036081 417 YHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 494 (614)
Q Consensus 417 vHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~ 494 (614)
+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986544332 22334567899999999999999999999999999999998 999
Q ss_pred CCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 495 VLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 495 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
||........... ....+... ..+......+.+++..|++.+|.+|||+.|++++|+..
T Consensus 250 p~~~~~~~~~~~~-----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 250 PYPGVKIDEEFCR-----RLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp SSTTCCCSHHHHH-----HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccchhHHHHH-----HhccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9976543321111 11111100 01111234678899999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=353.81 Aligned_cols=270 Identities=16% Similarity=0.166 Sum_probs=202.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecCCCc-----------chHHHHHHHHHHHHccCCCcccccc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLDTK-----------GDEEFINEVEIISKIRHRNLLSLRG 351 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~~~-----------~~~~f~~Ei~il~~l~H~NIv~l~g 351 (614)
.++|...+.||+|+||.||+|+.. ++..+|||++...... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367889999999999999999985 5788999998754322 1234677888899999999999999
Q ss_pred cccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC
Q 036081 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 352 ~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 431 (614)
++..... .....++||||+ +++|.+++... ..+++.+++.|+.||+.||+||| +.+|+||||||+|||++.+
T Consensus 116 ~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFK-GRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESS-SCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESS
T ss_pred ccccccC-CCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccC
Confidence 9875321 357899999999 99999998763 37999999999999999999999 8899999999999999988
Q ss_pred C--cEEEeeecccccccCCCc------cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 036081 432 M--KAKVADFGLAKQSLEGQS------HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF 503 (614)
Q Consensus 432 ~--~~KL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~ 503 (614)
+ .+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999986543221 11244579999999999999999999999999999999999999996533322
Q ss_pred hhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 504 LLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 504 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
............ .+...+..... .....+.+.+++..|++.+|++|||+.+|+++|+....
T Consensus 268 ~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAVQTAKTNLLD--ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHH--TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHHhhcc--cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 211111111110 11111111111 11234578889999999999999999999999997543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=349.58 Aligned_cols=267 Identities=23% Similarity=0.246 Sum_probs=207.3
Q ss_pred HhCCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
..++|...+.||+|+||.||+++. .+|+.||||++........+.+.+|++++++++||||+++++++..... .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG-AKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET-TEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC-CCcee
Confidence 346789999999999999999997 4799999999976655667789999999999999999999999864321 34578
Q ss_pred EEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 365 FLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
++||||+++|+|.+++.... ....+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 99999999999999987632 2356899999999999999999999 8899999999999999999999999999987
Q ss_pred cccCCCcc--------ccccccCCCCccchhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Q 036081 444 QSLEGQSH--------LTTRVAGTYGYLAPEYALYGQ---LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM 512 (614)
Q Consensus 444 ~~~~~~~~--------~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~ 512 (614)
........ ......||+.|+|||.+.... ++.++||||||+++|||++|+.||...........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----- 257 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA----- 257 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-----
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-----
Confidence 54321110 112345799999999987543 78999999999999999999999854211110010
Q ss_pred HhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 513 LANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 513 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
..................+.+++..|++.||.+|||+.+++++|+....
T Consensus 258 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 258 --------LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --------HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0000000001111233578889999999999999999999999998643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=369.80 Aligned_cols=264 Identities=19% Similarity=0.229 Sum_probs=208.8
Q ss_pred cChHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccc
Q 036081 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCC 353 (614)
Q Consensus 278 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~ 353 (614)
+...+++...++|...+.||+|+||.||+++.+ +|+.||||++++.. ....+.+.+|.+++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667789999999999999999999986 69999999996522 12234588999999999999999999998
Q ss_pred cccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc
Q 036081 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK 433 (614)
Q Consensus 354 ~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 433 (614)
. +....++||||+++|+|.+++.+. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.+++
T Consensus 131 ~-----~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 131 Q-----DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp E-----CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred e-----eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCC
Confidence 7 456799999999999999999753 346899999999999999999999 899999999999999999999
Q ss_pred EEEeeecccccccCCCccccccccCCCCccchhhhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhH
Q 036081 434 AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL-------YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLI 506 (614)
Q Consensus 434 ~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-------~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l 506 (614)
+||+|||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+.....
T Consensus 201 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~- 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY- 279 (412)
T ss_dssp EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-
T ss_pred EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH-
Confidence 999999999876554443344568999999999997 357899999999999999999999999765432211
Q ss_pred HHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 036081 507 TDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALR---PTIADALKM 563 (614)
Q Consensus 507 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ptm~eVl~~ 563 (614)
....... ..-.. +.. .......+.+++..|++ +|.+| |++.|++++
T Consensus 280 ~~i~~~~-~~~~~-----p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVHYK-EHLSL-----PLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTHH-HHCCC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHhcc-cCcCC-----Ccc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0110000 00000 000 11233467889999999 99988 699999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=355.65 Aligned_cols=269 Identities=20% Similarity=0.386 Sum_probs=214.5
Q ss_pred cChHHHHHHhCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCccccc
Q 036081 278 FRESELDQATGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLR 350 (614)
Q Consensus 278 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~ 350 (614)
+..++.+...++|...+.||+|+||.||+|++. +++.||||.+..... .....+.+|++++.+++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 445566677788999999999999999999865 368899999975432 3345789999999999999999999
Q ss_pred ccccccCCCCCceEEEEEecCCCCCcccccchhhh-------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCC
Q 036081 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALT-------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKS 423 (614)
Q Consensus 351 g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp 423 (614)
+++. .+...++||||+++|+|.+++..... ...+++..+++++.||+.||.||| +.+|+||||||
T Consensus 95 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp 166 (322)
T 1p4o_A 95 GVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAA 166 (322)
T ss_dssp EEEC-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSG
T ss_pred EEEc-----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCcc
Confidence 9986 34568999999999999999876432 145789999999999999999999 88999999999
Q ss_pred CceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 036081 424 TNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNS 501 (614)
Q Consensus 424 ~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~ 501 (614)
+|||++.++.+||+|||+++....... .......+|+.|+|||.+.++.++.++||||||+++|||++ |+.||.....
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 999999999999999999986543322 12233457889999999999999999999999999999999 8889875432
Q ss_pred cchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 502 SFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 502 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
.. .... ...+.... .+......+.+++..|++.+|.+|||+.|++++|+....
T Consensus 247 ~~-----~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 EQ-----VLRF-VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HH-----HHHH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH-----HHHH-HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 21 1111 11111110 112233467889999999999999999999999998644
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=361.04 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=200.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|...++||+|+||.||+++.+ +++.||||+++... .+..+.+.+|..++.++ +||||+++++++. ..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence 356888999999999999999986 58899999997532 23345688999999987 8999999999987 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||||+.++++||+|||+
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGl 199 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecce
Confidence 679999999999999999875 357999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch---hHHHHHHHHhhCCC
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL---LITDWAWMLANSGK 518 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~---~l~~~~~~~~~~~~ 518 (614)
++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+........+.
T Consensus 200 a~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 200 CKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp CBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred eeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 9853322 2234456899999999999999999999999999999999999999964332110 00011111111111
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTI------ADALKM 563 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm------~eVl~~ 563 (614)
. ..+......+.+++..|++.||.+||++ .|++++
T Consensus 279 ~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 I----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp C----------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred c----------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0 1122234567889999999999999985 666553
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=354.38 Aligned_cols=254 Identities=22% Similarity=0.266 Sum_probs=201.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC-----CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL-----DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-----~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
+.|...+.||+|+||.||+++.. +|+.||||++... .....+.+.+|++++.+++||||+++++++. ..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----SD 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 45888999999999999999976 6899999998531 1224577999999999999999999999987 45
Q ss_pred ceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc---EEEe
Q 036081 362 KRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK---AKVA 437 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~KL~ 437 (614)
...++||||+++|+|.+++.... ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEe
Confidence 67899999999999988876532 2335889999999999999999999 889999999999999987655 9999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ... ..+
T Consensus 176 Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~----~~i-~~~ 247 (351)
T 3c0i_A 176 GFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLF----EGI-IKG 247 (351)
T ss_dssp CCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHH----HHH-HHT
T ss_pred cCcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHH----HHH-HcC
Confidence 999998764432 223445799999999999999999999999999999999999999976321 111 111 111
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... ..+... ....+.+.+++..|++.||++|||+.|++++
T Consensus 248 ~~~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 248 KYK--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 110 000000 1123467889999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.37 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=195.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC--cchHHHHHHHHHHHHccC--CCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT--KGDEEFINEVEIISKIRH--RNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H--~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||++...+++.||||++..... +..+.+.+|++++.+++| +||+++++++. .+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~ 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence 456889999999999999999998899999999875432 334678999999999986 99999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||| +.+|+|.+++.. ...+++.++..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||++
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EEEEEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence 7999999 568899999875 457899999999999999999999 88999999999999997 678999999999
Q ss_pred ccccCCCcc-ccccccCCCCccchhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Q 036081 443 KQSLEGQSH-LTTRVAGTYGYLAPEYALY-----------GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA 510 (614)
Q Consensus 443 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~ 510 (614)
+........ ......||+.|+|||++.+ +.++.++|||||||++|||++|+.||.........+
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---- 230 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---- 230 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH----
Confidence 876443322 2345679999999999975 778999999999999999999999997543221111
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.. .++.......+......+.+++..|++.||.+|||+.|++++-
T Consensus 231 ~~---------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 231 HA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HH---------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11 1111111111111224677899999999999999999998763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=343.87 Aligned_cols=260 Identities=24% Similarity=0.360 Sum_probs=206.2
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCC------
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD------ 358 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~------ 358 (614)
..++|...+.||+|+||.||+|+.. +|+.||+|+++... +.+.+|++++.+++||||+++++++...+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456888999999999999999986 79999999997532 457899999999999999999998753110
Q ss_pred -----CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc
Q 036081 359 -----EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK 433 (614)
Q Consensus 359 -----~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 433 (614)
......++||||+++|+|.+++... ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence 1245689999999999999999753 2356899999999999999999999 889999999999999999999
Q ss_pred EEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 434 AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 434 ~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.... .+. ..
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~-~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KFF-TD 230 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HHH-HH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HHH-HH
Confidence 9999999998654432 2234568999999999999999999999999999999999998864211 111 11
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPE 575 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~~~~~p~ 575 (614)
...+... ......+.+++..|++.||.+|||+.|++++|+.....+...+
T Consensus 231 ~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 231 LRDGIIS------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp HHTTCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred hhccccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 1112111 1122356788999999999999999999999988665544433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=357.31 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=203.2
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
..++|...+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|++++.+++||||+++++++. +..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 3467899999999999999999976 689999999975432 23467889999999999999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC---cEEEeee
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM---KAKVADF 439 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~---~~KL~DF 439 (614)
..++||||+++|+|.+++.. +..+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 78999999999999988865 356899999999999999999999 88999999999999998654 5999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ...+..
T Consensus 176 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~~~-i~~~~~ 247 (362)
T 2bdw_A 176 GLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LYAQ-IKAGAY 247 (362)
T ss_dssp TTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH-HHHTCC
T ss_pred CcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHH-HHhCCC
Confidence 9998654322 2334679999999999999999999999999999999999999997644221 1111 111111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ..+ ........+.+++..|++.||++|||+.|++++
T Consensus 248 ~~-~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 DY-PSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC-CTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC-Ccc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000 001123467889999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=354.14 Aligned_cols=263 Identities=24% Similarity=0.242 Sum_probs=201.3
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC-----CCcchHHHHHHHHHHHHccCCCccccccccc
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL-----DTKGDEEFINEVEIISKIRHRNLLSLRGCCV 354 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-----~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~ 354 (614)
.++....++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++.+++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 345667788999999999999999999975 6889999998642 3344578999999999999999999999997
Q ss_pred ccCCCCCceEEEEEecCCCCCcccccchhhh-------------------------------------ccCCCccchhHH
Q 036081 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNALT-------------------------------------RKQLAWPQRKKI 397 (614)
Q Consensus 355 ~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------------------------------------~~~l~~~~r~~I 397 (614)
+....++||||+++|+|.+++..... ...+++..++.|
T Consensus 99 -----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 173 (345)
T 3hko_A 99 -----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173 (345)
T ss_dssp -----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred -----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence 45679999999999999998852110 112345667889
Q ss_pred HHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC--cEEEeeecccccccCCC---ccccccccCCCCccchhhhcc--
Q 036081 398 ILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM--KAKVADFGLAKQSLEGQ---SHLTTRVAGTYGYLAPEYALY-- 470 (614)
Q Consensus 398 a~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~--~~KL~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~~~~-- 470 (614)
+.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++...... ........||+.|+|||.+.+
T Consensus 174 ~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 174 MRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 999999999999 88999999999999998776 89999999998653322 122345679999999999975
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccC
Q 036081 471 GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVM 550 (614)
Q Consensus 471 ~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~ 550 (614)
..++.++||||||+++|||++|+.||....... ............. .+ ........+.+++..|++.+
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~--~~-----~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-----TISQVLNKKLCFE--NP-----NYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCCCTT--SG-----GGGGSCHHHHHHHHHHSCSC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-----HHHHHHhcccccC--Cc-----ccccCCHHHHHHHHHHcCCC
Confidence 788999999999999999999999997654321 1111111111000 00 01112346788999999999
Q ss_pred CCCCCCHHHHHHH
Q 036081 551 VALRPTIADALKM 563 (614)
Q Consensus 551 p~~RPtm~eVl~~ 563 (614)
|.+|||+.|++++
T Consensus 319 p~~Rps~~~~l~h 331 (345)
T 3hko_A 319 VDERFDAMRALQH 331 (345)
T ss_dssp TTTSCCHHHHHHS
T ss_pred hhHCCCHHHHhcC
Confidence 9999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.26 Aligned_cols=260 Identities=29% Similarity=0.433 Sum_probs=195.5
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..++|...+.||+|+||.||+|+.. ..+|||+++.... ...+.|.+|++++++++||||+++++++. ...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~ 93 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ 93 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CCc
Confidence 3567899999999999999999875 3599999865432 33467999999999999999999999763 345
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred cEEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecc
Confidence 79999999999999998653 456899999999999999999999 8899999999999999999999999999997
Q ss_pred cccCC-CccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 444 QSLEG-QSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 444 ~~~~~-~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
..... .........||+.|+|||.+. ...++.++||||||+++|||++|+.||.......... ... ..+..
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~----~~~~~ 243 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-EMV----GRGSL 243 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH-HHH----HHTSC
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH-HHh----ccccc
Confidence 54322 122234467999999999987 6778999999999999999999999997654332111 111 11111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
...... ........+.+++..|++.+|.+|||+.+++++|+...
T Consensus 244 ~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccchhh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111110 11123357888999999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.08 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=198.2
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++. .....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeEE
Confidence 46888999999999999999998899999999865332 23467889999999999999999999987 345789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++ +|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 77 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp EEEECCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEEEecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 99999975 888887652 356899999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC---chh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK---VDE 521 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~~~ 521 (614)
.... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +..... ...... ...
T Consensus 151 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~-~~~~~~~~~~~~ 227 (288)
T 1ob3_A 151 GIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFR-ILGTPNSKNWPN 227 (288)
T ss_dssp CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH-HHCCCCTTTSTT
T ss_pred Cccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-HHCCCChhhchh
Confidence 3222 12334578999999999976 4589999999999999999999999976543221 111111 111100 000
Q ss_pred h-----hhHHhh-------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 I-----FDEFIR-------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~-----~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. .++.+. ........+.+.+++..|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000000 00011233567889999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=356.19 Aligned_cols=264 Identities=19% Similarity=0.239 Sum_probs=193.8
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCC--
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDD-- 358 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~-- 358 (614)
++....+|...+.||+|+||.||+++.. +|+.||||++........+.+.+|+.++.++. ||||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3344567899999999999999999975 68999999997666566678999999999996 9999999999853221
Q ss_pred -CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc--eEecCCCCCceeecCCCcEE
Q 036081 359 -EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA--IYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 359 -~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~~~~~K 435 (614)
......++||||+. |+|.+++........+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEE
Confidence 24567899999995 899998876545567999999999999999999999 777 99999999999999999999
Q ss_pred EeeecccccccCCCcc-----------ccccccCCCCccchhhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 036081 436 VADFGLAKQSLEGQSH-----------LTTRVAGTYGYLAPEYA---LYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501 (614)
Q Consensus 436 L~DFGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~~---~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~ 501 (614)
|+|||+++........ ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999865432221 11134689999999998 567789999999999999999999999965332
Q ss_pred cchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 502 SFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 502 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.. .. +..............+.+++..|++.+|.+|||+.|++++|+...
T Consensus 259 ~~-----~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 259 LR-----IV-------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-----hh-------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 00 000000000111124677899999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=359.76 Aligned_cols=249 Identities=25% Similarity=0.320 Sum_probs=196.8
Q ss_pred ccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 291 SQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
...+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++.+++||||+++++++. .....++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEe
Confidence 33568999999999999975 68999999998765556678999999999999999999999987 4567899999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee--cCCCcEEEeeecccccccC
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL--DSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL--d~~~~~KL~DFGla~~~~~ 447 (614)
|+++|+|.+++... ...+++..++.++.||++||.||| +.+|+||||||+|||+ +.++++||+|||+++....
T Consensus 167 ~~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 167 YVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp CCTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred CCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 99999999988652 356899999999999999999999 8899999999999999 6778999999999987643
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
... .....||+.|+|||++.++.++.++|||||||++|||++|+.||....... .+..... ...... ..
T Consensus 242 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~---~~~~~~---~~-- 310 (373)
T 2x4f_A 242 REK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILA---CRWDLE---DE-- 310 (373)
T ss_dssp TCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH---TCCCSC---SG--
T ss_pred ccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh---ccCCCC---hh--
Confidence 322 233569999999999999999999999999999999999999997654321 1111111 000000 00
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
......+.+.+++..|++.||.+|||+.|++++
T Consensus 311 ---~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 311 ---EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011223477889999999999999999999873
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=350.26 Aligned_cols=245 Identities=25% Similarity=0.308 Sum_probs=202.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.. +|+.||+|+++.. .....+.+.+|+.++..++||||+++++++. +...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~ 80 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 80 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCCE
Confidence 56888999999999999999976 6999999999653 1233567889999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 81 ~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~ 154 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK 154 (318)
T ss_dssp EEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcce
Confidence 9999999999999999875 356899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+... ........ ..
T Consensus 155 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~-~~---- 220 (318)
T 1fot_A 155 YVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----TYEKILNA-EL---- 220 (318)
T ss_dssp ECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHC-CC----
T ss_pred ecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhC-CC----
Confidence 65332 234679999999999999999999999999999999999999997643221 11111111 10
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.+|.+|| ++.|++++
T Consensus 221 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 01112234678899999999999999 89998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=347.66 Aligned_cols=270 Identities=23% Similarity=0.279 Sum_probs=203.3
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-----CcchHHHHHHHHHHHHcc---CCCccccccccccc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-----TKGDEEFINEVEIISKIR---HRNLLSLRGCCVSS 356 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~~~~~~f~~Ei~il~~l~---H~NIv~l~g~~~~~ 356 (614)
.+++|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999964 68999999986422 122356788888888875 99999999999765
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV 436 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL 436 (614)
........++||||+. |+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 4434456899999997 69999886532 234899999999999999999999 889999999999999999999999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +..........
T Consensus 162 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred eeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence 999999865332 223456799999999999999999999999999999999999999976543321 11111111000
Q ss_pred --CCchhh---hhHHhh-------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 --GKVDEI---FDEFIR-------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 --~~~~~~---~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...... ....+. .....+..+.+.+++..|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 000000 00011233577889999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=339.93 Aligned_cols=261 Identities=18% Similarity=0.241 Sum_probs=204.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
..++|...+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|++++.+++|+|++..++.+.. .+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence 457899999999999999999997 468999999876532 23468899999999999998888887753 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee---cCCCcEEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL---DSEMKAKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~KL~DFGl 441 (614)
++||||+ +|+|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 9999999 99999998642 356999999999999999999999 8899999999999999 7899999999999
Q ss_pred cccccCCCc------cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHH
Q 036081 442 AKQSLEGQS------HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF--LLITDWAWML 513 (614)
Q Consensus 442 a~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~~l~~~~~~~ 513 (614)
++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+.......
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 987644332 12234679999999999999999999999999999999999999997644322 1111111111
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
... . . +.+. ......+.+++..|++.+|++|||+.++++.|+...
T Consensus 235 ~~~-~----~-~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 235 MST-P----I-EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHS-C----H-HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ccc-h----h-hhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 100 0 0 0000 112347888999999999999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=359.07 Aligned_cols=268 Identities=19% Similarity=0.266 Sum_probs=203.0
Q ss_pred hCCCccceeeecc--CcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQG--ASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G--~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|+..+.||+| +||.||+++.. +|+.||||+++... ....+.+.+|++++++++||||+++++++. ..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----AD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----EC
Confidence 4568899999999 99999999987 69999999997532 233467888999999999999999999987 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
+..++||||+++|+|.+++... ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred CEEEEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 6799999999999999998753 2356899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc------cccccccCCCCccchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 442 AKQSLEGQS------HLTTRVAGTYGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 442 a~~~~~~~~------~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
+........ .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 865422211 11223478999999999987 6799999999999999999999999976544332111110000
Q ss_pred h---hC------------------CCchhhhhHH---------hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 A---NS------------------GKVDEIFDEF---------IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~---~~------------------~~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. .. ....+.+... ............+.+++..|++.||.+|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 00 0000000000 0000112233468889999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.60 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=200.9
Q ss_pred CCCccceeeeccCcEEEEEEEEcC-C-------cEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED-G-------TLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~-g-------~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
++|...+.||+|+||.||+|+... + ..||+|++........+.+.+|++++.+++||||+++++++.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 82 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV----- 82 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC-----
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----
Confidence 467888999999999999998653 3 579999997766666788999999999999999999999997
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc------
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK------ 433 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~------ 433 (614)
.+...++||||+++|+|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccc
Confidence 345679999999999999999763 345899999999999999999999 889999999999999998887
Q ss_pred --EEEeeecccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Q 036081 434 --AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA 510 (614)
Q Consensus 434 --~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~ 510 (614)
+||+|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+..........
T Consensus 158 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---- 228 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---- 228 (289)
T ss_dssp CEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----
T ss_pred ceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH----
Confidence 99999999875422 223457899999999987 779999999999999999999665543322211111
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
.......... ......+.+++..|++.||.+|||+.|++++|+....
T Consensus 229 ~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 QFYEDRHQLP------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHTTCCCC------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHhhccCCCC------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0011111111 1112357788999999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=344.20 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=200.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++. .+...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 46888999999999999999986 689999999975432 23467889999999999999999999987 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++ +|.+.+.. ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 77 ~lv~e~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EEEEECCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999975 55555543 2457999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCccccccccCCCCccchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+.........+....... .... .+..
T Consensus 151 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~-~~~~-~~~~ 227 (292)
T 3o0g_A 151 FGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL-GTPT-EEQW 227 (292)
T ss_dssp CCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH-CCCC-TTTC
T ss_pred cCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCCC-hhhh
Confidence 54322 2234457899999999998765 89999999999999999999988644433222222222111 1100 0000
Q ss_pred hHHhh----------------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIR----------------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~----------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... ..........+.+++..|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 00111233567889999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=349.48 Aligned_cols=266 Identities=20% Similarity=0.315 Sum_probs=190.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeE
Confidence 356888899999999999999975 689999999975432 33467899999999999999999999987 45678
Q ss_pred EEEEecCCCCCcccccchhhh---ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNALT---RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~---~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
++||||++ |+|.+++..... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999998 699988865321 235888999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC-CCc
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS-GKV 519 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~-~~~ 519 (614)
++...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ +.......... ...
T Consensus 155 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 155 ARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDIMGTPNESL 232 (317)
T ss_dssp CEETTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCTTT
T ss_pred ceecCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhH
Confidence 98654322 12334578999999999976 4689999999999999999999999976543321 11111110000 000
Q ss_pred -h-----------------hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 -D-----------------EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 -~-----------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ..+...+...........+.+++..|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0001111111111233478899999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=350.83 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=193.2
Q ss_pred hCCCccceeeeccCcEEEEEEEE----cCCcEEEEEEeecCC----CcchHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL----EDGTLVAVKQITDLD----TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~----~~g~~vAVK~l~~~~----~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
.++|...+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 91 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ---- 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence 35688899999999999999987 468999999997532 223456889999999999999999999987
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.+...++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 92 -~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 92 -TGGKLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp -CSSCEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECC
T ss_pred -cCCEEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEe
Confidence 45678999999999999999865 356889999999999999999999 88999999999999999999999999
Q ss_pred ecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 439 FGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 439 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... ..
T Consensus 165 fg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~-~~ 237 (327)
T 3a62_A 165 FGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-----TIDKILK-CK 237 (327)
T ss_dssp CSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHH-TC
T ss_pred CCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHh-CC
Confidence 99997543222 22344679999999999999999999999999999999999999997644221 1111111 10
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
. ..+......+.+++..|++.+|.+|| ++.|++++
T Consensus 238 ~----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 L----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 01122334678899999999999999 78888764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.16 Aligned_cols=272 Identities=26% Similarity=0.320 Sum_probs=209.8
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHH--ccCCCcccccccccccCCCC
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISK--IRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~--l~H~NIv~l~g~~~~~~~~~ 360 (614)
-....++|...+.||+|+||.||+|+.. |+.||||++.. ...+.+.+|++++.. ++||||+++++++..... .
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~ 111 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNG-T 111 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-S
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-c
Confidence 3445678999999999999999999985 89999999864 345678899999998 689999999999874332 2
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcC-----CCceEecCCCCCceeecCCCcEE
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL-----KPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~-----~~~ivHrDIKp~NILLd~~~~~K 435 (614)
....++||||+++|+|.+++.+ ..+++.+++.++.|++.||.|||... +.+|+||||||+|||++.++++|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred cceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 2478999999999999999854 46999999999999999999999321 57999999999999999999999
Q ss_pred EeeecccccccCCCcc---ccccccCCCCccchhhhccC------CCCchhhHHHHHHHHHHHHhC----------CCCC
Q 036081 436 VADFGLAKQSLEGQSH---LTTRVAGTYGYLAPEYALYG------QLTEKSDVYSFGIVILELMSG----------RKVL 496 (614)
Q Consensus 436 L~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSfGvvL~ELltG----------~~p~ 496 (614)
|+|||+++........ ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999865443322 23445799999999999865 234789999999999999999 6777
Q ss_pred CCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 497 ETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 497 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
............+...... ......+... ....+..+.+.+++..|++.+|++|||+.||+++|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCE-QKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTT-SCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHH-HHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6543322222222222211 1111111111 01234566889999999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=337.70 Aligned_cols=262 Identities=18% Similarity=0.241 Sum_probs=207.8
Q ss_pred HhCCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
..++|...+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|++++.+++|++++..++++.. .+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccC----CCCce
Confidence 357799999999999999999997 479999999986543 23468999999999999998888777653 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee---cCCCcEEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL---DSEMKAKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~KL~DFGl 441 (614)
++||||+ +++|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 9999999 99999998642 456999999999999999999999 8899999999999999 5889999999999
Q ss_pred cccccCCCcc------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHH
Q 036081 442 AKQSLEGQSH------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF--LLITDWAWML 513 (614)
Q Consensus 442 a~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~~l~~~~~~~ 513 (614)
++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 9876543321 1245679999999999999999999999999999999999999997643221 1111111111
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
... . .+.+. ......+.+++..|++.+|.+|||+.++++.|+....
T Consensus 235 ~~~-~-----~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 235 MST-P-----IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHS-C-----HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cCC-c-----hHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 100 0 00011 1123468889999999999999999999999987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=358.06 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=189.8
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
...++|...+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++.+++||||+++++++. ....
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~ 122 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTE 122 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCe
Confidence 35577999999999999999999987 58899999997542 3456889999999999999999999997 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---CCcEEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~KL~DFG 440 (614)
.++||||+++|+|.+++.. ...+++.+++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||
T Consensus 123 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EEEEECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 8999999999999998865 356899999999999999999999 889999999999999975 8899999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .......
T Consensus 197 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-----i~~~~~~ 269 (349)
T 2w4o_A 197 LSKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-----ILNCEYY 269 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-----HHTTCCC
T ss_pred cccccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH-----HHhCCCc
Confidence 99865332 2233467999999999999999999999999999999999999999765433211111 1111110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+ ........+.+++..|++.||++|||+.|++++
T Consensus 270 -~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 -FISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011233467889999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.54 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=201.8
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+|+++ |+.||||+++... ....+.|.+|++++.+++||||+++++++... .+...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 85 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPHPT 85 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSSCE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCCeE
Confidence 46888899999999999999986 8999999997543 23356799999999999999999999998643 235689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc--eEecCCCCCceeecCCCcEEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA--IYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
+||||+++|+|.+++... ....+++.+++.++.|++.||+||| +.+ |+||||||+|||++.++.+||.|||++.
T Consensus 86 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 999999999999999763 2235899999999999999999999 777 9999999999999999999999998875
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTE---KSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~---ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
.... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... ........+...
T Consensus 162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~ 230 (271)
T 3kmu_A 162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEGLRP 230 (271)
T ss_dssp TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHHHHHHSCCCC
T ss_pred eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHHHHHhcCCCC
Confidence 4222 2346899999999998765544 8999999999999999999997644321 111111111111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+......+.+++..|++.||++|||+.|+++.|+..
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 231 ---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11122334678899999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=359.64 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=205.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||.||+|+.. +|+.||+|.+..........+.+|++++.+++||||+++++++. .....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence 457899999999999999999976 68999999997655455667999999999999999999999987 456799
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC--CCcEEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS--EMKAKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~--~~~~KL~DFGla~ 443 (614)
+||||+++|+|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++
T Consensus 125 lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccce
Confidence 999999999999988652 346899999999999999999999 889999999999999974 5789999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+ ..... .... .
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~----~~i~~-~~~~--~ 269 (387)
T 1kob_A 200 KLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TL----QNVKR-CDWE--F 269 (387)
T ss_dssp ECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HH----HHHHH-CCCC--C
T ss_pred ecCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HH----HHHHh-CCCC--C
Confidence 764432 2234579999999999999999999999999999999999999997654221 11 11111 1000 0
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+ ..........+.+++..|++.||.+|||+.|++++
T Consensus 270 ~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 D----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp C----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 00011223467889999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=344.13 Aligned_cols=256 Identities=29% Similarity=0.418 Sum_probs=199.6
Q ss_pred CCCccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.+|...+.||+|+||.||+|++.+ +..+|+|.+..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CCC
Confidence 457788999999999999998653 23689999875433 334679999999999999999999998764 234
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred ceEEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccc
Confidence 67999999999999999965 2456899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCc---cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 443 KQSLEGQS---HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSG-RKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 443 ~~~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG-~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
+....... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..|+........ .. . . ..+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~-~---~-~~~~ 249 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TV-Y---L-LQGR 249 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HH-H---H-HTTC
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HH-H---H-hcCC
Confidence 86543221 123345678899999999999999999999999999999995 455554332211 10 1 0 1111
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ...+......+.+++..|++.+|++|||+.|++++|+..
T Consensus 250 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 R---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 001111234678899999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=352.80 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=206.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc--------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE--------DGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVS 355 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~ 355 (614)
..++|...+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|++++.++ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc-
Confidence 3467889999999999999999863 467899999975432 3356789999999999 8999999999987
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhhh-------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCC
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALT-------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIK 422 (614)
.....++||||+++|+|.+++..... ...+++..++.++.||+.||.||| +.+|+|||||
T Consensus 112 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk 184 (334)
T 2pvf_A 112 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184 (334)
T ss_dssp ----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred ----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCc
Confidence 34568999999999999999875321 234889999999999999999999 8899999999
Q ss_pred CCceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 036081 423 STNILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSN 500 (614)
Q Consensus 423 p~NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~ 500 (614)
|+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999999986544332 22334567889999999999999999999999999999999 999997543
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
... ....... +.. ...+......+.+++..|++.+|.+|||+.|++++|+..
T Consensus 265 ~~~-----~~~~~~~-~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 VEE-----LFKLLKE-GHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHH-----HHHHHHH-TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-----HHHHHhc-CCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 221 1111111 110 011112334678899999999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=366.76 Aligned_cols=249 Identities=21% Similarity=0.275 Sum_probs=194.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+++.. +|+.||||+++.. .......+.+|++++.+++||||+++++++. ...
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence 467899999999999999999975 6899999999752 2333456889999999999999999999997 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCC-CceEecCCCCCceeecCCCcEEEeeecc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK-PAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+||| + .+|+||||||+||||+.++.+||+|||+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~ 295 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGL 295 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred EEEEEEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCC
Confidence 78999999999999998865 357999999999999999999999 6 8999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... .
T Consensus 296 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~~~~-~-- 366 (446)
T 4ejn_A 296 CKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELILMEE-I-- 366 (446)
T ss_dssp CCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCC-C--
T ss_pred ceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHHHhCC-C--
Confidence 98643322 22345689999999999999999999999999999999999999997644321 111111111 0
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+......+.+++..|++.||.+|| ++.|++++
T Consensus 367 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 --------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 01112234678899999999999999 99999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=357.14 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=202.7
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHc-cCCCcccccccccccCC
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~ 358 (614)
....++|...+.||+|+||.||+++.+ +|+.||||+++... ....+.+..|.+++.++ +||||+++++++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~---- 88 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ---- 88 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE----
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE----
Confidence 345678999999999999999999986 58999999997531 23456688999999987 8999999999987
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.....++||||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++++||+|
T Consensus 89 -~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~D 161 (345)
T 1xjd_A 89 -TKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIAD 161 (345)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred -eCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeE
Confidence 45679999999999999999865 357999999999999999999999 88999999999999999999999999
Q ss_pred ecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 439 FGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 439 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... ....... +.
T Consensus 162 FG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~~-~~ 234 (345)
T 1xjd_A 162 FGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIRM-DN 234 (345)
T ss_dssp CTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CC
T ss_pred ChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHh-CC
Confidence 99998643222 22445689999999999999999999999999999999999999997644321 1111111 11
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIA-DALK 562 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~-eVl~ 562 (614)
. ..+......+.+++..|++.||.+||++. ++++
T Consensus 235 ~----------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 P----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 0 01112234678899999999999999997 6653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=349.71 Aligned_cols=268 Identities=24% Similarity=0.359 Sum_probs=199.2
Q ss_pred HHHHHhCCCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccc
Q 036081 282 ELDQATGGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355 (614)
Q Consensus 282 el~~at~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~ 355 (614)
++....++|...+.||+|+||.||+|++. .+..||||+++... ....+.+.+|++++.+++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33445567888999999999999999865 24589999986542 2334679999999999999999999999976
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhh---hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNAL---TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 432 (614)
.........++||||+++|+|.+++.... ....+++..++.++.||++||.||| +.+|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence 54333345799999999999999985421 2356899999999999999999999 89999999999999999999
Q ss_pred cEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHH
Q 036081 433 KAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWA 510 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~ 510 (614)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~~- 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY--DY- 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--HH-
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HH-
Confidence 999999999986543322 12233467889999999999999999999999999999999 88898765432211 11
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ..+... ..+......+.+++..|++.+|.+|||+.+++++|+..
T Consensus 262 --~-~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 262 --L-LHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp --H-HTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --H-HcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111100 11122335788899999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=358.43 Aligned_cols=272 Identities=19% Similarity=0.267 Sum_probs=211.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++.+++||||+++++++... .....+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCeeE
Confidence 56888999999999999999987 48999999997533 23356788999999999999999999988643 234689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee----cCCCcEEEeeecc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL----DSEMKAKVADFGL 441 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~KL~DFGl 441 (614)
+||||+++|+|.+++........+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999987544445999999999999999999999 8899999999999999 8888899999999
Q ss_pred cccccCCCccccccccCCCCccchhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALY--------GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
++...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.......... +.....
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~ 239 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKI 239 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHH
Confidence 98654322 2334579999999999875 567889999999999999999999997543322111 111111
Q ss_pred hhCCC---chhh---hh------HHh--hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 514 ANSGK---VDEI---FD------EFI--REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 514 ~~~~~---~~~~---~d------~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
..... +... .. ..+ ...........+..++..|++.||++|||+.|+++.++...
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 11110 0000 00 000 01223566678889999999999999999999999987743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.37 Aligned_cols=245 Identities=22% Similarity=0.284 Sum_probs=202.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++.+++||||+++++++. ....
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 115 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCCE
Confidence 56888999999999999999986 68999999986432 233567889999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.+ ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~ 189 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccce
Confidence 9999999999999999875 356899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...... .+...
T Consensus 190 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~-~~~~~--- 256 (350)
T 1rdq_E 190 RVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----IYEKIV-SGKVR--- 256 (350)
T ss_dssp ECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH-HCCCC---
T ss_pred eccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-----HHHHHH-cCCCC---
Confidence 65432 234579999999999999999999999999999999999999997644221 111111 11110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
.+......+.+++..|++.||.+||+ +.|++++
T Consensus 257 -------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 -------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11123346788999999999999998 8888764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=343.46 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=205.0
Q ss_pred CCCccce-eeeccCcEEEEEEEEc---CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKN-LIGQGASGVVYKGTLE---DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|...+ .||+|+||.||+|++. ++..||||+++.... ...+.+.+|++++.+++||||+++++++. ..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence 3455555 8999999999999864 578899999976433 34567999999999999999999999983 23
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccce
Confidence 489999999999999998652 456999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccc--cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 443 KQSLEGQSHL--TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 443 ~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
+......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ... ...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~-i~~~~~ 231 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----MAF-IEQGKR 231 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-----HHH-HHTTCC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-----HHH-HhcCCc
Confidence 8764433221 223456889999999998999999999999999999999 9999976543211 111 111111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
. ..+......+.+++..|++.+|.+||++.+++++|+...
T Consensus 232 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 232 M---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 112223457888999999999999999999999998743
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.35 Aligned_cols=266 Identities=24% Similarity=0.383 Sum_probs=193.6
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCC
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~ 360 (614)
...++|...+.||+|+||.||+|... +|+.||||++... .......+.+|+.++.++. ||||+++++++... +
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---N 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---T
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---C
Confidence 34578999999999999999999975 6899999998643 2233456889999999997 99999999998642 3
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....++||||++ |+|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 356899999997 688887754 46899999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCC--------------------CccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 036081 441 LAKQSLEG--------------------QSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETS 499 (614)
Q Consensus 441 la~~~~~~--------------------~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~ 499 (614)
+++..... .....+..+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99864321 1112344689999999999986 67999999999999999999999999765
Q ss_pred CccchhHHHHHHHHhhCCC-----------chhhhh---------------------HHhhh-hCcHHHHHHHHHHHHHc
Q 036081 500 NSSFLLITDWAWMLANSGK-----------VDEIFD---------------------EFIRE-EGSRAVMERFVRVGILC 546 (614)
Q Consensus 500 ~~~~~~l~~~~~~~~~~~~-----------~~~~~d---------------------~~l~~-~~~~~~~~~l~~l~~~C 546 (614)
..... +..... ...... ....++ ..+.. .........+.+++..|
T Consensus 235 ~~~~~-~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 235 STMNQ-LERIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp SHHHH-HHHHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred CHHHH-HHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 43221 111111 000000 000000 00000 00012234678999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 036081 547 AHVMVALRPTIADALKM 563 (614)
Q Consensus 547 l~~~p~~RPtm~eVl~~ 563 (614)
++.||.+|||+.|++++
T Consensus 313 L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 313 LQFNPNKRISANDALKH 329 (388)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hccCcccCCCHHHHhCC
Confidence 99999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.74 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=200.5
Q ss_pred CCccceeeeccCcEEEEEEEEcC-C---cEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED-G---TLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~-g---~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.|...++||+|+||+||+|++.+ + ..+|+|.+..... ...+.+.+|++++++++||||+++++++... ...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----EGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----CCC
Confidence 35566899999999999998642 2 3799999875433 3356789999999999999999999998742 234
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+.+|+|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp CEEEECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred cEEEEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 5899999999999999865 2456899999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCC---ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 444 QSLEGQ---SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 444 ~~~~~~---~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
...... ........+|..|+|||.+.+..++.++||||||+++|||++|+.|+........ +.... ..+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~----~~~~~- 246 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFL----AQGRR- 246 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHH----HTTCC-
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHh----hcCCC-
Confidence 653322 1123345678999999999999999999999999999999996666543322211 11111 11110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
...+....+.+.+++..|++.+|.+|||+.+++++|+..
T Consensus 247 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 247 --------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001112234678899999999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.15 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=200.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|...+.||+|+||.||+++.+ +|+.||+|+++.... ...+.+.+|+.++.++ +||||+++++++. ...
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eCC
Confidence 46888999999999999999986 589999999975422 2345688999999998 8999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++++||+|||++
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccc
Confidence 79999999999999999865 356999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch---hHHHHHHHHhhCCCc
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL---LITDWAWMLANSGKV 519 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~---~l~~~~~~~~~~~~~ 519 (614)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ............+..
T Consensus 158 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 158 KEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp BCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred ccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 8643222 224456899999999999999999999999999999999999999965322110 000111111111110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTI------ADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm------~eVl~~ 563 (614)
..+......+.+++..|++.||.+||++ .|++++
T Consensus 237 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 ----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1122233567889999999999999995 677654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=381.82 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=200.1
Q ss_pred CCccce-eeeccCcEEEEEEEEc---CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 289 GFSQKN-LIGQGASGVVYKGTLE---DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++...+ .||+|+||.||+|++. ++..||||+++.... ...++|.+|++++.+++||||+++++++.. +.
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EA 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SS
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CC
Confidence 344444 7999999999999874 467899999976433 346789999999999999999999999862 34
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred eEEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 89999999999999998653 456999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcccc--ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 444 QSLEGQSHLT--TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 444 ~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
.......... ....+|+.|+|||++.++.++.++|||||||+||||++ |+.||....... + .. ....+..
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~---~~-~i~~~~~- 557 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--V---MA-FIEQGKR- 557 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--H---HH-HHHTTCC-
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--H---HH-HHHcCCC-
Confidence 7644332222 22345689999999999999999999999999999998 999997654322 1 11 1111111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
...+......+.+++..|++.+|++||++.+|+++|+..
T Consensus 558 --------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 558 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011222345788899999999999999999999999873
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=363.21 Aligned_cols=254 Identities=23% Similarity=0.289 Sum_probs=202.6
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
..++|...+.||+|+||.||+++.. +|+.+|+|++..... ...+.+.+|++++++++||||+++++++. +..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECC
Confidence 4567889999999999999999875 689999999875432 23457899999999999999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec---CCCcEEEeee
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD---SEMKAKVADF 439 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd---~~~~~KL~DF 439 (614)
..++||||+++|+|.+.+.. +..+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred EEEEEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccC
Confidence 78999999999999998865 456999999999999999999999 88999999999999998 4678999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
|+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . .. ...+..
T Consensus 158 G~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~----~~-i~~~~~ 230 (444)
T 3soa_A 158 GLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-Y----QQ-IKAGAY 230 (444)
T ss_dssp SSCBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H----HH-HHHTCC
T ss_pred ceeEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-H----HH-HHhCCC
Confidence 9998654332 223446799999999999999999999999999999999999999976442211 1 11 111111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ..+ ........+.+++..|++.||.+|||+.|++++
T Consensus 231 ~~-~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 DF-PSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CC-CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-Ccc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 000 001223467889999999999999999999885
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=351.47 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=199.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcE----EEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTL----VAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~----vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
.++|...+.||+|+||.||+|++. +|+. ||+|.+... .....+.+.+|+.++.+++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 356889999999999999999965 4443 577777543 33456789999999999999999999999863
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
...++|+||+++|+|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG 162 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred -CCceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCc
Confidence 2378999999999999998763 456899999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 441 LAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 441 la~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .... ..+.
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~----~~~~ 236 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSIL----EKGE 236 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHH----HTTC
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHH----HcCC
Confidence 9986543222 22233456889999999999999999999999999999999 9999976543321 1111 1111
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
....+......+.+++..|++.+|.+|||+.|+++.|+....
T Consensus 237 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 ---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 001111223467889999999999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=361.17 Aligned_cols=250 Identities=19% Similarity=0.281 Sum_probs=195.2
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC--CcchHHHHHHHHHHHHcc--CCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD--TKGDEEFINEVEIISKIR--HRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~--H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||++...+|+.||||++.... .+..+.+.+|++++.+++ |+||+++++++. ....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~~ 130 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQY 130 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCCE
Confidence 4588999999999999999998889999999986533 233567999999999996 599999999987 4456
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||| +.+++|.+++.. ...+++.+++.++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++
T Consensus 131 ~~lv~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred EEEEEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 999999 568899999875 357889999999999999999999 89999999999999995 5899999999998
Q ss_pred cccCCCcc-ccccccCCCCccchhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Q 036081 444 QSLEGQSH-LTTRVAGTYGYLAPEYALY-----------GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 444 ~~~~~~~~-~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~ 511 (614)
........ ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.........+ .
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~ 278 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----H 278 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----H
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH----H
Confidence 76443322 2345679999999999875 478999999999999999999999997543221111 1
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.... .......+......+.+++..|++.||.+|||+.|++++
T Consensus 279 ~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhC---------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111 111101111112467889999999999999999999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=349.88 Aligned_cols=274 Identities=20% Similarity=0.320 Sum_probs=205.3
Q ss_pred hHHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcc-----------hHHHHHHHHHHHHccCCCccc
Q 036081 280 ESELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKG-----------DEEFINEVEIISKIRHRNLLS 348 (614)
Q Consensus 280 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~-----------~~~f~~Ei~il~~l~H~NIv~ 348 (614)
..++....++|...+.||+|+||.||+|+..+|+.||||++....... .+.+.+|++++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 467888899999999999999999999998889999999986432211 267899999999999999999
Q ss_pred ccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee
Q 036081 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL 428 (614)
Q Consensus 349 l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL 428 (614)
+++++...+.......++||||++ |+|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 999997655556678999999997 688888764 2456999999999999999999999 8899999999999999
Q ss_pred cCCCcEEEeeecccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHH
Q 036081 429 DSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLIT 507 (614)
Q Consensus 429 d~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~ 507 (614)
+.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~ 244 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-LN 244 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HH
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-HH
Confidence 999999999999997543322 2344578999999999986 7799999999999999999999999976543221 11
Q ss_pred HHHHHHhhCCCchhhh-----------hHHhhh-------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 508 DWAWMLANSGKVDEIF-----------DEFIRE-------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~-----------d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... .........+.. ...+.. .........+.+++..|++.||.+|||+.|++++
T Consensus 245 ~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIV-EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHH-HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH-HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111 111111111100 000000 0001123467889999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=359.50 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=192.8
Q ss_pred CCccceeeeccCcEEEEEEEEc--CC--cEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE--DG--TLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~--~g--~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.|...+.||+|+||.||+|++. ++ ..||||.++... ....+.|.+|+.++++++||||+++++++... .+.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CCC
Confidence 3566789999999999999864 22 468999986533 33457899999999999999999999987642 345
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... ...+++..++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccc
Confidence 79999999999999999652 356889999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCc---cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 444 QSLEGQS---HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 444 ~~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
....... .......+|+.|+|||.+.++.++.++||||||+++|||++ |..||......... ... ..+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~--~~~----~~~~~ 314 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VYL----LQGRR 314 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--HHH----HTTCC
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--HHH----HcCCC
Confidence 6533221 12233567889999999999999999999999999999999 66777654432211 111 11110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ..+......+.+++..|++.+|++|||+.|++++|+..
T Consensus 315 ~---------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 L---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01112334678899999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=353.39 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=198.5
Q ss_pred CCCccceeeeccCcEEEEEEEEcC-----CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED-----GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~-----g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
++|...+.||+|+||.||+|++.. +..||||.++.... .....+.+|++++.+++||||+++++++. ..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----cC
Confidence 456778999999999999998753 24699999975432 33457899999999999999999999986 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++... ...+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CCcEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 5789999999999999998652 356999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 442 AKQSLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 442 a~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..... ..+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~~~~-~~~~ 267 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VMKAI-NDGF 267 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHH-HTTC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHH-HCCC
Confidence 9865433221 1223456789999999999999999999999999999999 999996543221 11111 1111
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
. ...+......+.+++..|++.+|.+||++.+++++|+...
T Consensus 268 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 R---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp C---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred c---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 0011123346788999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.81 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=178.9
Q ss_pred ceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEEEEEec
Q 036081 293 KNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
.+.||+|+||.||+++.. +|+.||||++.. .....+.+|+.++.+++ ||||+++++++. +....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence 478999999999999986 689999999865 34567889999999997 999999999987 45678999999
Q ss_pred CCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC---cEEEeeecccccccC
Q 036081 371 MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM---KAKVADFGLAKQSLE 447 (614)
Q Consensus 371 ~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~---~~KL~DFGla~~~~~ 447 (614)
+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 88 LNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp CCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 999999999875 457999999999999999999999 89999999999999997665 899999999986543
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHHhhCCCchhhhhH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF--LLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.... ...+.... .
T Consensus 162 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~~~--~- 236 (325)
T 3kn6_A 162 DN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDFSF--E- 236 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCCCC--C-
T ss_pred CC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCCCC--C-
Confidence 32 22334578999999999999999999999999999999999999997644321 011111111 11111110 0
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
........+.+.+++..|++.||.+|||+.|++++
T Consensus 237 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 237 ---GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ---SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ---cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 00011234578889999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.65 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=203.6
Q ss_pred hCCCccceeeeccCcEEEEEEEE----cCCcEEEEEEeecCC----CcchHHHHHHHHHHHHc-cCCCcccccccccccC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL----EDGTLVAVKQITDLD----TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSD 357 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~----~~g~~vAVK~l~~~~----~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~ 357 (614)
.++|...+.||+|+||.||+++. .+|+.||||+++... ....+.+.+|++++.++ +||||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 129 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 129 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence 35788999999999999999997 368999999986432 22345678899999999 6999999999886
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEe
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVA 437 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~ 437 (614)
.....++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++++||+
T Consensus 130 --~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 130 --TETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEES
T ss_pred --eCceEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEe
Confidence 45678999999999999999875 356899999999999999999999 8899999999999999999999999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
|||+++..............||+.|+|||++.+ ..++.++||||||++||||++|+.||........ ...+......
T Consensus 202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~ 280 (355)
T 1vzo_A 202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILK 280 (355)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHH
T ss_pred eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhc
Confidence 999998764444444455679999999999985 3578999999999999999999999975443221 1111111111
Q ss_pred CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhh
Q 036081 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKMLE 565 (614)
Q Consensus 516 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~L~ 565 (614)
.. ...+......+.+++..|++.||.+|| |+.|++++.-
T Consensus 281 ~~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 281 SE-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred cC-----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 10 011222334678899999999999999 9999988753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=335.02 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=203.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||.||+|+.. ++..+|+|++........+.+.+|++++.+++||||+++++++. .+...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence 456888999999999999999976 47799999998765566788999999999999999999999987 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee---cCCCcEEEeeeccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL---DSEMKAKVADFGLA 442 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~KL~DFGla 442 (614)
+||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 99999999999998865 356899999999999999999999 8999999999999999 88899999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
....... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ .... ..+....
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~-~~~~~~~- 226 (277)
T 3f3z_A 157 ARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-----MLKI-REGTFTF- 226 (277)
T ss_dssp EECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHH-HHCCCCC-
T ss_pred eeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-----HHHH-HhCCCCC-
Confidence 8654332 2334579999999998865 599999999999999999999999976543211 1111 1111100
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... ......+.+++..|++.+|.+|||+.|++++
T Consensus 227 ~~~~~-----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 PEKDW-----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred Cchhh-----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0123467889999999999999999999763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=336.51 Aligned_cols=252 Identities=26% Similarity=0.353 Sum_probs=202.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++.+++||||+++++++. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 577999999999999999999976 58999999986532 233467889999999999999999999986 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc---EEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK---AKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~KL~DFG 440 (614)
.++||||+++|+|.+.+.. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||
T Consensus 80 ~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 8999999999999888865 356899999999999999999999 889999999999999987665 9999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . ... ..+...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~----~~~-~~~~~~ 225 (284)
T 3kk8_A 154 LAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-Y----AQI-KAGAYD 225 (284)
T ss_dssp TCEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H----HHH-HHTCCC
T ss_pred eeEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-H----HHH-Hhcccc
Confidence 997654322 22346799999999999999999999999999999999999999976443211 1 111 111100
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ..+ ........+.+++..|++.+|++|||+.|++++
T Consensus 226 ~-~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 Y-PSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp C-CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C-Cch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 000 001123467889999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=352.83 Aligned_cols=253 Identities=22% Similarity=0.269 Sum_probs=193.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||.||+++.. +|+.||||++.... ...+.+.+|+.++++++||||+++++++. .....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence 467899999999999999999986 68999999997543 33467899999999999999999999997 456799
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc--EEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK--AKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--~KL~DFGla~ 443 (614)
+||||+++|+|.+++.. .+.+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++
T Consensus 93 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 93 IIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 99999999999999865 356999999999999999999999 899999999999999987775 9999999997
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEK-SDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~k-sDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
..... .......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||.......... .......... ..
T Consensus 167 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-~~~~~~~~~~-~~-- 240 (361)
T 3uc3_A 167 SSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-KTIQRILSVK-YS-- 240 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH-HHHHHHHTTC-CC--
T ss_pred ccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH-HHHHHHhcCC-CC--
Confidence 43222 12234579999999999998888766 899999999999999999997654322111 1111111110 00
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..........+.+++..|++.+|.+|||+.|++++
T Consensus 241 ------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 ------IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00001123467889999999999999999999886
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=334.84 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=204.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++.+++||||+++++++. .+...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 356888999999999999999986 68999999986433 334577899999999999999999999987 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 999999999999999865 356899999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCc-cccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 445 SLEGQS-HLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 445 ~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
...... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||............+. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~-- 227 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKTY-- 227 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTCTT--
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hcccc--
Confidence 543221 22344678999999999987665 7799999999999999999999976554332222221 11100
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ........+.+++..|++.||.+|||+.|++++
T Consensus 228 ~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 LN------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00 011123467789999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.51 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=199.8
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
+.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence 3567889999999999999999876 57899999986421 223467899999999999999999999987 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred CEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccc
Confidence 678999999999999999865 356899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... ..
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~-~~--- 223 (279)
T 3fdn_A 156 SVHAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISR-VE--- 223 (279)
T ss_dssp ESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHH-TC---
T ss_pred cccCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-----HHHHHHh-CC---
Confidence 8654322 2234578999999999999999999999999999999999999997543221 1111100 00
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+....+.+.+++..|++.+|.+|||+.|++++
T Consensus 224 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111223467789999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=361.98 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=197.7
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~ 362 (614)
.++|...+.||+|+||.||++... +|+.||||++... .....+.+.+|++++++++||||+++++++..... ++..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 577999999999999999999876 6899999999753 22335678899999999999999999999865432 2446
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||++++ |.+.+. ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 789999999754 555543 34899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC-----C
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS-----G 517 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~-----~ 517 (614)
+..... ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... +.......-.. .
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHT
T ss_pred eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 865432 234456899999999999999999999999999999999999999976543221 11111100000 0
Q ss_pred CchhhhhHHhh-------------------h---hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 KVDEIFDEFIR-------------------E---EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 ~~~~~~d~~l~-------------------~---~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+.......+. . .........+.+++..|++.||++|||+.|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0 0011224578899999999999999999999886
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.06 Aligned_cols=265 Identities=23% Similarity=0.402 Sum_probs=207.3
Q ss_pred hCCCccceeeeccCcEEEEEEEE-----cCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL-----EDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|...+.||+|+||.||++++ .+|+.||||++........+.+.+|++++.+++||||+++++++... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CC
Confidence 34578889999999999999984 36899999999876666667899999999999999999999988643 23
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++... ...+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 4679999999999999999763 346899999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+.... .....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~~~~-~~~~~ 264 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMI-GNDKQ 264 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHHHHH-CTTCC
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHHHhh-ccccc
Confidence 9876443321 12334577889999999999999999999999999999999998864211 111100 00100
Q ss_pred hhh----hhHHhh----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 520 DEI----FDEFIR----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 520 ~~~----~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
... +...+. ...+......+.+++..|++.+|++|||+.|+++.|+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 265 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000 001111 11122344578889999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=352.58 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=201.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|++++.+++||||+++++++. ....
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~ 89 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEED 89 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCCE
Confidence 56888999999999999999976 5889999998642 2233567889999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceee
Confidence 8999999999999999865 356999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ...........
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~~~--- 236 (384)
T 4fr4_A 164 MLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFETTV--- 236 (384)
T ss_dssp ECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHHHCC---
T ss_pred eccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhhcc---
Confidence 65432 22345679999999999974 4589999999999999999999999975433221 11111110000
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT-IADALK 562 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-m~eVl~ 562 (614)
...+......+.+++..|++.+|.+||+ +.++.+
T Consensus 237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0112223357788999999999999998 777765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.55 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=202.5
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~ 360 (614)
..++|...+.||+|+||.||+++.+ +|+.||||+++.. .....+.+..|.+++..+ +||||+++++++. .
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----C
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----c
Confidence 3467999999999999999999987 4889999999753 223456788999999988 7999999999987 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++++||+|||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence 5679999999999999999875 356999999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... ....... +..
T Consensus 167 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~~-~~~- 238 (353)
T 2i0e_A 167 MCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIME-HNV- 238 (353)
T ss_dssp TCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCC-
T ss_pred cccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-----HHHHHHh-CCC-
Confidence 998643222 22345679999999999999999999999999999999999999997644221 1111111 111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
..+......+.+++..|++.+|.+||+ +.|++++
T Consensus 239 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011223356788999999999999995 5777654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.23 Aligned_cols=270 Identities=24% Similarity=0.257 Sum_probs=208.3
Q ss_pred cccChHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-----CCCcccc
Q 036081 276 KWFRESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-----HRNLLSL 349 (614)
Q Consensus 276 ~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-----H~NIv~l 349 (614)
..++..+.....++|...++||+|+||.||+|+.. +|+.||||+++.. ....+.+..|++++.+++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34555566667889999999999999999999985 6899999998642 234567888999999997 9999999
Q ss_pred cccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 350 ~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
++++. .....++||||+ +++|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||++
T Consensus 102 ~~~~~-----~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~ 171 (360)
T 3llt_A 102 HGKFM-----YYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLD 171 (360)
T ss_dssp EEEEE-----ETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEES
T ss_pred cceee-----ECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEc
Confidence 99987 346789999999 999999987632 245899999999999999999999 89999999999999997
Q ss_pred C-------------------------CCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHH
Q 036081 430 S-------------------------EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGI 484 (614)
Q Consensus 430 ~-------------------------~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGv 484 (614)
. ++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 5 789999999999864332 23457899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh------------------------------hhhCc--
Q 036081 485 VILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI------------------------------REEGS-- 532 (614)
Q Consensus 485 vL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l------------------------------~~~~~-- 532 (614)
++|||++|+.||........ +.. ..... ............ ....+
T Consensus 248 il~ell~g~~pf~~~~~~~~-~~~-~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 248 VLAELYTGSLLFRTHEHMEH-LAM-MESII-QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHHHSSCSCCCSSHHHH-HHH-HHHHT-CCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHHHCCCCCCCCcHHHH-HHH-HHHhc-CCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 99999999999976543221 111 11110 000011100000 00000
Q ss_pred -HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 533 -RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 533 -~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....+.+.+++..|++.||++|||+.|++++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0011467799999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.09 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=196.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc--chHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK--GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++.+++||||+++++++. .....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 57888999999999999999986 5899999998654332 2466889999999999999999999987 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARL 151 (311)
T ss_dssp EEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence 999999999999887754 356899999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .. ..... ......
T Consensus 152 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~-~~~~~-~~~~~~- 226 (311)
T 4agu_A 152 LTGPS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LI-RKTLG-DLIPRH- 226 (311)
T ss_dssp CC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HH-HHHHC-SCCHHH-
T ss_pred ccCcc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HH-HHHhc-cccccc-
Confidence 54322 22334578999999999976 678999999999999999999999997654332111 01 11000 000000
Q ss_pred hHHhh-------------------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIR-------------------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~-------------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... ..........+.+++..|++.||.+|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 00001233467889999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=341.70 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=204.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc------chHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK------GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~------~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
.++|...+.||+|+||.||+++.. +|+.||||.++..... ..+.+.+|++++.+++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 456888999999999999999976 6899999999754321 3567999999999999999999999987
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC----cEE
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM----KAK 435 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~K 435 (614)
.....++||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++ .+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEE
Confidence 45679999999999999999865 356899999999999999999999 88999999999999999888 799
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
|+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..... .
T Consensus 160 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i-~ 231 (321)
T 2a2a_A 160 LIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANI-T 231 (321)
T ss_dssp ECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHH-H
T ss_pred EccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHH-H
Confidence 99999998654332 2234579999999999999999999999999999999999999997644321 11111 1
Q ss_pred CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... .++.... ...+.+.+++..|++.||.+|||+.|++++
T Consensus 232 ~~~~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 232 SVSYD--FDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TTCCC--CCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hcccc--cChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11100 1111111 122467889999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.44 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=193.5
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--------CcchHHHHHHHHHHHHccCCCcccccccccc
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--------TKGDEEFINEVEIISKIRHRNLLSLRGCCVS 355 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--------~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~ 355 (614)
...++|...+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999976 58999999986421 112235889999999999999999999974
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC---C
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE---M 432 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~ 432 (614)
....++||||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.+ +
T Consensus 211 -----~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~ 279 (419)
T 3i6u_A 211 -----AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDC 279 (419)
T ss_dssp -----SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSC
T ss_pred -----cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcc
Confidence 3457999999999999998865 457999999999999999999999 8899999999999999654 4
Q ss_pred cEEEeeecccccccCCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Q 036081 433 KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW 509 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~ 509 (614)
.+||+|||+++..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||........... .
T Consensus 280 ~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~-~ 356 (419)
T 3i6u_A 280 LIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-Q 356 (419)
T ss_dssp CEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH-H
T ss_pred eEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH-H
Confidence 5999999999865432 2334567999999999986 36788999999999999999999999976443321111 1
Q ss_pred HHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 510 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+.... ..+ .. ....+.+.+++..|++.||++|||+.|++++
T Consensus 357 ----i~~~~~~~-~~~-~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ----ITSGKYNF-IPE-VW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ----HHTTCCCC-CHH-HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HhcCCCCC-Cch-hh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111110 000 00 1123467889999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=342.41 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=205.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++... .+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 457888999999999999999986 68999999997543 23356789999999999999999999987532 3457
Q ss_pred EEEEEecCCCCCcccccchhhh-ccCCCccchhHHHHHHHHHHHHHHhcCCCc-----eEecCCCCCceeecCCCcEEEe
Q 036081 364 RFLVYDFMPSGSLGDHISNALT-RKQLAWPQRKKIILDVAKGLAYLHYGLKPA-----IYHRDIKSTNILLDSEMKAKVA 437 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~-~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~-----ivHrDIKp~NILLd~~~~~KL~ 437 (614)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 8999999999999999976432 345899999999999999999999 666 9999999999999999999999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .... ...+
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~-i~~~ 231 (279)
T 2w5a_A 159 DFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGK-IREG 231 (279)
T ss_dssp CCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH-HHHT
T ss_pred cCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-----HHHH-Hhhc
Confidence 9999986543322 2234578999999999999999999999999999999999999997654211 1111 1111
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
... ..+......+.+++..|++.+|++|||+.|+++++...
T Consensus 232 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 232 KFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ccc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 111 01112335778899999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=354.16 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=200.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++. ...
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 467899999999999999999974 6899999998642 1233457899999999999999999999987 455
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+ +|+|.+++.. ...+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s 155 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS 155 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCT
T ss_pred EEEEEEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccc
Confidence 789999999 7899888865 457999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+....+. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... ....+.
T Consensus 156 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~------~i~~~~--- 224 (336)
T 3h4j_B 156 NIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK------KVNSCV--- 224 (336)
T ss_dssp BTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC------CCCSSC---
T ss_pred eeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH------HHHcCC---
Confidence 8654332 2344579999999999987776 789999999999999999999997643221100 000000
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+......+.+++..|++.||.+|||+.|++++
T Consensus 225 -------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 -------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00111223467789999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.23 Aligned_cols=261 Identities=19% Similarity=0.235 Sum_probs=198.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+++.. +|+.||||++..... ...+.+.+|++++.+++||||+++++++. ...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----IDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eCC
Confidence 477999999999999999999976 689999999865322 22467899999999999999999999987 356
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++.. ...+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIA 181 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred eEEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence 78999999999999999875 356999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
...............||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .............
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~- 254 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAIPRP- 254 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCCCCG-
T ss_pred ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCCCCc-
Confidence 865544333344567999999999999999999999999999999999999999754321 1111111111000
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCCCCC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRP-TIADALKMLEGDIDIP 571 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-tm~eVl~~L~~~~~~~ 571 (614)
..........+.+++..|++.||++|| ++.++++.|+......
T Consensus 255 ------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 ------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 001122334678899999999999999 9999999999865544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.78 Aligned_cols=264 Identities=16% Similarity=0.180 Sum_probs=204.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEcC---------CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCccccc-------
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLED---------GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLR------- 350 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~---------g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~------- 350 (614)
.++|...+.||+|+||.||+|+... ++.||||.+... +.+.+|++++.+++||||++++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678999999999999999999763 789999998753 4688999999999999999843
Q ss_pred --------ccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCC
Q 036081 351 --------GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIK 422 (614)
Q Consensus 351 --------g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIK 422 (614)
+++.. .+...++||||+ +|+|.+++... ....+++..++.|+.||+.||.||| +.+|+|||||
T Consensus 116 ~~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dik 186 (352)
T 2jii_A 116 LLAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVT 186 (352)
T ss_dssp TCSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCC
T ss_pred ccCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCC
Confidence 34332 256789999999 99999999753 2357999999999999999999999 8899999999
Q ss_pred CCceeecCCC--cEEEeeecccccccCCCcc------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 036081 423 STNILLDSEM--KAKVADFGLAKQSLEGQSH------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK 494 (614)
Q Consensus 423 p~NILLd~~~--~~KL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~ 494 (614)
|+|||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 9999999999865432211 1234579999999999999999999999999999999999999
Q ss_pred CCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 495 VLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 495 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
||.........+.......... .....+.... .......+.+++..|++.||.+|||+.+++++|+....
T Consensus 267 pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 267 PWTNCLPNTEDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CcccCCcCHHHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 9986543222222221111111 1111111000 01123578889999999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=360.74 Aligned_cols=199 Identities=26% Similarity=0.403 Sum_probs=157.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++.+++||||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999876 689999999965322 23467899999999999999999999997655445577
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+ +|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 99999998 5788888754 356999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCc--------------------------cccccccCCCCccchhhh-ccCCCCchhhHHHHHHHHHHHHhC
Q 036081 444 QSLEGQS--------------------------HLTTRVAGTYGYLAPEYA-LYGQLTEKSDVYSFGIVILELMSG 492 (614)
Q Consensus 444 ~~~~~~~--------------------------~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwSfGvvL~ELltG 492 (614)
....... ...+..+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6532211 123446789999999986 466799999999999999999994
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.22 Aligned_cols=247 Identities=21% Similarity=0.348 Sum_probs=198.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~ 361 (614)
..++|...+.||+|+||.||+|+.. +|+.||||+++.. ......++.+|+..+.++ +||||+++++++. ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----ED 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ET
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cC
Confidence 3466888999999999999999986 7999999999753 233456788999999999 9999999999987 45
Q ss_pred ceEEEEEecCCCCCcccccchhhh-ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC---------
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALT-RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE--------- 431 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~-~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~--------- 431 (614)
...++||||+++|+|.+++..... ...+++..++.++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccc
Confidence 678999999999999999976432 256899999999999999999999 8899999999999999844
Q ss_pred ----------CcEEEeeecccccccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 036081 432 ----------MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSN 500 (614)
Q Consensus 432 ----------~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~ 500 (614)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|+.++....
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred cccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 479999999998654322 23589999999999866 66789999999999999999988764321
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. + .....+.... .+......+.+++..|++.||++|||+.|++++
T Consensus 236 ~-------~--~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 Q-------W--HEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H-------H--HHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H-------H--HHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 1 1111222111 111223467889999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=354.79 Aligned_cols=247 Identities=30% Similarity=0.416 Sum_probs=198.5
Q ss_pred CCCccceeeeccCcEEEEEEEE-cCCcEEEEEEeecCCCc---chHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTK---GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+.|...+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|++++.+++||||+++++++. ....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCe
Confidence 3478889999999999999996 47899999999754322 2357889999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||++ |+|.+++.. ....+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 129 ~~lv~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 202 (348)
T ss_dssp EEEEEECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred EEEEEecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCce
Confidence 899999997 788887754 2467999999999999999999999 8899999999999999999999999999997
Q ss_pred cccCCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
.... .....||+.|+|||++. .+.++.++||||||+++|||++|+.||....... ...........
T Consensus 203 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~- 271 (348)
T 1u5q_A 203 IMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNESP- 271 (348)
T ss_dssp SSSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCC-
T ss_pred ecCC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCC-
Confidence 6532 22357999999999985 5789999999999999999999999996543221 11111111110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
.. ......+.+.+++..|++.+|++|||+.+++++.
T Consensus 272 ~~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 272 AL--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CC--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 00 0111234677899999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=346.73 Aligned_cols=259 Identities=24% Similarity=0.280 Sum_probs=196.8
Q ss_pred CCCcc-ceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQ-KNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~-~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+.|.. .++||+|+||.||+++.. +|+.||||++........+.+.+|++++.++ +||||+++++++. ..+..
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCEE
Confidence 45666 368999999999999965 6899999999876656677899999999995 7999999999987 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc---EEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK---AKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~KL~DFGl 441 (614)
++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 87 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 999999999999999875 357899999999999999999999 889999999999999988776 99999999
Q ss_pred cccccCCCc------cccccccCCCCccchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh--H--
Q 036081 442 AKQSLEGQS------HLTTRVAGTYGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--I-- 506 (614)
Q Consensus 442 a~~~~~~~~------~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~--l-- 506 (614)
++....... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 876432211 11223569999999999975 56889999999999999999999999765432100 0
Q ss_pred -----HHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 507 -----TDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 507 -----~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..........+... ..+.. .......+.+++..|++.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~i~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYE-FPDKD-----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCC-CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhHHHHHHHHHhccCcc-cCchh-----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000111111100 00000 01123467889999999999999999999885
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=344.41 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=201.4
Q ss_pred hCCCccce-eeeccCcEEEEEEEEc---CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 287 TGGFSQKN-LIGQGASGVVYKGTLE---DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 287 t~~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
.++|...+ .||+|+||.||+|.+. +++.||||+++.... ...+++.+|++++.+++||||+++++++.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------ 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC------
Confidence 45577777 9999999999999653 468899999975432 23567999999999999999999999983
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....++||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 3457999999999999999865 356899999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCccc--cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 441 LAKQSLEGQSHL--TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 441 la~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. .....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~-~~~~~~ 236 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VT-AMLEKG 236 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HH-HHHHTT
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HH-HHHHcC
Confidence 998764433221 223456789999999999899999999999999999999 999997644321 11 111111
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
... ..+......+.+++..|++.||.+|||+.++++.|+..
T Consensus 237 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 237 ERM---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 110 11122345788899999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=340.84 Aligned_cols=260 Identities=19% Similarity=0.321 Sum_probs=196.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++.+++||||+++++++. ..+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCC
Confidence 456889999999999999999974 79999999997532 233567899999999999999999999987 356
Q ss_pred eEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 7899999999999999987532 2456889999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
++...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .+.... .......
T Consensus 183 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~-~~~~~~~ 257 (310)
T 2wqm_A 183 GRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKI-EQCDYPP 257 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH---HHHHHH-HTTCSCC
T ss_pred eeeecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH---HHHHHh-hcccCCC
Confidence 87654322 222345789999999999999999999999999999999999999965432211 111111 1111111
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ......+.+.+++..|++.||.+|||+.+|+++|+..
T Consensus 258 ~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 258 L--------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp C--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C--------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 0112234678899999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=350.13 Aligned_cols=256 Identities=14% Similarity=0.159 Sum_probs=204.1
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEE------EcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc---CCCcccccc
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGT------LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR---HRNLLSLRG 351 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~------~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~---H~NIv~l~g 351 (614)
.+++...++|...+.||+|+||+||+|+ ..+++.||||+++. ....++..|++++.+++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3444556789999999999999999994 34689999999865 34567889999999987 999999999
Q ss_pred cccccCCCCCceEEEEEecCCCCCcccccchhh--hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL--TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 352 ~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~--~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
++. ..+..++||||+++|+|.+++.... ....++|..++.|+.||++||+||| +.+|+||||||+||||+
T Consensus 135 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 135 AHL-----FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILG 206 (365)
T ss_dssp EEE-----CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEEC
T ss_pred eee-----cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEec
Confidence 987 4556899999999999999997532 2456999999999999999999999 89999999999999999
Q ss_pred C-----------CCcEEEeeecccccccC-CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 036081 430 S-----------EMKAKVADFGLAKQSLE-GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLE 497 (614)
Q Consensus 430 ~-----------~~~~KL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~ 497 (614)
. ++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8 89999999999976432 22233455689999999999999999999999999999999999999986
Q ss_pred CCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhhcC
Q 036081 498 TSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALR-PTIADALKMLEGD 567 (614)
Q Consensus 498 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Ptm~eVl~~L~~~ 567 (614)
........ ++..+..... .+.+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 287 ~~~~~~~~-----------------~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 287 KNEGGECK-----------------PEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp EEETTEEE-----------------ECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred cCCCCcee-----------------echhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 43321100 0011111111 2355677888999999988 6788888877753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=341.11 Aligned_cols=250 Identities=29% Similarity=0.392 Sum_probs=196.7
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.++|...+.||+|+||.||+++.+ |+.||||+++.. ...+.+.+|++++.+++||||+++++++.. .....++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceEE
Confidence 456888999999999999999986 899999998653 245679999999999999999999998763 2346799
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++.... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 999999999999987532 234889999999999999999999 8899999999999999999999999999987543
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ... ...+..
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-----~~~-~~~~~~------ 232 (278)
T 1byg_A 169 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPR-VEKGYK------ 232 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----HHH-HTTTCC------
T ss_pred cc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHH-HhcCCC------
Confidence 22 123357889999999999999999999999999999998 9999976543211 111 111110
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+......+.+++..|++.+|.+|||+.|+++.|+.
T Consensus 233 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 233 ---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 01112233577889999999999999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=381.65 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=196.5
Q ss_pred eeeeccCcEEEEEEEEc---CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLE---DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
+.||+|+||.||+|.+. .++.||||+++... ....++|.+|++++.+++|||||++++++. ....++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence 47999999999999763 46789999997532 233578999999999999999999999985 23478999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus 449 E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 449 EMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp ECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EccCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 99999999999964 457999999999999999999999 889999999999999999999999999999876443
Q ss_pred Cc--cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 449 QS--HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 449 ~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.. .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||....... .. .....+..
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~-~~i~~~~~------ 590 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VT-AMLEKGER------ 590 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HH-HHHHTTCC------
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH-HHHHcCCC------
Confidence 32 22333457889999999999999999999999999999998 999997654321 11 11111111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+......+.+++..|++.||++|||+.+|+++|+.
T Consensus 591 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 591 ---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 01122234578889999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.36 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=198.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|....+||+|+||.||+|+.. +++.||||.+........+.+.+|+.++.+++||||+++++++. .....++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEE
Confidence 34555679999999999999975 68899999998766666778999999999999999999999987 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-CCcEEEeeecccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-EMKAKVADFGLAKQS 445 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~KL~DFGla~~~ 445 (614)
||||+++++|.+++........+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++..
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999876433345678888999999999999999 889999999999999987 899999999999865
Q ss_pred cCCCccccccccCCCCccchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
.... .......||+.|+|||.+.++. ++.++||||||+++|||++|+.||........... .......
T Consensus 174 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~------- 243 (295)
T 2clq_A 174 AGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KVGMFKV------- 243 (295)
T ss_dssp CC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HHHHHCC-------
T ss_pred CCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hhccccc-------
Confidence 4322 1233457899999999997654 89999999999999999999999975432211110 0000000
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....+......+.+++..|++.||++|||+.|++++
T Consensus 244 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 ----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001112233467889999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=337.63 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=203.3
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 356888999999999999999987 58899999986532 233567889999999999999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++.. ...+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCc
Confidence 78999999999999998764 357999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .... ..+..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~-~~~~~--- 232 (294)
T 2rku_A 163 TKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRI-KKNEY--- 232 (294)
T ss_dssp EECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHH-HTTCC---
T ss_pred eecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH-hhccC---
Confidence 86543222 23345789999999999999999999999999999999999999976542211 1111 11110
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.||++|||+.|++++
T Consensus 233 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111223467789999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.16 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=199.1
Q ss_pred CccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++||||+++++++..... .....++
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~l 106 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC-CCceEEE
Confidence 667788999999999999975 5889999998753 23345678999999999999999999998864332 3567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc--eEecCCCCCceeec-CCCcEEEeeecccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA--IYHRDIKSTNILLD-SEMKAKVADFGLAK 443 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~--ivHrDIKp~NILLd-~~~~~KL~DFGla~ 443 (614)
||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999865 357899999999999999999999 777 99999999999997 78999999999997
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||........ .... ...+......
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~-~~~~~~~~~~ 251 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRR-VTSGVKPASF 251 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHH-HTTTCCCGGG
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----HHHH-HhccCCcccc
Confidence 54332 233457999999999876 5699999999999999999999999976443211 1111 1111111111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+ .. ....+.+++..|++.+|.+|||+.|++++
T Consensus 252 ~----~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 D----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C----CC----CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 11 12367889999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.76 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=200.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC------cchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT------KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~------~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
++|...+.||+|+||.||+++.. +|+.||||.++.... ...+.+.+|++++.+++||||+++++++. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 45888999999999999999987 689999999875321 13577999999999999999999999987 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC----cEEE
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM----KAKV 436 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~KL 436 (614)
....++||||+++++|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++ .+||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred CCeEEEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEE
Confidence 5678999999999999999865 357999999999999999999999 88999999999999998877 8999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ..
T Consensus 154 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~-~~ 225 (283)
T 3bhy_A 154 IDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-----TLTNI-SA 225 (283)
T ss_dssp CCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHH-HT
T ss_pred EecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-----HHHHh-Hh
Confidence 9999998654322 2234568999999999999999999999999999999999999997654321 11111 11
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.... .+..... ...+.+.+++..|++.+|++|||+.|++++
T Consensus 226 ~~~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 226 VNYD--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp TCCC--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred cccC--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1110 0111111 123467889999999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=343.45 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=203.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++|+||+++++++. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 356888999999999999999986 58899999986532 233567899999999999999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++.. ...+++.+++.++.||++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCc
Confidence 78999999999999998765 357999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ + ..... +..
T Consensus 189 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~-~~~~~-~~~--- 258 (335)
T 2owb_A 189 TKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----Y-LRIKK-NEY--- 258 (335)
T ss_dssp EECCSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----H-HHHHH-TCC---
T ss_pred eecccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH----H-HHHhc-CCC---
Confidence 8654322 223345799999999999999999999999999999999999999976442211 1 11111 110
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.||++|||+.|++++
T Consensus 259 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111123467789999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.15 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=205.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++. ...
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 367888999999999999999986 79999999996432 223457899999999999999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a 163 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 163 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccch
Confidence 78999999999999999865 456999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+...... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....... ..... ..+...
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-----~~~~i-~~~~~~- 234 (476)
T 2y94_A 164 NMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-----LFKKI-CDGIFY- 234 (476)
T ss_dssp EECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-----HHHHH-HTTCCC-
T ss_pred hhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-----HHHHH-hcCCcC-
Confidence 8754332 2334579999999999988765 689999999999999999999997654321 11111 111110
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcC
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGD 567 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~~ 567 (614)
.+......+.+++..|++.||.+|||+.|++++ +...
T Consensus 235 ---------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 ---------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ---------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 111123467889999999999999999999974 4443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.55 Aligned_cols=259 Identities=18% Similarity=0.275 Sum_probs=200.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+|+.. +|+.||||+++. ...+.+.+|++++.+++ ||||+++++++... .....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceE
Confidence 56888999999999999999864 689999999864 33567999999999997 99999999998742 245689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DFGla~~ 444 (614)
+||||+++++|.+++. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 110 lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 9999999999988874 3888899999999999999999 89999999999999999777 899999999986
Q ss_pred ccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH--------hh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML--------AN 515 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~--------~~ 515 (614)
...... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+....... ..
T Consensus 181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 543322 234578999999999987 6799999999999999999999999965443322111111100 00
Q ss_pred C--CCchhhhhHH------------hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 S--GKVDEIFDEF------------IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 ~--~~~~~~~d~~------------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. .......+.. ............+.+++..|++.||.+|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000001110 0011111234578899999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.88 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=203.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|++++.+++||||+++++++. .+...+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 107 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEIS 107 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEEE
Confidence 56888999999999999999986 68999999997643 233567899999999999999999999987 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCC-ceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP-AIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
+||||+++|+|.+++.. ...+++..+..++.+++.||.||| +. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999865 356899999999999999999999 64 899999999999999999999999999875
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHH-----------------
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLIT----------------- 507 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~----------------- 507 (614)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 182 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred cccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 4321 22345799999999999999999999999999999999999999976543221000
Q ss_pred -------HHHHHHhhCCCchhhhhHHhhhh----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 508 -------DWAWMLANSGKVDEIFDEFIREE----GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 508 -------~~~~~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+...........+.++...... ........+.+++..|++.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000001111222233322211 111234468899999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.24 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=181.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++.+++||||+++++++. ...
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence 356888999999999999999974 79999999986421 223467899999999999999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++... ...+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 159 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecce
Confidence 789999999999999998652 356899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .. ......
T Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~-~~~~~~--- 229 (278)
T 3cok_A 160 TQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----NK-VVLADY--- 229 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSCC---
T ss_pred eeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----HH-Hhhccc---
Confidence 86543221 223457899999999999999999999999999999999999999764432110 00 000000
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.||++|||+.+++++
T Consensus 230 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0111223467789999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=353.56 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=192.1
Q ss_pred CCCccc-eeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQK-NLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|... ++||+|+||+||+++.. +|+.||||+++. ...+.+|++++.++ +||||+++++++..... .....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~-~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeeccc-CCcEE
Confidence 455555 68999999999999976 689999999864 34678899988555 89999999998863211 24578
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---CCcEEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~KL~DFGl 441 (614)
++||||+++|+|.+++... ....+++..+..|+.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999999753 2346899999999999999999999 889999999999999998 78999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~ 519 (614)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... ..+..
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc
Confidence 98654322 23446789999999999999999999999999999999999999976543221 010000 11110
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ...........+.+++..|++.||.+|||+.|++++
T Consensus 285 ~~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EF------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 000001233567889999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.78 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=200.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcE--EEEEEeecC-CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTL--VAVKQITDL-DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~--vAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|...+.||+|+||.||+|+.. +|.. +|||+++.. .....+.+.+|++++.++ +||||+++++++. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence 56888999999999999999975 4664 499998753 233456799999999999 8999999999986 456
Q ss_pred eEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
..++||||+++|+|.+++.... ....+++.+++.++.||+.||.||| +.+|+||||||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEc
Confidence 7899999999999999987532 1246899999999999999999999 89999999999999999
Q ss_pred CCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITD 508 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~ 508 (614)
.++.+||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 177 ~~~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----- 249 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 249 (327)
T ss_dssp GGGCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----
T ss_pred CCCeEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----
Confidence 999999999999874322 112233457889999999999999999999999999999998 999997644221
Q ss_pred HHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 509 WAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 509 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.... ...+. ....+......+.+++..|++.+|.+|||+.|++++|+..
T Consensus 250 ~~~~-~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 250 LYEK-LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHHH-GGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-hhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 11110 0011122335688899999999999999999999998864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=339.30 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=200.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||.||+++.. +|+.||+|.++.......+.+.+|++++.+++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence 356888999999999999999976 69999999998655445567899999999999999999999987 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee---cCCCcEEEeeeccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL---DSEMKAKVADFGLA 442 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~KL~DFGla 442 (614)
+||||+++|+|.+++.. .+.+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 99999999999998865 356899999999999999999999 8899999999999999 78899999999998
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ..+...
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i-~~~~~~-- 225 (304)
T 2jam_A 157 KMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-----LFEKI-KEGYYE-- 225 (304)
T ss_dssp CCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHH-HHCCCC--
T ss_pred eecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHH-HcCCCC--
Confidence 754322 2234568999999999999999999999999999999999999997644221 11111 111100
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ..........+.+++..|++.||.+|||+.|++++
T Consensus 226 ~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 FE----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CC----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 00111233467889999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.96 Aligned_cols=251 Identities=24% Similarity=0.277 Sum_probs=196.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+++.. +|..+|+|++.... ....+.+.+|++++++++||||+++++++. .....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence 46888999999999999999975 68999999987543 334578999999999999999999999986 456789
Q ss_pred EEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee---cCCCcEEEeeecc
Q 036081 366 LVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL---DSEMKAKVADFGL 441 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~KL~DFGl 441 (614)
+||||+++|+|.+++.... ....+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 9999999999999986542 2457999999999999999999999 8899999999999999 5568899999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH-hhCCCch
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML-ANSGKVD 520 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~-~~~~~~~ 520 (614)
++...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||........ .... .......
T Consensus 174 a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~ 245 (285)
T 3is5_A 174 AELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-----QQKATYKEPNYA 245 (285)
T ss_dssp CCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCCCCCC
T ss_pred ceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-----HhhhccCCcccc
Confidence 97654322 234457899999999875 6789999999999999999999999976442211 1111 1111110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... . .....+.+++..|++.||++|||+.|++++
T Consensus 246 ~~~-----~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 246 VEC-----R----PLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp C-------C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccc-----C----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 022467789999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=342.62 Aligned_cols=267 Identities=22% Similarity=0.332 Sum_probs=205.4
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..++|...+.||+|+||.||+++.. +++.||||++...... ..+.+.+|++++.+++||||+++++++..........
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3567999999999999999999976 6889999999754332 3467899999999999999999999987655445567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||++ |+|.+++.. ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999997 588888754 46999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcc--ccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 444 QSLEGQSH--LTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 444 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ +...... .... ..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~-~~~~-~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGI-LGSP-SQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHH-HCSC-CH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHH-hCCC-CH
Confidence 65433221 2344689999999998764 4589999999999999999999999976554331 1111110 0100 00
Q ss_pred hhhhH--------Hhh----------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDE--------FIR----------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~--------~l~----------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+.+.. ... ..........+.+++..|++.||.+|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000 00001123467889999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=334.17 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=202.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++. .+..
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 88 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRKR 88 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCCE
Confidence 56888999999999999999976 57899999986421 223467899999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp EEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 8999999999999999865 356899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ...... ....
T Consensus 163 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~-~~~~---- 229 (284)
T 2vgo_A 163 HAPSL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-----THRRIV-NVDL---- 229 (284)
T ss_dssp ECSSS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHH-TTCC----
T ss_pred cCccc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-----HHHHHh-cccc----
Confidence 54332 1234578999999999999999999999999999999999999997644221 111111 1110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.+|.+|||+.|++++
T Consensus 230 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 ------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0111223467889999999999999999999873
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.34 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=204.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+++.. +|+.||||++... .......+.+|++++.+++||||+++++++. ...
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eCC
Confidence 456888999999999999999986 6999999999652 2234567889999999999999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.... ...+++..++.++.||+.||.||| +.+|+||||||+||||+.++++||+|||++
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccc
Confidence 7999999999999999986532 345899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... ..
T Consensus 334 ~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~i~~~i~~-~~---- 405 (576)
T 2acx_A 334 VHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE-VP---- 405 (576)
T ss_dssp EECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HHHHHHHHH-CC----
T ss_pred eecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HHHHHHhhc-cc----
Confidence 87644332 23458999999999999999999999999999999999999999765432110 011111111 00
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
...+......+.+++..|++.||.+|| ++.|++++
T Consensus 406 ------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 ------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 011122334678899999999999999 78888764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=350.28 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=201.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
.++|...+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++.+++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence 467889999999999999999842 47789999996543 3345679999999999999999999999873
Q ss_pred CCceEEEEEecCCCCCcccccchhhh----ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---CC
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALT----RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EM 432 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~ 432 (614)
....++||||+++|+|.+++..... ...+++..++.++.||+.||.||| +.+|+||||||+|||++. +.
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTC
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcc
Confidence 4457999999999999999976421 135888999999999999999999 889999999999999984 45
Q ss_pred cEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHH
Q 036081 433 KAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWA 510 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~ 510 (614)
.+||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||++ |+.||....... ..
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~ 255 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VL 255 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-----HH
Confidence 699999999975433222 22334567899999999999999999999999999999998 999987543221 11
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
... ..+... ..+......+.+++..|++.+|.+|||+.+++++|+....
T Consensus 256 ~~~-~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 EFV-TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHH-HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-hcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111 111100 0111233467889999999999999999999999987543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=358.11 Aligned_cols=249 Identities=16% Similarity=0.167 Sum_probs=188.4
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHH---HHHHHccCCCcccccccccc---
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEV---EIISKIRHRNLLSLRGCCVS--- 355 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei---~il~~l~H~NIv~l~g~~~~--- 355 (614)
..++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+ +++++++||||+++++.+..
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3567888999999999999999964 6999999999742 333457789999 45555689999999854431
Q ss_pred ----cCC--------CCC----ceEEEEEecCCCCCcccccchhhh----ccCCCccchhHHHHHHHHHHHHHHhcCCCc
Q 036081 356 ----SDD--------EKG----KRRFLVYDFMPSGSLGDHISNALT----RKQLAWPQRKKIILDVAKGLAYLHYGLKPA 415 (614)
Q Consensus 356 ----~~~--------~~~----~~~~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ 415 (614)
... .++ ...++||||+ +|+|.+++..... ...++|..++.|+.||+.||+||| +.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence 100 000 0378999999 6899999976321 122445888899999999999999 889
Q ss_pred eEecCCCCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccC-----------CCCchhhHHHHHH
Q 036081 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG-----------QLTEKSDVYSFGI 484 (614)
Q Consensus 416 ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----------~~s~ksDVwSfGv 484 (614)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985322 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 485 VILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 485 vL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
++|||++|+.||....... ....... . .......+.+++..|++.||++|||+.|++++
T Consensus 302 il~elltg~~Pf~~~~~~~--------------~~~~~~~----~--~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG--------------GSEWIFR----S--CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------C--------------CSGGGGS----S--CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCccccccc--------------chhhhhh----h--ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999996543211 0111110 0 01123467889999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.36 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=196.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc--CCc--EEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE--DGT--LVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~--~g~--~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
.++|...+.||+|+||.||+|++. +++ .||||+++.. .....+.+.+|++++.+++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 356888999999999999999864 233 6899998653 23345689999999999999999999999863
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeee
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADF 439 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DF 439 (614)
...++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 93 --~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 93 --PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred --CCceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccc
Confidence 2378999999999999998763 356899999999999999999999 889999999999999999999999999
Q ss_pred cccccccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhC
Q 036081 440 GLAKQSLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 440 Gla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
|+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... ........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~ 240 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKE 240 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTS
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-----HHHHHHcc
Confidence 999876443322 2234567889999999999899999999999999999999 999997654321 11111111
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
+... .......+.+.+++..|++.+|++|||+.+++++|++..
T Consensus 241 ~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 241 GERL---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCC---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1100 011223357888999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=337.63 Aligned_cols=248 Identities=26% Similarity=0.379 Sum_probs=203.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
+.|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++.+++||||+++++++. .....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEE
Confidence 45888999999999999999875 68999999997543 334578999999999999999999999987 345789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp EEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceec
Confidence 99999999999998854 56899999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...... +...
T Consensus 170 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~-~~~~----- 237 (303)
T 3a7i_A 170 TDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV-----LFLIPK-NNPP----- 237 (303)
T ss_dssp BTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHH-SCCC-----
T ss_pred Cccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH-----HHHhhc-CCCC-----
Confidence 4332 223345789999999999999999999999999999999999999975432211 111111 1100
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.........+.+++..|++.+|.+|||+.|++++
T Consensus 238 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 ----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111223467889999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.15 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=198.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||.||+++.+ +|+.||||++..... .+.+|++++.++ +||||+++++++. ++...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD-----DGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCEE
Confidence 456888999999999999999986 689999999975432 345789999988 7999999999987 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC----CcEEEeeec
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE----MKAKVADFG 440 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~----~~~KL~DFG 440 (614)
++||||+++|+|.+++.. .+.+++..+..++.||+.||.||| +.+|+||||||+|||+..+ +.+||+|||
T Consensus 92 ~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 999999999999998865 356899999999999999999999 8899999999999998433 359999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+..... ..+...
T Consensus 166 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~i-~~~~~~ 241 (342)
T 2qr7_A 166 FAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP--EEILARI-GSGKFS 241 (342)
T ss_dssp TCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--HHHHHHH-HHCCCC
T ss_pred CcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--HHHHHHH-ccCCcc
Confidence 9987544322 23345789999999999988899999999999999999999999975432211 1111111 111111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. .........+.+.+++..|++.||++|||+.|++++
T Consensus 242 ~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 L------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp C------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred c------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000111233567889999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.27 Aligned_cols=267 Identities=25% Similarity=0.275 Sum_probs=196.8
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc-----chHHHHHHHHHHHHccCCCcccccccccccC
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK-----GDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-----~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~ 357 (614)
....++|...+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++.+++||||+++++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 82 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--- 82 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe---
Confidence 334577999999999999999999976 5899999998643211 1346889999999999999999999986
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEe
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVA 437 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~ 437 (614)
.....++||||+++ +|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 83 --~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 83 --HKSNISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp --CTTCCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred --eCCceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEE
Confidence 34568999999985 78887765 2356899999999999999999999 8899999999999999999999999
Q ss_pred eecccccccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 438 DFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 438 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
|||+++...... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||........ +....... ..
T Consensus 155 Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~-~~ 231 (346)
T 1ua2_A 155 DFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETL-GT 231 (346)
T ss_dssp CCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHH-CC
T ss_pred ecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHc-CC
Confidence 999998654322 223445789999999999754 589999999999999999999999876543221 11111111 00
Q ss_pred CCchhh------hhHHhhh--------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 036081 517 GKVDEI------FDEFIRE--------EGSRAVMERFVRVGILCAHVMVALRPTIADALKML 564 (614)
Q Consensus 517 ~~~~~~------~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L 564 (614)
...... .+..... .........+.+++..|++.||.+|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000000 0000000 00012235788899999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=353.70 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=190.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHH-HHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEI-ISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~i-l~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|...+.||+|+||.||+++.+ +++.||||+++... ....+.+..|..+ ++.++||||+++++++. ..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----eC
Confidence 356889999999999999999986 58899999997532 2233456677776 46689999999999987 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++|+|.+++.+ ...+++...+.++.||+.||+||| +.+|+||||||+|||++.++++||+|||+
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~ 185 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL 185 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred CEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcc
Confidence 679999999999999999865 356889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....... +..
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~~-~~~-- 256 (373)
T 2r5t_A 186 CKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNILN-KPL-- 256 (373)
T ss_dssp CGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----HHHHHHH-SCC--
T ss_pred ccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHh-ccc--
Confidence 98643322 23445689999999999999999999999999999999999999997644221 1111111 110
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIAD 559 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~e 559 (614)
..+......+.+++..|++.||.+||++.+
T Consensus 257 --------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 --------QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 011123346788999999999999999853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=347.68 Aligned_cols=243 Identities=22% Similarity=0.285 Sum_probs=200.1
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--------cchHHHHHHHHHHHHccCCCccccccccccc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--------KGDEEFINEVEIISKIRHRNLLSLRGCCVSS 356 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--------~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~ 356 (614)
..++|...+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++.+++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 3467889999999999999999965 689999999976431 12346788999999999999999999987
Q ss_pred CCCCCceEEEEEecCCCC-CcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEE
Q 036081 357 DDEKGKRRFLVYDFMPSG-SLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAK 435 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~K 435 (614)
.....++||||+.+| +|.+++.. ...+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 100 ---~~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k 170 (335)
T 3dls_A 100 ---NQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIK 170 (335)
T ss_dssp ---CSSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEE
T ss_pred ---eCCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEE
Confidence 456789999999877 89888865 356999999999999999999999 88999999999999999999999
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA 514 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~ 514 (614)
|+|||+++...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 171 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------ 236 (335)
T 3dls_A 171 LIDFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------ 236 (335)
T ss_dssp ECCCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------
T ss_pred EeecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------
Confidence 99999998654432 2334679999999999988877 88999999999999999999999653211
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...... .+......+.+++..|++.+|++|||+.|++++
T Consensus 237 --------~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --------VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011123467889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=331.92 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=194.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 467889999999999999999986 79999999986432 233567899999999999999999999986 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 158 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred eEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccc
Confidence 78999999999999999865 356899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
....... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..... ..+..
T Consensus 159 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~-- 228 (276)
T 2h6d_A 159 NMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-----LFKKI-RGGVF-- 228 (276)
T ss_dssp GCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-HHCCC--
T ss_pred cccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHh-hcCcc--
Confidence 8654322 2234568999999999987765 689999999999999999999997543211 11111 11110
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.||++|||+.|++++
T Consensus 229 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 --------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111123467789999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=337.85 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=198.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|+..+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++.+++||||+++++++. .....+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeEE
Confidence 456888999999999999999986 58999999997766666788999999999999999999999987 345789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 93 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999988652 456999999999999999999999 889999999999999999999999999987643
Q ss_pred cCCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
... ........||+.|+|||.+. ...++.++||||||+++|||++|+.||....... ............
T Consensus 168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~ 241 (302)
T 2j7t_A 168 LKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSDPPT 241 (302)
T ss_dssp HHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCC
T ss_pred ccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----HHHHHhccCCcc
Confidence 211 11122356899999999984 6778999999999999999999999997654221 111111111100
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ..+......+.+++..|++.+|.+|||+.+++++
T Consensus 242 ~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 L--------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp C--------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred c--------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0111223467889999999999999999998763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=349.92 Aligned_cols=269 Identities=19% Similarity=0.282 Sum_probs=199.3
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCC---
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD--- 358 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~--- 358 (614)
++...++|...+.||+|+||.||+|+.. +|+.||||++..... ...+|++++++++||||+++++++.....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3456778999999999999999999874 699999999865322 23479999999999999999999865332
Q ss_pred ------------------------------CCCceEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHH
Q 036081 359 ------------------------------EKGKRRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAY 407 (614)
Q Consensus 359 ------------------------------~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~y 407 (614)
......++||||++ |+|.+.+.... ....+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 23456899999998 68887776532 34579999999999999999999
Q ss_pred HHhcCCCceEecCCCCCceeec-CCCcEEEeeecccccccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHH
Q 036081 408 LHYGLKPAIYHRDIKSTNILLD-SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIV 485 (614)
Q Consensus 408 LH~~~~~~ivHrDIKp~NILLd-~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvv 485 (614)
|| +.+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||++
T Consensus 157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99 89999999999999998 689999999999986543332 3345789999999998865 58999999999999
Q ss_pred HHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh---------------hHHhhhhCcHHHHHHHHHHHHHccccC
Q 036081 486 ILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF---------------DEFIREEGSRAVMERFVRVGILCAHVM 550 (614)
Q Consensus 486 L~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~~ 550 (614)
+|||++|+.||....... .+....... ......... ........+......+.+++..|++.+
T Consensus 232 l~ell~g~~pf~~~~~~~-~~~~i~~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID-QLVRIIQIM-GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH-HHHHHHHHH-CCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHH-HHHHHHHHh-CCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999997654332 111111111 111000000 000011112223346889999999999
Q ss_pred CCCCCCHHHHHHH
Q 036081 551 VALRPTIADALKM 563 (614)
Q Consensus 551 p~~RPtm~eVl~~ 563 (614)
|.+|||+.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=341.76 Aligned_cols=262 Identities=21% Similarity=0.331 Sum_probs=194.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||.||+|+.. +|+.||||+++..... ....+.+|++++.+++||||+++++++. .....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 56888999999999999999986 6899999998653322 2234668999999999999999999987 455689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++ |+|.+++... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 77 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp EEEECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred EEecccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 9999997 6888887653 356899999999999999999999 899999999999999999999999999999754
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC---Cchh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG---KVDE 521 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~~~ 521 (614)
.... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +. ......... ....
T Consensus 151 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~-~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 151 SIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LH-FIFRILGTPTEETWPG 227 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HH-HHHHHHCCCCTTTSTT
T ss_pred cCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHhCCCChHhchh
Confidence 3322 22334578999999999876 5789999999999999999999999976543321 11 111111111 0111
Q ss_pred hhhHH-hh------------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEF-IR------------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~-l~------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... .. ..........+.+++..|++.||.+|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 11000 00 00001123467889999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.90 Aligned_cols=266 Identities=25% Similarity=0.290 Sum_probs=202.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc--------CCCcccccccccccC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR--------HRNLLSLRGCCVSSD 357 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~--------H~NIv~l~g~~~~~~ 357 (614)
.++|...++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++.+++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 477999999999999999999865 6889999998643 234567899999999996 788999999886432
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCC-ceEecCCCCCceeecCCC----
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP-AIYHRDIKSTNILLDSEM---- 432 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~---- 432 (614)
. .+...++||||+ +++|.+.+... ....+++..++.|+.||+.||.||| +. +|+||||||+|||++.++
T Consensus 115 ~-~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 V-NGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp T-TEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred C-CCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence 1 356789999999 56666666542 2356999999999999999999999 77 999999999999999775
Q ss_pred ---------------------------------------------cEEEeeecccccccCCCccccccccCCCCccchhh
Q 036081 433 ---------------------------------------------KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467 (614)
Q Consensus 433 ---------------------------------------------~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 467 (614)
.+||+|||+++..... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999865432 234578999999999
Q ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--hHH--HHHHHHhhC--------CCch-hhh-----------
Q 036081 468 ALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LIT--DWAWMLANS--------GKVD-EIF----------- 523 (614)
Q Consensus 468 ~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~--~~~~~~~~~--------~~~~-~~~----------- 523 (614)
+.+..++.++|||||||+||||++|+.||........ ... ......... +... +.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999976543321 000 011010000 0000 000
Q ss_pred ------hHHhh--hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 ------DEFIR--EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 ------d~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...+. ...+......+.+++..|++.||++|||+.|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00011 11245566788999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.81 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=196.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCC-CCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467899999999999999999975 699999999865322 234678899999999999999999999875422 1234
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+ +++|.+++.. ..+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 679999999 7899888754 46899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+..... .+...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... +....... . ....+
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~-g-~~~~~ 248 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVT-G-TPPAE 248 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHH-C-CCCHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc-C-CCCHH
Confidence 865322 334578999999999987 7899999999999999999999999976543221 11111100 0 00011
Q ss_pred hhh--------HHhhh----------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFD--------EFIRE----------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d--------~~l~~----------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+. ..+.. .........+.+++..|++.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 100 00000 0011223467889999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=342.44 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=204.0
Q ss_pred HHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc--------chHHHHHHHHHHHHc-cCCCcccccc
Q 036081 282 ELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK--------GDEEFINEVEIISKI-RHRNLLSLRG 351 (614)
Q Consensus 282 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~--------~~~~f~~Ei~il~~l-~H~NIv~l~g 351 (614)
......++|...+.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|++++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455677999999999999999999986 6999999998754321 134678999999999 7999999999
Q ss_pred cccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC
Q 036081 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 352 ~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 431 (614)
++. .....++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 168 ~~~-----~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 168 SYE-----SSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDN 236 (365)
T ss_dssp EEE-----BSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred EEe-----eCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence 986 45679999999999999999865 357999999999999999999999 8899999999999999999
Q ss_pred CcEEEeeecccccccCCCccccccccCCCCccchhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh
Q 036081 432 MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY------GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL 505 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~ 505 (614)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .
T Consensus 237 ~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~ 313 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-M 313 (365)
T ss_dssp CCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred CCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-H
Confidence 999999999998654332 2344679999999999863 368899999999999999999999997543211 1
Q ss_pred HHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 506 ITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 506 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... ...+.... ..+.. . .....+.+++..|++.||++|||+.|++++
T Consensus 314 ----~~~-i~~~~~~~-~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 314 ----LRM-IMEGQYQF-SSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ----HHH-HHHTCCCC-CHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HHH-HHhCCCCC-CCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 11111100 00000 0 122467889999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.50 Aligned_cols=258 Identities=19% Similarity=0.260 Sum_probs=201.4
Q ss_pred HHHHhCCCccc-eeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHcc-CCCcccccccccccC
Q 036081 283 LDQATGGFSQK-NLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSD 357 (614)
Q Consensus 283 l~~at~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~ 357 (614)
.+...+.|... +.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++.+++ ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--- 99 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE--- 99 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE---
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE---
Confidence 34455666666 88999999999999976 68999999987532 233578999999999995 699999999986
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---CCcE
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKA 434 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~ 434 (614)
.....++||||+++|+|.+++... ....+++.+++.++.|++.||+||| +.+|+||||||+|||++. ++.+
T Consensus 100 --~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 100 --NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp --CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred --eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcE
Confidence 456789999999999999998653 2356899999999999999999999 889999999999999988 7899
Q ss_pred EEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh
Q 036081 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA 514 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~ 514 (614)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .. ..
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i---~~ 247 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL-NI---SQ 247 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HH---HH
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH-HH---Hh
Confidence 999999998654322 2334579999999999999999999999999999999999999997654322111 00 00
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....... .........+.+++..|++.||++|||+.|++++
T Consensus 248 ~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 VNVDYSE--------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TCCCCCT--------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cccccCc--------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0111100 0111223467889999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=343.76 Aligned_cols=267 Identities=27% Similarity=0.391 Sum_probs=202.5
Q ss_pred ccChHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCccccccccc
Q 036081 277 WFRESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCV 354 (614)
Q Consensus 277 ~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~ 354 (614)
.++..++....++|...+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|++++.++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3455566677889999999999999999999975 68999999986533 3457899999999999 7999999999987
Q ss_pred ccCCC-CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc
Q 036081 355 SSDDE-KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK 433 (614)
Q Consensus 355 ~~~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 433 (614)
..... .....++||||+++|+|.+++... ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCC
Confidence 54321 246789999999999999998763 2356889999999999999999999 889999999999999999999
Q ss_pred EEEeeecccccccCCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Q 036081 434 AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITD 508 (614)
Q Consensus 434 ~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~ 508 (614)
+||+|||++....... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||........
T Consensus 168 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---- 242 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---- 242 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----
T ss_pred EEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----
Confidence 9999999987653321 1223457899999999997 56789999999999999999999999965432211
Q ss_pred HHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 509 WAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 509 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
......... ... ........+.+++..|++.||.+|||+.+++++
T Consensus 243 -~~~~~~~~~-~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 -LFLIPRNPA-PRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -HHHHHHSCC-CCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHhhcCcc-ccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111110 000 011123467889999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=352.05 Aligned_cols=259 Identities=9% Similarity=-0.029 Sum_probs=184.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHc--cCCCcccccccc-------
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKI--RHRNLLSLRGCC------- 353 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l--~H~NIv~l~g~~------- 353 (614)
..+|...+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|++++..+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888999999999999999976 789999999986443 2345677886666666 599988755322
Q ss_pred cccCC------------CCCceEEEEEecCCCCCcccccchhhhccCCCccch------hHHHHHHHHHHHHHHhcCCCc
Q 036081 354 VSSDD------------EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQR------KKIILDVAKGLAYLHYGLKPA 415 (614)
Q Consensus 354 ~~~~~------------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r------~~Ia~~Ia~gL~yLH~~~~~~ 415 (614)
..... ......++||||++ |+|.+++... ...+.+..+ +.++.||+.||+||| +.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKG 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence 11110 01145899999999 9999999764 345677777 888999999999999 899
Q ss_pred eEecCCCCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhcc--CCCCchhhHHHHHHHHHHHHhCC
Q 036081 416 IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGR 493 (614)
Q Consensus 416 ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSfGvvL~ELltG~ 493 (614)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999865321 113457799999999987 78999999999999999999999
Q ss_pred CCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 494 KVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 494 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
.||.......... +........................+.+++..|++.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc-------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997653321000 0000000000000000001123457888999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=344.10 Aligned_cols=268 Identities=25% Similarity=0.322 Sum_probs=202.4
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++.+++||||+++++++..........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3567899999999999999999976 689999999965332 23457889999999999999999999887544334577
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||++ |+|.+++.. ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 688887754 46999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcc---------ccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 444 QSLEGQSH---------LTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 444 ~~~~~~~~---------~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
........ ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......... .... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~-~~ 238 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL-LLIF-GI 238 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHH-HH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHH-HH
Confidence 65432211 1223578999999998764 78999999999999999999999999765432211 1111 11
Q ss_pred hhCCC----chh----hhhHHhhh----------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANSGK----VDE----IFDEFIRE----------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~~~----~~~----~~d~~l~~----------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... ... .....+.. .........+.+++..|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11000 000 00000000 0001233467889999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=331.69 Aligned_cols=253 Identities=20% Similarity=0.271 Sum_probs=198.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC----CcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD----TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~----~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.++|...+.||+|+||.||++... +++.||||+++... ....+.+.+|++++.+++||||+++++++... +.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 468999999999999999999975 68999999986432 23457799999999999999999999998532 34
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+++| |.+++... ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 5789999999876 66666543 2456899999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCC-ccccccccCCCCccchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 442 AKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 442 a~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
+....... ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....... ..... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~i-~~~~ 229 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-----LFENI-GKGS 229 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHH-HHCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-----HHHHH-hcCC
Confidence 98654322 22233456899999999997644 3789999999999999999999997643211 11111 1111
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ..+......+.+++..|++.||.+|||+.|++++
T Consensus 230 ~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 Y----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp C----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0111223467789999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=353.80 Aligned_cols=204 Identities=25% Similarity=0.367 Sum_probs=169.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|+||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467999999999999999999976 588999999975322 23467899999999999999999999987554334467
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||++ |+|.+++.. ...+++..++.++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999999986 699888864 356999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCc---------------------cccccccCCCCccchhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 036081 444 QSLEGQS---------------------HLTTRVAGTYGYLAPEYA-LYGQLTEKSDVYSFGIVILELMSGRKVLE 497 (614)
Q Consensus 444 ~~~~~~~---------------------~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwSfGvvL~ELltG~~p~~ 497 (614)
....... ...+..+||+.|+|||.+ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 7543221 123556899999999986 46679999999999999999998655543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.66 Aligned_cols=261 Identities=19% Similarity=0.266 Sum_probs=192.2
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
...++|...+.||+|+||+||+++.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++. .+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence 34567999999999999999999865 689999999965332 22456789999999999999999999987 45
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee-----cCCCcEEE
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL-----DSEMKAKV 436 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL-----d~~~~~KL 436 (614)
...++||||++ |+|.+++.. ...+++..++.|+.||+.||.||| +.+|+||||||+|||+ +.++.+||
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred CEEEEEEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEE
Confidence 67999999997 589888865 356899999999999999999999 8899999999999999 45566999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN 515 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~ 515 (614)
+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.........
T Consensus 179 ~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~ 256 (329)
T 3gbz_A 179 GDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGL 256 (329)
T ss_dssp CCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCC
T ss_pred CcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCC
Confidence 9999998654322 223345789999999999874 589999999999999999999999976543221 1111111100
Q ss_pred CC--Cc-----------------hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 SG--KV-----------------DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 ~~--~~-----------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. .. ...+...+.. .....+.+++..|++.||.+|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGA----LLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGG----GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhccc----ccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 00 0000111111 123467889999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=345.94 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=197.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc--chHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK--GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|...+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|++++.+++||||+++++++. .....
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 99 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKRW 99 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCEE
Confidence 56888999999999999999986 5899999998654332 2456889999999999999999999987 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp EEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 999999999988877543 356999999999999999999999 88999999999999999999999999999976
Q ss_pred ccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......... ...... .+......
T Consensus 174 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~---~~~~~~~~ 248 (331)
T 4aaa_A 174 LAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL-YHIMMC---LGNLIPRH 248 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHH---HCSCCHHH
T ss_pred ecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHH---hCCCChhh
Confidence 54322 223345789999999999875 7899999999999999999999999765533211 111100 01100000
Q ss_pred hHH--------------hh-----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEF--------------IR-----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~--------------l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... +. ........+.+.+++..|++.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00 00011234578899999999999999999998864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.82 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=203.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|...+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|++++.+++||||+++++++. ....
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~~ 259 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TKTD 259 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eCCE
Confidence 56888899999999999999986 69999999996532 233467889999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 364 RFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
.++||||+++|+|.+++.... ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++++||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence 999999999999999986532 2346899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+....... ..
T Consensus 337 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~-~~--- 410 (543)
T 3c4z_A 337 VELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQ-AV--- 410 (543)
T ss_dssp EECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHC-CC---
T ss_pred eeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhc-cc---
Confidence 87544332 23345899999999999999999999999999999999999999976532211 11111111111 00
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTI-----ADALK 562 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm-----~eVl~ 562 (614)
..+......+.+++..|++.||.+||++ .++++
T Consensus 411 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1122234567889999999999999975 66654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=340.95 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=185.6
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..++|...+.||+|+||.||+|... +|+.||||++.... ....+++.+|++++.+++||||+++++++. ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecCC
Confidence 4578999999999999999999864 68999999986432 233567889999999999999999999987 3456
Q ss_pred EEEEEecCCCCCcccccchhh-----hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 364 RFLVYDFMPSGSLGDHISNAL-----TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~-----~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.++||||+++|+|.+++.... ....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEe
Confidence 899999999999999986421 2345899999999999999999999 88999999999999999999999999
Q ss_pred ecccccccCCCc----cccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 439 FGLAKQSLEGQS----HLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 439 FGla~~~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
||++........ .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||........... .
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~ 239 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----T 239 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----H
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----H
Confidence 999876543221 12234578999999999875 5789999999999999999999999976543321110 1
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... .....................+.+++..|++.||.+|||+.|++++
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hcc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111 1100000000001111223467889999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=341.90 Aligned_cols=268 Identities=23% Similarity=0.299 Sum_probs=200.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCC---CCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD---EKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~---~~~ 361 (614)
++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++.+++||||+++++++..... ..+
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57889999999999999999984 789999999864332 234678899999999999999999999875431 124
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
+..++||||+++ +|.+.+... ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 578999999974 777776542 356999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCC---ccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 442 AKQSLEGQ---SHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 442 a~~~~~~~---~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
++...... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +.... ......
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~-~~~~~~ 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALIS-QLCGSI 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH-HHHCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH-HHhCCC
Confidence 98654222 222344678999999999876 5689999999999999999999999986543321 11111 111100
Q ss_pred --CchhhhhH-Hhh-------h-h-CcH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 --KVDEIFDE-FIR-------E-E-GSR------AVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 --~~~~~~d~-~l~-------~-~-~~~------~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
......+. ... . . ... .....+.+++..|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000 000 0 0 000 012357789999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=343.98 Aligned_cols=259 Identities=21% Similarity=0.297 Sum_probs=203.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCc---ch--------------HHHHHHHHHHHHccCCCcccc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTK---GD--------------EEFINEVEIISKIRHRNLLSL 349 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~---~~--------------~~f~~Ei~il~~l~H~NIv~l 349 (614)
.++|...+.||+|+||.||+++. +|+.||||++...... .. +.+.+|++++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998642211 11 789999999999999999999
Q ss_pred cccccccCCCCCceEEEEEecCCCCCcccc------cchhhhccCCCccchhHHHHHHHHHHHHHHhcCC-CceEecCCC
Q 036081 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDH------ISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK-PAIYHRDIK 422 (614)
Q Consensus 350 ~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~------L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~-~~ivHrDIK 422 (614)
++++. .....++||||+++|+|.++ +... ....+++..++.++.|++.||.||| + .+|+|||||
T Consensus 109 ~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~ 179 (348)
T 2pml_X 109 EGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVK 179 (348)
T ss_dssp SEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCC
T ss_pred EEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCC
Confidence 99987 45678999999999999998 5431 2467999999999999999999999 6 999999999
Q ss_pred CCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCC
Q 036081 423 STNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTE-KSDVYSFGIVILELMSGRKVLETSN 500 (614)
Q Consensus 423 p~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~-ksDVwSfGvvL~ELltG~~p~~~~~ 500 (614)
|+|||++.++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus 180 p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 180 PSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999865432 23446799999999999877 6666 9999999999999999999998655
Q ss_pred ccchhHHHHHHHHhhCCCchhh------hhHHh---hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 501 SSFLLITDWAWMLANSGKVDEI------FDEFI---REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~------~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...... .. ...+..... ..... ...........+.+++..|++.||.+|||+.|++++
T Consensus 257 ~~~~~~----~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 257 SLVELF----NN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp CSHHHH----HH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cHHHHH----HH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 422111 11 111111000 00000 000012234577889999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=370.42 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=204.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~ 360 (614)
..++|...+.||+|+||.||+++.. +|+.||||+++.. .....+.+..|.+++..+ +||||+++++++. .
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----C
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----e
Confidence 3567999999999999999999976 5889999999742 223456788999999988 7999999999886 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....+|||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+||||+.++++||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecc
Confidence 5678999999999999999975 357999999999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+... ....... +..
T Consensus 488 la~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-----~~~~i~~-~~~- 559 (674)
T 3pfq_A 488 MCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIME-HNV- 559 (674)
T ss_dssp TCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHS-SCC-
T ss_pred eeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-----HHHHHHh-CCC-
Confidence 998643322 23445689999999999999999999999999999999999999997654321 1111111 111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTI-----ADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm-----~eVl~~ 563 (614)
..+......+.+++..|++.||.+||++ .||+++
T Consensus 560 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ---------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1122234577889999999999999997 777653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=332.76 Aligned_cols=268 Identities=19% Similarity=0.269 Sum_probs=197.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCC-------
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD------- 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~------- 358 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++...+....+.+.+|++++++++||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467888999999999999999987 489999999986665566789999999999999999999998753211
Q ss_pred --CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec-CCCcEE
Q 036081 359 --EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD-SEMKAK 435 (614)
Q Consensus 359 --~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd-~~~~~K 435 (614)
......++||||++ |+|.+++.+ ..+++..++.++.|++.||+||| +.+|+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEE
Confidence 24567899999997 699888853 56899999999999999999999 88999999999999997 567999
Q ss_pred EeeecccccccCCCc--cccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Q 036081 436 VADFGLAKQSLEGQS--HLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM 512 (614)
Q Consensus 436 L~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~ 512 (614)
|+|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||........ .......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILES 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh
Confidence 999999986543221 12234567999999998875 7899999999999999999999999976543221 1111100
Q ss_pred Hhh---------CCCchhhhhHHhhhh------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 513 LAN---------SGKVDEIFDEFIREE------GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 513 ~~~---------~~~~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... ...+...+....... ........+.+++..|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000 000000011110000 001234578899999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=330.61 Aligned_cols=252 Identities=27% Similarity=0.362 Sum_probs=202.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---------cchHHHHHHHHHHHHcc-CCCccccccccc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---------KGDEEFINEVEIISKIR-HRNLLSLRGCCV 354 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---------~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~ 354 (614)
..++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++.+++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3567899999999999999999986 689999999975431 12356889999999996 999999999986
Q ss_pred ccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcE
Q 036081 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA 434 (614)
Q Consensus 355 ~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 434 (614)
.....++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+
T Consensus 95 -----~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 163 (298)
T 1phk_A 95 -----TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNI 163 (298)
T ss_dssp -----CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred -----cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcE
Confidence 45679999999999999999865 357999999999999999999999 8899999999999999999999
Q ss_pred EEeeecccccccCCCccccccccCCCCccchhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Q 036081 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL------YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITD 508 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~ 508 (614)
||+|||++....... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||.......
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 236 (298)
T 1phk_A 164 KLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----- 236 (298)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred EEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-----
Confidence 999999998654332 233457899999999985 4578899999999999999999999997543221
Q ss_pred HHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 509 WAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 509 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
....... +..... . .........+.+++..|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~-~~~~~~-~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 237 MLRMIMS-GNYQFG-S-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHH-TCCCCC-T-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhc-CCcccC-c-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111 111000 0 001123346888999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.47 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=198.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~~~~ 365 (614)
..+|...+.||+|+||.||+|+..++..+|+|++..... ...+|++++++++||||+++++++..... ......+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346888999999999999999998777799998865322 22369999999999999999999875443 2445578
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec-CCCcEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD-SEMKAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd-~~~~~KL~DFGla~~ 444 (614)
+||||++++.+............+++..++.++.||++||+||| +.+|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999986544333322223467899999999999999999999 88999999999999999 799999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ +....... ... ..+.+
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~-g~p-~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVL-GTP-SREQI 266 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHH-CCC-CHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh-CCC-CHHHH
Confidence 543332 2345789999999999764 599999999999999999999999976543221 11111110 000 01111
Q ss_pred hHH----------------hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEF----------------IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~----------------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... +...........+.+++..|++.||.+|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 0011111233578899999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=336.78 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=185.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cch-HHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGD-EEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~-~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
..++|+..+.||+|+||.||+++.. +|+.||||+++.... ... +.+.++...++.++||||+++++++. .+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence 3467889999999999999999974 689999999975422 222 33444555577789999999999997 345
Q ss_pred eEEEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcCCC-ceEecCCCCCceeecCCCcEEEeeec
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGLKP-AIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
..++||||++ |+|.+++.... ....+++..++.++.|++.||.||| +. +|+||||||+|||++.++.+||+|||
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence 6899999997 58888776532 3457999999999999999999999 66 99999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYA----LYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~----~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
+++...... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||.........+.. ....
T Consensus 156 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~ 229 (290)
T 3fme_A 156 ISGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----VVEE 229 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----HHHS
T ss_pred Ccccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----Hhcc
Confidence 997654322 22334699999999996 5667899999999999999999999999754332211111 1111
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
.... .........+.+++..|++.+|++|||+.|+++
T Consensus 230 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSPQ---------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCC---------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC---------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1110 011122346788999999999999999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=337.68 Aligned_cols=271 Identities=23% Similarity=0.296 Sum_probs=205.6
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEE--cCCcEEEEEEeecCC--CcchHHHHHHHHHHHHc---cCCCccccccccccc
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTL--EDGTLVAVKQITDLD--TKGDEEFINEVEIISKI---RHRNLLSLRGCCVSS 356 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~--~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l---~H~NIv~l~g~~~~~ 356 (614)
..+.++|...+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34567899999999999999999998 368899999986432 22234677888888877 799999999998744
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV 436 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL 436 (614)
........++||||++ |+|.+++.... ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEE
Confidence 3334567899999997 69999886532 345899999999999999999999 889999999999999999999999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
+|||+++..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||....... .+....... ..
T Consensus 162 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~-~~ 237 (326)
T 1blx_A 162 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVI-GL 237 (326)
T ss_dssp CSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH-CC
T ss_pred ecCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHc-CC
Confidence 999999765322 22344678999999999999999999999999999999999999997654322 111111111 00
Q ss_pred CCchhhh------hHHh-------hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 GKVDEIF------DEFI-------REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 ~~~~~~~------d~~l-------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....... ...+ ...........+.+++..|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 0000 000112234567889999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=341.09 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=193.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467899999999999999999875 68999999997532 2334678899999999999999999999875431 2345
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||++ |+|.+.+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7899999997 46777663 35889999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH-----------
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW----------- 511 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~----------- 511 (614)
+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.... +.....
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHT
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 865332 223446799999999999999999999999999999999999999976543211 000000
Q ss_pred -------HHhhC-CC-----chhhhhHHhhh---hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 512 -------MLANS-GK-----VDEIFDEFIRE---EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 512 -------~~~~~-~~-----~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... .. ....+...... .........+.+++..|++.||.+|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000 00 00000000000 0012234578899999999999999999999885
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=335.93 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=195.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--------CcchHHHHHHHHHHHHccCCCcccccccccccC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--------TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSD 357 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--------~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~ 357 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++.+++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 456888999999999999999976 58899999986432 1223458899999999999999999999852
Q ss_pred CCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc---E
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK---A 434 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~ 434 (614)
...++||||+++|+|.+++.. ...+++...+.++.||+.||.||| +.+|+||||||+|||++.++. +
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCE
T ss_pred ----CceEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeE
Confidence 237999999999999998865 357899999999999999999999 889999999999999987664 9
Q ss_pred EEeeecccccccCCCccccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Q 036081 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~ 511 (614)
||+|||+++..... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||........... ..
T Consensus 157 kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~- 232 (322)
T 2ycf_A 157 KITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-QI- 232 (322)
T ss_dssp EECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH-HH-
T ss_pred EEccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH-HH-
Confidence 99999999865432 2233457899999999974 56789999999999999999999999976543321111 11
Q ss_pred HHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 512 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
..+.... .+.... ...+.+.+++..|++.||++|||+.|+++
T Consensus 233 ---~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 ---TSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HHTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HhCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111100 001111 12346788999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=332.19 Aligned_cols=252 Identities=27% Similarity=0.371 Sum_probs=198.9
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
..++|...+.||+|+||.||+|+.. +|+.||||.+.... ..+.+.+|++++.+++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence 4567899999999999999999986 58999999997532 3567999999999999999999999987 35678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++.. ....+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 100 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEEEECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 999999999999999864 2457999999999999999999999 89999999999999999999999999999976
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ........... ..
T Consensus 175 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-~~-- 245 (314)
T 3com_A 175 LTDTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIPTNPPP-TF-- 245 (314)
T ss_dssp CBTTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCC-CC--
T ss_pred hhhhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCc-cc--
Confidence 54322 22334578999999999999999999999999999999999999997543211 11111111100 00
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.||.+|||+.+++++
T Consensus 246 -----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 -----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0011123467889999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.12 Aligned_cols=263 Identities=26% Similarity=0.337 Sum_probs=196.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~~~~ 365 (614)
.+|...+.||+|+||.||+|++. +|+.||||++.... ..+.+|++++++++|+||+++++++..... .+....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35788899999999999999986 59999999986532 223479999999999999999999865332 2334567
Q ss_pred EEEecCCCCCcccccchh-hhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-CcEEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNA-LTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~KL~DFGla~ 443 (614)
+||||+++ +|.+.+... .....+++..++.++.||++||+||| +.+|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999985 565555432 23467999999999999999999999 8999999999999999965 568999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+....... ... ..+.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~l-g~p-~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVL-GTP-TREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH-CSC-CHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-CCC-CHHH
Confidence 7543322 2345789999999999764 79999999999999999999999997654322 111222111 000 0111
Q ss_pred hhHH----------------hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEF----------------IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~----------------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+... +...........+.+++..|++.||.+|||+.|++++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 1000 0000111223578899999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=343.56 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=201.1
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
.+.+...++|...+.||+|+||.||+|+.++ .+|+|+++... ....+.+.+|++++.+++|+||+++++++.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---- 99 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM---- 99 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE----
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe----
Confidence 3444456788999999999999999999863 49999986432 233456889999999999999999999987
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.....++||||+++++|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||++ ++.+||+|
T Consensus 100 -~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 100 -SPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp -CSSCEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECC
T ss_pred -cCCceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEee
Confidence 345689999999999999999762 346999999999999999999999 88999999999999998 67999999
Q ss_pred ecccccccCCC----ccccccccCCCCccchhhhcc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh
Q 036081 439 FGLAKQSLEGQ----SHLTTRVAGTYGYLAPEYALY---------GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL 505 (614)
Q Consensus 439 FGla~~~~~~~----~~~~~~~~gt~~Y~APE~~~~---------~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~ 505 (614)
||+++...... ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-- 250 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-- 250 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99987543211 112233468999999999874 457899999999999999999999997654321
Q ss_pred HHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCCC
Q 036081 506 ITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPT 572 (614)
Q Consensus 506 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~~~~ 572 (614)
..+.... +...... .......+.+++..|++.+|++|||+.+++++|+.......
T Consensus 251 ---~~~~~~~-~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 251 ---IIWQMGT-GMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp ---HHHHHHT-TCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred ---HHHHhcc-CCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111111 1111000 01122467789999999999999999999999998765443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=339.87 Aligned_cols=276 Identities=19% Similarity=0.255 Sum_probs=196.4
Q ss_pred hHHHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 280 ESELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 280 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
..+.....++|...+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3556677889999999999999999999985 68999999986533 334467789999999999999999999875432
Q ss_pred --CCCceEEEEEecCCCCCcccccch-hhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-CCcE
Q 036081 359 --EKGKRRFLVYDFMPSGSLGDHISN-ALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-EMKA 434 (614)
Q Consensus 359 --~~~~~~~LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~ 434 (614)
......++||||+++ +|.+.+.+ ......+++..+..++.|++.||.||| ..+.+|+||||||+|||++. ++.+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcE
Confidence 223447899999986 55444433 223456888899999999999999999 33689999999999999997 8999
Q ss_pred EEeeecccccccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHH
Q 036081 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 435 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~ 513 (614)
||+|||+++...... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... .+.......
T Consensus 172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHc
Confidence 999999998654332 23345789999999999765 48999999999999999999999998755332 111111111
Q ss_pred hhCCCchhhhhHH-------------------hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANSGKVDEIFDEF-------------------IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~~~~~~~~d~~-------------------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ....+.+... ............+.+++..|++.||.+|||+.|++++
T Consensus 249 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 G--CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp C--CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred C--CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0111111100 0001111134578899999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.94 Aligned_cols=259 Identities=19% Similarity=0.245 Sum_probs=203.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...++||+|+||.||+|+.. +|+.||||++..... .+++.+|++++..++|.+.+..+.++.. .+...+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence 467899999999999999999974 699999998865432 3458899999999988665555544432 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee---cCCCcEEEeeeccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL---DSEMKAKVADFGLA 442 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~KL~DFGla 442 (614)
|||||+ +++|.+++... ...+++..++.|+.||+.||.||| +.+|+||||||+|||| +.++.+||+|||++
T Consensus 80 lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999999 99999998642 457999999999999999999999 8899999999999999 68899999999999
Q ss_pred ccccCCCcc------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHHh
Q 036081 443 KQSLEGQSH------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL--LITDWAWMLA 514 (614)
Q Consensus 443 ~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~--~l~~~~~~~~ 514 (614)
+........ ......||+.|+|||.+.+..++.++|||||||+||||++|+.||........ .+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-
Confidence 876543321 12356799999999999999999999999999999999999999986543321 111111111
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
....++. +.. ...+.+.+++..|++.+|++||++.+|+++|+..
T Consensus 233 ----~~~~~~~-l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 233 ----VATSIEA-LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp ----HHSCHHH-HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ----ccccHHH-Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0111111 111 1234788999999999999999999999988763
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=355.01 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=200.4
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-------------cchHHHHHHHHHHHHccCCCcccccc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-------------KGDEEFINEVEIISKIRHRNLLSLRG 351 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-------------~~~~~f~~Ei~il~~l~H~NIv~l~g 351 (614)
..++|...++||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++.+++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4577999999999999999999976 588999999875321 23467899999999999999999999
Q ss_pred cccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC
Q 036081 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE 431 (614)
Q Consensus 352 ~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 431 (614)
++. .....++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 114 VFE-----DKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENK 182 (504)
T ss_dssp EEE-----CSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESST
T ss_pred EEE-----cCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecC
Confidence 997 45679999999999999998865 357999999999999999999999 8899999999999999877
Q ss_pred C---cEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Q 036081 432 M---KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITD 508 (614)
Q Consensus 432 ~---~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~ 508 (614)
+ .+||+|||+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.......
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----- 254 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----- 254 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred CCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 6 69999999998654332 234457999999999876 579999999999999999999999997654321
Q ss_pred HHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 509 WAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 509 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... ..+....... . .......+.+++..|++.||.+|||+.|++++
T Consensus 255 ~~~~i-~~~~~~~~~~-~-----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 255 IIKKV-EKGKYYFDFN-D-----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHH-HHCCCCCCHH-H-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH-HcCCCCCCcc-c-----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111 1111110000 0 01123467889999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=355.98 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=197.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.+.|...+.||+|+||+||+++.. ++..||||+++... ......+.+|++++++++||||+++++++. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 346888999999999999999986 68999999997543 334577999999999999999999999997 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC---CcEEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE---MKAKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~KL~DFG 440 (614)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 111 ~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 8999999999999988865 357999999999999999999999 8899999999999999764 559999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+++...... ......||+.|+|||++. +.++.++|||||||++|||++|+.||....... ..... ..+...
T Consensus 185 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i-~~~~~~ 255 (494)
T 3lij_A 185 LSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-----ILRKV-EKGKYT 255 (494)
T ss_dssp TCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-HHTCCC
T ss_pred CCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HhCCCC
Confidence 998754332 234457999999999876 579999999999999999999999997654321 11111 111110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ..+. .......+.+++..|++.+|.+|||+.|++++
T Consensus 256 ~-~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 F-DSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp C-CSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C-Cchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0 0000 01223467889999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=342.37 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=185.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++..... ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 477999999999999999999865 68999999986532 2235678899999999999999999999864321 2335
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++|+||+ +++|.+++.. ..+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 689999999 6899988854 46999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+..... .+...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+... .+...... ... ...+
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~-~g~-p~~~ 252 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRL-VGT-PGAE 252 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH-HCS-CCHH
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-hCC-CCHH
Confidence 864322 334679999999999986 789999999999999999999999997654322 11111111 000 0011
Q ss_pred hhh--------HHhhh---h--Cc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFD--------EFIRE---E--GS-----RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d--------~~l~~---~--~~-----~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+. ..+.. . .. ......+.+++..|++.||.+|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 110 00000 0 00 0112467889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=356.19 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=202.7
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++.+++||||+++++++. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 356888999999999999999986 78999999996532 234577999999999999999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee---cCCCcEEEeee
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL---DSEMKAKVADF 439 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~KL~DF 439 (614)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred EEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 79999999999999998865 457999999999999999999999 8899999999999999 56789999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
|+++...... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||....... ..... ..+..
T Consensus 174 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i-~~~~~ 244 (484)
T 3nyv_A 174 GLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-----ILKKV-EKGKY 244 (484)
T ss_dssp THHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-HHCCC
T ss_pred eeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHH-HcCCC
Confidence 9998654332 2344579999999998865 79999999999999999999999997654321 11111 11111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... ......+.+.+++..|++.+|.+|||+.|++++
T Consensus 245 ~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 TFELP------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCCSG------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 10000 011233467889999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=371.55 Aligned_cols=257 Identities=20% Similarity=0.297 Sum_probs=202.6
Q ss_pred HHHhCCCccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCC
Q 036081 284 DQATGGFSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 284 ~~at~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~ 358 (614)
+...++|...+.||+|+||.||+|++.. +..||||+++.... ...+.|.+|+.++.+++||||++++|++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---- 461 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---- 461 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence 3345678888999999999999998742 56799999875433 23467999999999999999999999984
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 462 --~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 462 --ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred --cCceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEe
Confidence 23479999999999999998752 346899999999999999999999 88999999999999999999999999
Q ss_pred ecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 439 FGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 439 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .........
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~~~i~~~~ 609 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIENGE 609 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHHTC
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHcCC
Confidence 99998765444333445567889999999999999999999999999999997 999997644221 111111111
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.. ..+......+.+++..|++.||.+|||+.|++++|+.
T Consensus 610 ~~----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 610 RL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 10 0112233577889999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.27 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=192.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCC-------
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD------- 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~------- 358 (614)
.++|+..+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++.+++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 456888999999999999999975 7999999998642 2335678999999999999999999998864321
Q ss_pred -CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEe
Q 036081 359 -EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVA 437 (614)
Q Consensus 359 -~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~ 437 (614)
......++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEe
Confidence 2356789999999999999999752 345788899999999999999999 8899999999999999999999999
Q ss_pred eecccccccCCC-------------ccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 036081 438 DFGLAKQSLEGQ-------------SHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSF 503 (614)
Q Consensus 438 DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~ 503 (614)
|||+++...... ........||+.|+|||.+.+. .++.++||||||+++|||++ |+......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~- 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER- 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence 999997653221 1122345789999999999854 78999999999999999998 44321110
Q ss_pred hhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 504 LLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 504 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....... ..... .+...........+.+++..|++.||.+|||+.|++++
T Consensus 235 ---~~~~~~~-~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 ---VNILKKL-RSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---HHHHHHH-HSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---HHHHHhc-ccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111111 11100 00011122233467889999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=353.68 Aligned_cols=251 Identities=27% Similarity=0.352 Sum_probs=200.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|+||+||+++.. +|+.||||++... .......+.+|++++.+++||||+++++++. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence 356888999999999999999976 6899999998642 2234567999999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec---CCCcEEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD---SEMKAKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd---~~~~~KL~DFG 440 (614)
.++||||+++|+|.+.+.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||
T Consensus 96 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 9999999999999998865 357999999999999999999999 88999999999999995 45679999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ..... ..+...
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i-~~~~~~ 240 (486)
T 3mwu_A 170 LSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----ILKRV-ETGKYA 240 (486)
T ss_dssp CTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-HHTCCC
T ss_pred cCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HhCCCC
Confidence 998654332 2334579999999999875 69999999999999999999999997654321 11111 111111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.... ........+.+++..|++.+|.+|||+.|++++
T Consensus 241 ~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 FDLP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCSG------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCc------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 011223467889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=338.80 Aligned_cols=257 Identities=19% Similarity=0.282 Sum_probs=196.7
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC--CcchHHHHHHHHHHHHcc--CCCccccccccccc
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD--TKGDEEFINEVEIISKIR--HRNLLSLRGCCVSS 356 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~--H~NIv~l~g~~~~~ 356 (614)
..+....++|...+.||+|+||.||+++..+|+.||||++.... ....+.+.+|++++.+++ |+||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-- 98 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-- 98 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE--
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee--
Confidence 33444566799999999999999999999889999999986533 233567899999999997 599999999987
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV 436 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL 436 (614)
.....++||| +.+++|.+++.. ...+++..++.++.|+++||.||| +.+|+||||||+|||++ ++.+||
T Consensus 99 ---~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL 167 (313)
T 3cek_A 99 ---TDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKL 167 (313)
T ss_dssp ---CSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred ---cCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEE
Confidence 4567899999 568899999875 357899999999999999999999 88999999999999996 489999
Q ss_pred eeecccccccCCCcc-ccccccCCCCccchhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch
Q 036081 437 ADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALY-----------GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL 504 (614)
Q Consensus 437 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~ 504 (614)
+|||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 999999865433221 2234578999999999875 5788999999999999999999999975432211
Q ss_pred hHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 505 LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 505 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+ ....... .....+......+.+++..|++.||.+|||+.|++++
T Consensus 248 ~~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 KL----HAIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HH----HHHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH----HHHHhcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 1111111 0001111113467889999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=349.09 Aligned_cols=201 Identities=22% Similarity=0.307 Sum_probs=171.9
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc------cCCCcccccccccccCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI------RHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l------~H~NIv~l~g~~~~~~~ 358 (614)
..++|...+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++..+ .|+||+++++++.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~---- 169 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT---- 169 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE----
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc----
Confidence 3467899999999999999999876 5899999999652 23346788899999988 4679999999987
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc--EEE
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK--AKV 436 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--~KL 436 (614)
.....++||||+. ++|.+++.... ...+++..++.|+.||+.||+||| +.+|+||||||+||||+.++. +||
T Consensus 170 -~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 170 -FRNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp -ETTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEE
T ss_pred -cCCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEE
Confidence 4567899999996 68988886532 345899999999999999999999 889999999999999999987 999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~ 501 (614)
+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 244 ~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 244 IDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999999754322 2345789999999999999999999999999999999999999976543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.49 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=200.7
Q ss_pred hCCCccceeeeccCcEEEEEEEE-c-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC------cccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTL-E-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN------LLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~-~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N------Iv~l~g~~~~~~~ 358 (614)
.++|...+.||+|+||.||++.. . +|+.||||+++.. ....+.+.+|++++.+++|+| ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 46789999999999999999987 3 6889999998653 233567899999999998765 889999886
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC--------
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-------- 430 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-------- 430 (614)
.....++||||+ +++|.+++... ....+++..++.++.||+.||+||| +.+|+||||||+|||++.
T Consensus 88 -~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 88 -HHGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred -cCCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccC
Confidence 456799999999 89999988653 2236889999999999999999999 889999999999999987
Q ss_pred -----------CCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 036081 431 -----------EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETS 499 (614)
Q Consensus 431 -----------~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~ 499 (614)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999864332 23457899999999999999999999999999999999999999765
Q ss_pred CccchhHHHHHHHHhhCCCchhhhh--------------------------HH----hh-hhCcHHHHHHHHHHHHHccc
Q 036081 500 NSSFLLITDWAWMLANSGKVDEIFD--------------------------EF----IR-EEGSRAVMERFVRVGILCAH 548 (614)
Q Consensus 500 ~~~~~~l~~~~~~~~~~~~~~~~~d--------------------------~~----l~-~~~~~~~~~~l~~l~~~Cl~ 548 (614)
..... +..... ... ........ .. .. ........+.+.+++..|++
T Consensus 238 ~~~~~-~~~~~~-~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 238 DSKEH-LAMMER-ILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CHHHH-HHHHHH-HHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred ChHHH-HHHHHH-HhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 43321 111111 000 00000000 00 00 00122345678999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 036081 549 VMVALRPTIADALKM 563 (614)
Q Consensus 549 ~~p~~RPtm~eVl~~ 563 (614)
.||.+|||+.|++++
T Consensus 315 ~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 315 YDPAKRITLREALKH 329 (339)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred cCcccccCHHHHhcC
Confidence 999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.93 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=181.9
Q ss_pred ceeeeccCcEEEEEEEEc---CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEEe
Q 036081 293 KNLIGQGASGVVYKGTLE---DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
.++||+|+||.||+|++. +++.||||++... ...+.+.+|++++++++||||+++++++... .+...++|||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~lv~e 100 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD 100 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEEEEEE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEEEEEe
Confidence 457999999999999976 4789999998653 2345788999999999999999999998642 3467899999
Q ss_pred cCCCCCcccccchhhh------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee----cCCCcEEEeee
Q 036081 370 FMPSGSLGDHISNALT------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL----DSEMKAKVADF 439 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~KL~DF 439 (614)
|++ |+|.+++..... ...+++..++.|+.||+.||.||| +.+|+||||||+|||| +.++.+||+||
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 996 578777754321 124899999999999999999999 8899999999999999 77899999999
Q ss_pred cccccccCCCc--cccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--------hhHHH
Q 036081 440 GLAKQSLEGQS--HLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSF--------LLITD 508 (614)
Q Consensus 440 Gla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--------~~l~~ 508 (614)
|+++....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99986543221 22345679999999999987 459999999999999999999999997544321 11111
Q ss_pred HHHHHhhC--CCchhh---------hhHHhhhh------------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 509 WAWMLANS--GKVDEI---------FDEFIREE------------GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 509 ~~~~~~~~--~~~~~~---------~d~~l~~~------------~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.....-.. .....+ ........ ........+.+++..|++.||.+|||+.|++++
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111000 000000 00000000 000012467889999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.20 Aligned_cols=263 Identities=20% Similarity=0.258 Sum_probs=201.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-----------CCCccccccccc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-----------HRNLLSLRGCCV 354 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-----------H~NIv~l~g~~~ 354 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++.. .....+.+.+|++++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357899999999999999999974 689999999864 2234567889999999986 899999999987
Q ss_pred ccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCC-ceEecCCCCCceeec----
Q 036081 355 SSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP-AIYHRDIKSTNILLD---- 429 (614)
Q Consensus 355 ~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~-~ivHrDIKp~NILLd---- 429 (614)
.... .+...++||||+ +++|.+++.... ...+++..++.++.||+.||+||| +. +|+||||||+|||++
T Consensus 97 ~~~~-~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGP-NGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEET-TEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEET
T ss_pred ccCC-CCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCC
Confidence 4322 345789999999 899999987532 345899999999999999999999 76 999999999999994
Q ss_pred --CCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc----
Q 036081 430 --SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF---- 503 (614)
Q Consensus 430 --~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~---- 503 (614)
.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999865432 234578999999999999999999999999999999999999997544221
Q ss_pred -hhHHHHHHHHhhCCCchhh----------------------------hhHHhh--hhCcHHHHHHHHHHHHHccccCCC
Q 036081 504 -LLITDWAWMLANSGKVDEI----------------------------FDEFIR--EEGSRAVMERFVRVGILCAHVMVA 552 (614)
Q Consensus 504 -~~l~~~~~~~~~~~~~~~~----------------------------~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~ 552 (614)
..+....... +..... +...+. ...+......+.+++..|++.||+
T Consensus 247 ~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 247 DDHIAQIIELL---GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHH---CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred HHHHHHHHHhc---CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 1111111100 110000 001111 123456677899999999999999
Q ss_pred CCCCHHHHHHH
Q 036081 553 LRPTIADALKM 563 (614)
Q Consensus 553 ~RPtm~eVl~~ 563 (614)
+|||+.|++++
T Consensus 324 ~Rpt~~ell~h 334 (373)
T 1q8y_A 324 KRADAGGLVNH 334 (373)
T ss_dssp TCBCHHHHHTC
T ss_pred ccCCHHHHhhC
Confidence 99999999884
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.94 Aligned_cols=261 Identities=21% Similarity=0.294 Sum_probs=196.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCC-CCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE-KGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~-~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+.. ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467889999999999999999976 689999999975332 2246788999999999999999999998754321 122
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+. |+|.+.+. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 3599999997 67777663 35899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +....... . ....+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~-~-~~~~~ 264 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVT-G-VPGTE 264 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH-C-CCCHH
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh-C-CCcHH
Confidence 864322 234578999999999987 7899999999999999999999999976543221 11111100 0 00000
Q ss_pred hh--------hHHhh---hh-------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IF--------DEFIR---EE-------GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~--------d~~l~---~~-------~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ...+. .. ........+.+++..|++.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00000 00 001123578899999999999999999999876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=331.13 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=191.9
Q ss_pred HHHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc------chHHHHHHHHHHHHc----cCCCccccc
Q 036081 282 ELDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK------GDEEFINEVEIISKI----RHRNLLSLR 350 (614)
Q Consensus 282 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~------~~~~f~~Ei~il~~l----~H~NIv~l~ 350 (614)
+.+...++|...+.||+|+||.||+|+.. +|+.||||++...... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455678999999999999999999874 6899999999654321 233466899999999 899999999
Q ss_pred ccccccCCCCCceEEEEEec-CCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 351 GCCVSSDDEKGKRRFLVYDF-MPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 351 g~~~~~~~~~~~~~~LV~Ey-~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
+++. ..+..++|||| +++++|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++
T Consensus 105 ~~~~-----~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 105 DWFE-----TQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILID 173 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEE
T ss_pred EEEe-----cCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEe
Confidence 9986 34567999999 789999999875 356999999999999999999999 88999999999999999
Q ss_pred -CCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCccchhHH
Q 036081 430 -SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLETSNSSFLLIT 507 (614)
Q Consensus 430 -~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~ 507 (614)
.++.+||+|||+++...... .....||..|+|||++.+..+. .++||||||+++|||++|+.||.....
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------ 244 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ 244 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------
T ss_pred CCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------
Confidence 88999999999998654322 2345689999999999877765 499999999999999999999964210
Q ss_pred HHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 508 DWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 508 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... .... .+......+.+++..|++.+|++|||+.|++++
T Consensus 245 -~~~---~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 -ILE---AELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HHH---TCCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -Hhh---hccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000 111223467889999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=331.12 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=196.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCC-CCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE-KGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~-~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.+++||||+++++++...... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467888999999999999999975 689999999965322 2246788999999999999999999998743321 123
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||++ |+|.+++. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 4699999997 68887763 34899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC----
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG---- 517 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~---- 517 (614)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+..........+
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 764322 234578999999999986 688999999999999999999999997654322 1111111000000
Q ss_pred -Cc-hhhhhHHhhh----------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 518 -KV-DEIFDEFIRE----------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 518 -~~-~~~~d~~l~~----------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+ .......+.. .........+.+++..|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 0000000000 0011234578899999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.49 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=185.5
Q ss_pred CccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceEEEEE
Q 036081 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
|...++||+|+||+||.+...+|+.||||++.. +..+.+.+|++++.++ +||||+++++++. .+...++||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~~~~lv~ 88 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSET-----TDRFLYIAL 88 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEEEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCeEEEEE
Confidence 445688999999999876666799999999865 2345688999999987 8999999999886 456789999
Q ss_pred ecCCCCCcccccchhhhc----cCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-------------
Q 036081 369 DFMPSGSLGDHISNALTR----KQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE------------- 431 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~----~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~------------- 431 (614)
||++ |+|.+++...... ....+..++.++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9995 7999998753211 11245567889999999999999 8899999999999999654
Q ss_pred CcEEEeeecccccccCCCcc---ccccccCCCCccchhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 036081 432 MKAKVADFGLAKQSLEGQSH---LTTRVAGTYGYLAPEYALY-------GQLTEKSDVYSFGIVILELMS-GRKVLETSN 500 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~ 500 (614)
+.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999876543322 1234579999999999975 678999999999999999999 999997543
Q ss_pred ccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 501 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
.... ............ ...........+.+++..|++.||.+|||+.||++
T Consensus 245 ~~~~---~i~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRES---NIIRGIFSLDEM--------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THHH---HHHHTCCCCCCC--------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhHH---HHhcCCCCcccc--------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 2211 111100000000 11123345568889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=322.36 Aligned_cols=251 Identities=27% Similarity=0.356 Sum_probs=199.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++. ....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence 457889999999999999999986 68999999986532 334578999999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC---CcEEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE---MKAKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~KL~DFG 440 (614)
.++||||+++++|.+.+.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++.+ +.+||+|||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 8999999999999988865 356899999999999999999999 8899999999999999764 469999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
++........ .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ..... ..+...
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~~ 240 (287)
T 2wei_A 170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----ILKRV-ETGKYA 240 (287)
T ss_dssp GGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-HHCCCC
T ss_pred cceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HcCCCC
Confidence 9986543322 223458899999998865 58999999999999999999999997654221 11111 111111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.... ........+.+++..|++.+|++|||+.|++++
T Consensus 241 ~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 FDLP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCSG------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCch------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000 001123467889999999999999999999873
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.49 Aligned_cols=259 Identities=19% Similarity=0.275 Sum_probs=197.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CC-cEEEEEEeecCCCcchHHHHHHHHHHHHccCCC------cccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DG-TLVAVKQITDLDTKGDEEFINEVEIISKIRHRN------LLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g-~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N------Iv~l~g~~~~~~~ 358 (614)
.++|...+.||+|+||.||+++.. ++ +.||||+++.. ....+.+.+|++++.+++|+| ++.+.+++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee----
Confidence 467999999999999999999975 34 78999998643 234567889999999998776 778877776
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceee----------
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL---------- 428 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILL---------- 428 (614)
.....++||||+ +++|.+++... ....+++.+++.++.||+.||.||| +.+|+||||||+|||+
T Consensus 93 -~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 93 -FHGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred -eCCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccc
Confidence 456789999999 66777776543 2246899999999999999999999 8999999999999999
Q ss_pred ---------cCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 036081 429 ---------DSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETS 499 (614)
Q Consensus 429 ---------d~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~ 499 (614)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999864332 23457999999999999999999999999999999999999999865
Q ss_pred CccchhHHHHHHHHhhCCCchhhhh----------------------HHhh---------hhCcHHHHHHHHHHHHHccc
Q 036081 500 NSSFLLITDWAWMLANSGKVDEIFD----------------------EFIR---------EEGSRAVMERFVRVGILCAH 548 (614)
Q Consensus 500 ~~~~~~l~~~~~~~~~~~~~~~~~d----------------------~~l~---------~~~~~~~~~~l~~l~~~Cl~ 548 (614)
..... +.... .... ......+. ..+. ..........+.+++..|++
T Consensus 243 ~~~~~-~~~~~-~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 243 ENREH-LVMME-KILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp SHHHH-HHHHH-HHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CHHHH-HHHHH-HHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 43321 11111 1100 00000000 0000 00112334578899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 036081 549 VMVALRPTIADALKM 563 (614)
Q Consensus 549 ~~p~~RPtm~eVl~~ 563 (614)
.||.+|||+.|++++
T Consensus 320 ~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 320 FDPAQRITLAEALLH 334 (355)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=334.82 Aligned_cols=206 Identities=22% Similarity=0.294 Sum_probs=172.4
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCC-----cccccccccc
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRN-----LLSLRGCCVS 355 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~N-----Iv~l~g~~~~ 355 (614)
.+...++|...+.||+|+||+||+|+.. +|+.||||+++.. ....+++..|++++..++ |+| ++++.+++.
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~- 126 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM- 126 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE-
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec-
Confidence 3445688999999999999999999976 6889999999742 233467888999999885 554 888888886
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec--CCCc
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD--SEMK 433 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd--~~~~ 433 (614)
.....++||||++ |+|.+++.... ...+++..++.++.|++.||.|||. .+.+|+||||||+|||++ .++.
T Consensus 127 ----~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 127 ----FRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp ----ETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCC
T ss_pred ----cCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCc
Confidence 4567899999996 59999987632 2458999999999999999999993 247899999999999994 5788
Q ss_pred EEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 036081 434 AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNS 501 (614)
Q Consensus 434 ~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~ 501 (614)
+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 200 ~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp EEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999865332 2345789999999999999999999999999999999999999986543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=333.58 Aligned_cols=255 Identities=27% Similarity=0.369 Sum_probs=176.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHH-HHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVE-IISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~-il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|+||.||+|+.. +|+.||||+++.... ....++..|+. +++.++||||+++++++. ..+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence 467888999999999999999986 689999999976432 23445666766 666679999999999987 3467
Q ss_pred EEEEEecCCCCCcccccchhh--hccCCCccchhHHHHHHHHHHHHHHhcCCC-ceEecCCCCCceeecCCCcEEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNAL--TRKQLAWPQRKKIILDVAKGLAYLHYGLKP-AIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~--~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
.++||||+++ +|.+++.... ....+++..+..++.+++.||.||| +. +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 8999999974 7877765321 2457899999999999999999999 66 99999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYA----LYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~----~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
+++...... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... ... ...
T Consensus 172 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~-~~~ 244 (327)
T 3aln_A 172 ISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ----LTQ-VVK 244 (327)
T ss_dssp SSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CC-CCC
T ss_pred Cceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH----HHH-Hhc
Confidence 998654322 22334789999999998 4667899999999999999999999999754321100 000 000
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
+... .+...........+.+++..|++.||.+|||+.|+++
T Consensus 245 ~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000 0111111123347888999999999999999999965
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.69 Aligned_cols=257 Identities=19% Similarity=0.254 Sum_probs=173.8
Q ss_pred HhCCCccc-eeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHH-HHHHccCCCcccccccccccCCCCCc
Q 036081 286 ATGGFSQK-NLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVE-IISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 286 at~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~-il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
..++|... ++||+|+||.||+|+.. +|+.||||++... ....+|+. .+..++||||+++++++..... .+.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHH-GKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccC-CCc
Confidence 35678874 46999999999999987 6999999998652 22333333 4566799999999999864322 245
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---CCcEEEeee
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADF 439 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~KL~DF 439 (614)
..++||||+++|+|.+++... ....+++.+++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 689999999999999999763 2346899999999999999999999 889999999999999976 455999999
Q ss_pred cccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 440 GLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 440 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
|+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ... .....+..
T Consensus 176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~~~~ 250 (336)
T 3fhr_A 176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-GMK-RRIRLGQY 250 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-hHH-Hhhhcccc
Confidence 999865322 2234578999999999998899999999999999999999999997544321100 000 00000000
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.............+.+++..|++.||.+|||+.|++++
T Consensus 251 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 ------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000011233467889999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.56 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=198.0
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc------chHHHHHHHHHHHHcc--CCCcccccccc
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK------GDEEFINEVEIISKIR--HRNLLSLRGCC 353 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~------~~~~f~~Ei~il~~l~--H~NIv~l~g~~ 353 (614)
.+...++|...+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++.+++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3445677999999999999999999865 6899999999753221 2345778999999996 59999999998
Q ss_pred cccCCCCCceEEEEEecCCC-CCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec-CC
Q 036081 354 VSSDDEKGKRRFLVYDFMPS-GSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD-SE 431 (614)
Q Consensus 354 ~~~~~~~~~~~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd-~~ 431 (614)
. .....++||||+.+ ++|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++ ++
T Consensus 118 ~-----~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 118 E-----RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp E-----CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTT
T ss_pred e-----cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCC
Confidence 7 45678999999976 899998865 457899999999999999999999 89999999999999999 78
Q ss_pred CcEEEeeecccccccCCCccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Q 036081 432 MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA 510 (614)
Q Consensus 432 ~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~ 510 (614)
+.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ..
T Consensus 187 ~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~ 256 (320)
T 3a99_A 187 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------II 256 (320)
T ss_dssp TEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HH
T ss_pred CCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hh
Confidence 99999999999865432 2234579999999999987766 6789999999999999999999964210 00
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. +... ......+.+.+++..|++.||++|||+.|++++
T Consensus 257 ----~-~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 ----R-GQVF----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----H-CCCC----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----c-cccc----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 011123467889999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=323.69 Aligned_cols=253 Identities=22% Similarity=0.356 Sum_probs=176.8
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc-ch-HHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK-GD-EEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-~~-~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
..++|...+.||+|+||.||+|+.. +|+.||||++...... .. +.+.++..++..++||||+++++++. ...
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence 3467888999999999999999986 6899999999764322 22 33444555677789999999999987 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCC-ceEecCCCCCceeecCCCcEEEeeecc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKP-AIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
..++||||+ ++.+..+... ....+++..++.++.|+++||.||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred cEEEEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 789999999 3444433322 2457899999999999999999999 64 999999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
++...... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||.........+. .....
T Consensus 172 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~ 245 (318)
T 2dyl_A 172 SGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT----KVLQE 245 (318)
T ss_dssp C----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----HHHHS
T ss_pred chhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH----HHhcc
Confidence 97654322 233457899999999994 56789999999999999999999999976433211111 11111
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... .+. ........+.+++..|++.||.+|||+.|++++
T Consensus 246 ~~~------~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 246 EPP------LLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCC------CCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCC------CCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 100 000 001123467889999999999999999999763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.29 Aligned_cols=251 Identities=24% Similarity=0.282 Sum_probs=187.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCceE
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
...+|...++||+|+||+||.....+|+.||||++.... ...+.+|++++.++ +||||+++++++. +....
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~ 93 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQ 93 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEE
Confidence 345688889999999999665555579999999986532 23467899999999 7999999999886 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-----CCcEEEeee
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-----EMKAKVADF 439 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-----~~~~KL~DF 439 (614)
++||||++ |+|.+++... ...+.+..++.++.||+.||.||| +.+|+||||||+|||++. +..+||+||
T Consensus 94 ~lv~E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred EEEEECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 99999996 6999988653 334667788899999999999999 889999999999999943 346889999
Q ss_pred cccccccCCCc--cccccccCCCCccchhhhc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHH
Q 036081 440 GLAKQSLEGQS--HLTTRVAGTYGYLAPEYAL---YGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWML 513 (614)
Q Consensus 440 Gla~~~~~~~~--~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~ 513 (614)
|+++....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||........ ...
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------~~~ 241 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------NIL 241 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------HHH
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------HHH
Confidence 99987643322 2234467999999999997 5678889999999999999999 8999865432211 111
Q ss_pred hhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 514 ANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 514 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....... ... ........+.+++..|++.||.+|||+.||+++
T Consensus 242 ~~~~~~~-~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 242 LGACSLD-CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTCCCCT-TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccCCcc-ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111111 000 011223457789999999999999999999853
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=352.77 Aligned_cols=242 Identities=20% Similarity=0.278 Sum_probs=192.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc--CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE--DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|...+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++.+++||||+++++++...+......
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 58999999986533 234567899999999999999999999998654323334
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.+|||||+++++|.+++.. .++|.+++.|+.||+.||.||| +.+|+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999987643 6999999999999999999999 8899999999999999886 89999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... ....||++|+|||++.++. +.++|||||||+||||++|..|+....... +.+ .
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------~~~-~ 287 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------LPE-D 287 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------CCT-T
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------ccc-c
Confidence 65432 3457999999999987654 899999999999999999998876422110 000 0
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhh
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPT-IADALKMLE 565 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-m~eVl~~L~ 565 (614)
.+ .......+.+++..|++.||.+||+ ++++...|.
T Consensus 288 ~~------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 288 DP------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp CH------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cc------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00 0112246788999999999999995 555555544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=353.72 Aligned_cols=264 Identities=25% Similarity=0.340 Sum_probs=198.7
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~~ 363 (614)
.++|...+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|++++.+++||||+++++++..... ..+..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999975 6899999998753 33345679999999999999999999998764221 23567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc---EEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK---AKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~KL~DFG 440 (614)
.++||||+++|+|.+++........+++..++.|+.+++.||+||| +.+|+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976544457999999999999999999999 889999999999999997765 9999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC--
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK-- 518 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~-- 518 (614)
+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .|.........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~----~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV----QWHGKVREKSNEH 243 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH----HSSTTCC------
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh----hhhhhhhcccchh
Confidence 998754332 2344679999999999999999999999999999999999999996542110 11000000000
Q ss_pred --chhhhh------HHh--hhhCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 036081 519 --VDEIFD------EFI--REEGSRAVMERFVRVGILCAHVMVALRPTIAD 559 (614)
Q Consensus 519 --~~~~~d------~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~e 559 (614)
..+... ..+ ...........+.+++..|++.||++|||+.|
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 000 01122335568899999999999999999976
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=333.54 Aligned_cols=249 Identities=17% Similarity=0.137 Sum_probs=183.0
Q ss_pred HHhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccC-CCccccccc-------
Q 036081 285 QATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRH-RNLLSLRGC------- 352 (614)
Q Consensus 285 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H-~NIv~l~g~------- 352 (614)
..+.+|...++||+|+||.||+|++. +|+.||||+++.... ...+.|.+|+.++..++| +|......+
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34455778899999999999999965 699999999874322 235779999999999987 333222211
Q ss_pred --------------ccccCCCCCceEEEEEecCCCCCcccccchhh----hccCCCccchhHHHHHHHHHHHHHHhcCCC
Q 036081 353 --------------CVSSDDEKGKRRFLVYDFMPSGSLGDHISNAL----TRKQLAWPQRKKIILDVAKGLAYLHYGLKP 414 (614)
Q Consensus 353 --------------~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~----~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~ 414 (614)
............+++|+++ +++|.+++.... ....++|..++.|+.||++||+||| +.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HY 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 1100000123467777765 689998884211 2345888999999999999999999 89
Q ss_pred ceEecCCCCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhh----------ccCCCCchhhHHHHHH
Q 036081 415 AIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA----------LYGQLTEKSDVYSFGI 484 (614)
Q Consensus 415 ~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~----------~~~~~s~ksDVwSfGv 484 (614)
+|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999999999999998864322 344567 999999999 5556888999999999
Q ss_pred HHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 485 VILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 485 vL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
++|||++|+.||....... . .+..+... ....+.+.+++..|++.||++|||+.++++
T Consensus 306 il~elltg~~Pf~~~~~~~--------------~----~~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALG--------------G----SEWIFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGS--------------C----SGGGGSSC--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhh--------------h----HHHHHhhc--ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999997543221 0 11111100 112356888999999999999999877643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.80 Aligned_cols=230 Identities=12% Similarity=0.082 Sum_probs=180.2
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc---chHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK---GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.|.+|+.++.+++||||+++++++. ..+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECC
Confidence 367999999999999999999986 4899999999754332 2367999999999999999999999987 346
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++++|.+++.+ .....+..+|+.|++.||+||| +.+|+||||||+|||++.++.+||+++|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred cEEEEEEecCCCCHHHHHhc-----CCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--
Confidence 78999999999999999853 2345568899999999999999 8999999999999999999999998443
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
|++| ++.++||||||+++|||++|+.||........... .... ..+....
T Consensus 175 -------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~-~~~~~~~- 224 (286)
T 3uqc_A 175 -------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERD-TAGQPIE- 224 (286)
T ss_dssp -------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBC-TTSCBCC-
T ss_pred -------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHH-hccCCCC-
Confidence 4433 68999999999999999999999986543210000 0000 0000000
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
...+ .....+.+.+++..|++.||++| |+.|+++.|+..
T Consensus 225 -~~~~----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 225 -PADI----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp -HHHH----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred -hhhc----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0011 11233467889999999999999 999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=307.22 Aligned_cols=233 Identities=19% Similarity=0.262 Sum_probs=177.9
Q ss_pred CCCccc-eeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHH-HHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQK-NLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEII-SKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il-~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|... +.||+|+||.||++... +|+.||||+++. ...+.+|++++ +..+||||+++++++..... .....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC-CCceE
Confidence 456665 78999999999999975 689999999864 35678899998 45589999999999863211 25678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---CCcEEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~KL~DFGl 441 (614)
++||||+++|+|.+++... ....+++..++.++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999763 2346899999999999999999999 899999999999999998 78999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
++... +..++.++||||||+++|||++|+.||........ .......
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~~~~~~ 213 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPGMKTR 213 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCS
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hHHHHHH
Confidence 86432 24567899999999999999999999965432110 0000000
Q ss_pred hhhHH--hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEF--IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... +...........+.+++..|++.||.+|||+.|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 0000001123467889999999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=312.61 Aligned_cols=248 Identities=18% Similarity=0.155 Sum_probs=182.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC--------cchHHHHHHHHHHHHcc----------------
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT--------KGDEEFINEVEIISKIR---------------- 342 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~--------~~~~~f~~Ei~il~~l~---------------- 342 (614)
.++|...+.||+|+||+||+|+. +|+.||||+++.... ...+.+.+|++++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35678889999999999999998 589999999975422 22377999999999997
Q ss_pred ----------CCCcccccccccccCC--------CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHH
Q 036081 343 ----------HRNLLSLRGCCVSSDD--------EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404 (614)
Q Consensus 343 ----------H~NIv~l~g~~~~~~~--------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~g 404 (614)
||||+++++++..... ......++||||+++|++.+.+.+ ..+++..++.|+.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 5555555555543110 025679999999999987777643 468999999999999999
Q ss_pred HHHHHhcCCCceEecCCCCCceeecCCC--------------------cEEEeeecccccccCCCccccccccCCCCccc
Q 036081 405 LAYLHYGLKPAIYHRDIKSTNILLDSEM--------------------KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464 (614)
Q Consensus 405 L~yLH~~~~~~ivHrDIKp~NILLd~~~--------------------~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~A 464 (614)
|+|||+ +.+|+||||||+||||+.++ .+||+|||+++..... ...||+.|+|
T Consensus 174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 999993 36899999999999999887 8999999999865432 3479999999
Q ss_pred hhhhccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHH
Q 036081 465 PEYALYGQLTEKSDVYSFGIV-ILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVG 543 (614)
Q Consensus 465 PE~~~~~~~s~ksDVwSfGvv-L~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 543 (614)
||.+.+.. +.++||||||++ .+++++|..||.... ................... ...........+.+++
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKMLKQMTFKTKC----NTPAMKQIKRKIQEFH 316 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHHHHTCCCSSCC----CSHHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----hhhHHHHhhhhhhccCccc----chhhhhhcCHHHHHHH
Confidence 99998665 899999998777 788888999884310 0000111111100000000 0011234566889999
Q ss_pred HHccccCCCCCCCHHHHH
Q 036081 544 ILCAHVMVALRPTIADAL 561 (614)
Q Consensus 544 ~~Cl~~~p~~RPtm~eVl 561 (614)
..|++.+ |+.|++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999965 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-30 Score=287.75 Aligned_cols=184 Identities=17% Similarity=0.159 Sum_probs=127.9
Q ss_pred eeccCcEEEEEEEE-cCCcEEEEEEeecCC----------CcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCce
Q 036081 296 IGQGASGVVYKGTL-EDGTLVAVKQITDLD----------TKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 296 LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~----------~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.+.|++|.+..++. --|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++. ++..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e-----d~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE-----NAQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE-----CSSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-----ECCE
Confidence 55666666665542 248889999996531 12235799999999999 7999999999997 5678
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.||||||++||+|.+.|.. ...++. .+|+.||+.||+|+| +.+||||||||+||||++++++||+|||+|+
T Consensus 317 ~yLVMEyv~G~~L~d~i~~---~~~l~~---~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr 387 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAA---GEEIDR---EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIV 387 (569)
T ss_dssp EEEEEECCCSEEHHHHHHT---TCCCCH---HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred EEEEEecCCCCcHHHHHHh---CCCCCH---HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCe
Confidence 9999999999999999975 244543 369999999999999 9999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 495 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p 495 (614)
....... ..+..+||++|||||++.+ .+..++|+||+|++++++.+|..+
T Consensus 388 ~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 388 TTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 7654332 2345689999999999864 567889999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-27 Score=263.03 Aligned_cols=184 Identities=16% Similarity=0.185 Sum_probs=144.5
Q ss_pred ccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCc--------chHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 291 SQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTK--------GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--------~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
...++||+|+||.||+|+.. ++.+++|+....... ..+.|.+|++++++++||||+++..++.. ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----LD 412 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----TT
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----CC
Confidence 34578999999999999654 788999986442211 12458999999999999999977666652 23
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. ++.++.|+++||.||| +.+|+||||||+|||++. ++||+|||++
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla 476 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLG 476 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred ccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccC
Confidence 45999999999999999854 6799999999999999 899999999999999998 9999999999
Q ss_pred ccccCCCccc------cccccCCCCccchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 036081 443 KQSLEGQSHL------TTRVAGTYGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVL 496 (614)
Q Consensus 443 ~~~~~~~~~~------~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSfGvvL~ELltG~~p~ 496 (614)
+......... .....||+.|||||++.. ..|+.++|+||..+-.++-+.++.++
T Consensus 477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9764432211 235689999999999986 67888999999999999998887765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-24 Score=217.62 Aligned_cols=150 Identities=16% Similarity=0.112 Sum_probs=121.6
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC------------------cchHHHHHHHHHHHHccCC
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT------------------KGDEEFINEVEIISKIRHR 344 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~------------------~~~~~f~~Ei~il~~l~H~ 344 (614)
+......|...+.||+|+||.||+|+..+|+.||||.++.... .....+.+|++++.+++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344455667799999999999999997799999999864221 12456899999999999
Q ss_pred CcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 036081 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424 (614)
Q Consensus 345 NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~ 424 (614)
| +++.+++. .+..++||||+++|+|.+ +. ......++.|++.||.||| +.+|+||||||+
T Consensus 163 ~-~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~ 222 (282)
T 1zar_A 163 G-LAVPKVYA------WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFY---HRGIVHGDLSQY 222 (282)
T ss_dssp T-SSSCCEEE------EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred C-CCcCeEEe------ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHH
Confidence 5 77777653 234699999999999987 42 2345679999999999999 899999999999
Q ss_pred ceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhc
Q 036081 425 NILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~ 469 (614)
|||++ ++.+||+|||+++. +..|+|||++.
T Consensus 223 NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999 99999999999863 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=180.55 Aligned_cols=143 Identities=17% Similarity=0.137 Sum_probs=106.6
Q ss_pred CccceeeeccCcEEEEEEEE-cCCcE--EEEEEeecCCCc------------------------chHHHHHHHHHHHHcc
Q 036081 290 FSQKNLIGQGASGVVYKGTL-EDGTL--VAVKQITDLDTK------------------------GDEEFINEVEIISKIR 342 (614)
Q Consensus 290 f~~~~~LG~G~fG~Vykg~~-~~g~~--vAVK~l~~~~~~------------------------~~~~f~~Ei~il~~l~ 342 (614)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999998 67999 999987542111 0136889999999999
Q ss_pred CCCcccccccccccCCCCCceEEEEEecCC-CCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCC
Q 036081 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMP-SGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDI 421 (614)
Q Consensus 343 H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~-~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDI 421 (614)
|+++....-+.. ...+|||||+. +|.+...|.+.. ...++.....++.|++.||.|||. +.+|+||||
T Consensus 129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELG--RELKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHG--GGGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHh--hccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 887532221111 23589999995 354444443321 123466788999999999999994 579999999
Q ss_pred CCCceeecCCCcEEEeeecccccc
Q 036081 422 KSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 422 Kp~NILLd~~~~~KL~DFGla~~~ 445 (614)
||+|||++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=169.60 Aligned_cols=144 Identities=15% Similarity=0.137 Sum_probs=102.5
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC--------------CcchHHHHHHHHHHHHccCCCccccccccc
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD--------------TKGDEEFINEVEIISKIRHRNLLSLRGCCV 354 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--------------~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~ 354 (614)
-|+..+.||+|+||.||+|...+|+.||||+++... .........++++.....|+|+++++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388899999999999999999999999999875311 001122334444544555666666654332
Q ss_pred ccCCC-CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-
Q 036081 355 SSDDE-KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM- 432 (614)
Q Consensus 355 ~~~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~- 432 (614)
..... .....+|||||+++++|.+... .+....++.|++.+|.||| +.+||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence 11100 1112379999999888765432 2345678999999999999 88999999999999998876
Q ss_pred ---------cEEEeeeccccc
Q 036081 433 ---------KAKVADFGLAKQ 444 (614)
Q Consensus 433 ---------~~KL~DFGla~~ 444 (614)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.1e-11 Score=124.56 Aligned_cols=147 Identities=13% Similarity=0.038 Sum_probs=112.4
Q ss_pred HHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCC
Q 036081 283 LDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 283 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~ 361 (614)
+.....+|.....++.|+.+.||+.... |+.+++|+...........+.+|+++++.+. |.++.++++++. ..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~ 82 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HD 82 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ET
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cC
Confidence 4445567877778888888999999865 7889999986432223446899999999995 667778888775 34
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhc------------------------------
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG------------------------------ 411 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~------------------------------ 411 (614)
...++||||+++.+|.+.+. +......++.+++++|+.||..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred CceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence 56899999999988866431 2234458899999999999961
Q ss_pred --------------------------CCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 412 --------------------------LKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 412 --------------------------~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
....++|+|+++.|||++++..+.|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01569999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=3.4e-11 Score=119.88 Aligned_cols=137 Identities=15% Similarity=0.127 Sum_probs=98.2
Q ss_pred hCCCccceeee-ccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCc--ccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIG-QGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL--LSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG-~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NI--v~l~g~~~~~~~~~~~~ 363 (614)
..++... .++ .|..+.||+....+|+.+++|..... ....+..|+++++.+++.++ .+++++.. .++.
T Consensus 19 ~~~~~~~-~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~ 89 (264)
T 1nd4_A 19 LFGYDWA-QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGR 89 (264)
T ss_dssp TTTCEEE-ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSC
T ss_pred cCCCceE-ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCC
Confidence 3444443 444 45569999998877888999997543 23468899999999975554 44676654 2345
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcC-------------------------------
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL------------------------------- 412 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~------------------------------- 412 (614)
.++||||+++.+|. ... .....++.++++.|..||...
T Consensus 90 ~~~v~e~i~G~~l~--~~~---------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH---------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp EEEEEECCSSEETT--TSC---------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CEEEEEecCCcccC--cCc---------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 89999999998874 211 123367788888888888421
Q ss_pred ------------------------CCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 413 ------------------------KPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 413 ------------------------~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
...++|+|++|.|||++++..++|.|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877667899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=2.8e-10 Score=117.14 Aligned_cols=189 Identities=21% Similarity=0.250 Sum_probs=120.6
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCc--ccccccccccCCCCCceEEEEEe
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNL--LSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NI--v~l~g~~~~~~~~~~~~~~LV~E 369 (614)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +..+ .++++... ........|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~--~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM--PSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC--CCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecC--CCCCCCcceEEEc
Confidence 3568999999999864 45888885431 33567889999999984 3332 23333221 1111124588999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhc--------------------------------------
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG-------------------------------------- 411 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~-------------------------------------- 411 (614)
++++.+|.+... ..++..++..++.++++.|+.||..
T Consensus 97 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 97 KIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred ccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999988865332 2466777788888888888888841
Q ss_pred -----------------CCCceEecCCCCCceeecC--CCcEEEeeecccccccCCCcccc-------------ccccCC
Q 036081 412 -----------------LKPAIYHRDIKSTNILLDS--EMKAKVADFGLAKQSLEGQSHLT-------------TRVAGT 459 (614)
Q Consensus 412 -----------------~~~~ivHrDIKp~NILLd~--~~~~KL~DFGla~~~~~~~~~~~-------------~~~~gt 459 (614)
....++|+|+++.||++++ +..+.|.||+.+........... ......
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1246899999999999998 45678999998865321100000 000001
Q ss_pred CCccc-hhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 036081 460 YGYLA-PEYALYGQLTEKSDVYSFGIVILELMSGRKVL 496 (614)
Q Consensus 460 ~~Y~A-PE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~ 496 (614)
.++.. |+.... .....+.|++|.++|++.+|+.++
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11122 222211 122368999999999999998765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=8.3e-10 Score=116.26 Aligned_cols=145 Identities=15% Similarity=0.206 Sum_probs=106.8
Q ss_pred cceeeeccCcEEEEEEEEcCCcEEEEEEee--cCC-CcchHHHHHHHHHHHHcc--CCCcccccccccccCCCCCceEEE
Q 036081 292 QKNLIGQGASGVVYKGTLEDGTLVAVKQIT--DLD-TKGDEEFINEVEIISKIR--HRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~--~~~-~~~~~~f~~Ei~il~~l~--H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++++.++ +..+.++++++...+ ..+..++
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence 3567899999999999876 4678888765 321 122456889999999997 455777887775322 2245799
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcC----------------------------------
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL---------------------------------- 412 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~---------------------------------- 412 (614)
||||+++..+.+... ..++..++..++.++++.|+.||...
T Consensus 119 vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999988865321 24677788899999999999999621
Q ss_pred ---------------------CCceEecCCCCCceeecCCCc--EEEeeeccccc
Q 036081 413 ---------------------KPAIYHRDIKSTNILLDSEMK--AKVADFGLAKQ 444 (614)
Q Consensus 413 ---------------------~~~ivHrDIKp~NILLd~~~~--~KL~DFGla~~ 444 (614)
...++|||+++.|||++.++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 267999999999999997753 68999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=3.3e-06 Score=86.96 Aligned_cols=137 Identities=15% Similarity=0.177 Sum_probs=89.7
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC---cccccccccccCCCCCceEEEEEe
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN---LLSLRGCCVSSDDEKGKRRFLVYD 369 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N---Iv~l~g~~~~~~~~~~~~~~LV~E 369 (614)
.+.++.|....||+. |..+++|+... ......+..|.+++..+.+.. +.+.+.+... ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEEe
Confidence 456888888999988 56688887432 223467889999999997532 3344444431 2345689999
Q ss_pred cCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhc--------------------------------------
Q 036081 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG-------------------------------------- 411 (614)
Q Consensus 370 y~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~-------------------------------------- 411 (614)
|+++.+|.+... ..++..++..++.++++.|+.||..
T Consensus 94 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 94 KVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred ccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 999987765211 1223333444444444444444421
Q ss_pred -------------------CCCceEecCCCCCceeecC---CCc-EEEeeeccccc
Q 036081 412 -------------------LKPAIYHRDIKSTNILLDS---EMK-AKVADFGLAKQ 444 (614)
Q Consensus 412 -------------------~~~~ivHrDIKp~NILLd~---~~~-~KL~DFGla~~ 444 (614)
....++|+|+++.|||++. ++. ..|.||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2456799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=1e-05 Score=80.86 Aligned_cols=134 Identities=15% Similarity=0.139 Sum_probs=91.1
Q ss_pred eeeccCcE-EEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEEEEEecC
Q 036081 295 LIGQGASG-VVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 295 ~LG~G~fG-~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
.+..|..| .||+.... ++..+.+|+-.. ....++..|...|+.+. +--+.++++++. +++..++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEee
Confidence 45556555 68988765 466788998653 23456888999999885 333456666664 345689999999
Q ss_pred CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcC---------------------------------------
Q 036081 372 PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL--------------------------------------- 412 (614)
Q Consensus 372 ~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~--------------------------------------- 412 (614)
++.++.+.... ....+..+..++++.|.-||...
T Consensus 103 ~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 103 PGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp CSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred CCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 98776554321 12233455566666666666210
Q ss_pred ----------------CCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 413 ----------------KPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 413 ----------------~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
...++|+|+.+.|||++.++.+-|.||+.+.
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1247999999999999987777899998775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=7.4e-06 Score=85.65 Aligned_cols=84 Identities=12% Similarity=0.055 Sum_probs=56.1
Q ss_pred ceee-eccCcEEEEEEEEc-------CCcEEEEEEeecCC---CcchHHHHHHHHHHHHcc-C--CCcccccccccccCC
Q 036081 293 KNLI-GQGASGVVYKGTLE-------DGTLVAVKQITDLD---TKGDEEFINEVEIISKIR-H--RNLLSLRGCCVSSDD 358 (614)
Q Consensus 293 ~~~L-G~G~fG~Vykg~~~-------~g~~vAVK~l~~~~---~~~~~~f~~Ei~il~~l~-H--~NIv~l~g~~~~~~~ 358 (614)
.+.| +.|....+|+.... +|+.+++|+..... ......+..|+++++.+. + -.+.++++++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~- 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD- 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence 4567 78888999998765 26678888764322 111246788999999885 3 34566676654221
Q ss_pred CCCceEEEEEecCCCCCccc
Q 036081 359 EKGKRRFLVYDFMPSGSLGD 378 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~ 378 (614)
.....++||||+++..+.+
T Consensus 104 -~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 -VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp -TTSSCEEEEECCCCBCCCB
T ss_pred -ccCCceEEEEecCCCChhh
Confidence 1134689999999888765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.7e-05 Score=81.75 Aligned_cols=145 Identities=19% Similarity=0.243 Sum_probs=82.2
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCC--CcccccccccccC-CCCCceEEEEEec
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHR--NLLSLRGCCVSSD-DEKGKRRFLVYDF 370 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~--NIv~l~g~~~~~~-~~~~~~~~LV~Ey 370 (614)
+.|+.|..+.||+....+| .+++|+... ..+....|++++..+... .+.+++....... ...++..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566567889999988655 488998864 123455677777766422 2333333110000 0123567999999
Q ss_pred CCCCCccc--------------ccchhhhcc-----------CCCccchh------------------------------
Q 036081 371 MPSGSLGD--------------HISNALTRK-----------QLAWPQRK------------------------------ 395 (614)
Q Consensus 371 ~~~gsL~~--------------~L~~~~~~~-----------~l~~~~r~------------------------------ 395 (614)
+++..+.. .++...... ...|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876641 111111000 01222110
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 396 -KIILDVAKGLAYLHY----------GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 396 -~Ia~~Ia~gL~yLH~----------~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.+...+.+++.+|+. .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666653 136789999999999999888899999999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.94 E-value=5.9e-05 Score=76.46 Aligned_cols=80 Identities=19% Similarity=0.164 Sum_probs=58.8
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCC---CcccccccccccCCCCCceEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHR---NLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~---NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.......+|.|..+.||+.++.||+.+.||+-..........|..|.+.|+.|.-. -+.+.+++. ..+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence 35556789999999999999999999999987654444455788999999998532 223333322 137
Q ss_pred EEEecCCCCCcc
Q 036081 366 LVYDFMPSGSLG 377 (614)
Q Consensus 366 LV~Ey~~~gsL~ 377 (614)
+||||++.+...
T Consensus 87 lv~e~l~~~~~~ 98 (288)
T 3f7w_A 87 LAMEWVDERPPT 98 (288)
T ss_dssp EEEECCCCCCCC
T ss_pred EEEEeecccCCC
Confidence 899999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=4.9e-05 Score=80.72 Aligned_cols=75 Identities=12% Similarity=0.019 Sum_probs=48.7
Q ss_pred ceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-------cchHHHHHHHHHHHHccC--CCcc-cccccccccCCCCC
Q 036081 293 KNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-------KGDEEFINEVEIISKIRH--RNLL-SLRGCCVSSDDEKG 361 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-------~~~~~f~~Ei~il~~l~H--~NIv-~l~g~~~~~~~~~~ 361 (614)
.+.||.|..+.||+++.. +++.++||....... ...+.+..|.+++..+.+ +..+ +++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence 467999999999999764 468899998643211 123457889999998853 3333 344332 1
Q ss_pred ceEEEEEecCCCC
Q 036081 362 KRRFLVYDFMPSG 374 (614)
Q Consensus 362 ~~~~LV~Ey~~~g 374 (614)
...++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 2348999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00066 Score=70.08 Aligned_cols=139 Identities=16% Similarity=0.149 Sum_probs=89.0
Q ss_pred cceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc---CCCcccccccccccCCCCCceEEEEE
Q 036081 292 QKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR---HRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~---H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
..+.|+.|....+|+.... +..+++|+... .....|..|.+.|+.|. ...+.++++++. .....++||
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEE
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEE
Confidence 4567899999999999864 67888998654 23567889999999984 245667777654 235689999
Q ss_pred ecCCCCCccc-----------ccchhhhccC-------------------CCccc-----hhHHHHH-------------
Q 036081 369 DFMPSGSLGD-----------HISNALTRKQ-------------------LAWPQ-----RKKIILD------------- 400 (614)
Q Consensus 369 Ey~~~gsL~~-----------~L~~~~~~~~-------------------l~~~~-----r~~Ia~~------------- 400 (614)
||+++..+.. .|+....... -+|.. |+.-..+
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 9999887632 1111100000 12321 1111111
Q ss_pred -HHHH-HHHHH-hcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 401 -VAKG-LAYLH-YGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 401 -Ia~g-L~yLH-~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
+..- ...|. ....+.++|+|+.+.||+++.++ +.|.||.
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111 12332 13367899999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00085 Score=68.66 Aligned_cols=163 Identities=13% Similarity=0.114 Sum_probs=89.8
Q ss_pred cChHHHHHHhCCCcc-----ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCc--cccc
Q 036081 278 FRESELDQATGGFSQ-----KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL--LSLR 350 (614)
Q Consensus 278 f~~~el~~at~~f~~-----~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NI--v~l~ 350 (614)
++.+++......|.. .+.|+.|....+|+....+| .+++|..... ...+.+..|++++..+....+ .+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555554543 34566788899999988766 5778887642 123456778888888853333 3333
Q ss_pred ccccccC-CCCCceEEEEEecCCCCCcccc--------------cchhhhc---cC------CCccchh-----------
Q 036081 351 GCCVSSD-DEKGKRRFLVYDFMPSGSLGDH--------------ISNALTR---KQ------LAWPQRK----------- 395 (614)
Q Consensus 351 g~~~~~~-~~~~~~~~LV~Ey~~~gsL~~~--------------L~~~~~~---~~------l~~~~r~----------- 395 (614)
....... ....+..+++++|+++..+... ++..... .. ..|....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 2110000 0012457899999998765321 1111000 00 1122100
Q ss_pred -HHHHHHHHHHHHHHhc----CCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 396 -KIILDVAKGLAYLHYG----LKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 396 -~Ia~~Ia~gL~yLH~~----~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.+...+.+.+.+++.. ....++|+|+++.|||++++..+.|.||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0111244556666532 24679999999999999887666899998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00015 Score=77.65 Aligned_cols=80 Identities=13% Similarity=0.054 Sum_probs=50.8
Q ss_pred CCceEecCCCCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccC---CCCchhhHHHHHHHHHHH
Q 036081 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG---QLTEKSDVYSFGIVILEL 489 (614)
Q Consensus 413 ~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSfGvvL~EL 489 (614)
...++|+|+++.|||++.++ ++|.||+.+............-..-...|.+|+..... .-....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 78899999999999998876 99999998875321110000000012346666655421 112245667888888888
Q ss_pred HhCC
Q 036081 490 MSGR 493 (614)
Q Consensus 490 ltG~ 493 (614)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0015 Score=66.90 Aligned_cols=146 Identities=12% Similarity=0.106 Sum_probs=84.1
Q ss_pred eeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC--cccccccccccC-CCCCceEEEEEec
Q 036081 294 NLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN--LLSLRGCCVSSD-DEKGKRRFLVYDF 370 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N--Iv~l~g~~~~~~-~~~~~~~~LV~Ey 370 (614)
..++ |....||+....+|+.+++|...... ...+.+..|..++..+.... +.+++.. .... ...++..+++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence 4566 77889999887778789999986321 23456778999998885333 3444443 1000 0123467899999
Q ss_pred CCCCCccc----c----------cchhhhc------cCCCccch----h---------------HHHHHHHHHHHHHHh-
Q 036081 371 MPSGSLGD----H----------ISNALTR------KQLAWPQR----K---------------KIILDVAKGLAYLHY- 410 (614)
Q Consensus 371 ~~~gsL~~----~----------L~~~~~~------~~l~~~~r----~---------------~Ia~~Ia~gL~yLH~- 410 (614)
+++..+.. . ++..... ..+++... . .+...+.+.+..+..
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98865531 0 1111000 01111100 0 001111122333321
Q ss_pred ---cCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 411 ---GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 411 ---~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
.....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1356789999999999999 4 899999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0017 Score=70.04 Aligned_cols=74 Identities=19% Similarity=0.279 Sum_probs=50.8
Q ss_pred ceeeeccCcEEEEEEEEcC--------CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCc-ccccccccccCCCCCce
Q 036081 293 KNLIGQGASGVVYKGTLED--------GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL-LSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~--------g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NI-v~l~g~~~~~~~~~~~~ 363 (614)
.+.|+.|-...+|+....+ +..+.+|+.... ...+.+.+|..++..+...++ .++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS-----G--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C---
Confidence 3567778889999998763 478889987431 112566789999999864444 45565442 1
Q ss_pred EEEEEecCCCCCcc
Q 036081 364 RFLVYDFMPSGSLG 377 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~ 377 (614)
.+|+||+++.+|.
T Consensus 148 -g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 148 -GRLEEYIPSRPLS 160 (429)
T ss_dssp -EEEECCCCEEECC
T ss_pred -CEEEEEeCCcccC
Confidence 3899999865554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0012 Score=67.09 Aligned_cols=128 Identities=13% Similarity=0.078 Sum_probs=75.2
Q ss_pred ceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc-cccccccccCCCCCceEEEEEecC
Q 036081 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL-SLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv-~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+....+. +++++.. ...++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~-------~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP-------ATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT-------TTCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC-------CCCEEEEeec
Confidence 577988999999998 45888876542211 12245788888888533333 4444332 1236899999
Q ss_pred -CCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHH-----------------------------------------
Q 036081 372 -PSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH----------------------------------------- 409 (614)
Q Consensus 372 -~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH----------------------------------------- 409 (614)
++.+|....... +..+..++++.|+-||
T Consensus 90 ~~g~~l~~~~~~~----------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 159 (301)
T 3dxq_A 90 AGAQTMSPEKFKT----------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREA 159 (301)
T ss_dssp TTCEECCHHHHHH----------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHH
T ss_pred CCCccCCHhhHhh----------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHH
Confidence 555553210000 0011122222222222
Q ss_pred ---------hcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 410 ---------YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 410 ---------~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
......++|+|+.+.||+ ..++.+.|.||..+..
T Consensus 160 ~~l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 160 GGVRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 122456899999999999 5667789999988764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.006 Score=63.31 Aligned_cols=32 Identities=25% Similarity=0.369 Sum_probs=28.3
Q ss_pred CCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 413 ~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
...++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 46799999999999999888899999987754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.007 Score=62.24 Aligned_cols=33 Identities=33% Similarity=0.413 Sum_probs=28.5
Q ss_pred CCceEecCCCCCceeecCC----CcEEEeeecccccc
Q 036081 413 KPAIYHRDIKSTNILLDSE----MKAKVADFGLAKQS 445 (614)
Q Consensus 413 ~~~ivHrDIKp~NILLd~~----~~~KL~DFGla~~~ 445 (614)
...++|||+.+.||+++.+ ..+.|.||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999875 67999999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0061 Score=64.54 Aligned_cols=141 Identities=18% Similarity=0.276 Sum_probs=80.3
Q ss_pred eeeeccCcEEEEEEEEc--------CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCc-ccccccccccCCCCCceE
Q 036081 294 NLIGQGASGVVYKGTLE--------DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL-LSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NI-v~l~g~~~~~~~~~~~~~ 364 (614)
+.|..|-...+|+.... +++.+.+|+... .........+|.++++.+...++ .++++++. +
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~---- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E---- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T----
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C----
Confidence 45666777889998875 247899998533 22334567799999998853333 45555543 1
Q ss_pred EEEEecCCCCCcccc-cchh---------h---h------ccCCC--ccchhHHHHHH-------------------HHH
Q 036081 365 FLVYDFMPSGSLGDH-ISNA---------L---T------RKQLA--WPQRKKIILDV-------------------AKG 404 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~-L~~~---------~---~------~~~l~--~~~r~~Ia~~I-------------------a~g 404 (614)
.+||||+++.+|... +.+. . . .+... |.+..++..++ ...
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 289999998666421 1100 0 0 01111 22222222222 112
Q ss_pred HHHHH-----hcCCCceEecCCCCCceeecCC----CcEEEeeeccccc
Q 036081 405 LAYLH-----YGLKPAIYHRDIKSTNILLDSE----MKAKVADFGLAKQ 444 (614)
Q Consensus 405 L~yLH-----~~~~~~ivHrDIKp~NILLd~~----~~~KL~DFGla~~ 444 (614)
+..|. ......++|+|+.+.|||++.+ +.+.|.||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22332 1224578999999999999876 7899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.011 Score=64.14 Aligned_cols=75 Identities=12% Similarity=0.052 Sum_probs=48.4
Q ss_pred ceeeeccCcEEEEEEEEcC-CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCc-ccccccccccCCCCCceEEEEEec
Q 036081 293 KNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL-LSLRGCCVSSDDEKGKRRFLVYDF 370 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NI-v~l~g~~~~~~~~~~~~~~LV~Ey 370 (614)
.+.|+.|-...+|+....+ +..+++|+..... ...-.-..|..++..+...++ .++++++. . .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-----~----G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT-----N----GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-----T----EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-----C----eEEEEe
Confidence 4578878889999999875 4778888764322 111122589999999975555 35565542 1 259999
Q ss_pred CCCCCcc
Q 036081 371 MPSGSLG 377 (614)
Q Consensus 371 ~~~gsL~ 377 (614)
+++.+|.
T Consensus 183 I~G~~l~ 189 (458)
T 2qg7_A 183 MDGYALS 189 (458)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9976654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0048 Score=64.58 Aligned_cols=74 Identities=14% Similarity=0.105 Sum_probs=44.4
Q ss_pred ceeeeccCcEEEEEEEEcC---------CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc-cccccccccCCCCCc
Q 036081 293 KNLIGQGASGVVYKGTLED---------GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL-SLRGCCVSSDDEKGK 362 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~---------g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv-~l~g~~~~~~~~~~~ 362 (614)
...|+.|....+|+....+ +..+++|+..... ........|.+++..+...+++ ++++...
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~-------- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN-------- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET--------
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC--------
Confidence 3467777788999998764 2678888764321 1111346789999888644443 5554321
Q ss_pred eEEEEEecCCCCCc
Q 036081 363 RRFLVYDFMPSGSL 376 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL 376 (614)
-++||||+++..+
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2689999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.88 E-value=0.013 Score=56.98 Aligned_cols=169 Identities=16% Similarity=0.082 Sum_probs=89.8
Q ss_pred CCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCCCcccc
Q 036081 374 GSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLT 453 (614)
Q Consensus 374 gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 453 (614)
-||.+.|... ..++++++.|.++.|.+++|.-+-.. ..+ ..+=+.|..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 4678888663 57899999999999999998776311 111 1223446899999999987763 1110
Q ss_pred ccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhh--hC
Q 036081 454 TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE--EG 531 (614)
Q Consensus 454 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~ 531 (614)
.....+.|||... ...+.+.=|||+|++||.-+--..|-+....-...+......+.....-....|+.+.. ++
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg 173 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEG 173 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCCC---------------
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhcccccccccccccccccc
Confidence 1122466888653 35578899999999999988744432211111112222222222221111122222210 00
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCCCC
Q 036081 532 SRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIP 571 (614)
Q Consensus 532 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~~~ 571 (614)
+.+..+ ...+..|++.++|++..+.....|
T Consensus 174 ~~d~~~----------~~~~~~~~sl~~Vi~~C~~hl~~p 203 (229)
T 2yle_A 174 LGDEDE----------KRKISAIRSYRDVMKLCAAHLPTE 203 (229)
T ss_dssp -----C----------CSCCCCCCSHHHHHHHHHTTSSSG
T ss_pred cccccc----------cccccCcCCHHHHHHHHHhhccCc
Confidence 111000 246678999999999998765433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.53 E-value=0.091 Score=56.31 Aligned_cols=75 Identities=8% Similarity=0.036 Sum_probs=48.3
Q ss_pred ceeeeccCcEEEEEEEEcC--------CcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCc-ccccccccccCCCCCce
Q 036081 293 KNLIGQGASGVVYKGTLED--------GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL-LSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~--------g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NI-v~l~g~~~~~~~~~~~~ 363 (614)
.+.+..|-...+|+....+ ++.+.+|+..... ...-.-.+|..+++.+...++ .++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--------- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP--------- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET---------
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC---------
Confidence 3567667778999998763 5788888864322 222234579999988853333 34444321
Q ss_pred EEEEEecCCCCCcc
Q 036081 364 RFLVYDFMPSGSLG 377 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~ 377 (614)
-++||||+++..|.
T Consensus 145 ~~~I~efI~G~~l~ 158 (424)
T 3mes_A 145 EGRIEEFIDGEPLT 158 (424)
T ss_dssp TEEEEECCCSEECC
T ss_pred CCEEEEEeCCccCC
Confidence 27899999987653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.17 E-value=0.15 Score=53.99 Aligned_cols=30 Identities=30% Similarity=0.443 Sum_probs=25.1
Q ss_pred ceEecCCCCCceee------cCCCcEEEeeeccccc
Q 036081 415 AIYHRDIKSTNILL------DSEMKAKVADFGLAKQ 444 (614)
Q Consensus 415 ~ivHrDIKp~NILL------d~~~~~KL~DFGla~~ 444 (614)
.++|+|+.+.|||+ +++..+++.||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999988754
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=90.76 E-value=0.11 Score=44.61 Aligned_cols=41 Identities=15% Similarity=0.302 Sum_probs=30.7
Q ss_pred ccccC-CCCChhchHHHHHhhhhhcccccccCCCcc------cceeeeeee
Q 036081 142 DSDCK-NMTGFTQCSSCVEAGYKVNSQLVSIQQNST------KCFYFAILY 185 (614)
Q Consensus 142 ~~~c~-~l~~~~~C~~c~~~~~~~~~~~~~~~~~~~------~c~~~~~~~ 185 (614)
-+||+ |+ +..+|+.|++..+..... .+.++.+ .|+.|++.|
T Consensus 59 l~qC~~Dl-s~~~C~~Cl~~a~~~~~~--~C~~~~g~~i~~~~C~lRY~~~ 106 (108)
T 3a2e_A 59 RATCKQSI-SQSDCTACLSNLVNRIFS--ICNNAIGARVQLVDCFIQYEQR 106 (108)
T ss_dssp EEEECTTS-CHHHHHHHHHHHHTTHHH--HTTSBSSEEEEETTEEEEEESS
T ss_pred EEEEcCCC-CHHHHHHHHHHHHHHHHH--HCCCCceEEEECCCEEEEEeCC
Confidence 58999 99 899999999998876542 2223222 799998876
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.02 E-value=0.16 Score=36.15 Aligned_cols=16 Identities=38% Similarity=0.617 Sum_probs=8.0
Q ss_pred EEEhhHHHHHHHHHHH
Q 036081 223 KIVVALLGALLGVLLA 238 (614)
Q Consensus 223 ~i~i~v~~~~~~~l~~ 238 (614)
.|+.++++++++++++
T Consensus 12 ~IA~gVVgGv~~~~ii 27 (44)
T 2ks1_B 12 SIATGMVGALLLLLVV 27 (44)
T ss_dssp SSTHHHHHHHHHHHHH
T ss_pred eEEeehhHHHHHHHHH
Confidence 3556666555444333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.91 E-value=0.14 Score=36.38 Aligned_cols=17 Identities=24% Similarity=0.567 Sum_probs=8.2
Q ss_pred EEEhhHHHHHHHHHHHH
Q 036081 223 KIVVALLGALLGVLLAG 239 (614)
Q Consensus 223 ~i~i~v~~~~~~~l~~~ 239 (614)
.|+.+++++++++++++
T Consensus 11 aIA~gVVgGv~~v~ii~ 27 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVG 27 (44)
T ss_dssp HHHHHHHHHHHHHHHHH
T ss_pred eEEEeehHHHHHHHHHH
Confidence 35556665444443333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.23 E-value=0.17 Score=35.88 Aligned_cols=26 Identities=31% Similarity=0.404 Sum_probs=10.4
Q ss_pred EEhhHHHHHHHHHHHHHHHHHHHHhh
Q 036081 224 IVVALLGALLGVLLAGGLIIMYRKWY 249 (614)
Q Consensus 224 i~i~v~~~~~~~l~~~~~~~~~~~~~ 249 (614)
|+.++++.++++++.+++++|.||++
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhh
Confidence 34444443333333333344444433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.24 E-value=2.3 Score=40.88 Aligned_cols=117 Identities=8% Similarity=0.096 Sum_probs=75.1
Q ss_pred cCCCcccccccccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCC
Q 036081 342 RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDI 421 (614)
Q Consensus 342 ~H~NIv~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDI 421 (614)
.||+++.. .+-. ..+...+.|+.-+ +..++- .-+.++...+++++.+|+.-..+++ .=+|--|
T Consensus 43 ~~~~Fl~~-~I~e-----~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L 105 (215)
T 4ann_A 43 HSPYFIDA-ELTE-----LRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVL 105 (215)
T ss_dssp CCTTBCCE-EEEE-----CSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCC
T ss_pred cCCcccce-EEEE-----cccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEE
Confidence 57776644 1221 2334555555443 222221 2245788899999999998876655 2367889
Q ss_pred CCCceeecCCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 036081 422 KSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLET 498 (614)
Q Consensus 422 Kp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~ 498 (614)
.|+||++|.++.+++.--|+-... +|. ..+...=.-.+=+++..+++++..|+.
T Consensus 106 ~P~NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 106 APDELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp SGGGEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred ecceEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999999999877763322 121 122222344677899999999988863
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.17 E-value=0.16 Score=55.03 Aligned_cols=58 Identities=7% Similarity=0.003 Sum_probs=16.7
Q ss_pred eeeeccCcEEEEEEEEcC-CcEEEE------EEeecCC--CcchHHHHHHHHHHHHccCCCccccccccc
Q 036081 294 NLIGQGASGVVYKGTLED-GTLVAV------KQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCV 354 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~-g~~vAV------K~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~ 354 (614)
+.|| ||.||+|.+.. ..+||| |..+... .+....|.+|..++..++|+|+++.+++..
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4455 99999999864 367888 7665422 223356889999999999999999988765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 614 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 1e-66
Identities = 72/280 (25%), Positives = 113/280 (40%), Gaps = 25/280 (8%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+ IG G+ G VYKG V + +T + + F NEV ++ K RH N+L
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G + +V + SL H+ + + I A+G+ YLH
Sbjct: 70 MGYST------APQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ-SHLTTRVAGTYGYLAPEYA 468
+I HRD+KS NI L ++ K+ DFGLA SH +++G+ ++APE
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 469 LY---GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525
+ +SDVY+FGIV+ ELM+G+ N+ D + G + +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----DQIIFMVGRGYLSPDLSK 233
Query: 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
+ R+ C RP L +E
Sbjct: 234 VRSN-----CPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-62
Identities = 62/276 (22%), Positives = 118/276 (42%), Gaps = 25/276 (9%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G G G V+ G T VAVK + + + F+ E ++ +++H+ L+ L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+++ ++M +GSL D + + +L + + +A+G+A++
Sbjct: 74 YAVVTQEP------IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ HRD+++ NIL+ + K+ADFGLA+ + + + APE
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
YG T KSDV+SFGI++ E+++ ++ ++ +I + + R
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--------------QNLERGYRM 229
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
E ++ LC RPT +LE
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-61
Identities = 71/293 (24%), Positives = 115/293 (39%), Gaps = 27/293 (9%)
Query: 293 KNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
+ IG+G G V++G G VAVK + E+ +RH N+L
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH--- 409
+ D+ + +LV D+ GSL D+++ R + K+ L A GLA+LH
Sbjct: 66 D-NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 410 --YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL---TTRVAGTYGYLA 464
KPAI HRD+KS NIL+ +AD GLA + + GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 465 PEYAL------YGQLTEKSDVYSFGIVILELMSGRKVLETSNS-----SFLLITDWAWML 513
PE + + +++D+Y+ G+V E+ + L+ +D +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 514 ANSGKVDEIFDEFIREEG-SRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
++ I S + ++ C + A R T K L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-61
Identities = 69/276 (25%), Positives = 118/276 (42%), Gaps = 25/276 (9%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+ IG G G+V+ G + VA+K I +E+FI E E++ K+ H L+ L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G C+ LV++FM G L D++ + LDV +G+AYL
Sbjct: 66 YGVCLEQA-----PICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLE 118
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
+ + HRD+ + N L+ KV+DFG+ + L+ Q +T + +PE
Sbjct: 119 ---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
+ + + KSDV+SFG+++ E+ S K+ + S+ ++ D + R
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--------------RL 221
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
R ++ C RP + L+ L
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-60
Identities = 78/288 (27%), Positives = 122/288 (42%), Gaps = 25/288 (8%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+ +GQG G V+ GT T VA+K + T E F+ E +++ K+RH L+ L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
+ ++V ++M GSL D + T K L PQ + +A G+AY+
Sbjct: 78 YAVV------SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
HRD+++ NIL+ + KVADFGLA+ + + + APE AL
Sbjct: 131 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
YG+ T KSDV+SFGI++ EL + +V + ++ +V+ +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----------QVERGYRMPCPP 237
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPERP 577
E E + C RPT LE +P
Sbjct: 238 E----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-60
Identities = 63/279 (22%), Positives = 119/279 (42%), Gaps = 26/279 (9%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+ +G G GVV G VA+K I + ++EFI E +++ + H L+ L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G C K + F++ ++M +G L +++ R + Q ++ DV + + YL
Sbjct: 65 YGVC-----TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
HRD+ + N L++ + KV+DFGL++ L+ + + + PE +
Sbjct: 118 S---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
Y + + KSD+++FG+++ E+ S K + + + E + +R
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRL 220
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568
E+ + C H RPT L + D+
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL-DV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-60
Identities = 57/258 (22%), Positives = 112/258 (43%), Gaps = 15/258 (5%)
Query: 283 LDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI-TDLDTKGDEEFINEVEIISK 340
++ F + + +G G GVV+K + G ++A K I ++ + I E++++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 341 IRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD 400
++ G S + + M GSL + ++ K+ +
Sbjct: 61 CNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIA 112
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
V KGL YL K I HRD+K +NIL++S + K+ DFG++ Q ++ GT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTR 167
Query: 461 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520
Y++PE + +SD++S G+ ++E+ GR + ++ L + + ++ +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 521 EIFDEFIREEGSRAVMER 538
R S + R
Sbjct: 228 PRPRTPGRPLSSYGMDSR 245
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 9e-58
Identities = 66/277 (23%), Positives = 121/277 (43%), Gaps = 25/277 (9%)
Query: 290 FSQKNLIGQGASGVVYKGTLED-GTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS 348
+ K+ +G G G VY+G + VAVK + DT EEF+ E ++ +I+H NL+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
L G C + +++ +FM G+L D++ R++++ + ++ + YL
Sbjct: 78 LLGVC-----TREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL 131
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
K HRD+ + N L+ KVADFGL++ + APE
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 469 LYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIR 528
Y + + KSDV++FG+++ E+ + + + +V E+ ++ R
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGM--------------SPYPGIDLSQVYELLEKDYR 234
Query: 529 EEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
E E+ + C + RP+ A+ + E
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-57
Identities = 73/276 (26%), Positives = 113/276 (40%), Gaps = 29/276 (10%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSL 349
IG+G G V G G VAVK I + + F+ E +++++RH NL+ L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G V ++V ++M GSL D++ + R L K LDV + + YL
Sbjct: 66 LGVIVEEKG----GLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
HRD+ + N+L+ + AKV+DFGL K++ S + APE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALR 173
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
+ + KSDV+SFGI++ E+ S +V G + D
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKGYKMDAPDG---- 224
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
V C H+ A+RP+ + LE
Sbjct: 225 -----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (488), Expect = 4e-57
Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 42/306 (13%)
Query: 278 FRESELDQATGGFSQK---------NLIGQGASGVVYKGTL----EDGTLVAVKQI-TDL 323
F + ++A F+++ +IG G G V G L + VA+K + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 324 DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNA 383
K +F++E I+ + H N++ L G K ++ +FM +GSL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQ- 120
Query: 384 LTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443
Q Q ++ +A G+ YL HRD+ + NIL++S + KV+DFGL++
Sbjct: 121 -NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 444 QSLEGQSHLTTRVA----GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETS 499
+ S T A + APE Y + T SDV+S+GIV+ E+MS +
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----- 231
Query: 500 NSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIAD 559
+ + V ++ R ++ + C RP
Sbjct: 232 ---------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 560 ALKMLE 565
+ L+
Sbjct: 283 IVNTLD 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-57
Identities = 57/279 (20%), Positives = 109/279 (39%), Gaps = 25/279 (8%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNL 346
+ IG G+ G K DG ++ K++ + + ++EV ++ +++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQ-LAWPQRKKIILDVAKGL 405
+ + D ++V ++ G L I+ +Q L +++ + L
Sbjct: 66 VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 406 AYLHYGLKPA--IYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYL 463
H + HRD+K N+ LD + K+ DFGLA+ L + GT Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYM 181
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523
+PE EKSD++S G ++ EL + + L GK I
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------GKIREGKFRRIP 235
Query: 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
+ E ++ R ++ RP++ + L+
Sbjct: 236 YRYSDE--LNEIITR-------MLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-56
Identities = 70/271 (25%), Positives = 110/271 (40%), Gaps = 26/271 (9%)
Query: 296 IGQGASGVVYKGTL-EDGTLVAVKQITD--LDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
IG+G+ VYKG E VA ++ D L + F E E++ ++H N++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
S+ K K LV + M SG+L ++ K + + + KGL +LH
Sbjct: 77 WESTVKGK-KCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 413 KPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
P I HRD+K NI + K+ D GLA ++ V GT ++APE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM-YEE 187
Query: 472 QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531
+ E DVY+FG+ +LE+ + + + SG FD+ E
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 532 SRAVMERFVRVGILCAHVMVALRPTIADALK 562
+ ++E C R +I D L
Sbjct: 243 -KEIIEG-------CIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 7e-56
Identities = 81/319 (25%), Positives = 128/319 (40%), Gaps = 44/319 (13%)
Query: 255 NALHEEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTLED--- 311
+AL+ E V++ + V+ F +IG+G G VY GTL D
Sbjct: 7 SALNPELVQAVQHVVIG-----------PSSLIVHF--NEVIGRGHFGCVYHGTLLDNDG 53
Query: 312 -GTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYD 369
AVK + + G+ +F+ E I+ H N+LSL G C+ S+ +V
Sbjct: 54 KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG----SPLVVLP 109
Query: 370 FMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429
+M G L + I N L VAKG+ +L HRD+ + N +LD
Sbjct: 110 YMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLD 164
Query: 430 SEMKAKVADFGLAKQSLEGQS---HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVI 486
+ KVADFGLA+ + + H T ++A E + T KSDV+SFG+++
Sbjct: 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224
Query: 487 LELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILC 546
ELM+ ++F D L R + V + C
Sbjct: 225 WELMTRGAPPYPDVNTF----DITVYLLQGR----------RLLQPEYCPDPLYEVMLKC 270
Query: 547 AHVMVALRPTIADALKMLE 565
H +RP+ ++ + +
Sbjct: 271 WHPKAEMRPSFSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-55
Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 32/290 (11%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGT-----LVAVKQI-TDLDTKGDEEFINEVEIISKIRH 343
+++ +IG G G VYKG L+ + VA+K + K +F+ E I+ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403
N++ L G ++ ++M +G+L + + + Q ++ +A
Sbjct: 69 HNIIRLEGVISKYK-----PMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAA 121
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVA--GTYG 461
G+ YL HRD+ + NIL++S + KV+DFGL++ + T
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521
+ APE Y + T SDV+SFGIV+ E+M+ + + ++ +V +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEVMK 224
Query: 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIP 571
++ R ++ + C A RP AD + +L+ I P
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 2e-55
Identities = 75/282 (26%), Positives = 110/282 (39%), Gaps = 41/282 (14%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIRHRN 345
FS IG G+ G VY + + +VA+K++ + ++ I EV + K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
+ RGC + +LV ++ + + +K L + + +GL
Sbjct: 77 TIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 128
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
AYLH + HRD+K+ NILL K+ DFG A GT ++AP
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAP 180
Query: 466 EYAL---YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITDWAWMLANSGKVD 520
E L GQ K DV+S GI +EL + L N+ L I SG
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
E F F+ C + RPT LK
Sbjct: 241 EYFRNFVD----------------SCLQKIPQDRPTSEVLLK 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-55
Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 31/276 (11%)
Query: 296 IGQGASGVVYKGTL---EDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLSLRG 351
+G G G V +G + VA+K + K D EE + E +I+ ++ + ++ L G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
C + + LV + G L + R+++ +++ V+ G+ YL
Sbjct: 77 VC------QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE- 127
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR--VAGTYGYLAPEYAL 469
HRD+ + N+LL + AK++DFGL+K S+ T R + APE
Sbjct: 128 --KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
+ + + +SDV+S+G+ + E +S + GK E E E
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKRMECPPECPPE 240
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
+ C RP + +
Sbjct: 241 ---------LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-54
Identities = 58/279 (20%), Positives = 110/279 (39%), Gaps = 33/279 (11%)
Query: 294 NLIGQGASGVVYKGTLED---GTLVAVKQITD--LDTKGDEEFINEVEIISKIRHRNLLS 348
+G G G V KG + VAVK + + D +E + E ++ ++ + ++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
+ G C + + LV + G L ++ + + +++ V+ G+ YL
Sbjct: 73 MIGIC------EAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYL 123
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTR--VAGTYGYLAPE 466
HRD+ + N+LL ++ AK++DFGL+K +++ + + APE
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526
Y + + KSDV+SFG+++ E S + + +V + ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKG 226
Query: 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
R + LC V RP A L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-54
Identities = 67/277 (24%), Positives = 106/277 (38%), Gaps = 28/277 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI-TDLDTKGDEEFINEVEIISKIRHRNLL 347
+ +G+GA G V VAVK + E E+ I + H N++
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
G +G ++L ++ G L D I + P ++ + G+ Y
Sbjct: 67 KFYGHR-----REGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVY 118
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-SLEGQSHLTTRVAGTYGYLAPE 466
LH I HRDIK N+LLD K++DFGLA + L ++ GT Y+APE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 467 YALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525
+ E DV+S GIV+ +++G + + S +DW +I
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
A++ + + R TI D K
Sbjct: 236 P------LALLHK-------ILVENPSARITIPDIKK 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-53
Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 34/277 (12%)
Query: 290 FSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITD---LDTKGDEEFINEVEIISKIRHRN 345
F +G+G G VY + ++A+K + + + EVEI S +RH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
+L L G R +L+ ++ P G++ + + + I ++A L
Sbjct: 68 ILRLYGYF-----HDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANAL 119
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
+Y H + HRDIK N+LL S + K+ADFG + + S T + GT YL P
Sbjct: 120 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPP 173
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525
E EK D++S G++ E + G+ E + + +V+ F +
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVEFTFPD 225
Query: 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
F+ E R ++ R + RP + + L+
Sbjct: 226 FVTEGA-RDLISR-------LLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-53
Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 36/278 (12%)
Query: 294 NLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGC 352
+G GA G VYK E L A K I + E+++ E++I++ H N++ L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
+ +++ +F G++ + + L Q + + L YLH
Sbjct: 78 FYYEN-----NLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQ 472
I HRD+K+ NIL + K+ADFG++ ++ + + GT ++APE +
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCET 186
Query: 473 L-----TEKSDVYSFGIVILELMSGRKVLETSNSSFLL---ITDWAWMLANSGKVDEIFD 524
K+DV+S GI ++E+ N +L LA + F
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246
Query: 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
+F+++ C V R T + L+
Sbjct: 247 DFLKK----------------CLEKNVDARWTTSQLLQ 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 2e-53
Identities = 63/305 (20%), Positives = 116/305 (38%), Gaps = 51/305 (16%)
Query: 290 FSQKNLIGQGASGVVYKGTL------EDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIR 342
IG+GA G V++ E T+VAVK + + +F E ++++
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN-------------------- 382
+ N++ L G C GK L++++M G L + + +
Sbjct: 75 NPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 383 -ALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441
+ L+ ++ I VA G+AYL + HRD+ + N L+ M K+ADFGL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 442 AKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
++ A ++ PE Y + T +SDV+++G+V+ E+ S
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADA 560
+ + G + + + LC + A RP+
Sbjct: 247 AH-----EEVIYYVRDGNILACPEN---------CPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 561 LKMLE 565
++L+
Sbjct: 293 HRILQ 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-53
Identities = 65/308 (21%), Positives = 127/308 (41%), Gaps = 35/308 (11%)
Query: 290 FSQKNLIGQGASGVVYKGTL-----EDGTLVAVKQITD-LDTKGDEEFINEVEIISKIRH 343
F + ++G GA G VYKG + VA+K++ + K ++E ++E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403
++ L G C++S L+ MP G L D++ + + + +AK
Sbjct: 71 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAK 122
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ-SLEGQSHLTTRVAGTYGY 462
G+ YL + HRD+ + N+L+ + K+ DFGLAK E + + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 463 LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522
+A E L+ T +SDV+S+G+ + ELM+ + + ++ I
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSI 225
Query: 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDIDIPTLPERPLPLTH 582
++ R + + C + RP + + + P+R L +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQG 282
Query: 583 ESFKASPS 590
+ PS
Sbjct: 283 DERMHLPS 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 7e-53
Identities = 65/307 (21%), Positives = 108/307 (35%), Gaps = 45/307 (14%)
Query: 290 FSQKNLIGQGASGVVYKGTL------EDGTLVAVKQIT-DLDTKGDEEFINEVEIISKI- 341
S +G GA G V + T + VAVK + E ++E++++S +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 342 RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN---------------ALTR 386
H N+++L G C G ++ ++ G L + +
Sbjct: 85 NHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 387 KQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446
L VAKG+A+L HRD+ + NILL K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 447 EGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL 505
++ + ++APE T +SDV+S+GI + EL S
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------- 246
Query: 506 ITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
+ K ++ E R + C RPT ++++E
Sbjct: 247 ---PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 566 GDIDIPT 572
I T
Sbjct: 304 KQISEST 310
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-52
Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 33/277 (11%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLS 348
+++ IGQGASG VY + G VA++Q+ E INE+ ++ + ++ N+++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
G ++V +++ GSL D + T + Q + + + L +L
Sbjct: 82 YLDSY-----LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFL 132
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYA 468
H + HRDIKS NILL + K+ DFG Q QS +T V GT ++APE
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 469 LYGQLTEKSDVYSFGIVILELMSGRKVLETSNSS---FLLITDWAWMLANSGKVDEIFDE 525
K D++S GI+ +E++ G N +L+ T+ L N K+ IF +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
F+ C + V R + + L+
Sbjct: 249 FLNR----------------CLDMDVEKRGSAKELLQ 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-52
Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 42/294 (14%)
Query: 290 FSQKNLIGQGASGVVYKGTLEDGTL---VAVKQITDLDTKGD-EEFINEVEIISKI-RHR 344
+++IG+G G V K ++ L A+K++ + +K D +F E+E++ K+ H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN-------------ALTRKQLAW 391
N+++L G C E +L ++ P G+L D + T L+
Sbjct: 72 NIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 392 PQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH 451
Q DVA+G+ YL + HRD+ + NIL+ AK+ADFGL++ +
Sbjct: 127 QQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV 181
Query: 452 LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAW 511
T ++A E Y T SDV+S+G+++ E++S +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--------------PY 227
Query: 512 MLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
++ E + R E + + C RP+ A L L
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-50
Identities = 58/305 (19%), Positives = 111/305 (36%), Gaps = 50/305 (16%)
Query: 290 FSQKNLIGQGASGVVYKGTLED------GTLVAVKQIT-DLDTKGDEEFINEVEIISKI- 341
++G GA G V T VAVK + D+ E ++E+++++++
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 342 RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISN------------------- 382
H N+++L G C S +L++++ G L +++ +
Sbjct: 99 SHENIVNLLGACTLSG-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 383 -ALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441
L + VAKG+ +L + HRD+ + N+L+ K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 442 AKQSLEGQSHLT-TRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSN 500
A+ + +++ ++APE G T KSDV+S+GI++ E+ S
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 501 SSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADA 560
++ + + E + C RP+ +
Sbjct: 271 PVDANF-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 561 LKMLE 565
L
Sbjct: 318 TSFLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-50
Identities = 58/279 (20%), Positives = 104/279 (37%), Gaps = 33/279 (11%)
Query: 296 IGQGASGVVYKGTLE----DGTLVAVKQI---TDLDTKGDEEFINEVEIISKIRHRNLLS 348
+G G+ GVV +G + VAVK + + ++FI EV + + HRNL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 349 LRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYL 408
L G ++ +V + P GSL D + + + + VA+G+ YL
Sbjct: 76 LYGVVLTPP------MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 409 HYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSH--LTTRVAGTYGYLAPE 466
HRD+ + N+LL + K+ DFGL + + H + + + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526
+ SD + FG+ + E+ + + + + + G+ ++
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQILHKIDKEGERLPRPED- 239
Query: 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
+ V + C RPT L
Sbjct: 240 --------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (438), Expect = 2e-49
Identities = 68/307 (22%), Positives = 122/307 (39%), Gaps = 32/307 (10%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G GA GVV++ T G A K + E E++ +S +RH L++L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
E ++Y+FM G L + +++ +++ + + + V KGL ++H +
Sbjct: 93 -----EDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---E 142
Query: 414 PAIYHRDIKSTNILLDSEM--KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
H D+K NI+ ++ + K+ DFGL QS T GT + APE A
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGK 200
Query: 472 QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531
+ +D++S G++ L+SG N L + + +D+ I E+G
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISEDG 256
Query: 532 SRAVMERFVRVGILCAHVMVALRPTIADALK---MLEGDI--DIPTLPERPLPLTHESFK 586
+ + + R TI AL+ + G+ +P +S K
Sbjct: 257 -KDFIRK-------LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 308
Query: 587 ASPSRYS 593
+
Sbjct: 309 TKYDAWP 315
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-49
Identities = 50/276 (18%), Positives = 100/276 (36%), Gaps = 30/276 (10%)
Query: 295 LIGQGASGVVYKGTL----EDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHRNLLSL 349
IG+G G V++G VA+K + + E+F+ E + + H +++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G +++ + G L + + L ++ LAYL
Sbjct: 74 IGVITE------NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE 125
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
HRDI + N+L+ S K+ DFGL++ + + ++ ++APE
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
+ + T SDV+ FG+ + E++ + + +G+ +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGERLPMPPNC--P 235
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
++M + C + RP + L
Sbjct: 236 PTLYSLMTK-------CWAYDPSRRPRFTELKAQLS 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 1e-48
Identities = 55/295 (18%), Positives = 121/295 (41%), Gaps = 37/295 (12%)
Query: 290 FSQKNLIGQGASGVVYKGTL------EDGTLVAVKQIT-DLDTKGDEEFINEVEIISKIR 342
+ +GQG+ G+VY+G E T VA+K + + EF+NE ++ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-------SNALTRKQLAWPQRK 395
+++ L G +G+ ++ + M G L ++ +N + +
Sbjct: 82 CHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 396 KIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL-TT 454
++ ++A G+AYL+ HRD+ + N ++ + K+ DFG+ + E +
Sbjct: 137 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 455 RVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA 514
+ +++PE G T SDV+SFG+V+ E+ + + S+ +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRFV 248
Query: 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569
G + + D + + +C +RP+ + + ++ +++
Sbjct: 249 MEGGLLDKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-47
Identities = 70/318 (22%), Positives = 121/318 (38%), Gaps = 48/318 (15%)
Query: 270 LPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT------LEDGTLVAVKQITDL 323
LP +KW E D+ +G+GA G V + VAVK + +
Sbjct: 1 LPYDASKW--EFPRDR----LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 54
Query: 324 DTKGD-EEFINEVEIISKIRHR-NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHIS 381
T + ++E++I+ I H N+++L G C + G ++ +F G+L ++
Sbjct: 55 ATHSEHRALMSELKILIHIGHHLNVVNLLGAC----TKPGGPLMVIVEFCKFGNLSTYLR 110
Query: 382 N-------------ALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILL 428
+ L + L VAKG+ +L HRD+ + NILL
Sbjct: 111 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL 167
Query: 429 DSEMKAKVADFGLAKQSLEGQSHL-TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVIL 487
+ K+ DFGLA+ + ++ ++APE T +SDV+SFG+++
Sbjct: 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227
Query: 488 ELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCA 547
E+ S I + G D E + + C
Sbjct: 228 EIFSLGASPYPGVK----IDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCW 274
Query: 548 HVMVALRPTIADALKMLE 565
H + RPT ++ ++ L
Sbjct: 275 HGEPSQRPTFSELVEHLG 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-47
Identities = 55/302 (18%), Positives = 106/302 (35%), Gaps = 39/302 (12%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIRHRN 345
F ++G+G+ V L A+K + + E +++S++ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
+ L + ++ + + +G L +I + ++ L
Sbjct: 70 FVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSAL 121
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK-QSLEGQSHLTTRVAGTYGYLA 464
YLH I HRD+K NILL+ +M ++ DFG AK S E + GT Y++
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 465 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524
PE + SD+++ G +I +L++G N + K++ F
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLEYDFP 230
Query: 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG-------DIDIPTLPERP 577
E + R ++E+ + R + + L ++
Sbjct: 231 EKFFPKA-RDLVEK-------LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282
Query: 578 LP 579
P
Sbjct: 283 PP 284
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (417), Expect = 3e-46
Identities = 62/306 (20%), Positives = 116/306 (37%), Gaps = 31/306 (10%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G GA GVV++ G + K I NE+ I++++ H L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
E L+ +F+ G L D I+ +++ + + +GL ++H +
Sbjct: 96 -----EDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---E 145
Query: 414 PAIYHRDIKSTNILLDS--EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
+I H DIK NI+ ++ K+ DFGLA + + T + APE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDRE 203
Query: 472 QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531
+ +D+++ G++ L+SG + L + + DE + E
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDEDAFSSVSPEA 259
Query: 532 SRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGDIDIPT--LPERPLPLTHESFKA 587
+ ++ R T+ DAL+ L+GD T +P + K
Sbjct: 260 -KDFIKN-------LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKE 311
Query: 588 SPSRYS 593
+ +
Sbjct: 312 KYADWP 317
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 83/348 (23%), Positives = 146/348 (41%), Gaps = 39/348 (11%)
Query: 268 SVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGTL-EDGTLVAVKQITDLDTK 326
+V+ G R E+ ++ +IG G+ GVVY+ L + G LVA+K++ +
Sbjct: 5 TVVATPGQGPDRPQEVS-----YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----Q 55
Query: 327 GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR-FLVYDFMPSGSLGDHISNALT 385
E++I+ K+ H N++ LR SS ++K + LV D++P +
Sbjct: 56 DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 386 RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQ 444
++ L K + + + LAY+H I HRDIK N+LLD + K+ DFG AKQ
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 445 SLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSF 503
+ G+ +++ + Y APE T DV+S G V+ EL+ G+ + +
Sbjct: 173 LVRGEPNVSYIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 504 LL---------ITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGI-LCAHVMV-- 551
L T N + F + ++ R I LC+ ++
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 552 -ALRPTIADALK------MLEGDIDIPTLPERPLP--LTHESFKASPS 590
R T +A + + ++ +P + P T + ++P
Sbjct: 291 PTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPP 338
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 62/303 (20%), Positives = 118/303 (38%), Gaps = 46/303 (15%)
Query: 290 FSQKNLIGQGASGVVYKGTL--------EDGTLVAVKQI-TDLDTKGDEEFINEVEIISK 340
+G+GA G V T VAVK + +D K + I+E+E++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 341 I-RHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHI-------------SNALTR 386
I +H+N+++L G C + +++ ++ G+L +++ +
Sbjct: 75 IGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 387 KQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446
+QL+ VA+G+ YL HRD+ + N+L+ + K+ADFGLA+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 447 EGQSHLTTRVA-GTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL 505
+ T ++APE T +SDV+SFG+++ E+ +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 242
Query: 506 ITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
+ + L G + + C H + + RPT ++ L+
Sbjct: 243 -VEELFKLLKEGHRMDKPSN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 566 GDI 568
+
Sbjct: 293 RIV 295
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (400), Expect = 1e-44
Identities = 54/249 (21%), Positives = 102/249 (40%), Gaps = 17/249 (6%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIRHRN 345
+ ++G G V+ L VAVK + D F E + + + H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
++++ + + G ++V +++ +L D + + + ++I D + L
Sbjct: 69 IVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQAL 124
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHL--TTRVAGTYGYL 463
+ H + I HRD+K NI++ + KV DFG+A+ + + + T V GT YL
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 464 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLI----TDWAWMLANSGKV 519
+PE A + +SDVYS G V+ E+++G + + D A +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 520 DEIFDEFIR 528
D +
Sbjct: 242 SADLDAVVL 250
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 2e-44
Identities = 68/296 (22%), Positives = 118/296 (39%), Gaps = 32/296 (10%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEE-FINEVEIISKIRHRNLL 347
+ ++++G GA V LVA+K I +G E NE+ ++ KI+H N++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
+L E G +L+ + G L D I + ++I V + Y
Sbjct: 71 ALDDIY-----ESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKY 122
Query: 408 LHYGLKPAIYHRDIKSTNILL---DSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
LH I HRD+K N+L D + K ++DFGL+K +E + + GT GY+A
Sbjct: 123 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGYVA 177
Query: 465 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524
PE ++ D +S G++ L+ G N + L +L + D +
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYW 233
Query: 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGDIDIPTLPERPL 578
+ I + + + R T AL+ + GD + + +
Sbjct: 234 DDISDSA-KDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSV 281
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (389), Expect = 3e-43
Identities = 74/292 (25%), Positives = 123/292 (42%), Gaps = 46/292 (15%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI---------TDLDTKGDEEFINEVEIIS 339
+ K ++G+G S VV + AVK I + + E + EV+I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 340 KIR-HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKII 398
K+ H N++ L+ E FLV+D M G L D+++ + L+ + +KI+
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIM 116
Query: 399 LDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAG 458
+ + + LH K I HRD+K NILLD +M K+ DFG + Q G+ V G
Sbjct: 117 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCG 171
Query: 459 TYGYLAPEYAL------YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITDWA 510
T YLAPE + ++ D++S G+++ L++G +L I
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231
Query: 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
+ S + D+ D + ++ R V R T +AL
Sbjct: 232 YQF-GSPEWDDYSDTV------KDLVSR-------FLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-43
Identities = 61/325 (18%), Positives = 122/325 (37%), Gaps = 30/325 (9%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G+G G+V++ K + + E+ I++ RHRN+L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
E + ++++F+ + + I+ + +L + + V + L +LH
Sbjct: 71 -----ESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---S 120
Query: 414 PAIYHRDIKSTNILLDS--EMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
I H DI+ NI+ + K+ +FG A+Q G + Y APE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHD 178
Query: 472 QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531
++ +D++S G ++ L+SG + ++ N + FDE +E
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYTFDEEAFKEI 230
Query: 532 SRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGDIDIPTLPERPLPLTHESFKASP 589
S M+ FV R T ++AL+ L+ I+ + +
Sbjct: 231 SIEAMD-FVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLI 286
Query: 590 SRYSFLMTNERSIATSGMTSTISSV 614
+ ++ + I+ G + V
Sbjct: 287 KKDLNMVVSAARISCGGAIRSQKGV 311
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 72/337 (21%), Positives = 132/337 (39%), Gaps = 32/337 (9%)
Query: 287 TGGFSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD-EEFINEVEIISKIRHR 344
++ + IG+GA G+V + VA+K+I+ + + + + E++I+ + RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
N++ + + E+ K +LV M G + L + L+ + + +G
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLM-----GADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLT--TRVAGTYGY 462
L Y+H + HRD+K +N+LL++ K+ DFGLA+ + H T T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 463 LAPEYALYGQL-TEKSDVYSFGIVILELMSGR------KVLETSNSSFLLITDWAWMLAN 515
APE L + T+ D++S G ++ E++S R L+ N ++ + N
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 516 SGKVDEIFDEFIREEGSRAVM--ERFVRVGILCAHVMVAL-------RPTIADALKM--L 564
+ + + V F ++ + R + AL L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
Query: 565 EGDIDIPTLP--ERPLPLTHESFKASPSRYSFLMTNE 599
E D P E P E + L+ E
Sbjct: 299 EQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEE 335
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-42
Identities = 55/278 (19%), Positives = 107/278 (38%), Gaps = 33/278 (11%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI---TDLDTKGDEEFINEVEIISK-IRHR 344
F ++G+G+ G V+ + A+K + L E + E ++S H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 345 NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKG 404
L + + + F V +++ G L HI + + + ++ G
Sbjct: 64 FLTHMFCTFQTKE-----NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILG 115
Query: 405 LAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
L +LH I +RD+K NILLD + K+ADFG+ K+++ G + T GT Y+A
Sbjct: 116 LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIA 171
Query: 465 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524
PE L + D +SFG+++ E++ G+ + L + +++
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 231
Query: 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
+ + + R + ++
Sbjct: 232 DLLVK----------------LFVREPEKRLGVRGDIR 253
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (385), Expect = 1e-41
Identities = 53/246 (21%), Positives = 96/246 (39%), Gaps = 22/246 (8%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQITD---LDTKGDEEFINEVEIISKIR--- 342
FS +IG+G G VY + G + A+K + +G+ +NE ++S +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 343 HRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVA 402
++ + + D + + D M G L H+S + + ++
Sbjct: 66 CPFIVCMSYAFHTPD-----KLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEII 117
Query: 403 KGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGY 462
GL ++H + +RD+K NILLD +++D GLA + + GT+GY
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGY 171
Query: 463 LAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521
+APE G +D +S G ++ +L+ G + D + D
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231
Query: 522 IFDEFI 527
E
Sbjct: 232 FSPELR 237
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 51/299 (17%), Positives = 110/299 (36%), Gaps = 27/299 (9%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGC 352
++G G +G V + A+K + + + EVE+ + + +++ +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL 412
+ + +V + + G L I + + + +I+ + + + YLH
Sbjct: 74 YENLYAGRKCL-LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 413 KPAIYHRDIKSTNILLDSEMK---AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
I HRD+K N+L S+ K+ DFG AK++ S T T Y+APE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIRE 529
+ + D++S G+++ L+ G +++ + + + + E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 530 EGSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGDIDIPTLPERPLPLTHESFK 586
E + ++ R TI + + + +P P + E +
Sbjct: 247 EV-KMLIRN-------LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 74/309 (23%), Positives = 113/309 (36%), Gaps = 46/309 (14%)
Query: 294 NLIGQGASGVVYKGT-LEDGTLVAVKQI-----TDLDTKGDEEFINEVEIISKIRHRNLL 347
+ +G+G VYK +VA+K+I ++ + + E++++ ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 348 SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
L LV+DFM + N L K +L +GL Y
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEY 115
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEY 467
LH + I HRD+K N+LLD K+ADFGLAK T +V T Y APE
Sbjct: 116 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPEL 171
Query: 468 ALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLL---------ITDWAWMLANSG 517
++ D+++ G ++ EL+ L + L T+ W S
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL-------RPTIADALKMLEGDIDI 570
F F F G ++ L R T ALKM
Sbjct: 232 PDYVTFKSFPGIPLH----HIFSAAGDDLLDLIQGLFLFNPCARITATQALKM------- 280
Query: 571 PTLPERPLP 579
RP P
Sbjct: 281 KYFSNRPGP 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-41
Identities = 65/287 (22%), Positives = 109/287 (37%), Gaps = 25/287 (8%)
Query: 294 NLIGQGASGVVYKGT--LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKI---RHRNL 346
IG+GA G V+K G VA+K++ + I EV ++ + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
+ L C S ++ + LV++ + + K ++ + +GL
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLD 130
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+LH + HRD+K NIL+ S + K+ADFGLA+ + T V T Y APE
Sbjct: 131 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPE 185
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL-----------ITDWAWMLAN 515
L D++S G + E+ + + S+ L DW +A
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
+ E+ + E + + C A R + AL
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 53/289 (18%), Positives = 107/289 (37%), Gaps = 26/289 (8%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNL 346
F + IG+G GVVYK G +VA+K+I I E+ ++ ++ H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 347 LSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLA 406
+ L + +LV++F+ ++ + P K + + +GLA
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLA 116
Query: 407 YLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPE 466
+ H + HRD+K N+L+++E K+ADFGLA+ T V +
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 467 YALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL------ITDWAWMLANSGKVD 520
+ D++S G + E+++ R + + L + ++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVAL-------RPTIADALK 562
+ + + + + ++ + R + AL
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 68/293 (23%), Positives = 115/293 (39%), Gaps = 45/293 (15%)
Query: 290 FSQKNL---------IGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGD------EEFIN 333
F Q+N+ +G G VV K G A K I TK E+
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 334 EVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQ 393
EV I+ +I+H N+++L E L+ + + G L D ++ ++ L +
Sbjct: 63 EVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAE---KESLTEEE 114
Query: 394 RKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE----MKAKVADFGLAKQSLEGQ 449
+ + + G+ YLH I H D+K NI+L + K+ DFGLA + G
Sbjct: 115 ATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 450 SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW 509
+ GT ++APE Y L ++D++S G++ L+SG L
Sbjct: 172 E--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---- 225
Query: 510 AWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
A + A + + ++ + + + R R TI D+L+
Sbjct: 226 ANVSAVNYEFEDEYFSNTSALA-KDFIRR-------LLVKDPKKRMTIQDSLQ 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 5e-39
Identities = 44/281 (15%), Positives = 90/281 (32%), Gaps = 30/281 (10%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
IG G+ G +Y GT + G VA+K + E +I ++ + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
+G +V + + ++ + + + + Y+H
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIH---S 121
Query: 414 PAIYHRDIKSTNIL---LDSEMKAKVADFGLAKQSLEGQSH------LTTRVAGTYGYLA 464
HRD+K N L + DFGLAK+ + ++H + GT Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 465 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524
L + + + D+ S G V++ G + ++ E+
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
+ E ++ C + +P + ++
Sbjct: 242 KGYPSE-----FATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (361), Expect = 7e-39
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 294 NLIGQGASGVVYKGT-LEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIRHRNLLSL 349
+G G+ G V+ +G A+K + + K E +E ++S + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 350 RGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLH 409
G + ++ F++ D++ G L + ++ P K +V L YLH
Sbjct: 70 WGTF-----QDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH 121
Query: 410 YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL 469
I +RD+K NILLD K+ DFG AK +T + GT Y+APE
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVS 174
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL 505
+ D +SFGI+I E+++G SN+
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (358), Expect = 8e-39
Identities = 60/284 (21%), Positives = 107/284 (37%), Gaps = 26/284 (9%)
Query: 294 NLIGQGASGVVYKGTLEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
IG+G GVVYK G A+K+I D I E+ I+ +++H N++ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
+ KR LV++ + L K +L + G+AY H
Sbjct: 68 VIHT-----KKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 412 LKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG 471
+ HRD+K N+L++ E + K+ADFGLA+ T + +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 472 QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEG 531
+ + D++S G + E+++G + + + L+ + + + K E + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 532 SRAVMERFVRVGIL-------------CAHVMVALRPTIADALK 562
+ V E L + R T AL+
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 1e-37
Identities = 60/295 (20%), Positives = 120/295 (40%), Gaps = 32/295 (10%)
Query: 294 NLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
IGQG G V+K + G VA+K++ + + E++I+ ++H N+++L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 351 GCCVSSDDEKGKRR---FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAY 407
C + + + +LV+DF G + + + K+++ + GL Y
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYY 132
Query: 408 LHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS---HLTTRVAGTYGYLA 464
+H + I HRD+K+ N+L+ + K+ADFGLA+ ++ + T T Y
Sbjct: 133 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 465 PEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLL---------ITDWAWMLA 514
PE L + D++ G ++ E+ + +++ + L IT W
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL-------RPTIADALK 562
++ ++ E + ++ + ++ L R DAL
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 62/351 (17%), Positives = 128/351 (36%), Gaps = 43/351 (12%)
Query: 278 FRESELDQATGGFSQK----NLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEE 330
F E+ + +G GA G V G VA+K++ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 331 FINEVEIISKIRHRNLLSLRGCCVSSDD-EKGKRRFLVYDFMPSGSLGDHISNALTRKQL 389
E+ ++ +RH N++ L + + +LV FM G+ + + ++L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKL---MKHEKL 118
Query: 390 AWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ 449
+ + ++ + KGL Y+H I HRD+K N+ ++ + + K+ DFGLA+Q+
Sbjct: 119 GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---D 172
Query: 450 SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL---- 505
S +T V + + + T+ D++S G ++ E+++G+ + + S+ L
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 506 -----ITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL------- 553
S + E + L +++ +
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELE-KKDFASILTNASPLAVNLLEKMLVLDAEQ 291
Query: 554 RPTIADAL-----KMLEGDIDIPTLPERPLPLTHESFKASPSRYSFLMTNE 599
R T +AL + L D P + + + + + + E
Sbjct: 292 RVTAGEALAHPYFESLHDTEDEPQVQ--KYDDSFDDVDRTLDEWKRVTYKE 340
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 3e-37
Identities = 54/286 (18%), Positives = 103/286 (36%), Gaps = 28/286 (9%)
Query: 294 NLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLR 350
IG+G G V+K E +VA+K++ D D + E+ ++ +++H+N++ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 351 GCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
K+ LV++F S L K + + KGL + H
Sbjct: 68 DVL-----HSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
+ HRD+K N+L++ + K+A+FGLA+ + V +
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 471 GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLI----------TDWAWMLANSGKVD 520
+ D++S G + EL + + L N + T+ W
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 521 EIFDEFIREEGSRAVMERFVRVGI----LCAHVMVALRPTIADALK 562
+ + + V+ + G R + +AL+
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (343), Expect = 1e-36
Identities = 41/283 (14%), Positives = 89/283 (31%), Gaps = 32/283 (11%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
IG+G+ GV+++GT L + VA+K + +E + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLK 413
++G LV D + ++ + + + +H +
Sbjct: 70 ----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH---E 119
Query: 414 PAIYHRDIKSTNILLDSEMK-----AKVADFGLAKQSLEGQS------HLTTRVAGTYGY 462
++ +RDIK N L+ V DFG+ K + + ++GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 463 LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522
++ L + + + D+ + G V + + G + ++ ++ E
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE--------RIGEK 231
Query: 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565
E E F + ++ P +
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 5e-36
Identities = 61/326 (18%), Positives = 115/326 (35%), Gaps = 31/326 (9%)
Query: 259 EEFVRSFKDSVLPNSGAKWFRESELDQATGGFSQKNLIGQGASGVVYKGT-LEDGTLVAV 317
+E V+ F + KW S+ F + +G G+ G V E G A+
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 318 KQI---TDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSG 374
K + + K E +NE I+ + L+ L + ++V +++ G
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----NLYMVMEYVAGG 126
Query: 375 SLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKA 434
+ H+ + + P + + YLH + +RD+K N+L+D +
Sbjct: 127 EMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 435 KVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK 494
+V DFG AK+ T + GT LAPE L + D ++ G++I E+ +G
Sbjct: 181 QVTDFGFAKR----VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 495 VLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALR 554
+ + + + +R + +RF L+
Sbjct: 237 PFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN-----------LK 285
Query: 555 PTIADALK-MLEGDIDIPTLPERPLP 579
+ D D + +R +
Sbjct: 286 NGVNDIKNHKWFATTDWIAIYQRKVE 311
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 16/208 (7%)
Query: 290 FSQKNLIGQGASGVVYKGT-LEDGTLVAVKQI---TDLDTKGDEEFINEVEIISKIRHRN 345
F L+G+G G V G A+K + + + E ++ RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
L +L+ + D R V ++ G L H+S + + + ++ L
Sbjct: 67 LTALKYAFQTHD-----RLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSAL 118
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAP 465
YLH + +RDIK N++LD + K+ DFGL K+ + + + T GT YLAP
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAP 174
Query: 466 EYALYGQLTEKSDVYSFGIVILELMSGR 493
E D + G+V+ E+M GR
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-34
Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 24/210 (11%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI------TDLDTKGDEEFINEVEIISKIR--HRN 345
L+G G G VY G + D VA+K + + EV ++ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 346 LLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
++ L D L+ + R L + V + +
Sbjct: 71 VIRLLDWFERPD-----SFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAV 123
Query: 406 AYLHYGLKPAIYHRDIKSTNILLD-SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA 464
+ H + HRDIK NIL+D + + K+ DFG + + T GT Y
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSP 177
Query: 465 PEYALYGQL-TEKSDVYSFGIVILELMSGR 493
PE+ Y + + V+S GI++ +++ G
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-34
Identities = 62/350 (17%), Positives = 124/350 (35%), Gaps = 41/350 (11%)
Query: 278 FRESELDQATGGFSQK----NLIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEE 330
F EL++ ++ + +G GA G V + G VAVK++ +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 331 FINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLA 390
E+ ++ ++H N++ L + + + + L + + ++L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLT 119
Query: 391 WPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQS 450
+ +I + +GL Y+H I HRD+K +N+ ++ + + K+ DFGLA+ +
Sbjct: 120 DDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DD 173
Query: 451 HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL----- 505
+T VA + + + D++S G ++ EL++GR + ++ L
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 506 ----ITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVAL-------R 554
+S + F+ L ++ + R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKR 292
Query: 555 PTIADAL-----KMLEGDIDIPTLPERPLPLTHESFKASPSRYSFLMTNE 599
T A AL D P P + ES + L +E
Sbjct: 293 ITAAQALAHAYFAQYHDPDDEPVAD--PYDQSFESRDLLIDEWKSLTYDE 340
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 2e-33
Identities = 48/295 (16%), Positives = 111/295 (37%), Gaps = 43/295 (14%)
Query: 294 NLIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRG 351
+G+G V++ + + V VK + ++ E++I+ +R N+++L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 352 CCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG 411
D + LV++ + + + L + + ++ K L Y H
Sbjct: 98 IV---KDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH-- 146
Query: 412 LKPAIYHRDIKSTNILLDSE-MKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYAL- 469
I HRD+K N+++D E K ++ D+GLA+ GQ + + + PE +
Sbjct: 147 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVD 203
Query: 470 YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF--------LLITDWAWMLANSGKVD- 520
Y D++S G ++ ++ ++ + ++ +L T+ + + ++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 521 -------------EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562
+ ++ F+ E V + R T +A++
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 5e-32
Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQI--TDLDTKGDEEFINEVEIISKIRHRNLLSLRG 351
IG GA G+V VA+K++ + + E+ ++ + H+N++SL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 352 CCVSSDD-EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHY 410
E+ + +LV + M + + +L + ++ + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH- 136
Query: 411 GLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY 470
I HRD+K +NI++ S+ K+ DFGLA+ G S + T T Y APE L
Sbjct: 137 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 471 GQLTEKSDVYSFGIVILELMSGR 493
E D++S G ++ E++ +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-30
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 290 FSQKNLIGQGASGVVYKGTL----EDGTLVAVKQI----TDLDTKGDEEFINEVEIISKI 341
F ++G GA G V+ + G L A+K + K E E +++ I
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 342 RHR-NLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILD 400
R L++L + + L+ D++ G L H+S R++ + + + +
Sbjct: 86 RQSPFLVTLHYAF-----QTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGE 137
Query: 401 VAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQSHLTTRVAGTY 460
+ L +LH K I +RDIK NILLDS + DFGL+K+ + ++ GT
Sbjct: 138 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 461 GYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGR 493
Y+AP+ G + D +S G+++ EL++G
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 1e-28
Identities = 43/214 (20%), Positives = 83/214 (38%), Gaps = 22/214 (10%)
Query: 295 LIGQGASGVVYKGT-LEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCC 353
+G G V+ + + T VA+K + D E +E++++ ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 354 VSS--------DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGL 405
+ + + +V F G + + + K+I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 406 AYLHYGLKPAIYHRDIKSTNILLDSE------MKAKVADFGLAKQSLEGQSHLTTRVAGT 459
Y+H + I H DIK N+L++ ++ K+AD G A E ++ T
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SIQT 192
Query: 460 YGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 493
Y +PE L +D++S +I EL++G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.5 bits (229), Expect = 3e-22
Identities = 32/207 (15%), Positives = 66/207 (31%), Gaps = 33/207 (15%)
Query: 294 NLIGQGASGVVYKGTLEDGTLVAVK----------QITDLDTKGDEEFINEVEIISKIRH 343
L+G+G V+ E VK ++ + GD F ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 344 RNLLSLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAK 403
R L L+G V ++ + + + ++ +++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWE-GNAVLMELIDAK----------ELYRVRVENPDEVLDMILE 114
Query: 404 GLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL--EGQSHLTTRVAGTYG 461
+A + I H D+ N+L+ E + DF + + + L V
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 462 YLAPEYALYGQLTEKSDVYSFGIVILE 488
Y + Y + D+ S IL+
Sbjct: 171 YFSRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 614 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.38 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.04 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=427.50 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=196.8
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|+..+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.. .+..++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEEE
Confidence 467788999999999999999998999999999753 3456789999999999999999999999973 4568999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ...++|..+++|+.|||+||+||| +.+|+||||||+|||+|+++.+||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccC
Confidence 9999999999998653 456899999999999999999999 89999999999999999999999999999987655
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHHh
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEFI 527 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 527 (614)
..........||+.|+|||++.++.++.|+|||||||++|||+||+.|+.........+ .......+
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~----~~i~~~~~--------- 220 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----EDISTGFR--------- 220 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH----HHHHHTCC---------
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH----HHHHhcCC---------
Confidence 44444445679999999999999999999999999999999999654443322211111 11111101
Q ss_pred hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 528 REEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 528 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+....+++.+++..|++.||++||||+||+++|++
T Consensus 221 -~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 221 -LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 01112223477889999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=428.53 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=209.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.. +..++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeEE
Confidence 35688889999999999999999988999999997543 446789999999999999999999998852 34689
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++... ....++|.++++|+.||++||.||| +.+|+||||||+||||++++.+||+|||+|+...
T Consensus 85 v~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEcc
Confidence 99999999999987654 2346999999999999999999999 8999999999999999999999999999999876
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
...........||+.|+|||++.++.++.++|||||||+||||+||+.|+.........+ .. ...+..
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~----~~-i~~~~~------- 228 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----QN-LERGYR------- 228 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HH-HHTTCC-------
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH----HH-HHhcCC-------
Confidence 555555556789999999999999999999999999999999999766654332221111 11 111110
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+....+.+.+++..|++.+|++||||+||+++|+.
T Consensus 229 --~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 01112234567889999999999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=420.88 Aligned_cols=258 Identities=29% Similarity=0.402 Sum_probs=202.1
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||+||+|+++ ..||||+++.. +.+..+.|.+|++++.+++|||||+++|++. .+..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~~ 78 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQL 78 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccEE
Confidence 466888899999999999999875 35999998643 3445678999999999999999999999875 2357
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|.+++... ...++|.+++.|+.|||+||+||| +++||||||||+||||+.++++||+|||+|+.
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEEECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEEecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 9999999999999999653 456999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCC-ccccccccCCCCccchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 445 SLEGQ-SHLTTRVAGTYGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 445 ~~~~~-~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
..... ........||+.|||||++.+ +.++.++|||||||+||||+||+.||......... ... ...+...
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~-~~~----~~~~~~~ 228 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IFM----VGRGYLS 228 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHH----HHHTSCC
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH-HHH----HhcCCCC
Confidence 54332 233455789999999999964 45899999999999999999999999765432211 111 1111111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
.... ..+...++.+.+++..|++.+|.+|||+.||+++|+..
T Consensus 229 p~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 229 PDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CCGG-----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccch-----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1010 11222345788899999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-52 Score=425.86 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=212.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||+||+|++. +|+.||||+++... ...++|.+|++++++++|||||+++|+|. +++..+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 89 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY 89 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCeeE
Confidence 456888899999999999999986 58899999987543 44678999999999999999999999997 445689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++|+|.+++... ....++|..++.|+.|||+||+||| +.+|+||||||+||||++++++||+|||+++..
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999998653 2457899999999999999999999 889999999999999999999999999999976
Q ss_pred cCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
............||+.|+|||++.++.++.|+|||||||++|||++|+.|+........ + ......+.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~----~~~i~~~~------- 233 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-V----YELLEKDY------- 233 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-H----HHHHHTTC-------
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-H----HHHHhcCC-------
Confidence 55554445556789999999999999999999999999999999998777644332111 1 11111111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
....+....+.+.+++..|++.||++||||.||+++|+...
T Consensus 234 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11112233457889999999999999999999999998643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-51 Score=426.15 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=194.7
Q ss_pred CCccceeeeccCcEEEEEEEEcC-C---cEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 289 GFSQKNLIGQGASGVVYKGTLED-G---TLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~-g---~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
+|+..++||+|+||+||+|+++. | ..||||++..... +..++|.+|++++++++|||||+++|+|. ....
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~~ 101 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KSTP 101 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCCE
Confidence 35566899999999999999752 3 3689999865433 34567999999999999999999999997 3456
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++... .+.++|.++++|+.|||+||.||| +.+|+||||||+||||+.++++||+|||+++
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccce
Confidence 89999999999999988652 456999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccc----cccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 444 QSLEGQSHL----TTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 444 ~~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
......... .....||+.|||||.+.++.++.++|||||||+||||+| |+.||....... ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-----~~~~i~~~~~ 251 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-----VINAIEQDYR 251 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTTCC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcCCC
Confidence 764432221 222457999999999999999999999999999999998 899997644321 1111111111
Q ss_pred chhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 519 VDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 519 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. ..+.+..+.+.+++..|++.||.+||||.||+++|+..
T Consensus 252 ~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 252 L----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 11223445788899999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=411.65 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=212.5
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|+|. +.+..++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEE
Confidence 5788889999999999999999989999999998643 34678999999999999999999999997 34568999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ...++|..+++++.|||+||+||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 9999999999987653 467899999999999999999999 88999999999999999999999999999987655
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
..........||+.|+|||.+.++.++.|+|||||||++|||+| |+.||+.....+ ..... ..+..
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-----~~~~i-~~~~~------- 219 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHI-AQGLR------- 219 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHH-HTTCC-------
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-----HHHHH-HhCCC-------
Confidence 54444555679999999999999999999999999999999998 899997654322 11111 11110
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+....+.+.+++..|++.||++|||++|++++|..
T Consensus 220 --~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01112233578899999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=419.13 Aligned_cols=258 Identities=29% Similarity=0.421 Sum_probs=204.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.++|+..+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|+|.. +..++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeEE
Confidence 3568899999999999999999998889999999654 3456789999999999999999999999852 34689
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++... ....++|.+++.|+.|||.||+||| +.+|+||||||+|||||.++++||+|||+++...
T Consensus 89 v~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp EECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 99999999999888764 2356999999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
...........||+.|+|||++..+.++.++||||||++||||++|+.|+.........+. .+ ..+..
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~-~i----~~~~~------- 232 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QV----ERGYR------- 232 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HH----HTTCC-------
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH-HH----HhcCC-------
Confidence 5444445556799999999999999999999999999999999998777654433221111 11 11110
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
...+....+.+.+++..|++.||++||||++|+++|+....
T Consensus 233 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 233 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 11122334578889999999999999999999999998543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=412.22 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=202.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|+..+.||+|+||+||+|+.. +|+.||||++.... .+..+.+.+|++++++++|||||++++++. +.+..+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCceeE
Confidence 56888999999999999999985 69999999996543 233567999999999999999999999997 456789
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||+++|+|.+++.. ...+++.+++.++.||+.||+||| +.+|+||||||+|||+++++++||+|||+|+..
T Consensus 80 ivmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp EEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence 99999999999999965 457999999999999999999999 899999999999999999999999999999876
Q ss_pred cCCC-ccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 446 LEGQ-SHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 446 ~~~~-~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
.... ....+..+||+.|||||++.+..+ +.++|||||||+||||++|+.||............+. .......
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~----~~~~~~~-- 227 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTYLN-- 227 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH----TTCTTST--
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCC--
Confidence 4433 233455789999999999988776 5789999999999999999999976544332221111 1111110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
......+.+.+++..|++.||++|||++|+++
T Consensus 228 -------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 -------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112346678899999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=414.41 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=198.9
Q ss_pred CCCccceeeeccCcEEEEEEEEcCC-----cEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDG-----TLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g-----~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
..|+..++||+|+||+||+|+++++ ..||||+++.... ...++|.+|++++.+++|||||+++|++. +.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence 4577889999999999999997642 4799999965433 33457999999999999999999999997 34
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
...++||||+.+|+|.+++... ...++|.++++++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccch
Confidence 5689999999999999887652 467999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc--cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQS--HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++....... .......||+.|||||++.++.++.++|||||||++|||++|+.|+.......... . ....+.
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~----~-~i~~~~- 230 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM----K-AINDGF- 230 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----H-HHHTTC-
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH----H-HHhccC-
Confidence 987544322 22334568999999999999999999999999999999999776654332221111 1 111111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
+...+.+.+..+.+++..|++.+|++||||.||+++|+...
T Consensus 231 --------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 231 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 11122233457889999999999999999999999998643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=414.08 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=205.0
Q ss_pred CCCccce-eeeccCcEEEEEEEEc---CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKN-LIGQGASGVVYKGTLE---DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|...+ +||+|+||+||+|+++ ++..||||+++.... ...++|.+|++++++++|||||+++|++.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 3455556 4999999999999864 356899999976443 335789999999999999999999999852 3
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++... +..++|.++++|+.|||+||+||| +++|+||||||+||||+.++.+||+|||++
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhh
Confidence 479999999999999987652 457999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 443 KQSLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 443 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
+........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ ... ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-----~~~-~i~~~~~ 230 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMA-FIEQGKR 230 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHH-HHHTTCC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-----HHH-HHHcCCC
Confidence 876543322 2334568999999999999999999999999999999998 899997654321 111 1122211
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
. ..+...+..+.+++..|++.+|++||||.+|++.|+.
T Consensus 231 ~---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 M---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 1122334577889999999999999999999998875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=405.82 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=204.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|++++++++|||||++++++. +.+.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 45888999999999999999986 6899999998642 2234567899999999999999999999997 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++.++..++.||++||+||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 81 ~~ivmEy~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred EEEEEeecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceee
Confidence 9999999999999999875 457999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... .....||+.|||||++.+..++.++|||||||+||||++|+.||...+.... ... ...+...
T Consensus 155 ~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~-i~~~~~~--- 222 (263)
T d2j4za1 155 HAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKR-ISRVEFT--- 222 (263)
T ss_dssp CCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHH-HHTTCCC---
T ss_pred ecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-----HHH-HHcCCCC---
Confidence 654322 3446799999999999999999999999999999999999999976442211 111 1111110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
.+....+.+.+++..|++.||++|||+.|+++
T Consensus 223 -------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11223356788999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=408.72 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=206.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++. ..+..++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEE
Confidence 46888999999999999999965 69999999997655555678999999999999999999999997 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSL 446 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~ 446 (614)
||||+++|+|.+++.+ +.+++.+++.++.||+.||+||| +.+|+||||||+|||++.++++||+|||+++...
T Consensus 95 vmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 9999999999987643 46999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 447 EGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 447 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
.... ......||+.|+|||++.++.++.++|||||||++|||++|+.||........ .......+....
T Consensus 168 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~~~~~~----- 236 (293)
T d1yhwa1 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLIATNGTPEL----- 236 (293)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHHCSCCC-----
T ss_pred cccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-----HHHHHhCCCCCC-----
Confidence 4332 33456799999999999999999999999999999999999999975443211 111111111100
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.||.+|||+.|++++
T Consensus 237 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112233567889999999999999999999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=410.68 Aligned_cols=246 Identities=25% Similarity=0.365 Sum_probs=197.9
Q ss_pred eeeeccCcEEEEEEEEcC---CcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEEE
Q 036081 294 NLIGQGASGVVYKGTLED---GTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLVY 368 (614)
Q Consensus 294 ~~LG~G~fG~Vykg~~~~---g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV~ 368 (614)
++||+|+||+||+|.+++ ++.||||+++... ....++|.+|++++++++|||||+++|+|.. +..+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 579999999999998753 4689999996532 2335679999999999999999999999852 3468999
Q ss_pred ecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccCC
Q 036081 369 DFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEG 448 (614)
Q Consensus 369 Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 448 (614)
||+++|+|.+++.. ...++|.++++|+.|||+||+||| +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 99999999999865 457999999999999999999999 889999999999999999999999999999876543
Q ss_pred Ccc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhH
Q 036081 449 QSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDE 525 (614)
Q Consensus 449 ~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 525 (614)
... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||......+ .... ...+...
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-----~~~~-i~~~~~~----- 229 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAM-LEKGERM----- 229 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHH-HHTTCCC-----
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-----HHHH-HHcCCCC-----
Confidence 332 2334678999999999999999999999999999999998 899997654321 1111 1122111
Q ss_pred HhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 526 FIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 526 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..+...+..+.+++..|++.||++|||+++|+++|+.
T Consensus 230 ----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 ----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1122234577889999999999999999999998875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=417.29 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=204.2
Q ss_pred CCCccceeeeccCcEEEEEEEEcC-C-----cEEEEEEeecC-CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED-G-----TLVAVKQITDL-DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~-g-----~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
++|...+.||+|+||+||+|++.. + ..||||++... .......|.+|+.++.++ +|||||+++|++.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~----- 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----- 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe-----
Confidence 568888999999999999998753 2 36999998653 334456799999999999 8999999999997
Q ss_pred CCceEEEEEecCCCCCcccccchhhh--------------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEec
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALT--------------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHR 419 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~--------------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHr 419 (614)
..+..++||||+++|+|.++|..... ...++|..++.|+.||+.||+||| +.+||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 34568999999999999999965321 235899999999999999999999 8899999
Q ss_pred CCCCCceeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 036081 420 DIKSTNILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLE 497 (614)
Q Consensus 420 DIKp~NILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~ 497 (614)
||||+|||++.++++||+|||+|+........ ......||+.|||||.+.++.++.++|||||||+||||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 2345678999999999999999999999999999999998 899997
Q ss_pred CCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 036081 498 TSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLE 565 (614)
Q Consensus 498 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~ 565 (614)
........ . .....+. +...+....+.+.+++..|++.||++|||++||+++|.
T Consensus 269 ~~~~~~~~-~----~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANF-Y----KLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHH-H----HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHH-H----HHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 65433211 1 1111111 01112223457888999999999999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=410.07 Aligned_cols=257 Identities=20% Similarity=0.302 Sum_probs=193.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+. .....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence 46888999999999999999975 689999999875432 2345689999999999999999999988632 23468
Q ss_pred EEEEecCCCCCcccccchhh-hccCCCccchhHHHHHHHHHHHHHHhcC--CCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNAL-TRKQLAWPQRKKIILDVAKGLAYLHYGL--KPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~--~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
++||||+++|+|.+++.+.. .+..+++..++.++.||+.||.|||+.. ..+|+||||||+||||+.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999999999999987543 3467999999999999999999999421 24599999999999999999999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
++...... .......||+.|||||++.+..++.++|||||||++|||+||+.||...+... .... ...+....
T Consensus 161 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-----~~~~-i~~~~~~~ 233 (269)
T d2java1 161 ARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGK-IREGKFRR 233 (269)
T ss_dssp HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHH-HHHTCCCC
T ss_pred eeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-----HHHH-HHcCCCCC
Confidence 98764432 23345689999999999999999999999999999999999999997644321 1111 11121111
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.+....+.+.+++..|++.||.+|||+.|++++
T Consensus 234 ---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111233467889999999999999999999763
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=406.00 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=205.2
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
.|+..+.||+|+||+||+|+.. +|+.||||+++....+..+.|.+|++++++++|||||++++++. +.+..++|
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~lv 87 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL 87 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEEE
Confidence 5788899999999999999976 68999999998766666788999999999999999999999987 45678999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++.+. .+.+++.++..++.||+.||.||| +.+|+||||||+|||++.++++||+|||+|+....
T Consensus 88 mEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999999987652 456999999999999999999999 89999999999999999999999999999976432
Q ss_pred CCccccccccCCCCccchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 448 GQSHLTTRVAGTYGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
.. .......||+.|+|||++. ...|+.++|||||||++|||++|+.||.......... ....... ...
T Consensus 163 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-----~i~~~~~-~~~ 235 (288)
T d2jfla1 163 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-----KIAKSEP-PTL 235 (288)
T ss_dssp HH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HHHHSCC-CCC
T ss_pred Cc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH-----HHHcCCC-CCC
Confidence 21 1233467999999999984 4568999999999999999999999997655432211 1111110 000
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..+......+.+++..|++.||++|||+.|++++
T Consensus 236 -------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 -------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112233467889999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=397.93 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=197.8
Q ss_pred ccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 291 SQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
...++||+|+||+||+|+.. +++.||+|++.... ....+.|.+|++++++++|||||++++++..... .....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc-cCCEEEEE
Confidence 44568999999999999976 58899999987532 2335679999999999999999999999864322 34678999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCc--eEecCCCCCceeec-CCCcEEEeeeccccc
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPA--IYHRDIKSTNILLD-SEMKAKVADFGLAKQ 444 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~--ivHrDIKp~NILLd-~~~~~KL~DFGla~~ 444 (614)
|||+++|+|.+++.+ ...+++..++.++.||++||+||| +.+ |+||||||+||||+ +++.+||+|||+++.
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999999865 457999999999999999999999 666 99999999999996 578999999999985
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
.... ......||+.|||||.+.+ .++.++|||||||++|||++|+.||......... ......+.....++
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~-----~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKPASFD 235 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHTTTCCCGGGG
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH-----HHHHHcCCCCcccC
Confidence 4322 2345689999999998864 6999999999999999999999999754432111 11112221111111
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ....+.+++..|++.||++|||+.|++++
T Consensus 236 ----~~----~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 ----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----cc----CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 22357789999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=414.83 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=205.5
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC-CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD-TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
..++|+..+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|++++++++|||||++++++. +...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 3567999999999999999999975 68999999997543 333567999999999999999999999997 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.+ .+.+++..+..++.|++.||.|||+ .++|+||||||+||||+.++++||+|||+|+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EEEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 9999999999999999975 3579999999999999999999993 2489999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHH---HH---------
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDW---AW--------- 511 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~---~~--------- 511 (614)
..... ..+..+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+......... ..
T Consensus 154 ~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 154 QLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred ccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 65332 2334689999999999999999999999999999999999999997654332110000 00
Q ss_pred --------H----HhhCCCchhhhhHHhhhh----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 512 --------M----LANSGKVDEIFDEFIREE----GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 512 --------~----~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ........+..+...... ........+.+++..|++.||.+|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 000001111111111110 001123467889999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-49 Score=408.33 Aligned_cols=265 Identities=24% Similarity=0.389 Sum_probs=211.0
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccc
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCC 353 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~ 353 (614)
.+++...++|+..+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345556678999999999999999999864 3578999999764333 356799999999999999999999999
Q ss_pred cccCCCCCceEEEEEecCCCCCcccccchhh---------------------hccCCCccchhHHHHHHHHHHHHHHhcC
Q 036081 354 VSSDDEKGKRRFLVYDFMPSGSLGDHISNAL---------------------TRKQLAWPQRKKIILDVAKGLAYLHYGL 412 (614)
Q Consensus 354 ~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~ 412 (614)
. .....++||||+++|+|.+++.... ....++|..++.|+.|++.||+|||
T Consensus 86 ~-----~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--- 157 (301)
T d1lufa_ 86 A-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--- 157 (301)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred c-----cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---
Confidence 7 3456899999999999999986421 1235889999999999999999999
Q ss_pred CCceEecCCCCCceeecCCCcEEEeeecccccccCCC-ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh
Q 036081 413 KPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS 491 (614)
Q Consensus 413 ~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt 491 (614)
+.+||||||||+|||||.++++||+|||+++...... ....+...||+.|+|||.+.+..++.|+|||||||++|||++
T Consensus 158 ~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 158 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 8999999999999999999999999999998654332 223345678999999999999999999999999999999999
Q ss_pred CC-CCCCCCCccchhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 492 GR-KVLETSNSSFLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 492 G~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
|. .||......+ ..+. ...+...+ .+...+.++.+++..|++.+|++||||.||+++|+...
T Consensus 238 ~~~~p~~~~~~~e-----~~~~-v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 238 YGLQPYYGMAHEE-----VIYY-VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTCCTTTTSCHHH-----HHHH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCCCCCHHH-----HHHH-HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 96 5666543321 1111 12222211 12223457889999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=405.52 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=201.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCc----EEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGT----LVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~ 361 (614)
.+|+..++||+|+||+||+|++. +|+ .||||+++.. +.+..++|.+|++++++++|||||+++|+|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 35889999999999999999875 344 6899988653 34456789999999999999999999999963
Q ss_pred ceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 362 KRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 362 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
+..++++||+.+|+|.+++.. ....++|..+++|+.|||+||+||| +++|+||||||+||||+.++++||+|||+
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred CCeeEEEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccc
Confidence 346889999999999988765 3567999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 442 AKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 442 a~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
++........ ......||+.|+|||++.++.++.++|||||||+||||+| |+.||........ ...+ ..+.
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~~~i----~~~~- 230 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSIL----EKGE- 230 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--HHHH----HHTC-
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--HHHH----HcCC-
Confidence 9976544333 2344578999999999999999999999999999999999 7888876543321 1111 1111
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
+...+....+.+.+++..|++.||.+|||+.|++++|+..
T Consensus 231 --------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 0011222345788899999999999999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=402.73 Aligned_cols=248 Identities=19% Similarity=0.242 Sum_probs=201.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++. +.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence 45889999999999999999975 6999999998642 2234567999999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. .+.+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccce
Confidence 8999999999999998765 467999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCC-ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 444 QSLEGQ-SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 444 ~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
...... ........||+.|+|||++.+..++.++|||||||+||||++|+.||...+.... ... ...+...
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~-i~~~~~~-- 228 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQK-IIKLEYD-- 228 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHH-HHTTCCC--
T ss_pred ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-----HHH-HHcCCCC--
Confidence 764332 2234456899999999999999999999999999999999999999976542211 111 1111110
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALK 562 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~ 562 (614)
.+......+.+++..|++.||.+|||++|++.
T Consensus 229 --------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 --------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11223346788999999999999999998643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=399.08 Aligned_cols=253 Identities=20% Similarity=0.308 Sum_probs=195.0
Q ss_pred CCCccceeeeccCcEEEEEEEEcC----CcEEEEEEeecCCCc-chHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED----GTLVAVKQITDLDTK-GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|+..+.||+|+||.||+|++.. +..||||.++..... ..+.|.+|++++++++|||||+++|++. .+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------SS
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cC
Confidence 468888999999999999998752 457999998654433 3567999999999999999999999985 23
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. ....++|..++.++.||++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred eEEEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhh
Confidence 57999999999999998765 3457999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
+..........+...||+.|+|||.+.++.++.++|||||||++|||++ |+.||......... .. ...+...
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~--~~----i~~~~~~- 228 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GR----IENGERL- 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HH----HHTTCCC-
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH--HH----HHcCCCC-
Confidence 8765555555566788999999999999999999999999999999998 88898765443211 11 1112111
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..+...++.+.+++..|++.||++|||+.||+++|+.
T Consensus 229 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122234578889999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=396.56 Aligned_cols=249 Identities=29% Similarity=0.404 Sum_probs=196.4
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
++|+..+.||+|+||.||+|+++ |+.||||++++. ...+.|.+|++++++++||||++++|+|.+. .+..++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEEE
Confidence 35677889999999999999996 889999999653 3457799999999999999999999998642 2347999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.++|... ....++|..+++|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999999763 2346899999999999999999999 89999999999999999999999999999986432
Q ss_pred CCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCCCchhhhhHH
Q 036081 448 GQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSGKVDEIFDEF 526 (614)
Q Consensus 448 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 526 (614)
. .....+|..|+|||++.++.++.++||||||+++|||+| |+.|+....... +..++ ..+...
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i----~~~~~~------ 219 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV----EKGYKM------ 219 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHH----TTTCCC------
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCCCC------
Confidence 2 233467899999999999999999999999999999998 677776544322 11111 111111
Q ss_pred hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 527 IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 527 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
..+......+.+++..|++.||.+||||.|++++|+.
T Consensus 220 ---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 220 ---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1122233477889999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-47 Score=405.18 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=206.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++. +.+..++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 57999999999999999999975 69999999997665555678999999999999999999999987 4567999
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec--CCCcEEEeeeccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD--SEMKAKVADFGLAKQ 444 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd--~~~~~KL~DFGla~~ 444 (614)
||||+++|+|.+++.+. ...+++..++.|+.||+.||.||| +.+||||||||+|||++ .++.+||+|||+++.
T Consensus 101 vmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 101 IYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999999998652 456999999999999999999999 89999999999999995 467899999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh-CCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN-SGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~~ 523 (614)
..... ......||+.|||||++.+..++.++|||||||++|||++|+.||...+.... ...... .......
T Consensus 176 ~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~~~~~~~~~- 247 (350)
T d1koaa2 176 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----LRNVKSCDWNMDDS- 247 (350)
T ss_dssp CCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHTCCCSCCG-
T ss_pred ccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCCCCCcc-
Confidence 64432 23446799999999999999999999999999999999999999975543211 111111 1111110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
....+.+.+.+++..|++.||.+|||+.|++++
T Consensus 248 -------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 -------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011223467889999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=401.35 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=197.7
Q ss_pred hCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccccCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~ 358 (614)
.++|...+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--- 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc---
Confidence 356888999999999999999864 246899999975433 3356788999999888 68999999998864
Q ss_pred CCCceEEEEEecCCCCCcccccchhhh-------------ccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCc
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALT-------------RKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTN 425 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~N 425 (614)
.+...++||||+++|+|.++|..... ...++|.+++.++.||++||.||| +.+|+||||||+|
T Consensus 89 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~N 164 (299)
T d1ywna1 89 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 164 (299)
T ss_dssp -TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred -CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccc
Confidence 33468999999999999999975321 235899999999999999999999 8999999999999
Q ss_pred eeecCCCcEEEeeecccccccCCCcc-ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCccc
Q 036081 426 ILLDSEMKAKVADFGLAKQSLEGQSH-LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR-KVLETSNSSF 503 (614)
Q Consensus 426 ILLd~~~~~KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~-~p~~~~~~~~ 503 (614)
|||++++++||+|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||+||. .||.......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999875443332 344568999999999999999999999999999999999975 5676543322
Q ss_pred hhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 504 LLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 504 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
... .....+... ..+......+.+++..|++.||++|||+.|++++|++
T Consensus 245 ~~~-----~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 245 EFC-----RRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHH-----HHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-----HHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 111111111 1112233467889999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=405.61 Aligned_cols=245 Identities=29% Similarity=0.400 Sum_probs=199.0
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc---chHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK---GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++. +.+..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCEE
Confidence 4888899999999999999975 6899999999754332 2356889999999999999999999987 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+++|+|..++.. ++.+++.+++.++.||+.||.||| +.+|+||||||+||||+.++++||+|||+++.
T Consensus 91 ~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence 999999999998765543 467999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCccccccccCCCCccchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
... .....||+.|||||++.+ +.|+.++|||||||++|||++|+.||........ ......... ..
T Consensus 165 ~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~i~~~~~-~~ 233 (309)
T d1u5ra_ 165 MAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNES-PA 233 (309)
T ss_dssp SSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCC-CC
T ss_pred cCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhCCC-CC
Confidence 433 234579999999999863 5689999999999999999999999975442211 111111111 10
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. .+....+.+.+++..|++.||.+|||+.|++++
T Consensus 234 ~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 L--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp C--------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C--------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 0 111223467889999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=399.90 Aligned_cols=252 Identities=29% Similarity=0.432 Sum_probs=200.8
Q ss_pred ceeeeccCcEEEEEEEEcCC----cEEEEEEeecC-CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEEE
Q 036081 293 KNLIGQGASGVVYKGTLEDG----TLVAVKQITDL-DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFLV 367 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g----~~vAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~LV 367 (614)
.++||+|+||+||+|++.++ ..||||+++.. +....++|.+|++++++++||||++++|++... ....++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEE
Confidence 46899999999999997542 36899999753 333457899999999999999999999998642 3468999
Q ss_pred EecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccccC
Q 036081 368 YDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQSLE 447 (614)
Q Consensus 368 ~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 447 (614)
|||+++|+|.+++... ...++|..+++++.|+|+||.||| +.+|+||||||+|||||+++.+||+|||+++....
T Consensus 108 ~E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 9999999999988653 456788899999999999999999 89999999999999999999999999999987654
Q ss_pred CCcc---ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 448 GQSH---LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 448 ~~~~---~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
.... ......||+.|+|||.+..+.++.++||||||+++|||+||+.|+......... .... ..+...
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~----~~~i-~~g~~~---- 253 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----TVYL-LQGRRL---- 253 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C----HHHH-HTTCCC----
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH----HHHH-HcCCCC----
Confidence 3322 233467899999999999999999999999999999999988887653322111 1111 112111
Q ss_pred HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 525 EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 525 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
..+....+.+.+++..|++.||++||||.||+++|++.
T Consensus 254 -----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 01122334678899999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-48 Score=400.41 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=189.6
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.+.|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++. +++..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 356888999999999999999976 689999999975432 23456889999999999999999999987 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec---CCCcEEEeeecc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD---SEMKAKVADFGL 441 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd---~~~~~KL~DFGl 441 (614)
++||||+++|+|.+++.. .+.+++.+...++.||+.||+||| +.+|+||||||+|||+. +++.+||+|||+
T Consensus 83 ~lvmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEEEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccce
Confidence 999999999999999865 467999999999999999999999 89999999999999994 578999999999
Q ss_pred cccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 442 AKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 442 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
++...... .....+||+.|||||.+.++.++.++|||||||+||||++|+.||....... ....... +...
T Consensus 157 a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~~~~i~~-~~~~- 227 (307)
T d1a06a_ 157 SKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-----LFEQILK-AEYE- 227 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHT-TCCC-
T ss_pred eEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHhc-cCCC-
Confidence 98654332 2344679999999999999999999999999999999999999997644321 1111111 1110
Q ss_pred hhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 522 IFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 522 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ........+.+.+++..|++.||++|||+.|++++
T Consensus 228 -~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 -FD----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -CC----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CC----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 00112233567889999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=388.84 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=204.1
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC------cchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT------KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~------~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
+.|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.|.+|++++++++|||||++++++. +
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence 56889999999999999999975 699999999864321 23567999999999999999999999987 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC----cEEE
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM----KAKV 436 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~KL 436 (614)
....++||||+++|+|.+++.. .+.+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+||
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred CCEEEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEe
Confidence 5679999999999999999865 357999999999999999999999 89999999999999998776 5999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.... .... ..
T Consensus 159 ~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~i-~~ 230 (293)
T d1jksa_ 159 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANV-SA 230 (293)
T ss_dssp CCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHH-HT
T ss_pred cchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-----HHHH-Hh
Confidence 9999998764332 23445789999999999999999999999999999999999999976543221 1111 11
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
+... ...... ......+.+++..|++.||.+|||++|++++
T Consensus 231 ~~~~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 231 VNYE--FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TCCC--CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCC--CCchhc----CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1110 000111 1123467789999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=396.00 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=196.1
Q ss_pred CCCccceeeeccCcEEEEEEEEcC--C--cEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED--G--TLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~--g--~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
++|+..+.||+|+||.||+|++.. + ..||||+++.. ..+..++|.+|++++++++|||||+++|++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 457888999999999999998642 2 37899998653 23335689999999999999999999999962
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
+..++||||+++|+|.+++... ...++|..+++++.|||+||.||| +++|+||||||+||||+.++++||+|||
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred -cchheeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccch
Confidence 2468999999999999887653 457999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCcc--ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccchhHHHHHHHHhhCC
Q 036081 441 LAKQSLEGQSH--LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSSFLLITDWAWMLANSG 517 (614)
Q Consensus 441 la~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 517 (614)
+++........ ......||..|+|||.+.+..++.++|||||||++|||+| |+.||...+... ........+
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----~~~~i~~~~ 231 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKEG 231 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTSC
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-----HHHHHHhCC
Confidence 99976544332 2334568899999999999999999999999999999998 899997544321 122222222
Q ss_pred CchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 518 KVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 518 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
...+ .+...+..+.+++..|++.||++|||+.||+++|++
T Consensus 232 ~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 ERLP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111 112223467889999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=398.50 Aligned_cols=248 Identities=22% Similarity=0.292 Sum_probs=205.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||.||+++.+ +|+.||||++++. .....+.+.+|+++|++++||||+++++++. +...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----cccc
Confidence 56889999999999999999975 7999999999742 2234567899999999999999999999997 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|.+++.. ...+++...+.++.||+.||+||| +.+|+||||||+|||++.+|.+||+|||+|+
T Consensus 80 ~~iv~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~ 153 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred cccceeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccc
Confidence 9999999999999998875 457889999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.... .... ..+..
T Consensus 154 ~~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~~i-~~~~~---- 222 (337)
T d1o6la_ 154 EGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELI-LMEEI---- 222 (337)
T ss_dssp CSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHH-HHCCC----
T ss_pred ccccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-----HHHH-hcCCC----
Confidence 654322 234456899999999999999999999999999999999999999976543221 1111 11111
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
..+......+.+++..|++.||.+||+ +.|++++
T Consensus 223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 011223346778999999999999995 8888764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.5e-47 Score=401.62 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=208.7
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++. +....++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 46899999999999999999975 69999999997655555667899999999999999999999987 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec--CCCcEEEeeeccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD--SEMKAKVADFGLAKQ 444 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd--~~~~~KL~DFGla~~ 444 (614)
||||+++|+|.+++... ...+++.+.+.|+.||+.||+||| +.+|+||||||+||||+ .++.+||+|||+|+.
T Consensus 104 vmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeeccccee
Confidence 99999999998877552 346999999999999999999999 89999999999999998 678999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhh-CCCchhhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLAN-SGKVDEIF 523 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~~ 523 (614)
..... ......||+.|+|||++.+..++.++|||||||+||||+||+.||........ ...... ......
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~~~~~~-- 249 (352)
T d1koba_ 179 LNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-----LQNVKRCDWEFDE-- 249 (352)
T ss_dssp CCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----HHHHHHCCCCCCS--
T ss_pred cCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCCCCCc--
Confidence 65433 23456799999999999999999999999999999999999999976443211 111111 111110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcC
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGD 567 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~~ 567 (614)
.........+.+++..|++.||.+|||+.|++++ +++.
T Consensus 250 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 ------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 0111233467889999999999999999999986 6553
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=394.06 Aligned_cols=266 Identities=26% Similarity=0.298 Sum_probs=199.1
Q ss_pred CCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHH--HHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEV--EIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei--~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
.|...+.||+|+||.||+|+++ |+.||||+++.. ..+.+..|. ..+.+++|||||+++|+|...+. .....++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC-cceEEEE
Confidence 4566789999999999999985 899999998642 233444444 44557899999999999975432 3457899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhc-----CCCceEecCCCCCceeecCCCcEEEeeecc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYG-----LKPAIYHRDIKSTNILLDSEMKAKVADFGL 441 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~-----~~~~ivHrDIKp~NILLd~~~~~KL~DFGl 441 (614)
||||+++|+|.++|++ ..++|.++++++.|+|.||+|||.. .+++|+||||||+|||||.++++||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999964 4699999999999999999999942 147999999999999999999999999999
Q ss_pred cccccCCCcc---ccccccCCCCccchhhhccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCccch--------
Q 036081 442 AKQSLEGQSH---LTTRVAGTYGYLAPEYALYGQ------LTEKSDVYSFGIVILELMSGRKVLETSNSSFL-------- 504 (614)
Q Consensus 442 a~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~~------~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~-------- 504 (614)
++........ ......||+.|+|||++.+.. ++.|+|||||||+||||+||+.|+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9876443322 234568999999999987543 57799999999999999999988754332210
Q ss_pred -hHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 505 -LITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 505 -~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
............+.....+.. .....+..+.+.+++..|++.||.+|||+.||+++|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 000111111111111111111 11123455678899999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=397.14 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=201.0
Q ss_pred CCCccceeeeccCcEEEEEEEEcC-Cc--EEEEEEeecC-CCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED-GT--LVAVKQITDL-DTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~vAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|+..+.||+|+||+||+|++++ |. .||||+++.. ..+..++|.+|++++.++ +|||||+++|+|. .++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cCC
Confidence 467788999999999999999863 44 5788988653 333456899999999999 7999999999997 456
Q ss_pred eEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec
Q 036081 363 RRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD 429 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd 429 (614)
..++||||+++|+|.++|+... ....++|.++++++.|||+||.||| +.+|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEc
Confidence 7999999999999999986531 2357999999999999999999999 89999999999999999
Q ss_pred CCCcEEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCccchhHHH
Q 036081 430 SEMKAKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK-VLETSNSSFLLITD 508 (614)
Q Consensus 430 ~~~~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~-p~~~~~~~~~~l~~ 508 (614)
.++.+||+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|.. ||...+.. +
T Consensus 162 ~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-----~ 234 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E 234 (309)
T ss_dssp GGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H
T ss_pred CCCceEEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-----H
Confidence 9999999999999854322 22234568999999999999999999999999999999999765 56543321 1
Q ss_pred HHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCC
Q 036081 509 WAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDI 568 (614)
Q Consensus 509 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~ 568 (614)
.... ...+.. ...+....+.+.+++..|++.||++||||.||+++|+...
T Consensus 235 ~~~~-i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 235 LYEK-LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHHH-GGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH-HHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 111110 1112223457888999999999999999999999988743
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-46 Score=391.09 Aligned_cols=245 Identities=25% Similarity=0.310 Sum_probs=202.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|+.++++++|||||++++++. +...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 46888999999999999999975 6999999999642 2234567999999999999999999999987 4568
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+++|+|..++.. ...+++.....++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+|+
T Consensus 79 ~~ivmE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~ 152 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK 152 (316)
T ss_dssp EEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred eeeEeeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccce
Confidence 9999999999999888765 456888899999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .....||+.|||||++.+..++.++|||||||+||||++|+.||...+.... ...... +..
T Consensus 153 ~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~i~~-~~~---- 218 (316)
T d1fota_ 153 YVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILN-AEL---- 218 (316)
T ss_dssp ECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHH-CCC----
T ss_pred Eeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-----HHHHHc-CCC----
Confidence 75432 2346899999999999999999999999999999999999999976543211 111111 110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
..+....+.+.+++..|++.||.+|| |++|++++
T Consensus 219 ------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 01122334677899999999999996 89999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=394.78 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=206.4
Q ss_pred CCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccccCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~ 359 (614)
++|+..+.||+|+||.||+|++. +++.||||+++.... ....+|.+|+.++.++ +|||||+++|+|.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~----- 97 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----- 97 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe-----
Confidence 56788899999999999999863 467899999976443 3345799999999999 6999999999997
Q ss_pred CCceEEEEEecCCCCCcccccchhh---------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNAL---------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~---------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~ 424 (614)
.....++||||+++|+|.++++... ....+++..+++++.||++||+||| +.+|+||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccc
Confidence 3456899999999999999987532 1235889999999999999999999 899999999999
Q ss_pred ceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcc
Q 036081 425 NILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR-KVLETSNSS 502 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~-~p~~~~~~~ 502 (614)
|||++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|++ +|+......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433 3344568899999999999999999999999999999999955 445443322
Q ss_pred chhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 503 FLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 503 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. .+...+ ..+ .....+......+.+++..|++.||.+||||.||+++|++.
T Consensus 255 ~-~~~~~i----~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 S-KFYKMI----KEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp H-HHHHHH----HHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-HHHHHH----hcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 111111 111 11111222345788999999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=393.94 Aligned_cols=260 Identities=20% Similarity=0.382 Sum_probs=208.4
Q ss_pred hCCCccceeeeccCcEEEEEEEEc------CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE------DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~ 359 (614)
-++|...+.||+|+||+||+|.++ +++.||||+++.... +....|.+|++++++++|||||+++|+|.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~----- 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-----
Confidence 457788899999999999999874 357899999975433 33456899999999999999999999997
Q ss_pred CCceEEEEEecCCCCCcccccchhh-------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNAL-------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~-------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 432 (614)
.....++||||+++|+|.+++.... ....++|..+.+++.|+|+||.||| +.+|+||||||+|||+|+++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence 3456899999999999999986532 1234788999999999999999999 88999999999999999999
Q ss_pred cEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCccchhHHHHH
Q 036081 433 KAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR-KVLETSNSSFLLITDWA 510 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~-~p~~~~~~~~~~l~~~~ 510 (614)
++||+|||+++....... .......||+.|+|||.+.++.++.++||||||++||||+||+ .|+......+ +.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-----~~ 245 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-----VL 245 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----HH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-----HH
Confidence 999999999986644332 2234457899999999999999999999999999999999985 6665433221 11
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCCC
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGDID 569 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~~~ 569 (614)
... ..+...+ .+......+.+++..|++.+|++||||.+|+++|++..+
T Consensus 246 ~~i-~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 RFV-MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHH-HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH-HhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 1221111 112233578899999999999999999999999998644
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-46 Score=384.46 Aligned_cols=261 Identities=21% Similarity=0.271 Sum_probs=202.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC---cchHHHHHHHHHHHHccCCCcccccccccccCCCCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT---KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
.++|...+.||+|+||+||+|+.. +|+.||||+++.... +..+.|.+|++++++++||||+++++++...+. .+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~-~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS-SSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC-CCc
Confidence 467899999999999999999975 799999999975432 234578999999999999999999999875433 345
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. .+.+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++..+|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhh
Confidence 68999999999999988765 467999999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCC--ccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 443 KQSLEGQ--SHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 443 ~~~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||....... ........+...
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPIP 233 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-----HHHHHHhcCCCC
Confidence 7543322 223445689999999999999999999999999999999999999997654321 122222222111
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhc
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRP-TIADALKMLEG 566 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-tm~eVl~~L~~ 566 (614)
. ........+.+.+++..|++.||.+|| |++++++.|..
T Consensus 234 ~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0 001112335788899999999999999 89999887754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=391.66 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=202.5
Q ss_pred CCCccceeeeccCcEEEEEEEEcC--------CcEEEEEEeecCCC-cchHHHHHHHHHHHHc-cCCCcccccccccccC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLED--------GTLVAVKQITDLDT-KGDEEFINEVEIISKI-RHRNLLSLRGCCVSSD 357 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~--------g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~ 357 (614)
++|...+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++|+|.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~--- 89 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--- 89 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc---
Confidence 457788999999999999998632 35799999976443 3357899999999999 8999999999997
Q ss_pred CCCCceEEEEEecCCCCCcccccchhh-------------hccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 036081 358 DEKGKRRFLVYDFMPSGSLGDHISNAL-------------TRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKST 424 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~ 424 (614)
+....++||||+++|+|.++|.... ....++|.++++++.||+.||+||| +.+||||||||+
T Consensus 90 --~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~ 164 (299)
T d1fgka_ 90 --QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 164 (299)
T ss_dssp --SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred --cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccc
Confidence 3456899999999999999996532 1245899999999999999999999 899999999999
Q ss_pred ceeecCCCcEEEeeecccccccCCCc-cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 036081 425 NILLDSEMKAKVADFGLAKQSLEGQS-HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLETSNSS 502 (614)
Q Consensus 425 NILLd~~~~~KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~ 502 (614)
|||++.++.+||+|||+++....... .......||+.|+|||.+.++.|+.|+|||||||++|||++ |+.||......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999987654332 23445678999999999999999999999999999999998 67888654432
Q ss_pred chhHHHHHHHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 503 FLLITDWAWMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 503 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
. +...+..+... ..+....+.+.+++.+|++.||.+|||+.||+++|++.
T Consensus 245 ~------~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 E------LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp H------HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H------HHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 11122222111 11122335788999999999999999999999999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.9e-46 Score=378.69 Aligned_cols=251 Identities=28% Similarity=0.375 Sum_probs=203.2
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc---------chHHHHHHHHHHHHcc-CCCccccccccccc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK---------GDEEFINEVEIISKIR-HRNLLSLRGCCVSS 356 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~---------~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~ 356 (614)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++ ||||+++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-- 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence 57889999999999999999975 7999999999754321 1245889999999997 999999999997
Q ss_pred CCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEE
Q 036081 357 DDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKV 436 (614)
Q Consensus 357 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL 436 (614)
+.+..++||||+++|+|.++|.. +..+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 81 ---~~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl 151 (277)
T d1phka_ 81 ---TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL 151 (277)
T ss_dssp ---CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred ---cCcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEE
Confidence 45679999999999999999975 457999999999999999999999 899999999999999999999999
Q ss_pred eeecccccccCCCccccccccCCCCccchhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Q 036081 437 ADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALY------GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA 510 (614)
Q Consensus 437 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~ 510 (614)
+|||+++...... ..+...||+.|+|||++.+ ..++.++||||+||+||||++|+.||........ .
T Consensus 152 ~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-----~ 224 (277)
T d1phka_ 152 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-----L 224 (277)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----H
T ss_pred ccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-----H
Confidence 9999998765433 2345689999999999863 3578899999999999999999999986543211 1
Q ss_pred HHHhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 511 WMLANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 511 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... ..+...- .........+.+.+++..|++.+|++|||+.||+++
T Consensus 225 ~~i-~~~~~~~------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 RMI-MSGNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHH-HHTCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHH-HhCCCCC------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 1111110 000111233578889999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=384.36 Aligned_cols=258 Identities=25% Similarity=0.254 Sum_probs=194.0
Q ss_pred cceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCc-----chHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 292 QKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTK-----GDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 292 ~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-----~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
..++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++. ..+..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence 3578999999999999975 6999999998643221 1346899999999999999999999997 445689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+||||++++++...+.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ivmE~~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp EEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred ehhhhhcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCcccccc
Confidence 99999998877665543 467999999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... .....+||+.|+|||.+..+ .++.++|||||||++|||++|+.||........ +...... ..........+
T Consensus 151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~-~~~~~~~~~~~ 227 (299)
T d1ua2a_ 151 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFET-LGTPTEEQWPD 227 (299)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHH-HCCCCTTTSSS
T ss_pred CCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHh-cCCCChhhccc
Confidence 44322 23345799999999998754 679999999999999999999999976543221 1111111 10000000000
Q ss_pred H-------Hh---h----hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 E-------FI---R----EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~-------~l---~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. .. . ........+.+.+++..|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 00 0 00001123468889999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-45 Score=385.69 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=202.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
++|+..+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|++++++++|||||++++++. ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence 46889999999999999999975 6999999998642 2233567899999999999999999999987 4567
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+.+|+|.+++.. .+.+++.+.+.++.||+.||.||| +.+||||||||+||||+.++++||+|||+|+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cccccccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence 8999999999999999865 457999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIF 523 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 523 (614)
..... .....||+.|||||++.+..++.++|||||||+||||+||+.||...+... ....... +...
T Consensus 190 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~i~~-~~~~--- 256 (350)
T d1rdqe_ 190 RVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----IYEKIVS-GKVR--- 256 (350)
T ss_dssp ECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCCC---
T ss_pred ecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-----HHHHHhc-CCCC---
Confidence 75432 234679999999999999999999999999999999999999997643221 1111111 1110
Q ss_pred hHHhhhhCcHHHHHHHHHHHHHccccCCCCC-----CCHHHHHHH
Q 036081 524 DEFIREEGSRAVMERFVRVGILCAHVMVALR-----PTIADALKM 563 (614)
Q Consensus 524 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R-----Ptm~eVl~~ 563 (614)
.+......+.+++..|++.||.+| ||++|++++
T Consensus 257 -------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 -------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111233467889999999999999 489999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-45 Score=391.70 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=196.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC---CcchHHHHHH---HHHHHHccCCCcccccccccccCCCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD---TKGDEEFINE---VEIISKIRHRNLLSLRGCCVSSDDEK 360 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E---i~il~~l~H~NIv~l~g~~~~~~~~~ 360 (614)
++|+..+.||+|+||.||+|+.. +|+.||||++.... .+....+.+| +++++.++|||||++++++. .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence 57899999999999999999976 69999999986421 1223345555 55566667999999999987 4
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
.+..++||||+++|+|.++|.+ ...+++..++.++.||+.||.||| +.+||||||||+||||+.++.+||+|||
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFG 152 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 152 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred CCEEEEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeec
Confidence 5678999999999999999875 457889999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCc
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKV 519 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 519 (614)
+|+...... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||......... .... .......
T Consensus 153 la~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~-~~~~~~~ 226 (364)
T d1omwa3 153 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDR-MTLTMAV 226 (364)
T ss_dssp TCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHH-HSSSCCC
T ss_pred eeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-hcccCCC
Confidence 998764432 334579999999999975 46899999999999999999999999765433211 0110 1011100
Q ss_pred hhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036081 520 DEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPT-----IADALKM 563 (614)
Q Consensus 520 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~eVl~~ 563 (614)
..+......+.+++..|++.||.+||| ++|++++
T Consensus 227 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 011123346788999999999999999 6888754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=388.05 Aligned_cols=262 Identities=20% Similarity=0.247 Sum_probs=202.3
Q ss_pred hCCCccc-eeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHc-cCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQK-NLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKI-RHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|... +.||+|+||+||+|+.. +|+.||||++++ .+.+.+|++++.++ +|||||++++++..... ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~-~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA-GRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc-CCCE
Confidence 3568765 46999999999999974 689999999864 35678899998766 89999999998864221 3467
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC---CCcEEEeeec
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS---EMKAKVADFG 440 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~KL~DFG 440 (614)
.++||||+++|+|.++|.+. ....+++.+.+.|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccc
Confidence 89999999999999999753 2346999999999999999999999 899999999999999975 5679999999
Q ss_pred ccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCch
Q 036081 441 LAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVD 520 (614)
Q Consensus 441 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 520 (614)
+++....... .....||+.|||||++.+..|+.++|||||||+||||+||+.||......... .........+...
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQYE 235 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSS
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--HHHHHHHhcCCCC
Confidence 9987654332 34567999999999999999999999999999999999999999765432210 0000001111110
Q ss_pred hhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCC
Q 036081 521 EIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGDI 568 (614)
Q Consensus 521 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~~~ 568 (614)
+. ........+.+.+++..|++.||++|||+.|++++ +.+..
T Consensus 236 --~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 236 --FP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp --CC----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred --CC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 00 00112334578889999999999999999999985 44433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=384.30 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=201.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC---CCcchHHHHHHHHHHH-HccCCCcccccccccccCCCCCc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL---DTKGDEEFINEVEIIS-KIRHRNLLSLRGCCVSSDDEKGK 362 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ei~il~-~l~H~NIv~l~g~~~~~~~~~~~ 362 (614)
++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+.+..|+.++. .++|||||++++++. +++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence 57888999999999999999986 6999999999642 1233456778888776 589999999999997 456
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+++|+|.+++.. ...+++.+.+.++.||+.||+||| +.+|+||||||+|||+++++++||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchh
Confidence 79999999999999999875 456899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI 522 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 522 (614)
+...... ...+...||+.|+|||++.++.++.++|||||||++|||++|+.||...+.... ......+..
T Consensus 151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~~~--- 220 (320)
T d1xjda_ 151 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMDNP--- 220 (320)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC---
T ss_pred hhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCC---
Confidence 8654332 234456899999999999999999999999999999999999999976543211 111111111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIA-DALK 562 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~-eVl~ 562 (614)
..+......+.+++..|++.||.+|||+. |+++
T Consensus 221 -------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01112334678899999999999999995 6754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=379.05 Aligned_cols=251 Identities=20% Similarity=0.234 Sum_probs=204.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
.++|...+.||+|+||+||+|+.. +|+.||||.++... .....+.+|+++|++++|||||++++++. +.+..+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence 467889999999999999999976 68899999997543 33456889999999999999999999987 456799
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC--CcEEEeeecccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE--MKAKVADFGLAK 443 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~--~~~KL~DFGla~ 443 (614)
+||||+++|+|.+++... ...+++.+...|+.||+.||+||| +.+|+||||||+|||++.+ ..+||+|||+++
T Consensus 78 lvmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhh
Confidence 999999999999998652 346899999999999999999999 8999999999999999854 589999999998
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCC-Cchhh
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSG-KVDEI 522 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~-~~~~~ 522 (614)
...... ......||+.|+|||...+..++.++|||||||++|||++|+.||....... ......... ...+.
T Consensus 153 ~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-----~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----IIENIMNAEYTFDEE 225 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHTCCCCCHH
T ss_pred ccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCCCCChh
Confidence 764332 2334578999999999999999999999999999999999999997654321 111111111 11111
Q ss_pred hhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. . .....+.+++..|++.||.+|||+.|++++
T Consensus 226 ~~----~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AF----K----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hc----c----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 1 123467889999999999999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=375.41 Aligned_cols=264 Identities=24% Similarity=0.315 Sum_probs=198.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++. .+...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 57889999999999999999974 69999999996432 233578999999999999999999999997 45679
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++||||+.++ +.+++... ....+++.++..++.||+.||+||| +.+||||||||+|||++.++.+||+|||+++.
T Consensus 77 ~iv~e~~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 77 YLVFEFLHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 151 (298)
T ss_dssp EEEEECCSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred eEEEeecCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCccee
Confidence 9999999754 44444322 3457999999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC-CCchhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS-GKVDEI 522 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~~ 522 (614)
..... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+...... ......... ......
T Consensus 152 ~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 152 FGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPG 229 (298)
T ss_dssp HCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCTTTSTT
T ss_pred ccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH-HHHHhcCCCchhhccc
Confidence 54332 2344457999999999887655 5789999999999999999999997654322111 111110000 000000
Q ss_pred hhH------Hhhh-------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDE------FIRE-------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~------~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
... .... .......+.+.+++..|++.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 0000 0001122467889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=378.95 Aligned_cols=270 Identities=24% Similarity=0.295 Sum_probs=203.0
Q ss_pred HhCCCccceeeeccCcEEEEEEEEc-C-CcEEEEEEeecC--CCcchHHHHHHHHHHHHc---cCCCcccccccccccCC
Q 036081 286 ATGGFSQKNLIGQGASGVVYKGTLE-D-GTLVAVKQITDL--DTKGDEEFINEVEIISKI---RHRNLLSLRGCCVSSDD 358 (614)
Q Consensus 286 at~~f~~~~~LG~G~fG~Vykg~~~-~-g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l---~H~NIv~l~g~~~~~~~ 358 (614)
..++|+..+.||+|+||+||+|+.. + ++.||||+++.. .......+.+|+++++.+ +||||+++++++.....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3468999999999999999999974 4 678999998642 222344677888888776 79999999999875544
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
......+++|||+++|++...... ....+++...+.++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence 456788999999988776544332 3456899999999999999999999 89999999999999999999999999
Q ss_pred ecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC
Q 036081 439 FGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK 518 (614)
Q Consensus 439 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 518 (614)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+... .+............
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCch
Confidence 9998764332 23445689999999999999999999999999999999999999997654322 11111111111000
Q ss_pred c--------h-hhhhHHh---hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 519 V--------D-EIFDEFI---REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 519 ~--------~-~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. . ....... .........+.+.+++..|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0 0000000 001111233467789999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=371.32 Aligned_cols=241 Identities=23% Similarity=0.330 Sum_probs=193.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC------cchHHHHHHHHHHHHcc--CCCcccccccccccC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT------KGDEEFINEVEIISKIR--HRNLLSLRGCCVSSD 357 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~------~~~~~f~~Ei~il~~l~--H~NIv~l~g~~~~~~ 357 (614)
.++|...++||+|+||+||+|+.. +|+.||||+++.... .....+.+|+.++++++ |||||++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--- 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe---
Confidence 357889999999999999999975 699999999864321 11234778999999997 999999999987
Q ss_pred CCCCceEEEEEecCCC-CCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCC-CcEE
Q 036081 358 DEKGKRRFLVYDFMPS-GSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSE-MKAK 435 (614)
Q Consensus 358 ~~~~~~~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~K 435 (614)
..+..++||||+.+ +++.+++.. +..+++.+++.++.||+.||+||| +.+|+||||||+|||++.+ +.+|
T Consensus 80 --~~~~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vk 151 (273)
T d1xwsa_ 80 --RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK 151 (273)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEE
T ss_pred --eCCeEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEE
Confidence 45678999999976 566666654 467999999999999999999999 8999999999999999854 7999
Q ss_pred EeeecccccccCCCccccccccCCCCccchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh
Q 036081 436 VADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA 514 (614)
Q Consensus 436 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~ 514 (614)
|+|||+++..... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . .
T Consensus 152 l~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i----~ 217 (273)
T d1xwsa_ 152 LIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------I----I 217 (273)
T ss_dssp ECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------H----H
T ss_pred ECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------H----h
Confidence 9999999864332 2345679999999999987766 5678999999999999999999964210 0 0
Q ss_pred hCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 515 NSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 515 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. +.. ..+......+.+++..|++.||++|||++|++++
T Consensus 218 ~-~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 R-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp H-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h-ccc----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 100 0111123467889999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-44 Score=371.00 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=198.5
Q ss_pred CCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCC--CcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLD--TKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|...+.||+|+||+||+|+.++|+.||||+++... ....+.+.+|++++++++||||+++++++. ..+..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCcee
Confidence 5788899999999999999999999999999996532 233568999999999999999999999997 456689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQS 445 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~~ 445 (614)
+++||+.++.+..+... .+.+++.++..|+.||+.||+||| +.+||||||||+|||++.++.+||+|||++...
T Consensus 77 i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (286)
T ss_dssp EEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence 99999987766666543 467999999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhh--
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEI-- 522 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~-- 522 (614)
.... .......|++.|+|||.+.. ..++.++|||||||++|||++|+.||........ +....... ........
T Consensus 151 ~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~-~~~~~~~~~~ 227 (286)
T d1ob3a_ 151 GIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRIL-GTPNSKNWPN 227 (286)
T ss_dssp CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH-CCCCTTTSTT
T ss_pred ccCc-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhh-CCCChhhccc
Confidence 4322 22334468999999999975 4568999999999999999999999976543221 11111111 11000000
Q ss_pred -hh-----HHhh-------hhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 -FD-----EFIR-------EEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 -~d-----~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. .... ..........+.+++..|++.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000 00111223467889999999999999999999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=372.85 Aligned_cols=263 Identities=26% Similarity=0.331 Sum_probs=197.1
Q ss_pred CCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCC-CCCceEEE
Q 036081 289 GFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGKRRFL 366 (614)
Q Consensus 289 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~~~~L 366 (614)
+|...++||+|+||+||+|+.. +|+.||||+++.... .+.+|++++++++|+||+++++++..... .+....+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4777889999999999999986 699999999975432 23479999999999999999999865432 24456799
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeeecccccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAKQS 445 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DFGla~~~ 445 (614)
||||+++|.+............+++.+++.++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999986644444333334567999999999999999999999 89999999999999999775 8999999999876
Q ss_pred cCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchhhhh
Q 036081 446 LEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDEIFD 524 (614)
Q Consensus 446 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 524 (614)
..... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||........ +....+.. .....+.+.
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~--g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVL--GTPTREQIR 248 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHH--CCCCHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHh--CCChHHhhh
Confidence 44332 234579999999998875 5789999999999999999999999976543221 11111110 000011110
Q ss_pred HH----------------hhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 525 EF----------------IREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 525 ~~----------------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
.. ............+.+++..|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000111233467889999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=366.95 Aligned_cols=271 Identities=21% Similarity=0.309 Sum_probs=200.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC-cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT-KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
+.+|+..++||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++||||+++++++...........
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 356889999999999999999864 799999999975433 235678999999999999999999999875443333344
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++ ++|+.+|+|.+++.. ..+++..++.++.||+.||+||| +.+||||||||+||||+.++.+||+|||+++.
T Consensus 87 ~l-~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YL-VTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EE-EEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EE-EEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55 456679999999854 46999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCc--cccccccCCCCccchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCCchh
Q 036081 445 SLEGQS--HLTTRVAGTYGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGKVDE 521 (614)
Q Consensus 445 ~~~~~~--~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 521 (614)
...... .......||+.|+|||.+. ...++.++||||+||++|||++|+.||......... ..... .........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~-~~~~~~~~~ 236 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILG-ILGSPSQED 236 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHH-HHCSCCHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HHHhh-hccCCChhh
Confidence 543322 2234567999999999985 456789999999999999999999999765432211 00110 011110000
Q ss_pred --------hhhHHhh--h--hC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcC
Q 036081 522 --------IFDEFIR--E--EG-----SRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGD 567 (614)
Q Consensus 522 --------~~d~~l~--~--~~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~~ 567 (614)
....... . .. ......++.+++..|++.||.+|||+.|++++ ++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0000000 0 00 00112367889999999999999999999986 5544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-42 Score=358.22 Aligned_cols=257 Identities=18% Similarity=0.239 Sum_probs=197.3
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcccccccccccCCCCCceEEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRRFL 366 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~~L 366 (614)
++|+..+.||+|+||+||+|++. +|+.||||++.... ..+++..|++++++++|+|++..++.+.. .+...++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence 46899999999999999999975 68999999987543 23468899999999998887777666643 4567899
Q ss_pred EEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeec---CCCcEEEeeecccc
Q 036081 367 VYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLD---SEMKAKVADFGLAK 443 (614)
Q Consensus 367 V~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd---~~~~~KL~DFGla~ 443 (614)
||||+ +|+|.+.+.. ....+++..+..++.|++.||+||| +.+|+||||||+|||++ .+..+||+|||+|+
T Consensus 81 vme~~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEc-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 99999 4566665543 2457999999999999999999999 89999999999999975 45679999999999
Q ss_pred cccCCCcc------ccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHHhh
Q 036081 444 QSLEGQSH------LTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLL--ITDWAWMLAN 515 (614)
Q Consensus 444 ~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~--l~~~~~~~~~ 515 (614)
........ ......||+.|||||.+.+..++.++|||||||++|||++|+.||......... ...+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 76543321 234467999999999999999999999999999999999999999765433211 1111100000
Q ss_pred CCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 036081 516 SGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEG 566 (614)
Q Consensus 516 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~ 566 (614)
.. .+.+.. ..+..+.+++..|++.+|++||+++++.+.|+.
T Consensus 235 -~~-----~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 -TP-----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -SC-----HHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred -CC-----hhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00 011111 223467889999999999999999998887775
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=362.93 Aligned_cols=270 Identities=21% Similarity=0.264 Sum_probs=195.5
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecC--CCcchHHHHHHHHHHHHccCCCcccccccccccCC---CC
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDL--DTKGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD---EK 360 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~---~~ 360 (614)
.++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||++++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367889999999999999999975 7999999998543 23345678999999999999999999998864321 12
Q ss_pred CceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeec
Q 036081 361 GKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFG 440 (614)
Q Consensus 361 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFG 440 (614)
....++||||++++.+...... ...++....+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecc
Confidence 4568999999988776654433 456888889999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCcc---ccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 441 LAKQSLEGQSH---LTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 441 la~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
+++........ ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ +..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~~ 241 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSI 241 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH-HHHHHHhcCCC
Confidence 99865432221 22235799999999999865 689999999999999999999999976543221 11111111000
Q ss_pred -CCchhh-----hhHHhh----hh-Cc------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 -GKVDEI-----FDEFIR----EE-GS------RAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 -~~~~~~-----~d~~l~----~~-~~------~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
...... ....+. .. .. ......+.+++..|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 000000 00 00 0112355678999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=366.46 Aligned_cols=268 Identities=23% Similarity=0.317 Sum_probs=196.0
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCC-CCCc
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGK 362 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~ 362 (614)
.++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++...+. ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467889999999999999999975 699999999975322 234578899999999999999999999875432 2344
Q ss_pred eEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccc
Q 036081 363 RRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLA 442 (614)
Q Consensus 363 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla 442 (614)
..++||||+ +.+|...+. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccce
Confidence 679999999 455655543 357999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccccccccCCCCccchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHh-------
Q 036081 443 KQSLEGQSHLTTRVAGTYGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLA------- 514 (614)
Q Consensus 443 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~------- 514 (614)
+..... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.... +........
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHH
Confidence 875432 244679999999999876 4568999999999999999999999976543221 111111000
Q ss_pred hCCCchh--hhhHHhhh-------hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcC
Q 036081 515 NSGKVDE--IFDEFIRE-------EGSRAVMERFVRVGILCAHVMVALRPTIADALKM--LEGD 567 (614)
Q Consensus 515 ~~~~~~~--~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~--L~~~ 567 (614)
....... .....+.. .........+.+++..|++.||.+|||+.|++++ ++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000 00000000 0001122467789999999999999999999986 5543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.3e-42 Score=357.78 Aligned_cols=259 Identities=18% Similarity=0.282 Sum_probs=197.9
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCCCCceEE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDEKGKRRF 365 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~~~~~~~ 365 (614)
++|+..++||+|+||+||+|+.. +|+.||||+++.. ..+.+.+|+++|.+++ ||||+++++++... .....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence 46899999999999999999975 6999999998653 3567899999999995 99999999988642 235689
Q ss_pred EEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC-cEEEeeeccccc
Q 036081 366 LVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM-KAKVADFGLAKQ 444 (614)
Q Consensus 366 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~KL~DFGla~~ 444 (614)
+||||+++|+|.... +.+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence 999999999997764 35899999999999999999999 89999999999999998655 699999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH--------HHHhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWA--------WMLAN 515 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~--------~~~~~ 515 (614)
...... .....||+.|+|||.+.+. .++.++||||+||+++||++|+.||.............. .....
T Consensus 180 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 180 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred ccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 644332 3445789999999998865 579999999999999999999999976544321110000 00000
Q ss_pred --CCCchhhhh------------HHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 516 --SGKVDEIFD------------EFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 516 --~~~~~~~~d------------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
......... ..............+.+++..|++.||.+|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 000111112233467889999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-41 Score=350.04 Aligned_cols=259 Identities=17% Similarity=0.199 Sum_probs=201.8
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHccC-CCcccccccccccCCCCCceE
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIRH-RNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H-~NIv~l~g~~~~~~~~~~~~~ 364 (614)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++++..++| +|++.+++++. .+...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCcc
Confidence 367899999999999999999975 68999999986532 23457889999999975 89999998876 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecC-----CCcEEEeee
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDS-----EMKAKVADF 439 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-----~~~~KL~DF 439 (614)
++||||+ +|+|.+++... ...+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+||
T Consensus 77 ~~vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEEEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEccc
Confidence 9999998 68998887653 456899999999999999999999 999999999999999964 578999999
Q ss_pred cccccccCCCc------cccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccch-hHHHHHHH
Q 036081 440 GLAKQSLEGQS------HLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFL-LITDWAWM 512 (614)
Q Consensus 440 Gla~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~-~l~~~~~~ 512 (614)
|+|+....... .......||+.|||||.+.+..++.++|||||||++|||+||+.||........ ........
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 99987543321 123346799999999999999999999999999999999999999976543321 11111100
Q ss_pred HhhCCCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 036081 513 LANSGKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRPTIADALKMLEGD 567 (614)
Q Consensus 513 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~L~~~ 567 (614)
........+ +.. ..++.+.+++..|++.+|++||+.+.+.+.|+..
T Consensus 231 ~~~~~~~~~-----l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 231 KKQSTPLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHSCHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccCCCChHH-----hcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 000011111 111 1234678888999999999999999888877653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=359.61 Aligned_cols=253 Identities=23% Similarity=0.299 Sum_probs=200.6
Q ss_pred CCCccceeeeccCcEEEEEEEEc----CCcEEEEEEeecC----CCcchHHHHHHHHHHHHccC-CCcccccccccccCC
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE----DGTLVAVKQITDL----DTKGDEEFINEVEIISKIRH-RNLLSLRGCCVSSDD 358 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~----~~~~~~~f~~Ei~il~~l~H-~NIv~l~g~~~~~~~ 358 (614)
++|+..+.||+|+||+||+|+.. +|+.||||.++.. +....+.+.+|++++++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 55899999999999999999852 4889999998542 12334678899999999977 89999999987
Q ss_pred CCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEee
Q 036081 359 EKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVAD 438 (614)
Q Consensus 359 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~D 438 (614)
.....++||||+.+|+|.+++.. .+.+.......++.||+.||.||| +.+|+||||||+||||+.++.+||+|
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred -cCCceeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEee
Confidence 45679999999999999999875 346778888999999999999999 89999999999999999999999999
Q ss_pred ecccccccCCCccccccccCCCCccchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC
Q 036081 439 FGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS 516 (614)
Q Consensus 439 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~ 516 (614)
||+++..............|++.|+|||.+.+. .++.++|||||||+||||++|+.||.......... .........
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~-~i~~~~~~~ 251 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRILKS 251 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHHHC
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcccC
Confidence 999987655444444556899999999999754 47889999999999999999999997654433211 111111111
Q ss_pred CCchhhhhHHhhhhCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036081 517 GKVDEIFDEFIREEGSRAVMERFVRVGILCAHVMVALRP-----TIADALKM 563 (614)
Q Consensus 517 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~eVl~~ 563 (614)
. ...+.....++.+++..|++.||++|| |++|++++
T Consensus 252 ~-----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 E-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp C-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred C-----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 011223345788899999999999999 57888864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=351.43 Aligned_cols=264 Identities=19% Similarity=0.226 Sum_probs=201.8
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCceE
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKRR 364 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~~ 364 (614)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++. .....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 46889999999999999999975 789999999965332 33578899999999999999999999997 45678
Q ss_pred EEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeeccccc
Q 036081 365 FLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 365 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
++|+|++.+++|..++.. .+.+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.++.
T Consensus 77 ~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhc
Confidence 999999999888777654 467889999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccccccccCCCCccchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhCCC-chhh
Q 036081 445 SLEGQSHLTTRVAGTYGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANSGK-VDEI 522 (614)
Q Consensus 445 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~~~-~~~~ 522 (614)
...... ......++..|+|||.+.... ++.++|||||||++|||++|+.||.........+............ ....
T Consensus 151 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 151 FGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred ccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 644332 233446788999999987654 6899999999999999999999975544332222111111111000 0000
Q ss_pred hhHHh-------------hhhCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 523 FDEFI-------------REEGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 523 ~d~~l-------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
..... .........+.+.+++..|++.||.+|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000111223467788999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=357.00 Aligned_cols=264 Identities=21% Similarity=0.269 Sum_probs=192.5
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCC-CCCce
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDD-EKGKR 363 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~-~~~~~ 363 (614)
++|+..++||+|+||+||+|+.. +|+.||||+++.... .....+.+|+.++++++||||+++++++..... +....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57899999999999999999976 699999999975432 234568899999999999999999999865432 24578
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++||||+.++.+ +.+ ...+++...+.++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~-----~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVI-----QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHH-----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhh-----hcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence 9999999976544 333 245899999999999999999999 8999999999999999999999999999988
Q ss_pred cccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH-------HhhC
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWM-------LANS 516 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~-------~~~~ 516 (614)
..... ...+...||+.|+|||.+.+..++.++||||+||+++||++|+.||...+.... ....... .+..
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHTT
T ss_pred ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHhccCCCHHHHHH
Confidence 65432 234456799999999999999999999999999999999999999975542211 1111000 0000
Q ss_pred C-----------------CchhhhhHHhhh---hCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 G-----------------KVDEIFDEFIRE---EGSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 ~-----------------~~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
. ............ .........+.+++..|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000011111100 0122345678899999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=356.19 Aligned_cols=265 Identities=21% Similarity=0.287 Sum_probs=196.9
Q ss_pred hCCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCC--cchHHHHHHHHHHHHccCCCcccccccccccCCCCCce
Q 036081 287 TGGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDT--KGDEEFINEVEIISKIRHRNLLSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 287 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~NIv~l~g~~~~~~~~~~~~ 363 (614)
.++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||+|++++++......+...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999965 799999999975432 23457889999999999999999999987554433445
Q ss_pred EEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 364 RFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
.++++||+.+|+|.+++.. +.+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence 5667788889999998854 46999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccccccccCCCCccchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHHhhC------
Q 036081 444 QSLEGQSHLTTRVAGTYGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLETSNSSFLLITDWAWMLANS------ 516 (614)
Q Consensus 444 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~~l~~~~~~~~~~------ 516 (614)
.... ......||+.|+|||...+. .++.++|||||||++|||++|+.||...+.... ...........
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHT
T ss_pred ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhh
Confidence 5422 23345789999999987765 468899999999999999999999976543221 11111100000
Q ss_pred CCchhhhhHHhh---hh-------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036081 517 GKVDEIFDEFIR---EE-------GSRAVMERFVRVGILCAHVMVALRPTIADALKM 563 (614)
Q Consensus 517 ~~~~~~~d~~l~---~~-------~~~~~~~~l~~l~~~Cl~~~p~~RPtm~eVl~~ 563 (614)
............ .. ........+.+++..|++.||.+|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000 00 001123467889999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-37 Score=325.35 Aligned_cols=269 Identities=19% Similarity=0.206 Sum_probs=195.0
Q ss_pred CCCccceeeeccCcEEEEEEEEc-CCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-----------CCCcccccccccc
Q 036081 288 GGFSQKNLIGQGASGVVYKGTLE-DGTLVAVKQITDLDTKGDEEFINEVEIISKIR-----------HRNLLSLRGCCVS 355 (614)
Q Consensus 288 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-----------H~NIv~l~g~~~~ 355 (614)
++|...++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35889999999999999999975 79999999997532 23467889999998886 4678888888753
Q ss_pred cCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCCc--
Q 036081 356 SDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEMK-- 433 (614)
Q Consensus 356 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~-- 433 (614)
. .....+++++++..+..............+++..+..++.||+.||+|||+ ..+|+||||||+||||+.++.
T Consensus 92 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 K---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp E---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTT
T ss_pred c---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccc
Confidence 2 234567777777665544444333345678888999999999999999993 489999999999999987653
Q ss_pred ----EEEeeecccccccCCCccccccccCCCCccchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc-----h
Q 036081 434 ----AKVADFGLAKQSLEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLETSNSSF-----L 504 (614)
Q Consensus 434 ----~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~-----~ 504 (614)
+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||....... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999998754322 234679999999999999999999999999999999999999997543221 1
Q ss_pred hHHHHHHHHhh-------CC-Cchhh-----------------hhHHh--hhhCcHHHHHHHHHHHHHccccCCCCCCCH
Q 036081 505 LITDWAWMLAN-------SG-KVDEI-----------------FDEFI--REEGSRAVMERFVRVGILCAHVMVALRPTI 557 (614)
Q Consensus 505 ~l~~~~~~~~~-------~~-~~~~~-----------------~d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm 557 (614)
.+....+.+-. .+ ..... ....+ ...........+.+++..|++.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111111100 00 00000 00111 112345566788999999999999999999
Q ss_pred HHHHHH--hhc
Q 036081 558 ADALKM--LEG 566 (614)
Q Consensus 558 ~eVl~~--L~~ 566 (614)
+|++++ +++
T Consensus 323 ~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 323 GGLVNHPWLKD 333 (362)
T ss_dssp HHHHTCGGGTT
T ss_pred HHHhcCcccCC
Confidence 999986 553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.9e-23 Score=199.81 Aligned_cols=163 Identities=17% Similarity=0.149 Sum_probs=120.2
Q ss_pred ccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCC-----c-------------chHHHHHHHHHHHHccCCCccccccc
Q 036081 291 SQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDT-----K-------------GDEEFINEVEIISKIRHRNLLSLRGC 352 (614)
Q Consensus 291 ~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-----~-------------~~~~f~~Ei~il~~l~H~NIv~l~g~ 352 (614)
...++||+|+||+||+|+..+|+.||||+++.... . ....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999998999999998753110 0 01234568888999999999887754
Q ss_pred ccccCCCCCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcCCCceEecCCCCCceeecCCC
Q 036081 353 CVSSDDEKGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGLKPAIYHRDIKSTNILLDSEM 432 (614)
Q Consensus 353 ~~~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 432 (614)
.. .+++|||++++.+ ..+++.....++.|++++|.||| +.+|+||||||+|||++++
T Consensus 83 ~~---------~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~- 139 (191)
T d1zara2 83 EG---------NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp ET---------TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-
T ss_pred cC---------CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-
Confidence 32 3799999986433 23566777899999999999999 8999999999999999865
Q ss_pred cEEEeeecccccccCCCccccccccCCCCccc------hhhhccCCCCchhhHHHHHHHH
Q 036081 433 KAKVADFGLAKQSLEGQSHLTTRVAGTYGYLA------PEYALYGQLTEKSDVYSFGIVI 486 (614)
Q Consensus 433 ~~KL~DFGla~~~~~~~~~~~~~~~gt~~Y~A------PE~~~~~~~s~ksDVwSfGvvL 486 (614)
.++|+|||+|+........ .|.. .|+ ..+.|+.++|+||..--+
T Consensus 140 ~~~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 GIWIIDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEEECCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CEEEEECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 5899999999764322111 0111 112 135678899999975444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=1.1e-06 Score=85.21 Aligned_cols=149 Identities=13% Similarity=0.044 Sum_probs=97.4
Q ss_pred HHHHHHhCCCccceeeeccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHcc-CCCcccccccccccCCC
Q 036081 281 SELDQATGGFSQKNLIGQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIR-HRNLLSLRGCCVSSDDE 359 (614)
Q Consensus 281 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~NIv~l~g~~~~~~~~ 359 (614)
.|+.+.-..|+..+..+-+....||+...+ ++.+.||+...........+.+|...+..+. +--+.+++.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~----- 80 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----- 80 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----
Confidence 456666677766554333334689998754 5667888876544444556788999988884 333445555543
Q ss_pred CCceEEEEEecCCCCCcccccchhhhccCCCccchhHHHHHHHHHHHHHHhcC---------------------------
Q 036081 360 KGKRRFLVYDFMPSGSLGDHISNALTRKQLAWPQRKKIILDVAKGLAYLHYGL--------------------------- 412 (614)
Q Consensus 360 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~r~~Ia~~Ia~gL~yLH~~~--------------------------- 412 (614)
.++..++||+++++.++.+... +......++.++++.|+.||...
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred cCCceEEEEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence 3456799999999877644321 12223445555556666665211
Q ss_pred -----------------------------CCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 413 -----------------------------KPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 413 -----------------------------~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
...++|+|+.|.|||+++++..-|.||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987767799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=2.3e-05 Score=75.07 Aligned_cols=141 Identities=16% Similarity=0.114 Sum_probs=82.2
Q ss_pred eeeccCc-EEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCC--cccccccccccCCCCCceEEEEEecC
Q 036081 295 LIGQGAS-GVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRN--LLSLRGCCVSSDDEKGKRRFLVYDFM 371 (614)
Q Consensus 295 ~LG~G~f-G~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~N--Iv~l~g~~~~~~~~~~~~~~LV~Ey~ 371 (614)
.+..|.. +.||+...++|..+.+|.-.... ...+..|.+.++.+.... +.+++++.. +++..++||||+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEee
Confidence 4455553 68999998888888899765432 335778999998885433 344555543 334679999999
Q ss_pred CCCCcccccchh-------h-----------hccCCCccch----------------------hHHHHHHHHHHHHHHhc
Q 036081 372 PSGSLGDHISNA-------L-----------TRKQLAWPQR----------------------KKIILDVAKGLAYLHYG 411 (614)
Q Consensus 372 ~~gsL~~~L~~~-------~-----------~~~~l~~~~r----------------------~~Ia~~Ia~gL~yLH~~ 411 (614)
++.++.+..... . ......+... ..........+..+...
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 886664321000 0 0000000000 00000111222222211
Q ss_pred ----CCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 412 ----LKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 412 ----~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
....++|+|+.|.|||++++..+-|.||+.+.
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 12348999999999999987767899998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.20 E-value=0.0012 Score=65.70 Aligned_cols=140 Identities=13% Similarity=0.079 Sum_probs=81.8
Q ss_pred EEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc--cccccccccCCCCCceEEEEEecCCCCCcccc
Q 036081 302 GVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL--SLRGCCVSSDDEKGKRRFLVYDFMPSGSLGDH 379 (614)
Q Consensus 302 G~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv--~l~g~~~~~~~~~~~~~~LV~Ey~~~gsL~~~ 379 (614)
-.||+.+.++|+.+++|..+.. ....+++..|.+.+..|....+. ..+..........+...+.+++++++..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5899999999999999987542 23457788999999998644332 22221111111245678999999987544210
Q ss_pred ----c----------chhh------hccCCC-------------------ccchhHHHHHHHHHHHHHH----hcCCCce
Q 036081 380 ----I----------SNAL------TRKQLA-------------------WPQRKKIILDVAKGLAYLH----YGLKPAI 416 (614)
Q Consensus 380 ----L----------~~~~------~~~~l~-------------------~~~r~~Ia~~Ia~gL~yLH----~~~~~~i 416 (614)
+ +... .+..++ -..+..+...+.+.++.+. .....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0000 001111 1112222222333333333 2235679
Q ss_pred EecCCCCCceeecCCCcEEEeeeccccc
Q 036081 417 YHRDIKSTNILLDSEMKAKVADFGLAKQ 444 (614)
Q Consensus 417 vHrDIKp~NILLd~~~~~KL~DFGla~~ 444 (614)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899987753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.08 E-value=0.0012 Score=67.65 Aligned_cols=76 Identities=12% Similarity=0.024 Sum_probs=46.4
Q ss_pred ceeeeccCcEEEEEEEEcC-CcEEEEEEeec----CC---CcchHHHHHHHHHHHHcc-C--CCcccccccccccCCCCC
Q 036081 293 KNLIGQGASGVVYKGTLED-GTLVAVKQITD----LD---TKGDEEFINEVEIISKIR-H--RNLLSLRGCCVSSDDEKG 361 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~----~~---~~~~~~f~~Ei~il~~l~-H--~NIv~l~g~~~~~~~~~~ 361 (614)
.+.||.|....||+....+ |+.++||.-.. .. ....+....|.+.|..+. + ..+.+++.+. .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 3568999999999998764 67899996432 10 112234556888887763 2 2344444432 2
Q ss_pred ceEEEEEecCCCCC
Q 036081 362 KRRFLVYDFMPSGS 375 (614)
Q Consensus 362 ~~~~LV~Ey~~~gs 375 (614)
...++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 23589999998654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.38 E-value=0.026 Score=54.93 Aligned_cols=163 Identities=12% Similarity=0.049 Sum_probs=88.0
Q ss_pred cChHHHHHHhCCCccceee-----eccCcEEEEEEEEcCCcEEEEEEeecCCCcchHHHHHHHHHHHHccCCCcc--ccc
Q 036081 278 FRESELDQATGGFSQKNLI-----GQGASGVVYKGTLEDGTLVAVKQITDLDTKGDEEFINEVEIISKIRHRNLL--SLR 350 (614)
Q Consensus 278 f~~~el~~at~~f~~~~~L-----G~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NIv--~l~ 350 (614)
.+.+|++.....|...++. ..|---+.|+.+.++|+ +++|+..... ..++...|++++..+.+.++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4567788887778664433 34545788999887665 8899875431 234456678888888544332 111
Q ss_pred ccccc-cCCCCCceEEEEEecCCCCCcccccchh--------------hhc------------------------cCCCc
Q 036081 351 GCCVS-SDDEKGKRRFLVYDFMPSGSLGDHISNA--------------LTR------------------------KQLAW 391 (614)
Q Consensus 351 g~~~~-~~~~~~~~~~LV~Ey~~~gsL~~~L~~~--------------~~~------------------------~~l~~ 391 (614)
..... .-.........++.+..+......-... ... .....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11000 0001234567777777764443211000 000 00011
Q ss_pred cchhHHHHHHHHHHHHHH-hcCCCceEecCCCCCceeecCCCcEEEeeecccc
Q 036081 392 PQRKKIILDVAKGLAYLH-YGLKPAIYHRDIKSTNILLDSEMKAKVADFGLAK 443 (614)
Q Consensus 392 ~~r~~Ia~~Ia~gL~yLH-~~~~~~ivHrDIKp~NILLd~~~~~KL~DFGla~ 443 (614)
......+..+...+.-.+ .....++||+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222222333333332 2236789999999999999988877899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.04 E-value=0.016 Score=58.89 Aligned_cols=74 Identities=19% Similarity=0.282 Sum_probs=48.9
Q ss_pred ceeeeccCcEEEEEEEEcCC--------cEEEEEEeecCCCcchHHHHHHHHHHHHccCCCc-ccccccccccCCCCCce
Q 036081 293 KNLIGQGASGVVYKGTLEDG--------TLVAVKQITDLDTKGDEEFINEVEIISKIRHRNL-LSLRGCCVSSDDEKGKR 363 (614)
Q Consensus 293 ~~~LG~G~fG~Vykg~~~~g--------~~vAVK~l~~~~~~~~~~f~~Ei~il~~l~H~NI-v~l~g~~~~~~~~~~~~ 363 (614)
.+.|+-|-.-.+|+...+++ +.|.+++.-. ........+|..+++.+.-.++ .++++++. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~-----~--- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS-----G--- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T---
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC-----C---
Confidence 35677777889999987643 4566666542 2333445689999998853444 46677663 1
Q ss_pred EEEEEecCCCCCcc
Q 036081 364 RFLVYDFMPSGSLG 377 (614)
Q Consensus 364 ~~LV~Ey~~~gsL~ 377 (614)
.+|+||+++.+|.
T Consensus 117 -g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 -GRLEEYIPSRPLS 129 (395)
T ss_dssp -EEEECCCCEEECC
T ss_pred -ceEEEEeccccCC
Confidence 6899999875543
|